Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8907089592151272,-2.346363535203749,0.0,0.0,0.0,6/13,5.31%,KCNMA1;SLC12A2;ATP1B1;ATP1A2;KCNJ2;ATP1B2
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.638584653519817,-2.247067084668308,0.0,0.002241843139959992,0.005,11/38,6.42%,BIN1;CACNB2;CTNNA3;ANK2;CACNA1C;SCN1B;JUP;KCNJ2;TRPM4;KCNJ3;AKAP9
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.47813672649941963,-2.243157751243467,0.0,0.0017934745119679932,0.006,39/159,8.99%,CADM1;TENM2;PTPRD;PTPRM;ADGRL3;LRRC4C;IL1RAPL1;PTPRT;SDK1;ITGAM;ACVR1;NTNG1;ROBO2;KIRREL3;ROBO1;TENM3;NLGN1;CNTN6;CDH23;TGFBR2;CNTN2;CDH11;GRID2;CNTN4;UNC5D;ATP2C1;CDH9;IGSF11;MAG;LRRC4B;ITGB2;CD164;CDH8;CDH2;CDH6;CDH12;BSG;TGFB2;CLDN11
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6194320187820849,-2.112879357933054,0.0,0.011881768641787957,0.051,16/32,11.50%,DLG2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;NEFL;OPRM1;RELN;GRIN1;GRIA3;DLG1;ACTN2;CAMK2A
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.8143028383487443,-2.1123501501699424,0.0,0.009505414913430365,0.051,7/12,11.24%,BIN1;CTNNA3;CACNA1C;RYR2;JUP;TRPM4;DLG1
prerank,triglyceride catabolic process (GO:0019433),0.8781803468538136,2.0721834285030267,0.0,0.0,0.0,3/19,1.44%,FABP4;LIPG;FABP5
prerank,regulation of T cell proliferation (GO:0042129),0.7263826528316614,2.0545468935628497,0.0,0.0,0.0,15/61,4.33%,GPNMB;LGALS3;ARG1;LILRB1;ANXA1;NCK2;CEBPB;FOXP3;TFRC;IL6;CD28;CD46;CD274;PLA2G2D;TNFRSF1B
prerank,cholesterol transport (GO:0030301),0.7392384396524382,2.0355019884873995,0.0,0.0010303967027305515,0.003,13/45,9.77%,CD36;CEL;SOAT1;ABCA1;APOE;LIMA1;LIPG;NPC1;ABCG1;SERAC1;STARD5;RELCH;VPS4A
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.7165259352469958,-2.0206647747660624,0.0,0.036915683704674525,0.192,11/18,14.95%,GRIK1;UNC13C;GRIA2;GRID2;GRIK2;SLC17A6;CDH8;GRIK5;GRID1;GRIK3;SLC1A4
prerank,cholesterol efflux (GO:0033344),0.8344346332125571,2.0146887912078046,0.0,0.0015455950540958269,0.006,5/20,1.98%,SOAT1;ABCA1;APOE;NPC1;ABCG1
prerank,acylglycerol catabolic process (GO:0046464),0.7681042190185878,1.9651929304411362,0.0012738853503184713,0.008037094281298299,0.032,4/30,1.78%,FABP4;LIPG;FABP5;MGLL
prerank,fatty acid transport (GO:0015908),0.8442378522517128,1.9608572729574405,0.0,0.007384509702902284,0.035,8/17,8.02%,FABP4;CD36;PPARG;APOE;FABP5;SLC27A4;SLC27A3;SLC27A1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.619417493817052,-1.958830630959468,0.0,0.07302003370155402,0.41,14/25,16.03%,ATP1B1;ANK2;ANK3;WNK3;ATP1B2;AKAP9;NDUFA4;TCAF1;GLRX;WNK2;ACTN2;WNK1;COX17;STAC
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.5436932383289171,-1.9498005186073046,0.0,0.07073015106573774,0.444,23/46,17.31%,GRM5;MEF2C;OPHN1;NRXN1;SYT1;NLGN1;GRM1;GRM8;GRIK1;ATP1A2;RELN;TSHZ3;GRM3;CDH2;CACNG4;HOMER1;NLGN3;GRIK3;CACNG3;CCR2;GRM7;CACNG2;TNF
prerank,positive regulation of synapse assembly (GO:0051965),-0.5999923812248809,-1.949478655917999,0.0,0.06336943275620244,0.445,10/27,10.46%,PTPRD;IL1RAPL1;NRXN1;NLGN1;GRID2;LRRC4B;CUX2;SYNDIG1;AGRN;NLGN3
prerank,intestinal lipid absorption (GO:0098856),0.9199291006312039,1.9471557038108989,0.0,0.010303967027305513,0.056,3/11,0.71%,CD36;CEL;LIMA1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.7589357457157158,1.9460446981403465,0.0,0.009659969088098918,0.059,6/27,2.82%,CD36;PPARG;ABCA1;PRKCH;ABCG1;NR1H3
prerank,iron ion transport (GO:0006826),0.7009997301684332,1.9240300335247285,0.0,0.014883507928330184,0.105,23/47,17.17%,ATP6V0D2;ATP6V1A;STEAP3;ABCB7;TFRC;ATP6V1E1;SLC11A2;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;HEPH;ATP6V0A1;SLC39A14;ATP6V0E1;RAB11B;ATP6V0C;ATP6V0B;SLC11A1;ATP6V1H;MELTF;ATP6V1F;FTH1
prerank,intracellular pH reduction (GO:0051452),0.7250145192780796,1.9110819269275796,0.0,0.0181349819680577,0.145,20/33,16.69%,ATP6V0D2;DMXL2;ATP6V1A;RAB20;ATP6V1E1;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B;SLC11A1;ATP6V1H;DMXL1;GPR89A;GPR89B;ATP6V1F
prerank,negative regulation of lipid storage (GO:0010888),0.7869333506042164,1.904027641124566,0.0,0.021638330757341576,0.179,6/19,2.98%,PPARG;OSBPL8;ABCA1;ABCG1;NR1H3;IL6
prerank,long-chain fatty acid transport (GO:0015909),0.7465487283977905,1.9027475754129992,0.0,0.020436201270822605,0.181,11/30,9.92%,FABP4;CD36;PPARG;APOE;FABP5;PRKAG2;ABCD1;SLC27A4;SLC27A1;CPT1A;SLC25A20
prerank,insulin receptor signaling pathway (GO:0008286),0.6505911887737429,1.9020816361664876,0.0,0.019022708358102484,0.182,30/69,14.52%,ATP6V0D2;NAMPT;GRB2;ATP6V1A;PDK4;BAIAP2;AP3S1;ATP6V1E1;SOS1;ATP6V1C1;TCIRG1;ATP6V0D1;FOXO4;IRS2;PIK3CA;APC;ATP6V1B2;ATP6V0A1;SLC39A14;SH2B2;GSK3B;FOXO1;APPL1;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;ATP6V1H;SHC1;PHIP
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.7597720675996937,-1.8967779192766179,0.0,0.11334758915637719,0.673,5/11,8.69%,ACVR1;TGFBR2;TGFBR1;SMAD7;TGFB2
prerank,regulation of cation channel activity (GO:2001257),-0.4417013124663237,-1.8954881197099351,0.0,0.10410304326286944,0.675,37/89,16.54%,FGF14;DLG2;CACNB2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;ANK2;NEFL;ANK3;OPRM1;CACNB4;FGF12;RELN;KCNAB1;GRIN1;FGF13;GRIA3;CACNG4;JPH1;HOMER1;SHISA6;PRKACA;DLG1;GSG1L;ACTN2;CAMK2A;SELENON;DLG3;CACNG3;STAC;CACNB1;CACNG2;SHISA7
prerank,regulation of synapse assembly (GO:0051963),-0.4961798924633425,-1.8950469195786697,0.0,0.0956519739716263,0.677,14/46,11.57%,PTPRD;MEF2C;IL1RAPL1;NRXN1;ROBO2;NLGN1;GRID2;LRRC4B;SLIT1;IL1RAPL2;CUX2;SYNDIG1;NLGN3;LRFN5
prerank,reverse cholesterol transport (GO:0043691),0.8702386016514615,1.891557952810883,0.0,0.022006329579745347,0.216,4/13,1.98%,ABCA1;APOE;LIPG;ABCG1
prerank,vacuolar acidification (GO:0007035),0.7917929835769836,1.8904584938824638,0.0,0.021294865189764724,0.224,15/21,15.74%,ATP6V0D2;DMXL2;TCIRG1;ATP6V0D1;PPT1;TMEM199;CLN5;CLN3;ATP6V0A1;ATP6V0E1;SLC11A1;ATP6V1H;ATP6AP2;DMXL1;GRN
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.8582070595587331,1.8876462458982317,0.0,0.021380731581658936,0.235,4/12,2.82%,PPARG;ABCA1;ABCG1;NR1H3
prerank,acute inflammatory response (GO:0002526),0.7509280253973587,1.886750617526978,0.0,0.020607934054611025,0.24,7/23,9.55%,SIGIRR;CEBPB;ANO6;IL6;HPR;HP;IL6R
prerank,secretory granule organization (GO:0033363),0.917859167130879,1.8812524712124132,0.0,0.021695575018604384,0.267,3/10,0.64%,LYST;ABCA1;DTNBP1
prerank,regulation of sequestering of triglyceride (GO:0010889),0.8240149250628787,1.8809246301484417,0.001422475106685633,0.020607934054611025,0.267,4/15,1.86%,PPARG;OSBPL8;PLIN2;PLIN3
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.5704264222477525,-1.8808432369044696,0.0,0.10333172380492515,0.737,9/25,6.42%,CTNNA3;ANK2;CACNA1C;RYR2;JUP;TRPM4;FGF13;NOS1AP;AKAP9
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5370430374830194,-1.8802200548819115,0.0,0.09736004493540537,0.744,8/37,5.61%,CADM1;TENM2;PTPRD;IL1RAPL1;TENM3;NLGN1;GRID2;CD164
prerank,transferrin transport (GO:0033572),0.724163904578435,1.879749616440845,0.0,0.01983513652756311,0.271,15/33,13.91%,ATP6V0D2;ATP6V1A;STEAP3;TFRC;ATP6V1E1;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;RAB11B;ATP6V0C;ATP6V0B;ATP6V1H
prerank,response to glucocorticoid (GO:0051384),0.7363605594220247,1.8758078729466592,0.0,0.020853266602880203,0.297,8/26,7.16%,ANXA1;BCL2L11;ADAM9;IL6;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,regulation of cholesterol efflux (GO:0010874),0.7288893105884025,1.87530115790654,0.0,0.02009273570324575,0.3,12/30,12.33%,PPARG;EEPD1;APOE;LRP1;NR1H3;RXRA;PLTP;ABCA3;ABCA2;LAMTOR1;SIRT1;TREM2
prerank,phagosome maturation (GO:0090382),0.7149273924010557,1.872543802961675,0.0,0.020652733911251484,0.318,18/35,13.91%,ATP6V0D2;PIKFYVE;ATP6V1A;MREG;RAB20;ATP6V1E1;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;RAB31;ATP6V0A1;ATP6V0E1;RAB43;ATP6V0C;ATP6V0B;ATP6V1H
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7716596370940695,1.8719416253488044,0.0013477088948787063,0.02009273570324575,0.322,10/21,12.33%,PPARG;EEPD1;APOE;LRP1;NR1H3;RXRA;PLTP;ABCA3;SIRT1;TREM2
prerank,positive regulation of cholesterol transport (GO:0032376),0.7475169178901936,1.870832541763935,0.0,0.019866048428645026,0.33,12/27,12.33%,PPARG;EEPD1;APOE;LIPG;LRP1;NR1H3;RXRA;PLTP;ABCA3;SIRT1;LPCAT3;TREM2
prerank,negative regulation of T cell proliferation (GO:0042130),0.738505578385229,1.8666168309307838,0.0,0.020726825981849165,0.351,7/28,4.18%,GPNMB;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D
prerank,cellular response to insulin stimulus (GO:0032869),0.611880540108364,1.8637905516317634,0.0,0.021218539508080978,0.369,42/124,14.52%,ATP6V0D2;PPARG;MYO5A;DENND4C;NAMPT;GRB2;LPIN3;ATP6V1A;PDK4;RAB8B;BAIAP2;AP3S1;ATP6V1E1;SOS1;PDPK1;ATP6V1C1;TCIRG1;ATP6V0D1;ENPP1;FOXO4;SLC27A4;IRS2;APC;ATP6V1B2;RAB31;SLC27A1;ATP6V0A1;SLC39A14;RAB12;SH2B2;GSK3B;RAB10;FOXO1;EPRS1;APPL1;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;ATP6V1H;SHC1;PHIP
prerank,toll-like receptor signaling pathway (GO:0002224),0.624111942246735,1.8553298536551759,0.0,0.024839920512254362,0.428,31/84,16.63%,SFTPA1;SFTPA2;CD36;CTSB;RFTN1;TLR8;CTSL;MAP3K1;MAPKAPK3;IRAK2;TNIP1;RIPK1;LY96;NR1H4;IRAK3;RPS27A;UBC;CTSS;TICAM2;UNC93B1;EPG5;BIRC3;TAB2;S100A1;BTK;TRAF3;LBP;MYD88;HSPD1;TLR1;TRIL
prerank,positive regulation of leukocyte migration (GO:0002687),0.7306318577972547,1.8530799168700753,0.001287001287001287,0.02504929915258754,0.443,7/27,10.24%,F7;LGALS3;VEGFA;IL6;ADAM8;IL6R;ADAM17
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.7228869211266792,-1.8485748398232262,0.006269592476489028,0.13050516198753764,0.856,7/12,12.13%,ATP1B1;ANK3;WNK3;ATP1B2;GLRX;WNK2;WNK1
prerank,phagosome acidification (GO:0090383),0.7330839151334687,1.8476366367493362,0.0,0.026652928043963593,0.473,14/26,13.91%,ATP6V0D2;ATP6V1A;RAB20;ATP6V1E1;RAB7A;ATP6V1C1;TCIRG1;ATP6V0D1;ATP6V1B2;ATP6V0A1;ATP6V0E1;ATP6V0C;ATP6V0B;ATP6V1H
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.721026415660678,-1.8409670796409543,0.0,0.1327171138856315,0.871,6/12,7.99%,SYT1;RIMS1;UNC13C;RIMS2;SYT7;SYT2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.7854557452939794,1.8389711810620744,0.0,0.030280367618952652,0.532,7/18,7.16%,ANXA1;BCL2L11;AQP1;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,"wound healing, spreading of cells (GO:0044319)",0.7397793709042153,1.8349001148784942,0.001288659793814433,0.031684698608964446,0.568,10/24,10.92%,ARHGAP24;MMP12;MRTFA;CD44;LCP1;ITGA5;CD151;ACVRL1;ADAM17;CCN1
prerank,positive regulation of nervous system development (GO:0051962),-0.5083036487738785,-1.8345944123106974,0.0,0.13361385114161548,0.89,13/42,10.46%,CX3CR1;PTPRD;IL1RAPL1;NUMB;NRXN1;NLGN1;OPRM1;GRID2;LRRC4B;CUX2;SYNDIG1;NAP1L1;NLGN3
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5845700600744369,-1.8297644590862885,0.0040650406504065045,0.13211928904830883,0.897,10/24,8.81%,ACVR1;ROBO2;ROBO1;BMPR1A;TGFBR2;FGFR2;ENG;ZFPM2;TGFB2;PARVA
prerank,sterol homeostasis (GO:0055092),0.6365325982695956,1.8276981436823712,0.0,0.03528328103289463,0.609,16/65,11.93%,SOAT1;ABCA1;GRAMD1B;APOE;LIMA1;LIPG;NPC1;ABCG1;NR1H3;ABCD1;FGFR4;ACSM3;ABCA2;LAMTOR1;SIRT1;RORA
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.4798926159273641,-1.82712963143107,0.0,0.12865819788486185,0.901,26/57,16.54%,DLG2;MEF2C;GRIN2A;NLGN1;GRIA4;GRIN2B;GRIA1;GRIA2;DLGAP1;NEFL;DLGAP2;OPRM1;RELN;GRIN1;AKAP9;GRIA3;CACNG4;SHISA6;DLG1;GSG1L;ACTN2;CAMK2A;DLG3;CACNG3;CACNG2;SHISA7
prerank,neutrophil activation involved in immune response (GO:0002283),0.5746661676513674,1.8247374319911902,0.0,0.03676091765918114,0.625,147/428,16.09%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;SYK;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;ANO6;PLEKHO2;CLEC4D;RAB7A;CD44;CYB5R3;GLA;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;DNAJC5;RNASE3;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ADAM8;ANXA2;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;ARSA;PTGES2;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;TYROBP;HP;VAPA;HRNR;HUWE1;ATP6V0A1;QSOX1;LAMTOR1;PLAU;XRCC5;DERA;COTL1;ROCK1;RAP2B;FAF2;MOSPD2;LTA4H;RAB10;DNASE1L1;NHLRC3;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;STXBP3;RAB24;PSMD12;VPS35L;FUCA1;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;DEGS1;SLPI;CREG1;GUSB;PRDX6;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;GRN;TOM1;RAB44;BST1
prerank,secondary alcohol metabolic process (GO:1902652),0.6689176723350143,1.8225195997716725,0.0,0.03706484139250754,0.633,7/42,3.66%,SOAT1;ABCA1;IDH1;APOE;ABCG1;OSBPL1A;RXRA
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.6426201278542739,1.8214650569684707,0.0,0.03672219360009159,0.641,19/56,16.52%,SFTPA1;SFTPA2;CD36;CTSB;TLR8;CTSL;MAPKAPK3;IRAK2;LY96;RPS27A;UBC;CTSS;UNC93B1;TAB2;S100A1;TRAF3;LBP;MYD88;TLR1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.5775155211700685,-1.8199354539734123,0.0,0.1319997240808443,0.92,9/25,12.19%,MEF2C;GRIN2A;GRIN2B;GRID2;GRIN1;ARRB2;GLRA1;NLGN3;GRIN2D
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.7403629900984976,1.8181335451820717,0.0025252525252525255,0.038180375120096914,0.664,8/24,12.64%,CCBE1;HPSE;IL6;ATF4;SULF2;BRCA1;RORA;SULF1
prerank,neutrophil mediated immunity (GO:0002446),0.5724025164317254,1.8175646890741093,0.0,0.03758236394696169,0.669,149/432,16.09%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;ANO6;PLEKHO2;CLEC4D;RAB7A;CD44;CYB5R3;GLA;IL6;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;DNAJC5;RNASE3;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ADAM8;ANXA2;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;ARSA;PTGES2;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;TYROBP;HP;VAPA;HRNR;HUWE1;ATP6V0A1;QSOX1;LAMTOR1;PLAU;XRCC5;DERA;COTL1;ROCK1;RAP2B;FAF2;MOSPD2;ADAM17;LTA4H;RAB10;DNASE1L1;KMT2E;NHLRC3;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;STXBP3;RAB24;PSMD12;VPS35L;FUCA1;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;DEGS1;SLPI;CREG1;GUSB;PRDX6;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;GRN;TOM1;RAB44;BST1
prerank,neutrophil degranulation (GO:0043312),0.5721230695026605,1.816156684440222,0.0,0.037411326437601554,0.677,146/425,16.09%,ANPEP;PSAP;LGALS3;CD36;IQGAP2;HPSE;IQGAP1;CTSB;ADGRE5;SDCBP;IDH1;CTSD;CLEC12A;CD300A;FTL;IGF2R;VAT1;ARG1;FRK;CPPED1;GALNS;ADGRG3;FABP5;LILRB3;DIAPH1;LAMP1;ATG7;GYG1;HK3;ANO6;PLEKHO2;CLEC4D;RAB7A;CD44;CYB5R3;GLA;PRKCD;CTSA;OSTF1;PYGL;DYNC1H1;PSMD1;SNAP29;GNS;CD63;ARHGAP9;PGRMC1;TCIRG1;CD93;APAF1;ATP8B4;TNFRSF1B;DNAJC5;RNASE3;IMPDH2;C3AR1;EEF1A1;AMPD3;CD53;ADAM8;ANXA2;NRAS;DDOST;RAB37;MANBA;PTAFR;DOK3;HSPA1B;CYBB;ARSA;PTGES2;CYBA;KCNAB2;RAB31;CAT;TIMP2;CTSS;LAMP2;CTSZ;SIRPA;TICAM2;CTSH;AGA;PAFAH1B2;TYROBP;HP;VAPA;HRNR;HUWE1;ATP6V0A1;QSOX1;LAMTOR1;PLAU;XRCC5;DERA;COTL1;ROCK1;RAP2B;FAF2;MOSPD2;LTA4H;RAB10;DNASE1L1;NHLRC3;RAB18;MAGT1;OLFM4;PSMD14;COMMD9;PGM1;BST2;GM2A;HMOX2;STXBP3;RAB24;PSMD12;VPS35L;FUCA1;DOCK2;BRI3;GLIPR1;MGST1;CRACR2A;LAMTOR3;CAP1;ATP6V0C;FGR;PPIE;SLC11A1;AGL;HSPA1A;ARL8A;DEGS1;SLPI;CREG1;GUSB;PRDX6;NCSTN;ATP6AP2;SLC44A2;DNAJC13;STK11IP;GRN;TOM1;RAB44;BST1
prerank,regulation of vasculature development (GO:1901342),0.7098419422282358,1.8138807342926535,0.00129366106080207,0.03791859866048428,0.691,6/26,9.13%,GPNMB;PLXND1;CTNNB1;IL6;HMOX1;VASH2
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7939231405649156,1.8118783479683915,0.0027624309392265192,0.038225204508613865,0.707,4/15,5.17%,APOE;LIPG;ABCG1;PLTP
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.7295409049948365,1.8111191717973383,0.0,0.03765854615931896,0.711,9/26,12.64%,CCBE1;HPSE;IL6;ATF4;SULF2;BRCA1;RORA;SARS1;SULF1
prerank,membrane repolarization (GO:0086009),-0.6547984455999498,-1.8068527041428488,0.006369426751592357,0.143435259183345,0.938,4/15,5.31%,ATP1B1;ATP1A2;KCNJ2;ATP1B2
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.6373170657291098,-1.8057475506543799,0.0,0.13846438448080167,0.94,7/17,19.77%,SNTA1;ANK2;SCN1B;NOS1AP;AKAP9;CACNA2D1;SCN4B
prerank,glutamate receptor signaling pathway (GO:0007215),-0.5226199486494634,-1.8044657535759911,0.0,0.13396474832873967,0.943,18/37,7.13%,GRM5;GRIN2A;GRIA4;GRM1;GRIN2B;GRM8;PLCB1;GRIK1;GRIA2;GRIN3A;GRID2;GRIK2;CDK5R1;GRIN1;FMR1;GRM3;GRIA3;HOMER1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.7102135753271759,1.8029909873149181,0.0,0.04330062422870014,0.764,8/31,4.18%,GPNMB;CD300A;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D
prerank,cholesterol homeostasis (GO:0042632),0.6274656691974431,1.8027209995199027,0.0,0.0425975364151562,0.765,15/64,11.93%,SOAT1;ABCA1;GRAMD1B;APOE;LIMA1;LIPG;NPC1;ABCG1;NR1H3;FGFR4;ACSM3;ABCA2;LAMTOR1;SIRT1;RORA
prerank,triglyceride metabolic process (GO:0006641),0.6528014786950235,1.8014473776114852,0.0,0.0426355257885397,0.772,6/48,1.54%,FABP4;APOE;LIPG;LPIN3;FABP5;GPAT2
prerank,lipid catabolic process (GO:0016042),0.7573484965211179,1.8005646310250187,0.0013908205841446453,0.04253746388011559,0.779,6/18,11.54%,CEL;LIPG;PPT1;ACADL;MT3;PLAAT3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.8164702193753697,1.7949619747303647,0.0,0.04647746829337806,0.804,4/13,0.68%,CD36;PPARG;ABCA1;SYK
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6689107259924407,-1.792817909879824,0.010067114093959731,0.14385160148076612,0.959,5/14,11.42%,ATP1B1;ANK2;ATP1B2;AKAP9;ACTN2
prerank,cGMP-mediated signaling (GO:0019934),0.7962723367800543,1.7907515012562585,0.0,0.04960930791688133,0.827,4/13,1.89%,CD36;HTR2B;APOE;AQP1
prerank,response to lipid (GO:0033993),0.5926097274425195,1.789408709080241,0.0,0.05004783984691249,0.837,35/105,17.41%,CD36;PPARG;ANXA1;CTNNB1;ABCG1;MAPKAPK3;SPP1;FOXO3;RXRA;LY96;RARA;FGFR4;STAT5B;IRAK3;GPX3;ABCA2;FOXP1;CTSH;HNRNPA0;ESR1;ADAM17;FOXO1;LIAS;STRN3;PPARD;TAB2;SLC11A1;ERBIN;SLPI;ASXL1;LBP;SCD;OTUD5;IFNAR1;ACER2
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.7453556327265766,1.7892835783503152,0.002631578947368421,0.04908809891808346,0.838,8/22,7.28%,SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;GADD45A;MFHAS1
prerank,phospholipid homeostasis (GO:0055091),0.8442753857990818,1.7886178660012224,0.004629629629629629,0.048913537594326754,0.847,3/11,1.98%,ABCA1;LIPG;ABCG1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.49537330693199716,-1.7885372128948467,0.0,0.14462578464509898,0.963,15/44,13.99%,KCNMA1;ATP1B1;ANK2;WNK3;KCNJ2;ATP1B2;KCNJ3;NOS1AP;AKAP9;GABBR1;KCNJ9;WNK2;ACTN2;WNK1;KCNN2
prerank,cellular response to amino acid starvation (GO:0034198),0.6151451945387768,1.7875376741203015,0.0,0.049122181270558396,0.856,26/71,13.91%,ATP6V0D2;TFEB;ATP6V1A;CEBPB;ATP6V1E1;CDKN1A;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMTOR1;MIOS;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,natural killer cell mediated immunity (GO:0002228),0.7732990014648936,1.7851899047179227,0.001422475106685633,0.05041167264491169,0.866,7/15,17.75%,LYST;PLEKHM2;SLAMF7;ARL8B;ULBP1;KLRD1;KIF5B
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.7196276562488015,1.7847982268984635,0.0013717421124828531,0.049783425878222376,0.868,9/21,11.90%,CD300A;ELF2;PRKCH;LPXN;STAP1;FOXP1;CD22;CBFB;PRKCB
prerank,regulation of platelet activation (GO:0010543),0.7419858775730229,1.7829372621617596,0.0013812154696132596,0.050564376375813784,0.876,4/21,3.72%,APOE;SYK;TEC;PDGFA
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.6649204247802065,-1.7816024017331924,0.0031446540880503146,0.15041042974408497,0.972,7/14,17.94%,ATP1B1;ANK3;WNK3;GLRX;WNK2;WNK1;SLC9A1
prerank,organic acid transport (GO:0015849),0.5929100216848038,1.7797333053606899,0.0,0.05212703319349378,0.886,30/94,13.46%,LRRC8D;SLC6A6;SLC7A2;SLC51A;SLC36A2;SLC43A2;SLC1A5;SLC7A4;SLC7A7;RXRA;SLC16A10;SLC16A1;SLC27A4;SLC38A1;SLC26A1;STARD5;SLC27A3;ABCC4;NR1H4;ABCC3;FOLR2;FOLR1;SLC27A1;SLC25A32;NCOA1;PPARD;SLC7A11;SLC23A2;SLC23A1;ATP8B1
prerank,negative regulation of leukocyte activation (GO:0002695),0.7937967756634016,1.7762218932906721,0.001430615164520744,0.05466525665012609,0.904,4/15,2.82%,CD300LF;CD300A;CD84;NR1H3
prerank,response to alcohol (GO:0097305),-0.5477720669572552,-1.7747273147204599,0.004366812227074236,0.1548366328665701,0.978,9/27,12.46%,GRIN2A;GRIN2B;CCR5;TGFBR2;GRIN3A;TGFBR1;GRIN1;GLRA1;SMAD2
prerank,regulation of neuron projection development (GO:0010975),-0.4052145651704381,-1.7725719036390748,0.0,0.15244533351727946,0.981,45/163,9.54%,TANC2;CSMD3;RTN4RL1;ARSB;CAMK1D;RIT2;LRRC4C;IL1RAPL1;CTNNA2;SPOCK1;NTNG1;TWF2;TENM3;DCC;DISC1;NTRK3;SETX;ITGA6;EPHA3;TOX;PTPRO;ABI2;MBOAT1;PLPPR5;KNDC1;MAGI2;SCN1B;RELN;FUT9;MAG;ARHGAP44;CDK5R1;NTRK2;SIPA1L1;ATP1B2;PRKD1;PAK1;SRCIN1;CDH2;MARK1;ULK4;MARK2;SEMA3A;DAB2IP;SERPINI1
prerank,peptidyl-arginine modification (GO:0018195),-0.6406499017284986,-1.7723893031311555,0.006944444444444444,0.14743597367350675,0.981,7/15,22.63%,PADI2;PRMT1;ART3;PRMT7;PARK7;PRMT8;KRTCAP2
prerank,regulation of mast cell activation (GO:0033003),0.8420760162977929,1.771139266155901,0.0015174506828528073,0.05919451402583098,0.925,2/10,1.73%,CD300LF;CD84
prerank,potassium ion transmembrane transport (GO:0071805),-0.4047254633551501,-1.7702898608643178,0.0,0.14551056540433652,0.981,33/135,13.99%,SLC24A3;SLC9A9;KCND2;SLC12A2;HCN1;ATP1B1;SLC12A6;KCNH7;SLC24A2;KCNC2;KCNB2;SLC1A3;ATP1A2;KCNH1;KCNAB1;KCNK2;KCNC1;KCNJ2;KCNK6;ATP1B2;KCNJ3;KCNC3;NALCN;KCNJ9;SLC24A4;KCNQ2;HCN2;HPN;KCNH8;PKD2;SLC12A4;PKD2L1;KCNN2
prerank,response to amino acid starvation (GO:1990928),0.6083260889353905,1.7702836119176921,0.0,0.05892471991547254,0.926,26/72,13.91%,ATP6V0D2;TFEB;ATP6V1A;CEBPB;ATP6V1E1;CDKN1A;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMTOR1;MIOS;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,cellular component disassembly (GO:0022411),0.6317686169149456,1.7690871929583538,0.0011627906976744186,0.059024557788081744,0.931,15/53,7.97%,MMP12;TIMP1;TLL2;CTSL;FLOT1;CD44;LCP1;KIF9;WASHC1;MMP14;ADAM8;CAPG;CAPN2;TIMP2;CTSS
prerank,negative regulation of T cell activation (GO:0050868),0.6723862295440571,1.7690460162195696,0.0,0.05807383383586288,0.931,9/35,5.64%,GPNMB;LGALS3;ARG1;LILRB1;CEBPB;FOXP3;CD274;PLA2G2D;DUSP3
prerank,extracellular matrix disassembly (GO:0022617),0.6271186534143276,1.766619099510195,0.0,0.059314287613634484,0.935,15/53,7.97%,MMP12;TIMP1;TLL2;CTSL;FLOT1;CD44;LCP1;KIF9;WASHC1;MMP14;ADAM8;CAPG;CAPN2;TIMP2;CTSS
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.44433920625677636,-1.763769436778158,0.0,0.14969726773281233,0.986,18/59,13.74%,CADM1;PTPRM;PTPRT;SDK1;ROBO2;KIRREL3;ROBO1;TENM3;CNTN6;CNTN2;CNTN4;IGSF11;CDH2;BSG;IGSF9;NEXN;CELSR2;PKD1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6068929230242113,-1.7632832157430764,0.0034602076124567475,0.14577585017589845,0.986,7/19,7.06%,MEF2C;ERBB4;BMPR1A;FGFR2;TGFBR1;FGF2;ZFPM2
prerank,response to hydrogen peroxide (GO:0042542),0.6338666215771811,1.7587555504693404,0.002328288707799767,0.06709027420001146,0.95,18/45,13.60%,NFE2L2;ANXA1;AQP1;ADAM9;IL6;PRKCD;RIPK1;MAPK7;PPIF;STK24;HMOX1;CAT;SIRPA;HP;PLEKHA1;SIRT1;RELA;TNFAIP3
prerank,sensory perception of taste (GO:0050909),0.8548463936931536,1.7583566556771646,0.0015479876160990713,0.06639618753219989,0.951,2/10,1.08%,CD36;TAS1R3
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.5129473133832313,-1.7539282897498245,0.0051813471502590676,0.15543445770389278,0.992,13/34,13.83%,MEF2C;GRIN2A;GRIN2B;GRID2;GABRA2;GRIN1;ARRB2;GABRA3;GLRA1;GABRG3;NLGN3;GRIN2D;GABRA4
prerank,Rac protein signal transduction (GO:0016601),-0.6105196857072653,-1.753392894909277,0.007462686567164179,0.15165409476199943,0.992,12/18,25.31%,ELMO1;TIAM1;ABI2;AIF1;NCKAP1;DBNL;HACD3;CYFIP1;RHOG;HACE1;RHOH;RAC1
prerank,amino acid transport (GO:0006865),0.6318730289780335,1.7523685492025176,0.002331002331002331,0.07203265564934808,0.957,12/49,7.52%,SLC6A6;SLC7A2;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC7A4;SLC7A7;SLC16A10;SLC38A1;SLC38A7
prerank,water transport (GO:0006833),0.8171667659848022,1.7522812954484124,0.0015337423312883436,0.07100370006088708,0.957,1/12,1.89%,AQP1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.526148316888018,-1.7508536089061073,0.014492753623188406,0.1512411434878152,0.992,10/27,11.24%,CTNNA3;ANK2;CACNA1C;RYR2;JUP;TRPM4;FGF13;AKAP9;PDE4B;DLG1
prerank,negative regulation of cell development (GO:0010721),0.7044225618858907,1.7496171305351416,0.0,0.07311202872807523,0.96,9/25,11.88%,LILRB1;HOOK3;FBXW7;IL6;APPL2;SORL1;IGF1;GSK3B;NOTCH1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.3570378846140416,-1.7426831156247857,0.0,0.15857303809983675,0.995,57/224,11.24%,GRM5;DLG2;KCND2;CACNB2;RIT2;GRIN2A;GABRB3;NRXN1;SYT1;NLGN1;RPS6KA1;CACNA1E;GRIA4;GRM1;GRIN2B;SLC12A6;CAMKK2;DTNA;GRIA1;GRIK1;UNC13C;GRIA2;HTR2C;MBP;DLGAP1;NOVA1;AMPH;GLRB;SLC1A3;GLRA3;CACNB4;CHRM3;SYN2;CHRM2;GRIK2;GABRA2;GRIN1;SYNJ2BP;HCRTR2;GABRB1;SNAP25;GRM3;KIF5A;SLC1A2;AKAP9;GRIA3;HOMER1;GABRA3;GLRA1;GABRG3;SLC6A1;SLC1A1;NLGN3;HTR1F;KCNQ2;PRKACA;DLG1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.40179342101151966,-1.740586832047559,0.0,0.15707443664952114,0.995,36/107,11.89%,CX3CR1;NRG3;GRM5;SLC12A2;MEF2C;OPHN1;LRRC4C;SYT1;NLGN1;RIMS1;GRM1;GRM8;GRIK1;DLGAP1;DLGAP2;RIMS2;GRID2;ATP1A2;GRIK2;SNCAIP;RELN;FMR1;GRM3;AKAP9;CDH2;GRIK5;HOMER1;CNTNAP4;BCR;LRP8;SLC4A8;GRID1;NLGN3;NMU;CAMK2A;GRIK3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.7033533837527175,1.7380883622851875,0.0013422818791946308,0.08628057096099645,0.981,10/24,11.88%,NFE2L2;VEGFA;CEBPB;ATF3;SESN2;MAPK7;ATF4;DDIT3;MT3;NOTCH1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.6651620264583056,-1.7377936449608564,0.0,0.15674023300646595,0.997,4/13,5.79%,CACNB2;ANK2;CACNA1C;KCNJ3
prerank,negative regulation of defense response (GO:0031348),0.5979912784893607,1.737317998435016,0.0,0.08615012431960219,0.983,24/77,14.37%,PPARG;APOE;NR1H3;RNF26;PRKCD;AOAH;MAPK7;NR1H4;IRAK3;PROC;METRNL;MFHAS1;RB1;SIRPA;MEFV;PTGER4;NLRC3;TRAFD1;PPARD;RORA;LPCAT3;TNFAIP3;TNFAIP8L2;ACOD1
prerank,vasoconstriction (GO:0042310),0.8084094814185595,1.7344924798794885,0.0,0.08874659601089277,0.986,3/11,5.02%,HTR2B;EDNRA;SLC8A1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.5738923376789127,1.7342161650100036,0.0,0.08794653547249492,0.986,18/110,5.04%,LGALS3;CD36;FNIP2;ABCA1;FBLIM1;APOE;SYK;BCL2L11;VEGFA;FNIP1;TFRC;TFIP11;KIF9;SH3GLB1;RAF1;AIDA;MTLN;SORL1
prerank,vasodilation (GO:0042311),-0.6648286018471952,-1.7336093104273262,0.01,0.15817065599779265,0.999,6/13,25.76%,KCNMA1;SOD2;ADRB1;KLF2;NOS1;ADRB2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.5679731990750027,-1.7323024651951329,0.003816793893129771,0.15632372214941023,0.999,5/21,6.42%,SNTA1;ANK2;SCN1B;NOS1AP;AKAP9
prerank,positive regulation of proteolysis (GO:0045862),0.622741321309529,1.7311542110591034,0.0034562211981566822,0.09116148606102238,0.988,17/55,13.02%,CCBE1;APOE;ADAM9;TNIP1;TANK;SNX9;TNFRSF1B;FGFR4;ADAM8;TBC1D10A;NLRC4;CTSH;CYFIP2;SNX33;STUB1;RHBDD1;GPLD1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.5822086966397622,1.7300530808500487,0.0010775862068965517,0.09107013049339063,0.988,27/88,14.84%,LGALS3;FNIP2;SDCBP;SYK;SYNPO2L;BCL2L11;VEGFA;FLOT1;FNIP1;TFRC;RAB7A;SH3GLB1;MTLN;HAS3;STAM;CHMP2A;PDCD6IP;TPR;VPS4A;GSK3B;PFN1;SDC4;SYNPO;BAX;PFN2;CX3CL1;SNF8
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.7698082574743363,1.7296171663408555,0.0,0.09057743988192211,0.988,6/15,7.16%,ANXA1;BCL2L11;UBE2L3;NR3C1;HNRNPU;ZFP36L2
prerank,regulation of steroid metabolic process (GO:0019218),0.7041608892737212,1.7284826848865134,0.0053404539385847796,0.09074360295380388,0.989,12/23,15.34%,APOE;ABCG1;NR1H4;ACADL;ACADVL;ABCA2;NR5A1;LAMTOR1;STUB1;RORA;DGKQ;PANK2
prerank,positive regulation of blood coagulation (GO:0030194),0.743991346324593,1.7281708858311746,0.005780346820809248,0.09002413297540605,0.989,4/17,7.33%,HPSE;ANO6;THBS1;ST3GAL4
prerank,myoblast differentiation (GO:0045445),0.7814013461915249,1.7268158448643613,0.0014705882352941176,0.09064814628956823,0.989,5/14,8.02%,EPAS1;MBNL1;IGF1;DDX5;RB1
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.6506405497377,1.725518058444852,0.0024813895781637717,0.09128257969061679,0.991,13/34,14.37%,CD300LF;CD300A;RAB7B;LY96;IRAK3;MFHAS1;GPR108;NFKBIL1;TICAM2;NLRP2B;TREM2;TNFAIP3;ACOD1
prerank,neutral amino acid transport (GO:0015804),0.6748656613075816,1.7237040768012202,0.003816793893129771,0.09269657425703832,0.991,7/28,5.28%,SLC6A6;SLC36A2;SLC36A4;SLC43A2;SLC38A6;SLC1A5;SLC38A1
prerank,axonal fasciculation (GO:0007413),-0.6800463842386965,-1.7236300359794166,0.0030959752321981426,0.16506527002222496,1.0,5/12,5.76%,SEMA5A;EPHA3;CNTN4;CDK5R1;MEGF8
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.7995088473577772,1.7202567016884025,0.004470938897168405,0.09598145285935085,0.992,5/12,12.62%,CTSB;CTSL;CTSS;CTSH;GAS2L1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.5802388141323648,1.7175261187713002,0.0,0.09886719967434375,0.992,18/90,10.40%,EPAS1;FABP4;CD36;CXCR4;SYK;FABP5;VEGFA;CEBPB;GADD45G;DYNC1H1;APPL2;SIRT6;ACADL;APC;KDM3A;KSR2;TRPV2;PTH2R
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.693615958947723,1.7150057905932719,0.005361930294906166,0.10159460172654276,0.992,6/22,8.59%,LGALS3;CD300A;DGKZ;DUSP3;LPXN;CD22
prerank,regulation of vacuole organization (GO:0044088),0.715836282161758,1.7143174913444819,0.0027210884353741495,0.10163684102716895,0.993,11/20,16.66%,MTM1;PIKFYVE;MTMR3;TBC1D12;ANXA2;SCARB2;RAB1B;ENO3;NPRL3;UBQLN2;NPRL2
prerank,cell-cell junction organization (GO:0045216),-0.41870165547066984,-1.7141068076272354,0.0,0.17586725660809954,1.0,16/79,8.69%,CADM1;CADM2;SDK1;CSF1R;SMAD3;CTNND1;TLN2;CTNND2;CDH11;CDH9;JUP;CDH8;CDH2;CDH6;CDH12;TGFB2
prerank,synapse organization (GO:0050808),-0.3956445158836264,-1.7130433432615437,0.0,0.1730911447597017,1.0,29/125,8.61%,CX3CR1;GRM5;PTPRD;CACNB2;ADGRL3;LRRC4C;SDK1;GPM6A;NRXN1;ARHGAP39;NTNG1;KIRREL3;NLGN1;DNM3;RYK;UNC13C;CTNND2;MAPT;CNTN2;ANK3;CACNB4;LRRC4B;FARP1;CDH2;PPFIA4;SEMA3E;REST;DNER;AGRN
prerank,regulation of immune response (GO:0050776),0.5566279025476237,1.7127539284879805,0.0,0.10276980446995902,0.996,36/135,13.44%,CD300LF;CD300A;SYK;ICAM2;CD200R1;SLAMF7;LILRB1;FOXP3;IFITM1;CLEC2D;FCRLB;ITGA4;CD3D;APPL2;COL1A1;ADCY7;RNF135;TKFC;GPR108;XIAP;DENND1B;FOXP1;CD22;TYROBP;ITGB1;TREML1;BIRC3;ULBP1;APPL1;IL15;CD300LD;TREM2;COL3A1;TRAF3;FGR;N4BP1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.6977293079987126,1.7100774246997434,0.005256241787122208,0.10575506864260388,0.996,4/22,3.72%,GPNMB;RAP2A;VEGFA;PDGFA
prerank,negative regulation of blood coagulation (GO:0030195),0.6397331144618293,1.709786687307876,0.0024783147459727386,0.10499263146543977,0.996,7/38,9.74%,F7;APOE;F11;PDGFA;F10;PROC;PLAU
prerank,central nervous system neuron differentiation (GO:0021953),-0.5074745156631002,-1.7094717277914249,0.015,0.17486376491687936,1.0,11/33,4.95%,OPHN1;MDGA2;SPOCK1;RYK;MAPT;TOX;GRID2;KNDC1;FAIM2;NTRK2;MAP2
prerank,response to chemokine (GO:1990868),-0.6376455574070741,-1.708807653518001,0.03048780487804878,0.17205398818146284,1.0,6/13,14.47%,DOCK8;SLC12A2;SH2B3;RIPOR2;WNK1;RHOA
prerank,acute-phase response (GO:0006953),0.7846836653946981,1.7087027938903414,0.001567398119122257,0.10579923845393119,0.996,5/12,15.53%,SIGIRR;CEBPB;IL6;IL6R;LBP
prerank,excitatory postsynaptic potential (GO:0060079),-0.5842497094679655,-1.7086032582106512,0.010714285714285714,0.16870356985403276,1.0,6/19,5.92%,MEF2C;GRIN2A;GRIN2B;GRID2;GRIN1;ARRB2
prerank,membrane raft organization (GO:0031579),0.762315806430493,1.7081767779757413,0.0,0.10536977190763899,0.996,6/15,5.78%,RFTN1;FLOT1;NPC1;PPT1;CLN3;ANXA2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.6905073211153782,1.7079537323657983,0.005201560468140442,0.10442896919808509,0.996,8/26,7.94%,IQGAP1;PDPK1;EEF1A1;STAT5B;DUSP3;PTPN12;ZFP36L2;SNAI2
prerank,sodium ion export across plasma membrane (GO:0036376),-0.6467332253616085,-1.704601457504186,0.030405405405405407,0.17116233879643478,1.0,3/13,5.31%,ATP1B1;ATP1A2;ATP1B2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7916107577395289,1.7017680652731044,0.005997001499250375,0.11351537008414907,0.999,2/12,0.46%,F7;CBLB
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6718012971822953,1.7015955034223982,0.007643312101910828,0.11257367053348506,0.999,13/27,16.52%,CD36;MAP3K1;IRAK2;TNIP1;LY96;IRAK3;RPS27A;UBC;TAB2;BTK;MYD88;HSPD1;TLR1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5817285142654713,-1.6985879325872117,0.022222222222222223,0.17632096295785335,1.0,8/19,14.51%,DLG2;PARD3B;PARD3;SYNJ2BP;PATJ;MARK2;DLG1;DLG3
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.6934986395346281,-1.6979188282062112,0.011461318051575931,0.17360101245437126,1.0,3/10,10.88%,ANK3;KCNAB1;KCNRG
prerank,phosphate ion homeostasis (GO:0055062),0.8258477219984433,1.6972323119824921,0.007874015748031496,0.11882041977465672,0.999,4/10,11.34%,TFAP2B;ENPP1;FGFR4;XPR1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6617527283379155,1.6967965139118635,0.005121638924455826,0.1183737459351958,0.999,6/30,4.04%,SYK;PIBF1;IL6;CD28;CD46;CD274
prerank,positive chemotaxis (GO:0050918),0.7442590604507093,1.6957862771117396,0.006896551724137931,0.11875870082322118,0.999,3/17,1.73%,GPNMB;LGALS3;VEGFA
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6057054126688577,-1.6945157685244763,0.010033444816053512,0.17531213354487135,1.0,10/17,14.96%,CACNB2;ANK2;CACNA1C;ATP1A2;SCN1B;KCNJ2;TRPM4;CACNA1G;HCN2;CACNA2D1
prerank,cellular response to increased oxygen levels (GO:0036295),0.7990944613572776,1.6939341014976523,0.003215434083601286,0.12062149190596275,0.999,6/11,10.58%,ATP6V1A;ATG7;FAS;ATP6V0D1;TMEM199;FOXO1
prerank,positive regulation of hemostasis (GO:1900048),0.8088955546889863,1.6923847795983264,0.0061633281972265025,0.12070513126935313,0.999,3/10,7.33%,HPSE;THBS1;ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.8088955546889863,1.6923847795983264,0.0061633281972265025,0.12070513126935313,0.999,3/10,7.33%,HPSE;THBS1;ST3GAL4
prerank,neutrophil activation (GO:0042119),0.7649718831535042,1.6915608365982364,0.00764525993883792,0.12097698430222165,0.999,5/12,12.24%,SYK;PRKCD;TYROBP;KMT2E;IL15
prerank,intracellular sterol transport (GO:0032366),0.7703917182255501,1.6908612559595664,0.004405286343612335,0.12085824759704204,0.999,6/13,9.77%,ABCA1;NPC1;ABCG1;SERAC1;RELCH;VPS4A
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5630762164447723,-1.6904233799590245,0.011538461538461539,0.17797597068764734,1.0,7/20,5.31%,KCNMA1;SLC12A2;ATP1B1;LACC1;ATP1A2;KCNJ2;ATP1B2
prerank,smooth muscle contraction (GO:0006939),0.7689742429134333,1.689510091440563,0.0060882800608828,0.12168985059247808,0.999,6/14,12.19%,TPCN2;EDNRA;ADRA1A;SLC8A1;ROCK1;MYLK
prerank,transition metal ion homeostasis (GO:0055076),0.6616361778934488,1.6883763658634432,0.0012690355329949238,0.1223621589361409,0.999,11/28,13.65%,FTL;ABCB7;HMOX1;XIAP;HEPH;PICALM;SLC39A14;MT3;HMOX2;PRKN;SLC11A1
prerank,cellular iron ion homeostasis (GO:0006879),0.5983931931210336,1.6879627840654219,0.0,0.1218090533482842,0.999,17/55,14.67%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;SLC39A14;GLRX3;HMOX2;SLC11A1;CUL1
prerank,chloride transmembrane transport (GO:1902476),-0.461381598870951,-1.6851253327660554,0.0,0.18233082706766918,1.0,20/48,13.83%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;GABRA3;GLRA1;GABRG3;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3;SLC12A4;GABRA4
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.6947752901320646,1.6842601872293015,0.013175230566534914,0.12654872125768424,0.999,10/22,13.02%,APOE;TIMP1;ADAM9;SNX9;TNFRSF1B;ADAM8;TIMP2;SNX33;ROCK1;GPLD1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6584223390707145,1.6836723958654158,0.009067357512953367,0.12626322672690524,0.999,6/26,7.23%,CD36;PIKFYVE;ABCB7;ABCD1;SPHK2;CYBA
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.5983598414052052,-1.6826649024159674,0.013245033112582781,0.18242681309470665,1.0,8/17,17.03%,NLGN1;RAB27A;SCAMP5;SYT4;SLC4A8;CACNA1G;STX1A;CACNA1I
prerank,lipid homeostasis (GO:0055088),0.6003943809653679,1.6815318735503437,0.001148105625717566,0.12872108142587277,0.999,13/57,8.18%,PPARG;ABCA1;APOE;LIPG;ABCG1;FBXW7;RBP1;NR1H3;ABCD1;IRS2;ZBTB20;ABHD4;ABCA2
prerank,regulation of glucose import (GO:0046324),0.6492950924257059,1.681488695652789,0.0038022813688212928,0.1275844973899857,0.999,7/30,5.81%,OSBPL8;PRKAG2;ENPP1;APPL2;PID1;IGF1;IRS2
prerank,peptide metabolic process (GO:0006518),0.5740230178523397,1.6807822302914737,0.001088139281828074,0.12774030151140897,0.999,23/75,17.56%,ANPEP;CPQ;TPP1;NPEPPS;GSTM1;NAT8;NLN;RHD;CPXM1;CLN5;GSR;HPGDS;BACE1;DNPEP;LTA4H;HM13;SPCS2;GSTA4;CPM;LNPEP;PARL;ACE;OPLAH
prerank,positive regulation of protein maturation (GO:1903319),0.8013394309244389,1.6801940469803722,0.013493253373313344,0.12744480699143243,0.999,4/11,11.89%,CCBE1;ADAM8;NLRC4;RHBDD1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.8153499393063115,1.6800990297072729,0.004746835443037975,0.12641738629005195,0.999,6/10,12.33%,CD300A;ANO6;APPL2;RAB31;STAP1;TREM2
prerank,negative regulation of interleukin-12 production (GO:0032695),0.7600047212501199,1.6800774285744684,0.005681818181818182,0.12529623905203502,0.999,6/14,8.64%,TLR8;LILRB1;PIBF1;THBS1;IRAK3;MEFV
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.7955418186274748,1.6800524575117703,0.0074850299401197605,0.12423242407786457,0.999,2/11,1.98%,PLA2G7;ABCG1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.6368608029162034,-1.6793715836900536,0.034482758620689655,0.1837481062493134,1.0,6/13,17.03%,SYT1;SCAMP5;SYT4;CACNA1G;STX1A;CACNA1I
prerank,cellular response to starvation (GO:0009267),0.5437757934107563,1.6763742429031219,0.0,0.12989438433797013,0.999,43/147,13.91%,ATP6V0D2;MTMR3;TFEB;ATP6V1A;ATG7;CEBPB;FNIP1;PDK4;CPEB4;PRKAG2;ATP6V1E1;CDKN1A;FOXO3;ATP6V1C1;FAS;TCIRG1;ATP6V0D1;SESN2;SH3GLB1;SIK1;STK24;FLCN;EIF2AK4;ATF4;ATP6V1B2;LAMP2;BMPR2;LAMTOR1;FOXO1;SIRT1;ATG5;XPR1;GAS2L1;MIOS;WRN;ATP6V0E1;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;CASTOR1;NPRL3;ATP6V1H
prerank,regulation of lysosomal lumen pH (GO:0035751),0.7624012830718319,1.6743951893525335,0.010802469135802469,0.13250172112723577,1.0,8/12,15.74%,TMEM165;PPT1;TMEM199;CLN5;CLN3;VPS33A;ATP6AP2;GRN
prerank,ceramide transport (GO:0035627),0.8012693412120016,1.673121654707806,0.0,0.13342733443603857,1.0,4/12,8.18%,PSAP;CERT1;PLTP;ABCA2
prerank,lipid transport (GO:0006869),0.5633942016067922,1.6731115469001556,0.0010695187165775401,0.1322850166879466,1.0,29/97,13.98%,CD36;OSBPL8;ABCA1;APOE;SLC51A;FABP5;ABCG1;CERT1;ABCD1;RXRA;SLC27A4;CLN3;PLTP;STARD5;SLC27A3;ABCC4;NR1H4;ABCC3;ABCA3;SLC27A1;ABCA2;NCOA1;PITPNA;ABCA6;PPARD;GM2A;PITPNC1;ATP8B1;PRELID3A
prerank,lipoprotein localization (GO:0044872),0.7841688263643417,1.672000181535768,0.006153846153846154,0.13312547744674805,1.0,5/11,11.90%,CD36;PPARG;LRP1;VMP1;PRKCB
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6853278529116843,1.6710459937975126,0.0026490066225165563,0.13259808416070695,1.0,8/23,10.24%,SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;HIPK2;ADAM17
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6853278529116843,1.6710459937975126,0.0026490066225165563,0.13259808416070695,1.0,8/23,10.24%,SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;HIPK2;ADAM17
prerank,regulation of fatty acid metabolic process (GO:0019217),0.7099427161907005,1.6691231483774316,0.00410958904109589,0.13457500465410277,1.0,6/17,11.10%,PPARG;PDK4;PRKAG2;NCOR1;EIF6;PPARD
prerank,regulation of blood coagulation (GO:0030193),0.656118109108505,1.6691036797543017,0.013071895424836602,0.13345354628198525,1.0,5/27,7.33%,HPSE;APOE;THBS1;PROC;ST3GAL4
prerank,high-density lipoprotein particle assembly (GO:0034380),0.8059739932991214,1.6669810593972083,0.00463678516228748,0.1359186923329118,1.0,2/10,0.58%,ABCA1;APOE
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5688315444141656,-1.6646048431565308,0.01838235294117647,0.20416261671693833,1.0,11/18,19.40%,PLCB1;RGS10;OPRM1;CHRM3;GNA15;CHRM2;CDK5R1;AGRN;GRK2;GNA11;RGS8
prerank,negative regulation of reproductive process (GO:2000242),0.7270824110365951,1.663188660586445,0.011396011396011397,0.14189069349076444,1.0,5/17,12.64%,TIMP1;WEE2;IGF1;WDR77;SULF1
prerank,cytosolic transport (GO:0016482),0.55641731894092,1.6626030995582244,0.0,0.1417256212747599,1.0,44/108,19.25%,TMEM87B;PHETA2;PIKFYVE;LAMP1;HOOK3;RIC1;RAB7A;EEA1;WASHC1;KIF16B;SNX5;CLN5;WDR91;CLN3;STX8;VTI1B;GAK;TBC1D10A;TBC1D23;STX5;VPS54;KLHL20;SNX16;VTI1A;DENND2A;VPS52;VPS13C;VPS51;AP1G1;SPAG9;EPS15;VAMP3;PLEKHJ1;STX6;SNF8;TMEM87A;RAB29;ERC1;UBE2O;VPS29;AP4M1;BAIAP3;ANKRD27;VPS13A
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6750157897497088,1.6606147028914051,0.00804289544235925,0.14398962955576608,1.0,12/22,15.53%,RAB7B;FLOT1;NR1H3;APPL2;NINJ1;MFHAS1;TICAM2;APPL1;TREM2;TNFAIP3;ACOD1;LBP
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.5874109467356237,-1.6605015250461006,0.03501945525291829,0.20721035879344496,1.0,6/17,8.24%,CTNNA2;FCHSD2;ABI2;NCKAP1;PICK1;ARFIP2
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.7174633803055397,1.6599887732666512,0.003989361702127659,0.14392581143740338,1.0,4/18,2.62%,GPR137B;LILRB3;LILRB1;FBXW7
prerank,sterol metabolic process (GO:0016125),0.5871933586731363,1.6599672249233184,0.0,0.14284078735392491,1.0,8/60,3.66%,LIPA;SOAT1;ABCA1;APOE;ABCG1;OSBPL1A;PRKAG2;RXRA
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.7019679025732861,1.6599497517512154,0.013531799729364006,0.14174039682443096,1.0,9/20,11.52%,FBXW7;SIK1;ACADL;ACADVL;BRCA1;SLC27A1;ABCA2;ERLIN1;WDTC1
prerank,potassium ion transport (GO:0006813),-0.3909028403131044,-1.6596306453920209,0.0,0.2052427059924074,1.0,26/120,11.82%,KCNMA1;SLC24A3;SLC9A9;KCND2;HCN1;KCNH7;SLC24A2;KCNC2;KCNB2;SLC1A3;ATP1A2;KCNH1;KCNAB1;KCNK2;KCNC1;KCNJ2;KCNK6;KCNJ3;KCNC3;NALCN;SLC24A4;KCNQ2;HCN2;HPN;KCNH8;PKD2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5963274978773964,1.6574385975344177,0.00589622641509434,0.14527788511076764,1.0,12/47,8.66%,CD36;XDH;SYK;GRB2;PRKCD;CDKN1A;RIPK1;PID1;THBS1;GADD45A;CYBA;TYROBP
prerank,iron ion homeostasis (GO:0055072),0.5838070190611198,1.6573637665952992,0.0011248593925759281,0.14424755081093818,1.0,17/58,14.67%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;PICALM;GLRX3;HMOX2;SLC11A1;CUL1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.6165985635677579,1.6572973216879878,0.005973715651135006,0.14327269845044188,1.0,12/37,13.63%,SDCBP;APOE;OPTN;NCOR1;ATXN2;TRAT1;BRCA1;ABCA2;RIN3;MT3;ANKRD13D;PRKN
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.7620761979930094,1.6548747075590384,0.014970059880239521,0.14655230049828727,1.0,7/12,11.52%,PIBF1;ACADL;ACADVL;BRCA1;SIRT1;ERLIN1;WDTC1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.47683991961562966,-1.6547234661947305,0.011560693641618497,0.2101921206052144,1.0,25/38,37.96%,KCNMA1;ANK2;KCNJ2;KCNJ3;NOS1AP;GABBR1;KCNJ9;DLG1;ACTN2;KCNN2;KCNJ6;ADRA2A;KCNMB4;GNB1;KCNJ12;KCNJ16;FHL1;KCNJ10;KCNN1;GNG2;AKAP6;KCNQ1;KCNMB2;KCNN3;KCNJ15
prerank,response to thyroid hormone (GO:0097066),0.7559532981239081,1.652964900838914,0.011764705882352941,0.14927481929027522,1.0,5/13,12.62%,CTSB;CTSL;CTSS;CTSH;GAS2L1
prerank,receptor metabolic process (GO:0043112),0.6082111289765455,1.6526075313444104,0.003484320557491289,0.14882647112371347,1.0,17/53,13.61%,CD36;SYK;GRB2;PHETA2;LILRB1;TFRC;LRP1;KIF16B;UVRAG;SH3GLB1;RAB31;PICALM;ITGB1;SNX25;ARFGEF2;RAB11B;PLEKHJ1
prerank,regulation of cholesterol storage (GO:0010885),0.7199067827836709,1.6511122992073668,0.014204545454545454,0.15039947096049888,1.0,4/15,2.82%,PPARG;ABCA1;ABCG1;NR1H3
prerank,cardiac muscle cell action potential (GO:0086001),-0.48925345913242324,-1.6494113655370055,0.012552301255230125,0.2153689308015802,1.0,9/30,11.03%,ATP1B1;ANK2;CACNA1C;ATP1A2;SCN1B;FGF12;KCNJ2;CACNA1G;HCN2
prerank,lipoprotein transport (GO:0042953),0.7953499652146181,1.6486472210796597,0.00792393026941363,0.15379624859274524,1.0,5/10,11.90%,CD36;PPARG;LRP1;VMP1;PRKCB
prerank,amyloid precursor protein catabolic process (GO:0042987),0.7407558769416315,1.6483466762707226,0.017118402282453638,0.15319574506773342,1.0,11/14,23.20%,ABCG1;CLN3;DYRK1A;BACE1;ADAM17;ADAM19;NCSTN;ADAM10;APH1B;PSEN2;ABCA7
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.5723655968649819,1.6457410976808229,0.0011001100110011,0.15687601770477255,1.0,40/71,25.10%,CTSB;CTSL;FBXL17;LONP1;SOCS6;CAPN2;RPS27A;UBC;CTSS;CTSZ;PDCD6IP;CTSH;RSPRY1;VPS4A;DDB1;ZER1;HM13;STUB1;CTSW;RHBDD1;OMA1;CHFR;TNFAIP3;PRKN;RNF123;ATE1;DDI2;ATXN3;PSMA6;CUL4B;LGMN;USP9X;CLPX;VCP;MALT1;ISG15;CASP8;PRPF19;CTSK;CTSO
prerank,B cell receptor signaling pathway (GO:0050853),0.6297011757474891,1.6452158163249544,0.011406844106463879,0.15682189816992587,1.0,12/32,14.42%,CD38;RFTN1;SYK;VAV3;TEC;MS4A1;BLNK;PLEKHA1;SH2B2;PRKCB;BTK;BAX
prerank,platelet degranulation (GO:0002576),0.5461567791008799,1.644412831548136,0.0010482180293501049,0.15738383018469304,1.0,26/118,11.59%,PSAP;CD36;VWF;TIMP1;VEGFA;HGF;APLP2;CD63;PDGFA;LHFPL2;ANXA5;IGF1;ACTN1;THBS1;VTI1B;ABCC4;OLA1;TLN1;LAMP2;F13A1;QSOX1;ITIH3;WDR1;APP;CTSW;GTPBP2
prerank,regulation of trophoblast cell migration (GO:1901163),0.7428754557264697,1.6440505779458705,0.008784773060029283,0.1569514977552072,1.0,5/14,11.98%,TIMP1;VEGFA;YTHDF3;AGO2;ACVR1B
prerank,cellular response to hydrogen peroxide (GO:0070301),0.6238209141204091,1.6407474898411754,0.012422360248447204,0.16240075123958184,1.0,13/33,13.60%,NFE2L2;ANXA1;AQP1;IL6;PRKCD;RIPK1;MAPK7;PPIF;SIRPA;PLEKHA1;SIRT1;RELA;TNFAIP3
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.6319911333337873,1.6392585178368257,0.010554089709762533,0.16429022356705922,1.0,10/30,13.13%,CD300LF;IKBKE;TANK;RIPK1;LY96;RPS27A;UBC;TICAM2;BIRC3;TRAF3
prerank,regulation of exosomal secretion (GO:1903541),0.7018178997751655,1.6389180043845293,0.012517385257301807,0.1638618980195487,1.0,10/19,14.84%,SDCBP;RAB7A;STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SDC4;PRKN;SNF8
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.6321505332761777,1.6385016056111679,0.013175230566534914,0.16356116549315933,1.0,10/29,13.13%,CD300LF;IKBKE;TANK;RIPK1;LY96;RPS27A;UBC;TICAM2;BIRC3;TRAF3
prerank,positive regulation of exosomal secretion (GO:1903543),0.7400995276881378,1.6383439180956574,0.00860832137733142,0.16273872337401624,1.0,8/15,14.84%,SDCBP;RAB7A;STAM;CHMP2A;PDCD6IP;VPS4A;SDC4;SNF8
prerank,regulation of organelle assembly (GO:1902115),0.5599271059094558,1.6359303706526498,0.002190580503833516,0.16657139025922238,1.0,28/73,16.66%,PIKFYVE;MTMR3;TBC1D22A;PLK2;TBC1D1;TBC1D2;KIF9;TBC1D12;ATXN2;CENPJ;STAM;TBC1D10A;TBC1D2B;RAB1B;MSN;PDCD6IP;TBC1D22B;ATG5;TBC1D24;TBC1D15;CEP76;NPRL3;IFT140;VPS11;UBQLN2;ALMS1;RABGAP1;NPRL2
prerank,epithelial cell differentiation (GO:0030855),0.5481871574080007,1.6358605469069907,0.001095290251916758,0.16563451758859135,1.0,13/88,10.38%,LGALS3;PPARG;ANXA4;CTSB;ANXA1;VEGFA;TPP1;TST;ACADVL;CPT1A;FSTL1;FZD7;RAB10
prerank,cardiac cell development (GO:0055006),0.7766232884511238,1.635613098343916,0.01228878648233487,0.16494701811548798,1.0,4/11,11.88%,ALPK3;VEGFA;SLC8A1;NOTCH1
prerank,carboxylic acid transport (GO:0046942),0.5884740022669964,1.6332363533118328,0.0011641443538998836,0.16823819452368355,1.0,10/55,5.69%,PSAP;SLC6A6;SLC36A2;SLC36A4;SLC38A6;SLC1A5;SLC16A1;CLN3;SLC38A1;SLC17A5
prerank,positive regulation of protein processing (GO:0010954),0.6971632607586902,1.6319997967099753,0.017881705639614855,0.16947278035376953,1.0,6/19,12.30%,CCBE1;ADAM8;NLRC4;RHBDD1;LPCAT3;MYH9
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6877528439639614,1.6310972272372513,0.012195121951219513,0.1702884087194762,1.0,10/20,12.04%,TXN;ANO6;P2RX4;PSTPIP1;C3AR1;ENTPD1;MEFV;NT5E;APP;SUGT1
prerank,positive regulation of lipid transport (GO:0032370),0.7557185437719338,1.6308984044705193,0.01002865329512894,0.16964261503836875,1.0,4/12,7.78%,APOE;LRP1;SPP1;ABCA3
prerank,lysosome localization (GO:0032418),0.6182546697331032,1.6300563330348772,0.006195786864931847,0.17036565613708987,1.0,11/37,12.45%,PLEKHM1;PLEKHM2;TFEB;FLCN;HPS6;BORCS5;VPS33A;LAMTOR1;ARL8B;MYH9;SPAG9
prerank,response to laminar fluid shear stress (GO:0034616),0.7944690622731222,1.6292929002929613,0.009538950715421303,0.17076483537070863,1.0,4/10,5.24%,ABCA1;NFE2L2;MAP2K5;MAPK7
prerank,neuropeptide signaling pathway (GO:0007218),-0.4217863159341414,-1.6290708393981403,0.0,0.24875491480996065,1.0,15/58,14.83%,SORCS3;GLRB;OPRM1;GLRA3;SORCS1;HCRTR2;GPR37;PPY;GLRA1;CYSLTR1;ADCYAP1;NMU;GPR149;GPR84;RAPGEF2
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7110153608967209,1.628100521017446,0.01991465149359886,0.17187017001545596,1.0,2/15,1.73%,F7;VEGFA
prerank,negative regulation of cytokine production (GO:0001818),0.5225004706686152,1.6275621900784694,0.0010214504596527069,0.17192433189342002,1.0,44/163,15.15%,GPNMB;ANXA4;TLR8;CD200R1;LILRB1;ANXA1;CD84;SIGIRR;PIBF1;FOXP3;IKBKE;IL6;ATP2B1;ABCD1;CD274;APPL2;HOMER3;RARA;MAP2K5;TRIM25;THBS1;NPLOC4;ADCY7;NR1H4;IRAK3;RNF135;SIRPA;MEFV;TYROBP;DDIT3;PTGER4;MAVS;NLRC3;TAX1BP1;SARS1;TREM2;GAS6;N4BP1;TNFAIP3;SLC11A1;ACOD1;JAK3;CX3CL1;ARRB1
prerank,amino acid transmembrane transport (GO:0003333),0.5909383233467653,1.6273559674403,0.00842358604091456,0.17124274374296525,1.0,9/45,7.52%,LRRC8D;SLC6A6;SLC36A2;SLC36A4;SLC38A6;SLC7A7;SLC38A1;MFSD12;SLC38A7
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5007996282260466,-1.624987805891586,0.013953488372093023,0.251718557937934,1.0,14/29,13.99%,SNTA1;KCNIP4;DPP10;DPP6;FGF12;KCNAB1;WNK3;KCNIP3;HOMER1;DLG1;WNK1;ATP2B4;KCNIP1;KCNN2
prerank,cardiac muscle cell development (GO:0055013),0.6818694362352828,1.6246350709301063,0.006756756756756757,0.17567611631744046,1.0,5/20,6.79%,ALPK3;VEGFA;MYL2;SLC8A1;PDLIM5
prerank,lipoprotein biosynthetic process (GO:0042158),0.7618413265683681,1.6194500199727477,0.009202453987730062,0.18525107008965747,1.0,3/11,5.36%,APOE;ATG7;ATG10
prerank,cellular protein catabolic process (GO:0044257),0.5699058792291066,1.619367761345759,0.002232142857142857,0.18429289026275114,1.0,34/59,27.13%,CTSB;CTSL;RAB7A;TCIRG1;RIPK1;LONP1;HTRA2;CAPN2;AFG1L;CTSS;CTSZ;CTSH;RSPRY1;RAB12;CTSW;AP2B1;PRKN;RNF123;BNIP3;MYLIP;PSMA6;LGMN;CLPX;MALT1;SIAH2;AP2S1;CASP8;CTSK;CTSO;CLTC;UBE2G1;AP2A2;AP2A1;MAGEC2
prerank,energy reserve metabolic process (GO:0006112),0.682683754098308,1.6191527053422923,0.010854816824966078,0.18353221269691938,1.0,8/19,12.59%,PRKAG2;PYGL;PID1;GBE1;GFPT1;GSK3B;MT3;UGP2
prerank,mesonephric tubule development (GO:0072164),-0.6077607004731113,-1.6189069099535194,0.03460207612456748,0.258838869888542,1.0,6/15,13.74%,SALL1;ROBO2;FGFR2;PKD2;NPNT;PKD1
prerank,positive regulation of neuron projection development (GO:0010976),-0.38283713969716504,-1.6183485274496852,0.014084507042253521,0.25566975542832615,1.0,24/85,9.54%,ARSB;CAMK1D;RIT2;TWF2;TENM3;NTRK3;SETX;ITGA6;EPHA3;TOX;PLPPR5;MAGI2;SCN1B;RELN;FUT9;NTRK2;ATP1B2;CUX2;PRKD1;VLDLR;MARK2;LRP8;DAB2IP;SERPINI1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.6825605883329829,1.6181638274693648,0.016415868673050615,0.18323361242544636,1.0,8/20,15.24%,MGST2;GSTM1;AKR1A1;HPGDS;ESD;MGST1;GSTO2;GSTA4
prerank,glutathione derivative metabolic process (GO:1901685),0.6825605883329829,1.6181638274693648,0.016415868673050615,0.18323361242544636,1.0,8/20,15.24%,MGST2;GSTM1;AKR1A1;HPGDS;ESD;MGST1;GSTO2;GSTA4
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5251391646490475,1.617855528053855,0.0,0.18278860532036542,1.0,41/151,15.60%,CDO1;PLPP3;B4GALT5;APOE;SPTLC2;ARG1;MGST2;MOCOS;LPIN3;SAMD8;SGPL1;GSTM1;AKR1A1;CERT1;TNIP1;RHD;LCMT2;SGMS2;HACD4;ARG2;CERS6;SPHK2;ST3GAL4;SPTSSA;SLC27A1;HPGDS;VAPA;CSNK2A2;ESD;PCYT1A;ELOVL1;ALDH3A2;LPCAT3;MGST1;DEGS1;GSTO2;GOLPH3;SLC25A15;GSTA4;SLC44A2;PRKD3
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.6869017147305744,1.6153283282238327,0.016877637130801686,0.1868764929043136,1.0,6/18,10.35%,F7;IL6;SLC8B1;IL6R;ADAM17;PTK2B
prerank,positive regulation of metabolic process (GO:0009893),0.5375173286826873,1.6148879727693422,0.0010683760683760685,0.18661353295717648,1.0,19/103,10.40%,EPAS1;FABP4;CD36;CXCR4;SYK;FABP5;VEGFA;CEBPB;GADD45G;DYNC1H1;FASN;APPL2;SIRT6;ACADL;APC;KDM3A;KSR2;TRPV2;PTH2R
prerank,defense response to bacterium (GO:0042742),0.5330768559609486,1.6142613926245295,0.0010638297872340426,0.18671158455885756,1.0,25/105,15.73%,LYST;SYK;OPTN;MPEG1;CEBPB;AQP1;IL6;STAB2;PRKCD;ANKRD17;LYZL4;RNASE3;GBP6;NLRC4;IL6R;MAVS;ADAM17;DROSHA;TREM2;FGR;SLC11A1;SLPI;SHC1;LBP;MYD88
prerank,negative regulation of DNA metabolic process (GO:0051053),0.6614190346868952,1.6134666455791904,0.0107095046854083,0.18717033438826328,1.0,8/24,9.80%,CDKN1A;NIBAN2;ZRANB3;ACVRL1;RTEL1;DACH1;BMPR2;XRCC5
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.7054517153561678,1.6133631005091769,0.008595988538681949,0.18628231040548246,1.0,4/16,7.09%,APLNR;VEGFA;THBS1;HMOX1
prerank,chemical synaptic transmission (GO:0007268),-0.3306747545301293,-1.612645695588005,0.0,0.2627580275229358,1.0,72/284,11.24%,GRM5;DLG2;KCND2;CACNB2;RIT2;GRIN2A;GABRB3;NRXN1;SYT1;NLGN1;RPS6KA1;CACNA1E;GRIA4;RIMS1;GRM1;GRIN2B;SLC12A6;FCHSD2;CAMKK2;DTNA;GRIA1;GRIK1;UNC13C;GRIA2;HTR2C;MBP;DLGAP1;NOVA1;DLGAP2;AMPH;GLRB;SLC1A3;GLRA3;CACNB4;GRID2;CHRM3;SYN2;CHRM2;GRIK2;GABRA2;PTPRN2;LIN7A;GRIN1;SYNJ2BP;SLC17A6;HCRTR2;GABRB1;SNAP25;GRM3;KIF5A;CDH8;SLC1A2;AKAP9;GRIK5;GRIA3;HOMER1;NSG1;SHISA6;GABRA3;GLRA1;GABRG3;PDLIM4;SLC6A1;RIC3;GRID1;SLC1A1;KIF1B;NLGN3;HTR1F;KCNQ2;PRKACA;DLG1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.749225409891533,1.6123928933448628,0.019938650306748466,0.18726550898566535,1.0,3/12,2.77%,GCNT2;FLOT1;CD44
prerank,cellular lipid catabolic process (GO:0044242),0.6388229746764169,1.6122651186024493,0.015789473684210527,0.1864475717888229,1.0,9/27,11.17%,CEL;MGST2;LIPG;LPIN3;AOAH;ACADL;PLBD2;PPARD;MT3
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.5419526340070843,1.611637755071966,0.0,0.18684327186897187,1.0,28/86,20.47%,EPAS1;NFE2L2;VEGFA;ATF3;PSMD1;BACH1;MAPK7;CREBBP;ATF4;HMOX1;RPS27A;UBC;DDIT3;EGLN3;PSMF1;PSMD14;PSMD12;LIMD1;HSPA1A;PSME2;INO80;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6
prerank,serine family amino acid metabolic process (GO:0009069),0.6992924853028466,1.6097651375368345,0.021216407355021217,0.18972402640912708,1.0,5/16,12.15%,CDO1;BAAT;SEPHS2;GLYAT;SARS1
prerank,regulation of mast cell degranulation (GO:0043304),0.7146075403763428,1.6086220969324416,0.02463768115942029,0.1912807120396525,1.0,7/14,13.43%,CD300A;SYK;GAB2;CD84;SPHK2;FES;FGR
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.6808671385411285,1.608550443678888,0.009641873278236915,0.19037609479649667,1.0,10/20,16.61%,NFE2L2;VEGFA;RUNX2;SESN2;ATF4;CARF;MT3;NOTCH1;RELA;CREB3
prerank,synaptic membrane adhesion (GO:0099560),-0.5924379960173114,-1.6052545001760061,0.020905923344947737,0.27289784093260677,1.0,4/14,5.18%,PTPRD;LRRC4C;NTNG1;LRRC4B
prerank,membrane depolarization during action potential (GO:0086010),-0.4970827658182891,-1.6042664617010223,0.015625,0.2706651950978363,1.0,13/26,21.29%,SCN2A;CACNA1C;ATP1A2;SCN1B;KCNJ2;SCN9A;CACNA1G;HCN2;YWHAH;SCN8A;CACNA1I;SCN4B;SCN1A
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6255314756141104,-1.603687209542912,0.014534883720930232,0.26788352505253277,1.0,6/13,7.06%,MEF2C;ERBB4;BMPR1A;FGFR2;FGF2;ZFPM2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5885848304577813,1.6031106902151133,0.004722550177095631,0.20152451875790361,1.0,12/44,7.84%,VEGFA;AQP1;FNIP1;DNAJB6;CD44;HGF;MAP2K5;RAF1;PCID2;THBS1;SH3RF1;XIAP
prerank,blood vessel morphogenesis (GO:0048514),0.5736141135822476,1.602714048990828,0.002336448598130841,0.2011951437461615,1.0,5/54,1.73%,CCBE1;APLNR;SYK;STRA6;VEGFA
prerank,glycogen metabolic process (GO:0005977),0.6237570608012202,1.6024026153756465,0.016518424396442185,0.20068422972057723,1.0,9/27,13.87%,GYG1;PRKAG2;PYGL;GBE1;NHLRC1;GSK3B;PGM1;UGP2;AGL
prerank,positive regulation of protein catabolic process (GO:0045732),0.5383762461251734,1.6021290202267484,0.004291845493562232,0.20012721657614718,1.0,30/84,17.29%,APOE;ATG7;WWP1;TIPARP;RAB7A;PLK2;ADAM9;SNX9;TNFRSF1B;SORL1;ADAM8;STX5;APC;MSN;NEDD4L;WWP2;HUWE1;SNX33;DDB1;GSK3B;OAZ2;FOXO1;GPLD1;TNFAIP3;PRKN;VPS11;SNF8;SH3D19;OAZ1;CSNK2A1
prerank,sulfur amino acid metabolic process (GO:0000096),0.6492581176617753,1.6019903430521039,0.00788436268068331,0.19929589558646746,1.0,3/24,3.71%,CDO1;MSRA;TST
prerank,alanine transport (GO:0032328),0.7787725232839113,1.6018252225546834,0.02531645569620253,0.19850791726085262,1.0,3/10,1.64%,SLC6A6;SLC36A2;SLC36A4
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6752719094723438,1.601447787755225,0.015193370165745856,0.19828908855183972,1.0,8/20,13.93%,EPAS1;ZMIZ1;WASHC1;HSPA1B;DCUN1D5;DCUN1D3;PRKN;HSPA1A
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.6588901640329559,1.601372637646028,0.03064066852367688,0.197312522698288,1.0,8/21,14.60%,CTNNB1;APC;DVL1;GSK3B;FZD5;FZD2;PPP1CA;LRP6
prerank,receptor internalization (GO:0031623),0.5999744730661177,1.601013846861557,0.009592326139088728,0.1971249692000986,1.0,10/44,9.77%,CD36;SYK;GRB2;LILRB1;TFRC;LRP1;LMBRD1;RAB31;PICALM;ITGB1
prerank,organonitrogen compound catabolic process (GO:1901565),0.5604183785758263,1.5997881512616932,0.007927519818799546,0.19864934486263697,1.0,13/57,10.32%,ANPEP;PLA2G7;CPQ;TPP1;SGPL1;NPEPPS;TST;PPT1;CLN5;RENBP;NAGK;LTA4H;GGACT
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5646887265548698,1.598885909804652,0.00681044267877412,0.19959227313268296,1.0,19/55,17.48%,XDH;GRB2;PIKFYVE;MPV17;CDKN1A;COQ7;RIPK1;PID1;THBS1;GADD45A;SPHK2;EIF6;BRCA1;MT3;PRKN;ACOD1;BST1;PARL;ARF4
prerank,synapse assembly (GO:0007416),-0.3810038612978535,-1.5970991372890293,0.0,0.276814878534707,1.0,16/67,6.51%,ADGRL3;GABRB3;SDK1;GPM6A;NRXN1;KIRREL3;NLGN1;DNM3;RYK;LRRTM3;GRID2;GABRA2;LGI2;FGF13;FARP1;CDH2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.7009067343920639,1.5966602518123698,0.026836158192090395,0.2035226342890676,1.0,8/15,16.08%,APOE;ADAM9;SNX9;TNFRSF1B;ADAM8;SNX33;GPLD1;SH3D19
prerank,long-chain fatty acid import into cell (GO:0044539),0.7563072873360157,1.596032781285061,0.022796352583586626,0.2039363346377717,1.0,4/10,12.32%,CD36;SLC27A4;SLC27A1;SLC2A1
prerank,snRNA metabolic process (GO:0016073),0.6969481814377451,1.5948539921951481,0.008403361344537815,0.20540331307976853,1.0,10/17,17.19%,INTS9;INTS6;INTS1;INTS8;MEPCE;INTS5;INTS7;INTS2;MTREX;RBM7
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5414866465742487,-1.5942399147605075,0.01818181818181818,0.2791582066454529,1.0,9/17,22.78%,ATP1B1;CACNA1C;ATP1A2;RYR2;ATP1B2;PRKACA;FKBP1B;GJC1;GJD3
prerank,regulation of autophagy (GO:0010506),0.508366286955824,1.593868240759859,0.0,0.20674638683261476,1.0,74/216,19.52%,ATP6V0D2;PSAP;HTR2B;TPCN2;GPR137B;OPTN;MTMR3;TFEB;ERN1;ATP6V1A;PRKAG2;ATP6V1E1;FBXW7;PLK2;HGF;ABL2;FOXO3;ATP6V1C1;CTSA;WASHC1;ATP6V0D1;DAPK1;SNX5;SH3GLB1;HTRA2;EEF1A1;FLCN;ATP6V1B2;DCAF12;MEFV;CSNK2A2;ATP6V0A1;DDIT3;LAMTOR1;ROCK1;GSK3B;FOXK1;FOXO1;MT3;TAB2;FZD5;TREM2;ATP6V0E1;ATG13;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;VDAC1;PRKN;ZKSCAN3;ATP6V1H;MCL1;UBQLN2;USP36;EXOC4;BNIP3;RUBCN;NPRL2;PIP4K2A;ACER2;KEAP1;DRAM2;TRIM14;EXOC7;EXOC1;VPS29;CASP3;RHEB;EIF4G3;EIF4G2;PIK3CB;TLK2;ATP6V1G2
prerank,Golgi localization (GO:0051645),0.7410540183126519,1.593322854685508,0.02631578947368421,0.20687236837491332,1.0,3/11,4.23%,ARHGAP21;HOOK3;UVRAG
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.7242039391517665,1.592665297947391,0.017699115044247787,0.2073029366306028,1.0,3/12,10.01%,PPARG;NCOR1;ESR1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.6152637666553018,1.5921533476818153,0.017721518987341773,0.2073126132835753,1.0,13/30,15.07%,MICALL2;NPEPPS;FBXW7;SH3GLB1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;FZD5;ATG13;VPS11;USP36
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6701978233393212,1.5921474631448014,0.02627939142461964,0.20624930288882867,1.0,5/19,13.36%,SYK;ZMIZ1;MMP14;BTK;GAS6
prerank,regulation of protein autophosphorylation (GO:0031952),0.5979784567987364,1.5921234404555842,0.009708737864077669,0.20522331866999563,1.0,5/36,4.24%,GPNMB;RAP2A;VEGFA;PDGFA;ENPP1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.6966986446444218,1.5908911487460762,0.02064896755162242,0.20682585244298646,1.0,6/15,15.73%,CD36;MEFV;NLRP2B;NLRC3;TREM2;MYD88
prerank,cellular response to oxygen levels (GO:0071453),0.7570636242367434,1.5907988557110735,0.015479876160990712,0.20604795790541794,1.0,4/10,4.28%,ATP6V1A;CPEB4;ATP6V0D1;TMEM199
prerank,glycoprotein catabolic process (GO:0006516),0.6880057795684137,1.5905397590184074,0.020026702269692925,0.20555373414724265,1.0,6/17,12.93%,MMP12;CTSL;MANBA;EDEM2;OGA;FBXO6
prerank,nitric oxide mediated signal transduction (GO:0007263),0.6905509299298596,1.5903948803069097,0.028901734104046242,0.20483665105537993,1.0,2/16,0.58%,CD36;APOE
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6166197015846189,1.5897290427237107,0.008567931456548347,0.2053838227717671,1.0,8/31,12.03%,GPNMB;CDKN1A;PTEN;APC;RB1;BRD7;DCUN1D3;CDK2AP2
prerank,regulation of small molecule metabolic process (GO:0062012),0.628820515581679,1.5894276569916759,0.014230271668822769,0.20501305938109554,1.0,11/28,15.34%,APOE;PDK4;NR1H4;ACADL;ACADVL;FOXK1;SIRT1;RORA;DGKQ;PRKN;PANK2
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.4184243910442424,-1.5887181974920783,0.015037593984962405,0.28581578454655643,1.0,15/54,13.99%,BIN1;KCNMA1;KCNIP4;DPP10;DPP6;KCNAB1;KCNJ2;KCNIP3;KCNJ3;NOS1AP;GABBR1;KCNJ9;DLG1;KCNIP1;KCNN2
prerank,regulation of interleukin-10 production (GO:0032653),0.5754718053926838,1.586689861580448,0.0059031877213695395,0.210078503986411,1.0,8/44,4.04%,SYK;LILRB1;PIBF1;FOXP3;IL6;CD28;CD46;CD274
prerank,positive regulation of protein polymerization (GO:0032273),-0.4051356031449989,-1.5848969142348481,0.017094017094017096,0.2893556413323009,1.0,17/65,7.80%,NAV3;BIN1;EVL;FCHSD2;PRKCE;VASP;MAPT;FER;HCK;CDK5R1;NCKAP1;NCK1;HSP90AA1;PAK1;AKAP9;TPPP;CARMIL1
prerank,regulation of postsynapse organization (GO:0099175),-0.49077726165351304,-1.5845667863656316,0.020100502512562814,0.2859221831336752,1.0,8/28,7.13%,TANC2;IL1RAPL1;ABI2;ARHGAP44;CDK5R1;SIPA1L1;SRCIN1;HOMER1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.48527170791324814,-1.5839138338088852,0.015544041450777202,0.28317242773894646,1.0,10/31,8.84%,TANC2;NLGN1;ABI2;RELN;ARHGAP44;CDK5R1;SIPA1L1;CUX2;SRCIN1;LRP8
prerank,carboxylic acid transmembrane transport (GO:1905039),0.578681302914574,1.5830085090386723,0.013221153846153846,0.21733756658875245,1.0,16/40,19.68%,SLC36A2;SLC36A4;SLC38A6;SLC7A7;SLC16A1;SLC38A1;SLC38A7;SLC27A1;SLC7A11;SLC23A2;SLC23A1;SLC38A9;SLC36A1;ABCC1;SLC19A1;SLC7A8
prerank,positive regulation of wound healing (GO:0090303),0.602669037794666,1.5828751811448312,0.013819095477386936,0.21656009132143328,1.0,8/36,12.19%,HPSE;PLPP3;ANXA1;THBS1;ST3GAL4;RREB1;ITGB1;MYLK
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.5463231324284311,1.5828163430235267,0.0022346368715083797,0.21565449039343562,1.0,31/80,18.49%,TMEM87B;RAB7B;PHETA2;PIKFYVE;SNX8;RIC1;RAB7A;WASHC1;SNX5;CLN5;VTI1B;TBC1D10A;TBC1D23;STX5;VPS54;VTI1A;DENND2A;VPS52;VPS51;SPAG9;VAMP3;PLEKHJ1;TRAPPC10;STX6;TMEM87A;RAB29;ERC1;UBE2O;SNX3;VPS29;BAIAP3
prerank,adherens junction organization (GO:0034332),-0.4104711651180074,-1.5820985831812,0.006097560975609756,0.2828600139078169,1.0,11/48,7.68%,CADM1;CADM2;CTNND1;CDH11;CDH9;JUP;CDH8;CDH2;CDH6;SMAD7;CDH12
prerank,regulation of protein processing (GO:0070613),0.6506572544788355,1.5820281854047409,0.022135416666666668,0.21650335379120964,1.0,4/21,7.30%,CCBE1;CLN3;ADAM8;NLRC4
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5919863456006771,1.5819094218681466,0.012091898428053204,0.2156864209145642,1.0,11/36,13.93%,CD300LF;CXCR4;RIPK1;UBE2K;HSPA1B;TICAM2;MAVS;ADAM17;GAS6;PRKN;HSPA1A
prerank,regulation of histone deacetylation (GO:0031063),0.7197003758052473,1.5818431768256696,0.01639344262295082,0.2147485435738913,1.0,4/13,6.98%,APLNR;FOXP3;SPHK2;NIPBL
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6787851654988484,1.581405520784852,0.014005602240896359,0.21479580643332374,1.0,3/19,3.68%,CCBE1;XDH;CD63
prerank,receptor clustering (GO:0043113),-0.4899175562357161,-1.5806785456601813,0.03879310344827586,0.2816352808627072,1.0,10/27,11.24%,DLG2;NRXN1;NLGN1;MAGI2;SYNJ2BP;ITGB2;ITGB1BP1;PICK1;AGRN;DLG1
prerank,potassium ion homeostasis (GO:0055075),-0.5050856396662287,-1.5796261755112648,0.020491803278688523,0.2801713966228948,1.0,7/23,5.31%,KCNMA1;SLC12A2;ATP1B1;SLC12A6;ATP1A2;KCNJ2;ATP1B2
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.43975199461722614,-1.5778675412481202,0.018518518518518517,0.2797936698053964,1.0,26/41,37.96%,KCNMA1;ANK2;ANK3;KCNJ2;KCNJ3;NOS1AP;GABBR1;KCNJ9;ACTN2;KCNN2;STAC;KCNJ6;NOS1;KCNMB4;GNB1;KCNJ12;KCNJ16;KCNJ10;KCNN1;GNG2;AKAP6;KCNQ1;PDZK1;KCNMB2;KCNN3;KCNJ15
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.7668245269042073,1.5768672312443257,0.029141104294478526,0.22423394911802946,1.0,3/10,4.62%,PPARG;RXRA;RARA
prerank,cholesterol metabolic process (GO:0008203),0.546464651077028,1.5760339067794076,0.0033519553072625698,0.2251343544515823,1.0,17/68,15.79%,CEL;SOAT1;ABCA1;APOE;ABCG1;OSBPL1A;RXRA;MVD;PLPP6;IDI1;PPARD;MT3;CYP46A1;INSIG2;PMVK;SNX17;ACAA2
prerank,peptide catabolic process (GO:0043171),0.636465442479563,1.5758931153543567,0.023004059539918808,0.22435916129596686,1.0,6/23,10.31%,ANPEP;CPQ;TPP1;NPEPPS;CTSH;LTA4H
prerank,pentose-phosphate shunt (GO:0006098),0.7380420522105765,1.5750644781774048,0.025297619047619048,0.22517312357745994,1.0,6/11,20.16%,PGD;TALDO1;SHPK;DERA;RPIA;RBKS
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.6799335634692347,1.5748124221624797,0.026988636363636364,0.22477574426902017,1.0,7/16,11.52%,NCOR1;APPL2;ACADL;ACADVL;BRCA1;ERLIN1;WDTC1
prerank,negative regulation of viral release from host cell (GO:1902187),-0.621435176075037,-1.5745897499290356,0.035483870967741936,0.28302407394633367,1.0,9/13,34.71%,TRIM11;TRIM13;TRIM8;PML;TRIM5;TRIM32;TRIM35;TRIM28;CHMP3
prerank,neuronal action potential (GO:0019228),-0.5129784798096846,-1.573243231881744,0.02127659574468085,0.2819727870366894,1.0,9/22,25.85%,SCN2A;ANK3;SCN9A;CACNA1G;MYH14;SCN8A;CACNA1I;SCN1A;KCNMB4
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5242726926513166,-1.5731578539994344,0.03985507246376811,0.2785714285714286,1.0,6/21,5.93%,ST3GAL6;B3GALT1;ST8SIA6;FUT9;ST3GAL2;ST6GALNAC5
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.45446963523246975,-1.57293641173563,0.0111731843575419,0.27554189585414435,1.0,8/35,7.68%,NLGN1;CDH23;CDH11;ATP2C1;CDH9;CDH8;CDH6;CDH12
prerank,positive regulation of cell communication (GO:0010647),-0.48044432065625053,-1.5728777331434398,0.009389671361502348,0.2722800512132872,1.0,11/28,20.41%,SYT1;RIMS1;RIMS2;ANK3;GRIK2;CD80;HOMER1;NMU;TNF;CDKN2AIP;SOX11
prerank,protein-containing complex disassembly (GO:0032984),0.5531247670272543,1.569107315804686,0.01740139211136891,0.23758072439284475,1.0,19/54,14.88%,CTNNB1;SNAP29;TECPR1;UVRAG;CLN3;VTI1B;APC;RPL23;LAMP2;DVL1;VPS33A;VPS4A;GSK3B;EPG5;FZD5;FZD2;PPP1CA;LRP6;SNX14
prerank,regulation of p38MAPK cascade (GO:1900744),0.596781889823746,1.5685845386299355,0.01845018450184502,0.23765909134275956,1.0,8/35,7.28%,SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;GADD45A;MFHAS1
prerank,intracellular cholesterol transport (GO:0032367),0.6882973398313619,1.5683984378045484,0.02545968882602546,0.2369959899999288,1.0,6/15,9.77%,ABCA1;NPC1;ABCG1;SERAC1;RELCH;VPS4A
prerank,negative regulation of immune effector process (GO:0002698),0.7230768952291041,1.5677916226150663,0.026986506746626688,0.23735046249686867,1.0,3/13,1.46%,LGALS3;CD300A;LILRB1
prerank,smooth muscle cell differentiation (GO:0051145),0.7218117199377259,1.5677692764810052,0.027377521613832854,0.23631842551619814,1.0,3/12,0.87%,APLNR;MRTFA;MRTFB
prerank,superoxide anion generation (GO:0042554),0.7279047717239638,1.5676557255832964,0.023088023088023088,0.23542222846705074,1.0,6/13,16.76%,CYBB;CYBA;NCF2;NCF4;TAFA4;NCF1
prerank,phagosome-lysosome fusion (GO:0090385),0.7440961242953008,1.5675722634857714,0.03363914373088685,0.23454812908399597,1.0,6/10,9.65%,RAB7B;PIKFYVE;RAB20;RAB7A;CLN3;ARL8B
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6029845765712258,1.5673620187063104,0.018292682926829267,0.23389541009324621,1.0,8/33,12.03%,GPNMB;CDKN1A;PTEN;APC;RB1;BRD7;DCUN1D3;CDK2AP2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.559865087438646,1.5671630332146065,0.015098722415795587,0.23327164814956,1.0,9/51,10.24%,F7;PLA2G7;VEGFA;ANO6;IL6;THBS1;IL6R;MOSPD2;ADAM17
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.5878471331887528,1.566691273968063,0.017391304347826087,0.2334354530065504,1.0,17/38,18.01%,MICALL2;NPEPPS;FBXW7;SH3GLB1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;BAG4;FZD5;ATG13;PRKN;VPS11;USP36;PARL;TOMM7
prerank,response to interleukin-6 (GO:0070741),-0.6384489872297392,-1.5652138842725676,0.05263157894736842,0.28335816882761783,1.0,3/10,0.56%,SELPLG;ST3GAL6;PTPRT
prerank,protein localization to lysosome (GO:0061462),0.6096296693144089,1.563079571833977,0.023316062176165803,0.2413967599748125,1.0,17/28,24.58%,RAB7A;SORL1;GLMP;RNF128;LMBRD1;SCARB2;NCOA4;SNX16;VPS4A;M6PR;RTN4;AP4M1;NAGPA;GGA3;ZFYVE16;KPTN;ATP13A2
prerank,alcohol catabolic process (GO:0046164),0.7642028736395802,1.5629651446057444,0.024242424242424242,0.2405839522552466,1.0,6/10,17.69%,CEL;APOE;MT3;CYP46A1;SNX17;CYP27A1
prerank,regulation of interleukin-1 production (GO:0032652),0.6916412163510528,1.5622058548161366,0.03025936599423631,0.24143965030060804,1.0,5/15,13.36%,ANXA1;SIRPA;FOXP1;MEFV;GAS6
prerank,regulation of macroautophagy (GO:0016241),0.5174901936123114,1.5615114154281209,0.002129925452609159,0.24209351302005655,1.0,38/105,19.59%,ATP6V0D2;ERN1;ATP6V1A;TBC1D25;PRKAG2;ATP6V1E1;ATP6V1C1;WAC;ATP6V0D1;SNX5;SESN2;SH3GLB1;CLN3;PIK3CA;ATP6V1B2;EPM2A;PAFAH1B2;ATP6V0A1;QSOX1;LAMTOR1;SIRT1;ATP6V0E1;ATG13;SLC38A9;LAMTOR3;ATP6V0C;ATP6V0B;ATP6V1H;UBQLN2;USP36;EXOC4;BNIP3;EXOC7;EXOC1;CASP3;RHEB;ATP6V1G2;TBK1
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6636862909584595,1.5614893259947145,0.03506311360448808,0.24108583114542767,1.0,3/17,5.64%,LGALS3;DGKZ;DUSP3
prerank,regulation of response to biotic stimulus (GO:0002831),0.6010117908026821,1.5606638967860644,0.023622047244094488,0.2421969849696481,1.0,19/28,24.87%,CD36;APPL2;RNF135;TKFC;XIAP;FOXP1;BIRC3;APPL1;TREM2;TRAF3;FGR;N4BP1;CX3CL1;BIRC2;FCGR2B;TIRAP;CASP8;DHX58;ZMPSTE24
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5384151434415841,-1.5599996384375103,0.03424657534246575,0.28964613368283093,1.0,9/18,16.44%,NRXN1;NLGN1;RELN;TSHZ3;CACNG4;NLGN3;CACNG3;CCR2;CACNG2
prerank,microglial cell activation (GO:0001774),-0.5166463049249785,-1.559835648204945,0.017921146953405017,0.28648117866171097,1.0,7/21,8.08%,CX3CR1;ITGAM;MAPT;IFNGR1;AIF1;ITGB2;CLU
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.6719794042274094,1.559249010196754,0.023448275862068966,0.24465899890938533,1.0,5/16,11.20%,LYST;PLEKHM2;SLAMF7;ARL8B;ULBP1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6071970780910969,1.5578654611994993,0.01532567049808429,0.24699763719376788,1.0,15/30,20.41%,ACD;CDKN1A;NIBAN2;TENT4B;HNRNPU;ACVRL1;DACH1;TERF1;NAT10;BMPR2;TEN1;STN1;EXOSC10;GNL3L;CERS1
prerank,protein targeting to lysosome (GO:0006622),0.6542186818305596,1.557674194535188,0.03142857142857143,0.2464770825179711,1.0,12/20,21.68%,RAB7A;SORL1;SCARB2;NCOA4;LAMP2;SNX16;VPS4A;M6PR;AP4M1;NAGPA;GGA3;ZFYVE16
prerank,leukocyte cell-cell adhesion (GO:0007159),0.6389609317041368,1.556822428335668,0.021333333333333333,0.2475726231522213,1.0,8/24,10.11%,SYK;TNIP1;ITGA4;CERCAM;MSN;NT5E;ITGB1;ROCK1
prerank,positive regulation of bone resorption (GO:0045780),0.7313685041349388,1.5564823747471646,0.03582089552238806,0.24736536332445438,1.0,4/11,5.73%,SYK;PLEKHM1;SPP1;ADAM8
prerank,negative regulation of lymphocyte activation (GO:0051250),0.6390170133511873,1.554528075452852,0.019151846785225718,0.2511242675887844,1.0,4/21,5.64%,GPNMB;LGALS3;PIBF1;DUSP3
prerank,vasculature development (GO:0001944),0.6835922398034124,1.5541238592040492,0.023448275862068966,0.2510689822332653,1.0,6/16,9.37%,APLNR;STRA6;FBXW7;PIK3CA;ACVRL1;BMPR2
prerank,positive regulation of calcium ion import (GO:0090280),0.7184084391010964,1.5533661487130996,0.039097744360902256,0.25198394659254736,1.0,2/12,6.26%,LGALS3;SPHK2
prerank,negative regulation of chemokine production (GO:0032682),0.7016783050754054,1.5527002024759242,0.02967359050445104,0.2525851532337858,1.0,5/14,8.64%,SIGIRR;IL6;MAP2K5;SIRPA;MEFV
prerank,fluid transport (GO:0042044),0.7266559484383749,1.5517746973792457,0.03943217665615142,0.25383822771767134,1.0,1/12,1.89%,AQP1
prerank,positive regulation of organelle organization (GO:0010638),0.5826632759580103,1.551036029336857,0.032175032175032175,0.2547089343090036,1.0,10/32,12.33%,ANXA1;FYCO1;SORBS3;UVRAG;HTRA2;ANXA2;RAB3GAP2;GSK3B;SHCBP1L;TREM2
prerank,early endosome to late endosome transport (GO:0045022),0.6538915927318152,1.5509789635571551,0.03081232492997199,0.2537926688551952,1.0,7/20,9.44%,HOOK3;RAB7A;EEA1;KIF16B;WDR91;STX8;SNX16
prerank,positive regulation of interleukin-17 production (GO:0032740),0.634162840869271,1.5501545003545314,0.026881720430107527,0.2547115207256028,1.0,8/22,19.58%,RFTN1;IL6;LY9;NR1H4;IL15;MYD88;ZBTB7B;OSM
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5293912791098909,1.5491007942057111,0.00776914539400666,0.2562056063715678,1.0,23/74,20.47%,EPAS1;NFE2L2;VEGFA;PSMD1;CITED2;BACH1;CREBBP;RPS27A;UBC;EGLN3;PSMF1;PSMD14;NOTCH1;PSMD12;LIMD1;PSME2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6
prerank,negative regulation of type I interferon production (GO:0032480),0.5659094492292706,1.5485255599458703,0.022304832713754646,0.2567159785088688,1.0,19/40,24.55%,LILRB1;IKBKE;TRIM25;NPLOC4;RNF135;REL;SIRPA;MAVS;NLRC3;TAX1BP1;RELB;TNFAIP3;ACOD1;OTUD5;TBK1;RNF125;ISG15;DHX58;GPATCH3
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5644322446104879,1.5470758302890404,0.009324009324009324,0.25946729328189727,1.0,13/45,15.42%,IQGAP1;REPS2;GRB2;NCK2;SOS1;PDPK1;KIF16B;PIK3CA;ADAM17;PTK2B;ERBIN;SHC1;CBL
prerank,negative regulation of mitochondrion organization (GO:0010823),0.5945146161569944,1.54688067282112,0.0275,0.25895913246437935,1.0,13/33,15.79%,VAT1;SLC35F6;TFRC;HGF;IGF1;PPIF;FLCN;HUWE1;OMA1;PRKN;HSPA1A;BNIP3;ACAA2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.574859580486091,1.5465659383078814,0.025485436893203883,0.25865865616326805,1.0,6/35,5.24%,CD36;HTR2B;APOE;AQP1;PDE7B;MAPK7
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5674801329638284,1.5462760807811593,0.018691588785046728,0.25836473146579103,1.0,10/46,8.05%,DDHD1;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;DGKA;GPD1L;SLC27A1;ABHD4
prerank,defense response to Gram-negative bacterium (GO:0050829),0.5685782722857676,1.5461461100120444,0.02026221692491061,0.2576527563111798,1.0,12/42,17.91%,OPTN;MPEG1;AQP1;IL6;RNASE3;IL6R;DROSHA;TREM2;SLC11A1;LBP;TNFRSF14;DEFA6
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.6305865450565997,1.5460594273496964,0.02699055330634278,0.2568561406101509,1.0,4/23,4.49%,PPARG;ARG1;NR1H3;IFNGR2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.6278380250682455,-1.5452144132833736,0.04941860465116279,0.31194986613108405,1.0,3/11,5.79%,ATP1B1;KCNJ2;KCNJ3
prerank,regulation of interleukin-4 production (GO:0032673),0.6277009167020563,1.544984202482795,0.036684782608695655,0.25866637226760875,1.0,6/21,9.52%,SYK;CEBPB;FOXP3;CD28;RARA;DDIT3
prerank,positive regulation of endocytosis (GO:0045807),0.5712145919549377,1.5437453777541112,0.022700119474313024,0.2608858560743515,1.0,12/45,7.99%,APOE;FLOT1;ANO6;LRP1;CD151;PPT1;APPL2;CLN3;RAB21;RAB31;STAP1;NEDD4L
prerank,regulation of hemopoiesis (GO:1903706),0.7483018731125034,1.5434076555468756,0.038338658146964855,0.2606254589119173,1.0,5/10,11.90%,LGALS3;CREBBP;CBFB;MAFB;PRKCB
prerank,negative regulation of inflammatory response (GO:0050728),0.4989522186762704,1.5432116323162925,0.0,0.2601408208827065,1.0,45/182,15.74%,PPARG;APOE;SYK;CD200R1;GPR15;PTGDR;NR1H3;PLK2;IL6;HTR6;PRKCD;RHBDF2;TNFRSF1B;AOAH;IGF1;MAPK7;GPR83;ADCY7;NR1H4;PTGER2;PROC;METRNL;MFHAS1;GPR176;RB1;SIRPA;MEFV;PTGER4;VIPR1;NLRC3;ADAM17;PTH2R;PPARD;RORA;LPCAT3;MYH9;TREM2;FGR;TNFAIP3;TNFAIP8L2;ACOD1;ADCY8;ADCY3;CD247;GRN
prerank,peptide cross-linking (GO:0018149),0.6276645847572278,1.5423292598833502,0.03080872913992298,0.26129008887171556,1.0,6/25,15.27%,ANXA1;TGM2;THBS1;F13A1;COL3A1;CD247
prerank,cellular glucan metabolic process (GO:0006073),0.7197320832764886,1.5417270334266477,0.0381791483113069,0.26165260395680356,1.0,5/11,12.59%,PRKAG2;PYGL;GBE1;GSK3B;UGP2
prerank,regulation of glycogen metabolic process (GO:0070873),-0.6068413426752928,-1.5416288114625545,0.034482758620689655,0.3155896701576783,1.0,6/12,29.00%,RUBCNL;PPP1R3B;PPP1R3F;KHK;PPP1R3C;PPP1R3E
prerank,negative regulation of anoikis (GO:2000811),0.6886199908143518,1.5404214304151518,0.0350140056022409,0.2638015248273686,1.0,7/14,14.77%,PDK4;ITGA5;PIK3CA;SNAI2;ITGB1;NOTCH1;MCL1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5854488468149193,-1.538258132754494,0.07119741100323625,0.31879009450231083,1.0,2/13,3.51%,CYRIB;STX7
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.6262800165599074,1.5368550461171246,0.027131782945736434,0.27151152035232407,1.0,5/23,8.14%,IRX3;HOPX;ID2;MYL2;MYBPC3
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.7032420807396296,1.5364208717201933,0.034482758620689655,0.2715769032616019,1.0,4/13,5.49%,PLXNA1;PLXNC1;PLXND1;NRP2
prerank,protein processing (GO:0016485),0.5124598557559011,1.5360468070607074,0.004246284501061571,0.2714680784285858,1.0,47/102,25.50%,F7;CD5L;CTSL;PCSK4;KLK3;TMPRSS4;CPXM1;CLN5;MMP14;CLN3;HTRA2;FAM111A;PITRM1;CTSS;CTSH;HPR;HP;BACE1;ADAM17;HM13;MYRFL;LONP2;OMA1;SPCS2;ADAM19;NCSTN;CPM;PARL;CASP2;DDI2;AFG3L2;TYSND1;OGT;LGMN;ADAM10;APH1B;FURIN;XPNPEP3;PSEN2;PCSK7;SPRTN;SRGN;KLK1;ZMPSTE24;FXN;RCE1;SPPL3
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.7282376089286613,1.535480688578609,0.04141104294478527,0.27192247641296097,1.0,3/10,15.73%,CD36;TREM2;MYD88
prerank,regulation of fatty acid oxidation (GO:0046320),0.6694361421253706,1.5352900568184886,0.03566529492455418,0.27131167933114325,1.0,6/16,6.43%,PDK4;PRKAG2;ABCD1;APPL2;ACADL;ACADVL
prerank,regulation of keratinocyte migration (GO:0051547),0.713547161835702,1.5342529184548284,0.039705882352941174,0.27282875119042044,1.0,3/12,4.72%,IQSEC1;ADAM9;PTEN
prerank,regulation of cholesterol esterification (GO:0010872),0.7348764145238263,1.5335084652455864,0.0364741641337386,0.2736189281930147,1.0,4/10,9.57%,APOE;ABCG1;ABCA2;LAMTOR1
prerank,organic hydroxy compound transport (GO:0015850),0.5783041006874559,1.532199571132811,0.0199501246882793,0.27592939071016026,1.0,9/36,9.35%,STRA6;SLC51A;RXRA;SLC16A1;STARD5;ABCC4;NR1H4;ABCC3;NCOA1
prerank,oligosaccharide metabolic process (GO:0009311),-0.4139563863147175,-1.5312161410819893,0.012738853503184714,0.3300496886996379,1.0,16/46,13.96%,ST3GAL6;B3GALT1;ST6GALNAC3;ST8SIA6;FUT9;MAN2B2;ST3GAL2;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST6GAL2;ST8SIA3;GAL3ST4;B4GALT1;ST6GALNAC6
prerank,zymogen activation (GO:0031638),0.5674438441747665,1.5310935698503594,0.02813599062133646,0.2777980383871011,1.0,12/39,9.74%,CD5L;CTSL;KLK3;F11;MMP14;TBC1D10A;NLRC4;CTSH;HPR;HP;CYFIP2;PLAU
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6117830485718484,1.5309258564713624,0.02389937106918239,0.27722285020031223,1.0,9/26,14.77%,EYA1;MAP2K5;HTRA2;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.7436958078400114,1.529962387751992,0.03543913713405239,0.27882381557048164,1.0,5/10,13.63%,AOC3;ETFBKMT;HP;MT3;PRKN
prerank,positive regulation of cellular component organization (GO:0051130),0.5126891802393291,1.5298020735718625,0.007376185458377239,0.2781727631804911,1.0,19/107,8.02%,LGALS3;FNIP2;APOE;SYK;PLEKHM2;BCL2L11;VEGFA;FLOT1;ABCB7;FNIP1;TFRC;LRP1;CD151;SH3GLB1;MTLN;HAS3;ASAP1;NEDD4L;RB1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5291094630848722,-1.5294647470187046,0.027972027972027972,0.3300192376966882,1.0,9/19,20.41%,GRM5;RYR2;TRPM2;PRKACA;PRNP;FIS1;PTPRJ;FKBP1B;ADGRL1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.5570674320598211,-1.529403037556384,0.02768166089965398,0.3265010494782172,1.0,7/16,35.28%,CLDN11;CLDN12;CLDN10;CLDN14;CLDN18;CLDN1;CLDN5
prerank,inflammatory response (GO:0006954),0.48562657854790164,1.5284471563485709,0.0,0.2805720792911175,1.0,43/195,14.81%,CDO1;ADGRE5;CXCR4;AOC3;HRH1;ANXA1;PTGDR;MGLL;CEBPB;IL36G;CD44;IL6;XCR1;IL10RB;PLA2G2D;PARP4;C3AR1;THBS1;ADAM8;PTGER2;CYBB;REL;CYBA;MFHAS1;NLRC4;FOLR2;BLNK;MEFV;HPR;HP;HNRNPA0;PTGER4;NFATC3;LIAS;SIGLEC1;RELB;AFAP1L2;RELA;SLC11A1;TRAF3IP2;ADCY8;NRROS;CX3CL1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.6679241715243136,1.526809116665243,0.02446043165467626,0.283832621147377,1.0,2/16,0.58%,HTR2B;APOE
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.5159470613629854,-1.5261975584348144,0.0547945205479452,0.3296484130149866,1.0,10/18,11.82%,CAMK1D;RPS6KA5;EPHA5;RELN;PRKD1;CD200;LRP8;LPAR5;ADCY1;PRKD2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.5040122130750497,1.5260658497862996,0.0031914893617021275,0.28483486288741316,1.0,23/113,12.33%,LGALS3;CD36;FNIP2;ABCA1;SYK;BCL2L11;VEGFA;FNIP1;TFRC;LCP1;SH3GLB1;GTF2H5;MTLN;ASAP1;CAPG;TERF1;IL5;DDB1;ESR1;GSK3B;PIEZO1;STUB1;CUL4A
prerank,positive regulation of lyase activity (GO:0051349),-0.5717406029594474,-1.5252854129511297,0.045307443365695796,0.3283986824118598,1.0,6/14,25.21%,ORAI1;CACNA1C;AKAP5;PARK7;ISCU;NOS1
prerank,cell differentiation in hindbrain (GO:0021533),-0.6239188488926746,-1.5246683522653344,0.061046511627906974,0.3261261684369033,1.0,4/11,3.92%,OPHN1;GRID2;KNDC1;FAIM2
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5601529089623776,1.524440315325816,0.0196078431372549,0.28810869557042235,1.0,21/46,24.06%,PPARG;CTNNB1;ID2;IL6;IGF1;THBS1;HMOX1;FOXP1;IL6R;XRCC5;RBPMS2;TNFAIP3;CX3CL1;APOD;TCF7L2;HES5;PRKDC;IGFBP3;MFN2;PDGFRB;OGN
prerank,protein neddylation (GO:0045116),0.6934576441751696,1.524383345122376,0.035398230088495575,0.2872371317502693,1.0,8/13,17.28%,DCUN1D5;DCUN1D3;UBA3;DCUN1D4;UBE2F;RNF7;DCUN1D1;UBE2M
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5901821531700414,1.5242600148734706,0.03383458646616541,0.28653614975098746,1.0,12/30,16.58%,GRB2;TGM2;NOTCH2;IGF1;IRS2;VAV1;NOTCH1;RAPGEF1;RASGEF1A;ERBIN;SHC1;LRRC59
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.5581746463914524,-1.524228591085631,0.049342105263157895,0.3236466346939294,1.0,7/15,15.83%,GRM5;GRM1;GRM8;GRM3;HOMER1;GRIK3;GRM7
prerank,regulation of protein neddylation (GO:2000434),0.7506477492790178,1.5239397837285602,0.0350076103500761,0.2862568514871005,1.0,6/10,16.62%,EPAS1;COPS9;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1
prerank,nucleoside triphosphate metabolic process (GO:0009141),0.6772733372965162,1.5214020296270925,0.038028169014084505,0.2916726896689758,1.0,3/14,6.34%,AK8;ENPP1;ITPA
prerank,negative regulation of response to external stimulus (GO:0032102),0.507657655710894,1.5209205064486142,0.010649627263045794,0.2918349370959432,1.0,29/105,14.37%,PPARG;APOE;SIGIRR;NR1H3;RNF26;PRKCD;AOAH;PTEN;MAPK7;DUSP3;NR1H4;IRAK3;PROC;METRNL;MFHAS1;RB1;SIRPA;NFKBIL1;MEFV;PTGER4;NLRC3;TRAFD1;PPARD;RORA;LPCAT3;TNFAIP3;TNFAIP8L2;INPP5F;ACOD1
prerank,regulation of cell communication (GO:0010646),0.5643685834776143,1.5197723202291251,0.024509803921568627,0.29389121954809744,1.0,5/35,5.02%,MTCH1;ANXA1;MGLL;CDC42SE2;SLC8A1
prerank,inhibitory synapse assembly (GO:1904862),-0.6073748874363198,-1.5197618104805883,0.058981233243967826,0.32956028258720194,1.0,4/11,5.30%,GABRB3;GABRA2;LGI2;FGF13
prerank,response to fatty acid (GO:0070542),0.6585343075083109,1.5195081185994035,0.033576642335766425,0.29358605554241585,1.0,7/17,12.56%,CD36;PDK4;FOXO3;PID1;NR1H4;FOXO1;KCNK4
prerank,regulation of brown fat cell differentiation (GO:0090335),0.6669475443991342,1.518352699247355,0.04143646408839779,0.2956726992374334,1.0,7/16,10.59%,PIM1;FLCN;HNRNPU;METRNL;RREB1;FTO;SIRT1
prerank,fatty acid metabolic process (GO:0006631),0.49761448180755635,1.518246865539407,0.0031545741324921135,0.29492647955682016,1.0,18/115,9.09%,CD36;PPARG;CEL;BAAT;LIPG;LPIN3;GPAT2;SGPL1;FASN;AOAH;SLC27A4;PON3;ACSM3;SLC27A3;GPX4;CRAT;CPT1A;NDUFAB1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.623984096304643,-1.5182111556129896,0.05965909090909091,0.3291857753719397,1.0,3/10,10.33%,WHRN;PLS1;ADGRV1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.6930678410527475,1.5174249379567792,0.04310344827586207,0.29616648888695385,1.0,4/13,4.59%,CBLB;IPO5;KPNA4;KPNA2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.5205625023981975,-1.5170985376968062,0.048582995951417005,0.3282607379711214,1.0,10/19,21.64%,PTPRD;IL1RAPL1;RELN;CUX2;LRP8;CDKL3;DBNL;SS18L2;CUL7;DBN1
prerank,triglyceride homeostasis (GO:0070328),0.6123650081228345,1.5169960071906057,0.029831387808041506,0.2963312454242252,1.0,6/26,11.93%,APOE;NR1H3;MTLN;NR1H4;SIRT1;RORA
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5252792525580019,1.5168425385060573,0.017640573318632856,0.2956481951845167,1.0,23/74,14.77%,LGALS3;EYA1;FAS;BIRC6;RIPK1;MAP2K5;IGF1;MAPK7;THBS1;HSPA1B;HMOX1;SH3RF1;BRCA1;SNAI2;GSK3B;ARHGEF2;RNF34;RELA;TNFAIP3;HSPA1A;GDNF;PHIP;MCL1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.6567156467152485,1.5162182735883343,0.0371900826446281,0.2962085350595171,1.0,11/18,22.83%,APOE;ABCG1;CLN3;BACE1;ADAM17;ADAM19;NCSTN;ADAM10;APH1B;LDLRAP1;PSEN2
prerank,receptor-mediated endocytosis (GO:0006898),0.5007942772521029,1.5149875802117445,0.0041279669762641896,0.2985145114202301,1.0,35/132,14.60%,CD36;TPCN2;APOE;SYK;IGF2R;GRB2;PIKFYVE;CTSL;LILRB1;TFRC;LRP1;STAB2;SNX9;PPT1;SORL1;CLN3;GAK;LMBRD1;SCARB2;RAB31;MICALL1;FOLR1;HPR;HP;PICALM;ITGB1;FCHO1;M6PR;AP1G2;AP1G1;EPS15;AP2B1;INPP5F;RABEPK;LRP6
prerank,establishment of protein localization to membrane (GO:0090150),0.5276421003699477,1.514788999082045,0.01564245810055866,0.29805561646424183,1.0,23/66,17.78%,RFTN1;SDCBP;PIKFYVE;ZDHHC14;ZDHHC19;NPC1;SYNE3;GRIN3B;RAB3GAP2;YIF1B;MICALL1;ZDHHC12;ZDHHC18;NACA;RAB10;RAB11B;RABGEF1;ZDHHC24;BID;NCF1;ZDHHC4;SEC63;ICMT
prerank,cellular response to fluid shear stress (GO:0071498),0.697204282706446,1.5147144014244283,0.03816793893129771,0.29719128071203965,1.0,4/12,5.24%,MTSS1;NFE2L2;MAP2K5;MAPK7
prerank,regulation of cellular metabolic process (GO:0031323),0.5502120503454083,1.5132990273696172,0.01717791411042945,0.29985960402315026,1.0,17/45,17.48%,FLOT1;PDK4;ABCG1;MPV17;COQ7;FASN;KIF16B;PID1;EIF6;ABCA2;LAMTOR1;STUB1;RNF34;PRKN;PANK2;PARL;ARF4
prerank,positive regulation of integrin activation (GO:0033625),-0.6120182600129495,-1.5131374008268903,0.04610951008645533,0.3333779263281919,1.0,3/11,11.63%,P2RY12;FERMT2;RAP1B
prerank,glucan biosynthetic process (GO:0009250),0.704541869033241,1.5128181288672002,0.04066265060240964,0.2990365966665084,1.0,5/12,12.59%,GYG1;GBE1;NHLRC1;PGM1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.704541869033241,1.5128181288672002,0.04066265060240964,0.2990365966665084,1.0,5/12,12.59%,GYG1;GBE1;NHLRC1;PGM1;UGP2
prerank,regulation of B cell differentiation (GO:0045577),0.6538643373628552,1.5126049469444418,0.030942334739803096,0.2986888727670357,1.0,5/17,12.78%,SYK;ID2;MMP14;ZFP36L2;BTK
prerank,sterol transport (GO:0015918),0.6411491614418444,1.5108759396481815,0.04172461752433936,0.30255590775329855,1.0,2/19,1.84%,CD36;NPC1
prerank,proteolysis (GO:0006508),0.48368840861230145,1.510875153652864,0.0,0.30153375941629423,1.0,77/252,22.83%,F7;ANPEP;MMP12;CTSB;ADAM33;CTSD;CAPN15;TINAGL1;CTSL;CPQ;PCSK4;TPP1;KLK3;NPEPPS;TMPRSS4;HGF;NLN;CTSA;CNDP2;CPXM1;MMP14;LONP1;CLN3;HTRA2;FAM111A;PITRM1;PROC;CAPN2;CTSS;CTSZ;CTSH;VASH2;BACE1;RSPRY1;PLAU;ADAM17;HM13;CTSW;PGPEP1;LONP2;ATG4B;UBA3;FBXO6;FBXW2;CAPN7;RNF123;TMPRSS5;ADAM19;NCSTN;CASP6;CPM;LNPEP;PARL;ACE;SENP1;CASP2;CASP3;APEH;PRCP;RNPEPL1;DDI2;LAP3;UFSP2;AFG3L2;TYSND1;PSMA6;OGT;LGMN;ADAM10;MMP19;CLPX;DPP3;APH1B;FURIN;XPNPEP3;MALT1;PSEN2
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4502486408948285,-1.510719605784832,0.027777777777777776,0.3352183210319376,1.0,7/30,4.61%,SNTA1;ANK2;CACNA1C;RYR2;SCN1B;FGF12;KCNJ2
prerank,melanocyte differentiation (GO:0030318),0.7226116678330939,1.510665063228188,0.03426791277258567,0.3011082835915396,1.0,5/11,7.95%,LRMDA;MITF;MREG;ENPP1;HPS6
prerank,endosome organization (GO:0007032),0.5671708978479536,1.5088977453261851,0.020606060606060607,0.3049663046447379,1.0,19/41,19.18%,PHETA2;HOOK3;SNX10;CORO1C;RNF26;EEA1;LAMTOR1;SNX33;PI4K2A;ARFGEF2;PLEKHJ1;SQSTM1;VPS11;DNAJC13;USP8;RAB22A;SNX3;ALS2CL;WASHC5
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5535958095561194,1.5081856778073277,0.03369434416365824,0.30591754414078187,1.0,12/40,17.91%,MPEG1;IL6;STAB2;RNASE3;GBP6;ADAM17;DROSHA;FGR;LBP;MYD88;TNFRSF14;DEFA6
prerank,response to ethanol (GO:0045471),-0.5731725290958023,-1.507390373543154,0.05647840531561462,0.33860266070754136,1.0,5/14,8.54%,GRIN2A;GRIN2B;GRIN3A;GRIN1;GLRA1
prerank,positive regulation of vasoconstriction (GO:0045907),0.6797935597071932,1.5072367202348682,0.03484848484848485,0.3074909840288511,1.0,2/13,1.52%,ADRA1D;ADRA1A
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6448525467654511,1.5050480058680078,0.051893408134642355,0.3124258653535099,1.0,4/17,4.62%,SYK;CEBPB;CD28;RARA
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5991998543783025,-1.5041479366221662,0.06936416184971098,0.342193178575148,1.0,5/11,16.41%,BIN1;CACNB2;NOS1AP;CACNA2D1;CACNB1
prerank,regulation of tissue remodeling (GO:0034103),0.6527641861475172,1.504004971083109,0.040376850605652756,0.3143972349884507,1.0,1/18,0.01%,GPNMB
prerank,positive regulation of DNA binding (GO:0043388),0.586053767321232,1.5010577995448098,0.0460772104607721,0.3216504030619445,1.0,5/31,8.02%,PPARG;TXN;NIBAN2;IGF1;RB1
prerank,phagolysosome assembly (GO:0001845),0.6927142554703583,1.501040210425061,0.05286343612334802,0.32062623715393584,1.0,6/12,9.65%,RAB7B;PIKFYVE;RAB20;RAB7A;CLN3;ARL8B
prerank,positive regulation of monooxygenase activity (GO:0032770),0.5969661268183813,1.5007892944383643,0.032552083333333336,0.32025743025819037,1.0,8/26,19.22%,HTR2B;APOE;POR;S100A1;GDNF;ATP7A;GCH1;PIK3CB
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6845559702874228,1.5002505915872895,0.06412213740458016,0.32070255545116894,1.0,2/11,2.06%,ANXA1;FOXP3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5407298301679023,1.5001927277512952,0.016147635524798153,0.3197921753621073,1.0,15/50,13.36%,VEGFA;AQP1;FNIP1;DNAJB6;CD44;HGF;MAP2K5;RAF1;THBS1;SH3RF1;XIAP;PAK2;MT3;RNF34;GAS6
prerank,protein heterooligomerization (GO:0051291),-0.5201373127756201,-1.5001646315438824,0.045454545454545456,0.34742039029166394,1.0,8/17,21.94%,GRIN2B;KCNC2;GRIN1;TMEM120A;PKD2;PKD1;MAT2A;NUDT21
prerank,chloride transport (GO:0006821),-0.3737182879334748,-1.4990168454633614,0.0,0.3465544595433538,1.0,24/74,14.64%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;TTYH1;GABRA3;GLRA1;GABRG3;SLC4A10;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3;CLCN6;SLC12A4;GABRA4;CLCN2
prerank,positive regulation of cell projection organization (GO:0031346),-0.34233784901622355,-1.4989333844631656,0.0,0.3434162076225951,1.0,27/115,6.14%,PTPRD;ARSB;CAMK1D;RIT2;PLXNA4;IL1RAPL1;TWF2;ROBO2;ROBO1;TENM3;NTRK3;SETX;ITGA6;EPHA3;TOX;TIAM1;ARHGDIA;PLPPR5;MAGI2;SCN1B;RELN;FUT9;NTRK2;ATP1B2;MAP3K13;CUX2;PRKD1
prerank,neuron migration (GO:0001764),-0.4054019024803011,-1.4987769844001062,0.032679738562091505,0.34049790392547064,1.0,16/48,9.05%,ADGRL3;MEF2C;GPM6A;SPOCK1;DISC1;AUTS2;RELN;CDK5R1;NTRK2;FGF13;ASTN2;MARK1;TUBB2A;DNER;MARK2;SEMA3A
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.5907470915576994,1.4985989417571906,0.041884816753926704,0.3234575831175522,1.0,9/26,11.52%,PDK4;PRKAG2;NR1H3;EIF6;ACADL;ACADVL;BRCA1;ERLIN1;WDTC1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.5400657695502387,-1.4985328756133827,0.03900709219858156,0.33770957445916944,1.0,9/16,13.96%,ST6GALNAC3;ST8SIA6;ST3GAL5;ST6GALNAC5;ST6GALNAC4;ST8SIA1;ST8SIA5;ST8SIA3;ST6GALNAC6
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.7090024536002785,1.4980847517244023,0.0442225392296719,0.323771318624337,1.0,7/11,21.02%,VCPIP1;LPCAT3;ATL2;ATL1;MOSPD3;RTN4;ARL6IP1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5770869783765179,1.4979249077341448,0.03694267515923567,0.3231257582556381,1.0,5/33,5.80%,LGALS3;CD300A;DGKZ;DUSP3;TRAT1
prerank,regulation of RNA splicing (GO:0043484),0.5171412871471713,1.4978569617792779,0.016666666666666666,0.32226899317652086,1.0,25/69,18.29%,HNRNPLL;ERN1;AHNAK;POLR2A;HNRNPH2;MBNL1;SRPK2;CELF1;RBM39;AHNAK2;DYRK1A;SF1;GRSF1;PTBP3;LARP7;SRSF3;PTBP2;PQBP1;RPS26;HSPA1A;PRX;MBNL2;SRPK1;RBM22;CLK3
prerank,positive regulation of protein deacetylation (GO:0090312),0.6732566828906345,1.497382745613945,0.04090267983074753,0.32262975732836635,1.0,3/14,6.98%,APLNR;DYRK1A;NIPBL
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.49347586857187753,-1.4972089349941922,0.05190311418685121,0.3375468487733095,1.0,12/20,26.97%,PRKCE;MTDH;HCK;IL18;TNF;CD14;LYN;CCL3;IL1B;CCL5;TGFB1;TICAM1
prerank,positive regulation of transporter activity (GO:0032411),0.6847889787515474,1.4967140731408848,0.050724637681159424,0.3234425125877936,1.0,3/13,3.66%,SGK1;NR1H3;RXRA
prerank,brain development (GO:0007420),-0.32889574148772016,-1.4966691361424218,0.0,0.3356841307882112,1.0,32/136,11.45%,ZFHX3;CX3CR1;CNTNAP2;ADGRL3;GRIN2A;CTNNA2;PHF8;ROBO2;PTCH1;GRIN2B;NFIB;TGFBR2;EML1;CNTN4;RELN;CDK5R1;GRIN1;PBX3;ARNT2;CDH2;POU6F1;ADGRG1;BBS2;MEIS3;PAX2;QARS1;UFM1;EPHA7;MEIS1;SOX6;IER3IP1;NDUFS4
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.6180438078897335,1.4966597764480847,0.03305785123966942,0.3225568276907629,1.0,5/22,5.24%,GCNT2;FLOT1;CD44;MAP2K5;MAPK7
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.5875257325139017,1.4965366465238856,0.04804045512010114,0.3218828455304499,1.0,10/26,12.33%,CD36;FLOT1;APPL2;IRAK3;GPR108;NFKBIL1;NLRP2B;BIRC3;APPL1;TREM2
prerank,T cell activation involved in immune response (GO:0002286),0.6904162275127803,1.4963377991604538,0.04580152671755725,0.32145116376133925,1.0,4/12,13.65%,LILRB1;LCP1;EIF2AK4;SLC11A1
prerank,negative regulation of interferon-beta production (GO:0032688),0.737721572547225,1.4959282363535842,0.04961240310077519,0.3216300420772407,1.0,5/10,12.23%,LILRB1;REL;SIRPA;NLRC3;RELB
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.5027455292331616,1.495515574651309,0.011689691817215728,0.3217559515130306,1.0,33/94,18.22%,FNIP2;BCL2L11;ERN1;CEBPB;IKBKE;PRKCD;CDKN1A;APAF1;TNFRSF1B;E2F1;HTRA2;CUL3;GSKIP;MLLT11;STK24;DDX5;ATF4;PRODH;BRCA1;TOPORS;HIPK2;DDIT3;CUL4A;BAX;CUL1;MCL1;QRICH1;BNIP3;TRAF2;RRP8;BBC3;C1QBP;CASP2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.5105953796244534,1.4952362965752952,0.011827956989247311,0.3215160720890082,1.0,20/80,13.36%,CTSD;SYK;VEGFA;AQP1;FNIP1;DNAJB6;CD44;HGF;DAPK1;MAP2K5;RAF1;HTRA2;THBS1;SH3RF1;XIAP;CYCS;SIRT1;MT3;SOX2;GAS6
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5164482595690933,-1.4950192651692378,0.04964539007092199,0.33599114550345843,1.0,7/18,5.88%,NRXN1;NLGN1;RIMS1;RIMS2;RELN;GRIN1;CUX2
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5043971490563266,1.4944751685716788,0.005387931034482759,0.3226912673879443,1.0,32/91,20.67%,FLVCR1;FTL;ATP6V1A;ABCB7;TFRC;SLC11A2;ATP6V0D1;TMEM199;NUBP1;HMOX1;FRRS1;HEPH;SLC39A14;GLRX3;MT3;APP;HMOX2;SLC11A1;SLC39A12;CUL1;ATP7A;SLC31A2;FTH1;SLC30A1;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,phosphatidic acid metabolic process (GO:0046473),0.547024763881642,1.4943615635527434,0.027906976744186046,0.3219909447068586,1.0,10/48,8.05%,DDHD1;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;DGKA;GPD1L;SLC27A1;ABHD4
prerank,monocarboxylic acid metabolic process (GO:0032787),0.49039665298792756,1.4934633484104056,0.008429926238145416,0.3235637645959533,1.0,27/117,15.94%,CD36;PPARG;BAAT;GPAT2;NPC1;SGPL1;AMACR;KYNU;MTHFS;FASN;PDZD11;SLC16A1;AOAH;SLC27A4;IGF1;GLYAT;CPT1A;GRHPR;MCCC1;PPARD;SLC6A8;MTHFD1L;HAGH;VDAC1;ME2;PANK2;ALDH1A2
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.6274111685441675,1.4934586469210938,0.0374331550802139,0.32157917835403665,1.0,8/21,14.77%,EYA1;MAP2K5;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.6274111685441675,1.4934586469210938,0.0374331550802139,0.32157917835403665,1.0,8/21,14.77%,EYA1;MAP2K5;MAPK7;HSPA1B;SNAI2;HSPA1A;GDNF;MCL1
prerank,NAD biosynthetic process (GO:0009435),0.6326343409162449,1.4929960149582944,0.0443213296398892,0.3219117821899893,1.0,3/20,6.98%,NAMPT;KYNU;NMNAT1
prerank,positive regulation of lipid metabolic process (GO:0045834),0.6038308674048302,1.492931561107105,0.025435073627844713,0.3210823590395186,1.0,4/22,11.10%,PPARG;APOE;ZBTB20;PPARD
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3820090701361175,-1.491941040713975,0.0,0.33924135903855845,1.0,19/63,10.66%,SLC12A2;GABRB3;SLC12A6;ANO4;GLRB;SLC1A3;ANO3;GLRA3;GABRA2;GABRB1;SLC25A14;GABRA3;GLRA1;GABRG3;SLC6A1;SLC4A8;SLC1A1;LRRC8A;CLCN3
prerank,nitrogen compound transport (GO:0071705),0.48606930374013535,1.490576578369193,0.002066115702479339,0.3265034102349588,1.0,43/141,21.63%,LRRC8D;SLC6A6;SLC7A2;FLVCR1;SLC18A1;SLC36A2;SLC43A2;AQP1;CERT1;RAB7A;SLC1A5;SLC7A4;SLC7A7;ARRDC4;SLC16A10;PPT1;SLC38A1;CHMP2A;SCARB2;KIF3A;SLC15A3;SLC6A8;SLC7A11;MYH9;SLC23A1;SLC52A1;SLC11A1;SLC44A2;TOM1;SLC7A1;SLC36A1;ABCC1;SLC6A4;LRP2;SLC19A2;SLC7A8;CALCRL;VAMP2;TMEM30A;ARRDC3;CHMP2B;NDC1;SLC22A5
prerank,endocytic recycling (GO:0032456),0.5405304778904483,1.4905450753362182,0.022274325908558032,0.3255645191691484,1.0,22/50,20.13%,MICALL2;SNX27;DENND1A;RAB7A;WASHC1;MICALL1;DENND1B;EIPR1;VPS52;VPS51;VPS35L;RAB11B;EPS15;ARL4C;STX6;SNF8;SNX17;SNX3;VPS29;ANKRD27;ANKRD50;RAB13
prerank,regulation of acrosome reaction (GO:0060046),-0.623250683326581,-1.4904489111213368,0.0335195530726257,0.33946309088579907,1.0,2/10,8.54%,PLCB1;GLRA1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.45534476836722565,-1.490290978900387,0.03734439834024896,0.3367526146697425,1.0,12/28,23.22%,ITGAM;ANK3;ITGB2;ITGB1BP1;TCAF1;PRNP;GDI1;FIS1;AKT2;MIEF2;CIB1;C2CD5
prerank,ureteric bud development (GO:0001657),-0.5397426698455544,-1.4894992302826953,0.06761565836298933,0.3353482692728926,1.0,12/17,36.11%,SALL1;ROBO2;FGFR2;PKD2;NPNT;FOXC1;FOXJ1;BMP2;BMP4;LHX1;BMP7;SLIT2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.5449982443012374,1.4892618636209611,0.024676850763807285,0.32809522243571376,1.0,13/47,12.29%,FBXW7;GLA;SIK1;ACADL;ACADVL;BRCA1;SNAI2;SLC27A1;ABCA2;SIRPA;ERLIN1;WDTC1;PGP
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6110966508464067,-1.4882959835286624,0.05322128851540616,0.33503663426616,1.0,6/10,31.30%,GLI3;LAG3;IRF1;FOXJ1;BMP4;ZC3H8
prerank,cardiac muscle cell differentiation (GO:0055007),0.6116511975560849,1.4873368898499724,0.051351351351351354,0.3324746694143912,1.0,6/21,7.98%,ALPK3;IRX3;VEGFA;SLC8A1;SIK1;AKAP13
prerank,intermediate filament organization (GO:0045109),0.648547782169979,1.4864389090089996,0.05357142857142857,0.33388277447542375,1.0,3/17,2.65%,MTM1;VIM;DNAJB6
prerank,sphingolipid metabolic process (GO:0006665),0.4937781695373575,1.4863406603058678,0.003188097768331562,0.33318125671154486,1.0,39/108,20.50%,PSAP;PLPP3;SPTLC2;CERK;SAMD8;SGPL1;GALC;CERT1;GLA;CTSA;ESYT1;PPT1;SGMS2;HACD4;HEXA;CERS6;SPHK2;ARSA;SPTSSA;ABCA2;VAPA;ELOVL1;GM2A;ALDH3A2;DEGS1;PRKD3;ESYT2;SUMF1;NEU1;ACER2;SGMS1;CERKL;PPP2CA;NSMAF;ASAH1;SGPP2;PPP2R1A;CERS1;ARV1
prerank,angiogenesis involved in wound healing (GO:0060055),0.6967119880182236,1.4859406363933396,0.05246913580246913,0.33326680621889276,1.0,2/11,1.73%,HPSE;VEGFA
prerank,regulation of lymphocyte proliferation (GO:0050670),0.6482221501584772,1.4858579232037636,0.0425531914893617,0.33249112285475413,1.0,3/16,8.59%,LGALS3;TNFRSF1B;CD22
prerank,granulocyte chemotaxis (GO:0071621),0.5281308256101382,1.4857444092407517,0.028901734104046242,0.33188924004398407,1.0,4/55,1.55%,LGALS3;SYK;PIKFYVE;ANXA1
prerank,positive regulation of lipid storage (GO:0010884),0.6138754543453843,1.485525884243381,0.04973118279569892,0.3315209391329948,1.0,3/21,2.44%,PLIN2;PLIN3;IKBKE
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.6086551463052036,1.4847523788251522,0.05843293492695883,0.3326683146898796,1.0,6/22,10.25%,LGALS3;MGAT5;STYXL1;BOD1;ROCK1;GSK3B
prerank,protein transport (GO:0015031),0.46953145938164076,1.4845553598041423,0.0,0.33217794768145503,1.0,92/332,16.85%,ATP6V0D2;CD36;PPARG;ABCA1;APOE;TLK1;OPTN;STX3;SNX8;ATP6V1A;STEAP3;ACD;ABCG1;RAB8B;TBC1D22A;SNX27;RIC1;TBC1D25;TFRC;RAB20;ATP6V1E1;RAB7A;LRP1;TBC1D1;TBC1D2;ATP6V1C1;CTSA;ARRDC4;TCIRG1;SNX9;ATP6V0D1;TBC1D12;PPT1;RAB21;STX8;TBC1D10A;COG7;STX5;RAB3GAP2;CHMP2A;TANGO6;ATP6V1B2;VMP1;TBC1D2B;RAB31;KIF3A;RAB1B;LAMP2;TICAM2;RAB28;VPS33A;UNC93B1;STX11;ATP6V0A1;SNX33;RAB12;SIL1;TBC1D22B;RAB10;ARHGEF2;RAB18;TBC1D15;WLS;PRKCB;STXBP3;RAB24;MYH9;AP3D1;ATP6V0E1;RAB43;RAB11B;MACF1;ATP6V0C;ATP6V0B;ATP6V1H;ARL4C;STX6;SLC10A7;AP3B1;GOLPH3;GOLPH3L;GOLGA4;SNX17;TOM1;TBC1D9;NEURL1B;RABGAP1;ZDHHC17;RAB29;ATP6V1F;GGA2;RAB22A
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6969665118091916,1.4841611902413605,0.07120743034055728,0.3313483043913083,1.0,5/11,14.64%,SYK;STAT5B;PTK2B;SHC1;JAK3
prerank,cellular response to interleukin-2 (GO:0071352),0.6969665118091916,1.4841611902413605,0.07120743034055728,0.3313483043913083,1.0,5/11,14.64%,SYK;STAT5B;PTK2B;SHC1;JAK3
prerank,response to copper ion (GO:0046688),0.6289890195435135,1.4841502020129786,0.04685408299866131,0.3304249555433681,1.0,11/20,20.67%,AQP1;MT3;ATP5F1D;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5815663528776489,1.4833116870160885,0.049872122762148335,0.33172748116211875,1.0,9/27,9.37%,HGF;CDKN1A;NIBAN2;PDGFA;PARP4;FGFR4;ACVRL1;DACH1;BMPR2
prerank,negative regulation of autophagy (GO:0010507),0.5213010013061504,1.4825927223286761,0.025056947608200455,0.33282414312600733,1.0,18/54,19.38%,HTR2B;ATG7;HGF;CTSA;WASHC1;PIK3CA;QSOX1;FOXK1;MT3;TAB2;TREM2;ZKSCAN3;MCL1;USP36;RUBCN;EIF4G3;EIF4G2;TLK2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.580919821992405,1.4818384193029936,0.040342298288508556,0.3338964571127326,1.0,13/30,19.10%,DNAJB13;CHCHD4;GAK;HSPA1B;DNAJB5;DNAJB14;HSPA1A;UGGT1;HSPA13;DNAJC18;HSPE1;CCT2;BAG1
prerank,positive regulation of secretion (GO:0051047),0.697298559727579,1.4817685398574576,0.04599406528189911,0.3331108273786857,1.0,3/11,13.02%,AQP1;TRH;GPLD1
prerank,response to insulin (GO:0032868),0.5075468997397808,1.481721926828364,0.0087527352297593,0.332282090454536,1.0,30/80,22.58%,PPARG;MYO5A;DENND4C;LPIN3;RAB8B;PDPK1;ENPP1;IRS2;EIF6;RAB31;SLC27A1;SLC39A14;RAB12;RAB10;FOXO1;SIRT1;EPRS1;GPLD1;INSIG2;EPM2AIP1;ZBTB7B;CPEB2;RAB13;VAMP2;GCK;OGT;TBC1D4;PKM;PRKDC;SYAP1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.5147849241954777,1.4793828994394016,0.03686635944700461,0.3379493323949893,1.0,32/59,26.82%,TLR8;IRAK2;TANK;RIPK1;LY96;REL;RPS27A;UBC;NFKBIL1;TICAM2;NLRC3;ROCK1;BIRC3;TAB2;RELB;RELA;TRAF2;ERC1;BIRC2;CARD11;TBK1;AZI2;BCL3;BCL10;TRAF6;PRDX4;TAB1;FAIM;TLR9;MAP3K7;TAB3;RNF31
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.45451205352390556,-1.4793054312290888,0.0410958904109589,0.34964249440431194,1.0,8/26,14.50%,NAV3;MAPT;CDK5R1;PAK1;AKAP9;NUMA1;STMN2;MAPRE1
prerank,regulation of DNA metabolic process (GO:0051052),0.53835018450734,1.479101169732754,0.037125748502994015,0.3377362066004607,1.0,20/44,19.35%,MPV17;ALYREF;PDGFA;KPNA2;HELB;THOC1;WDR18;POLH;XRCC5;WDR70;NBN;IL7R;SIRT7;KDM1B;HNRNPD;MPHOSPH8;CDT1;UBE2V1;RADX;HDAC8
prerank,positive regulation of cellular metabolic process (GO:0031325),0.498655650690438,1.478857973988914,0.018259935553168637,0.337459348783379,1.0,25/98,16.95%,PPARG;XDH;APOE;GRB2;VEGFA;NR1H3;CDKN1A;FASN;CD63;IL10RB;RIPK1;PID1;THBS1;GADD45A;ANXA2;RAB1B;PAX8;PPARD;MT3;VAMP3;INPP5F;ACOD1;ARRB1;RAB29;IFNAR1
prerank,DNA modification (GO:0006304),0.6086005596238296,1.4770067792646369,0.04979811574697174,0.3417619783616692,1.0,8/22,11.05%,ACD;MUTYH;PARP2;PARP3;NEIL1;EXOSC3;TERF1;MBD4
prerank,regulation of interleukin-17 production (GO:0032660),0.5677297060268623,1.4767496708334131,0.04534005037783375,0.34149284226563975,1.0,10/31,19.58%,RFTN1;FOXP3;IL6;LY9;NR1H4;DDIT3;IL15;MYD88;ZBTB7B;OSM
prerank,RNA metabolic process (GO:0016070),0.487831883246973,1.4766341995562111,0.010384215991692628,0.3408476183785303,1.0,43/127,15.47%,APOBEC1;RBMS1;DHX8;POLR2A;ATXN1;WTAP;TFIP11;HNRNPH2;MPHOSPH10;RBM39;ATXN2;RNASE3;AGO2;NUFIP1;RNASEL;HNRNPUL1;THOC1;HNRNPU;RBPMS;POLR2L;TENT2;HNRNPA0;WDR74;POLR2G;DKC1;AGO3;FTO;POLR2I;NCBP2;DROSHA;HNRNPM;GTF2F2;SND1;DEDD2;DDX20;SIDT2;RNASEH2A;MRPL44;HNRNPD;RNASEH1;MTREX;ADARB1;PCBP1
prerank,placenta development (GO:0001890),0.6733626212820053,1.4753470917784288,0.050221565731166914,0.34353951483785844,1.0,1/12,0.13%,PPARG
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6518101008987729,1.473403021530892,0.06770098730606489,0.34786367327692347,1.0,2/15,1.26%,CD36;PRKCH
prerank,lytic vacuole organization (GO:0080171),0.5518046541331374,1.4732888807771367,0.048507462686567165,0.34717112567211617,1.0,7/32,5.15%,ABCA1;TPCN2;TFEB;TPP1;HOOK3;CLN5;CLN3
prerank,regulation of receptor recycling (GO:0001919),0.6456833620742644,1.4732428011253644,0.055162659123055166,0.3463435388916868,1.0,8/16,16.65%,OPTN;KIF16B;ANXA2;TRAT1;LAMTOR1;VAMP3;INPP5F;RAB29
prerank,regulation of cytokine production (GO:0001817),0.4807523847855593,1.4732377299941493,0.005208333333333333,0.3453993653102663,1.0,24/126,13.65%,GPNMB;HTR2B;ANXA1;FLOT1;FOXP3;RNF26;IL6;CD28;ATP2B1;PLD3;TNFRSF1B;IGF2BP3;SNAI2;SIRPA;FOXP1;PTGER4;IL15;TREM2;AFAP1L2;TRAF3;FGR;N4BP1;POLA1;SLC11A1
prerank,O-glycan processing (GO:0016266),0.5285921967970756,1.4720563912443152,0.02910360884749709,0.34779342560852405,1.0,7/54,7.77%,B4GALT5;B3GNT8;GALNT3;GALNT6;GALNT9;ST3GAL4;GXYLT2
prerank,endocardial cushion morphogenesis (GO:0003203),-0.510984092703035,-1.4717499745310207,0.04887218045112782,0.36191395920995145,1.0,6/18,8.69%,ACVR1;BMPR1A;TGFBR2;ENG;MDM4;TGFB2
prerank,B cell differentiation (GO:0030183),0.5334728113765012,1.4717107887111662,0.029447852760736196,0.3478119856088884,1.0,12/46,17.62%,ADGRG3;FNIP1;TPD52;ITGA4;MS4A1;BLNK;ITGB1;ADAM17;DCAF1;JAK3;KLF6;ZBTB7A
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.5926598240938367,1.4712556400715149,0.047748976807639835,0.34808231724769595,1.0,12/24,15.74%,CTNNB1;FBXW7;FOXO3;TFAP2B;SRPK2;ATF4;TYROBP;BACE1;DDIT3;BAX;MCL1;GRN
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4876558473633228,1.4708111766935008,0.012738853503184714,0.34847388543758323,1.0,35/109,19.69%,SYK;GRB2;VAV3;MAP3K1;GAB2;TEC;SOS1;PDPK1;PSMD1;JUN;PIK3CA;VAV1;MAP2K4;PPP3CA;PPP3R1;PAK2;PSMF1;NFATC3;PSMD14;TAB2;PSMD12;BTK;RELA;SHC1;PSME2;CUL1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PIK3CB;PSMA2;PSMD11;LAT2
prerank,regulation of neuron differentiation (GO:0045664),-0.3650054357730607,-1.4706370375156845,0.0,0.36105833702589546,1.0,10/76,4.40%,ZFHX3;BIN1;MEF2C;BRINP3;NLGN1;ZEB1;TIAM1;CNTN4;CDK5R1;VWC2
prerank,purine-containing compound catabolic process (GO:0072523),0.6704201840299012,1.469456227833392,0.06231884057971015,0.35125426604159726,1.0,4/13,9.10%,XDH;ITPA;NT5C2;NT5E
prerank,negative regulation of immune response (GO:0050777),0.4783674559178566,1.468821422456711,0.0051387461459403904,0.35202665974058417,1.0,33/154,15.27%,LGALS3;CD300A;SYK;GPR15;LILRB1;PTGDR;FOXP3;PLK2;FCRLB;RNF26;IL6;HTR6;RHBDF2;GPR83;ADCY7;IRAK3;PTGER2;GPR176;PTGER4;VIPR1;NLRC3;ADAM17;PTH2R;TRAFD1;MYH9;TREM2;COL3A1;FGR;TNFAIP3;ACOD1;ADCY8;ADCY3;CD247
prerank,plasma membrane organization (GO:0007009),0.5163332282330716,1.4687663415008032,0.02413793103448276,0.3512039223012948,1.0,18/61,14.25%,MYOF;CXCR4;PLSCR4;ANO6;ABCD1;BIN3;SNX9;AHNAK2;CLN3;FER1L6;MICALL1;A4GALT;ARL8B;EPB41L3;SNX33;MYH9;DEGS1;WHAMM
prerank,negative regulation of histone modification (GO:0031057),0.6636760135971327,1.4680877485760957,0.07079646017699115,0.3521867699886374,1.0,4/14,7.94%,FOXP3;TAF7;SPHK2;BRCA1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5959486036255301,-1.4676235269055327,0.060790273556231005,0.3641582176086272,1.0,8/11,18.96%,PLCB1;GHR;GIGYF1;IRS1;IGF1R;GIGYF2;TSC2;EIF2AK3
prerank,regulation of fibroblast proliferation (GO:0048145),0.5354918034867755,1.4670323855272718,0.031990521327014215,0.3541101848801953,1.0,13/45,17.17%,CD300A;CTNNB1;AQP1;CDKN1A;PDGFA;B4GALT7;E2F1;IGF1;NLRC3;S100A6;GAS6;CDC73;FTH1
prerank,Fc receptor signaling pathway (GO:0038093),0.48646711363378675,1.466882941435643,0.008501594048884165,0.35357487292007966,1.0,35/110,19.69%,SYK;GRB2;VAV3;MAP3K1;GAB2;TEC;SOS1;PDPK1;PSMD1;JUN;PIK3CA;VAV1;MAP2K4;PPP3CA;PPP3R1;PAK2;PSMF1;NFATC3;PSMD14;TAB2;PSMD12;BTK;RELA;SHC1;PSME2;CUL1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PIK3CB;PSMA2;PSMD11;LAT2
prerank,lysosome organization (GO:0007040),0.5449056272960445,1.4667716956802257,0.04785276073619632,0.352927670631454,1.0,12/36,13.77%,ABCA1;TPCN2;TFEB;TPP1;HOOK3;TMEM165;CLN5;CLN3;VPS33A;LAMTOR1;CLVS2;ZKSCAN3
prerank,muscle cell development (GO:0055001),0.5822153479190659,1.4661191318508482,0.04893350062735257,0.35389240033564684,1.0,5/30,5.08%,MYOF;ALPK3;VEGFA;SLC8A1;IGF1
prerank,regulation of autophagosome assembly (GO:2000785),0.5625956272470478,1.4660079897652178,0.052303860523038606,0.3532645473912862,1.0,13/33,17.73%,MTM1;PIKFYVE;MTMR3;TBC1D12;SH3GLB1;RAB3GAP2;RAB1B;NPRL3;UBQLN2;NPRL2;PIP4K2A;TMEM39A;PHF23
prerank,AMP metabolic process (GO:0046033),0.6682742497113647,1.465738453576136,0.06567164179104477,0.3532149904667475,1.0,4/13,9.10%,XDH;ADSL;AMPD3;NT5E
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.688749326754656,1.465663261061053,0.06402439024390244,0.35249261826018075,1.0,4/11,9.52%,CEBPB;ATF3;ATF4;DDIT3
prerank,response to X-ray (GO:0010165),0.6614372538404905,1.4653137920663664,0.054093567251461985,0.35258904436921346,1.0,6/14,15.38%,XRRA1;ANXA1;NIPBL;XRCC4;XRCC5;BRCC3
prerank,regulation of anoikis (GO:2000209),0.617420176823626,1.465182887135439,0.04894179894179894,0.3519741464100042,1.0,8/19,14.77%,PDK4;ITGA5;SIK1;PIK3CA;SNAI2;ITGB1;NOTCH1;MCL1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.5914111686590027,1.4640698114091688,0.036939313984168866,0.35418993645887004,1.0,2/25,0.46%,PPARG;CBLB
prerank,transport along microtubule (GO:0010970),0.6764033896264283,1.4634543633408315,0.06962962962962962,0.35496344284038717,1.0,4/13,11.47%,ARHGAP21;SPG11;BORCS5;APP
prerank,nuclear migration (GO:0007097),0.6791872144328246,1.4632218435490834,0.06871345029239766,0.35471338162805416,1.0,3/13,5.00%,HOOK3;DYNC1H1;SYNE3
prerank,negative regulation of histone acetylation (GO:0035067),0.6860954702051414,1.4631289985200882,0.06576980568011959,0.354053029993267,1.0,6/11,22.85%,TAF7;BRCA1;SIRT1;NOC2L;SIN3A;CTBP1
prerank,positive regulation of T cell proliferation (GO:0042102),0.5266565277059847,1.4627881037894435,0.02947845804988662,0.35398884507210737,1.0,9/55,5.08%,SYK;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274;IGF1
prerank,fatty acid transmembrane transport (GO:1902001),0.6224327531039029,1.4619899159880378,0.06666666666666667,0.35529162938257547,1.0,7/19,12.32%,CD36;PRKAG2;ABCD1;SLC27A1;CPT1A;SLC25A20;SLC2A1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.5195689307345102,-1.4615890479376707,0.06188925081433225,0.37367041456853145,1.0,6/16,7.06%,MEF2C;ERBB4;BMPR1A;FGFR2;FGF2;ZFPM2
prerank,negative regulation of platelet activation (GO:0010544),0.6400122645280265,1.4615395608452382,0.060781476121562955,0.35567346971891267,1.0,3/16,3.72%,APOE;PRKCD;PDGFA
prerank,myoblast fusion (GO:0007520),-0.5545633617972565,-1.4614788203247344,0.08959537572254335,0.37077491666842444,1.0,4/12,10.08%,ADGRB3;KCNH1;JAM2;ADAMTS5
prerank,regulation of inflammatory response (GO:0050727),0.46942821530785894,1.4612832833752243,0.002036659877800407,0.355357388510807,1.0,45/190,16.09%,PPARG;PLA2G7;APOE;MGST2;CD200R1;ANXA1;MGLL;NR1H3;IL6;PRKCD;TNIP1;RIPK1;TNFRSF1B;CELF1;SHPK;AOAH;NINJ1;MAPK7;NR1H4;PROC;METRNL;MFHAS1;XIAP;RB1;SIRPA;FOXP1;MEFV;PTGER4;NLRC3;BIRC3;PPARD;APP;RORA;LPCAT3;IL15;RELA;VAMP3;TNFAIP3;TNFAIP8L2;CASP12;ACOD1;CX3CL1;MYD88;GRN;BST1
prerank,acylglycerol homeostasis (GO:0055090),0.6127011468178009,1.4609242283697126,0.06225165562913907,0.3555030044269394,1.0,4/20,11.93%,APOE;NR1H3;MTLN;RORA
prerank,somite development (GO:0061053),-0.5780368398782955,-1.460883662100973,0.08771929824561403,0.36911763541806836,1.0,7/11,37.44%,PTCH1;SMO;SOX11;MTHFD1;MEOX2;SHH;SFRP2
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.636694575373948,1.4606815129193722,0.05263157894736842,0.35531781298299847,1.0,9/16,18.43%,ABCD1;APPL2;ADCY7;SIRPA;MEFV;NLRC3;TREM2;APOD;CUEDC2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.5305206325291143,1.460102436876259,0.03263403263403263,0.35604622065209385,1.0,14/48,14.77%,FNIP2;BCL2L11;IKBKE;TNFRSF1B;E2F1;HTRA2;BRCA1;HIPK1;TOPORS;HIPK2;SIRT1;DYRK2;BAX;MCL1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.7011296918708603,1.4589569869709857,0.07004470938897168,0.35850864759098056,1.0,3/10,4.15%,NFE2L2;TXN;RIPK1
prerank,T cell activation (GO:0042110),0.5052693162123385,1.458621452089819,0.02106430155210643,0.35862331545448617,1.0,18/69,17.11%,KIF13B;NCK2;FOXP3;CD44;LCP1;CD28;DDOST;EIF2AK4;LFNG;MSN;PPP3CA;NLRC3;CTPS1;GPR89A;GPR89B;HSPD1;RAB29;CHD7
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.65928608230031,1.458092230942894,0.07058823529411765,0.3591304301640667,1.0,6/13,13.43%,SYK;LAMP1;GAB2;SPHK2;AP1G1;FGR
prerank,pinocytosis (GO:0006907),0.7017681178385488,1.4580312918709626,0.07507507507507508,0.3584032294592801,1.0,5/10,12.43%,MAPKAPK3;SNX5;PPT1;SNX33;DOCK2
prerank,positive regulation of programmed cell death (GO:0043068),0.46398805512422603,1.458029572463018,0.0030181086519114686,0.3574868888624685,1.0,80/272,18.60%,MTCH1;ABR;CTSD;MAP3K20;SYK;VAV3;LILRB1;RPS6KA2;BCL2L11;CTNNB1;ATG7;TGM2;GADD45B;ANO6;GADD45G;SOS1;IL6;FOXO3;FAS;JUN;APAF1;DAPK1;RIPK1;GNA13;SLC27A4;E2F1;HTRA2;GADD45A;AIFM2;MELK;MLLT11;SPHK2;STK3;APC;FLCN;CTNNBL1;ATF4;RPS27A;UBC;NLRC4;TNFAIP8;AKAP13;VAV1;ING3;NLRP2B;ITGB1;FOXO1;SIRT1;ARHGEF2;ING4;STPG1;DCUN1D3;DDX20;OMA1;GPLD1;BCLAF1;MCF2;SOS2;BAX;SQSTM1;FGD3;LATS1;NCSTN;QRICH1;BNIP3;HSPD1;BID;IFIT2;ADAMTSL4;CCAR1;UTP11;PRR7;SHQ1;C1QBP;ITSN1;CASP2;CASP3;STK4;CRADD;HTT
prerank,cellular response to unfolded protein (GO:0034620),0.5831391171918837,1.4576895446841975,0.06080206985769728,0.35746332670558983,1.0,10/26,16.54%,OPTN;ERN1;HSPA1B;RHBDD1;PRKN;HSPA1A;BAX;HSPA13;HSPD1;PTPN1
prerank,integrated stress response signaling (GO:0140467),0.6493867719788122,1.4550420300850462,0.07604017216642754,0.3641584918356833,1.0,8/14,22.65%,NFE2L2;EIF2AK4;ATF4;DDIT3;OMA1;QRICH1;EIF2S1;HERPUD1
prerank,negative regulation of phagocytosis (GO:0050765),0.6138238238765962,1.4547302664767623,0.08055555555555556,0.36410496412620136,1.0,7/17,20.76%,CD300LF;CD300A;SIRPA;APPL1;SNX3;FCGR2B;CD47
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.44643602449310205,-1.454627755545323,0.05952380952380952,0.3798885219313668,1.0,9/26,10.46%,NRXN1;NLGN1;RIMS1;RIMS2;RELN;GRIN1;CUX2;MTMR2;NLGN3
prerank,regulation of viral genome replication (GO:0045069),0.5176215034121584,1.4542464294095352,0.03737259343148358,0.3644570672399229,1.0,21/56,17.55%,IFITM1;CD28;TNIP1;SRPK2;FAM111A;RNASEL;RAD23A;ZC3HAV1;IFITM2;PPIH;MAVS;DDB1;CNOT7;PKN2;BST2;N4BP1;PPIE;SLPI;ADARB1;TMEM39A;SRPK1
prerank,activin receptor signaling pathway (GO:0032924),-0.5154946315496303,-1.4538469584611506,0.06506849315068493,0.3787702461243372,1.0,4/15,4.28%,ACVR1;SMAD3;ACVR2B;TGFBR1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6078164359868351,1.453749251729438,0.08089260808926081,0.3648595595380171,1.0,5/20,7.73%,ANO6;IL6;ITGA4;THBS1;PIAS4
prerank,apoptotic cell clearance (GO:0043277),0.5634937232940604,1.4533593567260017,0.049429657794676805,0.3650908882748141,1.0,9/30,13.36%,ANXA1;TGM2;LRP1;NR1H3;RARA;THBS1;TYROBP;TREM2;GAS6
prerank,cellular response to decreased oxygen levels (GO:0036294),0.501830767308834,1.4531362656358169,0.025842696629213482,0.36483310558192106,1.0,17/65,15.79%,EPAS1;VEGFA;AQP1;NPEPPS;CPEB4;LMNA;ADAM8;HMOX1;HIPK2;EGLN3;SIRT1;MT3;STUB1;RORA;SUV39H2;BNIP3;ACAA2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.5641675780070883,1.452887648072496,0.05459057071960298,0.3645714404065666,1.0,12/31,16.54%,OPTN;ERN1;HSPA1B;STUB1;RHBDD1;DNAJB14;PRKN;HSPA1A;BAX;HSPA13;DNAJC18;PTPN1
prerank,metanephric mesenchyme development (GO:0072075),-0.601878457867036,-1.4522185492238722,0.07671232876712329,0.379635510795337,1.0,5/10,20.46%,PAX2;BASP1;STAT1;PKD2;WNT4
prerank,positive regulation of transport (GO:0051050),0.49294815645922185,1.4520076535151403,0.015435501653803748,0.3660387444654914,1.0,22/85,14.42%,APOE;SGK1;ANXA1;FLOT1;LRP1;NR1H3;DYNC1H1;RXRA;CD151;MERTK;ANXA2;CYBA;NEDD4L;SIRPA;GSK3B;IL15;TREM2;DOCK2;GPLD1;GAS6;SLC11A1;BAX
prerank,regulation of mitochondrial fusion (GO:0010635),0.6887026343803031,1.451878965589327,0.0736196319018405,0.36545852653271504,1.0,7/11,15.63%,VAT1;TFRC;PID1;HUWE1;OMA1;PRKN;BNIP3
prerank,sodium-independent organic anion transport (GO:0043252),-0.5957257080349945,-1.4517896208259868,0.06887052341597796,0.3775548526186589,1.0,6/10,23.40%,SLCO2B1;SLCO1B1;SLC16A2;SLCO5A1;SLCO4A1;MFSD10
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6732191047402407,1.4508002866213516,0.0662739322533137,0.3676691835583632,1.0,3/13,2.99%,NFE2L2;TXN;HGF
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.5784214040361806,-1.449586984125919,0.07102272727272728,0.37943989497691355,1.0,5/11,31.82%,MEF2C;TGFB2;TGFB1;GREM1;EFNB2
prerank,electron transport chain (GO:0022900),0.6405825700477947,1.4495018404044113,0.06827880512091039,0.37057627883252464,1.0,6/15,10.60%,ETFRF1;POR;UQCRFS1;ENOX2;SDHB;SDHA
prerank,positive regulation of developmental growth (GO:0048639),-0.3922307034903153,-1.4467035185102515,0.030120481927710843,0.3828367507070428,1.0,13/49,8.61%,SYT1;TWF2;RIMS1;PLCB1;MAPT;GHR;RIMS2;SMURF1;LIMK1;MAP3K13;SYT2;SYT4;AGRN
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.4447315166265226,-1.4466980989249099,0.056768558951965066,0.3798690239573758,1.0,8/27,8.86%,SYT1;RIMS1;RIMS2;VAMP7;SYT7;SYT2;SYT4;SYT6
prerank,sulfur compound transport (GO:0072348),0.5686129436718653,1.446387046482292,0.06324110671936758,0.3787768961025181,1.0,5/27,8.02%,SLC26A11;LRRC8D;SLC6A6;SLC26A1;SLC27A1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.6875835183840425,1.4458281484104556,0.0837138508371385,0.3794563382149652,1.0,3/11,10.59%,TMEM106A;TAF7;SIRT1
prerank,epithelium development (GO:0060429),0.4764071066148308,1.4453170808593407,0.02328042328042328,0.3800866296487111,1.0,14/107,9.86%,LGALS3;PPARG;ANXA4;CTSB;VEGFA;TPP1;TST;DAG1;ACADVL;SNAI2;CPT1A;DVL1;RIPK4;PAX8
prerank,cilium-dependent cell motility (GO:0060285),-0.4730896733354672,-1.445014814941059,0.056856187290969896,0.3803407601572739,1.0,16/22,41.61%,RFX3;CCDC39;CFAP44;CFAP54;DNAH8;EFHC2;EFHC1;DNAH2;RSPH9;DRC1;GAS8;DNAAF2;DNAH17;CCDC65;DNAH1;TEKT5
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.6147390450873539,1.4449300647320416,0.06388888888888888,0.3793809265215757,1.0,6/19,10.93%,POLR2A;ACD;POLR2L;TERF1;POLR2G;POLR2I
prerank,regulation of DNA recombination at telomere (GO:0072695),0.6147390450873539,1.4449300647320416,0.06388888888888888,0.3793809265215757,1.0,6/19,10.93%,POLR2A;ACD;POLR2L;TERF1;POLR2G;POLR2I
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4874039962374882,-1.4447195472750192,0.06825938566552901,0.37817669041291513,1.0,7/20,13.96%,ST3GAL6;B3GALT1;FUT9;ST3GAL2;ST6GALNAC5;B4GALT1;ST6GALNAC6
prerank,ceramide metabolic process (GO:0006672),0.5296111521897243,1.4439876955992001,0.02485207100591716,0.3810800981907446,1.0,18/49,20.41%,PLPP3;SPTLC2;CERK;SAMD8;SGPL1;SGMS2;CERS6;SPTSSA;ABCA2;DEGS1;TLCD3B;ACER2;SGMS1;PPP2CA;NSMAF;ASAH1;PPP2R1A;CERS1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.4553983536039473,1.4435553412009199,0.0010030090270812437,0.381365187455361,1.0,56/308,14.14%,EPAS1;FABP4;CD36;HTR2B;B4GALT5;ABCA1;SDCBP;APOE;CXCR4;SYK;PRKCH;FABP5;GCNT2;ADRA1D;ADRA1A;CTNNB1;VEGFA;FLOT1;CEBPB;TFRC;GADD45G;LRP1;IL6;CD28;NIBAN2;DYNC1H1;APPL2;SORL1;COL1A1;AGO2;SIRT6;ACADL;APC;KDM3A;RREB1;SLC27A1;KSR2;NCOA3;TRPV2;BMPR2;PTGER4;PAX8;ROCK1;PTH2R;CFL1;SIRT1;ACVR1B;IL15;TREM2;KMT5B;OMA1;GAS6;FGR;SLC11A1;IL4R;GDNF
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7030311532139892,1.4431671369691692,0.06973058637083994,0.38065260964887543,1.0,6/10,21.77%,ASCC2;ASCC1;FTO;ALKBH1;ALKBH5;MGMT
prerank,DNA dealkylation (GO:0035510),0.7030311532139892,1.4431671369691692,0.06973058637083994,0.38065260964887543,1.0,6/10,21.77%,ASCC2;ASCC1;FTO;ALKBH1;ALKBH5;MGMT
prerank,regulation of dendritic spine development (GO:0060998),-0.4857279642019697,-1.4430588191303266,0.06642066420664207,0.37863371941112167,1.0,5/19,5.48%,TANC2;MEF2C;NLGN1;GRIN3A;FMR1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.5034641066103709,1.442946933654537,0.02466367713004484,0.380423963225842,1.0,19/66,15.64%,GPNMB;ANXA1;ID2;CDKN1A;ANKRD17;APPL2;PTEN;E2F1;APC;RB1;BRD7;ADAM17;KMT2E;DCUN1D3;CDK2AP2;APPL1;PSME2;INO80;CDC73
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5888427064071056,1.442771036275059,0.06589147286821706,0.37999433656049586,1.0,7/23,13.36%,LILRB1;FOXP3;CD274;RARA;NR1H4;DDIT3;GAS6
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.4286411483453858,-1.4421770305852488,0.028169014084507043,0.3774185066031292,1.0,13/31,20.63%,SYT1;SCAMP5;SYT7;REST;SYT2;SYT4;SYT6;CACNA1G;STX1A;CACNA1I;SYT3;SYT12;SYT11
prerank,negative regulation of receptor binding (GO:1900121),-0.5913690244189604,-1.4420449389858934,0.0927536231884058,0.3748964016229812,1.0,4/10,25.39%,ADAM15;HFE;ATP2A2;ATP2A3
prerank,positive regulation of viral process (GO:0048524),0.5112511938045812,1.4420320638827442,0.03758542141230068,0.3812169134392103,1.0,22/60,17.55%,MDFIC;POLR2A;RAB7A;CD28;SRPK2;KPNA2;POLR2L;RAD23A;VPS4A;PPIH;DDB1;POLR2G;CNOT7;PKN2;POLR2I;GTF2F2;CTDP1;PPIE;ADARB1;TMEM39A;NELFE;SRPK1
prerank,amyloid fibril formation (GO:1990000),0.5192264661113598,1.4415408667093164,0.03068181818181818,0.38169121617846974,1.0,22/51,22.82%,CD36;MFGE8;NAT8;RIPK1;SORL1;RPS27A;UBC;CALB1;BACE1;APP;TSPAN15;PRKN;NCSTN;GGA2;CALCA;ADAM10;GGA3;USP9X;APH1B;FKBP1A;FURIN;SIAH2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5247699895472662,-1.439948120150762,0.08865248226950355,0.3764436575638893,1.0,4/15,5.31%,SLC12A2;ATP1B1;ATP1A2;ATP1B2
prerank,superoxide metabolic process (GO:0006801),0.564843935920545,1.4382827839086927,0.06701030927835051,0.3902974279713074,1.0,12/29,16.76%,PRDX1;CYBB;CYBA;NCF2;MT3;CYB5R4;NCF4;SH3PXD2B;NRROS;TAFA4;ATP7A;NCF1
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.4624583389835108,-1.4381719603987007,0.07168458781362007,0.3773022004552665,1.0,10/23,18.68%,HACD2;ELOVL7;ACOT7;FAR2;ACSL6;ACSL4;ELOVL6;TECR;DGAT1;ACSBG1
prerank,cochlea morphogenesis (GO:0090103),-0.6044331355609285,-1.437834698671197,0.07246376811594203,0.37522235911885116,1.0,4/10,19.45%,PAX2;HPN;SOX9;MYO3B
prerank,neuron projection fasciculation (GO:0106030),-0.6031713825084473,-1.4373487344167242,0.058823529411764705,0.3734780709252189,1.0,3/10,4.39%,SEMA5A;CNTN4;CDK5R1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.5198186514309703,1.4363023013733172,0.05434782608695652,0.39521520341686467,1.0,8/45,11.75%,CD36;TLR8;IL6;TMEM106A;NLRC4;TYROBP;APP;FZD5
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.6062307578694079,1.4361778447072588,0.06836461126005362,0.3946271467625084,1.0,9/20,20.08%,SLC8B1;MICU2;MICU1;PMPCA;LETM1;SMDT1;PMPCB;PARL;AFG3L2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5635219319536984,1.435490614526577,0.04779874213836478,0.39558872170558934,1.0,13/31,21.08%,FBXW7;ARRDC4;PTEN;UBE2L3;TOPORS;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1;UBE2S;CDC14B;RAB1A;ARRDC3
prerank,regulation of autophagosome maturation (GO:1901096),0.6539805319979238,1.4350944773059087,0.07794117647058824,0.3958906798164913,1.0,7/13,17.73%,FYCO1;TBC1D25;UVRAG;CLN3;RUBCN;TMEM39A;PHF23
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.5846448496174423,1.4348189793344273,0.057692307692307696,0.3958265262292254,1.0,14/25,26.73%,DNAJB13;GAK;HSPA1B;DNAJB5;DNAJB14;HSPA1A;HSPA13;DNAJC18;HSPE1;BAG1;HSPA9;ST13;ERO1A;DNAJB12
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.5790559662274956,1.4345160594262376,0.056265984654731455,0.39578221027417826,1.0,8/26,19.17%,SPTLC2;CYB5R3;ARG2;SPHK2;ABCA2;ACER2;GCH1;ASAH1
prerank,negative regulation of endocytosis (GO:0045806),0.5806402878036907,1.433775454095452,0.06357615894039735,0.3970876068610292,1.0,7/24,13.04%,LGALS3;CD300A;LILRB1;NR1H3;PICALM;SNX33;MCTP1
prerank,regulation of B cell apoptotic process (GO:0002902),0.6566600260424967,1.4330873863723241,0.08796296296296297,0.39820458234911005,1.0,5/12,18.51%,FNIP1;IRS2;FOXP1;BTK;NOC2L
prerank,regulation of T cell activation (GO:0050863),0.5215387733611507,1.433072721394054,0.06921241050119331,0.39731854411007056,1.0,5/42,8.21%,GPNMB;LGALS3;TNFRSF1B;DUSP3;SIRPA
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),-0.4458661604742138,-1.4326859807721408,0.05042016806722689,0.3807198016161121,1.0,11/27,16.51%,IL1RAPL1;CTNNA2;NTNG1;DISC1;MBOAT1;MARK1;HOMER1;ULK4;NCS1;NDEL1;BRSK1
prerank,purine nucleotide catabolic process (GO:0006195),0.6563565808054382,1.432573577094315,0.08112094395280237,0.3979242102106024,1.0,4/13,9.10%,XDH;ITPA;NT5C2;NT5E
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5619720853661248,1.4323380130066063,0.061068702290076333,0.3977548452172822,1.0,3/29,2.36%,LGALS3;PLA2G7;ANO6
prerank,cellular response to chemical stress (GO:0062197),0.4796839324023143,1.432177215849336,0.02054054054054054,0.39728052309484946,1.0,23/96,11.17%,LRRC8D;MSRA;PRDX1;NFE2L2;ATG7;TXNRD1;FOXO3;FAS;SESN2;LONP1;HTRA2;PIK3CA;HSPA1B;CYBB;GPX3;ATF4;CYBA;NCF2;CAT;GSR;CYCS;FOXO1;MT3
prerank,sphingosine metabolic process (GO:0006670),0.6247606321880599,1.4313485021057,0.08228730822873083,0.3988692056698239,1.0,4/17,8.18%,PLPP3;SPTLC2;SPHK2;ABCA2
prerank,wound healing (GO:0042060),0.506087759224057,1.431193673078467,0.03662597114317425,0.3983729317182464,1.0,15/62,13.65%,MYOF;HPSE;MMP12;PDGFA;RAF1;AHNAK2;IGF1;HMOX1;PPP3CA;ARL8B;FZD7;MYH9;COL3A1;MACF1;SLC11A1
prerank,cellular response to copper ion (GO:0071280),0.631106879646449,1.4310791235038551,0.08100558659217877,0.3977857229093526,1.0,10/16,20.67%,AQP1;MT3;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,positive regulation of dendrite development (GO:1900006),-0.5994164798806019,-1.430279414329948,0.0953757225433526,0.38331674533647353,1.0,9/10,36.28%,VLDLR;LRP8;DAB2IP;PACSIN1;BMP5;PTN;ZDHHC15;BMP7;COBL
prerank,protein maturation (GO:0051604),0.4800616196379488,1.4298805119513622,0.023630504833512353,0.40053332570076516,1.0,42/95,25.56%,F7;PCSK4;TMPRSS4;CPXM1;MMP14;SORL1;CLN3;TSPAN17;PITRM1;CTSS;NDUFAB1;BACE1;GLRX3;ADAM17;STUB1;LONP2;NAA10;TSPAN15;CIAO2B;ADAM19;NCSTN;CPM;HSPD1;CIAO2A;CASP2;DDI2;AFG3L2;TYSND1;OGT;ADAM10;APH1B;NAA15;FURIN;XPNPEP3;PSEN2;PCSK7;GCSH;SRGN;TSPAN5;TSPAN33;CIAO1;TSPAN14
prerank,regulation of interleukin-8 production (GO:0032677),0.4899208626049123,1.4296878370685608,0.04555555555555556,0.4002246407592096,1.0,17/69,16.52%,ANXA4;SYK;TLR8;ANXA1;IL6;RIPK1;MAP2K5;HSPA1B;DDIT3;MAVS;AFAP1L2;RELA;HSPA1A;ARRB1;LBP;MYD88;TLR1
prerank,sulfation (GO:0051923),-0.5616419426480074,-1.4281326897560007,0.0989010989010989,0.385234509267508,1.0,6/11,35.35%,UST;HS3ST5;SULT1A1;SULT4A1;SULT6B1;SULT2B1
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.7023031277545946,1.4275894248514323,0.0967238689547582,0.4057151404212281,1.0,4/10,6.37%,SIGIRR;MAP2K5;MAPK7;IRAK3
prerank,proteoglycan metabolic process (GO:0006029),0.5676728560473174,1.4271893258898491,0.06900878293601004,0.40596208850752363,1.0,7/26,12.64%,HPSE;XYLT1;B4GALT7;IGF1;SULF2;BMPR2;SULF1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.3948366981080086,-1.427097502588459,0.05172413793103448,0.38468765271493766,1.0,13/41,20.02%,SLC12A2;ATP1B1;SLC12A6;ATP1A2;KCNJ2;ATP1B2;KCNJ3;KCNJ9;HCN2;SLC12A4;KCNK9;ABCC9;KCNJ6
prerank,regulation of protein localization to cell periphery (GO:1904375),0.6077507461095895,1.4261274104430575,0.0907840440165062,0.4081788919926832,1.0,7/18,12.23%,MMP14;CLN3;STX8;VTI1B;ABCA2;VPS4A;APPL1
prerank,cell junction assembly (GO:0034329),-0.3310239788416418,-1.4254525229706385,0.0,0.3855907491832166,1.0,23/100,8.46%,ADGRL3;OPHN1;SDK1;GPM6A;NRXN1;KIRREL3;NLGN1;DNM3;CTNND1;RYK;TLN2;ITGA6;CTNND2;VASP;CDH11;CDH9;CDH8;FARP1;CDH2;CDH6;CDH12;SH3BP1;DNER
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3430098144766424,-1.42457018702803,0.04040404040404041,0.38491823978907513,1.0,26/75,19.20%,MEF2C;OPHN1;CTNNA2;NTNG1;DCC;MEF2A;RYK;BTBD3;ANK3;CNTN4;FGFR2;PARD3;MAP2;FARP1;SPTBN4;PAX2;RAB8A;KLF7;CELSR2;BRSK1;SLITRK5;SLITRK3;ADGRB1;ABITRAM;S100B;LMTK2
prerank,lipoprotein catabolic process (GO:0042159),0.6862170142307428,1.4243785595429994,0.08858858858858859,0.41232609108282436,1.0,4/11,9.85%,CTSD;APOE;PPT1;ABHD10
prerank,positive regulation of cell killing (GO:0031343),0.6626135155325912,1.4241981789961349,0.0680786686838124,0.41191402068791916,1.0,3/13,9.79%,SYK;CYBA;FZD7
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.4574130017502111,-1.4239054118413594,0.07936507936507936,0.3837231484278555,1.0,11/24,23.22%,ITGAM;ANK3;ITGB2;ITGB1BP1;TCAF1;PRNP;FIS1;AKT2;MIEF2;CIB1;C2CD5
prerank,regulation of macrophage migration (GO:1905521),-0.5818343697380971,-1.4236074638529266,0.09615384615384616,0.3817091112851879,1.0,5/10,6.61%,CX3CR1;P2RY12;CSF1;MTUS1;CD200
prerank,positive regulation of apoptotic process (GO:0043065),0.4513137407504927,1.4224879478533092,0.0030181086519114686,0.4161253563259668,1.0,86/293,18.60%,MTCH1;ABR;CTSD;MAP3K20;VAV3;LILRB1;RPS6KA2;BCL2L11;CTNNB1;ATG7;TGM2;GADD45B;ANO6;GADD45G;SOS1;IL6;FOXO3;FAS;TFAP2B;JUN;APAF1;SRPK2;DAPK1;RIPK1;GNA13;SLC27A4;E2F1;HTRA2;GADD45A;AIFM2;MELK;MLLT11;SIK1;SPHK2;STK3;APC;FLCN;CTNNBL1;ATF4;RPS27A;UBC;NLRC4;TNFAIP8;AKAP13;VAV1;ING3;DLC1;BACE1;DDIT3;NLRP2B;ITGB1;FOXO1;SIRT1;ARHGEF2;ING4;STPG1;DCUN1D3;DDX20;OMA1;GPLD1;BCLAF1;MCF2;SOS2;BAX;SQSTM1;FGD3;LATS1;NCSTN;QRICH1;BNIP3;GRN;HSPD1;BID;IFIT2;ADAMTSL4;CCAR1;UTP11;PRR7;SHQ1;C1QBP;ITSN1;CASP2;CASP3;STK4;CRADD;HTT
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.5293787442039467,-1.4211934211600243,0.08974358974358974,0.38406585645915947,1.0,4/15,13.99%,ATP1B1;KCNJ2;KCNJ3;KCNN2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.5693467363072036,1.420936381065544,0.08005249343832022,0.41986792187719546,1.0,8/25,15.04%,SDCBP;ATXN2;ABCA2;PICALM;RIN3;ANKRD13D;APP;UBQLN2
prerank,negative regulation of biosynthetic process (GO:0009890),0.6170073865709287,1.4209300881097517,0.0784313725490196,0.41894621492766776,1.0,3/16,3.44%,ABCB7;IL6;ABCD1
prerank,negative regulation of leukocyte migration (GO:0002686),0.6764529908644983,1.4208312833616927,0.10232558139534884,0.41833873009434425,1.0,3/10,7.09%,CD300A;CD200R1;HMOX1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5970715619366387,1.4191433650056131,0.08460471567267684,0.42258127166769593,1.0,2/18,5.64%,GPNMB;DUSP3
prerank,negative regulation of programmed cell death (GO:0043069),0.444380723076508,1.4191385738272582,0.0,0.4216550398930615,1.0,95/355,18.72%,HTR2B;ARHGAP10;ANXA4;CD38;ANXA1;CTNNB1;VEGFA;AQP1;TFRC;RAB7A;CD44;PLK2;NAT8;IL6;HGF;CD28;NIBAN2;FAS;TFAP2B;BIRC6;RIPK1;PPT1;ANXA5;NOTCH2;CITED2;RAF1;PIM1;IGF1;CLN3;PCID2;PPIF;THBS1;BABAM2;AIFM2;NR1H4;PROC;GPX4;HSPA1B;RPS27A;UBC;CAT;TNFAIP8;BFAR;SH3RF1;XIAP;KLHL20;CTSH;TOPORS;COPS5;FSTL1;PIM3;GSK3B;PTK2B;CFL1;POU3F3;FOXO1;SIRT1;BIRC3;PAK2;BAG4;MT3;TAX1BP1;RHBDD1;TREM2;ZFAND6;ATAD3A;RELA;GAS6;VDAC1;HSPA1A;GDNF;SHC1;PHIP;SQSTM1;GOLPH3;MCL1;CX3CL1;RPL10;CBL;BNIP3;MYD88;HSPD1;MIEN1;TMBIM4;BID;ERC1;UBE2O;ARF4;TEK;HMGN5;BIRC2;CASP2;CASP3;SOX8;LRP2
prerank,neuron maturation (GO:0042551),0.6042430931991714,1.4189996271918512,0.06179775280898876,0.42113586764612243,1.0,4/18,5.70%,MTCH1;B4GALT5;CLN5;B4GALT6
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.47777372461757345,1.4189192558867396,0.035398230088495575,0.42045268145724896,1.0,19/76,15.15%,ANXA4;FOXP3;IRAK2;MAP2K5;RWDD3;NFKBIB;IRAK3;NWD1;NFKBIL1;DDIT3;NLRP2B;NLRC3;SIRT1;TAX1BP1;TRAF3;TNFAIP3;ERBIN;ACOD1;ARRB1
prerank,monocyte chemotaxis (GO:0002548),0.5464998628564818,1.4185277461985706,0.0685640362225097,0.4207407100055669,1.0,9/32,19.46%,LGALS3;ANXA1;IL6;FOLR2;IL6R;CX3CL1;CCL7;CALCA;CCL25
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6836631336467385,1.4183240701825703,0.08982035928143713,0.4203443548980643,1.0,2/10,2.89%,IQSEC1;ADAM9
prerank,entry into host (GO:0044409),0.6405903624165734,1.418060552078712,0.07727272727272727,0.4202297394519162,1.0,3/13,1.59%,CXCR4;GRB2;CTNNB1
prerank,regulation of metal ion transport (GO:0010959),-0.5106774783083916,-1.41792333429143,0.09090909090909091,0.38814787402426226,1.0,7/16,14.96%,ANK2;ORAI1;EPB41;BCL2;DLG1;IL16;CACNA2D1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6099419443943762,1.4178512366538374,0.06882022471910113,0.4199301620012593,1.0,5/17,8.41%,CD36;SASH1;SIGIRR;LY96;NFKBIL1
prerank,regulation of synapse maturation (GO:0090128),-0.5791602583750863,-1.4178096354193745,0.10249307479224377,0.38579562631102104,1.0,5/10,24.26%,NRXN1;RELN;DAB2IP;ADGRL1;YWHAZ
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.6531342720062114,1.4173851142442326,0.07929515418502203,0.42044297919443996,1.0,1/13,0.52%,NAMPT
prerank,cellular senescence (GO:0090398),0.5550803856076676,1.41702243846131,0.07033248081841433,0.4205158366502077,1.0,4/27,3.13%,NSMCE2;ID2;PRKCD;CDKN1A
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5446493334151746,1.4162254717897924,0.0685785536159601,0.42190309494320877,1.0,7/33,9.32%,HTR2B;PIK3R5;PTEN;IGF1;PIK3CA;PIK3C2G;PLEKHA1
prerank,digestive tract morphogenesis (GO:0048546),0.6269604284780435,1.4159387912955084,0.10115606936416185,0.42177269085602365,1.0,4/14,10.79%,STRA6;ID2;NIPBL;RBPMS2
prerank,regulation of interleukin-12 production (GO:0032655),0.5143564287449658,1.4158261342203253,0.07021791767554479,0.42121484903556,1.0,16/47,22.18%,SYK;TLR8;LILRB1;PIBF1;THBS1;IRAK3;FOXP1;MEFV;JAK3;HSPD1;LTB;C1QBP;SCIMP;CD47;SLAMF1;TIRAP
prerank,adipose tissue development (GO:0060612),0.6737612734981926,1.4149269310662653,0.07987711213517665,0.4231111653425165,1.0,4/11,13.34%,NAMPT;SPTLC2;ARID5B;SH3PXD2B
prerank,water-soluble vitamin metabolic process (GO:0006767),0.487799401236664,1.4147220255295347,0.03139013452914798,0.4228053621213094,1.0,24/68,20.90%,MMAB;MTHFS;CYB5R3;PDZD11;ENPP1;LMBRD1;ACP5;FOLR2;SLC25A32;CYB5A;MCCC1;SLC2A1;MTHFD1L;SLC23A2;SLC23A1;SLC52A1;GSTO2;PANK2;MTRR;ABCC1;SLC19A1;SLC19A2;GSTO1;BTD
prerank,carbohydrate homeostasis (GO:0033500),0.49150868937471076,1.4139208659425253,0.031638418079096044,0.4243929546063007,1.0,9/67,5.34%,PPARG;PDK4;IL6;PYGL;TFAP2B;SLC8B1;APPL2;TENT4B;FGFR4
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.5607769357652431,1.4135914511108778,0.08796895213454076,0.42446507482722906,1.0,9/26,18.05%,SIGIRR;RNF26;IRAK3;NFKBIL1;NLRC3;TRAFD1;TNFAIP3;ACOD1;C1QBP
prerank,regulation of cholesterol transport (GO:0032374),0.5945557590109429,1.4135309139210854,0.09345794392523364,0.4237439240194431,1.0,5/20,9.57%,LIPG;LRP1;NR1H3;ABCA2;LAMTOR1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6346932224418576,1.413337152227291,0.08050847457627118,0.42335223138999617,1.0,3/15,5.22%,GRB2;SOS1;ZFYVE27
prerank,regulation of dendrite development (GO:0050773),-0.40035674582116804,-1.4130855273297058,0.0374331550802139,0.39325515623922186,1.0,9/37,9.38%,CSMD3;CAMK1D;ADGRB3;DCC;KNDC1;VLDLR;MARK1;LRP8;DAB2IP
prerank,positive regulation of exocytosis (GO:0045921),0.5412818142675262,1.4129288694641509,0.06411837237977805,0.4236179413922846,1.0,10/35,14.84%,SDCBP;RAB7A;STAM;CHMP2A;STXBP5;PDCD6IP;VPS4A;SDC4;CLASP1;SNF8
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.5172561448489811,1.4126000274476935,0.0710128055878929,0.4236822105236218,1.0,14/43,15.53%,LILRB1;CD274;RARA;IGF1;ARG2;NR1H4;IRAK3;SIRPA;NFKBIL1;NLRC3;GAS6;TNFAIP3;CX3CL1;LBP
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6384693369090855,1.4125792837814473,0.0625,0.42283128142265813,1.0,9/15,22.20%,IQGAP2;ARPC2;WASHC1;ACTR3;WHAMM;ARPC1A;ARPC4;ARPC5L;ARPC5
prerank,membrane depolarization (GO:0051899),-0.42377050895491175,-1.4124922796085513,0.0430622009569378,0.39193356743825053,1.0,11/32,17.03%,CACNA1E;SCN2A;CACNB4;SCN1B;CACNG4;SCN9A;CACNA1G;YWHAH;SCN8A;CACNG2;CACNA1I
prerank,vesicle organization (GO:0016050),0.5148115145358669,1.412060378265493,0.053927315357561546,0.42346645393960547,1.0,23/46,23.93%,PHETA2;HOOK3;SNX10;RNF26;LAMTOR1;SNX33;PI4K2A;ARFGEF2;EPS15;PLEKHJ1;SQSTM1;VPS11;WASL;DNAJC13;USP8;RAB22A;ALS2CL;WASHC5;CHMP2B;ZFYVE16;PI4K2B;SRGN;HOOK1
prerank,phospholipid biosynthetic process (GO:0008654),0.5332565918087993,1.4109185292444384,0.05845771144278607,0.42594521208261743,1.0,8/36,8.56%,GPAT2;SAMD8;AGPAT4;SGMS2;CLN3;MVD;SPHK2;IDI1
prerank,sodium ion transmembrane transport (GO:0035725),-0.34576298092008806,-1.4107772529266422,0.01098901098901099,0.39303639954545955,1.0,19/84,11.82%,SLC24A3;SLC9A9;SLC12A2;HCN1;ATP1B1;SLC24A2;SCN2A;ATP1A2;SCN1B;TRPM4;ATP1B2;SLC6A15;NALCN;SLC6A1;SLC4A8;SCN9A;SLC24A4;HCN2;PKD2
prerank,liver development (GO:0001889),0.5405991486309023,1.4099383228134572,0.075,0.4280978369391702,1.0,6/32,9.11%,ANXA1;CEBPB;IL6;CCDC40;CITED2;ARID5B
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6557030988859363,1.4088262859765217,0.10090361445783133,0.43074545238378315,1.0,3/12,8.73%,CD300A;ELF2;CBFB
prerank,ERK1 and ERK2 cascade (GO:0070371),0.5838074712808882,1.4084452777378529,0.08097165991902834,0.4310112058387682,1.0,6/21,11.17%,HTR2B;IGF1;ZFP36L2;CTSH;PTGER4;MT3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.6616088551424869,1.4083709071802208,0.11317829457364341,0.43027612439299767,1.0,4/11,7.63%,PRKCD;GSKIP;STK24;PRODH
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5342542907539186,1.408076836737166,0.05889724310776942,0.43031422724075735,1.0,10/38,13.60%,LGALS3;FAS;RIPK1;THBS1;HMOX1;BRCA1;GSK3B;ARHGEF2;RNF34;TNFAIP3
prerank,myotube differentiation (GO:0014902),-0.4950824669812457,-1.4074659395820133,0.07191780821917808,0.3973601029016145,1.0,5/17,4.15%,MEF2C;ADGRB3;MYEF2;KCNH1;JAM2
prerank,central nervous system neuron axonogenesis (GO:0021955),0.648917038085892,1.4060673186742312,0.09667673716012085,0.4355478130266593,1.0,3/12,5.70%,B4GALT5;PTEN;B4GALT6
prerank,prostanoid biosynthetic process (GO:0046457),-0.5098677545197277,-1.4055910298758776,0.09006211180124224,0.3985822413773024,1.0,7/15,27.75%,PTGS1;PLA2G4A;CD74;PNPLA8;PTGDS;PTGIS;PRXL2B
prerank,positive regulation of phagocytosis (GO:0050766),0.5058150024453428,1.4054639379466136,0.057007125890736345,0.43648954953365293,1.0,13/47,13.65%,CD300LF;ANO6;APPL2;MERTK;CYBA;RAB31;STAP1;SIRPA;IL15;TREM2;DOCK2;GAS6;SLC11A1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.6272324924488878,1.4049060130873436,0.09014084507042254,0.4372990563392222,1.0,10/15,21.02%,REEP4;ZFYVE27;RTN3;RAB10;RAB18;ATL2;ATL1;RTN4;TMEM170A;ARL6IP1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.456312535084076,1.4046273453513318,0.022587268993839837,0.43721142113397865,1.0,28/132,11.47%,APOE;OPTN;TFEB;PLK2;ADAM9;PRKCD;FOXO3;ABCD1;SNX9;DAPK1;TNFRSF1B;SH3GLB1;MTLN;IGF1;ADAM8;IRS2;FLCN;ZBTB20;MSN;MEFV;ZC3HAV1;SNX33;ROCK1;CNOT7;GRSF1;GSK3B;FOXO1;APP
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6096931889615533,1.404323989860857,0.06791907514450866,0.4373146476519511,1.0,3/17,4.62%,ANXA4;ANXA1;MAP2K5
prerank,purine nucleotide metabolic process (GO:0006163),0.5623002556985525,1.4040885114731125,0.08258064516129032,0.4370696554651528,1.0,6/24,9.10%,XDH;ADSL;PPAT;ITPA;NT5C2;NT5E
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5671144247892049,-1.4039510316797235,0.10263929618768329,0.3998233227341808,1.0,6/11,18.38%,CSNK1E;CSNK1D;RSPO3;WNT5B;NKD1;DAB2
prerank,nucleotide catabolic process (GO:0009166),0.611710630435585,1.403294016199841,0.1044349070100143,0.43855666858518766,1.0,5/16,9.82%,XDH;ITPA;NT5C2;NT5E;DERA
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.638831052531165,1.403146284050387,0.08047690014903129,0.43810359681588057,1.0,4/12,16.54%,BCL2L11;ERN1;BAX;PTPN1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5792301490346451,1.402667896769751,0.09972677595628415,0.43876438262064227,1.0,11/21,25.65%,PRKCH;TRAT1;STAP1;FOXP1;PRKCB;RELA;RAB29;CARD11;PTPRC;BCL10;SLC39A10
prerank,epiboly involved in wound healing (GO:0090505),0.6151061492634401,1.402633210422287,0.08583690987124463,0.43796572699200204,1.0,4/16,3.78%,MRTFA;CD44;LCP1;CD151
prerank,cardiac muscle cell contraction (GO:0086003),-0.48298263446785605,-1.4022447751972211,0.09057971014492754,0.4009162815295118,1.0,9/19,21.29%,CACNA1C;SCN1B;FGF12;KCNJ2;CACNA1G;CACNA2D1;GSN;SCN4B;SCN1A
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.663065213887059,1.4020907096303896,0.10194902548725637,0.4386219192314352,1.0,2/10,4.04%,FOXP3;CD274
prerank,regulation of neuroinflammatory response (GO:0150077),0.5881918515934614,1.4017658225186793,0.08100929614873838,0.4387335293860394,1.0,4/19,5.08%,CD200R1;IL6;TNFRSF1B;IGF1
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.46720821000525325,1.4015172904385298,0.026595744680851064,0.43854662970863617,1.0,21/102,15.56%,PPARG;MYO5A;DENND4C;LPIN3;RAB8B;PDPK1;PRKCD;ENPP1;ADCY7;IRS2;RAB31;SLC39A14;RAB12;RAB10;FOXO1;EPRS1;GPLD1;RELA;ADCY8;ADCY3;INSIG2
prerank,negative regulation of cell death (GO:0060548),0.47493198737049175,1.4006393751926765,0.03691639522258415,0.4402916978706905,1.0,21/88,16.19%,GPNMB;HTR2B;CD200R1;SPEF1;CCN5;TNFRSF1B;SORL1;HTRA2;CHMP2A;HSPA1B;GSK3B;ATG5;NENF;CCN1;MT3;DUS2;PRKN;HSPA1A;BNIP3;INPP5A;TRAF2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5846121030948261,1.4006097451092732,0.09917355371900827,0.4395108371867202,1.0,5/18,10.01%,IL6;RIPK1;NCOR1;DDX5;ESR1
prerank,myelin maintenance (GO:0043217),0.6880014940849518,1.4002729802848115,0.08433734939759036,0.4396006630930732,1.0,6/10,14.93%,CXCR4;ABCD1;PTEN;EPB41L3;DEGS1;PRX
prerank,negative regulation of cellular catabolic process (GO:0031330),0.4898578280355219,1.400064365523347,0.04680365296803653,0.43935862028192324,1.0,21/63,19.38%,HTR2B;TIMP1;RIC1;HGF;WASHC1;SORL1;TIMP2;HP;ROCK1;FOXK1;MT3;TAB2;TREM2;GPLD1;ZKSCAN3;MCL1;RUBCN;NELL1;EIF4G3;EIF4G2;TLK2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5140178357622273,1.3995985745568944,0.06082725060827251,0.43987192737915753,1.0,12/48,13.36%,PPARG;ARG1;SIGIRR;NR1H3;IL6;YTHDF3;IRAK3;STAP1;NLRP2B;CNOT7;TREM2;GAS6
prerank,regulation of interleukin-6 production (GO:0032675),0.46345851012875844,1.3972290127204183,0.032017075773746,0.44611130387239906,1.0,26/96,16.52%,SYK;RAB7B;TLR8;CD200R1;IL6;TMEM106A;SPHK2;IRAK3;CYBA;SIRPA;TYROBP;IL6R;MAVS;NLRC3;ARHGEF2;APP;TREM2;AFAP1L2;GAS6;TNFAIP3;CX3CL1;ARRB1;LBP;MYD88;HSPD1;TLR1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5188655603884617,1.3966739499407856,0.07231920199501247,0.4469613265465657,1.0,5/41,4.74%,PLPP3;GCNT2;FLOT1;CD44;CITED2
prerank,plasma membrane repair (GO:0001778),0.6468853612756037,1.396303763888459,0.09185185185185185,0.4471314342200609,1.0,4/13,12.30%,MYOF;AHNAK2;ARL8B;MYH9
prerank,melanosome organization (GO:0032438),0.5556937139555642,1.3960365331395321,0.09067357512953368,0.44709602649352664,1.0,9/26,18.68%,LYST;DTNBP1;PIKFYVE;AP1G1;AP3D1;AP3B1;TRAPPC6A;RAB29;AP1M1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5589677740996678,1.3957531827291911,0.07388535031847134,0.4470378180619782,1.0,9/26,16.76%,CBLB;NCK2;FBXW7;ADAM17;CHMP6;APP;SHC1;CBL;NCF1
prerank,protein catabolic process (GO:0030163),0.4947078297321242,1.3955003769148924,0.06979405034324943,0.4468674379029866,1.0,15/59,13.63%,CTSD;APOE;TPP1;RIPK1;PPT1;CLN5;HTRA2;SOCS6;MANBA;LAMP2;DDB1;RAB12;OGA;FBXO6;PRKN
prerank,regulation of MAP kinase activity (GO:0043405),0.4714449048066516,1.3953525940994855,0.02608695652173913,0.4463985973309402,1.0,11/92,6.37%,HTR2B;PIK3R5;APOE;CD300A;VEGFA;PRKCD;PDGFA;SORL1;ADAM8;PPEF2;IRAK3
prerank,regulation of protein localization to cell surface (GO:2000008),0.5458254354073029,1.3952956794264861,0.07061790668348046,0.44566004994417824,1.0,11/33,12.95%,CTNNB1;STX3;RANGRF;GPD1L;KCNAB2;NEDD4L;ABCA2;TYROBP;PICALM;SNX33;RAB11B
prerank,regulation of biosynthetic process (GO:0009889),0.6749899322119952,1.394701532438035,0.10766961651917405,0.4467349045848515,1.0,2/11,6.26%,PIKFYVE;SPHK2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4563138813119553,1.3941671682007124,0.012269938650306749,0.4475328813216335,1.0,26/150,10.01%,F7;OSBPL8;HPSE;GDF15;PIK3R5;GRB2;GCNT2;GAB2;TXN;HGF;CD28;PDPK1;PDGFA;P2RX4;F10;FGFR4;THBS1;ADAM8;TRAT1;IRS2;PIK3CA;MFHAS1;VAV1;STRN;ITGB1;ESR1
prerank,regulation of embryonic development (GO:0045995),0.5371128944902904,1.393825876757317,0.06565656565656566,0.44757341576506954,1.0,8/34,13.74%,B4GALT5;TRIP12;NIBAN2;DAG1;WDPCP;NIPBL;CFL1;CLASP1
prerank,retrograde axonal transport (GO:0008090),-0.49855432205076267,-1.393773163730208,0.09090909090909091,0.41671437402599,1.0,4/16,5.92%,DLG2;DST;NEFL;KIF5A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.6639781717613086,1.3932586264938214,0.10742496050552923,0.4484693672932342,1.0,4/10,11.90%,ENPP1;APPL2;PID1;PRKCB
prerank,regulation of phosphate metabolic process (GO:0019220),-0.4980560174725328,-1.392997564062549,0.11384615384615385,0.4158590646864519,1.0,6/16,23.02%,SMG6;SIRT2;TIGAR;SMG7;IGBP1;SMG5
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.6362710383729681,1.3929641280250946,0.1222707423580786,0.44853455831491146,1.0,5/13,9.86%,STX3;RANGRF;GPD1L;TYROBP;SNX33
prerank,glycosphingolipid metabolic process (GO:0006687),0.5115240509898596,1.392835253854757,0.05952380952380952,0.44806687950606505,1.0,15/42,16.71%,PSAP;CERK;GALC;GLA;CTSA;ESYT1;B4GALT6;HEXA;ARSA;ABCA2;A4GALT;GM2A;ESYT2;SUMF1;NEU1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.6036010012324556,1.391875968885583,0.10228802153432032,0.45014433731589837,1.0,5/17,12.13%,APOE;ABCG1;ABCA2;ERLIN1;LPCAT3
prerank,carbohydrate derivative catabolic process (GO:1901136),0.586714118191,1.3905580276823832,0.10854816824966079,0.45317051025040683,1.0,6/18,12.93%,AOAH;MANBA;DERA;OGA;FUCA1;FBXO6
prerank,cellular response to hormone stimulus (GO:0032870),0.47934786082368663,1.3903952562162614,0.047830923248053395,0.4527941874222366,1.0,15/69,12.62%,CTSB;CTSL;RARA;UBE2L3;STAT5B;NR3C1;SLC5A5;NCOA4;CTSS;CTSH;NCOA3;NCOA1;PAX8;BCAS3;GAS2L1
prerank,regulation of potassium ion transport (GO:0043266),-0.40446768904641045,-1.3902855321093885,0.0794392523364486,0.4190244522505849,1.0,11/31,13.99%,KCNIP4;ANK2;DPP10;ANK3;DPP6;KCNAB1;KCNIP3;DLG1;ACTN2;KCNIP1;KCNN2
prerank,positive regulation of lipid localization (GO:1905954),0.662052281396159,1.3901881803539307,0.09642301710730948,0.4525392571998208,1.0,2/11,2.65%,IKBKE;LRP1
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5425435041634756,-1.3900563457436705,0.11363636363636363,0.4169379871697592,1.0,3/11,8.69%,BMPR1A;ZFPM2;TGFB2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.46378278265203077,-1.3894187678161114,0.07692307692307693,0.4156126540637879,1.0,5/20,3.74%,ATP1B1;ANK2;CACNA1C;ATP1A2;RYR2
prerank,regulation of organelle organization (GO:0033043),0.4761298093930439,1.389207093190639,0.04021739130434782,0.45471528191897187,1.0,20/80,14.71%,MYO5A;MTM1;DIAPH1;ZEB2;SPEF1;TBC1D25;RAB33B;CLN3;STX5;CAPN2;SCARB2;MSN;MAVS;PAK2;CPLANE2;SIRT7;PRKN;SQSTM1;VPS11;GOLPH3
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5508513292227303,1.3888194808501393,0.09542483660130718,0.4549859357935319,1.0,15/24,26.97%,IRAK2;RPS27A;UBC;TAB2;RNF34;TNFAIP3;UBE2V1;AAMP;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.517793098331736,1.3887531221556424,0.06815365551425032,0.45431604893374145,1.0,13/37,18.43%,IL6;ABCD1;PLD3;APPL2;ADCY7;SIRPA;MEFV;NLRC3;APPL1;TREM2;MYD88;APOD;CUEDC2
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.4868522150973845,-1.3882646270450048,0.07272727272727272,0.4155989702424597,1.0,4/17,10.88%,ANK3;KCNAB1;NOS1AP;KCNRG
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.5873246192157952,1.3881320493172127,0.08888888888888889,0.45536275105837476,1.0,9/19,19.82%,UGDH;RENBP;GFPT1;NAGK;SLC35D1;UGP2;GNPDA1;NANS;PMM2
prerank,regulation of apoptotic process (GO:0042981),0.4336194204000107,1.387778020511974,0.0,0.4555319422977846,1.0,179/676,18.72%,MTCH1;HTR2B;ARHGAP10;ANXA4;ABR;CD38;CTSB;CTSD;SGK1;MAP3K20;VAV3;LILRB1;RPS6KA2;ANXA1;BCL2L11;CTNNB1;STEAP3;ATG7;VEGFA;AQP1;TGM2;GADD45B;ANO6;TFRC;GADD45G;CD44;PLK2;NAT8;SOS1;IL6;HGF;CD28;FOXO3;NIBAN2;FAS;TFAP2B;BIRC6;JUN;APAF1;DAPK1;RIPK1;PPT1;ANXA5;NOTCH2;GNA13;CITED2;RAF1;SLC27A4;OSGIN1;E2F1;PIM1;IGF1;CLN3;HTRA2;PCID2;ACTN1;PPIF;THBS1;GADD45A;BABAM2;AIFM2;MELK;MLLT11;NR1H4;SPHK2;STK3;CREBBP;HS1BP3;APC;PROC;FLCN;CTNNBL1;HSPA1B;ATF4;RPS27A;UBC;ANP32B;NLRC4;CAT;TNFAIP8;BFAR;USP42;NF2;SH3RF1;XIAP;AKAP13;VAV1;ING3;KLHL20;FBXO11;CTSH;TOPORS;COPS5;FSTL1;NLRP2B;EGLN3;ITGB1;PAX8;PIM3;GSK3B;PTK2B;CFL1;POU3F3;FOXO1;SIRT1;BIRC3;PAK2;ARHGEF2;BAG4;ING4;MT3;OLFM4;STPG1;DCUN1D3;TAX1BP1;RHBDD1;DDX20;ZFAND6;OMA1;WRN;GPLD1;BCLAF1;ATAD3A;RELA;GAS6;VDAC1;PRKN;MCF2;HSPA1A;SOS2;GDNF;BAX;SHC1;PHIP;SQSTM1;JAK3;GOLPH3;FGD3;MCL1;CX3CL1;RPL10;LATS1;NCSTN;USP36;CASP6;QRICH1;RTN4;CBL;BNIP3;MYD88;HSPD1;MIEN1;TMBIM4;BID;TRAF2;IFIT2;ADAMTSL4;CCAR1;UTP11;ERC1;UBE2O;GAS1;PRR7;ACER2;ARF4;TEK;ZBTB7A;SHQ1;HMGN5;BIRC2;C1QBP;ITSN1;CASP2;CASP3;STK4;CRADD;HTT;SOX8;LRP2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.549271824195471,1.3874383179675926,0.08781127129750983,0.45569043106937296,1.0,3/26,3.86%,CD36;TMEM106A;P2RX4
prerank,regulation of innate immune response (GO:0045088),0.48391104156386155,1.3871117393740524,0.06395348837209303,0.4558282565246764,1.0,22/57,20.24%,TLR8;APPL2;ADAM8;IFNAR2;RNASEL;IRAK3;RNF135;TKFC;XIAP;NLRC3;TRAFD1;BIRC3;APPL1;TREM2;FGR;N4BP1;TNFAIP3;ACOD1;PTPN1;BIRC2;FCGR2B;POLR3C
prerank,glycolipid metabolic process (GO:0006664),0.49740902845830226,1.3871086419762635,0.049586776859504134,0.45496116004661796,1.0,12/47,8.18%,PSAP;CERK;PGAP3;GALC;GLA;CTSA;ESYT1;HEXA;PGAP1;ARSA;ST3GAL4;ABCA2
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.5966256567513094,1.387054945111766,0.10087719298245613,0.4542651634057407,1.0,8/18,17.47%,MDFIC;FLCN;MFHAS1;POLR1A;GSK3B;LATS1;CTNNA1;APOD
prerank,retinol metabolic process (GO:0042572),0.619905425293759,1.3860879403248418,0.0953757225433526,0.45647171840075257,1.0,2/14,5.07%,DHRS3;RDH12
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.6489581353241793,1.3859951816629132,0.10371517027863777,0.45590081138767385,1.0,6/11,14.62%,SORL1;RAB21;MSN;EIPR1;PRKN;VPS11
prerank,amide biosynthetic process (GO:0043604),0.5085843889507208,1.384650075160021,0.06534422403733955,0.4590883867938482,1.0,17/47,22.96%,SPTLC2;ARG1;SAMD8;RHD;SGMS2;ARG2;CERS6;SPTSSA;DEGS1;SLC25A15;TLCD3B;SGMS1;PAM;ASAH1;CERS1;FURIN;CERS2
prerank,regulation of protein metabolic process (GO:0051246),0.5077183718857339,1.3842618134294737,0.07508939213349225,0.4594301113621052,1.0,20/44,23.20%,APOE;MAP2K5;MAPK7;NEDD4L;MTPN;CHMP6;APP;TRAF3;SNF8;PARL;ACE;WFS1;SPOP;GSAP;VPS35;FKBP1A;FURIN;PLAUR;FAF1;ABCA7
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.6380577337738247,1.3839452134178511,0.09457364341085271,0.459493642096353,1.0,5/12,10.35%,IL6;NOTCH2;DOCK10;LFNG;PTK2B
prerank,regulation of lymphocyte activation (GO:0051249),-0.5424179404407332,-1.383038941022709,0.1072463768115942,0.4243712788471996,1.0,1/12,0.04%,PAG1
prerank,positive regulation of catabolic process (GO:0009896),0.48010492414428535,1.382923347156585,0.05869074492099323,0.4617480028661609,1.0,20/65,17.29%,ATG7;WWP1;TIPARP;RAB7A;PLK2;SORL1;STX5;APC;NEDD4L;WWP2;HUWE1;DDB1;GSK3B;OAZ2;FOXO1;TNFAIP3;PRKN;SNF8;OAZ1;CSNK2A1
prerank,central nervous system development (GO:0007417),-0.2824610022081731,-1.3828223696912072,0.0,0.4222702930968056,1.0,55/250,12.19%,ZFHX3;CX3CR1;CNTNAP2;ADGRL3;GRIN2A;ITGAM;SPOCK1;ADAM23;DCLK1;PHF8;ROBO2;CNTN6;PTCH1;MARCKS;GRIN2B;NFIB;TGFBR2;GRIK1;MBP;EML1;SMO;CNTN4;ANKLE2;RELN;CDK5R1;NCKAP1;GRIN1;PBX3;ARNT2;IL1RAPL2;TPPP;CDH2;POU6F1;MYRF;ADGRG1;MEIS3;ATN1;MAL;QARS1;DNER;UFM1;SZT2;EPHA7;SERPINI1;MEIS1;SOX6;ADAM22;SH3GL3;IER3IP1;HAPLN2;NDUFS4;SNTG2;PKD2;RPS6KA6;GRIN2D
prerank,T cell migration (GO:0072678),-0.5251492275270209,-1.3828106838647454,0.10423452768729642,0.41973281828424275,1.0,4/13,7.37%,SLC12A2;GPR183;S1PR1;CXCL16
prerank,membrane fusion (GO:0061025),0.5278353455960092,1.382115489419372,0.0980891719745223,0.4633258565541998,1.0,12/33,20.44%,MYOF;SNAP29;VTI1B;RABEP1;VAPA;HUWE1;STX11;VAMP3;RABIF;GCA;VAMP2;SNAP23
prerank,T cell homeostasis (GO:0043029),0.6553962482556586,1.3819188019560262,0.10895522388059702,0.46312988897672175,1.0,3/10,14.64%,FOXP3;FAS;JAK3
prerank,monocarboxylic acid transport (GO:0015718),0.4993755538961234,1.380917129137556,0.05847953216374269,0.46541350801010767,1.0,13/51,13.46%,CD36;SLC51A;RXRA;SLC16A1;SLC27A4;STARD5;ABCC4;NR1H4;ABCC3;SLC27A1;NCOA1;SLC6A8;ATP8B1
prerank,neutrophil chemotaxis (GO:0030593),0.4932044753290208,1.3801770961891107,0.06612529002320186,0.4668128027769779,1.0,3/53,1.15%,LGALS3;SYK;PIKFYVE
prerank,cellular amide metabolic process (GO:0043603),0.45995192471411345,1.3801607099919546,0.036519871106337275,0.46599348718896244,1.0,31/102,20.90%,PLPP3;BAAT;CERK;SGPL1;MTHFS;NLN;PDZD11;CPXM1;ACSM3;ATF4;GLYAT;FOLR2;ABHD4;ABCA2;PLAAT1;SLC25A32;DNPEP;MCCC1;PLAAT3;MTHFD1L;ACOT9;PANK2;CPM;MTRR;SLC19A1;PPP2CA;NSMAF;ACOT2;PPP2R1A;ACOT6;BTD
prerank,cellular response to reactive oxygen species (GO:0034614),0.4826730179474815,1.3800781122850025,0.06484641638225255,0.4653685229419387,1.0,16/59,13.60%,NFE2L2;ANXA1;AQP1;MPV17;IL6;PRKCD;JUN;RIPK1;MAPK7;PPIF;SIRPA;PLEKHA1;SIRT1;ERCC6L2;RELA;TNFAIP3
prerank,carnitine metabolic process (GO:0009437),0.6388367269051728,1.3799048646840968,0.11532385466034756,0.464989398990445,1.0,4/12,8.37%,TMLHE;ACADL;CRAT;CPT1A
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6065192542630811,1.3796768508688344,0.10806916426512968,0.46486833279869355,1.0,5/15,10.19%,TENT4B;AGO2;TNRC6B;POLR2G;CNOT7
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.6032690715653234,1.3788676133214648,0.10826210826210826,0.46654461025875377,1.0,6/16,13.63%,PDK4;SCARB2;FOXK1;SIRT1;RORA;PRKN
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.47113900608890463,1.3788133150567374,0.056666666666666664,0.4658264672500417,1.0,34/76,24.93%,FBXW7;TNIP1;TANK;UBE2L3;RWDD3;CUL3;PIAS4;XIAP;BRCA1;HUWE1;DCUN1D5;BIRC3;STUB1;DCUN1D3;NSMCE3;DCUN1D4;CENPX;DCUN1D1;CRY1;PHF23;BIRC2;MYCBP2;WFS1;PAXIP1;PIAS1;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;TRAF6;FBXO4;NDFIP1;DCUN1D2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.6022754404867977,1.3782729381095897,0.09241379310344827,0.4665570541093593,1.0,2/15,2.82%,PPARG;NR1H3
prerank,cellular defense response (GO:0006968),0.5099727333830352,1.37745483793685,0.07747318235995232,0.46813006153436487,1.0,14/40,16.76%,CD5L;VEZF1;TCIRG1;LY96;TRAT1;LSP1;NCF2;ZNF148;TYROBP;ITGB1;PTK2B;RELA;LBP;NCF1
prerank,second-messenger-mediated signaling (GO:0019932),0.46849893545575905,1.37743628262761,0.045657015590200446,0.4673166832782023,1.0,9/82,3.93%,CD36;HTR2B;TPCN2;APOE;CXCR4;HRH1;PDPK1;P2RX4;XCR1
prerank,connective tissue development (GO:0061448),0.5251121397971991,1.3767313422959468,0.07588739290085679,0.4687670611394342,1.0,13/35,20.91%,NAMPT;SPTLC2;CD44;SULF2;ARID5B;TRIP11;SULF1;SH3PXD2B;ATP7A;COL11A2;SOX8;HES5;ZBTB16
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5715716878935985,1.3765333823893424,0.11360634081902246,0.4684793589666099,1.0,4/19,5.81%,PRKCD;ABCD1;MTLN;IRS2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5744386852108567,1.37582788119187,0.09646739130434782,0.46990494686179085,1.0,5/21,12.13%,OSBPL8;PLA2G2D;PLA2G4F;PLAAT3;LPCAT3
prerank,snRNA transcription (GO:0009301),0.47221041347776127,1.3755170902218814,0.05790645879732739,0.47003485952481316,1.0,23/70,14.20%,POLR2A;GTF2B;INTS9;TAF5;POLR2L;RPAP2;INTS6;SNAPC1;INTS1;POLR2G;INTS13;INTS8;CDK7;POLR2I;NCBP2;GTF2F2;INTS5;INTS7;ICE2;INTS2;POU2F1;USPL1;GTF2A1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4748094766000145,1.3750666743948845,0.05649717514124294,0.4706451428244318,1.0,7/66,5.73%,HTR2B;PIK3R5;SASH1;VEGFA;TAOK3;PDGFA;ADAM8
prerank,regulation of cellular biosynthetic process (GO:0031326),0.5522066602676441,1.374971524716664,0.08982826948480846,0.4700913548573872,1.0,10/28,10.59%,MITF;PDK4;PRKAG2;TNFRSF1B;FGFR4;MFSD12;NR1H4;EIF6;SIRPA;SIRT1
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.6527916006316818,1.3744837313693317,0.10089020771513353,0.470693578651397,1.0,3/11,7.63%,CORO1C;CD44;RREB1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.5761326175201543,1.37423633468154,0.10828877005347594,0.47060096037526933,1.0,8/21,20.16%,TGM2;SLC8B1;MICU2;MICU1;LETM1;SMDT1;AFG3L2;BCAP31
prerank,Golgi to lysosome transport (GO:0090160),0.6511174722611613,1.3735295970385206,0.11635220125786164,0.4720448071036761,1.0,5/11,18.26%,LAMP1;CLN3;GAK;AP1G1;AP4M1
prerank,intestinal absorption (GO:0050892),0.634701367873283,1.3729208727891606,0.10632183908045977,0.4730447277247612,1.0,1/13,0.12%,CD36
prerank,negative regulation of apoptotic process (GO:0043066),0.43060802710502183,1.372760315244985,0.0,0.472665236189193,1.0,104/444,16.13%,HTR2B;ARHGAP10;ANXA4;CD38;APOE;PRKCH;ANXA1;CTNNB1;VEGFA;AQP1;FNIP1;PDK4;CPEB4;TFRC;DNAJB6;CD44;PLK2;NAT8;IL6;HGF;CD28;ITGA5;PRKCD;NIBAN2;FAS;TFAP2B;BIRC6;RIPK1;PPT1;ANXA5;NOTCH2;MAP2K5;CITED2;RAF1;PIM1;IGF1;CLN3;PCID2;PPIF;THBS1;MERTK;BABAM2;ADAM8;NR1H4;PIK3CA;PROC;HSPA1B;RPS27A;UBC;CAT;TNFAIP8;BFAR;SH3RF1;XIAP;SNAI2;RB1;KLHL20;CTSH;TOPORS;COPS5;CSNK2A2;FSTL1;ITGB1;PIM3;GSK3B;PTK2B;CFL1;POU3F3;FOXO1;SIRT1;BIRC3;PAK2;BAG4;MT3;TAX1BP1;NOTCH1;RHBDD1;TREM2;ZFAND6;MAZ;HCLS1;ATAD3A;RELA;GAS6;VDAC1;PRKN;HSPA1A;GDNF;SHC1;PHIP;SQSTM1;GOLPH3;MCL1;CX3CL1;RPL10;CBL;PRKCG;BNIP3;MYD88;GRN;HSPD1;MIEN1;TMBIM4;BID
prerank,neurotransmitter transport (GO:0006836),-0.33528729715957284,-1.3727477784921205,0.018867924528301886,0.4390825355640677,1.0,15/73,6.70%,NRXN1;SYT1;CASK;RIMS1;SLC1A3;ATP1A2;SYN2;GABRA2;PTPRN2;LIN7A;SLC17A6;SNAP25;SLC6A15;SLC1A2;PPFIA4
prerank,regulation of cardiac conduction (GO:1903779),-0.3497484084655193,-1.372458860409627,0.06666666666666667,0.4370922912401038,1.0,14/54,12.39%,ATP1B1;RYR3;ANK2;ITPR2;TRPC1;ASPH;ATP1A2;RYR2;ATP1B2;ATP2B3;PRKACA;ATP2B2;ATP2B4;AGT
prerank,regulated exocytosis (GO:0045055),0.4444732999060015,1.372279156576641,0.018367346938775512,0.47327985442585524,1.0,34/173,13.36%,PSAP;CD36;VWF;TIMP1;VEGFA;HGF;APLP2;CD63;PDGFA;LHFPL2;ANXA5;DNAJC5;IGF1;ACTN1;THBS1;VTI1B;ABCC4;OLA1;RAB31;TLN1;LAMP2;F13A1;QSOX1;ITIH3;ARHGAP17;SYT17;RAB10;WDR1;APP;CTSW;GTPBP2;MYH9;RAB11B;GAS6
prerank,sulfur compound biosynthetic process (GO:0044272),0.4547191879478544,1.3720137850522096,0.03415154749199573,0.47333190431600836,1.0,26/104,15.24%,CDO1;B4GALT5;MGST2;PAPSS2;GSTM1;AKR1A1;DSE;CNDP2;UGDH;SLC26A1;B4GALT6;ST3GAL4;LUM;HPGDS;SLC35B3;PAPSS1;ESD;B4GALT3;LIAS;GGTA1;MGST1;HAGH;B4GALT2;SLC10A7;GSTO2;GSTA4
prerank,positive regulation of histone deacetylation (GO:0031065),0.6369771856290461,1.3719694737315598,0.10237388724035608,0.472580468070371,1.0,3/12,6.98%,APLNR;VEGFA;NIPBL
prerank,positive regulation of interleukin-1 production (GO:0032732),0.49408922089610574,1.3718072577871476,0.06753554502369669,0.4722289354128612,1.0,8/51,11.75%,CD36;TLR8;IL6;TMEM106A;NLRC4;TYROBP;APP;FZD5
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.45841063793419207,1.3717589759082234,0.03695881731784583,0.4715327197704329,1.0,29/108,18.54%,MTCH1;PPARG;CTSD;XDH;SYK;ST18;FAS;APAF1;DAPK1;RIPK1;HTRA2;ANP32B;NLRC4;DLC1;EGLN3;CYCS;SIRT1;CASP12;BAX;HSPD1;BID;TRAF2;HSPE1;PRR7;ACER2;BBC3;SENP1;CASP2;CRADD
prerank,eosinophil chemotaxis (GO:0048245),0.6171659841484272,1.3711371830654229,0.12481203007518797,0.4717316347625662,1.0,1/14,0.11%,LGALS3
prerank,eosinophil migration (GO:0072677),0.6171659841484272,1.3711371830654229,0.12481203007518797,0.4717316347625662,1.0,1/14,0.11%,LGALS3
prerank,regulation of DNA binding (GO:0051101),0.5042677677095355,1.3711099491263428,0.07582938388625593,0.4709619701780131,1.0,6/44,6.69%,PPARG;TXN;JUN;E2F1;IGF1;DOT1L
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4998870429018347,-1.3704329764765937,0.10034602076124567,0.43897957541297544,1.0,4/16,10.16%,MEF2C;PLCB1;RIPOR2;LRRC8A
prerank,ganglioside metabolic process (GO:0001573),-0.4619513959944864,-1.370401506588386,0.12014134275618374,0.43644043064612836,1.0,8/20,13.96%,HEXB;ST6GALNAC3;ST8SIA6;ST3GAL5;ST6GALNAC5;ST6GALNAC4;ST8SIA3;ST6GALNAC6
prerank,membrane repolarization during action potential (GO:0086011),-0.5238796270681048,-1.370161031631887,0.11009174311926606,0.4343848017236832,1.0,2/13,4.61%,ATP1B1;KCNJ2
prerank,macrophage chemotaxis (GO:0048246),0.6684962617093947,1.369676626180452,0.1148036253776435,0.47450974931654993,1.0,2/10,6.88%,LGALS3;CKLF
prerank,positive regulation of TOR signaling (GO:0032008),0.5187308049011571,1.3695702430344625,0.07605985037406483,0.4739861897190131,1.0,13/40,14.71%,GPR137B;FNIP1;HTR6;SIK3;PIK3CA;FLCN;LAMTOR1;TREM2;MIOS;SLC38A9;LAMTOR3;GAS6;GOLPH3
prerank,regulation of store-operated calcium entry (GO:2001256),0.6577291110743869,1.369349390070821,0.10843373493975904,0.47385298995409464,1.0,3/10,4.59%,CD84;SLC8B1;HOMER3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5215389720009058,1.3692856612932753,0.09420289855072464,0.47319952948910426,1.0,6/37,5.08%,PPARG;ERN1;CDKN1A;JUN;PTEN;IGF1
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.4504023651106829,-1.36923967233729,0.08403361344537816,0.4339631470435303,1.0,8/22,14.83%,NTRK3;ACAP2;MAPT;MAGI2;NTRK2;EHD1;STMN2;RAPGEF2
prerank,actomyosin structure organization (GO:0031032),-0.3395222473743359,-1.3690644033143617,0.010752688172043012,0.43184676540936295,1.0,13/75,5.85%,EPB41L2;FRMD5;SORBS1;F11R;CAPN3;MYO18A;PHACTR1;CIT;EPB41;CDC42BPA;TMOD2;EPB41L4B;FRMD3
prerank,activation of protein kinase B activity (GO:0032148),0.5333706120764242,1.3680275110566453,0.08436724565756824,0.4763160829441696,1.0,7/29,15.50%,OSBPL8;TXN;PDPK1;IGF1;MT3;GAS6;MAPKAP1
prerank,regulation of necroptotic process (GO:0060544),0.5537522140083991,1.3679186127433896,0.11006711409395974,0.47580407742695224,1.0,7/23,11.49%,SDCBP;FLOT1;RIPK1;PDCD6IP;BIRC3;ARHGEF2;STUB1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.5879557430471368,1.3674990380779064,0.10738255033557047,0.47628572294451016,1.0,7/20,13.22%,APOE;NR1H4;ACADL;ACADVL;ABCA2;LPCAT3;DGKQ
prerank,natural killer cell activation (GO:0030101),0.5601968501771211,1.3670777680243649,0.09762532981530343,0.47673265239145535,1.0,3/23,2.24%,PRDX1;SLAMF7;SNX27
prerank,negative regulation of inclusion body assembly (GO:0090084),0.659924001829151,1.3669419863351957,0.12898089171974522,0.47635257869128633,1.0,4/10,13.93%,DNAJB6;SORL1;HSPA1B;HSPA1A
prerank,positive regulation of immune effector process (GO:0002699),0.5414667625529194,1.3665208651770866,0.0938722294654498,0.4767210730741264,1.0,4/27,4.47%,LILRB1;CD46;ANKRD17;APPL2
prerank,response to nitric oxide (GO:0071731),0.6214248267183706,1.3659996899696656,0.12244897959183673,0.47758978357109966,1.0,4/13,11.17%,TXN;AQP1;FOXO1;MT3
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.6268956368590914,1.3659772810276265,0.09913793103448276,0.47681334345525145,1.0,4/13,15.63%,BCL2L11;VDAC2;BAX;BNIP3
prerank,negative regulation of interleukin-10 production (GO:0032693),0.584464976329991,1.3647966363556818,0.11773049645390071,0.4797214476074171,1.0,7/16,19.77%,LILRB1;FOXP3;CD274;TYROBP;JAK3;TNFRSF21;FCGR2B
prerank,cellular response to acid chemical (GO:0071229),0.5405924354745146,1.3646158104980404,0.11315789473684211,0.4794664431721706,1.0,8/27,13.12%,VEGFA;IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.44300441260250034,1.3644632548993225,0.034161490683229816,0.4790946271783881,1.0,31/136,15.15%,ANXA4;ADGRG3;SIGIRR;FOXP3;IRAK2;ID2;MAP2K5;PIM1;RWDD3;SIK1;IRAK3;BHLHE40;NWD1;PEX14;EIF2AK4;RB1;WWP2;NFKBIL1;DDIT3;NLRP2B;ESR1;NLRC3;SIRT1;TAX1BP1;TBX6;TRAF3;GAS6;TNFAIP3;ERBIN;ACOD1;ARRB1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.47324216668885577,1.3635193296393546,0.06305309734513274,0.481312761553549,1.0,13/75,10.59%,HTR2B;APLNR;VEGFA;PDPK1;ITGA4;NRP2;SIRT6;NRAS;HMOX1;VASH2;BMPR2;ADAM17;SIRT1
prerank,regulation of calcium ion import (GO:0090279),0.5735901975139603,1.3632291216380714,0.10504774897680765,0.4814280468207931,1.0,3/21,6.26%,LGALS3;CTNNB1;SPHK2
prerank,regulation of Golgi organization (GO:1903358),0.5833003840787753,1.3628103170151666,0.12410841654778887,0.48187618666753135,1.0,3/17,6.52%,MYO5A;RAB33B;STX5
prerank,generation of neurons (GO:0048699),-0.28881924477525855,-1.3621609937792492,0.0,0.44485424730091655,1.0,32/190,9.05%,CX3CR1;PTPRD;ADGRL3;MEF2C;OPHN1;IL1RAPL1;GPM6A;SPOCK1;TAFA1;DISC1;AUTS2;RYK;MAPT;FZD3;EML1;MYEF2;CIT;RELN;FUT9;MYT1L;CDK5R1;NTRK2;FGF13;ASTN2;ACSL4;MARK1;MAP2K1;TUBB2A;DNER;MARK2;TGFB2;SEMA3A
prerank,response to estradiol (GO:0032355),0.5204066410000711,1.3621096790120915,0.10038119440914867,0.4831319743965301,1.0,8/31,12.68%,ANXA1;CTNNB1;STAT5B;LCOR;NCOA3;ESR1;STRN3;FAM210B
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.46836009448521804,1.361297219191996,0.0686936936936937,0.4847854925888628,1.0,22/67,20.47%,CD36;PSMD1;CYBB;CYBA;NCF2;PSMF1;PSMD14;PSMD12;NCF4;VAMP3;PSME2;NCF1;PSMB10;PSMD5;PSMD8;PSMA3;TAPBP;PSMA2;PSMD11;ITGAV;SNAP23;PSMA6
prerank,ovarian follicle development (GO:0001541),0.6252714112073555,1.3612055389133386,0.11747430249632893,0.48421835450126555,1.0,2/13,1.88%,VEGFA;CEBPB
prerank,positive regulation of glucose import (GO:0046326),0.5657754245140617,1.361156237232032,0.10960757780784844,0.4835422748869426,1.0,3/21,5.81%,OSBPL8;IGF1;IRS2
prerank,negative regulation of mRNA processing (GO:0050686),-0.48908200602170243,-1.360605908690292,0.11808118081180811,0.4455495746642786,1.0,8/15,30.89%,SRSF6;RBMX;PCBP4;SRSF12;SRSF9;SRSF4;SAP18;SRSF7
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.4701373225017519,1.3601523595895306,0.05752212389380531,0.48590258375991224,1.0,22/73,18.54%,MTCH1;PPARG;XDH;FAS;APAF1;RIPK1;ANP32B;NLRC4;DLC1;EGLN3;CYCS;CASP12;BAX;HSPD1;BID;TRAF2;HSPE1;ACER2;BBC3;SENP1;CASP2;CRADD
prerank,cellular macromolecule catabolic process (GO:0044265),0.4901727887229426,1.3599373153686025,0.07790697674418605,0.48567338563755347,1.0,16/49,15.02%,RIPK1;RNASE3;HTRA2;MANBA;DFFB;RAB12;DNASE1L1;OGA;SND1;FBXO6;PRKN;SIDT2;RNASEH2A;HNRNPD;RNASEH1;MTREX
prerank,snRNA 3'-end processing (GO:0034472),0.581180995061535,1.3593848351760272,0.10620689655172413,0.4866302023688447,1.0,10/19,13.45%,TOE1;INTS6;EXOSC3;EXOSC9;INTS1;INTS8;EXOSC8;INTS5;INTS7;INTS2
prerank,muscle contraction (GO:0006936),0.44505436195756115,1.3588731084127432,0.040880503144654086,0.4873811934836291,1.0,16/126,12.19%,MYOF;TPCN2;EDNRA;ADRA1A;VIM;SORBS3;MYL2;SLC8A1;KLHL41;TLN1;MYBPC3;TPM3;ROCK1;TPM4;SLC6A8;MYLK
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5719101647734018,1.357920667438903,0.1297071129707113,0.4896388379749955,1.0,9/19,18.74%,ACD;TENT4B;HNRNPU;TERF1;NAT10;TEN1;STN1;EXOSC10;GNL3L
prerank,mRNA polyadenylation (GO:0006378),0.5409000842245127,1.356883091552056,0.10309278350515463,0.49119876847268873,1.0,9/26,15.64%,CPSF1;TENT4B;CSTF3;WDR33;TENT2;GRSF1;APP;SSU72;CDC73
prerank,RNA polyadenylation (GO:0043631),0.5409000842245127,1.356883091552056,0.10309278350515463,0.49119876847268873,1.0,9/26,15.64%,CPSF1;TENT4B;CSTF3;WDR33;TENT2;GRSF1;APP;SSU72;CDC73
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.6247252060816801,1.3560922077501083,0.12652439024390244,0.4927872230808861,1.0,2/12,2.39%,IQGAP1;MYO1E
prerank,ERBB signaling pathway (GO:0038127),0.47388453631527566,1.3559356463989332,0.057757644394110984,0.49241161265890787,1.0,16/64,15.42%,IQGAP1;REPS2;GRB2;NCK2;SOS1;PDPK1;KIF16B;PIK3CA;PTPN12;ADAM17;PTK2B;NRG4;STUB1;ERBIN;SHC1;CBL
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.5832279564445975,1.3553684455459802,0.11328671328671329,0.4933683597878016,1.0,5/17,12.33%,NFE2L2;HTRA2;MAPK7;SIRT1;TREM2
prerank,response to interferon-alpha (GO:0035455),0.5952775403819835,1.3550586762307433,0.13617021276595745,0.4934283685590332,1.0,8/16,16.95%,IFITM1;IFNAR2;KLHL20;IFITM2;TPR;BST2;GAS6;IFNAR1
prerank,phasic smooth muscle contraction (GO:0014821),0.6608940639800654,1.3548784849453217,0.12363067292644757,0.493146460026566,1.0,1/10,0.14%,HTR2B
prerank,membrane lipid biosynthetic process (GO:0046467),0.47572286810960945,1.3547555245078076,0.07053469852104664,0.4926555807177614,1.0,18/58,17.42%,PLPP3;SPTLC2;SAMD8;SGPL1;CERT1;SGMS2;HACD4;CERS6;SPHK2;ST3GAL4;SPTSSA;VAPA;ELOVL1;ALDH3A2;DEGS1;PRKD3;ACER2;SGMS1
prerank,protein import into nucleus (GO:0006606),0.4744202628954336,1.3544684868373325,0.06764374295377677,0.49271649245976645,1.0,13/66,12.23%,MMP12;CBLB;SYK;IPO5;KPNA4;E2F3;APPL2;KPNA2;RPL23;TPR;NUP50;TNPO1;APPL1
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.5470402697736264,1.3543650869694044,0.11973684210526316,0.4922280018585497,1.0,9/25,22.13%,LYST;CHMP2A;CHMP6;CHMP5;TMEM50A;CHMP7;LEPROTL1;CHMP2B;VCP
prerank,long-term memory (GO:0007616),0.5789002922145309,1.3542230938800688,0.10863509749303621,0.49182818831195957,1.0,4/19,8.37%,APOE;SGK1;EIF2AK4;CALB1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5941653841563952,1.3537059671954912,0.11657303370786516,0.49253483670471143,1.0,5/16,8.87%,ADSL;IMPDH2;PPAT;AMPD3;LHPP
prerank,positive regulation of cell death (GO:0010942),0.47601788800197636,1.3534808934049667,0.08200455580865604,0.49234748307391274,1.0,13/59,11.17%,CD36;SLC6A6;LRP1;RIPK1;CELF1;APC;PRODH;TYROBP;HPR;HP;PICALM;GSK3B;MT3
prerank,negative regulation of cellular component organization (GO:0051129),0.4663592690198564,1.3533995405318353,0.07461024498886415,0.49175552755878243,1.0,15/74,10.25%,LGALS3;LILRB1;VEGFA;DNAJB6;TFIP11;RAF1;AIDA;SORL1;NR1H4;IRAK3;HSPA1B;RTEL1;XRCC5;SNX33;GSK3B
prerank,sensory perception of chemical stimulus (GO:0007606),0.6115021056869603,1.352944473152914,0.13469985358711567,0.4923532808453402,1.0,1/15,0.12%,CD36
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.558146980571535,1.35267630355857,0.12041884816753927,0.492350124312098,1.0,8/21,20.34%,HK3;PGD;TALDO1;SHPK;DERA;RPIA;RBKS;GCK
prerank,protein localization to chromosome (GO:0034502),0.5219452405037606,1.3522461365622431,0.10275689223057644,0.49291214575805664,1.0,13/34,18.57%,ACD;TPP1;MCM9;PARP3;RB1;BOD1;XRCC4;XRCC5;ESR1;TNKS;CHMP7;TNKS2;RAD21
prerank,regulation of cell junction assembly (GO:1901888),0.5375460230009204,1.352209833028021,0.10943396226415095,0.49218902532900877,1.0,8/27,12.79%,APLNR;PRKCH;FLOT1;PDLIM5;SNAI2;CBFB;ROCK1;RAPGEF1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5685320869035274,1.3518051280744634,0.1092896174863388,0.4926154902970977,1.0,9/20,20.59%,SDCBP;FLOT1;RIPK1;PDCD6IP;BIRC3;STUB1;BIRC2;ASAH1;OGT
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3738295097192448,-1.351616187029028,0.0875,0.46317760324796264,1.0,16/41,14.96%,GRIN2A;RYR3;GRIN2B;SLC24A2;HTR2C;ITPR2;RYR2;GRIN1;FGF2;TRPM2;PKD2;GRIN2D;ATP2B4;HTR2A;CHERP;CACNA2D1
prerank,integrin-mediated signaling pathway (GO:0007229),0.4617004480699475,1.3515656062261063,0.07119021134593993,0.4925656277833355,1.0,19/73,16.18%,PLPP3;SYK;NEDD9;TEC;PRAM1;ADAM9;ITGA5;CUL3;ITGB1;PTK2B;ITGA10;FBLN1;MYH9;DOCK1;COL3A1;FGR;ERBIN;LAMA3;NRP1
prerank,actin nucleation (GO:0045010),0.5638094602909228,1.351300829363998,0.11486486486486487,0.492652860720148,1.0,9/21,22.20%,IQGAP2;ARPC2;WASHC1;ACTR3;WHAMM;ARPC1A;ARPC4;ARPC5L;ARPC5
prerank,diterpenoid metabolic process (GO:0016101),0.4871716721966237,1.3511851341488068,0.07523148148148148,0.49220324617680955,1.0,6/55,5.07%,APOE;STRA6;DHRS3;LRP1;RBP1;RDH12
prerank,regulation of glucose metabolic process (GO:0010906),0.5169242946584619,1.3507619555922192,0.09913258983890955,0.4927462801655459,1.0,12/34,13.63%,PDK4;ZNF692;GNMT;SDHAF3;IRS2;FOXK1;SIRT1;RORA;SIRT7;GPLD1;DGKQ;PRKN
prerank,thyroid hormone generation (GO:0006590),0.6511208145201145,1.3506803529313292,0.1638846737481032,0.49219240316612806,1.0,2/10,5.98%,CPQ;SLC5A5
prerank,bile acid metabolic process (GO:0008206),0.5395128035698425,1.3504811709220712,0.1018041237113402,0.4919821193865909,1.0,4/27,2.13%,BAAT;NPC1;AMACR;OSBPL1A
prerank,negative regulation of receptor internalization (GO:0002091),0.6311706136106789,1.3503703591458938,0.13122171945701358,0.49149583215567644,1.0,5/12,15.04%,SDCBP;ATXN2;RIN3;ANKRD13D;UBQLN2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6349990850985726,1.3489616302646692,0.14138438880706922,0.49490224789175413,1.0,4/12,8.87%,ADSL;IMPDH2;PPAT;LHPP
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.46925201875396927,1.3489438488798267,0.0686936936936937,0.49413866703212755,1.0,19/67,12.85%,VAV3;NCK2;VEGFA;MAPKAPK3;BAIAP2;ABI1;NRP2;PIK3CA;CYBB;CYBA;NCF2;VAV1;CYFIP2;ROCK1;PTK2B;PAK2;SULF1;DOCK1;NCF4
prerank,regulation of cellular catabolic process (GO:0031329),0.4765284612402015,1.3489046709488997,0.07390817469204927,0.49346542681227357,1.0,19/62,17.97%,PSAP;TPCN2;GPR137B;MTMR3;ABL2;ABCD1;DAPK1;WDR91;SCARB2;DCAF12;DDIT3;ROCK1;LONP2;PRKN;PIP4K2A;ACER2;KEAP1;DRAM2;VPS29
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.4646234391189229,1.3487960963595893,0.06494960806270997,0.49301699648636416,1.0,22/69,14.20%,POLR2A;GTF2B;INTS9;TAF5;POLR2L;RPAP2;INTS6;SNAPC1;INTS1;POLR2G;INTS13;INTS8;CDK7;POLR2I;NCBP2;GTF2F2;INTS5;INTS7;ICE2;INTS2;POU2F1;GTF2A1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.5005351722267471,1.348690252970374,0.10143198090692124,0.49253635852417554,1.0,13/41,15.53%,LILRB1;RARA;IGF1;ARG2;NR1H4;IRAK3;SIRPA;NFKBIL1;NLRC3;GAS6;TNFAIP3;CX3CL1;LBP
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4855433884511552,1.348491844389548,0.08244994110718493,0.49232959583403724,1.0,6/53,5.96%,HTR2B;HRH1;ANXA1;HTR6;XCR1;CNR2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.6566410519797166,1.3480332463390983,0.13819875776397517,0.49289546507978865,1.0,6/10,22.65%,NFE2L2;ATF4;DDIT3;QRICH1;EIF2S1;HERPUD1
prerank,regulation of lipid storage (GO:0010883),0.5475808800551789,1.3473503404843576,0.11580381471389646,0.49420339025646826,1.0,5/22,10.59%,IKBKE;FBXW7;IL6;FTO;SIRT1
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.43104603073814063,1.347209201699186,0.018311291963377416,0.49383601972473684,1.0,37/182,11.88%,SDCBP;APLNR;APOBEC1;XDH;APOE;OPTN;VEGFA;TIPARP;FBXW7;ID2;CD28;CD46;NOTCH2;CELF1;ATXN2;CITED2;IGF1;AGO2;TRAT1;FLCN;REL;RB1;WWP2;ZNF148;FOXP1;ACVRL1;PICALM;TNRC6B;CNPY2;ESR1;CNOT7;RIN3;AGO3;SIRT1;ANKRD13D;APP;NOTCH1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6287338946716575,1.3462907566908793,0.1426448736998514,0.49587131564290826,1.0,4/11,13.36%,LILRB1;MERTK;HCLS1;GAS6
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6399478446335432,1.345957456824029,0.12557427258805512,0.4961460162162432,1.0,5/11,11.88%,P2RX4;LMNA;GLRX3;FOXO1;NOTCH1
prerank,sphingosine biosynthetic process (GO:0046512),0.644688307913873,1.3459410563318193,0.13343328335832083,0.4946070366123215,1.0,5/11,19.17%,SPTLC2;SPHK2;ABCA2;ACER2;ASAH1
prerank,sphingoid biosynthetic process (GO:0046520),0.644688307913873,1.3459410563318193,0.13343328335832083,0.4946070366123215,1.0,5/11,19.17%,SPTLC2;SPHK2;ABCA2;ACER2;ASAH1
prerank,protein acylation (GO:0043543),0.5024158928189403,1.3456301833176056,0.09125,0.49476297972142785,1.0,15/38,21.77%,ZDHHC14;ZDHHC16;GTF2B;CREBBP;ZDHHC12;ZDHHC18;NAT10;FOXO1;ING4;NAA10;ZDHHC17;NAT9;CLOCK;NAA80;KAT2A
prerank,mononuclear cell differentiation (GO:1903131),0.5350313855284308,1.3454781363089259,0.10821382007822686,0.4944247586767851,1.0,7/24,13.36%,PPARG;LILRB1;VEGFA;RELB;MYH9;TREM2;GAS6
prerank,regulation of cell death (GO:0010941),0.45521124417548736,1.3454133222156706,0.051227321237993596,0.49383291861106493,1.0,27/94,18.25%,CD36;HTR2B;SPEF1;CCN5;LRP1;TNFRSF1B;CELF1;APC;CHMP2A;HSPA1B;PRODH;CTSZ;HPR;HP;SNCG;ATG5;CCN1;MT3;OLFM4;DUS2;PRKN;HSPA1A;BNIP3;RAB29;PRR7;ACER2;CCN2
prerank,neurotrophin signaling pathway (GO:0038179),0.5736141927060575,1.345289192165277,0.11265646731571627,0.49344773378776474,1.0,7/21,18.31%,GRB2;SOS1;KIDINS220;ZFYVE27;RAPGEF1;FRS2;CASP3
prerank,regulation of gluconeogenesis (GO:0006111),0.5359284085340114,1.3452815104692653,0.10582010582010581,0.4926878928387429,1.0,12/27,20.59%,ZNF692;GNMT;SDHAF3;SIK1;DDB1;SIRT1;PGP;SIRT7;DGKQ;CRY1;GCK;OGT
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5879520164170571,1.3452324630258983,0.12719891745602166,0.4920522835796574,1.0,5/18,10.24%,PPARG;PDPK1;ITGA4;SIRT6;ADAM17
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.4710419173940507,1.3449722303898395,0.07639680729760548,0.4920842690304986,1.0,23/61,22.88%,PDK4;PRKAG2;PSMD1;FGFR4;NR1H4;OAZ2;SIRT1;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;PANK2;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,regulation of multicellular organismal development (GO:2000026),0.551817182401297,1.3447508329541868,0.1081441922563418,0.49197668809498024,1.0,3/25,6.98%,HPSE;TRIP12;NIPBL
prerank,negative regulation of neuron death (GO:1901215),0.45765352639297086,1.344709781944461,0.048179871520342615,0.4913108398879833,1.0,21/93,16.19%,GPNMB;APOE;CD200R1;CPEB4;PPT1;TNFRSF1B;SORL1;CLN3;HTRA2;ADAM8;ATF4;GSK3B;PTK2B;NENF;MT3;PRKN;GDNF;PRKCG;GRN;INPP5A;TRAF2
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.45326570436485775,1.343973172634033,0.05603448275862069,0.49278640530572526,1.0,22/93,16.76%,SDCBP;SASH1;XDH;VEGFA;GADD45B;GADD45G;RELL1;TAOK3;RIPK1;GADD45A;MFHAS1;SH3RF1;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;TRAF5;TRAF2;LTBR;NCF1
prerank,organelle transport along microtubule (GO:0072384),0.5252047808631055,1.34360745376744,0.10466582597730138,0.49313545144357596,1.0,10/31,19.75%,ARHGAP21;CLN3;PEX14;UXT;BORCS5;NDE1;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,macroautophagy (GO:0016236),0.440953115449413,1.3434043811833816,0.04716981132075472,0.4929747161517944,1.0,45/118,23.39%,PLEKHM1;MTMR3;ATG7;PRKAG2;SNAP29;TCIRG1;TECPR1;UVRAG;CLN3;ATG10;VTI1B;STAM;CHMP2A;TOMM20;AMBRA1;LAMP2;VPS33A;CSNK2A2;ARL8B;VPS4A;EPG5;ATG5;FUNDC1;CHMP6;ATG4B;ATG13;VDAC1;PRKN;SQSTM1;SNF8;SNX14;STAM2;PIP4K2A;CSNK2A1;TOMM7;TOMM22;ACBD5;PLAA;VPS36;CHMP2B;VPS37B;VCP;MFN2;MTERF3;KLHL3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6153511152834157,1.3432347353125074,0.14754098360655737,0.4926744980071672,1.0,4/13,12.99%,ATG7;ATG10;UBA3;UBA5
prerank,glucose homeostasis (GO:0042593),0.4570283952520421,1.3424806978477808,0.05384615384615385,0.4941792337684077,1.0,14/83,11.99%,PPARG;LRRC8D;PDK4;HK3;IL6;PYGL;TFAP2B;SLC8B1;APPL2;FGFR4;FOXK1;FOXO1;SIRT1;CYB5R4
prerank,positive regulation of catalytic activity (GO:0043085),0.5029149195064951,1.342387611934002,0.10209102091020911,0.4937304011650785,1.0,12/37,15.41%,ABL2;CHTOP;FGFR4;XRCC4;XRCC5;MT3;BCAS3;WRN;SSBP1;PHACTR4;NCSTN;ATP7A
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.4935615985090458,-1.3420353384864154,0.12949640287769784,0.483351571171465,1.0,8/14,30.89%,SRSF6;RBMX;PCBP4;SRSF12;SRSF9;SRSF4;SAP18;SRSF7
prerank,blood vessel diameter maintenance (GO:0097746),0.5086127534000419,1.341923760123934,0.10709838107098381,0.49429393524053933,1.0,2/34,1.12%,HTR2B;EDNRA
prerank,regulation of acute inflammatory response (GO:0002673),0.5609631252862735,1.3412620107831206,0.14206896551724138,0.49552861211063903,1.0,3/18,5.73%,IL6;PLA2G2D;ADAM8
prerank,neutrophil migration (GO:1990266),0.4765942192058509,1.3410930836698776,0.08342989571263036,0.4952638897637033,1.0,3/58,1.15%,LGALS3;SYK;PIKFYVE
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5275303714786167,1.340456683254007,0.11518987341772152,0.4964528714447081,1.0,7/27,13.36%,AQP1;CDKN1A;PDGFA;E2F1;IGF1;S100A6;GAS6
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.4451585480978667,-1.338884000139173,0.13688212927756654,0.48774400626040293,1.0,15/20,33.30%,PLCB1;RGS10;CHRM3;CHRM2;CDK5R1;AGRN;GRK2;GNA11;RGS8;LYPD1;CHRNA7;GNB1;LY6G6D;CHRNB2;LY6H
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4567974967981135,1.3385524410113878,0.08044692737430167,0.5014844152498712,1.0,23/70,20.47%,CD36;PSMD1;CYBB;CYBA;NCF2;PSMF1;PSMD14;PSMD12;NCF4;VAMP3;PSME2;LNPEP;NCF1;PSMB10;PSMD5;PSMD8;PSMA3;TAPBP;PSMA2;PSMD11;ITGAV;SNAP23;PSMA6
prerank,dopaminergic neuron differentiation (GO:0071542),0.5681560365352797,1.3384279550813813,0.12824010914051842,0.5010316023150972,1.0,2/19,1.73%,CTNNB1;VEGFA
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.590551614845205,1.3383947371790423,0.14872521246458922,0.5003571078915227,1.0,3/17,4.72%,PPARG;CDKN1A;PTEN
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.46884930091911975,1.3376179257179812,0.0835214446952596,0.5020147220132317,1.0,10/63,5.81%,CD38;VAV3;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274;IRS2
prerank,monocyte differentiation (GO:0030224),0.6298827846972257,1.33758302850664,0.13928012519561817,0.5013535956684939,1.0,2/10,1.73%,PPARG;VEGFA
prerank,regulation of primary metabolic process (GO:0080090),0.44176275310748847,1.3373865310603175,0.040880503144654086,0.5012153089792284,1.0,39/126,20.51%,PSAP;PPARG;APOE;ID2;FASN;PSMD1;RXRA;NCOR1;FGFR4;MVD;IRS2;CREBBP;IDI1;TBL1XR1;NCOA1;OAZ2;PSMF1;PPARD;PSMD14;PSMD12;PSME2;AZIN1;PMVK;SCD;SC5D;OAZ1;PSMB10;PSMD5;NFYC;PSMD8;PSMA3;NCOA6;HMGCR;NCOA2;PSMA2;PSMD11;SREBF1;PSMA6;SIN3A
prerank,hydrogen peroxide catabolic process (GO:0042744),0.6311569947350432,1.3373397157522955,0.14329268292682926,0.5005941528974723,1.0,3/11,7.47%,PRDX1;GPX3;CAT
prerank,axonal transport of mitochondrion (GO:0019896),-0.5543291843490955,-1.337210383069765,0.14244186046511628,0.4889535455999033,1.0,3/11,9.70%,MAPT;NEFL;SPAST
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.556587784822045,-1.336766504818677,0.14084507042253522,0.4873291064265656,1.0,6/10,44.36%,SAG;GNB1;PDE6G;PDE6B;PDE6A;CNGB1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.636056399624283,1.3362765634260707,0.11246200607902736,0.5029514415600238,1.0,4/12,17.56%,MGST2;CNDP2;HAGH;OPLAH
prerank,regulation of integrin activation (GO:0033623),0.5891333249647607,1.3362666790442044,0.12769010043041606,0.5022086744137234,1.0,3/15,10.70%,FBLIM1;PTGER4;PIEZO1
prerank,regulation of kinase activity (GO:0043549),-0.32193358046761616,-1.3361861034502347,0.047619047619047616,0.4858921002812842,1.0,28/89,19.20%,ERBB4;EPHA5;CSF1R;NTRK3;CAMKK2;EPHA6;RYK;MAPT;EPHA3;FGFR2;NTRK2;FLT3;TSPYL2;EGFR;VAC14;IGF1R;RAD50;EPHA7;LDB1;LDB2;ERBB3;RBL1;CD74;ANKRD54;TYRO3;FGFR3;ECT2;LMTK2
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5371833889657206,1.3361267171283038,0.12043301759133965,0.5018921036525101,1.0,11/24,18.74%,ACD;TENT4B;HNRNPU;TERF1;NAT10;TEN1;STN1;TNKS;EXOSC10;TNKS2;GNL3L
prerank,regulation of mitotic spindle assembly (GO:1901673),0.5643533153047215,1.335853132985331,0.14565826330532214,0.5019839099591804,1.0,8/19,17.04%,CHMP2A;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR;HSPA1A;CHMP5
prerank,axon development (GO:0061564),-0.3212947941697856,-1.3355306646300353,0.03529411764705882,0.48474841622785736,1.0,26/78,19.20%,RTN4RL1;SEMA5A;CTNNA2;NTNG1;DCC;RYK;MAPT;ANK3;CNTN4;FGFR2;PARD3;CDK5R1;SPTBN4;PAX2;MARK2;RAB8A;KLF7;SVBP;GRM7;BRSK1;SLITRK5;SLITRK3;DHFR;ADGRB1;S100B;LMTK2
prerank,activation of GTPase activity (GO:0090630),0.448792582192296,1.3350648015961313,0.056745182012847964,0.5036107411338004,1.0,16/89,11.45%,ARHGAP24;ABR;TBC1D22A;CORO1C;TBC1D25;TBC1D1;TBC1D2;TBC1D12;RALGAPA2;SLC27A4;TBC1D10A;TBC1D2B;TBC1D22B;CCDC125;BCAS3;TBC1D15
prerank,myeloid leukocyte differentiation (GO:0002573),0.4602150565233122,1.3347040294664858,0.10573678290213723,0.5039998988567654,1.0,14/65,12.33%,PPARG;GAB2;VEGFA;SNX10;CDKN1A;RXRA;RARA;E2F1;FOXP1;TYROBP;SIRT1;IL15;MYH9;TREM2
prerank,membrane lipid catabolic process (GO:0046466),0.6487553030112656,1.333740420184795,0.13694267515923567,0.5061062444722688,1.0,3/10,4.22%,MGST2;SGPL1;PPT1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.5674954634065834,1.3336642057784467,0.11972789115646258,0.5055561069910998,1.0,6/20,8.87%,ADSL;IMPDH2;PPAT;AMPD3;NT5C2;LHPP
prerank,positive regulation of interleukin-8 production (GO:0032757),0.4792861892796135,1.333502474419302,0.0976470588235294,0.5052813730232705,1.0,13/49,16.52%,SYK;TLR8;IL6;RIPK1;HSPA1B;DDIT3;MAVS;AFAP1L2;RELA;HSPA1A;LBP;MYD88;TLR1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6243645824047899,1.333046931574289,0.12235649546827794,0.504352564795197,1.0,3/12,8.02%,NSMCE2;CUL3;RB1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6243645824047899,1.333046931574289,0.12235649546827794,0.504352564795197,1.0,3/12,8.02%,NSMCE2;CUL3;RB1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6243645824047899,1.333046931574289,0.12235649546827794,0.504352564795197,1.0,3/12,8.02%,NSMCE2;CUL3;RB1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5049559043299219,1.3326944439487443,0.11224489795918367,0.5046254492349813,1.0,7/33,11.88%,PPARG;APOE;MAP2K5;THBS1;GADD45A;ACVRL1;NOTCH1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5566308425266049,1.332508238473144,0.11320754716981132,0.5043807471937302,1.0,9/20,18.37%,CELF1;AGO2;EIF6;TNRC6B;CNOT7;AGO3;LIMD1;CNOT6;AGO4
prerank,leukocyte tethering or rolling (GO:0050901),-0.4657361081072964,-1.332267295801317,0.11071428571428571,0.49000285773411245,1.0,4/17,5.37%,CX3CR1;SELPLG;JAM2;ADD2
prerank,cellular protein metabolic process (GO:0044267),0.42118410531032274,1.3318473799291468,0.008008008008008008,0.505633276981078,1.0,95/396,17.38%,SFTPA1;SFTPA2;MFGE8;APOE;MSRA;TIMP1;RPL3L;KLK3;ITIH2;SPP1;IL6;MSRB1;ABL2;TNIP1;APLP2;FAM20C;RIPK1;D2HGDH;CLN5;PARP4;B4GALT7;IGF2BP3;GNMT;IGF1;HTRA2;UBE2L3;EEF1A1;AGO2;RPL18A;RPS14;MRPL11;MANBA;RPS11;PIGH;PROC;CSF2RB;RPS27A;MRPL23;RPL17;RPL23;DARS1;PPP4R2;ABCA3;WWP2;FBXO11;CTSH;RPL36A;EIF4EBP2;COPS5;MRPS7;QSOX1;FSTL1;RPL22;RPS21;RAB12;RRBP1;ADAM17;LTA4H;MRPL32;CCN1;MRPL36;HM13;IGFALS;APP;SARS1;STK38;RPL10A;CSF2RA;MRPL28;OMA1;UBA3;FBXW2;DHPS;GAS6;RPS26;PRKN;SPCS2;MRPS21;SRBD1;SERPINC1;MCRS1;NUCB1;MRPL35;RPL15;RPL10;NCSTN;RPSA;CDC34;MELTF;PARL;MRPL43;RPL7;UBE2M;RPL26;TTF1
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6489741628662258,1.3317260195861471,0.1558641975308642,0.5044607784856898,1.0,2/10,6.54%,WASHC1;APC
prerank,regulation of pseudopodium assembly (GO:0031272),0.6489741628662258,1.3317260195861471,0.1558641975308642,0.5044607784856898,1.0,2/10,6.54%,WASHC1;APC
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.6306594702146772,1.3315883745073003,0.147239263803681,0.5041681408788167,1.0,4/11,12.53%,SOAT1;AGO2;ABCA2;ITM2C
prerank,cellular response to ketone (GO:1901655),0.5105055904056305,1.3313684522904423,0.10579345088161209,0.5040762648506892,1.0,12/35,14.71%,AQP1;SPP1;NR3C1;SPHK2;PTGER2;NCOA4;MSN;PTGER4;ACOD1;ADCY8;ADCY3;GOLPH3
prerank,endomembrane system organization (GO:0010256),0.43211102333247353,1.3309600506875918,0.027522935779816515,0.5045478244860007,1.0,53/178,19.75%,MYOF;ARHGAP21;OPTN;PLEKHM2;PHETA2;HOOK3;SNX10;REEP4;RNF26;ATP8B4;NPLOC4;GAK;COG7;VMP1;FER1L6;TICAM2;VAPA;HUWE1;A4GALT;LAMTOR1;VPS4A;SNX33;BCAS3;TRIP11;PI4K2A;VPS51;AP3D1;ARFGEF2;LEMD3;RAB43;ATL2;DYM;ATP8B1;PLEKHJ1;CLASP1;ATL1;SQSTM1;VPS11;GOLPH3;GOLPH3L;DNAJC13;USP8;RAB2A;RAB29;RAB22A;COG2;TMEM170A;ALS2CL;HTT;ARFGEF1;WASHC5;SEC31A;RAB1A
prerank,amide transport (GO:0042886),0.5348410158142809,1.3307462088943613,0.11352040816326531,0.5043923169790684,1.0,6/26,8.91%,CERT1;PLTP;FOLR2;FOLR1;SLC27A1;SLC25A32
prerank,response to interferon-beta (GO:0035456),0.5459199955641787,1.3302971632443532,0.14322916666666666,0.5050362952611006,1.0,9/22,16.15%,IKBKE;IFITM1;HTRA2;IFNAR2;UBE2K;IFITM2;BST2;ACOD1;CDC34
prerank,regulation of lipid biosynthetic process (GO:0046890),0.5140360984908912,1.3297200000971707,0.09571788413098237,0.5060587788181858,1.0,6/32,9.47%,APOE;PDK4;PRKAG2;EIF6;ZBTB20;NR5A1
prerank,negative regulation of protein transport (GO:0051224),0.5288596399772035,1.3291578490947793,0.13229571984435798,0.5069720947042223,1.0,5/25,8.26%,APOE;SERGEF;RHBDF2;WWP2;PKDCC
prerank,regulation of osteoclast differentiation (GO:0045670),0.5093560847015612,1.3290185847153635,0.11151960784313726,0.506661875552341,1.0,4/33,5.29%,GPR137B;LILRB3;CEBPB;PRXL2A
prerank,RNA catabolic process (GO:0006401),0.4884402284086387,1.328836551609649,0.08875739644970414,0.5065043791859866,1.0,23/46,25.90%,ERN1;RNASE3;HSPA1B;ZFP36L2;AGO3;SND1;HSPA1A;SIDT2;RNASEH2A;HNRNPD;RNASEH1;RNH1;MTREX;AGO4;EXOSC7;RNASEH2B;LSM5;PABPC4;ZC3H12D;XRN2;LSM6;ZFP36;RIDA
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.592234907424409,1.3286776254004373,0.12889518413597734,0.5062003700548039,1.0,8/16,20.78%,STAM;CHMP6;SNF8;CHMP5;TMEM50A;CHMP7;LEPROTL1;VPS36
prerank,regulation of leukocyte migration (GO:0002685),0.5925540946300198,1.3285288108522757,0.13333333333333333,0.5059201947052285,1.0,3/16,7.09%,ANXA1;VEGFA;HMOX1
prerank,regulation of protein kinase B signaling (GO:0051896),0.43107716818563896,1.3281844061113282,0.019250253292806486,0.5062026065220294,1.0,33/193,10.59%,F7;OSBPL8;HPSE;GDF15;PIK3R5;XDH;GRB2;GCNT2;GAB2;TXN;HGF;CD28;PDPK1;PDGFA;P2RX4;PTEN;F10;FGFR4;THBS1;DAG1;ADAM8;TRAT1;IRS2;PIK3CA;FLCN;MFHAS1;VAV1;STRN;PLEKHA1;DDIT3;ITGB1;ESR1;SIRT1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.47290250053229854,1.3275436266494285,0.0992108229988726,0.5074337939633387,1.0,19/59,15.31%,CTNNB1;MITF;CEBPB;RUNX2;IL6;CDKN1A;JUN;MED12;PTEN;MED15;CBFB;TNRC6B;AGO3;MED16;MED26;BCLAF1;RELA;BAX;CDK8
prerank,regulation of RNA metabolic process (GO:0051252),0.4692818649616439,1.3274338486975268,0.08863636363636364,0.5070586740149019,1.0,17/59,15.85%,HNRNPLL;MITF;AHNAK;HNRNPH2;MBNL1;TNFRSF1B;CELF1;IGF2BP3;AHNAK2;GRSF1;PTBP3;PTBP2;PQBP1;PRX;USP36;PCBP1;MBNL2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6048251154813515,1.3272649865911503,0.15582450832072617,0.5068092808651684,1.0,4/13,13.36%,LAMP1;TYROBP;AP1G1;GAS6
prerank,activation of phospholipase C activity (GO:0007202),0.5259975236358403,1.3269238011361866,0.13700384122919335,0.5070796144586358,1.0,5/29,5.05%,HTR2B;EDNRA;ADRA1A;GNAQ;LPAR2
prerank,neuromuscular process (GO:0050905),0.5701108824353954,1.3266059617261385,0.15895953757225434,0.507337030639149,1.0,7/16,18.89%,STRA6;TPP1;CLN3;UBA5;MYCBP2;PAFAH1B1;GCH1
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5267731519652576,-1.3264988446442716,0.15142857142857144,0.5008302075688544,1.0,3/11,11.12%,P3H2;P4HTM;CRTAP
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.49025000272902824,1.3261777749083459,0.10939357907253269,0.5078403202854244,1.0,13/43,15.85%,ERN1;ID2;IL6;JUN;IGF1;THBS1;HMOX1;FOXP1;IL6R;RBPMS2;HTR1B;CX3CL1;DNMT1
prerank,positive regulation of cell motility (GO:2000147),0.42402416556224853,1.3261575037364806,0.025303643724696356,0.507150076826499,1.0,36/205,12.51%,GPNMB;F7;SDCBP;NEDD9;GCNT2;VEGFA;RUFY3;ARHGEF39;ADAM9;MGAT5;HGF;WASHC1;PDGFA;CD151;SEMA4B;MMP14;IGF1;F10;COL1A1;THBS1;APC;CFAP20;GTSE1;SNAI2;CTSH;PPP3CA;PLAU;ITGB1;ADAM17;RHOD;PTK2B;CCN1;NOTCH1;MYLK;SPAG9;MAZ
prerank,neuron projection extension (GO:1990138),0.5082231963916269,1.3261547870364603,0.13561470215462612,0.506418104205844,1.0,7/32,6.97%,IQGAP1;CTNNB1;ALCAM;SPG11;NRP2;TNN;EIF2AK4
prerank,positive regulation of cytokine production (GO:0001819),0.4170648963909335,1.3260300834661285,0.014084507042253521,0.5060392695632262,1.0,53/292,13.93%,CCBE1;HTR2B;HPSE;RFTN1;SYK;RAB7B;TLR8;LILRB1;ANXA1;CTNNB1;FLOT1;CEBPB;PIBF1;IL6;CD28;CD46;TMEM106A;LY9;CD274;RIPK1;RARA;SORL1;NR1H4;SPHK2;CREBBP;HSPA1B;ATF4;HMOX1;SULF2;CYBA;POLR2L;BRCA1;FOXP1;TYROBP;DDIT3;IL6R;XRCC5;PTGER4;MAVS;ADAM17;ARHGEF2;APP;FZD5;RORA;PQBP1;APPL1;IL15;AFAP1L2;SULF1;RELA;FGR;SLC11A1;HSPA1A
prerank,postsynaptic membrane organization (GO:0001941),0.5829306939601309,1.3255976493010826,0.1522633744855967,0.506597171297811,1.0,2/17,0.58%,CEL;APOE
prerank,regulation of cellular amide metabolic process (GO:0034248),0.5146731234862757,1.3255241015422512,0.12309644670050761,0.5060554581735542,1.0,10/32,11.47%,SAMD8;PRKCD;FOXO3;ATXN2;NR1H4;PUM3;PICALM;ROCK1;MTPN;APP
prerank,regulation of presynapse organization (GO:0099174),-0.4502211030986742,-1.3254882433909998,0.1037037037037037,0.49790245512119,1.0,4/18,5.60%,PTPRD;IL1RAPL1;LRRC4B;IL1RAPL2
prerank,regulation of presynapse assembly (GO:1905606),-0.4502211030986742,-1.3254882433909998,0.1037037037037037,0.49790245512119,1.0,4/18,5.60%,PTPRD;IL1RAPL1;LRRC4B;IL1RAPL2
prerank,positive regulation of fat cell differentiation (GO:0045600),0.48314552767283053,1.3250858236186833,0.10340775558166862,0.5066612072139768,1.0,8/47,7.63%,PPARG;CEBPB;ID2;ASXL2;PIM1;HNRNPU;METRNL;RREB1
prerank,regulation of dendrite extension (GO:1903859),-0.4624182971435866,-1.3242768033981334,0.12956810631229235,0.49788202379283514,1.0,10/18,23.00%,SYT1;RIMS1;RIMS2;SMURF1;SYT2;SYT4;SYT3;UNC13A;RASAL1;CPNE5
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),0.5646965099025327,1.3237993502685628,0.14725568942436412,0.5099055869067731,1.0,4/20,8.02%,NIBAN2;GTF2B;IGF1;RB1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5223146200108227,1.3235622817347759,0.1371794871794872,0.5099596290870969,1.0,10/28,17.62%,FBXW7;NIBAN2;MMP14;RITA1;LFNG;WWP2;TSPAN15;ARRB1;EGFL7;ZBTB7A
prerank,glucose metabolic process (GO:0006006),0.46987158161327397,1.3234899253422157,0.1010332950631458,0.5094370898013126,1.0,19/58,22.69%,SORD;TPI1;AKR1A1;TFAP2B;SLC25A1;IRS2;ATF4;ENO3;SLC39A14;PPARD;PGM1;OMA1;CRY1;APOD;GAPDHS;MDH1;GALM;SLC37A4;SLC25A13
prerank,response to steroid hormone (GO:0048545),0.5096234717637113,1.3233344227115968,0.12075471698113208,0.5092023670791982,1.0,7/31,8.18%,NR1H3;CATSPERB;UBE2L3;THBS1;NR3C1;CATSPER2;ABCA2
prerank,regulation of protein kinase C signaling (GO:0090036),0.5898353223084289,1.322363060916073,0.14866760168302945,0.5113969022582365,1.0,4/14,6.26%,ADRA1A;VEGFA;GPD1L;SPHK2
prerank,positive regulation of actin nucleation (GO:0051127),-0.5325490390937199,-1.3222224076371216,0.15584415584415584,0.500130028746497,1.0,5/11,17.41%,FCHSD2;ABI2;NCKAP1;CYFIP1;GSN
prerank,positive regulation of organelle assembly (GO:1902117),0.4879735127712809,1.3222210249227955,0.10253317249698432,0.5110886594657846,1.0,15/44,18.60%,SDCBP;LCP1;DYNC1H1;SH3GLB1;ASAP1;CAPG;RAB3GAP2;PDCD6IP;IL5;CNOT6L;SDC4;CNOT6;CCP110;PIP4K2A;HTT
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.43315701747911195,1.3215768913407042,0.052127659574468084,0.5121888209381361,1.0,39/105,26.33%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;TRAF6;HRAS;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5967041183054441,1.3214916482753605,0.15182481751824817,0.511714276183381,1.0,4/13,13.29%,PPARG;NFATC3;PPARD;RELA
prerank,negative regulation of response to wounding (GO:1903035),-0.4567781685448069,-1.3213140908843028,0.14583333333333334,0.4998594720257603,1.0,5/19,16.93%,RTN4RL1;CASK;FGF2;GIT1;CRK
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.6268603822584043,1.3210876837129266,0.16885007278020378,0.5121560162731617,1.0,1/11,1.08%,TAS1R3
prerank,microtubule polymerization or depolymerization (GO:0031109),-0.40759975113285785,-1.3205580253597513,0.11666666666666667,0.4989844642186506,1.0,10/25,15.78%,HDGFL3;MAPT;STMN3;FGF13;TPPP;STMN4;STMN2;KIF18A;TPPP3;STMN1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.6329984998024185,1.320163878145306,0.15707620528771385,0.5142448278742265,1.0,4/10,12.09%,ACD;TFIP11;RTEL1;DCLRE1B
prerank,protein import (GO:0017038),0.4507963619621095,1.3200396939878845,0.08379272326350606,0.5138697596282306,1.0,18/84,12.77%,MMP12;APOE;SYK;IPO5;RAB8B;E2F3;ABCD1;APPL2;PEX14;LAMP2;TPR;SNX33;NUP50;TNPO1;ALDH3A2;PXMP2;APPL1;GDAP1
prerank,regulation of extracellular matrix organization (GO:1903053),0.5917848845935659,1.319826351522378,0.14163090128755365,0.5137375171272127,1.0,5/15,11.88%,RIC1;LRP1;FGFR4;RB1;NOTCH1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6394180937783606,1.319541450646777,0.15592203898050974,0.5122744906361598,1.0,3/10,12.78%,TERF1;NBN;WRN
prerank,t-circle formation (GO:0090656),0.6394180937783606,1.319541450646777,0.15592203898050974,0.5122744906361598,1.0,3/10,12.78%,TERF1;NBN;WRN
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6394180937783606,1.319541450646777,0.15592203898050974,0.5122744906361598,1.0,3/10,12.78%,TERF1;NBN;WRN
prerank,glycosaminoglycan metabolic process (GO:0030203),0.47884979121913546,1.319486636463465,0.08558030480656506,0.5117011585733623,1.0,16/54,14.87%,HPSE;GCNT2;XYLT1;NDST1;GNS;EXT1;UGDH;B4GALT7;HEXA;HS2ST1;IDUA;FUCA1;SGSH;SDC4;HS3ST2;GUSB
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.43317359677472494,1.3194067815585926,0.05,0.5104512187546815,1.0,39/104,26.33%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;TRAF6;HRAS;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,cellular response to lectin (GO:1990858),0.43317359677472494,1.3194067815585926,0.05,0.5104512187546815,1.0,39/104,26.33%,SYK;ICAM2;CLEC4D;PDPK1;PRKCD;PSMD1;RAF1;NRAS;CREBBP;TYROBP;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELB;RELA;PSME2;CUL1;KLRD1;PSMB10;PSMD5;PSMD8;CARD11;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;MALT1;PSME3;BCL10;TRAF6;HRAS;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5581028001358944,1.3192166082412125,0.15405777166437415,0.51025653375133,1.0,6/19,11.47%,TMEM106A;MAP2K5;MAPK7;PAX8;MTPN;APP
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6098496563361724,1.3187090061230156,0.13973799126637554,0.5111423485029006,1.0,2/13,4.30%,IDH1;D2HGDH
prerank,modified amino acid transport (GO:0072337),0.5876192093308672,1.318590501048006,0.15472779369627507,0.5107929688523302,1.0,6/15,18.75%,FOLR2;FOLR1;SLC25A32;SLC6A8;MGST1;SLC19A1
prerank,negative regulation of axon extension (GO:0030517),-0.40542801768110853,-1.3180450960105938,0.12376237623762376,0.5023710894813083,1.0,10/30,11.89%,SEMA5A;MAG;RNF6;MAP2;SEMA4G;SEMA3E;DIP2B;SEMA3A;CDKL3;SEMA6A
prerank,regulation of interleukin-1 beta production (GO:0032651),0.4570672283016843,1.3179916875889284,0.088,0.5118397522397322,1.0,16/66,15.73%,CD36;TLR8;IL6;TMEM106A;IGF1;NLRC4;SIRPA;FOXP1;MEFV;TYROBP;NLRP2B;APP;FZD5;TNFAIP3;CX3CL1;MYD88
prerank,negative regulation of secretion by cell (GO:1903531),0.49696981221873154,1.3179224976560433,0.12953995157384987,0.5113176742059777,1.0,13/38,19.58%,APOE;LILRB1;ANXA1;SERGEF;RHBDF2;TNFRSF1B;TRH;NOTCH1;VAMP3;HTR1B;HMGCR;SLC30A1;OSM
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5498390492401247,1.3177996974995068,0.13672922252010725,0.5109738698062608,1.0,6/21,9.53%,NCK2;PTEN;GADD45A;GPD1L;CNKSR3;NLRP2B
prerank,glycoprotein biosynthetic process (GO:0009101),0.4555677631014535,1.31707888714265,0.08586956521739131,0.5123444998234433,1.0,14/79,7.33%,B4GALT5;B3GNT8;GCNT2;NPC1;XYLT1;TMEM106A;TNIP1;B4GALT7;IGF1;DDOST;COG7;DAD1;B3GALNT2;ST3GAL4
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5877121346829908,1.3170048981602211,0.17113095238095238,0.511141705523013,1.0,4/15,10.19%,AGO2;ZFP36L2;TNRC6B;CNOT7
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5877121346829908,1.3170048981602211,0.17113095238095238,0.511141705523013,1.0,4/15,10.19%,AGO2;ZFP36L2;TNRC6B;CNOT7
prerank,monocarboxylic acid catabolic process (GO:0072329),0.5495729442636903,1.3167826102120412,0.1480484522207268,0.5111243213252487,1.0,2/21,1.42%,CEL;LPIN3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.550879125049362,1.3166764461931548,0.12995896032831739,0.5107040372554607,1.0,8/21,15.06%,ADAM9;DAG1;BACE1;ADAM17;HM13;MYH9;ADAM19;NCSTN
prerank,central nervous system myelination (GO:0022010),0.6284028972607762,1.3162109911181272,0.167420814479638,0.5113771172891801,1.0,4/11,8.18%,B4GALT5;PTEN;B4GALT6;ABCA2
prerank,protein palmitoylation (GO:0018345),0.5038516486878523,1.3161705947861269,0.1291139240506329,0.5107725248593967,1.0,8/30,17.10%,ZDHHC14;ZDHHC19;ZDHHC16;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC17;ZDHHC4
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.37163127490230324,-1.3160120325869828,0.0440251572327044,0.5047222263353278,1.0,10/44,4.76%,BIN1;EVL;FCHSD2;SPIRE1;PRKCE;VASP;FER;HCK;NCKAP1;NCK1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4734457432126867,1.3149291244357644,0.11097852028639618,0.513798215650995,1.0,18/52,18.01%,MICALL2;NPEPPS;FBXW7;SH3GLB1;E2F1;HTRA2;UBE2L3;HUWE1;CSNK2A2;ARIH2;PPP3R1;FZD5;ATG13;VPS11;USP36;BID;BBC3;TOMM7
prerank,positive regulation of TORC1 signaling (GO:1904263),0.5825611734190882,1.3145062697204926,0.14504881450488144,0.5143167897418284,1.0,3/16,6.69%,GPR137B;SIK3;FLCN
prerank,cellular response to chemokine (GO:1990869),-0.3577838620960643,-1.3143769365039832,0.0736196319018405,0.5057458008553494,1.0,9/46,15.94%,DOCK8;SLC12A2;SH2B3;RIPOR2;CCL4;WNK1;RHOA;CCR2;CCR1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.469716536166407,1.313586241803325,0.11458333333333333,0.5165803119915453,1.0,11/54,10.98%,PPARG;APOE;VEGFA;PDPK1;P2RX4;THBS1;GADD45A;ACVRL1;ADAM17;SIRT1;ATP5F1A
prerank,glutathione biosynthetic process (GO:0006750),0.6360674144473185,1.3133465789112324,0.1393188854489164,0.5166169307593396,1.0,4/11,17.56%,MGST2;CNDP2;HAGH;OPLAH
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.4508839563923159,1.313283337869783,0.07964601769911504,0.5161090339282699,1.0,18/78,12.72%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;MMP14;PID1;CLN3;STAC2;STX8;VTI1B;PICALM;VPS4A;ITGB1;APPL1;TREM2;ITGA3
prerank,dendrite morphogenesis (GO:0048813),-0.38585688342198265,-1.3132386828287923,0.07456140350877193,0.5060014203403169,1.0,23/35,32.83%,CTNNA2;MEF2A;PHACTR1;CTNND2;BTBD3;MAP2;FARP1;KLF7;CELSR2;ABITRAM;TAOK2;MAPK8IP2;DIP2A;PAK3;MAP6;DCDC2;SHANK1;CHRNA7;WNT7A;PTN;EPHB3;SHANK3;SDC2
prerank,RNA stabilization (GO:0043489),0.5065786428207699,1.3130718304547366,0.12158808933002481,0.5160295000868153,1.0,11/33,17.11%,TRDMT1;E2F1;TENT5A;HNRNPU;TENT2;DKC1;SLC11A1;TENT5D;GDNF;THRAP3;TAF15
prerank,import into cell (GO:0098657),0.4844025909485659,1.3130641450807587,0.11407766990291263,0.5153291051537601,1.0,15/41,19.68%,LRRC8D;SLC6A6;SLC11A2;SLC38A1;SLC27A1;LRRC8C;SLC39A14;TREM2;SLC12A7;NEURL1B;SLC7A1;SLC36A1;LRP2;SLC19A1;SLC7A8
prerank,protein autoprocessing (GO:0016540),0.5676934529545398,1.3127176663017615,0.15362731152204837,0.5156425857563978,1.0,5/17,12.75%,CTSL;HTRA2;FAM111A;MYRFL;OMA1
prerank,lipid modification (GO:0030258),0.49901505566325566,1.3126953199304658,0.1192214111922141,0.5149999255903344,1.0,8/37,13.22%,PLPP3;PLA2G7;DGKZ;DGKA;PLPP6;PLPP5;LPCAT3;DGKQ
prerank,P-body assembly (GO:0033962),0.6252259313155915,1.3125779540974678,0.1800302571860817,0.5146336147108945,1.0,6/12,16.07%,DYNC1H1;DDX6;ATXN2;PATL1;LIMD1;EDC3
prerank,primary alcohol metabolic process (GO:0034308),0.5211916004608068,1.312349693547533,0.1482444733420026,0.5146315625068464,1.0,5/25,14.45%,DHRS3;RDH12;IGF1;ALDH3A2;GDE1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5545361833008847,1.3120393630987086,0.1655359565807327,0.5148412412751512,1.0,1/18,0.05%,DDHD1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5284473040643194,1.3117025197673156,0.1487935656836461,0.5151856652225608,1.0,7/25,15.35%,ARHGAP24;PRKCD;ODF2L;STAP1;CAPZB;PFN2;CCP110
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.5837263419870025,1.3110317189251337,0.17083946980854198,0.5164187802467884,1.0,3/14,5.58%,ANO6;ITGA4;THBS1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.5111789190593784,1.3109451823528488,0.13010204081632654,0.5159461972668481,1.0,7/27,17.59%,AK8;TXNRD1;GSR;CTPS1;AK2;CTPS2;RRM1
prerank,response to estrogen (GO:0043627),0.5066541950773944,1.3109385056492726,0.13956466069142126,0.5152643304456956,1.0,7/31,11.32%,RARA;CITED2;TRIM25;NCOA4;BRCA1;ESR1;BCAS3
prerank,protein targeting to membrane (GO:0006612),0.44852717484279364,1.310549023303414,0.08278867102396514,0.5157100449659513,1.0,29/83,21.96%,SDCBP;PIKFYVE;ZDHHC14;ZDHHC19;RAB8B;ABCD1;YIF1B;PEX14;MICALL1;ZDHHC12;GET3;ZDHHC18;NACA;SIL1;ALDH3A2;PXMP2;GDAP1;RABGEF1;ZDHHC24;NCF1;ZDHHC4;SGTA;SEC63;ICMT;ACBD5;SLC25A17;ARL6IP1;VPS37B;PXMP4
prerank,sensory perception (GO:0007600),-0.3608313025968522,-1.310455904701547,0.07602339181286549,0.5102527433688733,1.0,9/45,10.33%,WHRN;PCDH15;CDH23;OPRM1;MYO7A;TMEM150C;GNAL;SCN9A;ADGRV1
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.5967327954395729,1.3104427882661926,0.16119828815977175,0.5152879510785566,1.0,3/13,8.18%,SOAT1;IGF1;ABCA2
prerank,regulation of lipid metabolic process (GO:0019216),0.452098247156508,1.3103449915592669,0.07860262008733625,0.5148893721640498,1.0,32/88,23.76%,PSAP;PPARG;PRKAG2;ID2;FASN;RXRA;NCOR1;FGFR4;MVD;IRS2;CREBBP;IDI1;TBL1XR1;NCOA1;PPARD;RORA;PANK2;PMVK;SCD;SC5D;NFYC;NCOA6;HMGCR;NCOA2;SREBF1;SIN3A;DISP3;ADIPOR1;CERS2;ABCA7;EDF1;MBOAT7
prerank,bile acid and bile salt transport (GO:0015721),0.5256120584286386,1.3099289523388014,0.13151041666666666,0.5154119701938905,1.0,8/24,13.46%,SLC51A;RXRA;STARD5;ABCC4;NR1H4;ABCC3;NCOA1;ATP8B1
prerank,cellular response to hypoxia (GO:0071456),0.42628553981243017,1.3098416158717499,0.04801670146137787,0.5149585296699175,1.0,33/126,19.66%,EPAS1;VEGFA;AQP1;NPEPPS;PSMD1;LMNA;BACH1;ADAM8;CREBBP;HMOX1;RPS27A;UBC;HIPK2;EGLN3;SIRT1;PSMF1;MT3;PSMD14;STUB1;RORA;PSMD12;LIMD1;SUV39H2;PSME2;BNIP3;ACAA2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;CPEB2;PSMD11
prerank,mesenchyme morphogenesis (GO:0072132),-0.4649480357553507,-1.3097321610994554,0.13090909090909092,0.5094479317559956,1.0,6/17,12.46%,ACVR1;BMPR1A;ENG;MDM4;TGFB2;SMAD2
prerank,cellular response to fatty acid (GO:0071398),0.6019015577828963,1.30940499404056,0.17091454272863568,0.5155589902112313,1.0,4/12,12.56%,PDK4;PID1;NR1H4;KCNK4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.44888284144533963,-1.3091897392447798,0.13011152416356878,0.5081983886884408,1.0,4/18,5.37%,CX3CR1;SELPLG;JAM2;ADD2
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4471047730601587,1.3085755557994867,0.08928571428571429,0.5173968091075388,1.0,35/80,24.93%,FBXW7;ARRDC4;UBE2L3;SPSB4;CUL3;XIAP;BRCA1;TOPORS;HUWE1;DCUN1D5;BIRC3;STUB1;DCUN1D3;NSMCE3;DCUN1D4;CENPX;DCUN1D1;CRY1;PHF23;BIRC2;MYCBP2;WFS1;PAXIP1;ARRDC3;PEF1;FANCM;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;TRAF6;FBXO4;NDFIP1;DCUN1D2
prerank,iron ion transmembrane transport (GO:0034755),0.6294322935433576,1.3085207215074166,0.17511520737327188,0.5168786478751193,1.0,3/10,9.94%,ABCB7;SLC11A2;SLC39A14
prerank,regulation of receptor internalization (GO:0002090),0.5008612312480939,1.3082869371755046,0.14039408866995073,0.5168749995666232,1.0,7/35,11.29%,SDCBP;VEGFA;FLOT1;CD63;ATXN2;RIN3;ANKRD13D
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.5562360556408692,-1.3081035324496435,0.18156424581005587,0.5081040747446784,1.0,5/10,14.96%,CACNB2;NOS1AP;PDE4B;NIPSNAP2;CACNA2D1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4434624346982475,1.30794836529586,0.07742639040348964,0.5171566590771856,1.0,24/87,20.47%,GPNMB;CDKN1A;PSMD1;PTEN;APC;ZFP36L2;RB1;BRD7;PSMF1;PSMD14;DCUN1D3;CDK2AP2;PSMD12;PSME2;CUL1;CDC73;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;PSMA2;PSMD11;PSMA6
prerank,response to cytokine (GO:0034097),0.4247122216983613,1.3078791029371537,0.0498960498960499,0.5166948469791742,1.0,37/141,15.94%,CXCR4;TIMP1;ANXA1;SIGIRR;MAPKAPK3;IRAK2;IKBKE;KYNU;IFITM1;ADAM9;CD274;RIPK1;PID1;IFNAR2;DDOST;IRAK3;PTPN12;NUB1;REL;TIMP2;KLHL20;MEFV;MAP4K3;IFITM2;IL6R;APP;BST2;RELB;HCLS1;COL3A1;RELA;SLC11A1;JAK3;MCL1;YTHDC2;MYD88;ALDH1A2
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5546740573692227,1.307695703123256,0.14722222222222223,0.51653123718047,1.0,5/17,11.05%,ACD;MUTYH;NEIL1;TERF1;MBD4
prerank,phospholipid transport (GO:0015914),0.46894552011623336,1.3072139785593773,0.1251435132032147,0.5172756973282103,1.0,12/52,13.98%,OSBPL8;ABCA1;APOE;ABCG1;ATP8B4;PLTP;SCARB2;ABCA3;PITPNA;PITPNC1;ATP8B1;PRELID3A
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.6021028415286047,1.3072000312138563,0.14244186046511628,0.5166323660277656,1.0,4/13,7.63%,PIM1;HNRNPU;METRNL;RREB1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4303740613555805,-1.3068168656769583,0.10408921933085502,0.5085587195678939,1.0,14/21,41.77%,SMO;ARMC9;TTC23;ULK3;PDCL;TEDC2;DCDC2;GAS8;KIF7;SFRP1;SHH;STK36;TEDC1;EVC
prerank,snRNA processing (GO:0016180),0.5725694801839851,1.306566271900485,0.15694444444444444,0.5177764066669005,1.0,8/16,13.45%,TOE1;INTS9;INTS6;INTS1;INTS8;INTS5;INTS7;INTS2
prerank,regulation of angiogenesis (GO:0045765),0.4192648973913221,1.3064323536898796,0.03458799593082401,0.5174803365962563,1.0,30/192,12.64%,GPNMB;PPARG;APLNR;SASH1;PLXND1;CTNNB1;VEGFA;AQP1;KLK3;IL6;PDPK1;NIBAN2;RHOJ;CEMIP2;NINJ1;FOXO4;THBS1;AGO2;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;ROCK1;SIRT1;PRKCB;SARS1;SULF1
prerank,nucleic acid metabolic process (GO:0090304),0.45509339311410735,1.3063623664334523,0.1040268456375839,0.5169710178631822,1.0,21/69,15.86%,POLR2A;WTAP;HNRNPH2;ENPP1;KPNA2;ATXN2;HNRNPU;POLR2L;NT5E;HNRNPA0;WDR74;POLR2G;DNASE1L1;POLR2I;NCBP2;HNRNPM;GTF2F2;WRN;HNRNPD;PCBP1;DNASE2
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5831312881497828,1.305821713668783,0.16467065868263472,0.5179072533350872,1.0,8/15,19.91%,ANP32B;GTSE1;TPR;GSK3B;GAS6;CAMK1;RBM22;TCF7L2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.5725979760747738,1.3058030653813069,0.16246498599439776,0.5172741970466067,1.0,9/15,25.46%,FBXW7;NR1H3;SIK1;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1;C3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.5438718555282309,1.305488979728869,0.15733333333333333,0.5175884890749252,1.0,9/22,21.82%,STAM;MVB12B;RNF115;VPS4A;UBAP1;SNF8;PLAA;VPS36;VPS37B
prerank,positive regulation of cell junction assembly (GO:1901890),-0.3383301482150723,-1.3052828292070668,0.09448818897637795,0.5096261468756489,1.0,15/56,12.73%,CNTNAP2;PTPRD;IL1RAPL1;NRXN1;NLGN1;GRID2;LRRC4B;CUX2;PPM1F;SYNDIG1;FERMT2;NLGN3;NPHP1;AGT;LIMS1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6121803112923825,1.3051529804040287,0.16114457831325302,0.5178610056262389,1.0,3/11,6.40%,IL6;RIPK1;DDX5
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.530159752525917,1.304214711498556,0.14620689655172414,0.5199946026839382,1.0,8/22,22.66%,ERCC6;ALYREF;TCERG1;THOC1;CDC73;CDK13;CCNT1;SUPT4H1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5951286851016823,1.302903767132125,0.16224188790560473,0.5231584040965415,1.0,4/14,8.87%,ADSL;IMPDH2;PPAT;LHPP
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5135866139212013,1.3026444472453766,0.14437086092715232,0.5232117927407328,1.0,8/27,15.15%,CD200R1;IRAK3;SIRPA;NLRC3;GAS6;TNFAIP3;CX3CL1;ARRB1
prerank,negative regulation of viral genome replication (GO:0045071),0.4873991775895017,1.3025289192517677,0.13105076741440377,0.5228577692793808,1.0,13/40,17.55%,IFITM1;TNIP1;SRPK2;FAM111A;RNASEL;ZC3HAV1;IFITM2;MAVS;BST2;N4BP1;SLPI;MPHOSPH8;SRPK1
prerank,positive regulation of protein metabolic process (GO:0051247),0.43122524577416227,1.301965037666073,0.08617021276595745,0.5238875782965916,1.0,25/110,13.63%,APOE;ATG7;WWP1;TIPARP;RAB7A;NR1H3;PLK2;MAP2K5;SORL1;MAPK7;STX5;APC;RAB1B;NEDD4L;WWP2;ABCA2;HUWE1;DDB1;GSK3B;MTPN;OAZ2;FOXO1;APP;TNFAIP3;PRKN
prerank,regulation of JNK cascade (GO:0046328),0.4314707455869018,1.3011354721685708,0.08562367864693446,0.5256661528223189,1.0,26/101,16.76%,SDCBP;RAP2A;GADD45B;GADD45G;TAOK3;RIPK1;NCOR1;AIDA;GADD45A;DUSP3;MFHAS1;SH3RF1;SIRPA;COPS5;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;PRKN;FKTN;TRAF5;TRAF2;LTBR;NCF1
prerank,positive regulation of transmembrane transport (GO:0034764),0.5862829074017679,1.3011175176475178,0.17138599105812222,0.52502903906718,1.0,7/13,25.46%,ANO6;ACSL5;AZIN1;CA2;AZIN2;BRAF;C3
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.43245497659148413,-1.3009065579354504,0.11494252873563218,0.5174891356832448,1.0,6/22,6.54%,PPM1E;DUSP6;PPP5C;PPM1F;DUSP7;PPP2CB
prerank,calcium import into the mitochondrion (GO:0036444),0.6312434848153531,1.3002216035788148,0.17095310136157338,0.5270742473073627,1.0,6/10,28.08%,MICU2;MICU1;SMDT1;AFG3L2;SLC25A23;MICU3
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.5039126859062139,-1.3000627909825124,0.1643059490084986,0.5169980270407637,1.0,5/12,14.47%,DOCK8;JAM2;AIF1;PYCARD;RHOA
prerank,response to exogenous dsRNA (GO:0043330),0.5538736652427058,1.300028623018082,0.15266106442577032,0.5269413671907663,1.0,5/18,12.10%,RFTN1;FLOT1;IRAK3;MAVS;PQBP1
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4974342249137735,1.2999081090771312,0.15125,0.5266135305229769,1.0,10/33,15.64%,FBXW7;ID2;CDKN1A;APPL2;PTEN;E2F1;APPL1;PSME2;INO80;CDC73
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.49198753436640297,1.2999012492800746,0.1251596424010217,0.5259529488043497,1.0,6/32,7.09%,ANXA1;VEGFA;RHOJ;MAP2K5;THBS1;HMOX1
prerank,regulation of melanin biosynthetic process (GO:0048021),0.6180999685810095,1.2997211265411788,0.18238993710691823,0.5258381712943837,1.0,4/10,15.41%,ZEB2;MFSD12;APPL1;ATP7A
prerank,regulation of fibrinolysis (GO:0051917),0.5784085611854906,1.2995536752054218,0.1787878787878788,0.5256566095655161,1.0,2/13,5.58%,F11;THBS1
prerank,vesicle transport along actin filament (GO:0030050),0.5456874259010622,1.2994866125970417,0.14979757085020243,0.525167338970367,1.0,4/19,9.51%,MYO5A;MYO1E;MYO19;MYO1F
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5144910660389778,-1.299045343345943,0.16434540389972144,0.5169468316080418,1.0,7/11,17.86%,TRIM37;MDM1;CENATAC;RBM14;TMEM67;CCNF;NPM1
prerank,replicative senescence (GO:0090399),-0.5026036439623542,-1.2989996952988134,0.1749271137026239,0.5145195659642169,1.0,8/12,40.78%,ATM;ATR;CHEK2;ROMO1;CDKN2A;CHEK1;TERT;PLA2R1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.544773418159145,1.2986833785840777,0.1600547195622435,0.5268512013488829,1.0,4/18,7.09%,ANXA1;VEGFA;RHOJ;HMOX1
prerank,amyloid-beta metabolic process (GO:0050435),0.5775969619289769,1.2984614164507915,0.16045845272206305,0.5268694984534027,1.0,9/16,23.20%,NAT8;DYRK1A;BACE1;NCSTN;ACE;APEH;APH1B;PSEN2;ABCA7
prerank,membrane organization (GO:0061024),0.4136252597056299,1.2984376303035463,0.04124748490945674,0.5262484217045323,1.0,73/227,20.73%,MYOF;MTCH1;REPS2;IGF2R;GRB2;ARPC2;NPC1;CORO1C;TFRC;CERT1;REEP4;SNAP29;SNX9;CD3D;PPT1;SH3GLB1;CLN3;GRIN3B;VTI1B;STAM;GAK;CHMP2A;SCARB2;SH3KBP1;RPS27A;UBC;RABEP1;FER1L6;ACTR3;PDCD6IP;TRIP10;VAPA;HUWE1;STX11;PICALM;A4GALT;VPS4A;FCHO1;CHMP6;M6PR;LPCAT3;AP3D1;IL7R;LEMD3;EPS15;AP2B1;VAMP3;OCRL;STAM2;WASL;ARRB1;MOSPD3;CBL;GAPVD1;RABIF;ARPC1A;CHMP5;NEMP1;CHMP7;SNX3;TMEM170A;ITSN1;FCHO2;LRP2;SYNJ2;AZIN2;GCA;AGFG1;ARPC4;ACTG1;VAMP2;SNAP23;TOR1A
prerank,regulation of programmed cell death (GO:0043067),0.42095446124364816,1.2979004085927945,0.049689440993788817,0.5271472207614938,1.0,46/161,20.21%,CTSB;SGK1;BCL2L11;STEAP3;TGM2;FAS;APAF1;DAPK1;RIPK1;RAF1;OSGIN1;ACTN1;AIFM2;CREBBP;HS1BP3;ANP32B;NLRC4;USP42;NF2;FBXO11;PAX8;SIRT1;BIRC3;OLFM4;OMA1;WRN;PRKN;BAX;JAK3;USP36;CASP6;RTN4;BNIP3;BID;TRAF2;GAS1;ACER2;ZBTB7A;BIRC2;CASP2;CRADD;ASAH1;BCL3;AKT1S1;AMIGO2;WFS1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.5816243083292745,1.297741342193776,0.1631504922644163,0.5269360874479311,1.0,3/14,11.39%,ERN1;CPSF1;NCBP2
prerank,receptor recycling (GO:0001881),0.6350734779469638,1.297427414574673,0.18683001531393567,0.5272134416911801,1.0,5/10,13.61%,PHETA2;SORL1;ARFGEF2;RAB11B;PLEKHJ1
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.571045072637703,1.2973219739660138,0.15950069348127602,0.5268261657026614,1.0,2/15,5.28%,PAOX;SAT1
prerank,positive regulation of macroautophagy (GO:0016239),0.46915766327819414,1.2973094874254187,0.12160566706021252,0.5262038368684427,1.0,12/48,10.59%,OPTN;SPTLC2;FYCO1;WAC;UVRAG;SESN2;SH3GLB1;RAB3GAP2;VPS13D;EPM2A;PAFAH1B2;SIRT1
prerank,protein modification by small protein conjugation (GO:0032446),0.4084740517747114,1.2963690503297576,0.008008008008008008,0.528306109934587,1.0,125/361,23.81%,EPAS1;EYA1;FBXO32;NSMCE2;NFE2L2;ATG7;WWP1;FBXW7;RNF26;WAC;ARRDC4;BIRC6;UBE2Q2;TRIM17;FBXL17;BRAP;UHRF2;UBE2L3;TSPAN17;ZNRF3;ATG10;SPSB4;CUL3;UBE2K;FBXL3;KLHL41;RNF135;SUMO2;DET1;PEX14;NUB1;CNOT4;RPS27A;UBC;PIAS4;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;EIPR1;MEFV;TOPORS;SPSB2;HUWE1;VCPIP1;TRIM7;PCNP;TPR;ARIH2;RLIM;DDB1;DCUN1D5;NUP50;SIRT1;MIB2;FBXO9;LZTR1;CAND2;KLHL24;STUB1;DCUN1D3;TRIM41;CUL4A;RNF34;UBA3;CHFR;UBA5;DCUN1D4;PRKN;UBE2F;VPS11;CUL1;ARRB1;CBL;CDC73;NUP98;CDC34;RNF7;DCUN1D1;TMEM129;UBE2M;KEAP1;GAN;TRIM14;MYLIP;MYCBP2;AMFR;TRPC4AP;TNFAIP1;NFX1;RNF43;UBE2S;FBXO7;NUP88;CBLL1;PIAS2;UBE2R2;DTX1;BCL11A;CUL4B;MKRN1;FBXO45;DTX2;PIAS1;NUP188;USP9X;NDC1;NUP43;UBE2H;VCP;PRKDC;UBR3;KCTD10;RNF168;NUP54;RANBP2;RNF138;ARIH1;UBE2D3;KLHL3;BCL10;EGR2;ISG15;MIB1
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.5729130752192054,1.2963109983293604,0.16907514450867053,0.52715095311695,1.0,6/16,11.32%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.5729130752192054,1.2963109983293604,0.16907514450867053,0.52715095311695,1.0,6/16,11.32%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;BCAS3
prerank,positive regulation of biosynthetic process (GO:0009891),0.4782093940177,1.2961762396689505,0.12239902080783353,0.5268295643374555,1.0,6/40,10.42%,CD36;APOE;VIM;CYBA;ZBTB20;MTPN
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5536016004786504,1.2956908192593934,0.15159944367176634,0.527644805654269,1.0,3/17,7.98%,ADRA1D;ADRA1A;AKAP13
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.41959987252166897,1.2956324403367803,0.06288659793814433,0.5271275290284333,1.0,26/140,10.80%,ARHGAP24;ARHGAP21;ARHGAP10;ABR;ARHGAP19;ARHGAP15;VAV3;TGM2;SOS1;RHOJ;ARAP2;ARHGAP9;ARHGAP31;MYO9B;GNA13;FLCN;ARAP1;AKAP13;VAV1;TRIP10;DLC1;ARHGAP18;ARHGAP17;RHOD;FAM13B;ARHGEF2
prerank,regulation of microtubule polymerization (GO:0031113),-0.3691506832389881,-1.2955019699572081,0.08284023668639054,0.5204592701397314,1.0,11/40,15.78%,NAV3;MAPT;CDK5R1;MAP2;TUBB4A;PAK1;AKAP9;NUMA1;STMN2;MAPRE1;STMN1
prerank,response to unfolded protein (GO:0006986),0.47177934979366865,1.295399186635718,0.13846153846153847,0.5271543702488722,1.0,16/48,19.26%,OPTN;ERN1;HSPA1B;DNAJB5;DDIT3;RHBDD1;PRKN;HSPA1A;BAX;HSPA13;HSPD1;PTPN1;HSPA4;HSPE1;HSPA4L;DNAJA1
prerank,icosanoid biosynthetic process (GO:0046456),0.615078779384804,1.294322280098164,0.1643835616438356,0.5296147169526509,1.0,2/10,10.31%,MGST2;LTA4H
prerank,glial cell differentiation (GO:0010001),-0.4037121063473534,-1.294186230051418,0.125,0.5210918322882615,1.0,15/28,22.50%,NFIB;RELN;TPPP;CDH2;MYRF;PAX2;PICK1;ERBB3;EIF2B5;SOX10;FGF10;SOX9;SOX11;GPC1;METRN
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.5688544670537135,1.2935222690376424,0.16411682892906815,0.5313255017940177,1.0,4/15,13.02%,PPARG;IRS2;PPARD;GPLD1
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4583720053065833,1.2933764141460031,0.12209302325581395,0.5310654131700934,1.0,16/54,17.90%,SYK;RIPK1;UBE2K;HSPA1B;HIPK1;NLRP2B;ADAM17;BIRC3;TRAF1;TAX1BP1;GAS6;TNFAIP3;PRKN;HSPA1A;TRAF2;BIRC2
prerank,membrane protein proteolysis (GO:0033619),0.4890161220328564,1.293364725271435,0.13985148514851486,0.5304280853712435,1.0,17/37,23.92%,ADAM9;DAG1;CTSH;BACE1;ADAM17;HM13;RHBDD1;MYH9;RELA;ADAM19;NCSTN;PARL;AFG3L2;ADAM10;APH1B;PSEN2;TRAF6
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4066597371732022,1.2925497064491174,0.011011011011011011,0.5322240570858057,1.0,78/390,13.51%,ATP6V0D2;MTSS1;GDF15;SDCBP;NAMPT;SYK;GALNT3;GRB2;FRK;NEDD9;VAV3;NCK2;ARPC2;ATP6V1A;VEGFA;POLR2A;PDK4;MAPKAPK3;BAIAP2;AP3S1;ATP6V1E1;SOS1;HGF;ATP6V1C1;PDGFA;KIF16B;TCIRG1;COL4A6;ATP6V0D1;ABI1;ANKS1B;FOXO4;IGF1;ZFYVE27;FGFR4;NRP2;COL1A1;MERTK;IRS2;PIK3CA;APC;CYBB;ATP6V1B2;SULF2;CYBA;NCF2;POLR2L;STAP1;VAV1;ACTR3;BLNK;ATP6V0A1;CYFIP2;SLC39A14;SH2B2;ROCK1;POLR2G;GSK3B;PTK2B;FOXO1;PAK2;FES;POLR2I;NCBP2;HNRNPM;ROR1;GTF2F2;APPL1;SULF1;DOCK1;RAPGEF1;NCF4;ATP6V0E1;GPLD1;ATP6V0C;ATP6V0B;FGR;AP2B1
prerank,response to organic cyclic compound (GO:0014070),0.46604568888617315,1.292106645930444,0.12110726643598616,0.5328807413639062,1.0,10/52,11.09%,ANXA1;CTNNB1;TIPARP;KYNU;SPP1;FGFR4;STAT5B;ABCA2;ESR1;STRN3
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4202599107526432,-1.2918408601655529,0.11336032388663968,0.5243344622355747,1.0,7/24,8.61%,TENM2;GPM6A;NLGN1;PLPPR5;RIPOR2;FMR1;AGRN
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5413055546047622,1.291101505790317,0.1592442645074224,0.5352305138110284,1.0,5/19,15.91%,HRH1;PPP3CA;PPP3R1;NFATC3;INPP5A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.49570111404564027,1.290322894243649,0.1402831402831403,0.5368561972116841,1.0,5/33,6.88%,PPARG;FOXO3;JUN;NR3C1;KLF5
prerank,cellular respiration (GO:0045333),0.482517072419632,1.2898382065695817,0.13701923076923078,0.537524046379546,1.0,14/41,16.71%,ETFRF1;LYRM7;UQCRFS1;MTLN;MTFR1L;NDUFS8;SDHAF4;CYCS;SDHB;SDHA;ATP5F1D;NDUFS1;SIRT3;COX15
prerank,glutathione metabolic process (GO:0006749),0.48531532406927624,1.2896980643239628,0.14443084455324356,0.5372805053875213,1.0,9/38,17.56%,MGST2;GSTM1;NAT8;CNDP2;GSR;HPGDS;HAGH;GSTA4;OPLAH
prerank,hexose metabolic process (GO:0019318),0.4889188519944793,1.2894774379505334,0.1297709923664122,0.537274762733338,1.0,18/39,26.10%,SORD;AKR1A1;TFAP2B;IRS2;GALK2;PPARD;PGM1;FUCA1;OMA1;APOD;SLC35A2;PMM2;GALM;SLC37A4;HK1;GALT;CHST15;BRAT1
prerank,primary miRNA processing (GO:0031053),-0.5383782452916438,-1.2890127717050044,0.18037135278514588,0.5285031485774668,1.0,5/10,12.46%,SMAD3;DGCR8;METTL3;SMAD1;SMAD2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5693375361121458,1.2887114901097625,0.1673758865248227,0.5389712602165905,1.0,6/15,16.59%,FLOT1;ADAM9;CD53;TYROBP;TREM2;CAMK1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.47944054897190497,1.2885560792552893,0.1341317365269461,0.5387901694724614,1.0,10/38,13.60%,TNIP1;TANK;RIPK1;NR1H4;ESR1;NLRC3;SIRT1;RORA;TREM2;TNFAIP3
prerank,regulation of mitochondrion organization (GO:0010821),0.469272890116188,1.2883668983751861,0.14719626168224298,0.5386702201149448,1.0,18/47,16.47%,FBXW7;PID1;HTRA2;MYO19;FLCN;CSNK2A2;INF2;GSK3B;FZD5;TREM2;OMA1;SIRT7;VDAC1;PRKN;SQSTM1;GOLPH3;USP36;PARL
prerank,negative regulation by host of viral process (GO:0044793),0.6276559099984402,1.2882105809252635,0.17674418604651163,0.5384654568855067,1.0,3/10,13.63%,EIF2AK4;VAPA;PRKN
prerank,positive regulation of immune system process (GO:0002684),0.5619334889085648,1.288044037754141,0.17275280898876405,0.5382586295723853,1.0,2/16,1.73%,ANXA1;VEGFA
prerank,actin filament-based transport (GO:0099515),0.5325739743333171,1.2872370205749737,0.148,0.5400912434932892,1.0,4/21,9.51%,MYO5A;MYO1E;MYO19;MYO1F
prerank,lipid oxidation (GO:0034440),0.5973242576055972,1.2870238554965545,0.1827956989247312,0.5400563506226705,1.0,1/12,0.37%,PLA2G7
prerank,regulation of cell migration (GO:0030334),0.4033932353013126,1.2860712727479187,0.015015015015015015,0.5421939750664528,1.0,75/382,13.09%,GPNMB;F7;PLXNA1;SDCBP;SASH1;SGK1;PLXNC1;PLXND1;NEDD9;ADGRG3;GCNT2;ANXA1;MITF;RAP2A;VEGFA;RUFY3;CORO1C;ARHGEF39;IFITM1;ADAM9;MGAT5;HGF;FOXO3;WASHC1;PDGFA;CD151;SEMA4B;LMNA;APPL2;MMP14;PTEN;CITED2;YTHDF3;OSGIN1;SORL1;IGF1;CLN3;F10;COL1A1;ZMYND8;THBS1;DAG1;DUSP3;GNA12;STK24;APC;FLCN;DOCK10;GTSE1;NF2;SNAI2;CTSH;DLC1;ACVRL1;DACH1;PPP3CA;PLAU;ITGB1;ROCK1;RAP2B;ADAM17;RHOD;PTK2B;CCN1;BST2;NOTCH1;MYLK;APPL1;SPAG9;MAZ;SULF1;ARID2;MACF1;MCTP1;PODN
prerank,positive regulation of dendrite extension (GO:1903861),-0.46243271594375845,-1.285786171323996,0.1503267973856209,0.5335629785472856,1.0,10/17,23.00%,SYT1;RIMS1;RIMS2;SMURF1;SYT2;SYT4;SYT3;UNC13A;RASAL1;CPNE5
prerank,axonogenesis (GO:0007409),-0.2595709391473787,-1.2853263175926732,0.0,0.5320912790734132,1.0,57/237,12.35%,UNC5C;OPHN1;SEMA5A;RPS6KA5;EPHA5;CTNNA2;NRXN1;NTNG1;ROBO2;ROBO1;NRXN3;DCC;CNTN6;NCAM1;EVL;AUTS2;EPHA6;SIAH1;RYK;DAB1;VASP;CNTN2;EPHA3;PTPRO;ENAH;ANK3;CNTN4;UNC5D;FGFR2;DOK6;PARD3;SCN1B;RELN;CDK5R1;HSP90AA1;SLIT1;TUBB3;SEMA4G;KIF5A;VLDLR;SEMA3E;SPTBN4;BSG;PAX2;RAP1GAP;SEMA3A;EPHA7;EFNB3;RAB8A;NLGN3;PRKCA;KLF7;IGSF9;NEXN;SEMA6A;ULK2;GFRA2
prerank,cellular zinc ion homeostasis (GO:0006882),0.5166306168870066,1.2848232144057943,0.16732026143790849,0.5452823466387793,1.0,17/26,29.02%,SLC39A14;MT3;SLC39A12;SLC30A1;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;ATP13A2;SLC39A10;SLC30A9;SLC39A13;SLC30A5
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.3190727864301755,-1.2846711607508237,0.08333333333333333,0.5312912031060614,1.0,22/75,20.02%,SLC9A9;SLC12A2;ATP1B1;SLC12A6;SLC24A2;ATP1A2;KCNJ2;TRPM4;ATP1B2;KCNJ3;TRPM2;KCNJ9;SLC6A1;HCN2;ATP2B4;SLC12A4;CACNA2D1;KCNK9;SLC39A8;SLC9A1;ABCC9;KCNJ6
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.4178847890554589,1.2846244463124905,0.07135470527404343,0.5451758554372625,1.0,18/140,10.01%,CD36;CXCR4;EDNRA;ADRA1D;ADRA1A;PTGDR;ABL2;P2RX4;XCR1;GPR157;C3AR1;SLC8A1;LPAR2;PTGER2;P2RX3;TRPC3;PTGER4;ESR1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.5164308429921615,1.284514391712901,0.14868421052631578,0.5447832651302763,1.0,3/26,5.81%,OSBPL8;IGF1;IRS2
prerank,response to histamine (GO:0034776),0.6166079344416671,1.284359649226063,0.1780821917808219,0.5445984932203856,1.0,2/10,1.52%,HRH1;DIAPH1
prerank,positive regulation of cell migration (GO:0030335),0.4076329198649325,1.2842032933210563,0.026183282980866064,0.5444307568314791,1.0,55/253,16.52%,GPNMB;F7;SDCBP;NEDD9;GCNT2;VEGFA;KIF20B;RUFY3;ARHGEF39;ADAM9;MGAT5;HGF;WASHC1;PDGFA;CD151;SEMA4B;DOCK5;MMP14;IGF1;F10;COL1A1;THBS1;AGO2;APC;NIPBL;GTSE1;RREB1;SNAI2;CTSH;PPP3CA;BMPR2;PLAU;ITGB1;ADAM17;RHOD;PTK2B;ARHGEF2;CCN1;NOTCH1;ACVR1B;PFN1;MYLK;SPAG9;MAZ;DOCK1;FGR;CAPN7;CLASP1;RTN4;GRN;CCL7;MIEN1;SEMA3B;NRP1;CCAR1
prerank,protein targeting (GO:0006605),0.4215372172102465,1.2841635640314093,0.08148148148148149,0.5438838823157052,1.0,35/118,19.16%,SDCBP;KIF13B;PIKFYVE;ZDHHC14;ZDHHC19;TIMM22;ZFAND2A;HOMER3;SORL1;PITRM1;YIF1B;TOMM20;TIMM17A;MICALL1;LAMP2;ZDHHC12;ZDHHC18;NACA;TIMM17B;ZFAND6;LONP2;GDAP1;SPCS2;ZFAND2B;RABGEF1;ZDHHC24;TOMM34;NCF1;ZDHHC4;SEC63;ICMT;TOMM7;AP4M1;TOMM22;FBXO7
prerank,positive regulation of cyclase activity (GO:0031281),-0.48077272103222113,-1.2832716270389641,0.16507936507936508,0.5319351903825829,1.0,2/14,2.42%,ORAI1;CACNA1C
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5076898713043065,1.2830448277510687,0.1553784860557769,0.5464766157192741,1.0,15/26,26.97%,IRAK2;RPS27A;UBC;TAB2;TNFAIP3;UBE2V1;AAMP;ALPK1;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,regulation of endocytosis (GO:0030100),0.4551583039277487,1.2828414183322039,0.12672811059907835,0.5463808745158502,1.0,17/61,16.54%,LGALS3;APOE;LILRB1;FLOT1;LRP1;ABL2;CD151;NEDD4L;CD22;PICALM;SNX33;ROCK1;MCTP1;STON1;SNX17;RUBCN;PTPN1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.5006310005787684,1.2823568749537244,0.15201005025125627,0.5471812559165329,1.0,5/32,9.30%,APLNR;PDPK1;P2RX4;P2RX3;TRPC3
prerank,sulfate transport (GO:0008272),0.5731022365226413,1.2822939479941764,0.18100890207715134,0.5466755131229828,1.0,2/14,5.29%,SLC26A11;SLC26A1
prerank,regulation of AMPA receptor activity (GO:2000311),-0.40611186313507364,-1.2814131627092564,0.1228813559322034,0.5340028060457531,1.0,17/25,29.74%,MEF2C;NLGN1;RELN;CACNG4;SHISA6;NLGN3;GSG1L;CACNG3;CACNG2;SHISA7;MAPK8IP2;CACNG7;ADRB2;CNIH3;CACNG5;SHANK1;SHISA8
prerank,cellular response to mechanical stimulus (GO:0071260),0.4773690148728301,1.280855472596008,0.14628297362110312,0.550254624443187,1.0,16/46,18.54%,TLR8;MAP3K1;AQP1;FAS;GADD45A;MAP2K4;PTGER4;PIEZO1;PIEZO2;KCNK4;MAP3K2;BNIP3;MYD88;LTBR;CASP2;CRADD
prerank,heart trabecula morphogenesis (GO:0061384),-0.43167873121349565,-1.2805133832748485,0.1781818181818182,0.5335207770038871,1.0,5/18,8.69%,BMPR1A;TGFBR1;ENG;S1PR1;TGFB2
prerank,sphingoid metabolic process (GO:0046519),0.6013176354472887,1.2803903839651498,0.19004524886877827,0.5509853563560622,1.0,2/12,6.26%,PLPP3;SPHK2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.617724580362006,1.2802028484284715,0.17901234567901234,0.5508720489741491,1.0,5/10,22.85%,TAF7;BRCA1;SIRT1;NOC2L;CTBP1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.5410998706616368,1.2798038053355585,0.18156424581005587,0.5513732211626078,1.0,5/19,8.86%,PAPSS2;ENPP1;SLC26A1;SLC35B3;PAPSS1
prerank,secondary palate development (GO:0062009),-0.48167349918764935,-1.2790364574883266,0.16013071895424835,0.5345224503426104,1.0,7/14,29.95%,TGFBR2;TGFB2;SMAD2;SMAD4;WNT5A;LEF1;WNT7A
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4256376247233943,-1.2781943368220243,0.14695340501792115,0.5339840961482006,1.0,7/20,18.45%,CCND3;EGFR;PKD2;PKD1;RGCC;TTBK1;PSMD10
prerank,actin polymerization or depolymerization (GO:0008154),0.45719736654839815,1.2770983910793774,0.12455516014234876,0.5589637585042369,1.0,19/50,19.63%,VILL;DIAPH1;MICALL2;MSRB1;ABI1;PSTPIP1;CAPG;SVIL;CFL1;WDR1;PSTPIP2;MICAL2;WASL;DSTN;WASHC3;FLII;WASHC5;CFL2;MICAL1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5811031371109425,1.276965168936096,0.1935483870967742,0.5586976993468493,1.0,4/13,10.59%,CD44;DYRK1A;SNAI2;SIRT1
prerank,calcium ion transport (GO:0006816),-0.2996077217743479,-1.2769501617946704,0.03773584905660377,0.5347086498100502,1.0,35/113,15.94%,SLC24A3;TRPM3;CACNB2;CACNA1E;RYR3;CCR5;CDH23;SLC24A2;ANK2;ORAI1;TRPC1;CACNA1C;GRIN3A;RYR2;ATP2C1;TRPM4;CRACR2B;RAMP1;NALCN;TRPC7;TRPM2;TRPC4;MCOLN1;SLC24A4;CACNA1G;CAMK2A;PKD2;ATP2B2;ATP2B4;PKD1;CACNA2D1;CACNG3;TRPM6;ORAI2;CCR1
prerank,regulation of cellular component size (GO:0032535),0.5019717230629033,1.2765249503973255,0.15796178343949044,0.5593910606803131,1.0,11/30,16.85%,VAV3;PTEN;PEX11A;MSN;VAV1;PICALM;RIN3;MTPN;RAP1GAP2;PPP1CA;RAB22A
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5382740150746584,1.2765237116942034,0.17103448275862068,0.558712217480222,1.0,1/19,0.58%,APOE
prerank,actin crosslink formation (GO:0051764),0.6005285528651935,1.27644963356082,0.18085106382978725,0.558263167329154,1.0,3/12,3.00%,GAS2L3;BAIAP2;LCP1
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.42049951660949314,1.2752961150271966,0.09299895506792058,0.5610967026679512,1.0,27/118,14.52%,GPNMB;KIF13B;PLXND1;CTNNB1;RAP2A;RUFY3;ZMYM6;IL6;PID1;DAG1;MYO19;PDLIM5;HMOX1;LFNG;NEDD4L;VASH2;CAPZB;INF2;TNIK;GSK3B;CFL1;PAK2;TNFAIP3;CLASP1;GDNF;RNH1;PHIP
prerank,glycine metabolic process (GO:0006544),0.5994209542844496,1.2752305876559864,0.1722560975609756,0.5605995808386229,1.0,6/12,25.90%,BAAT;GLYAT;GCSH;SHMT2;AMT;RIDA
prerank,oogenesis (GO:0048477),-0.4634853914599335,-1.2751995732512842,0.15359477124183007,0.5365009572932458,1.0,8/15,38.44%,FMN2;METTL3;IHO1;TRIP13;PIWIL2;PTN;HORMAD1;NANOS1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5105990415777196,1.2749910845944525,0.15354330708661418,0.5606157400902377,1.0,7/26,13.63%,NFE2L2;TXN;HTRA2;MAPK7;ATF4;SIRT1;PRKN
prerank,protein oxidation (GO:0018158),0.5955600641242891,1.2745282243638116,0.18973561430793157,0.5612992479102032,1.0,2/11,15.68%,CHCHD4;SUMF1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.482047994847468,1.2743781619159051,0.16646562123039807,0.5610254627596317,1.0,3/36,2.92%,HTR2B;APOE;GLA
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.6013750371718174,1.274057034918992,0.19062027231467474,0.5613708258355796,1.0,7/10,27.28%,NPLOC4;TKFC;C1QBP;RNF125;DHX58;GPATCH3;RIOK3
prerank,cellular response to interleukin-15 (GO:0071350),0.5693083709248261,1.2735548099785008,0.18664643399089528,0.561595997591603,1.0,5/13,14.64%,GRB2;STAT5B;IL15;SHC1;JAK3
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5693083709248261,1.2735548099785008,0.18664643399089528,0.561595997591603,1.0,5/13,14.64%,GRB2;STAT5B;IL15;SHC1;JAK3
prerank,protein tetramerization (GO:0051262),-0.3191962820810035,-1.2734633622420601,0.028846153846153848,0.5381863251681936,1.0,20/67,16.74%,HCN1;RYR3;GRIN2B;ACACA;KCNC1;KCNJ2;GRIN1;TRPM4;HOMER1;KCNC3;TRPM2;SOD2;MCOLN1;APIP;PKD2;PKD1;PKD2L1;ALDOA;GBP5;OSBPL2
prerank,cellular response to glucose starvation (GO:0042149),0.4706554813146158,1.2733710015408102,0.15089820359281436,0.5614769267395384,1.0,8/41,6.99%,MTMR3;CPEB4;PRKAG2;FOXO3;SESN2;SH3GLB1;SIK1;ATF4
prerank,autophagosome maturation (GO:0097352),0.4955254453371423,1.2730770671553502,0.16297262059973924,0.5616912872032656,1.0,9/32,10.44%,SNAP29;TECPR1;UVRAG;CLN3;VTI1B;VMP1;LAMP2;VPS33A;EPG5
prerank,positive regulation of phospholipase C activity (GO:0010863),0.47717859644244165,1.2717995485955131,0.16666666666666666,0.5649282897084645,1.0,6/40,5.05%,HTR2B;EDNRA;ADRA1A;GNAQ;ABL2;LPAR2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5509748386617381,1.271367773294278,0.17705382436260622,0.5655877152991671,1.0,8/18,23.13%,APOE;RNF128;MSN;ABCA2;VPS11;VPS35;FAF1;EZR
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.5908919465981158,1.270669660542337,0.18562874251497005,0.5671278771668409,1.0,2/12,7.23%,CD36;CYBA
prerank,cellular response to UV-A (GO:0071492),0.6043621758403855,1.2704405522867968,0.19461077844311378,0.5671520377450582,1.0,1/11,0.97%,TIMP1
prerank,sphingolipid biosynthetic process (GO:0030148),0.4393110971662701,1.270384418512618,0.11568409343715239,0.5666664820077593,1.0,23/71,20.41%,PLPP3;SPTLC2;SAMD8;SGPL1;CERT1;SGMS2;HACD4;B4GALT6;CERS6;SPHK2;SPTSSA;VAPA;A4GALT;ELOVL1;ALDH3A2;DEGS1;PRKD3;TLCD3B;ACER2;SGMS1;ASAH1;SGPP2;CERS1
prerank,protein localization to microtubule organizing center (GO:1905508),0.5633539339420766,1.2703794275694005,0.17489421720733428,0.5659988761544316,1.0,3/15,2.21%,HOOK3;PIBF1;SNX10
prerank,cellular response to oxidative stress (GO:0034599),0.41963354733118885,1.2701979102708216,0.09554140127388536,0.5658511303967642,1.0,27/118,13.93%,MSRA;PRDX1;NFE2L2;TXNRD1;MPV17;PRKCD;FOXO3;JUN;DAPK1;SESN2;LONP1;HTRA2;HSPA1B;CYBB;GPX3;ATF4;HMOX1;CYBA;NCF2;CAT;GSR;CYCS;FOXO1;MT3;NCF4;ERCC6L2;HSPA1A
prerank,neuron differentiation (GO:0030182),-0.27390789467578797,-1.270188500530162,0.0,0.5436275116596316,1.0,20/165,4.88%,ATP8A2;TENM2;PTPRD;MEF2C;OPHN1;IL1RAPL1;EPHA5;SPOCK1;TENM3;RYK;RORB;FZD3;MYEF2;MYO7A;FUT9;MYT1L;TGFBR1;CDK5R1;PBX3;NTRK2
prerank,zinc ion homeostasis (GO:0055069),0.5053966177554029,1.2701102642409348,0.18604651162790697,0.5654473639017689,1.0,18/28,29.02%,SLC39A14;MT3;PRKN;SLC39A12;SLC30A1;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;ATP13A2;SLC39A10;SLC30A9;SLC39A13;SLC30A5
prerank,regulation of spindle assembly (GO:0090169),0.5096164732946848,1.2700680366325516,0.17608409986859397,0.5649183615834784,1.0,9/25,17.04%,DYNC1H1;CHMP2A;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR;HSPA1A;CHMP5
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.6157160892341949,1.2696025381977099,0.21642969984202212,0.5656951322933914,1.0,5/10,13.22%,ZNF692;GNMT;SDHAF3;SIRT7;DGKQ
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3806398771587644,-1.269540637007668,0.14903846153846154,0.5426850069293334,1.0,4/29,3.51%,CADM1;ITGAM;CYRIB;STX7
prerank,regulation of DNA recombination (GO:0000018),0.48947992818945396,1.2694467388000399,0.15990159901599016,0.5655056674874394,1.0,8/32,12.69%,ALYREF;ZRANB3;KPNA2;SIRT6;THOC1;PPP4R2;RTEL1;IL7R
prerank,fat cell differentiation (GO:0045444),0.4444946498699622,1.2691440348973098,0.1379703534777651,0.5657317403693313,1.0,8/57,10.59%,PPARG;OSBPL8;TFAP2B;PID1;METRNL;MAFB;FOXO1;SIRT1
prerank,gliogenesis (GO:0042063),-0.46277911924223736,-1.2689723515995797,0.16774193548387098,0.5416252449796916,1.0,6/15,8.69%,NFIB;RELN;METTL3;CDH2;PAX2;TGFB2
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5452158684028487,1.2685867984725685,0.17256011315417255,0.5667779373165178,1.0,6/17,13.63%,CD44;DYRK1A;SNAI2;SIRT1;RNF34;PRKN
prerank,modification-dependent protein catabolic process (GO:0019941),0.40703373517663255,1.268301456147305,0.056179775280898875,0.5670324209572458,1.0,78/193,24.75%,RNF149;TRIP12;BIRC6;RNF19A;RNF130;TRIM25;WDR91;LONP1;UBE2L3;ZNRF3;ANAPC1;SPSB4;CUL3;NPLOC4;UBE2K;RNF128;NUB1;CNOT4;RPS27A;UBC;KCTD21;BFAR;NEDD4L;FBXO11;RNF146;TOPORS;SPSB2;ARIH2;RLIM;DDB1;PSMF1;PSMD14;STUB1;RNF34;CHFR;PRKN;SQSTM1;UBQLN2;ARRB1;ANAPC10;CBL;PCYOX1;CDC34;RNF7;KEAP1;MYLIP;AMFR;TRPC4AP;RNF43;UBE2S;FBXO7;ATXN3;ANAPC15;PSMD11;UBE2R2;RNF19B;FBXO45;FBXL4;TAF1;UBE2H;UBR3;KCTD10;RNF125;HERPUD1;UBE4A;RNF168;SIAH2;ARIH1;KLHL3;UBE4B;ISG15;MIB1;PTTG1;NDFIP1;RNF150;TTC3;UBE2E1;ANAPC7
prerank,negative regulation of cell population proliferation (GO:0008285),0.39653926388703314,1.2666465683497372,0.023,0.5712704231743152,1.0,66/351,16.17%,GPNMB;PPARG;MTSS1;CD300A;ADAMTS8;FRK;RPS6KA2;ADRA1A;CTNNB1;NCK2;FOXP3;ST18;IFITM1;E2F3;IL6;CDKN1A;NIBAN2;TFAP2B;RUNX3;LMNA;APPL2;B4GALT7;CELF1;ABI1;PTEN;RAF1;FOXO4;E2F1;TNN;APC;FLCN;NUDT6;HSPA1B;HMOX1;NF2;TES;MCC;BNIPL;P3H3;DLC1;STRN;ACVRL1;BRD7;BMPR2;NLRC3;CNOT7;PTK2B;ING4;FBLN1;APP;NOTCH1;TREM2;ARID2;GPLD1;PODN;SOX2;TNFAIP3;TENM1;HSPA1A;SPEG;FKTN;ADARB1;SMYD2;CDC73;ALDH1A2;NELL1
prerank,embryonic hemopoiesis (GO:0035162),-0.5018189437206922,-1.266383984984259,0.16363636363636364,0.5452445271373325,1.0,5/12,9.12%,TGFBR2;KITLG;SH2B3;TAL1;THOC5
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.5687374381905982,1.2663545736407358,0.1836734693877551,0.5715105032418613,1.0,3/15,3.02%,VEGFA;ITGA5;PDPK1
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.46145839759719265,1.2662736201444977,0.12808460634547592,0.5710873597996006,1.0,14/48,17.86%,PAPSS2;ADSL;IMPDH2;COASY;SLC26A1;AMPD3;ADCY7;SLC35B3;PAPSS1;ADCY8;ADCY3;PANK2;NPR2;ADSS1
prerank,positive regulation of viral genome replication (GO:0045070),0.49806504102511395,1.2661998434211543,0.1685823754789272,0.570647028517744,1.0,11/29,17.55%,CD28;SRPK2;RAD23A;PPIH;DDB1;CNOT7;PKN2;PPIE;ADARB1;TMEM39A;SRPK1
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5171549387754667,1.265676482226501,0.1864864864864865,0.5715359873010568,1.0,5/24,10.11%,PRKCH;CTSL;NCOA3;CBFB;ROCK1
prerank,acidic amino acid transport (GO:0015800),0.5357409599965774,1.2655862609334338,0.1997126436781609,0.5711542136210703,1.0,2/17,0.69%,LRRC8D;SLC6A6
prerank,protein localization to Golgi apparatus (GO:0034067),0.5069027652484029,1.2649446271306308,0.17724867724867724,0.5724306671667654,1.0,10/27,19.36%,OPTN;RAB33B;SORL1;GAK;COG7;VPS13D;VPS13C;GOLPH3;VPS13A;ARL5B
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.5346275627633222,1.264888694967443,0.18461538461538463,0.5719425632264207,1.0,6/18,19.77%,BCL2L11;ERN1;DDIT3;BAX;ATXN3;FCGR2B
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6113908829879371,1.2647496868836288,0.20094936708860758,0.5716665009595946,1.0,1/10,0.55%,XDH
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.522027565451914,1.2647198634132655,0.17089452603471295,0.5710961687539422,1.0,10/24,16.71%,LYRM7;PID1;MTLN;ACADVL;SDHAF4;GFPT1;CYCS;MT3;NDUFS1;COX15
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.5106280505094596,1.2646035110681917,0.17834394904458598,0.5707459915824886,1.0,4/26,10.56%,GPR137B;LILRB3;RARA;MAFB
prerank,protein lipidation (GO:0006497),0.4442385642050679,1.2644542637471725,0.1384083044982699,0.5705299337447715,1.0,14/59,16.35%,ZDHHC14;ATG7;PGAP3;DPM2;ZDHHC16;ATG10;PIGH;ZDHHC12;ZDHHC18;ATG5;PIGC;GPLD1;PIGQ;ZDHHC17
prerank,adrenergic receptor signaling pathway (GO:0071875),0.527103818175337,1.263965596287887,0.16893732970027248,0.5713291817582598,1.0,4/20,10.49%,ADRA1D;ADRA1A;AKAP13;LMBRD2
prerank,retinoid metabolic process (GO:0001523),0.4388568698419766,1.2635969310014918,0.13172338090010977,0.5717839042449948,1.0,6/71,5.07%,APOE;STRA6;DHRS3;LRP1;RBP1;RDH12
prerank,regulation of actin filament polymerization (GO:0030833),-0.31751050731200897,-1.2630389529374755,0.06862745098039216,0.5507615461494895,1.0,14/69,7.80%,SSH2;BIN1;TWF2;EVL;FCHSD2;PRKCE;VASP;CYRIB;FER;HCK;NCKAP1;NCK1;SSH3;CARMIL1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.42084335740950846,1.2627732972379626,0.09568874868559411,0.5735420215761,1.0,12/110,6.49%,ADGRE5;ABCA1;ADGRG3;ADRA1D;ADRA1A;GNAQ;GNA13;LPAR2;ADCY7;CNR2;ADGRE1;PTGER2
prerank,positive regulation of B cell activation (GO:0050871),0.45446223104667954,1.2625410588037647,0.13921113689095127,0.5735974591517039,1.0,8/50,7.15%,CD38;SYK;VAV3;TFRC;IL6;MMP14;IRS2;SH3KBP1
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5886447681758976,1.2624760227817062,0.191904047976012,0.5731238392366229,1.0,4/12,22.36%,IRX3;SRI;CALM2;PDE4D
prerank,protein ubiquitination (GO:0016567),0.39586035050750834,1.2623956384468868,0.016,0.5727002118037666,1.0,160/471,23.99%,EPAS1;FBXO32;SASH1;TRIP12;NFE2L2;CTNNB1;ZNRF1;WWP1;NPEPPS;FBXW7;RNF26;WAC;PSMD1;ARRDC4;BIRC6;UBE2Q2;RNF19A;TRIM17;FBXL17;BRAP;TRIM25;UHRF2;UBE2L3;TSPAN17;ZNRF3;SPSB4;CUL3;FBXW10;RNF10;UBE2K;FBXL3;KLHL41;RNF135;DET1;PEX14;NUB1;CNOT4;RPS27A;UBC;NHLRC1;BFAR;SH3RF1;LONRF1;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RNF146;EIPR1;MEFV;CBFB;TOPORS;SPSB2;HUWE1;VCPIP1;TRIM7;PCNP;ARIH2;RLIM;DDB1;SIRT1;MIB2;FBXO9;NHLRC3;PSMF1;ASB4;LZTR1;UNKL;PSMD14;CAND2;KLHL24;STUB1;RUSC1;TRIM41;PSMD12;CUL4A;RNF34;CHFR;FBXO6;FBXW2;PRKN;PSME2;VPS11;CUL1;FBXO28;TNKS;ARRB1;CBL;CDC73;LNPEP;CDC34;RNF7;TRAF2;BLMH;TMEM129;UBE2O;PSMB10;KEAP1;PSMD5;GAN;TRIM14;UBE2V1;BIRC2;MYLIP;TNKS2;PSMD8;MYCBP2;AMFR;PSMA3;TRPC4AP;TNFAIP1;FBXO31;NFX1;RNF43;UBE2S;FBXO7;PSMA2;CBLL1;PSMD11;PELI2;UBE2R2;DTX1;DDA1;RNF19B;PSMA6;SPOP;CUL4B;MKRN1;FBXO45;FBXL4;DTX2;TAF1;USP9X;UBE2H;VCP;PSMB3;PRKDC;UBR3;KCTD10;RNF141;RNF125;KLHL12;IRF2BP1;UBE4A;RNF168;OBI1;SIAH2;PSME3;RNF138;ARIH1;UBE2D3;KLHL3;UBE4B;BCL10;ISG15;MIB1;TRAF6;FBXO4
prerank,protein localization to nucleus (GO:0034504),0.4198233769892521,1.2623834256359996,0.11720430107526882,0.5720702933056974,1.0,19/102,12.78%,MMP12;SYK;PIKFYVE;IPO5;E2F3;LMNA;APPL2;COL1A1;HNRNPU;DVL1;TOPORS;TPR;INTS13;NUP50;SUPT7L;TNPO1;NOL8;APPL1;WRN
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.4298524420182204,-1.2623080841063146,0.1624548736462094,0.5499841716020063,1.0,5/19,8.69%,ACVR1;BMPR1A;TGFBR2;MDM4;TGFB2
prerank,regulation of hydrolase activity (GO:0051336),0.43956591976006265,1.2619681860919152,0.14221218961625282,0.5727256610423189,1.0,17/71,14.72%,PLXNA1;GPR137B;PLXNC1;PLXND1;ARHGAP15;FGD6;VAV3;ARHGAP9;ADAP1;RAB3GAP2;SCARB2;VAV1;TBC1D15;FGD5;WRN;OCRL;FGD3
prerank,cellular response to ionizing radiation (GO:0071479),0.4592818345418079,1.2617898268583356,0.16489988221436985,0.572616524259187,1.0,16/47,20.59%,MAP3K20;GRB2;CDKN1A;TANK;GADD45A;NIPBL;XRCC5;SIRT1;WRN;INTS7;INO80;RPL26;CLOCK;TLK2;EEF1D;TNKS1BP1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.41296822112171916,1.260768230385697,0.07708333333333334,0.5749815407042311,1.0,19/142,10.01%,CD36;CXCR4;EDNRA;ADRA1D;ADRA1A;PTGDR;ABL2;ATP2B1;XCR1;SLC8B1;C3AR1;SLC8A1;LPAR2;CLN3;PTGER2;CALB1;TRPC3;PTGER4;ESR1
prerank,negative regulation of catabolic process (GO:0009895),-0.339848381173058,-1.2607339197443068,0.09876543209876543,0.5512343550006515,1.0,18/47,23.87%,PDE3B;FMN2;CST3;BANP;CBFA2T3;EGFR;MDM4;APOC1;SIRT2;GIT1;CYP51A1;TNF;ADGRB1;TIGAR;AGAP2;PFKFB1;IL1B;ADRA2A
prerank,negative regulation of cell activation (GO:0050866),0.5626012663216874,1.2603607853760486,0.2055393586005831,0.5755850524891669,1.0,3/14,12.33%,APOE;PDGFA;TREM2
prerank,regulation of muscle cell differentiation (GO:0051147),-0.37778419388484225,-1.2602025510182493,0.16037735849056603,0.5501602101380756,1.0,7/31,7.03%,MEF2C;CTNNA2;MEF2A;FGFR2;CDH2;CDON;HDAC9
prerank,L-glutamate transmembrane transport (GO:0015813),-0.5251951891636581,-1.2601571362339063,0.1930835734870317,0.5478511580247957,1.0,8/10,32.45%,SLC1A3;SLC1A2;SLC1A1;ARL6IP5;PRAF2;SLC1A6;SLC25A18;SLC25A12
prerank,positive regulation of neuron differentiation (GO:0045666),-0.35856739475870797,-1.2601434504084503,0.12650602409638553,0.5454719004173882,1.0,13/40,23.56%,MEF2C;BRINP3;ZEB1;VWC2;REST;RHOA;HOXD3;BRINP1;ECT2;NBL1;SOX11;TRIM32;MMD
prerank,response to muscle stretch (GO:0035994),0.5493906883794553,1.2600614012400904,0.20356612184249628,0.5758437113231122,1.0,3/15,6.41%,CTNNB1;SLC8A1;PIK3CA
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.42681598263570397,1.2598569993707138,0.12823275862068967,0.5758249532269695,1.0,21/86,13.22%,VEGFA;TEC;CD44;IL6;HGF;ITGA5;PRKCD;PDGFA;IGF1;IL5;IL6R;RAP2B;CNOT7;PTK2B;PAK2;ARHGEF2;APP;IL15;TREM2;HCLS1;DGKQ
prerank,DNA geometric change (GO:0032392),0.5179786154894693,1.2592332954303467,0.19727891156462585,0.5769512546734162,1.0,6/24,12.78%,ANXA1;MCM9;ZRANB3;RTEL1;NBN;WRN
prerank,positive regulation of MAPK cascade (GO:0043410),0.40051754372110143,1.2592209862055268,0.06143001007049345,0.5763305012177684,1.0,21/245,5.73%,GPNMB;CD36;HTR2B;IQGAP1;GDF15;PIK3R5;APOE;GCNT2;ADRA1D;ADRA1A;VEGFA;FBXW7;CD44;TAOK3;IL6;TMEM106A;PDGFA;NOTCH2;IGF1;FGFR4;ADAM8
prerank,mitotic sister chromatid cohesion (GO:0007064),0.564555413942185,1.2590754775232782,0.17510853835021709,0.5761556299861946,1.0,7/16,19.90%,NIPBL;RB1;SMC1A;BOD1;RAD21;SGO1;PDS5A
prerank,regulation of protein sumoylation (GO:0033233),0.5394604555739896,1.2589359732109493,0.18994413407821228,0.5759364098034887,1.0,4/17,7.73%,ZMIZ1;CTNNB1;RWDD3;PIAS4
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.538706529689818,1.2588411133512964,0.20054570259208732,0.5755800686460635,1.0,3/17,10.22%,PLA2G7;ANO6;MOSPD2
prerank,regulation of defense response (GO:0031347),0.4304445110186651,1.258482056913914,0.13510520487264674,0.575978832808442,1.0,23/76,17.90%,APOE;ANXA1;MGLL;APPL2;CELF1;SHPK;RNF135;TKFC;XIAP;FOXP1;BIRC3;APPL1;TREM2;TRAF3;RELA;FGR;N4BP1;CASP12;MYD88;GRN;BST1;NLRP6;BIRC2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.4126393059496378,1.2583076017615318,0.09138110072689512,0.5758720524258332,1.0,32/138,12.94%,PPARG;POLR2A;NR1H3;E2F3;RXRA;NCOR1;NOTCH2;RARA;GTF2H5;GTF2B;TAF7;MAML1;NR3C1;MAML2;NR1H4;CREBBP;TAF5;POLR2L;TBL1XR1;NR5A1;NR2C1;ESR1;POLR2G;CDK7;MED26;POLR2I;PPARD;NOTCH1;RORA;GTF2F2;MAZ;NRBF2
prerank,post-translational protein modification (GO:0043687),0.400111966498338,1.2579460710306496,0.033066132264529056,0.576376250704075,1.0,89/332,21.30%,EPAS1;MFGE8;FBXO32;APOE;TIMP1;CCDC8;GPS1;ITIH2;FBXW7;SPP1;IL6;APLP2;PSMD1;FAM20C;SPSB4;CUL3;FBXW10;SOCS6;FBXL3;DCAF13;KLHL41;PROC;NUB1;BTBD1;RAB1B;WSB2;KLHL20;FBXO11;SPSB2;COPS5;QSOX1;FSTL1;DDB1;FBXO9;ATG5;CCN1;PSMF1;ASB4;PSMD14;APP;DCUN1D3;ASB8;WDTC1;RHBDD1;PSMD12;CUL4A;COPS7A;UBA3;FBXO6;RAB11B;FBXW2;GAS6;RBBP7;UBE2F;SERPINC1;PSME2;CUL1;NUCB1;SUMF1;RNF7;MELTF;RAB2A;LRRC41;DCUN1D1;UBE2M;PSMB10;KEAP1;PSMD5;GAN;DCAF10;ICMT;PSMD8;PSMA3;FBXO31;FBXO7;PSMA2;PSMD11;RAB1A;DCAF7;SHISA5;RAB13;WFS1;DDA1;PSMA6;ANO8;CUL4B;ZBTB16;FBXL4;ADAM10
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.45760398312475636,1.2578851703977025,0.15739644970414202,0.5759015971148892,1.0,10/48,10.98%,ANXA1;VEGFA;PDPK1;RHOJ;P2RX4;THBS1;HMOX1;ADAM17;SIRT1;ATP5F1A
prerank,Rap protein signal transduction (GO:0032486),0.606095347720417,1.2574799057608632,0.215311004784689,0.5764478915756005,1.0,4/10,12.79%,RAP2A;PLK2;RAP2B;RAPGEF1
prerank,positive regulation of chemotaxis (GO:0050921),0.46318981675234755,1.2571916258461289,0.17044100119189512,0.5765934056947526,1.0,10/43,12.33%,F7;STX3;VEGFA;IL6;P2RX4;THBS1;DSCAM;IL6R;ADAM17;TREM2
prerank,myeloid cell differentiation (GO:0030099),0.46013393034357625,1.256806310460548,0.15948777648428406,0.5770688306164352,1.0,19/47,23.28%,FLVCR1;RPS14;MFHAS1;HIPK2;TET2;KMT2E;HCLS1;UBA5;JAK3;ACIN1;CASP3;NCOA6;ZBTB16;CEBPA;SNRK;TIRAP;JAK2;SLC25A38;HSPA9
prerank,regulation of smooth muscle cell migration (GO:0014910),0.527636418216345,1.2565603920408288,0.19027777777777777,0.5771585295632936,1.0,7/20,16.73%,LRP1;PDGFA;SORL1;IGF1;PLAU;NRP1;ACE
prerank,protein polyubiquitination (GO:0000209),0.3948910543582812,1.2564029467888167,0.03313253012048193,0.5769616104460104,1.0,120/297,26.32%,FBXO32;SASH1;TRIP12;CTNNB1;ZNRF1;WWP1;NPEPPS;FBXW7;RNF26;PSMD1;UBE2Q2;RNF19A;FBXL17;UBE2L3;ANAPC1;CUL3;FBXW10;UBE2K;FBXL3;RNF135;RPS27A;UBC;NHLRC1;BFAR;LONRF1;BRCA1;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RNF146;CBFB;TOPORS;HUWE1;ARIH2;RLIM;MIB2;FBXO9;NHLRC3;PSMF1;UNKL;PSMD14;STUB1;RUSC1;TRAF1;PSMD12;RNF34;CHFR;FBXO6;FBXW2;TRAF3;TNFAIP3;PRKN;HECTD1;TRAF3IP2;PSME2;CUL1;FBXO28;TNKS;TRAF5;ANAPC10;LNPEP;CDC34;TRAF2;BLMH;TMEM129;UBE2O;PSMB10;PSMD5;TRIM14;UBE2V1;BIRC2;MYLIP;TNKS2;PSMD8;AMFR;PSMA3;FBXO31;UBE2S;FBXO7;PSMA2;PSMD11;PELI2;UBE2R2;DDA1;RNF19B;PSMA6;SPOP;MKRN1;FBXL4;TAF1;UBE2H;PSMB3;RNF125;IRF2BP1;UBE4A;RNF168;SIAH2;PSME3;ARIH1;UBE2D3;KLHL3;UBE4B;TRAF6;FBXO4;TTC3;UBE2J2;PRPF19;UBE2E1;ANAPC7;PSMC5;UBR5;FBXW8;FZR1;FBXO30;UBE2G1;FBXL12;PSMC1;RC3H1
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.399193981765371,1.2563196462527482,0.06484295845997974,0.5765430074325794,1.0,54/208,18.29%,HTR2B;LITAF;OPTN;TFRC;IKBKE;PLK2;PDPK1;TMEM106A;TNIP1;ANKRD17;TANK;RIPK1;TRIM25;NR1H4;SPHK2;REL;HMOX1;AKAP13;TICAM2;VAPA;MAVS;ESR1;NLRC3;SIRT1;MIB2;BIRC3;TAB2;BST2;TRAF1;WLS;PRKCB;RORA;ROR1;TREM2;ZFAND6;TRAF3;RELA;TNFAIP3;GOLT1B;PRKN;TRAF3IP2;SQSTM1;CX3CL1;TRAF5;SLC44A2;MYD88;GPR89A;TRAF2;ZDHHC17;LTBR;TRIM14;UBE2V1;BIRC2;CARD11
prerank,signal peptide processing (GO:0006465),0.5968823682887864,1.2559955359712163,0.20652173913043478,0.5768908854035072,1.0,6/11,25.50%,CLN5;HM13;SPCS2;PARL;FURIN;SPPL3
prerank,regulation of response to external stimulus (GO:0032101),0.4133746195330153,1.255494140290951,0.10922587486744433,0.5778367238954565,1.0,28/121,16.79%,CD36;CXCR4;ANXA1;MGLL;P2RX4;PPEF1;APPL2;CELF1;SHPK;STK24;RNF135;TKFC;CAMKMT;XIAP;FOXP1;BIRC3;APPL1;TREM2;TRAF3;RELA;FGR;N4BP1;CASP12;CX3CL1;MYD88;GRN;BST1;NLRP6
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.4819714376046378,-1.2550955326317221,0.18446601941747573,0.5553035667972865,1.0,2/12,1.95%,MEF2C;DOCK4
prerank,innate immune response (GO:0045087),0.39808780618770084,1.2550253822017303,0.06802030456852792,0.578686551352642,1.0,52/217,17.91%,PPARG;SYK;TLR8;FRK;CLEC4D;KYNU;IFITM1;MSRB1;ANKRD17;SRPK2;TRIM17;RNASE3;TRIM25;ANKHD1;RNF135;CYBB;NUB1;REL;CYBA;NCF2;MFHAS1;TKFC;AKAP1;MEFV;TYROBP;IFITM2;MAVS;PTK2B;TREML1;FES;APP;BST2;RELB;TREM2;BTK;MFAP4;CYBC1;ATAD3A;RELA;FGR;SLC11A1;SLPI;NRROS;KLRD1;LBP;MYD88;NCF1;CAPZA1;MASP1;SRPK1;TRIM14;DEFA6
prerank,regulation of cell cycle (GO:0051726),0.3985448623979169,1.2548009247628629,0.0482897384305835,0.5787448841961458,1.0,61/271,14.60%,IQGAP1;SDCBP;MAP3K20;LILRB1;RPS6KA2;ERN1;KIF20B;GADD45B;GADD45G;ID2;CDKN1A;LIN37;ANKRD17;RUNX3;JUN;SRPK2;NOTCH2;FBXL17;RARA;CITED2;FOXO4;UHRF2;HTRA2;THBS1;GADD45A;APBB2;FBXL3;SIK1;APC;NUDT6;HNRNPU;RPL23;NF2;XIAP;BRCA1;RB1;PPP1R9B;RAD23A;CSNK2A2;HIPK2;NLRP2B;PIM3;INTS13;SIRT1;BIRC3;CDK7;ING4;NBN;DCUN1D3;CDC123;NOTCH1;SND1;AFAP1L2;GAS2L1;SOX2;HBP1;PHACTR4;JUNB;WHAMM;UHMK1;LRP6
prerank,positive regulation of RNA metabolic process (GO:0051254),0.4619524599180207,1.2545219165629524,0.18028846153846154,0.57891526172481,1.0,11/45,13.93%,HNRNPLL;ERN1;POLR2A;IL6;RIPK1;DDX5;DYRK1A;GRSF1;SIRT7;RELA;HSPA1A
prerank,cellular response to arsenic-containing substance (GO:0071243),0.5459028473421738,1.2543413231417273,0.19971056439942114,0.5788184168393621,1.0,7/15,22.13%,ATF3;PPIF;GSTO2;CPEB2;MKNK2;GSTO1;VCP
prerank,ethanol metabolic process (GO:0006067),-0.49368015491840433,-1.2538445116797847,0.1723076923076923,0.5559654021371737,1.0,5/12,24.60%,ACSS1;ACSS2;ALDH1A1;SULT1A1;ADH5
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.40377997197902094,-1.25353917440479,0.1306122448979592,0.5543699592123404,1.0,5/24,6.89%,MEF2C;CTNNA2;MEF2A;CDH2;CDON
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6093540308679469,1.253488841008831,0.21571648690292758,0.5807595050634248,1.0,1/10,0.52%,NAMPT
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.46099686756122904,1.2530563231775838,0.1773049645390071,0.5814745276484018,1.0,11/43,15.42%,CBLB;GRB2;RAB7A;DUSP3;STAM;SH3KBP1;RNF115;CHMP6;EPS15;STAM2;CBL
prerank,keratan sulfate catabolic process (GO:0042340),0.5794797937582101,1.2529030140380661,0.21052631578947367,0.5812957094626683,1.0,4/11,7.90%,GALNS;GNS;HEXA;LUM
prerank,negative regulation of catalytic activity (GO:0043086),0.5180327284673016,1.2528363537329403,0.1842456608811749,0.5808447412968278,1.0,7/24,11.88%,TIMP1;CLN3;HP;NOSIP;SIRT1;MT3;NOTCH1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.556334803185637,1.2527252418493986,0.2088888888888889,0.5805383679182483,1.0,8/14,26.83%,ACD;TPP1;XRCC5;TNKS;TNKS2;TERF2IP;BRCA2;TINF2
prerank,defense response to protozoan (GO:0042832),0.5754648345690672,1.2527002524189634,0.20972644376899696,0.5799538501610425,1.0,4/12,15.73%,LYST;GBP6;SLC11A1;MYD88
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3968137326232059,1.2521436792484057,0.054490413723511606,0.5809924473870159,1.0,63/234,18.84%,CD36;PPARG;PLPP3;RAB7B;PRKCH;CTNNB1;VEGFA;FLOT1;IRAK2;TFRC;IKBKE;IL6;RIPK1;PTEN;TRIM25;ADAM8;NFKBIB;CRTC1;IRAK3;STK3;HSPA1B;RPS27A;UBC;NLRC4;COPS5;ARID5B;HIPK2;RIPK4;DDIT3;MAVS;ESR1;MTPN;ARHGEF2;APP;TAB2;TRAF1;TRIM41;PRKCB;ROR1;HCLS1;FZD2;BTK;PPRC1;BUD31;RELA;HSPA1A;ADCY8;LRP6;CX3CL1;TRAF5;PPARGC1B;MYD88;NHLH2;TRAF2;SLCO3A1;ERC1;SMARCB1;ZBTB7A;TRIM14;UBE2V1;CARD11;CRTC3;CLOCK
prerank,muscle cell differentiation (GO:0042692),0.4868745526217282,1.2519631639150102,0.17440401505646172,0.5809101837540787,1.0,4/32,4.98%,MRTFA;MRTFB;NINJ1;MTLN
prerank,extracellular transport (GO:0006858),0.5778581814884358,1.251916359829667,0.19616519174041297,0.5803878111274839,1.0,3/13,12.50%,CCDC40;WWP2;SPAG17
prerank,macromolecule catabolic process (GO:0009057),0.5096129344805547,1.2517617344742764,0.18664850136239783,0.5802047313714671,1.0,6/26,4.48%,TPP1;KIF16B;PPT1;UVRAG;CLN5;SH3GLB1
prerank,regulation of protein catabolic process (GO:0042176),0.413332394498963,1.2517206198502762,0.13276231263383298,0.5796865791114739,1.0,28/99,17.81%,ATG7;WWP1;TIPARP;RAB7A;PLK2;CTSA;WDR91;SORL1;EEF1A1;IRAK3;STX5;APC;NEDD4L;WWP2;HUWE1;DDB1;GSK3B;OAZ2;FOXO1;CHMP6;TNFAIP3;PRKN;SNF8;AZIN1;PRKCG;OAZ1;CSNK2A1;SNX3
prerank,proton transmembrane transport (GO:1902600),0.47977900000157164,1.2510235677120227,0.16953316953316952,0.5811357616045009,1.0,10/36,17.24%,SLC36A2;ATP6V1A;ATP6V0D1;NNT;ATP6V0E1;ATP6V0C;ATP6V1H;ATP6V1F;COX15;SLC36A1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.5561875533436594,1.2509378788453274,0.22922636103151864,0.5801417762173977,1.0,4/15,14.70%,DTNBP1;AP3S1;AP3D1;AP3B1
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.5561875533436594,1.2509378788453274,0.22922636103151864,0.5801417762173977,1.0,4/15,14.70%,DTNBP1;AP3S1;AP3D1;AP3B1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.4275208902790443,1.2508519544702883,0.14626218851570963,0.5797441276192327,1.0,34/77,25.29%,LGALS3;SLC35F6;HGF;BIRC6;RIPK1;IGF1;PPIF;THBS1;SH3RF1;RB1;CSNK2A2;MAZ;RELA;PRKN;HSPA1A;PHIP;MCL1;CX3CL1;ACAA2;CAAP1;NDUFS3;CSNK2A1;NOC2L;HTT;TCF7L2;ITGAV;PLAUR;HERPUD1;SIAH2;PSME3;NDUFA13;BCL2L1;GPX1;FXN
prerank,response to progesterone (GO:0032570),0.534258520311485,1.25040216847148,0.2175732217573222,0.5804776138372745,1.0,6/18,17.67%,NR1H3;CATSPERB;THBS1;CATSPER2;ACOD1;CATSPER3
prerank,blood circulation (GO:0008015),0.4606047007859173,1.2499818122745154,0.14685314685314685,0.5811222028951993,1.0,6/49,10.11%,MYOF;CYB5R3;MYL2;C3AR1;ACVRL1;ROCK1
prerank,regulation of protein kinase activity (GO:0045859),0.41613042820021323,1.249954335098684,0.11522198731501057,0.5805662652648743,1.0,23/106,13.43%,IQGAP1;DTNBP1;GNAQ;PRKAG2;PDPK1;CDKN1A;SNX9;UVRAG;TAF7;GSKIP;CACUL1;RB1;DVL1;CEP85;XRCC5;RAP2B;PTK2B;SIRT1;PAK2;CCN1;TAB2;GAS6;FGR
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.38591326392068465,-1.2490780067147023,0.14485981308411214,0.5631509967579499,1.0,6/27,7.55%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.44547823555250055,-1.2487775784302004,0.18120805369127516,0.5614575873475081,1.0,6/17,18.45%,CCND3;EGFR;PKD2;PKD1;RGCC;PSMD10
prerank,protein targeting to peroxisome (GO:0006625),0.4907521337345583,1.2486124331758708,0.20387096774193547,0.5839804416906876,1.0,9/29,12.77%,RAB8B;ABCD1;PEX7;PEX14;ALDH3A2;PXMP2;ZFAND6;LONP2;GDAP1
prerank,negative regulation of DNA recombination (GO:0045910),0.46221758245181244,1.2485119737826895,0.170316301703163,0.583683577826586,1.0,10/43,10.93%,POLR2A;ACD;ZRANB3;HELB;PARP3;POLR2L;RTEL1;TERF1;POLR2G;POLR2I
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.38953961479850197,-1.248383791665776,0.17370892018779344,0.5599511009940753,1.0,7/26,11.42%,ATP1B1;ANK2;KCNAB1;ATP1B2;AKAP9;DLG1;ACTN2
prerank,positive regulation of angiogenesis (GO:0045766),0.41450693040862496,1.2481888664473648,0.12433581296493093,0.5839550417491238,1.0,20/108,12.09%,APLNR;SASH1;VEGFA;AQP1;ITGA5;PDPK1;NINJ1;THBS1;AGO2;SIRT6;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;SIRT1;PRKCB;S100A1
prerank,embryonic heart tube development (GO:0035050),-0.4771509432318767,-1.2481045161307147,0.16666666666666666,0.5582933519627685,1.0,3/14,5.76%,ACVR1;RYR2;MEGF8
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.5600924040635904,1.2478893057630152,0.20434782608695654,0.5841785630137186,1.0,6/14,15.74%,CD200R1;TNFRSF1B;IGF1;TREM2;CX3CL1;GRN
prerank,rRNA 3'-end processing (GO:0031125),0.6011752561546788,1.2478275810809518,0.21732522796352582,0.5837191690385498,1.0,7/10,21.01%,EXOSC3;EXOSC9;RPS21;ERI1;EXOSC8;EXOSC10;EXOSC7
prerank,protein localization to vacuole (GO:0072665),0.571415678774193,1.2475174358375212,0.2274741506646972,0.5839750814980799,1.0,4/13,6.78%,SH3GLB1;GLMP;RNF128;LMBRD1
prerank,positive regulation of interleukin-6 production (GO:0032755),0.432222144726893,1.2472168860241104,0.15706214689265538,0.5843169576666515,1.0,16/68,16.52%,SYK;RAB7B;TLR8;IL6;TMEM106A;SPHK2;CYBA;TYROBP;IL6R;MAVS;ARHGEF2;APP;LBP;MYD88;HSPD1;TLR1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.49516103846583676,1.2471412891865545,0.17506631299734748,0.5838948321901318,1.0,2/25,3.86%,CD36;P2RX4
prerank,signal transduction in response to DNA damage (GO:0042770),0.4469301066807695,1.2468010133153036,0.17330210772833723,0.5842528698902724,1.0,16/49,20.44%,MAP3K20;GRB2;ERCC6;SESN2;BRIP1;E2F1;GADD45A;DOT1L;NBN;FBXO6;INTS7;BID;ACER2;CLOCK;BCL3;PAXIP1
prerank,ether lipid metabolic process (GO:0046485),0.5556095406874451,1.2466529106001276,0.21669106881405564,0.5840210111327644,1.0,5/14,11.54%,PLA2G7;NCEH1;PEX7;PEDS1;PLAAT3
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.5793135108297762,1.2466401427334706,0.21739130434782608,0.583437240058378,1.0,8/12,23.24%,APOE;ABCA2;PICALM;ROCK1;RANBP9;FKBP1A;ABCA7;TMED10
prerank,multivesicular body assembly (GO:0036258),0.4926658135103678,1.2466035279058119,0.18562091503267975,0.5829296122825075,1.0,12/30,21.82%,STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SNF8;STAM2;CHMP5;CHMP7;VPS36;CHMP2B;VPS37B
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.5484126037955072,1.2465139060093426,0.21757925072046108,0.5825548144811483,1.0,5/14,16.54%,BCL2L11;BFAR;COPS5;BAX;PTPN1
prerank,regulation of amyloid-beta clearance (GO:1900221),0.5326925681993925,1.246353983070861,0.2127371273712737,0.5823670576375368,1.0,4/16,12.33%,APOE;LRP1;ROCK1;TREM2
prerank,regulation of mRNA stability (GO:0043488),0.40714773877086907,1.246231928410465,0.0976116303219107,0.5821117562694069,1.0,43/145,21.01%,SAMD4A;VIM;PRKCD;PSMD1;CELF1;IGF2BP3;YTHDF3;E2F1;PCID2;TENT5A;HNRNPU;RPS27A;UBC;ZFP36L2;EXOSC3;EXOSC9;SERBP1;ROCK1;FTO;PSMF1;PSMD14;TNPO1;PUM2;EXOSC8;PSMD12;SLC11A1;HSPA1A;TENT5D;GDNF;HNRNPD;PSME2;THRAP3;EXOSC1;TAF15;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;XPO1;PSMA6;EXOSC7
prerank,phospholipid dephosphorylation (GO:0046839),0.4680678689546039,1.2460297489741738,0.17,0.5820584121431027,1.0,8/37,13.76%,PLPP3;MTM1;MTMR3;PTEN;PLPP6;PLPP5;OCRL;INPP5F
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3452520406471517,-1.245841065314943,0.13259668508287292,0.561509511611403,1.0,12/39,13.58%,FGF14;PRKCE;ANK3;SCN1B;FGF12;WNK3;FGF13;PTPN3;GLRX;WNK2;WNK1;YWHAH
prerank,regulation of tumor necrosis factor production (GO:0032680),0.4136005166246722,1.245546527675346,0.11228813559322035,0.582905529740061,1.0,28/112,15.53%,SYK;LILRB1;IL6;TMEM106A;RIPK1;LY96;RARA;IGF1;THBS1;ARG2;NR1H4;SPHK2;IRAK3;CYBA;SIRPA;FOXP1;NFKBIL1;TYROBP;MAVS;NLRC3;ARHGEF2;APP;FZD5;ARFGEF2;GAS6;TNFAIP3;CX3CL1;LBP
prerank,hydrogen peroxide metabolic process (GO:0042743),0.5389936355935117,1.2450648502921862,0.19113573407202217,0.583667546056956,1.0,4/19,7.47%,PRDX1;GPX3;CYBA;CAT
prerank,regulation of protein kinase A signaling (GO:0010738),-0.41947992627587904,-1.244863977673323,0.16554054054054054,0.5614218451715166,1.0,6/20,19.74%,PJA2;AKAP12;ADGRV1;AKAP5;PRKAR2B;TCIM
prerank,negative regulation of protein polymerization (GO:0032272),-0.38778991104263877,-1.244791207203613,0.15611814345991562,0.5592324810175157,1.0,10/27,15.78%,SSH2;TWF2;CYRIB;MAP2;TUBB4A;SSH3;HIP1R;STMN2;MAPRE1;STMN1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.4406012913168162,1.2447448257131073,0.15878378378378377,0.5839853725815763,1.0,20/62,20.91%,LGALS3;THBS1;EIF6;CREBBP;CNOT4;CBFB;TNRC6B;PTK2B;AGO3;MAFB;KMT2E;FES;PRKCB;CDC73;AGO4;KMT2A;PURB;RBM15;SIN3A;ZBTB16
prerank,positive regulation of RNA splicing (GO:0033120),0.4905574574406989,1.2447120623976535,0.19845360824742267,0.5834604709910091,1.0,10/29,19.65%,HNRNPLL;ERN1;POLR2A;DYRK1A;HSPA1A;PRDX6;NUP98;THRAP3;RBM22;NCL
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.5137913307071144,1.2445504904428275,0.2002652519893899,0.583318530373184,1.0,5/23,10.70%,NIBAN2;MMP14;IGF1;MAML1;PIEZO1
prerank,DNA damage checkpoint signaling (GO:0000077),0.48745795350292476,1.2444784642157833,0.18527918781725888,0.58290492268708,1.0,8/28,13.23%,MAP3K20;ERCC6;BRIP1;E2F1;DOT1L;NBN;FBXO6;INTS7
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.5832841997034575,1.2436270554078768,0.21069182389937108,0.5848622244751798,1.0,2/11,3.44%,ABCB7;ABCD1
prerank,respiratory electron transport chain (GO:0022904),0.5519085723362098,1.2432264925769039,0.21594202898550724,0.5853910929155263,1.0,9/14,25.81%,ETFRF1;UQCRFS1;SDHB;SDHA;ETFA;SLC25A13;GPD2;SLC25A22;NDUFA5
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.58890227388809,1.2430902784425077,0.2275449101796407,0.5851650425520778,1.0,5/11,17.40%,ST18;FAS;HTRA2;CAAP1;PRR7
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.5543238868527556,1.2429544190374862,0.22011661807580174,0.584944979458117,1.0,2/14,6.98%,AK8;NMNAT1
prerank,inositol phosphate metabolic process (GO:0043647),-0.3387178683054801,-1.2428089316266864,0.12738853503184713,0.5617402301962345,1.0,13/46,11.08%,INPP4B;INPP5D;PLCB1;IP6K2;IMPA1;PPIP5K1;PLCH1;FGF2;ITPK1;PLD4;ITPKC;NUDT3;MINPP1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.5176844683545199,1.2425350751584185,0.20666666666666667,0.5855622397547282,1.0,4/22,6.54%,IPO5;CDKN1A;PTEN;APC
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.44806105770714466,1.2422542765934985,0.17936694021101993,0.5857860180220558,1.0,10/52,8.57%,TATDN2;ERN1;TPP1;CXXC1;ATP6V0D1;LMNA;YIF1A;ACADVL;TLN1;GFPT1
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.41487976665169424,-1.24198894763699,0.14516129032258066,0.5613649950564484,1.0,5/22,7.52%,SSH2;TWF2;CYRIB;TMSB4X;SSH3
prerank,response to muramyl dipeptide (GO:0032495),0.5812603427472185,1.2418168833426397,0.2242152466367713,0.5864482532910421,1.0,5/12,17.04%,VIM;ARHGEF2;TRIM41;ERBIN;CHMP5
prerank,small GTPase mediated signal transduction (GO:0007264),0.41196787281988534,1.240686701121574,0.11833688699360341,0.5892487969570412,1.0,29/103,16.18%,ABR;GRB2;PLK2;SOS1;CDKN1A;PLD2;RGL1;JUN;RGL2;ARHGAP31;BRAP;IGF1;NRAS;RREB1;RB1;KSR2;RGS19;ARHGAP18;RRAD;CCNA2;RAB18;RIT1;ARL3;RRAS;SHC1;NUCB1;DNMT1;USP8;CCDC88C
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5254875434215556,1.2406437773297176,0.20473537604456823,0.5887616679286563,1.0,9/18,24.55%,ANKRD17;NPLOC4;BIRC3;PUM2;BIRC2;C1QBP;RNF125;DHX58;GPATCH3
prerank,heart morphogenesis (GO:0003007),0.44637259615275093,1.2405935263072152,0.16923076923076924,0.5882733854657185,1.0,7/50,8.84%,HTR2B;SYNPO2L;VEGFA;NIPBL;MYBPC3;DLC1;ACVRL1
prerank,regulation of translational initiation (GO:0006446),0.4340990294830117,1.2404615489605637,0.17225950782997762,0.5880287134300682,1.0,21/63,18.86%,NCK2;CEBPB;EIF1;ATF3;YTHDF3;AGO2;EIF2AK4;ATF4;EIF4EBP2;TPR;EIF3B;EIF5;POLR2G;NCBP2;CDC123;UHMK1;ALKBH1;EIF3H;EIF2B2;EIF4G3;EIF4G2
prerank,glycoprotein metabolic process (GO:0009100),0.4441102455939852,1.2404040343577485,0.16628440366972477,0.5875880858198202,1.0,12/53,12.93%,HPSE;B4GALT5;MAN1C1;TNIP1;B4GALT7;MAN2A1;MANBA;ST3GAL4;AGA;OGA;MAN2A2;FBXO6
prerank,microtubule polymerization (GO:0046785),-0.3676596957614908,-1.2399021477857213,0.15859030837004406,0.5641928491715413,1.0,7/29,6.59%,TUBGCP5;HDGFL3;MAPT;FGF13;AKAP9;TPPP;CSNK1D
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.49317710260964004,1.2394932920517931,0.189937106918239,0.5897271084288086,1.0,9/28,14.59%,APOE;EIF2AK4;CALB1;TYROBP;GSK3B;APP;CYP46A1;ADCY8;SQSTM1
prerank,membrane assembly (GO:0071709),0.47908078187385794,1.2390507394843402,0.1925925925925926,0.5904902880209304,1.0,9/34,9.77%,CEL;RFTN1;FLOT1;PTEN;ANXA2;GAK;CHMP2A;PICALM;VPS4A
prerank,mesenchymal cell differentiation (GO:0048762),0.4489544412983589,1.2389758855706858,0.17185697808535177,0.5900821869217958,1.0,10/51,11.88%,HTR2B;CTNNB1;HGF;HNRNPAB;FBXL17;DDX5;SNAI2;ROCK1;GSK3B;NOTCH1
prerank,chromosome condensation (GO:0030261),0.4648483120365208,1.2388858601713728,0.18952618453865336,0.5896934243734471,1.0,13/36,20.68%,NCAPG2;NCAPG;INCENP;RB1;DFFB;CSNK2A2;SMC2;CSNK2A1;ACIN1;PHF13;MCPH1;NCAPD2;NCAPH
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.45149587375087274,1.2387909675808997,0.1650943396226415,0.5893586839152252,1.0,10/44,10.56%,CELF1;YTHDF3;AGO2;ZFP36L2;ZC3HAV1;TNRC6B;ROCK1;POLR2G;CNOT7;FTO
prerank,organophosphate ester transport (GO:0015748),0.5037259124221326,1.238763026928843,0.20576671035386632,0.5888207380894275,1.0,7/24,13.98%,OSBPL8;PLTP;ABCA3;PITPNA;EPG5;PITPNC1;PRELID3A
prerank,regulation of sprouting angiogenesis (GO:1903670),0.4772600383115681,1.2385493365893177,0.16940581542351454,0.5888635894535484,1.0,6/33,5.58%,VEGFA;ITGA5;PDPK1;RHOJ;CEMIP2;THBS1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.42111045624305016,1.2381689556807849,0.14578833693304535,0.5894031492040401,1.0,17/86,12.64%,GDF15;SDCBP;ZEB2;CITED2;THBS1;CREBBP;FLCN;RBPMS;ACVR2A;ACVRL1;HIPK2;BMPR2;ADAM17;CCN1;NOTCH1;ACVR1B;SULF1
prerank,cellular response to nutrient levels (GO:0031669),0.43624582919002763,1.2381541009956285,0.17381489841986456,0.5888214391711848,1.0,12/62,12.78%,TFEB;ATG7;FNIP1;PDK4;STK24;FLCN;LAMP2;BMPR2;FOXO1;SIRT1;GAS2L1;WRN
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4103930464669145,1.2377323942771001,0.12200208550573514,0.5895003224039997,1.0,22/117,15.27%,SYK;GPR15;PTGDR;PLK2;IL6;HTR6;RHBDF2;PLA2G2D;GPR83;ADCY7;PTGER2;GPR176;PTGER4;VIPR1;ADAM17;PTH2R;MYH9;TREM2;FGR;ADCY8;ADCY3;CD247
prerank,regulation of nuclear division (GO:0051783),0.5212212680212903,1.2375745637842954,0.21904761904761905,0.5893664139227633,1.0,2/20,2.06%,CCDC8;KIF20B
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.47183307347270725,1.2368172057299927,0.19035532994923857,0.5910467580227592,1.0,3/35,0.58%,PPARG;XDH;APOE
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.41582138287348075,1.2367180523535617,0.15783783783783784,0.5907273987005374,1.0,31/88,20.44%,MYO5A;DTNBP1;FTL;KIF16B;CLINT1;SORL1;CHMP2A;RABEP1;KLHL20;RAB10;VPS13C;APP;AP1G2;VPS35L;AP1G1;ARFGEF2;CLVS2;EPS15;ARL3;EXOC4;ARRB1;SH3D19;RABIF;FTH1;EXOC1;AP4M1;AP1M1;GOPC;VPS13A;VAMP2;SNAP23
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.44519745180457265,1.236429727654185,0.1874258600237248,0.590992740973542,1.0,8/52,5.48%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;CLN3;STAC2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.5430706838451597,1.2364239169425704,0.22351233671988388,0.5903904494366932,1.0,8/16,26.44%,MUS81;MSH4;EME1;CENPX;RMI1;FANCM;ERCC4;HFM1
prerank,telomere maintenance via recombination (GO:0000722),0.5766373673753571,1.2358744234160164,0.23303834808259588,0.591435900738451,1.0,2/11,4.72%,NSMCE2;TEP1
prerank,regulation of intracellular protein transport (GO:0033157),0.47725845523884963,1.2355994628464286,0.19416243654822335,0.5916835942295641,1.0,12/32,16.74%,KIF20B;RUFY3;LCP1;TPR;OAZ2;BCAS3;SIRT7;TENM1;UHMK1;PTPN1;RAB29;OAZ1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.5868425546078238,1.235534045785792,0.22910216718266255,0.5912688339272574,1.0,4/11,12.33%,P2RX4;TRAT1;P2RX3;TREM2
prerank,ventricular septum morphogenesis (GO:0060412),-0.37358752094448433,-1.2353333672177915,0.15695067264573992,0.5730929226166486,1.0,9/27,8.69%,ACVR1;ROBO2;ROBO1;BMPR1A;TGFBR2;TGFBR1;ZFPM2;SMAD7;TGFB2
prerank,positive regulation of autophagy (GO:0010508),0.42121607120197374,1.235091985103443,0.16043956043956045,0.5919998202423198,1.0,25/81,19.59%,OPTN;TFEB;PLK2;FOXO3;WAC;DAPK1;SESN2;SH3GLB1;FLCN;EIF2AK4;EPM2A;PAFAH1B2;MEFV;ROCK1;GSK3B;FOXO1;SIRT1;PRKN;BNIP3;NPRL2;TRIM14;HTT;FBXO7;PIK3CB;TBK1
prerank,aggrephagy (GO:0035973),0.4845410278683517,1.2350421436642756,0.20149253731343283,0.5915321485909004,1.0,12/27,20.02%,VIM;DYNC1H1;RPS27A;UBC;ATG5;WDFY3;PRKN;SQSTM1;UBE2V1;ARL13B;ACBD5;IFT88
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.37104775466545314,-1.2345265378248367,0.13865546218487396,0.572675601110603,1.0,8/28,14.50%,NAV3;MAPT;CDK5R1;PAK1;AKAP9;NUMA1;GIT1;MAPRE1
prerank,cellular polysaccharide catabolic process (GO:0044247),0.5397963321868379,1.2336913649017909,0.22598870056497175,0.5949435817763932,1.0,6/16,21.74%,PYGL;AOAH;AGL;PHKG2;MGAM;PYGB
prerank,purine-containing compound salvage (GO:0043101),-0.4813704137131757,-1.2333536205215652,0.20943952802359883,0.5730261320318393,1.0,5/12,11.94%,GMPR2;PNP;AMPD2;DCK;GMPR
prerank,carbohydrate derivative transport (GO:1901264),0.5313066497912156,1.2331458205314438,0.22131147540983606,0.5959788928675429,1.0,6/18,15.53%,ABCG1;CLN3;PLTP;SLC15A3;SLC10A7;LBP
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5274233700618886,1.2330933355966407,0.21560283687943263,0.5955160161688103,1.0,6/18,16.13%,SLC35F6;GSK3B;HSPA1A;BAX;ACAA2;BID
prerank,fatty acid catabolic process (GO:0009062),0.4326781504477588,1.233081433940479,0.15942028985507245,0.5949412631301066,1.0,19/67,19.80%,CEL;LPIN3;ABCD1;HADHA;SLC27A4;MTLN;ACADL;ACADVL;AIG1;PPARD;ALDH3A2;MCEE;ECHDC1;EHHADH;ACAA2;ACAD10;NUDT7;ACBD5;SLC25A17
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.5696235817725505,1.2329343541808153,0.23493044822256567,0.5947622032624975,1.0,5/12,19.65%,NCOR1;FOXP1;SIRT1;ZBTB7A;PIAS2
prerank,cell projection assembly (GO:0030031),0.4981476444881574,1.2326631317835313,0.20512820512820512,0.5949075033062987,1.0,4/22,6.27%,RHOJ;PDGFA;CAPG;PARVB
prerank,regulation of biomineral tissue development (GO:0070167),0.4919115909617893,1.2324289721938904,0.2222222222222222,0.594978222125302,1.0,6/26,13.36%,CEBPB;ENPP1;SGMS2;ROCK1;NOTCH1;GAS6
prerank,negative regulation of axonogenesis (GO:0050771),-0.3902298873641225,-1.2322927568540176,0.19915254237288135,0.5733371999555151,1.0,14/27,16.87%,DCC;ARHGDIA;MAG;RNF6;MAP2;FGF13;DIP2B;EFNB3;CDKL3;LINGO1;ULK2;GDI1;RHOA;OMG
prerank,regulation of cellular component biogenesis (GO:0044087),0.45423586421424406,1.231931642283164,0.19805589307411908,0.595825833275029,1.0,9/39,16.19%,CD36;APOE;MSN;ROCK1;NOTCH1;RAPGEF1;VPS11;LATS1;TRAF2
prerank,stress granule assembly (GO:0034063),0.5244879358836124,1.2317051054915908,0.2079343365253078,0.5958827550456874,1.0,5/20,4.89%,DYNC1H1;UBAP2L;DDX6;ATXN2;YTHDF3
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43893069437852567,1.231555685451731,0.14927048260381592,0.5957121109697049,1.0,16/60,15.31%,CTNNB1;CEBPB;RUNX2;IL6;CDKN1A;MED12;PTEN;MED15;CBFB;TNRC6B;AGO3;MED16;MED26;RELA;BAX;CDK8
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.5198776977691445,1.2314928002584389,0.23226703755215578,0.5952966353584591,1.0,10/20,23.92%,ADAM9;ADAM17;HM13;RHBDD1;RELA;NCSTN;ADAM10;APH1B;PSEN2;TRAF6
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4922663708279689,1.231289340602868,0.21548387096774194,0.5952705213638398,1.0,9/26,20.34%,B4GALT5;TPI1;TNIP1;ST3GAL4;GOLPH3;GK5;RRM1;ALG6;GK
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5003791817926476,1.2311675821635015,0.215633423180593,0.5944156291583302,1.0,6/22,17.10%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC4
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5003791817926476,1.2311675821635015,0.215633423180593,0.5944156291583302,1.0,6/22,17.10%,ZDHHC14;ZDHHC19;ZDHHC12;ZDHHC18;ZDHHC24;ZDHHC4
prerank,carboxylic acid metabolic process (GO:0019752),0.47539995866897855,1.2305233490533425,0.20532319391634982,0.5956492841163664,1.0,11/33,14.57%,CYB5R3;GNMT;PON3;GLYAT;GRHPR;CYB5A;LIAS;SLC2A1;SLC23A2;SLC23A1;GSTO2
prerank,L-amino acid transport (GO:0015807),0.48005739142704207,1.2303849805803184,0.18773946360153257,0.5954578431063307,1.0,3/28,1.64%,SLC7A2;SLC36A2;SLC36A4
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.5334254778275244,1.2301199134414562,0.20502092050209206,0.595628113969648,1.0,5/18,13.63%,NFE2L2;HTRA2;MAPK7;SIRT1;PRKN
prerank,carboxylic acid catabolic process (GO:0046395),0.5799333595506275,1.2300756423253627,0.22473604826546004,0.5951516792213475,1.0,4/12,14.51%,RENBP;PON3;NAGK;GNPDA1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.4763100864215966,1.2298224507812883,0.2068095838587642,0.5953040954338122,1.0,8/32,11.32%,MMP12;CORO1C;PTEN;THBS1;NF2;DLC1;ACVRL1;BCAS3
prerank,organophosphate biosynthetic process (GO:0090407),0.4619116320173721,1.2295628880309821,0.19807923169267708,0.5954687676706751,1.0,6/37,7.25%,MOCOS;GPAT2;TPI1;AGPAT4;ITPKB;IPPK
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.5017511878781866,1.2295484497001625,0.20855614973262032,0.5949123508997665,1.0,6/24,13.53%,PLA2G2D;SERAC1;ABCA3;SLC27A1;PLA2G4F;CDS2
prerank,proteasomal protein catabolic process (GO:0010498),0.39212191971960064,1.2290131658058912,0.08877551020408163,0.5959413238194068,1.0,69/201,23.39%,NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;ZFAND2A;FBXL17;SPSB4;CUL3;SOCS6;UBE2K;NHLRC1;BFAR;NEDD4L;KLHL20;WWP2;RAD23A;TOPORS;SPSB2;HUWE1;TBL1XR1;PCNP;DDIT3;DDB1;SIRT1;NHLRC3;PSMF1;PSMD14;STUB1;RHBDD1;PSMD12;CUL4A;RNF34;PRKN;ZFAND2B;PSME2;ARRB1;ATE1;CDC34;KCTD5;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PPP2R5C;TNFAIP1;AGAP3;CLOCK;DDI2;PSMA2;ATXN3;PSMD11;BRSK2;PLAA;PSMA6;SPOP;CUL4B;FBXO45;KCTD2;VCP;PSMB3;KCTD10;FAF1;SIAH2;PSME3;UBE2D3;UBE4B
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.5602995937329786,1.2290018971478034,0.22814814814814816,0.5953698962347718,1.0,4/13,10.19%,AGO2;TNRC6B;POLR2G;CNOT7
prerank,steroid metabolic process (GO:0008202),0.419632990324493,1.2289890168589914,0.16519823788546256,0.594806925767635,1.0,4/72,1.88%,LIPA;BAAT;NPC1;AMACR
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.4628235751410776,-1.2288255298124997,0.19722222222222222,0.5795911797843232,1.0,6/13,31.26%,GTPBP1;RAB23;MFN1;ENTPD7;EFL1;AK4
prerank,regulation of developmental growth (GO:0048638),0.4899277363309813,1.2283593997656599,0.213653603034134,0.5961068924579442,1.0,7/29,14.94%,APOE;IGF1;STAT5B;NIPBL;GSK3B;APP;LATS1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.46040823887144217,1.2281045928365666,0.19851116625310175,0.5962312459994068,1.0,17/36,27.76%,TAOK3;NCOR1;AIDA;DUSP3;SIRPA;FOXO1;TREM2;PRKN;FKTN;DUSP10;EZR;MEN1;FOXM1;PPIA;CYLD;PER1;PTPN22
prerank,response to lipopolysaccharide (GO:0032496),0.3980635517930486,1.2266026477508827,0.12721584984358708,0.6001130213134075,1.0,35/138,17.04%,LILRB1;MAPKAPK3;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;IRAK3;STAP1;SIRPA;FOXP1;NFKBIL1;TICAM2;HNRNPA0;ADAM17;LIAS;TAB2;TRIM41;RELA;TNFAIP3;SLC11A1;ERBIN;SLPI;ACOD1;LBP;CDC73;MYD88;OTUD5;IFNAR1;CHMP5
prerank,phosphatidylserine metabolic process (GO:0006658),0.4758420598660327,1.2263769053236597,0.22040302267002518,0.6001707633245251,1.0,6/32,12.13%,OSBPL8;PLA2G2D;SLC27A1;PLA2G4F;PLAAT3;LPCAT3
prerank,transport across blood-brain barrier (GO:0150104),0.4152293753642596,1.2254910097384912,0.17155266015200868,0.6021854164104943,1.0,15/83,8.18%,CD36;SLC6A6;SLC7A2;FABP5;TFRC;LRP1;SLC1A5;SLC16A1;SLC27A4;SLC38A1;SLC5A5;ABCC4;ABCC3;SLC27A1;ABCA2
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4167874098574699,1.2252046979112108,0.15948275862068967,0.6023985230289517,1.0,23/86,16.58%,DENND4C;GRB2;DENND1A;MYO9B;NOTCH2;RAF1;IGF1;IRS2;FLCN;AKAP13;VAV1;DLC1;ARHGAP17;ARHGEF2;LZTR1;NOTCH1;RAPGEF1;RASGEF1A;ERBIN;SHC1;SQSTM1;MAPKAP1;LRRC59
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.367295889672732,-1.2251612980505624,0.16,0.586273748107594,1.0,8/31,8.69%,BMPR1A;FGFR2;RYR2;TGFBR1;ENG;ZFPM2;SMAD7;TGFB2
prerank,mitotic chromosome condensation (GO:0007076),0.48404913413890155,1.2251399366993225,0.22121604139715395,0.601989856547032,1.0,10/26,20.68%,NCAPG2;NCAPG;RB1;CSNK2A2;SMC2;CSNK2A1;PHF13;MCPH1;NCAPD2;NCAPH
prerank,response to amyloid-beta (GO:1904645),0.4520977047478951,1.224917179351856,0.18509615384615385,0.6020516894988506,1.0,8/44,12.33%,CD36;MMP12;LRP1;ITGA4;IGF1;GSK3B;APP;TREM2
prerank,female gonad development (GO:0008585),0.5179771598326466,1.22469663429453,0.23097826086956522,0.6020699915304905,1.0,3/19,9.47%,VEGFA;CEBPB;NR5A1
prerank,positive regulation of viral transcription (GO:0050434),0.5016685820618129,1.2243650458874007,0.20794701986754968,0.60245891060844,1.0,7/25,13.48%,MDFIC;POLR2A;POLR2L;POLR2G;POLR2I;GTF2F2;CTDP1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.44878562446791476,1.2242665284951282,0.20606060606060606,0.6021642456469865,1.0,9/43,13.29%,PPARG;FOXO3;JUN;NR3C1;DDX5;KLF5;NFATC3;PPARD;RELA
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.48072751963276616,1.223874493295766,0.22106631989596878,0.602699639361154,1.0,9/30,16.19%,FAS;RIPK1;HMOX1;BRCA1;GSK3B;ARHGEF2;RNF34;TNFAIP3;TRAF2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.38473336233044364,1.2233183776817744,0.03614457831325301,0.6037198247399175,1.0,116/341,23.39%,RNF149;TRIP12;NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;BIRC6;RNF19A;RNF130;ZFAND2A;FBXL17;TRIM25;WDR91;UBE2L3;ZNRF3;ANAPC1;SPSB4;CUL3;NPLOC4;UBE2K;MVB12B;RNF128;NUB1;CNOT4;NHLRC1;KCTD21;BFAR;NEDD4L;KLHL20;WWP2;FBXO11;RNF115;RAD23A;RNF146;TOPORS;SPSB2;HUWE1;TBL1XR1;PCNP;DDIT3;ARIH2;VPS4A;RLIM;DDB1;SIRT1;NHLRC3;PSMF1;PSMD14;STUB1;UBAP1;PSMD12;CUL4A;RNF34;CHFR;TNFAIP3;PRKN;ZFAND2B;PSME2;SQSTM1;UBQLN2;ARRB1;ANAPC10;CBL;ATE1;CDC34;RNF7;KCTD5;PSMB10;KEAP1;PSMD5;BIRC2;MYLIP;PSMD8;AMFR;PSMA3;TRPC4AP;PPP2R5C;TNFAIP1;AGAP3;CLOCK;RNF43;UBE2S;FBXO7;PSMA2;ATXN3;ANAPC15;PSMD11;UBE2R2;PLAA;RNF19B;PSMA6;SPOP;FBXO45;FBXL4;TAF1;USP9X;VPS37B;KCTD2;UBE2H;VCP;PSMB3;UBR3;KCTD10;RNF125;HERPUD1;UBE4A;FAF1;RNF168;SIAH2;PSME3;ARIH1;UBE2D3;KLHL3;UBE4B
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5212722756091913,1.2231190433867432,0.22812051649928264,0.6036911236774262,1.0,6/18,16.35%,POR;ABL2;PDP1;GDNF;ATP7A;SIRT3
prerank,negative regulation of gene expression (GO:0010629),0.3860694932228631,1.2229408848129508,0.05120481927710843,0.6036090594779289,1.0,56/302,13.93%,GPNMB;APLNR;XDH;APOE;SAMD4A;ERN1;VEGFA;TIPARP;FOXP3;DNMT3A;FBXW7;ID2;CD28;CD46;ATP2B1;DAPK1;DDX6;NCOR1;NOTCH2;CELF1;IGF2BP3;CITED2;IGF1;AGO2;SMYD5;EED;FLCN;HSPA1B;REL;ZFP36L2;RB1;WWP2;EPC1;ZNF148;FOXP1;ACVRL1;PICALM;TNRC6B;PTGER4;CNPY2;ESR1;CNOT7;AGO3;SIRT1;PTBP3;APP;EPRS1;NOTCH1;PTBP2;DGKQ;N4BP1;RPS26;PRKN;SLC11A1;RBBP7;HSPA1A
prerank,regulation of membrane depolarization (GO:0003254),0.5201097914656649,1.222414658600582,0.23579545454545456,0.604572949828712,1.0,4/18,7.99%,ABCD1;RANGRF;GPD1L;NEDD4L
prerank,microtubule anchoring (GO:0034453),0.5659632678045499,1.2223843913530237,0.2534142640364188,0.6040554568732843,1.0,4/12,13.74%,SAXO2;DAG1;PEX14;CLASP1
prerank,regulation of actin filament bundle assembly (GO:0032231),0.48990085795713456,1.2222739057837446,0.2109479305740988,0.6038093950465163,1.0,9/26,15.12%,SYNPO2L;PTGER4;ROCK1;PFN1;SYNPO;PRKN;PFN2;CX3CL1;ALMS1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.4690203389910099,-1.2213281248035157,0.2324159021406728,0.5936039047010839,1.0,5/12,23.37%,CD80;IL18;CARD9;RASGRP1;IL1B
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.48668314269057406,1.2209702643658285,0.22857142857142856,0.607054073315744,1.0,10/26,19.65%,NCOR1;BRCA1;FOXP1;SIRT1;STRN3;VPS11;CRY1;ZBTB7A;CLOCK;PIAS2
prerank,regulation of multicellular organism growth (GO:0040014),0.5432699685711294,1.2209691651935515,0.24420190995907232,0.6064569482266545,1.0,4/15,11.47%,GDF15;IGF1;STAT5B;APP
prerank,ketone body metabolic process (GO:1902224),0.5854979175517301,1.2208881588421203,0.23197492163009403,0.6060846508165306,1.0,3/10,12.18%,ACSS3;AACS;HMGCL
prerank,regulation of B cell proliferation (GO:0030888),0.4454056167611453,1.2205875735388396,0.19239904988123516,0.606391520141195,1.0,7/44,8.66%,CD38;CD300A;VAV3;TFRC;IRS2;CD22;TYROBP
prerank,lamellipodium assembly (GO:0030032),-0.3956239213324626,-1.2204687530278229,0.18009478672985782,0.5933627591693946,1.0,9/26,9.92%,P2RY12;ABLIM1;SPATA13;PTPRO;SRGAP2;S1PR1;CARMIL1;ARFIP2;ARHGEF6
prerank,regulation of protein localization (GO:0032880),0.4348620140188087,1.2199505658837189,0.1899886234357224,0.6076772198245879,1.0,11/58,9.77%,CTSD;PLEKHM2;FBXW7;DNAJB6;TRIM17;TRIM25;WDPCP;DVL1;PICALM;TPR;VPS4A
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.5905038063134105,1.2197119932661977,0.2553191489361702,0.607820018612304,1.0,2/10,8.66%,LILRB1;TYROBP
prerank,RNA interference (GO:0016246),0.5209391229985826,1.2184918279963446,0.22788203753351208,0.6107912948261981,1.0,7/17,22.39%,CELF1;AGO2;AGO3;DROSHA;MRPL44;AGO4;TSNAX
prerank,androgen receptor signaling pathway (GO:0030521),0.5919821996959468,1.2184781005367913,0.2404870624048706,0.610230599530326,1.0,3/11,7.28%,ZMIZ1;DDX5;KDM3A
prerank,sympathetic nervous system development (GO:0048485),0.5375561452263308,1.2183678201531676,0.24113475177304963,0.6099268316824145,1.0,5/15,16.18%,CTNNB1;TFAP2B;NRP2;GDNF;NRP1
prerank,positive regulation of T cell activation (GO:0050870),0.430278470500459,1.2179948185942622,0.18430034129692832,0.6104228277493134,1.0,8/62,4.04%,ZMIZ1;ANXA1;NCK2;TFRC;IL6;CD28;CD46;CD274
prerank,negative regulation of nervous system development (GO:0051961),0.518940038138757,1.217880105808539,0.226890756302521,0.6101306131670919,1.0,4/17,5.04%,HOOK3;IL6;APPL2;SORL1
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.4921746137702148,1.217518836529836,0.23056994818652848,0.6105505334681554,1.0,6/24,14.94%,APOE;NUB1;PTK2B;PSMD14;PSME2;LATS1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.41469248671745873,1.2162491615484354,0.15498938428874734,0.6137422966723445,1.0,25/93,19.59%,FNIP2;NCK2;VEGFA;TXN;FNIP1;TFRC;CD44;IL6;PTEN;RAF1;GPD1L;CNKSR3;NLRP2B;APP;HCLS1;GAS6;TENM1;PFN2;LATS1;CAMK1;SH2D3C;STK4;BCAR3;OSM;TBK1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.5694122728569753,1.2161579620844385,0.25,0.6134042488711094,1.0,4/13,10.24%,PDPK1;ITGA4;SIRT6;ADAM17
prerank,regulation of mRNA catabolic process (GO:0061013),0.3974462205400742,1.2148532877558205,0.14270833333333333,0.6168251368353701,1.0,34/121,21.01%,SAMD4A;VIM;PRKCD;PSMD1;IGF2BP3;YTHDF3;PCID2;RPS27A;UBC;ZFP36L2;ZC3HAV1;EXOSC3;EXOSC9;SERBP1;CNOT7;PSMF1;PSMD14;TNPO1;PUM2;EXOSC8;PSMD12;HSPA1A;HNRNPD;PSME2;EXOSC1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;XPO1;PSMA6;EXOSC7
prerank,negative regulation of cell communication (GO:0010648),-0.40586200960557023,-1.2146561606772286,0.19117647058823528,0.6059361247154584,1.0,5/21,12.20%,ACVR1;UBASH3B;OPRM1;GLRA1;ERBB3
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.3640117345279254,-1.2145926487245453,0.19047619047619047,0.6037256780974329,1.0,11/31,21.98%,TGFBR2;FGFR2;TGFBR1;MEGF8;HOXD4;HOXD3;HOXC9;HOXA9;SOX11;HOXB9;DSCAML1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.425765698608575,1.2145363765108037,0.16592920353982302,0.6171279758754087,1.0,21/73,20.59%,FNIP2;VEGFA;TXN;FNIP1;TFRC;CD44;IL6;RAF1;APP;HCLS1;GAS6;TENM1;PFN2;LATS1;CAMK1;SH2D3C;STK4;BCAR3;OSM;TBK1;TNKS1BP1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.5718289138183448,1.2141940178979465,0.24882629107981222,0.6175722423416495,1.0,4/11,14.51%,RENBP;GFPT1;NAGK;GNPDA1
prerank,hexose biosynthetic process (GO:0019319),0.4513582546894236,1.2136957213775281,0.20552884615384615,0.618469458397733,1.0,15/42,25.98%,SORD;TPI1;SLC25A1;ATF4;ENO3;SLC39A14;PGM1;CRY1;GAPDHS;MDH1;SLC37A4;SLC25A13;GOT1;PGK1;CHST15
prerank,negative regulation of heart contraction (GO:0045822),-0.47492576741080494,-1.2133730065394415,0.2127659574468085,0.60450766496845,1.0,5/11,18.41%,ATP1A2;SPTBN4;GRK2;PIK3CG;FKBP1B
prerank,amino acid import across plasma membrane (GO:0089718),0.49355550719019553,1.2133678817150682,0.225,0.6188401754187558,1.0,3/24,3.08%,SLC6A6;SLC7A2;SLC1A5
prerank,phosphatidylcholine metabolic process (GO:0046470),0.4161871251872441,1.2128397322507931,0.18232044198895028,0.6197966724011356,1.0,14/70,13.02%,PLA2G7;LPIN3;NR1H3;PLA2G2D;ABCA3;SLC27A1;ABHD4;PLAAT1;CSNK2A2;PLA2G4F;PCYT1A;PLAAT3;LPCAT3;GPLD1
prerank,neurogenesis (GO:0022008),0.442081269695774,1.2122826446451822,0.2066905615292712,0.6208145150488587,1.0,8/43,11.70%,CXCR4;ANXA1;ERCC6;CLN5;RITA1;BTBD1;WDR62;THOC2
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5669443940663271,1.2120358175990213,0.25768667642752563,0.6210034540340833,1.0,3/11,9.17%,RFTN1;RIPK1;UNC93B1
prerank,cellular response to lipid (GO:0071396),0.3877650437972858,1.2119506784367984,0.11020408163265306,0.6206252575365908,1.0,47/191,15.73%,LILRB1;AQP1;PDK4;VIM;SPP1;IL36G;NR1H3;ADAM9;IL6;ABL2;CD274;TNFRSF1B;LY96;SHPK;PID1;HTRA2;UBE2L3;NR3C1;NFKBIB;NR1H4;SPHK2;NCOA4;STAP1;MSN;LCOR;SIRPA;NFKBIL1;TICAM2;NCOA3;FZD7;ESR1;PTK2B;FES;TRIM41;RORA;KCNK4;FAM210B;MGST1;GPLD1;RELA;TNFAIP3;ACOD1;ADCY8;ADCY3;LBP;CDC73;MYD88
prerank,lamellipodium organization (GO:0097581),-0.3775928727325695,-1.211409114429792,0.1674641148325359,0.6070344116446608,1.0,9/29,9.92%,P2RY12;ABLIM1;SPATA13;PTPRO;SNX2;S1PR1;CARMIL1;ARFIP2;ARHGEF6
prerank,glucose import (GO:0046323),0.5463294675090409,1.211259648831635,0.2723404255319149,0.6220754990671409,1.0,3/13,12.32%,SLC27A4;SLC27A1;SLC2A1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.29479362408304083,-1.2110885328939616,0.07228915662650602,0.6055235973340126,1.0,18/86,8.08%,NAV3;BIN1;SEMA5A;EVL;FCHSD2;PRKCE;VASP;MAPT;FER;HCK;LIMK1;CDK5R1;NCKAP1;NCK1;PAK1;AKAP9;CARMIL1;CLU
prerank,positive regulation of vasculature development (GO:1904018),0.40909711801573295,1.2110436147408148,0.18538713195201745,0.6221197488870266,1.0,17/94,11.90%,APLNR;SASH1;VEGFA;AQP1;PDPK1;NINJ1;THBS1;AGO2;HMOX1;BRCA1;HIPK1;CTSH;VASH2;HIPK2;ITGB1;SIRT1;PRKCB
prerank,mRNA splice site selection (GO:0006376),-0.36979497699281233,-1.2110403681681292,0.16666666666666666,0.6032615267256106,1.0,14/30,19.17%,LUC7L2;SETX;SF3A1;SLU7;SRSF6;SRSF5;CELF2;SNRPC;CELF5;SF3A2;SRSF12;CELF4;SRSF1;SRSF9
prerank,action potential (GO:0001508),-0.33933095367022875,-1.2103457579470298,0.1566265060240964,0.6028106030558047,1.0,12/44,18.07%,KCND2;SCN2A;ANK3;GNA15;KCNJ2;SCN9A;CACNA1G;MYH14;YWHAH;SCN8A;CACNA1I;GNA11
prerank,icosanoid secretion (GO:0032309),0.5632372535119772,1.21013597687873,0.24024024024024024,0.6240519751267029,1.0,4/12,22.02%,ANXA1;ABCC4;ACE;DRD2
prerank,regulation of filopodium assembly (GO:0051489),-0.3437479777732033,-1.2096162421221035,0.13793103448275862,0.6023596992695927,1.0,9/38,8.61%,TENM2;GPM6A;NLGN1;PLPPR5;RIPOR2;ARHGAP44;FMR1;TRPM2;AGRN
prerank,negative regulation of phosphorylation (GO:0042326),0.412270010018176,1.2089498626348774,0.1668496158068057,0.6269390385191814,1.0,14/85,11.32%,PLPP3;XDH;CORO1C;CDKN1A;NCOR1;PTEN;PID1;IRS2;HNRNPU;STAP1;SIRPA;ROCK1;SIRT1;FBLN1
prerank,programmed necrotic cell death (GO:0097300),0.5048059744827639,1.20880952217977,0.23829201101928374,0.6267552369364333,1.0,5/18,13.47%,RIPK1;LY96;PPIF;TICAM2;TRPM7
prerank,retinal metabolic process (GO:0042574),-0.47492891782463953,-1.208550945818633,0.23270440251572327,0.6028715911819232,1.0,8/12,42.58%,BCO2;RDH11;DHRS13;ABCA4;CYP1B1;ALDH1A3;RDH10;ALDH8A1
prerank,Golgi organization (GO:0007030),0.40007083133742316,1.2082588467149469,0.15424973767051417,0.6277445512174361,1.0,30/112,16.89%,ARHGAP21;OPTN;PLEKHM2;ATP8B4;VTI1B;NPLOC4;GAK;COG7;STX5;VMP1;TICAM2;HUWE1;VCPIP1;VTI1A;BET1;BCAS3;TRIP11;PI4K2A;VPS51;RAB43;ATL2;DYM;ATP8B1;CLASP1;STX6;GOLPH3;GOLPH3L;RAB2A;RAB29;COG2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3183588489334592,-1.2080217466622316,0.14285714285714285,0.6019738340218439,1.0,14/52,9.79%,RBFOX1;RBFOX2;NOVA1;KHDRBS2;SRSF6;RBFOX3;SRRM4;KHDRBS3;FMR1;KHDRBS1;RBM8A;REST;RBMX;CELF2
prerank,granulocyte differentiation (GO:0030851),0.5150578436715239,1.2079187034947487,0.2288021534320323,0.6281322170039327,1.0,4/18,4.96%,CDKN1A;RXRA;RARA;E2F1
prerank,immunoglobulin mediated immune response (GO:0016064),0.5778611665814227,1.2078981527293389,0.2643312101910828,0.627576178062884,1.0,1/10,0.91%,TLR8
prerank,regulation of fibroblast migration (GO:0010762),0.5116656287959653,1.2077902449028153,0.23809523809523808,0.6273110716026441,1.0,7/20,12.23%,CORO1C;APPL2;CLN3;THBS1;GNA12;ITGB1;APPL1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.512964083598706,1.2076748172975462,0.23378378378378378,0.6270355665371977,1.0,6/18,17.63%,NCOR1;ESR1;PTBP3;PTBP2;RPS26;SHQ1
prerank,phosphorylation (GO:0016310),0.3813823153518786,1.2074269661288541,0.05711422845691383,0.6271618515436135,1.0,73/385,13.58%,HTR2B;FNIP2;SGK1;MAP3K20;MAK;SYK;TLK1;FRK;PRKCH;MAP3K1;CERK;ERN1;TEC;PDK4;PRKAG2;IKBKE;PLK2;TAOK3;PDPK1;PRKCD;PPP4R1;RUNX3;BIRC6;SIK3;FAM20C;SRPK2;DAPK1;SHPK;RARA;DGKZ;MAPK6;PIM1;MAML1;PKN3;DGKA;MERTK;RNASEL;MELK;SIK1;SPHK2;IRAK3;STK24;STK3;PIK3CA;DYRK1A;EIF2AK4;TKFC;TOP1;BRD2;ACVR2A;HIPK1;MAP4K3;ACVRL1;HIPK2;BMPR2;TNIK;PIM3;ROCK1;GSK3B;PTK2B;PKN2;PAK2;CDK7;APP;PRKCB;ACVR1B;STK38;BTK;DGKQ;DYRK2;GAS6;FGR;LIMD1
prerank,muscle filament sliding (GO:0030049),0.4530992317839388,1.2062129166623596,0.23950617283950618,0.6295348085212423,1.0,5/38,10.90%,VIM;MYL2;MYBPC3;TPM3;TPM4
prerank,actin-myosin filament sliding (GO:0033275),0.4530992317839388,1.2062129166623596,0.23950617283950618,0.6295348085212423,1.0,5/38,10.90%,VIM;MYL2;MYBPC3;TPM3;TPM4
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.38925359565167006,-1.206186706153314,0.20703125,0.6042905428709389,1.0,5/22,6.14%,CASK;FGFR2;SRSF6;EPB41L4B;PRKD1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.5031752316681591,1.2060743359069837,0.23848238482384823,0.6293342975396439,1.0,7/20,17.56%,MGST2;MTHFS;CNDP2;SLC27A1;HAGH;PTDSS1;OPLAH
prerank,positive regulation of JNK cascade (GO:0046330),0.41728654884961836,1.2058443585305032,0.1875,0.629437170475384,1.0,18/70,16.76%,SDCBP;GADD45B;GADD45G;TAOK3;RIPK1;GADD45A;MFHAS1;SH3RF1;HIPK2;FZD7;PTK2B;APP;TRAF1;TRAF3;TRAF5;TRAF2;LTBR;NCF1
prerank,bone development (GO:0060348),0.4497479250195791,1.2053184115731632,0.22208883553421369,0.6303819123472585,1.0,10/39,14.60%,TGM2;SULF2;AKAP13;PTGER4;PLS3;SULF1;SH3PXD2B;DYM;SLC10A7;LRP6
prerank,protein localization to centrosome (GO:0071539),0.5194650966816351,1.204341668305065,0.23994452149791956,0.6326123511662889,1.0,3/17,2.21%,HOOK3;PIBF1;SNX10
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.5068392939443858,1.204269997913953,0.24376731301939059,0.6322364578366492,1.0,5/18,17.17%,CD300A;B4GALT7;NLRC3;CDC73;FTH1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.45591253628917905,1.2036672425589345,0.22627737226277372,0.6334334233947245,1.0,10/33,16.21%,RAB7B;FOXO3;STAT5B;HSPA1B;ACVR2A;FES;ACVR1B;FAM210B;HSPA1A;BRD1
prerank,cellular response to alcohol (GO:0097306),0.44710801136641676,1.2034452567020137,0.218335343787696,0.6334670688062378,1.0,14/42,15.70%,GRAMD1B;CTNNB1;ADCY7;SPHK2;PTGER2;BRCA1;GRAMD1C;PTGER4;GPLD1;ADCY8;ADCY3;LRP6;GOLPH3;CTNNA1
prerank,regulation of blood circulation (GO:1903522),-0.35851892953341447,-1.2033961813377494,0.18181818181818182,0.6088983399128423,1.0,22/34,37.45%,CELF2;ECE1;AGT;KCNG2;ADORA3;TPM1;FXYD1;KCNMB4;PER2;TMIGD3;DMPK;KCNJ12;AGER;CACNA1H;BDKRB2;KCNQ1;PLN;KCNIP2;CAMK2D;KCNMB2;TBX2;DES
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.47725896072998925,1.2030238579416512,0.21446700507614214,0.6340590270111136,1.0,8/30,14.00%,DPM2;MGAT5;MCFD2;NUDT14;DDOST;DAD1;MAGT1;UGGT1
prerank,positive regulation of ERAD pathway (GO:1904294),0.5418116185601602,1.202861608292644,0.24273255813953487,0.6338959338546102,1.0,8/13,27.94%,NFE2L2;UBQLN2;SGTA;ATXN3;BCAP31;HERPUD1;RNFT1;RNF185
prerank,response to molecule of bacterial origin (GO:0002237),0.4106599663871955,1.2024803586124664,0.18878718535469108,0.6344109402271966,1.0,23/69,23.10%,MAPKAPK3;IL6;LY96;IRAK3;FOXP1;HNRNPA0;ADAM17;LIAS;TAB2;FZD5;TNFAIP3;SLC11A1;ERBIN;SLPI;ACOD1;LBP;OTUD5;IFNAR1;GCH1;FCGR2B;TIRAP;JAK2;IRAK1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.47301650932015477,1.2015905263772761,0.2370088719898606,0.6364094050853453,1.0,6/28,4.97%,PRKCD;ENPP1;APPL2;PID1;SLC27A4;PTPRE
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5693769639225619,1.2013075130611086,0.2548435171385991,0.6366346109665884,1.0,2/11,2.06%,LILRB1;FOXP3
prerank,Notch signaling involved in heart development (GO:0061314),0.5754753426795727,1.2012784207189215,0.24850299401197604,0.6361239503749228,1.0,3/11,11.88%,NOTCH2;SNAI2;NOTCH1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.5201242508490548,1.2012205732404955,0.2378917378917379,0.6356845112641094,1.0,2/15,5.83%,AK8;ENTPD1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.38711932519787984,1.2007334605543587,0.13003095975232198,0.6365307313135803,1.0,54/158,24.45%,HTR2B;LITAF;TFRC;IKBKE;PLK2;TMEM106A;ANKRD17;RIPK1;TRIM25;REL;HMOX1;AKAP13;TICAM2;VAPA;MAVS;MIB2;BIRC3;TAB2;BST2;WLS;PRKCB;ROR1;RELA;GOLT1B;PRKN;TRAF3IP2;CX3CL1;TRAF5;SLC44A2;MYD88;GPR89A;TRAF2;ZDHHC17;LTBR;TRIM14;UBE2V1;BIRC2;CARD11;TBK1;PELI2;SHISA5;EEF1D;TIRAP;FKBP1A;MALT1;ALPK1;IRAK1;BCL10;FLNA;TRAF6;TFG;NDFIP1;TERF2IP;CASP8
prerank,vitamin transport (GO:0051180),0.4647690402958572,1.200511036100861,0.23522012578616353,0.6365699281936211,1.0,8/29,19.48%,FOLR2;FOLR1;SLC27A1;SLC25A32;SLC23A1;SLC52A1;SLC19A1;SLC19A2
prerank,regulation of protein export from nucleus (GO:0046825),0.4861343625311807,1.199896058943647,0.25066666666666665,0.6377863692819186,1.0,10/23,19.91%,ANP32B;GTSE1;TPR;GSK3B;SIRT7;GAS6;UHMK1;CAMK1;RBM22;TCF7L2
prerank,detection of calcium ion (GO:0005513),-0.4659684727032666,-1.1987700184990113,0.23668639053254437,0.6184167084845668,1.0,2/13,3.74%,SYT1;RYR2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.4717080524831466,1.1984845397927697,0.2541507024265645,0.6413354330096332,1.0,8/27,13.58%,IL6;RIPK1;DDX6;AGO2;DDX5;TNRC6B;PUM2;LIMD1
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5144108326691468,1.1983322748809722,0.25470332850940663,0.6411864420770894,1.0,4/17,6.69%,NCOR1;PID1;PPIF;FLCN
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.341477616867981,-1.198013357668014,0.18235294117647058,0.6179678973832531,1.0,13/37,15.78%,MAPT;EPHA3;PRKAA2;STMN3;TRIM36;TPPP;MARK2;STMN4;BICD1;MAP6D1;STMN2;MAPRE1;STMN1
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.4734515050746262,1.1979972115865265,0.22756827048114434,0.6415480788728896,1.0,9/29,17.11%,DHX34;E2F1;TENT5A;HNRNPU;SLC11A1;TENT5D;GDNF;THRAP3;TAF15
prerank,protein K48-linked ubiquitination (GO:0070936),0.42549178767626805,1.1975988521082561,0.2251732101616628,0.6421794780454256,1.0,23/54,25.99%,ZNRF1;UBE2Q2;CUL3;UBE2K;BFAR;NEDD4L;RNF115;RNF146;TOPORS;ARIH2;RNF34;TNFAIP3;PRKN;CDC34;AMFR;UBE2R2;UBE2H;UBE2D3;KLHL3;TTC3;UBE2E1;UBR5;UBE2G1
prerank,negative regulation of transport (GO:0051051),0.42953750696802817,1.1973386582475487,0.21462264150943397,0.6423448497596387,1.0,12/51,13.63%,LGALS3;LILRB1;RAB7A;NR1H3;PTEN;TRAT1;WWP2;SIRPA;SNX33;BST2;MCTP1;PRKN
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.4310800633295277,-1.197316656191041,0.20422535211267606,0.6174036007449818,1.0,4/16,3.74%,ANK2;CACNA1C;ATP1A2;RYR2
prerank,regulation of urine volume (GO:0035809),0.5842919513867916,1.1972731222752855,0.24774774774774774,0.6419516584307493,1.0,1/10,3.48%,TFAP2B
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.37556673004524116,1.1970754766913516,0.037,0.6419313461949266,1.0,101/509,16.45%,F7;OSBPL8;HTR2B;HPSE;IQGAP1;GDF15;PIK3R5;SASH1;VWF;LITAF;GRB2;GCNT2;ADRA1D;ADRA1A;BCL2L11;GAB2;VEGFA;TXN;FNIP1;TGM2;TFRC;IKBKE;PLK2;IL6;HGF;CD28;PDPK1;HTR6;TMEM106A;ANKRD17;PDGFA;P2RX4;RIPK1;TRIM25;IGF1;F10;FGFR4;THBS1;ADAM8;TRAT1;IRS2;SPHK2;PIK3CA;FLCN;REL;HMOX1;P2RX3;MFHAS1;RPL23;AKAP13;VAV1;TICAM2;STRN;VAPA;STYXL1;DDIT3;LAMTOR1;ITGB1;MAVS;ESR1;ROCK1;SIRT1;MIB2;BIRC3;NRG4;APP;TAB2;BST2;WLS;PRKCB;ROR1;PUM2;TREM2;MAZ;HCLS1;MIOS;BCLAF1;SLC38A9;LAMTOR3;SOX2;RELA;GAS6;FGR;GOLT1B;PRKN;BAX;TRAF3IP2;SHC1;GOLPH3;CX3CL1;TRAF5;SLC44A2;RTN4;CBL;MYD88;FRS2;GPR89A;BID;TRAF2;ZDHHC17;LTBR
prerank,peptidyl-asparagine modification (GO:0018196),0.47176200425655834,1.1969724683881615,0.21645569620253163,0.6416184664085364,1.0,8/31,14.00%,DPM2;MGAT5;MCFD2;NUDT14;DDOST;DAD1;MAGT1;UGGT1
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.47526337736961544,1.1965984550869264,0.23969072164948454,0.642176413949333,1.0,9/28,20.17%,ERN1;CEBPB;ATF4;DDIT3;BAX;QRICH1;TRAF2;BBC3;BRSK2
prerank,bile acid biosynthetic process (GO:0006699),0.48548033710805827,1.1961922470671644,0.24412532637075718,0.642793078702934,1.0,3/24,2.13%,BAAT;AMACR;OSBPL1A
prerank,respiratory tube development (GO:0030323),0.4741413918462224,1.1960737530823844,0.24664879356568364,0.6425284201707376,1.0,5/28,12.72%,STRA6;VEGFA;CCDC40;ABCA3;ITGA3
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.5114284201030248,1.1959511590076113,0.2451523545706371,0.6422700283960399,1.0,4/18,13.02%,SPG21;C3AR1;SH2B2;GPLD1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4705553424401287,1.1957679790224411,0.24396442185514614,0.6422428045245181,1.0,9/26,16.52%,FLOT1;NR1H3;NINJ1;CYBA;MFHAS1;TICAM2;RTN4;LBP;TLR1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5804140778823007,1.1955882822394477,0.270516717325228,0.6421628151628684,1.0,3/10,8.73%,RUNX3;SH3RF1;CBFB
prerank,skeletal system development (GO:0001501),0.39084023967811227,1.195434046171116,0.1380020597322348,0.6419995068678722,1.0,29/148,17.11%,PRDX1;TRPS1;HAPLN4;XYLT1;TGM2;PAPSS2;CD44;EXT1;RAB33B;MMP14;IGF1;COL1A1;SULF2;AKAP13;PKDCC;PAPSS1;PTGER4;TRIP11;PLS3;SULF1;SH3PXD2B;DYM;GDF10;SLC10A7;ATP7A;WWOX;COL11A2;BPNT2;CHD7
prerank,chemical homeostasis (GO:0048878),0.42480195482385863,1.1953690435203306,0.2158438576349024,0.6416112528905024,1.0,9/61,8.05%,PPARG;FBXW7;RBP1;NR1H3;TENT4B;IRS2;ZBTB20;NEDD4L;ABHD4
prerank,intracellular protein transport (GO:0006886),0.37689232422887103,1.1953344580652312,0.08917835671342686,0.6411116792976448,1.0,89/304,22.21%,MMP12;KIF13B;SYK;TLK1;STX3;SNX8;ACD;IPO5;TBC1D22A;SNX27;RIC1;TBC1D25;RAB20;RAB7A;TBC1D1;E2F3;TBC1D2;CTSA;RANGRF;SNX9;TBC1D12;APPL2;HOMER3;SORL1;RAB21;STX8;STAM;TBC1D10A;COG7;STX5;RAB3GAP2;TBC1D2B;RAB31;RAB1B;LAMP2;TECPR2;TICAM2;RAB28;VPS33A;UNC93B1;STX11;TPR;SIL1;TBC1D22B;NUP50;ARHGEF2;RAB18;TBC1D15;TNPO1;WLS;STXBP3;RAB24;APPL1;AP3D1;RAB43;ARL4C;STX6;AP3B1;SNF8;SNX17;TBC1D9;RABGAP1;RAB29;GGA2;RAB22A;ARF4;VPS29;AP4M1;ARF5;STXBP2;NUP88;ARL5B;SEC31A;XPO1;RAB1A;SGSM2;VPS36;CSE1L;NUP188;GGA3;PREB;RPGR;PPP1R10;TBC1D4;DNAJC27;GIPC1;RPAIN;VPS35;SNX13
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.5399776608065802,1.1948345592423595,0.23823975720789076,0.6419323621581309,1.0,3/15,6.37%,LILRB1;FOXP3;IRAK3
prerank,positive regulation of phospholipid transport (GO:2001140),0.582027742235364,1.194717495083133,0.24812030075187969,0.641715390666594,1.0,2/10,7.78%,APOE;ABCA3
prerank,establishment of protein localization to organelle (GO:0072594),0.4136236227115488,1.1943676665946759,0.1919191919191919,0.6421033080126951,1.0,12/72,12.23%,MMP12;SYK;LAMP1;IPO5;E2F3;APPL2;TSPAN17;LAMP2;TPR;NUP50;TNPO1;APPL1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.37215699534934266,1.194270580731065,0.035,0.6417911729349133,1.0,119/532,18.42%,CD300LF;CD36;SYK;GRB2;TIMP1;ANXA1;BCL2L11;STX3;GAB2;VEGFA;TEC;ST18;IRAK2;VIM;IL17RE;IFITM1;IL36G;CD44;SOS1;IL6;HGF;LCP1;TALDO1;ABL2;PRKCD;CDKN1A;FOXO3;PSMD1;IL10RB;RIPK1;TNFRSF1B;APPL2;IFNGR2;TRIM25;PIM1;STAT5B;SOCS6;ANXA2;IRS2;IFNAR2;RNASEL;MAOA;IRAK3;PIK3CA;PTAFR;CSF2RB;HMOX1;RPS27A;UBC;MSN;SLC27A1;F13A1;VAV1;MAP3K8;IRF2;IL20RB;IFITM2;IL5;IL6R;ITGB1;IL3RA;ADAM17;PTK2B;PITPNA;CFL1;FOXO1;SIRT1;BIRC3;PAK2;PSMF1;BAG4;MT3;PSMD14;NUMBL;TAB2;BST2;TRAF1;RORA;PSMD12;APPL1;IL15;CSF2RA;IL7R;RAPGEF1;TRAF3;SOX2;RELA;POU2F1;JUNB;IL4R;TRAF3IP2;SHC1;PSME2;SQSTM1;JAK3;CUL1;MCL1;CX3CL1;TRAF5;CBL;LBP;MYD88;CCL7;TRAF2;LTB;LTBR;IFIT2;BRWD1;CAPZA1;IFNAR1;HNRNPDL;TNFRSF14;PSMB10;PSMD5;UBE2V1;BIRC2;PSMD8;CASP3;PSMA3
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.4513160926810035,1.1941685944745482,0.23832923832923833,0.6415082110035121,1.0,11/35,19.21%,ARHGAP24;ABL2;CUL3;FLCN;DLC1;CCDC125;LZTR1;ITGA3;MAPKAP1;TNFAIP1;STAMBP
prerank,organelle organization (GO:0006996),0.3747730419354792,1.1940887258240054,0.07114228456913828,0.6411724428877391,1.0,100/388,18.60%,ARHGAP21;ARHGAP10;APOE;OPTN;PLEKHM2;PIKFYVE;PALLD;FGD6;NEDD9;DIAPH1;MREG;RAB7A;ZMYM6;ABCD1;KIF9;PLD2;ATP8B4;PEX11A;YTHDF3;SYNE3;LONP1;NPLOC4;GAK;PEX7;WDPCP;COG7;CHMP2A;POLG2;PEX14;SH3KBP1;VMP1;RAB31;VPS13D;KIF3A;ABCA3;AFG1L;HPS6;KLHL20;GABPB1;PDCD6IP;TICAM2;VAPA;HUWE1;CAPZB;TNIK;VPS4A;CYCS;FAF2;CFL1;RAB18;VPS13C;BCAS3;CHMP6;TRIP11;PLAAT3;SPRYD3;PI4K2A;CFAP410;VPS51;LONP2;MICAL2;FGD5;POLRMT;PPRC1;RAB43;ATL2;ATAD3A;SSBP1;DYM;ATP8B1;EPS15;LIMD1;TNFAIP3;PRKN;CLASP1;MAST4;ATL1;PHIP;VPS11;GOLPH3;FGD3;WASL;GOLPH3L;ATP7A;TWNK;CCL7;SH3D19;SIRT3;RAB2A;RAB29;BRWD1;COG2;CHMP5;TFB2M;CHMP7;GABPA;KIF5C;RANBP9;TMEM135;HTT
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4925415305187052,-1.193885185976387,0.25073746312684364,0.623912559657756,1.0,3/10,11.42%,SEMA5A;CARMIL1;ACTN2
prerank,genitalia development (GO:0048806),0.552088784115328,1.193539976467345,0.2674772036474164,0.6422672913743999,1.0,1/12,1.11%,STRA6
prerank,cellular response to peptide (GO:1901653),0.42118325490843617,1.1934679894115312,0.22209436133486765,0.6418858160760896,1.0,11/56,12.33%,CD36;VIM;LRP1;ITGA4;IGF1;RPL23;GSK3B;ARHGEF2;APP;TRIM41;TREM2
prerank,macrophage migration (GO:1905517),0.5525529969050006,1.193376821412346,0.2434017595307918,0.6415857662803865,1.0,3/13,6.88%,LGALS3;P2RX4;CKLF
prerank,aorta development (GO:0035904),0.5477975861910671,1.19293490214615,0.28059701492537314,0.6423052801663816,1.0,3/14,3.48%,APLNR;LRP1;TFAP2B
prerank,protein import into peroxisome membrane (GO:0045046),0.49136715923301055,1.1927161970896463,0.26222826086956524,0.6423504419946849,1.0,12/22,27.23%,RAB8B;ABCD1;PEX14;ALDH3A2;PXMP2;GDAP1;ACBD5;SLC25A17;PXMP4;ABCD2;PEX3;ABCD3
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.40856741035260885,1.1925168301816218,0.21739130434782608,0.6423386974573446,1.0,18/72,17.90%,SYK;SIGIRR;IRAK2;RIPK1;IFNGR2;IFNAR2;RNASEL;IRAK3;HIPK1;CBFB;BIRC3;TRAF1;TAX1BP1;GAS6;TNFAIP3;TRAF2;PTPN1;BIRC2
prerank,regulation of Wnt signaling pathway (GO:0030111),0.39523829118954024,1.1923725163362613,0.18487394957983194,0.642189777499599,1.0,30/108,19.01%,MDFIC;CTNNB1;FOXP3;GNAQ;LRP1;GSKIP;SULF2;FOLR1;CBFB;FZD7;ESR1;APP;WLS;APCDD1;SULF1;ITGA3;MACF1;ATP6V0C;TNFAIP3;PRKN;PPP1CA;KREMEN1;ATP6AP2;DEPDC1B;CDC73;WWOX;CSNK2A1;SNX3;PPP2CA;RNF43
prerank,mitotic sister chromatid segregation (GO:0000070),0.3966241380942936,1.1923168293849247,0.19435396308360478,0.6417896761812931,1.0,28/98,21.40%,NCAPG2;SPDL1;PIBF1;CUL3;NCAPG;CHMP2A;NIPBL;EML3;RB1;PDCD6IP;SMC1A;CSNK2A2;BOD1;SMC2;VPS4A;CHMP6;INO80;CHMP5;CSNK2A1;CHMP7;RAD21;PHF13;MCPH1;SGO1;NCAPD2;PDS5A;NCAPH;CHMP2B
prerank,positive regulation of intracellular transport (GO:0032388),0.44570384086048553,1.1922411805742408,0.24879227053140096,0.6414205307723583,1.0,12/38,16.74%,KIF20B;RUFY3;DYNC1H1;SORL1;PGAP1;EIPR1;TPR;OAZ2;BCAS3;TENM1;RAB29;OAZ1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.4139103114088639,1.1917074467330222,0.2164835164835165,0.6423995032959484,1.0,15/75,14.94%,APOE;CD300A;IPO5;PRKCD;PTEN;SLC8A1;SORL1;GADD45A;IRAK3;APC;RB1;SIRT1;STK38;LRP6;LATS1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5456994717764955,1.1916758733112858,0.27540500736377027,0.6419041504812839,1.0,5/13,22.36%,IRX3;SLC8A1;SRI;CALM2;PDE4D
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.4136032637086817,1.191508135341325,0.21388577827547592,0.6417694944180566,1.0,14/69,12.62%,SYK;IL6;TMEM106A;RIPK1;LY96;THBS1;SPHK2;CYBA;TYROBP;MAVS;ARHGEF2;APP;FZD5;ARFGEF2
prerank,regulation of ruffle assembly (GO:1900027),0.49341785483409345,1.1914858355756397,0.26766304347826086,0.6412398636488748,1.0,4/23,7.70%,ARHGAP24;PLEKHM1;P2RX4;STAP1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4129700128347708,1.1912489785066869,0.22808988764044943,0.6413862220166443,1.0,13/66,13.24%,MTSS1;XDH;APOE;FBXW7;RUNX3;THBS1;MCC;SNAI2;WDR77;NLRC3;ATP5F1A;SULF1;SOX2
prerank,positive regulation of nervous system process (GO:0031646),-0.4086377555305738,-1.1911963918875186,0.22007722007722008,0.6286364147936234,1.0,9/18,14.58%,RIMS1;RIMS2;PARD3;TPPP;MYRF;CST7;TENM4;ATPSCKMT;DICER1
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5775974395255314,1.1905746266935702,0.27439024390243905,0.6428172567495916,1.0,1/10,0.37%,PLA2G7
prerank,protein targeting to mitochondrion (GO:0006626),0.42681759617659415,1.1901371971997219,0.21678321678321677,0.643509955340092,1.0,21/52,23.52%,CHCHD4;TIMM22;IMMP2L;PITRM1;TOMM20;TIMM17A;PMPCA;TIMM17B;GDAP1;HSPD1;PMPCB;TOMM34;HSPA4;TOMM7;TOMM22;FBXO7;BCAP31;MFN2;AIFM1;AIP;NDUFA13
prerank,regulation of epidermal cell differentiation (GO:0045604),0.49870281164491265,1.1898297701161846,0.2752420470262794,0.6437944850805777,1.0,4/21,10.64%,CTSL;CBFB;ROCK1;MAFG
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.38288041748311546,1.1895499881960323,0.1524390243902439,0.6440129267949979,1.0,40/172,18.20%,DDHD1;PIK3R5;MTM1;PIKFYVE;MTMR3;LPIN3;GPAT2;AGPAT4;PLD2;PLA2G2D;DGKZ;INPP4A;PTEN;CLN3;DGKA;GPD1L;FIG4;PIK3CA;PIK3C2G;SLC27A1;ABHD4;CSNK2A2;PLEKHA1;TAMM41;PCYT1A;PI4K2A;LPCAT3;DGKQ;CDS2;OCRL;INPP5F;GPD1;SLC44A2;GPAT3;PIP4K2A;DGKG;CSNK2A1;PTDSS1;ETNPPL;PITPNM1
prerank,negative regulation of JNK cascade (GO:0046329),0.46362686059833297,1.1893070815847322,0.24903225806451612,0.6441832421558594,1.0,9/31,20.07%,TAOK3;NCOR1;AIDA;DUSP3;SIRPA;PRKN;FKTN;DNAJA1;DUSP10
prerank,negative regulation of protein phosphorylation (GO:0001933),0.3867684526450227,1.1892907230641303,0.15030674846625766,0.6436332797564449,1.0,25/150,11.32%,PLPP3;XDH;DTNBP1;NCK2;CORO1C;GNAQ;PRKAG2;PDPK1;PRKCD;ENPP1;PTEN;PID1;TAF7;GPD1L;GSKIP;PPEF2;RB1;CNKSR3;SIRPA;DVL1;CEP85;NLRP2B;SNX25;PAK2;FBLN1
prerank,ventricular septum development (GO:0003281),-0.3331968981867592,-1.189195915130439,0.18888888888888888,0.631420578040297,1.0,11/37,8.69%,ACVR1;SALL1;ROBO2;ROBO1;BMPR1A;TGFBR2;TGFBR1;MDM4;ZFPM2;SMAD7;TGFB2
prerank,phospholipid translocation (GO:0045332),0.46796443047418823,1.1891809759687377,0.24577373211963588,0.6433869877618205,1.0,4/28,4.27%,ABCA1;PLSCR4;ANO6;ATP8B4
prerank,epidermal cell differentiation (GO:0009913),0.4377343561363911,1.1889664900602404,0.23647058823529413,0.6434444743110156,1.0,3/41,2.89%,ANXA1;CTNNB1;ADAM9
prerank,negative regulation of cell cycle process (GO:0010948),0.4144095076233321,1.1888943061994919,0.20342857142857143,0.6430729133883967,1.0,26/61,24.52%,TOM1L2;APAF1;FOXO4;E2F1;EED;CHMP2A;UXT;BRCA1;EPC1;ZFYVE19;TERF1;VPS4A;CBX3;RBBP7;CCP110;AURKAIP1;FBXO5;MGA;EHMT2;PPP1R10;CBX5;WAPL;TFDP1;PHC3;RNF2;PCGF6
prerank,negative regulation of MAP kinase activity (GO:0043407),0.44053764412755914,1.188882317462899,0.23309178743961353,0.6425278072021562,1.0,6/44,6.37%,APOE;CD300A;PRKCD;AIDA;SORL1;IRAK3
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3430326526215168,-1.1877858638372303,0.20772946859903382,0.6303529534247952,1.0,12/32,14.85%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,tRNA export from nucleus (GO:0006409),-0.3430326526215168,-1.1877858638372303,0.20772946859903382,0.6303529534247952,1.0,12/32,14.85%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,cellular response to zinc ion (GO:0071294),0.528296350665637,1.1873995256632477,0.2839335180055402,0.646164843925616,1.0,10/15,20.67%,P2RX4;MT3;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,establishment of melanosome localization (GO:0032401),0.5019171067581861,1.1872219138050952,0.2459016393442623,0.6460987209317465,1.0,2/19,2.08%,MYO5A;MREG
prerank,cellular response to BMP stimulus (GO:0071773),-0.2955672298957059,-1.1871150710654748,0.0989010989010989,0.6296955436501549,1.0,18/66,13.61%,ACVR1;SMAD3;BMPR1A;ACVR2B;HIVEP1;SMURF1;MEGF8;RGMB;ENG;SMAD1;SMAD7;PDCD4;VSTM2A;TGFB2;RGMA;SMAD2;TMEM100;ADAMTS12
prerank,lymphocyte differentiation (GO:0030098),0.40907414380966056,1.1871062793604197,0.20159453302961275,0.6458664042825107,1.0,16/68,17.62%,ADGRG3;TPD52;ITGA4;MS4A1;LFNG;BLNK;ITGB1;ADAM17;RELB;DCAF1;JAK3;GPR89A;GPR89B;KLF6;CHD7;ZBTB7A
prerank,dicarboxylic acid metabolic process (GO:0043648),0.42662321051980967,1.1870072577195128,0.22362385321100917,0.6455704545349059,1.0,18/52,24.33%,IDH1;MTHFS;D2HGDH;SDHAF3;FOLR2;SLC25A32;SDHA;MTHFD1L;ME2;ALDH18A1;OGDH;MTRR;SLC19A1;MDH1;IDH2;ACOT8;GOT1;SHMT2
prerank,regulation of receptor binding (GO:1900120),-0.4796515516511602,-1.1869202594315234,0.25663716814159293,0.6278285849699913,1.0,4/10,25.39%,ADAM15;HFE;ATP2A2;ATP2A3
prerank,cellular response to superoxide (GO:0071451),0.5726909448544077,1.186890316773726,0.28810975609756095,0.645324192388327,1.0,3/10,15.41%,PRDX1;MT3;ATP7A
prerank,mRNA catabolic process (GO:0006402),0.43795128678175976,1.1861417848006957,0.23522316043425814,0.6470029540509786,1.0,22/44,26.99%,DHX34;ERN1;DDX5;HSPA1B;ZFP36L2;EXOSC9;AGO3;NBDY;HSPA1A;RNH1;EXOSC10;THRAP3;AGO4;LSM5;ZC3H12D;XRN2;LSM6;ZFP36;RIDA;RC3H1;EXOSC4;TUT7
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.4175991169387245,1.1860759639915746,0.21763392857142858,0.646611425183062,1.0,16/62,16.58%,GRB2;SYNPO2L;NOTCH2;IGF1;IRS2;AKAP13;VAV1;NOTCH1;RAPGEF1;RASGEF1A;COL3A1;LPAR6;ERBIN;SHC1;ARRB1;LRRC59
prerank,regulation of fat cell differentiation (GO:0045598),0.4082899847633826,1.1860630110315473,0.2088888888888889,0.6460716819422515,1.0,13/74,11.93%,PPARG;CEBPB;ID2;IL6;ASXL2;ENPP1;E2F1;ZFP36L2;FTO;FOXO1;SIRT1;PPARD;RORA
prerank,innate immune response in mucosa (GO:0002227),0.5774118090808054,1.1853951160657958,0.2993730407523511,0.6474393717814543,1.0,2/10,17.91%,RNASE3;DEFA6
prerank,exit from mitosis (GO:0010458),0.5520826404445199,1.1852603021298338,0.28402366863905326,0.647291330818279,1.0,7/12,23.54%,CHMP2A;SIRT7;CTDP1;CLASP1;CHMP7;UBE2S;EPS8
prerank,receptor catabolic process (GO:0032801),0.48676187715356667,1.1850442794941938,0.2513586956521739,0.6473538776170992,1.0,13/24,27.02%,KIF16B;UVRAG;SH3GLB1;ZNRF3;SNX25;AP2B1;MYLIP;RNF43;LGMN;AP2S1;CLTC;AP2A2;AP2A1
prerank,synaptic vesicle cycle (GO:0099504),-0.3617872504854457,-1.1850370704960733,0.22110552763819097,0.6302974956278986,1.0,10/30,16.84%,NLGN1;RIMS1;SLC17A6;SNAP25;SYT7;SYNDIG1;STX1A;CPLX1;BRSK1;CPLX2
prerank,response to organophosphorus (GO:0046683),0.5269076754040452,1.1849116550510603,0.2575976845151954,0.6471647040282243,1.0,4/16,13.22%,P2RX4;RFC3;TRPC3;DGKQ
prerank,response to ketone (GO:1901654),0.4861986991495184,1.184515509149703,0.24867021276595744,0.6477355444044349,1.0,4/24,6.89%,NR1H3;CATSPERB;THBS1;CATSPER2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.3817182813451382,1.1842746376171658,0.1441717791411043,0.647860086847722,1.0,31/170,15.47%,APLNR;APOE;AFF1;MTMR3;TFEB;FLOT1;TMPRSS4;C1D;AFF4;COQ7;KIF16B;HNRNPAB;TRIM17;IGF2BP3;SLC8A1;IGF1;SCARB2;SIRPA;FOXP1;MEFV;LAMTOR1;APP;TREM2;SOX2;GDNF;PRDM2;HNRNPD;ZNF513;ZFP64;TOB2;PCBP1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.565655875465103,1.184196100192018,0.2800608828006088,0.64751286961805,1.0,6/11,19.17%,FGFR4;NR1H4;NR5A1;SIRT1;DGKQ;ASAH1
prerank,regulation of cytoskeleton organization (GO:0051493),0.3920277617196805,1.1832058313255296,0.17752100840336135,0.6498892002119568,1.0,20/108,12.03%,IQGAP2;IQGAP1;DIAPH1;SPEF1;BAIAP2;LRP1;SORBS3;PRKCD;PDGFA;CLN3;CAPN2;DLC1;ARHGAP18;ARHGAP17;ROCK1;GSK3B;RHOD;PAK2;BST2;CDK2AP2
prerank,regulation of protein localization to nucleus (GO:1900180),0.43950443794510796,1.183193688823498,0.23728813559322035,0.6493453586042024,1.0,10/43,15.70%,TFRC;BYSL;SESN2;FLCN;MFHAS1;GTSE1;TPR;GSK3B;LATS1;CTNNA1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.40829368943767724,1.183103273625823,0.22062084257206208,0.6490261651091542,1.0,15/73,12.62%,SYK;IL6;TMEM106A;RIPK1;LY96;THBS1;ADAM8;SPHK2;CYBA;TYROBP;MAVS;ARHGEF2;APP;FZD5;ARFGEF2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5342321088223667,1.1830743494112512,0.27123695976154993,0.6485390119640506,1.0,2/13,7.63%,ARG1;PRODH
prerank,erythrocyte differentiation (GO:0030218),0.44155981478933065,1.1828935280378399,0.22623345367027678,0.6484809884487588,1.0,12/44,18.31%,FLVCR1;VEGFA;ID2;RPS14;MFHAS1;HIPK2;KMT2E;HCLS1;UBA5;JAK3;ACIN1;CASP3
prerank,B cell mediated immunity (GO:0019724),0.5718864548782987,1.1827673575707207,0.27602523659305994,0.6483352967556217,1.0,1/10,0.91%,TLR8
prerank,embryonic limb morphogenesis (GO:0030326),0.44252592835666527,1.1827292636548423,0.23362175525339926,0.6478701480921218,1.0,6/34,6.98%,MAP3K20;CTNNB1;MBNL1;CREBBP;WDPCP;NIPBL
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3925742775577412,1.1820374109160263,0.1905759162303665,0.6492220231095437,1.0,21/116,15.27%,SYK;GPR15;PTGDR;PLK2;IL6;HTR6;RHBDF2;GPR83;ADCY7;PTGER2;GPR176;PTGER4;VIPR1;ADAM17;PTH2R;MYH9;TREM2;FGR;ADCY8;ADCY3;CD247
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4830269093479254,-1.1818540106708253,0.27218934911242604,0.6365060751485528,1.0,4/11,17.09%,GTF2H2;ARRB2;GRK2;SAG
prerank,nitric oxide metabolic process (GO:0046209),0.524337523874221,1.1817525615441944,0.2817919075144509,0.6494599535865555,1.0,2/14,6.12%,CYB5R3;ARG2
prerank,regulation of macrophage activation (GO:0043030),0.4634877008384778,1.1815560977151454,0.2516297262059974,0.6494742562535559,1.0,6/30,7.28%,GPR137B;NR1H3;IL6;SHPK;THBS1;MFHAS1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.5499539361679183,1.181058631586958,0.2943854324734446,0.6503705605103194,1.0,6/11,16.52%,CYBA;MFHAS1;TREM2;TNFAIP3;ACOD1;TLR1
prerank,regulation of isotype switching (GO:0045191),0.5351678331042163,1.1808261423640294,0.27890173410404623,0.6504886199368575,1.0,6/14,20.44%,TFRC;PARP3;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,response to ionizing radiation (GO:0010212),0.4156411529304105,1.1808035934855416,0.22483221476510068,0.6499840533843625,1.0,16/70,15.38%,EYA1;GRB2;XRRA1;ANXA1;CDKN1A;TANK;GADD45A;BABAM2;BRCA1;XRCC4;SIRT1;INIP;DCUN1D3;INTS7;INO80;BRCC3
prerank,gene expression (GO:0010467),0.3728187434967018,1.1804202793008347,0.08817635270541083,0.650504417769123,1.0,88/348,17.04%,APOBEC1;RBMS1;RPL3L;DHX8;POLR2A;ATXN1;ALYREF;TNIP1;TFIP11;CPSF1;MPHOSPH10;RBM39;IGF2BP3;E2F1;CHTOP;SORL1;TSPAN17;EEF1A1;AGO2;NUFIP1;NFKBIB;RNASEL;RPL18A;HNRNPUL1;RPS14;MRPL11;RPS11;THOC1;HNRNPU;RPS27A;MRPL23;RPL17;RPL23;DARS1;RBPMS;POLR2L;WDR33;EPC1;TAF1B;RPL36A;EIF4EBP2;TOPORS;COPS5;MRPS7;TPR;PAX8;RPL22;RPS21;RRBP1;POLR2G;DKC1;NUP50;MRPL32;POLR2I;MRPL36;NCBP2;STUB1;DROSHA;SRSF3;THOC2;SARS1;DEDD2;RPL10A;DDX20;MRPL28;DHPS;TSPAN15;RPS26;UPF2;MRPS21;MRPL44;SRBD1;HNRNPD;GOLPH3;MRPL35;RPL15;RPL10;PWP1;ADARB1;RPSA;DDX39A;NUP98;HSPD1;EIF4A3;SYNCRIP;DHX38;MRPL43;RPL7
prerank,negative regulation of neurogenesis (GO:0050768),0.44717640167475714,1.1800730357647582,0.2573248407643312,0.6509513028713237,1.0,6/34,5.04%,HOOK3;RUFY3;IL6;APPL2;PTEN;SORL1
prerank,purine ribonucleotide transport (GO:0015868),0.5192243642927468,1.1799024046572768,0.2629370629370629,0.6508808441821782,1.0,7/16,19.80%,LRRC8D;ABCC4;LRRC8C;SLC25A42;SLC17A9;SLC19A1;SLC25A17
prerank,protein heterotetramerization (GO:0051290),-0.4408132324929276,-1.179836780396731,0.2727272727272727,0.639563483811652,1.0,4/13,13.74%,GRIN2B;GRIN1;PKD2;PKD1
prerank,response to prostaglandin E (GO:0034695),0.5654981720691046,1.1798175233248618,0.3010590015128593,0.6505533628689576,1.0,2/10,9.82%,PTGER2;PTGER4
prerank,negative regulation of growth (GO:0045926),0.38676551513615487,1.1797928986941948,0.20042417815482502,0.6500491451280737,1.0,38/121,20.67%,TMPRSS4;CDKN1A;PPT1;ENPP1;MYL2;SESN2;NOTCH2;OSGIN1;APBB2;SPHK2;FLCN;HSPA1B;RB1;PPP1R9B;ACVRL1;BMPR2;NAIF1;SIRT1;ING4;MT3;DCUN1D3;BST2;NOTCH1;ACVR1B;RBBP7;HSPA1A;RTN4;NDUFS3;PPP2CA;PPP2R1A;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,mitochondrion morphogenesis (GO:0070584),0.5607954246708492,1.1786498948009085,0.28700906344410876,0.6527789075987238,1.0,2/11,4.84%,MTM1;PID1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4155975123060951,-1.1779097543695918,0.2332155477031802,0.6423084399907191,1.0,5/17,11.03%,SLC9A9;SLC12A2;TRPM4;SLC6A1;HCN2
prerank,error-free translesion synthesis (GO:0070987),0.49501911804509935,1.1778936650358884,0.2537313432835821,0.6544825191528711,1.0,5/22,9.32%,RFC3;NPLOC4;RPS27A;UBC;POLH
prerank,regulation of response to oxidative stress (GO:1902882),0.559840288099442,1.1775883319292826,0.30568356374807987,0.6548252250496477,1.0,4/11,13.63%,ABCD1;AIFM2;MCTP1;PRKN
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.4852140883241816,1.1774325231756835,0.2691790040376851,0.6547355202444105,1.0,9/22,19.11%,MAN1C1;RPS27A;UBC;EDEM3;EDEM2;DERL2;UGGT1;AMFR;MAN1B1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.40502259852929023,1.177419298011272,0.2253052164261931,0.6542019289314498,1.0,17/72,16.18%,ABCA1;APOE;SYNPO2L;ABL2;MYO9B;RAF1;CUL3;FLCN;AKAP13;DLC1;CCDC125;ARHGEF2;ITGA3;COL3A1;LPAR6;ARRB1;NRP1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.37401821057582724,1.1766585880996456,0.1062124248496994,0.6558263534080708,1.0,66/306,15.03%,B4GALT5;APOE;RBMS1;RPL3L;POLR2A;TNIP1;MCM9;EXT1;RFC3;IGF2BP3;BRIP1;E2F1;FAM111A;EEF1A1;AGO2;NFKBIB;RPL18A;RPS14;MRPL11;RPS11;HELB;RPS27A;ST3GAL4;MRPL23;RPL17;RPL23;DARS1;POLR2L;TOP1;BRCA1;EPC1;TAF1B;RPL36A;EIF4EBP2;TOPORS;COPS5;MRPS7;PAX8;RPL22;RPS21;RRBP1;POLR2G;POLL;MRPL32;POLR2I;MRPL36;DBF4;ING4;NBN;GTPBP2;SARS1;RPL10A;MRPL28;WRN;DHPS;RPS26;POLA1;RNASEH2A;MRPS21;SRBD1;GOLPH3;MRPL35;RPL15;RPL10;PWP1;ORC1
prerank,nucleotide-excision repair (GO:0006289),0.3930386383360553,1.1765712771726506,0.2129237288135593,0.6555103295920762,1.0,22/101,13.59%,POLR2A;ERCC6;GPS1;RFC3;GTF2H5;BRIP1;RPS27A;UBC;POLR2L;RAD23A;ISY1;COPS5;DDB1;POLR2G;SIRT1;POLL;CDK7;POLR2I;CUL4A;COPS7A;PPIE;POLA1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5394175911875442,1.1765649238255496,0.29685157421289354,0.6549558982126166,1.0,6/12,25.32%,RAB10;CELSR1;LAMA3;VANGL2;ACTG1;ACTB
prerank,carbohydrate transport (GO:0008643),0.5533636592977895,1.1764161202268635,0.29558823529411765,0.6548072314461277,1.0,4/11,19.45%,AQP1;SLC23A2;SLC23A1;SLC50A1
prerank,endocardial cushion development (GO:0003197),-0.3893003131469802,-1.1763708952118095,0.21292775665399238,0.6440392964861296,1.0,6/21,12.53%,ACVR1;BMPR1A;ENG;MDM4;TGFB2;CRELD1
prerank,amino sugar biosynthetic process (GO:0046349),0.5435088851381019,1.1762757332130245,0.2740963855421687,0.6546014297314736,1.0,4/12,14.51%,RENBP;GFPT1;NAGK;GNPDA1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3809861109536423,1.176251818759716,0.19262295081967212,0.6541191228188069,1.0,24/151,16.18%,GPNMB;CD36;HTR2B;APOE;GCNT2;ADRA1A;FBXW7;CD44;PDGFA;NOTCH2;FGFR4;MFHAS1;PTK2B;MT3;APP;NOTCH1;ROR1;TREM2;GAS6;SHC1;CX3CL1;ARRB1;CCL7;NRP1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.46573141514797967,-1.17608116291329,0.2542857142857143,0.6424361669251126,1.0,3/11,7.30%,USP7;ATP9A;MAP2K1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.4139441960249546,-1.1760264141738543,0.23825503355704697,0.6402091129745028,1.0,11/16,48.81%,TGFB2;SOX6;SOX9;NUDT21;FOXC1;PTN;SP7;LTBP3;DHX36;TCF15;RBM24
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.37755493550801383,1.1758853553552189,0.1768355739400207,0.6546071758043875,1.0,40/163,19.69%,CD38;RFTN1;SYK;VAV3;TEC;PRAM1;CD28;PDPK1;PSMD1;SPG21;CD3D;MS4A1;TRAT1;PIK3CA;DENND1B;BLNK;PLEKHA1;SH2B2;PAK2;PSMF1;PSMD14;TAB2;PRKCB;PSMD12;BTK;RELA;PSME2;CUL1;CD247;PSMB10;PSMD5;EIF2B2;PSMD8;CARD11;PSMA3;TNFRSF21;PIK3CB;PSMA2;PSMD11;LAT2
prerank,positive regulation of endothelial cell migration (GO:0010595),0.40285590673162414,1.1756291452398324,0.22295081967213115,0.6547822213635583,1.0,20/84,17.88%,PLPP3;SASH1;VEGFA;PDPK1;P2RX4;NRP2;THBS1;FOXP1;BMPR2;ADAM17;PTK2B;SIRT1;ATP5F1A;BCAS3;GPLD1;RRAS;GRN;NRP1;TEK;AAMP
prerank,maintenance of blood-brain barrier (GO:0035633),-0.35507263227196034,-1.1755691360020804,0.20704845814977973,0.638968685400984,1.0,5/30,4.33%,SLC12A2;F11R;MBP;JAM2;WNK3
prerank,adenine nucleotide transport (GO:0051503),0.5079745570198039,1.1754112227746378,0.27045769764216365,0.6548211260815032,1.0,7/17,19.80%,LRRC8D;ABCC4;LRRC8C;SLC25A42;SLC17A9;SLC19A1;SLC25A17
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.49619015818909884,1.1749863531069598,0.27479892761394104,0.655451950387381,1.0,7/20,23.99%,IPO5;PTEN;APC;LATS1;CEBPA;MEN1;NR2F2
prerank,regulation of response to stress (GO:0080134),-0.48532898976084465,-1.1749696196701696,0.2598870056497175,0.6382495393135525,1.0,8/10,32.55%,OPRM1;EIF4G1;MLC1;STOX1;SLC38A2;DYRK3;CORO2B;CRHBP
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.4090590291111935,1.1744742789027813,0.23170731707317074,0.6563163094847794,1.0,18/72,15.08%,POLR2A;ERCC6;GPS1;RFC3;GTF2H5;RPS27A;UBC;POLR2L;ISY1;COPS5;DDB1;POLR2G;CDK7;POLR2I;CUL4A;COPS7A;PPIE;MNAT1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.48791150119602145,1.1743160309180223,0.256,0.6562156274456323,1.0,7/23,12.63%,GPS1;RPS27A;UBC;COPS5;DDB1;CUL4A;COPS7A
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4853180159606059,1.1742455224168677,0.27308707124010556,0.655844384271177,1.0,8/21,12.72%,HPSE;XYLT1;EXT1;UGDH;SULF2;HS2ST1;SULF1;SGSH
prerank,diol biosynthetic process (GO:0034312),0.528895367435128,1.1741946310504878,0.28450704225352114,0.6554114957747507,1.0,6/15,19.17%,SPTLC2;SPHK2;ABCA2;ACER2;GCH1;ASAH1
prerank,epithelial cell migration (GO:0010631),0.4411311706139427,1.1741699272808779,0.24815724815724816,0.6549197886397652,1.0,8/37,10.73%,PLXND1;ZEB2;PKN3;LPXN;PIK3CA;FSTL1;ROCK1;PKN2
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.43732814423910843,1.1740794907107215,0.25398773006134967,0.6545977011494253,1.0,6/39,5.58%,NFE2L2;ANO6;PDPK1;ITGA4;MAPK7;THBS1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.2560748915656036,-1.17400810044924,0.11764705882352941,0.6382918345849933,1.0,20/138,5.66%,PTPRD;ERBB4;PTPRT;LIFR;EPHA5;PTPRG;YES1;CSF1R;NTRK3;EPHA6;RYK;ACVR2B;EPHA3;FER;CSF1;HCK;FGFR2;NTRK2;IL6ST;FLT3
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.332286497347395,-1.1734159085042821,0.19310344827586207,0.6375388500531046,1.0,7/41,8.69%,MEF2C;BMPR1A;TGFBR2;FGFR2;ENG;SMAD7;TGFB2
prerank,neuromuscular junction development (GO:0007528),-0.3719944542132667,-1.1733340607383405,0.21666666666666667,0.6354571714727868,1.0,4/24,3.24%,CACNB2;UNC13C;ANK3;CACNB4
prerank,regulation of protein modification process (GO:0031399),0.4292348267019076,1.173039228816514,0.2631578947368421,0.6570709309647521,1.0,13/50,16.18%,FNIP2;ATG7;FNIP1;CORO1C;SESN2;ATG10;FLCN;ABCA2;PUM3;MT3;PHIP;FKTN;CCDC88C
prerank,protein O-linked glycosylation (GO:0006493),0.3916282817124954,1.1729411280012962,0.2205726405090138,0.6568282403183057,1.0,15/96,14.54%,B4GALT5;B3GNT8;GALNT3;DPM2;GALNT6;GALNT9;TET3;B3GALNT2;ST3GAL4;GXYLT2;TET2;OGA;TMTC4;POFUT2;FKTN
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3693427425829747,1.1723883931823789,0.10821643286573146,0.6578927900139232,1.0,112/314,24.75%,NFE2L2;CTNNB1;ZNRF1;WWP1;FBXW7;PSMD1;ZFAND2A;FBXL17;TRIM25;UBXN8;ANAPC1;SPSB4;CUL3;NPLOC4;FAM8A1;UBE2K;FBXL3;RPS27A;UBC;NHLRC1;BFAR;NEDD4L;RB1;KLHL20;WWP2;RAD23A;DCAF12;TMUB2;TOPORS;SPSB2;HUWE1;TBL1XR1;PCNP;DDIT3;DDB1;FAF2;UBXN4;SIRT1;FBXO9;NHLRC3;PSMF1;ERLIN1;PSMD14;STUB1;PSMD12;CUL4A;DNAJB14;RNF34;FBXO6;PRKN;DERL2;ZFAND2B;PSME2;CUL1;AMN1;UBQLN2;ARRB1;TMUB1;ANAPC10;DNAJC18;CDC34;KCTD5;TMEM129;PSMB10;PSMD5;SGTA;BIRC2;PSMD8;AMFR;PSMA3;PPP2R5C;TNFAIP1;AGAP3;CLOCK;FBXO5;FBXO31;UBE2S;MAN1B1;PSMA2;ATXN3;ANAPC15;PSMD11;WFS1;PLAA;PSMA6;SPOP;CUL4B;FOXRED2;FBXO45;FBXL4;JKAMP;TAF1;KCTD2;ECPAS;VCP;PSMB3;UBR3;KCTD10;HERPUD1;UBE4A;FAF1;SIAH2;PSME3;UBE2D3;UBE4B;CDK2;FBXO4;PTTG1;DMAC2;UBE2J2;UBE2E1;ANAPC7
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4053832767537047,-1.1723176959855444,0.26440677966101694,0.6357898720182028,1.0,3/17,3.74%,SNTA1;ANK2;RYR2
prerank,GPI anchor metabolic process (GO:0006505),0.4631703018519063,1.1719561536005763,0.2605820105820106,0.6585846031821908,1.0,7/26,15.13%,PGAP3;DPM2;PIGH;PGAP1;PIGC;GPLD1;PIGQ
prerank,intracellular lipid transport (GO:0032365),0.4862167948297554,1.1716224420112955,0.2753824756606398,0.6589347113230868,1.0,5/21,9.92%,PRKAG2;CERT1;ABCD1;CPT1A;SLC25A20
prerank,cellular component assembly (GO:0022607),0.36970918813100584,1.17147369091194,0.14602215508559918,0.6588414841600809,1.0,70/253,21.02%,FBLIM1;LIMA1;REPS2;NEDD9;MITF;ACD;DNAJB13;SPEF1;BAIAP2;SKAP2;LCP1;FAS;RHOJ;PDGFA;CCDC40;SNX9;YTHDF3;HAS3;ZFYVE27;CAPG;LPXN;PARVB;CREBBP;APC;DET1;PEX14;VMP1;DARS1;ABCA3;RTN3;DVL1;VCPIP1;PICALM;QSOX1;PPIH;RHOD;PTK2B;TOGARAM1;PLS3;TUBGCP4;TRAF1;EPRS1;SLC2A1;SPAG17;GAS6;VAMP3;WASL;MNAT1;CD247;RTN4;NLGN2;FANCA;TRAF2;MYO9A;KPNA3;CAPZA1;RANBP9;NOC2L;RAD21;TAPBP;CORO1B;KMT2A;MICAL1;AFG3L2;ACTG1;VAMP2;PPP2R1A;PAWR;HES5;ARL6IP1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.41632190701475175,-1.1712976069679821,0.23448275862068965,0.6362932923811219,1.0,7/18,18.68%,HACD2;ELOVL7;ACSL6;ACSL4;ELOVL6;TECR;ACSBG1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4678397147566327,-1.1712629788699362,0.2586750788643533,0.6341437413383333,1.0,6/12,38.29%,FUT9;WNK1;LCK;PPARA;FUT4;ADTRP
prerank,histone H4-K5 acetylation (GO:0043981),0.5085556269682789,1.1711866989573687,0.2966101694915254,0.6585284735308026,1.0,6/15,22.41%,KANSL1;PHF20;ING4;MCRS1;OGT;KANSL3
prerank,histone H4-K8 acetylation (GO:0043982),0.5085556269682789,1.1711866989573687,0.2966101694915254,0.6585284735308026,1.0,6/15,22.41%,KANSL1;PHF20;ING4;MCRS1;OGT;KANSL3
prerank,polyol metabolic process (GO:0019751),-0.32022472045933537,-1.1710995484162423,0.19875776397515527,0.6323247462709454,1.0,12/46,11.08%,INPP4B;INPP5D;PLCB1;IP6K2;IMPA1;PPIP5K1;PLCH1;ITPK1;PLD4;ITPKC;NUDT3;MINPP1
prerank,acylglycerol metabolic process (GO:0006639),0.4476351193070731,1.1709899769360468,0.25547445255474455,0.6585636410993425,1.0,9/37,17.89%,APOE;MGLL;DGKZ;DGKA;PLAAT3;DGKQ;DGKG;GK5;LYPLA2
prerank,pigment granule transport (GO:0051904),0.5025120837458146,1.1703516862702024,0.2698191933240612,0.6592893430495079,1.0,2/18,2.08%,MYO5A;MREG
prerank,melanosome transport (GO:0032402),0.5025120837458146,1.1703516862702024,0.2698191933240612,0.6592893430495079,1.0,2/18,2.08%,MYO5A;MREG
prerank,thymus development (GO:0048538),-0.4405708512611494,-1.1703477734567609,0.24085365853658536,0.6321779697715236,1.0,9/13,45.49%,TGFBR1;FGF10;FOXE1;EPHB3;HES1;SHH;FADD;RIPK3;TBX1
prerank,protein N-linked glycosylation (GO:0006487),0.40718405870703894,1.1703476052904493,0.22690992018244013,0.658739117973389,1.0,21/66,19.82%,MAN1C1;DPM2;MGAT5;MCFD2;NUDT14;TMEM165;B4GALT7;DDOST;DAD1;GFPT1;ALG13;ALG12;MAGT1;MPDU1;MOGS;UGGT1;FUT8;ALG6;DPAGT1;ALG5;PMM2
prerank,DNA biosynthetic process (GO:0071897),0.5110517705789256,1.170285418127366,0.28011611030478956,0.6583620030455118,1.0,6/16,13.59%,RFC3;POLH;SIRT1;POLL;WRN;POLA1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5232134400271011,1.1697568576931205,0.2998565279770445,0.659313460895392,1.0,6/14,26.08%,VEGFA;PIK3CA;NRP1;GAB1;MYO1C;KDR
prerank,protein autoubiquitination (GO:0051865),0.40873381532563646,1.1697092427834146,0.24364896073903003,0.6588944062613042,1.0,23/61,23.92%,TRIM17;UHRF2;CUL3;RNF10;CNOT4;BFAR;SH3RF1;BRCA1;WWP2;RNF115;RNF146;ASB4;KLHL24;STUB1;PRKN;TRAF2;AMFR;NFX1;RNF19B;RNF141;OBI1;UBE2D3;TRAF6
prerank,cellular response to calcium ion (GO:0071277),-0.2919245154210349,-1.169600370850658,0.1485148514851485,0.6317498453921859,1.0,20/67,12.13%,MEF2C;SYT1;NLGN1;MEF2A;RYR3;CAPN3;ADD1;PRKAA2;KCNH1;SYT7;SYT2;TRPM2;SYT4;SYT6;CPNE8;MCOLN1;ADGRV1;ADCY1;PKD2;CPNE4
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.556672837269432,1.168404176703513,0.2824773413897281,0.6621525477785137,1.0,5/11,19.08%,NEDD4L;PICALM;SNX33;LEPROTL1;GOPC
prerank,regulation of protein ubiquitination (GO:0031396),0.38671321298210926,1.1683072059883213,0.21170212765957447,0.6618701131116449,1.0,44/108,24.60%,SASH1;FBXW7;WASHC1;UBE2L3;CUL3;HSPA1B;XIAP;BRCA1;HUWE1;BIRC3;STUB1;NSMCE3;SIRT7;N4BP1;TNFAIP3;PRKN;HSPA1A;SQSTM1;ARRB1;PRKCG;CENPX;DCUN1D1;CRY1;PRR7;PHF23;BIRC2;MYCBP2;GNL3L;DNAJA1;HDAC8;WFS1;PAXIP1;OGT;GTPBP4;HSPBP1;FKBP1A;MALT1;SPRTN;BCL10;ISG15;TRAF6;FBXO4;NDFIP1;SOX4
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.5015695679105892,1.1681979336880315,0.27722772277227725,0.6616318929646998,1.0,12/19,24.58%,FBXW7;HTRA2;CSNK2A2;FZD5;VDAC1;PRKN;USP36;HTT;FBXO7;SREBF1;HAX1;ATP13A2
prerank,positive regulation of cell population proliferation (GO:0008284),0.3678956843615016,1.1679956749838776,0.08316633266533066,0.6616178102191057,1.0,74/423,14.85%,HTR2B;HPSE;CDCA7L;SDCBP;NAMPT;TIMP1;SLC35F6;PRKCH;GCNT2;ADRA1D;STX3;GAB2;VEGFA;AQP1;KIF20B;KDM4C;ID2;IL6;CDKN1A;TFAP2B;PDGFA;TCIRG1;SRPK2;RARA;PTEN;PID1;E2F1;CHTOP;PIM1;IGF1;FGFR4;MVD;CUL3;THBS1;IRS2;COPS9;SIRT6;DOT1L;HNRNPU;CACUL1;HMOX1;RPL23;FOLR2;FOXP1;CTSH;CNOT6L;IL6R;VIPR1;WDR77;CNOT7;ADAM17;PTK2B;POU3F3;SIRT1;RBPMS2;CCN1;BST2;CDC123;NOTCH1;TBX6;IL15;MAZ;S100A6;HCLS1;IL7R;DHPS;RELA;GAS6;DERL2;GDNF;SHC1;PHIP;CX3CL1;CNOT6
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5413876688975193,1.1675595445576903,0.2911764705882353,0.6623451130380111,1.0,3/12,5.81%,ABCD1;MTLN;IRS2
prerank,positive regulation of heart rate (GO:0010460),0.49370020012642307,1.1674930556940244,0.28356164383561644,0.661987566313793,1.0,2/17,1.52%,ADRA1D;ADRA1A
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.5278700957161482,1.167200040778269,0.275811209439528,0.6622791991498791,1.0,6/13,22.72%,ALG13;ALG12;MPDU1;ALG6;DPAGT1;SRD5A3
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.49924689750817886,1.1671793420782541,0.27475592747559274,0.6617855651264283,1.0,6/18,12.72%,ABL2;CUL3;FLCN;DLC1;CCDC125;ITGA3
prerank,regulation of interferon-beta production (GO:0032648),0.423671605619292,1.1669610230037457,0.2562574493444577,0.6618332010526755,1.0,10/46,13.13%,TLR8;LILRB1;FLOT1;RNF135;REL;SIRPA;MAVS;NLRC3;RELB;TRAF3
prerank,pore complex assembly (GO:0046931),0.4972135964603341,1.166947349769037,0.2912751677852349,0.6613199077425399,1.0,11/19,24.82%,ANO6;PDZD11;TPR;RTN4;NUP98;TMEM170A;ADAM10;NDC1;GSDMD;AFDN;TSPAN33
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.37752587789257186,-1.1667225015065934,0.22014925373134328,0.6372214941022281,1.0,7/22,15.79%,ORAI1;CACNA1C;GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,regulation of establishment of protein localization (GO:0070201),0.5244379791395716,1.1666338724792782,0.2832618025751073,0.6616754111378411,1.0,5/14,19.26%,CTSD;CENPJ;TREM2;GAPVD1;DNAJA1
prerank,response to peptide hormone (GO:0043434),0.4342996834201786,1.1660089196228953,0.25544794188861986,0.6628818902354071,1.0,13/43,20.59%,ANXA1;STAT5B;EIF6;SLC27A1;ROCK1;SIRT1;CRY1;EIF2B2;CREB1;EPM2AIP1;ZBTB7B;STAT6;OGT
prerank,regulation of type I interferon production (GO:0032479),0.3873808805326816,1.1656490453875448,0.24096385542168675,0.6633438975015482,1.0,32/84,24.55%,CTNNB1;IKBKE;RNF26;TRIM25;NPLOC4;CREBBP;RNF135;POLR2L;XRCC5;MAVS;TAX1BP1;PQBP1;TRAF3;RELA;POLA1;TNFAIP3;ACOD1;MYD88;OTUD5;STAT6;TBK1;POLR3C;MRE11;TIRAP;PRKDC;RNF125;POLR3K;IRAK1;ISG15;LRRFIP1;DHX58;GPATCH3
prerank,regulation of cellular component movement (GO:0051270),0.42293782711931976,1.1653103912520297,0.26254375729288215,0.6637557309858659,1.0,13/49,13.76%,DIAPH1;VEGFA;ABL2;RAF1;ACTN1;ARAP1;ARHGAP18;ROCK1;ADAM17;PKN2;FES;NRG4;INPP5F
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.525123370924174,1.1652254153582577,0.2818696883852691,0.6634499240190667,1.0,4/14,12.40%,ABCD1;MTLN;IRS2;LONP2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.3662065848598519,1.1650636923043087,0.11646586345381527,0.66337735662151,1.0,98/336,22.19%,FNIP2;GRB2;TRIP12;VAV3;BCL2L11;IKBKE;TAOK3;CDKN1A;WAC;MUS81;MCM9;TANK;ZDHHC16;RFC3;MUTYH;UVRAG;TNFRSF1B;ZRANB3;PARP4;BACH1;E2F1;PARP2;HTRA2;FAM111A;GADD45A;BABAM2;APC;HELB;DOT1L;PARP3;NIPBL;ENDOV;XIAP;BRCA1;FOXP1;SMC1A;TOPORS;VCPIP1;RTEL1;SETD7;POLH;DDIT3;XRCC5;DDB1;XRCC2;DCUN1D5;FOXO1;SIRT1;MBD4;INIP;NBN;CBX3;CBX1;CUL4A;KMT5B;WRN;NSMCE3;SIRT7;FBXO6;DYRK2;USP16;POLA1;BAX;MCL1;INO80;NSMCE4A;MTREX;MNAT1;ALKBH8;FANCA;BID;RNF169;BAZ1B;ALKBH1;CRY1;POLI;ACER2;CASP2;NCOA6;FBXO31;ZBTB40;TLK2;BCL3;PDS5A;PHF1;MRE11;CUL4B;USP3;FBXO45;EPHA2;RAD51B;TAF1;XPC;MGMT;RPAIN;CBX5;VCP;PRKDC
prerank,cobalamin metabolic process (GO:0009235),0.5089629259591641,1.1650364668623638,0.29445234708392604,0.662896901548707,1.0,4/17,18.34%,MMAB;LMBRD1;MTRR;ABCC1
prerank,cytoskeleton organization (GO:0007010),0.38334215017576767,1.1648423879457268,0.20575692963752665,0.6629017888567735,1.0,30/114,16.83%,ARHGAP10;APOE;PALLD;FGD6;NEDD9;DIAPH1;ZMYM6;PLD2;SYNE3;WDPCP;SH3KBP1;KLHL20;CAPZB;EPB41L3;TNIK;RHOD;CFL1;SPRYD3;CFAP410;MICAL2;FGD5;LIMD1;TNFAIP3;MAST4;PHIP;FGD3;RND2;CCL7;SH3D19;BRWD1
prerank,positive regulation of binding (GO:0051099),0.3987543067788488,1.1648321135192088,0.22601984564498345,0.6623716211143299,1.0,12/84,11.47%,PPARG;APOE;FLOT1;TXN;LRP1;CLN5;RARA;IGF1;STK3;HIPK2;GSK3B;APP
prerank,sphingolipid catabolic process (GO:0030149),0.5259406314930297,1.1648256380664788,0.3104956268221574,0.6618311313454006,1.0,3/15,4.22%,SGPL1;GLA;PPT1
prerank,microtubule depolymerization (GO:0007019),-0.3938313460686864,-1.1648254620580005,0.2558922558922559,0.6397095547911678,1.0,13/17,36.45%,STMN3;STMN4;STMN2;KIF18A;STMN1;NCKAP5;KATNB1;KIF14;CCSAP;KIF2C;KIF18B;KIF19;KIF2A
prerank,nucleic acid-templated transcription (GO:0097659),0.4272627677401055,1.1644734759699,0.2690909090909091,0.6622461269662399,1.0,10/42,10.93%,POLR2A;E2F1;NFKBIB;POLR2L;EPC1;TAF1B;TOPORS;PAX8;POLR2G;POLR2I
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.43785113286968863,-1.1643198531459777,0.27906976744186046,0.6388085962045997,1.0,6/13,15.33%,SESN3;ATM;STK11;SZT2;DEPDC5;SESN1
prerank,RNA processing (GO:0006396),0.37478972771074553,1.1640874901612794,0.19258496395468588,0.6627361809986068,1.0,42/176,15.34%,APOBEC1;RBMS1;DHX8;ATXN1;TFIP11;MBNL1;SRPK2;MPHOSPH10;SCAF11;CELF1;RBM39;TENT4B;RNPC3;NUFIP1;TCERG1;RNASEL;HNRNPUL1;CSTF3;THOC1;HNRNPU;PRPF8;RBPMS;PPP1R9B;SNRNP25;TENT2;HNRNPA0;DKC1;PRPF6;DDX23;NCBP2;DROSHA;ZMAT5;SF3A3;DEDD2;SNRNP35;DDX20;RSRC1;SNRPF;MRPL44;HNRNPD;ADARB1;ZRSR2
prerank,positive regulation of response to external stimulus (GO:0032103),0.37884300500216617,1.1637103681018244,0.22210526315789475,0.6632916444116461,1.0,19/128,12.33%,PLA2G7;SASH1;OPTN;TLR8;MGST2;STX3;TNIP1;ANKRD17;RIPK1;LY96;NINJ1;THBS1;ADAM8;CYBA;PTGER4;APP;PUM2;IL15;TREM2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.4420813549734308,-1.163368423615981,0.2672672672672673,0.6389666121341805,1.0,7/13,22.48%,ARSB;HEXB;HYAL1;IDS;BCAN;CSPG4;NCAN
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4248143262289771,1.16334799788782,0.2590286425902864,0.6637482119523439,1.0,5/40,5.53%,SDCBP;GCNT2;CTNNB1;IL6;COL1A1
prerank,negative regulation of cellular process (GO:0048523),0.363829594443245,1.163133944075437,0.074,0.6637987291774,1.0,91/521,13.93%,GPNMB;HTR2B;PLXNA1;PLXNC1;ADAMTS8;FRK;PLXND1;HOPX;LILRB1;RPS6KA2;ADRA1A;CTNNB1;NCK2;FOXP3;SPEF1;ST18;CCN5;IFITM1;NR1H3;IL6;CDKN1A;NIBAN2;TFAP2B;RUNX3;PPT1;ENPP1;TNFRSF1B;LMNA;MYL2;SESN2;APPL2;CELF1;ABI1;PTEN;RAF1;FOXO4;OSGIN1;HTRA2;ACTN1;APBB2;SMYD5;LPXN;SPHK2;APC;CHMP2A;FLCN;NUDT6;HSPA1B;ANP32B;NF2;TES;RB1;PPP1R9B;SIRPA;BNIPL;P3H3;DLC1;STRN;ACVRL1;BRD7;DSCAM;BMPR2;NLRP2B;CNOT7;NAIF1;PTK2B;SIRT1;ATG5;CCN1;ING4;MT3;VPS13C;FBLN1;APP;DCUN1D3;BST2;NOTCH1;ACVR1B;LPCAT3;MYH9;TREM2;DUS2;SIRT7;ARID2;GPLD1;PODN;VAMP3;PRKN;RBBP7;TENM1;HSPA1A
prerank,positive regulation of epithelial cell migration (GO:0010634),0.39614898512264174,1.1631224787098047,0.22717391304347825,0.6632709046771517,1.0,24/92,17.88%,SASH1;IQSEC1;VEGFA;ADAM9;DOCK5;NRP2;THBS1;RREB1;FOXP1;CTSH;BMPR2;PTK2B;BCAS3;PFN1;DOCK1;GPLD1;CAPN7;CLASP1;RRAS;RTN4;GRN;NRP1;TEK;AAMP
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.41128288461862444,1.1627557721542567,0.24235560588901472,0.6638086445311395,1.0,24/63,24.45%,LGALS3;FAS;BIRC6;RIPK1;IGF1;THBS1;SH3RF1;PAK2;TRAF1;DEDD2;RELA;PHIP;WWOX;BID;TRAF2;LTBR;HTT;TCF7L2;ITGAV;SIAH2;PSME3;BCL10;BCL2L12;CASP8
prerank,protein localization to chromatin (GO:0071168),0.4979694878124515,1.1624172963553978,0.2911392405063291,0.6642127293821088,1.0,8/18,22.54%,MCM9;NIPBL;ESR1;CHMP7;RAD21;SGF29;RUVBL2;WAPL
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5332513063275609,1.1624020651809215,0.291350531107739,0.6637055598631387,1.0,3/12,10.01%,IL6;NCOR1;ESR1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.49793128839953993,1.16234538632604,0.2991573033707865,0.6633240768650287,1.0,4/18,12.32%,PRKAG2;PRKCB;APPL1;SLC2A1
prerank,protein-containing complex subunit organization (GO:0043933),0.385758973040062,1.162250415388465,0.21436114044350582,0.6630355008402945,1.0,38/109,21.59%,REPS2;MITF;SKAP2;FAS;SNX9;CAPG;LPXN;CREBBP;APC;DET1;PEX14;DARS1;PICALM;TPR;PPIH;PTK2B;TUBGCP4;TRAF1;EPRS1;SLC2A1;VAMP3;WASL;MNAT1;CD247;NUP98;FANCA;TRAF2;KPNA3;CAPZA1;RANBP9;TAPBP;KMT2A;AFG3L2;VAMP2;PPP2R1A;HES5;WIPF1;NDC1
prerank,fat-soluble vitamin metabolic process (GO:0006775),0.46650445147922937,1.1622380879702452,0.27994616419919244,0.6625271524897484,1.0,5/22,20.88%,RBP1;PIAS4;ALDH1A2;LRP2;LGMN
prerank,regulation of myotube differentiation (GO:0010830),0.46833572426883674,1.1620702391857716,0.2914438502673797,0.6624273689741411,1.0,5/24,11.88%,MMP14;MAML1;SIK1;PIEZO1;NOTCH1
prerank,response to zinc ion (GO:0010043),0.466996791772566,1.161908144713868,0.2908622908622909,0.662367807304737,1.0,12/25,20.67%,P2RX4;D2HGDH;MT3;PAM;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,vesicle transport along microtubule (GO:0047496),0.47579682717542937,1.161423573321545,0.29049531459170014,0.6632169666313267,1.0,9/23,19.75%,FYCO1;DYNC1H1;CLN3;KIF3A;NDE1;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,negative regulation of B cell activation (GO:0050869),0.48494522849931454,1.161370148865394,0.27408412483039346,0.6628199090340945,1.0,7/21,19.77%,CD300A;ID2;PARP3;TYROBP;TNFAIP3;TNFRSF21;FCGR2B
prerank,aminoglycan biosynthetic process (GO:0006023),0.4201038205328583,1.1613057547751788,0.23910482921083628,0.6624702655736979,1.0,9/49,8.85%,B3GNT8;GCNT2;XYLT1;NDST1;EXT1;UGDH;B4GALT7;HEXA;HS2ST1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5123776386637446,1.1612968123080813,0.3035971223021583,0.6619462095544872,1.0,3/14,10.59%,LILRB1;MAVS;SIRT1
prerank,cellular response to ATP (GO:0071318),-0.43226972798853863,-1.1612592543393934,0.2573099415204678,0.6423200859291085,1.0,3/14,6.68%,P2RY12;RYR3;HSP90B1
prerank,actin filament bundle organization (GO:0061572),0.44369139278567793,1.1607678630307547,0.2771392081736909,0.6628956184374807,1.0,4/33,3.00%,LIMA1;NEDD9;BAIAP2;LCP1
prerank,transepithelial transport (GO:0070633),-0.4246639510395105,-1.1603942126155586,0.26666666666666666,0.6423009786945985,1.0,5/15,11.91%,SLC12A2;SLC1A3;SLC1A2;SLC1A1;ABCG2
prerank,neurotransmitter uptake (GO:0001504),-0.446257863737616,-1.160137776116722,0.29573170731707316,0.640827832039807,1.0,3/12,5.23%,SLC1A3;ATP1A2;SNAP25
prerank,cellular response to cadmium ion (GO:0071276),0.4734293201821761,1.159841016720886,0.2845849802371542,0.6649900458590137,1.0,11/24,20.67%,JUN;MT3;NCF1;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,regulation of vasoconstriction (GO:0019229),0.45675988332976347,1.1592504534659864,0.2853437094682231,0.6661201157840506,1.0,4/27,9.37%,ADRA1D;ADRA1A;ATP2B1;BMPR2
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5352164428236035,1.159249686215965,0.29685157421289354,0.6655761564340316,1.0,1/13,0.52%,NAMPT
prerank,regulation of myoblast fusion (GO:1901739),0.5456778964127339,1.159081803835991,0.32755905511811023,0.6655169875870189,1.0,2/11,5.60%,FLOT1;CD53
prerank,cellular response to cytokine stimulus (GO:0071345),0.365154362559746,1.1590470071303807,0.0970970970970971,0.6650682415929478,1.0,83/416,14.81%,CD36;CXCR4;SYK;GRB2;TIMP1;NFE2L2;ANXA1;BCL2L11;STX3;GAB2;VEGFA;TEC;SIGIRR;IRAK2;VIM;IL36G;SOS1;IL6;HGF;ABL2;CDKN1A;FOXO3;TANK;DAPK1;IL10RB;RIPK1;TNFRSF1B;IFNGR2;SHPK;PID1;PIM1;HTRA2;STAT5B;SOCS6;IFNAR2;UBE2K;MAOA;IRAK3;PIK3CA;PTAFR;CSF2RB;PTPN12;HNRNPU;GBP6;HMOX1;RPS27A;UBC;ZFP36L2;BRCA1;F13A1;VAV1;SIRPA;IL20RB;IFITM2;IL5;TPR;IL6R;ITGB1;IL3RA;GSK3B;FOXO1;SIRT1;ARHGEF2;BAG4;NUMBL;EPRS1;RORA;CSF2RA;ZFAND6;HCLS1;RAPGEF1;SOX2;RELA;GAS6;POU2F1;JUNB;IL4R;ERBIN;ACOD1;SHC1;JAK3;MCL1;CX3CL1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4449621995497115,1.1589952972897348,0.27261462205700127,0.664697088707021,1.0,5/34,8.02%,NSMCE2;CD28;IGF1;CUL3;RB1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.5233941413865629,1.1589286449433465,0.2934947049924357,0.664327387665873,1.0,4/13,14.51%,RENBP;GFPT1;NAGK;GNPDA1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.5409313109083178,1.158889768740863,0.3245227606461087,0.6639085425957734,1.0,4/11,15.85%,SIRT6;TPR;MPHOSPH8;DNMT1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.5540177045533892,1.1588157068719165,0.30923076923076925,0.6635982244824109,1.0,5/11,15.82%,TENT4B;EXOSC3;DKC1;LARP7;EXOSC10
prerank,mitochondrial protein processing (GO:0034982),0.5585048543735858,1.1584054162258335,0.31386861313868614,0.6642068470871089,1.0,5/11,20.08%,IMMP2L;PMPCA;OMA1;PMPCB;AFG3L2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.40604162937673643,1.1583385323581952,0.24858115777525538,0.6638463236917642,1.0,28/69,23.39%,TRIM25;UBXN8;NPLOC4;FAM8A1;EDEM2;TMUB2;FAF2;UBXN4;ERLIN1;STUB1;DNAJB14;FBXO6;DERL2;UBQLN2;TMUB1;DNAJC18;TMEM129;SGTA;AMFR;MAN1B1;WFS1;FOXRED2;JKAMP;ECPAS;VCP;HERPUD1;UBE4A;UBE4B
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5610519261585507,1.1581842268004054,0.2992248062015504,0.6637435673745812,1.0,3/10,17.47%,LRP1;PTPN12;APOD
prerank,telomere capping (GO:0016233),0.5023131689574856,1.1579298104308051,0.28735632183908044,0.6639533726597209,1.0,7/16,14.75%,ACD;TFIP11;TERF1;NBN;DCLRE1B;TEN1;STN1
prerank,negative regulation of hemostasis (GO:1900047),0.5352252399605573,1.157651632934908,0.3073529411764706,0.6642383539160949,1.0,2/12,6.55%,APOE;PROC
prerank,regulation of cell differentiation (GO:0045595),0.3826509073754052,1.1575412166733363,0.20185375901132852,0.6639963546258231,1.0,24/148,10.80%,LGALS3;SLC6A6;HOPX;TRPS1;CEBPB;RUNX2;ID2;TFAP2B;RUNX3;RAF1;DAG1;SMYD5;SIK1;DDX5;CREBBP;KLHL41;APC;ATF4;ANP32B;SNAI2;CBFB;ROCK1;MAFB;FES
prerank,organelle fission (GO:0048285),0.47648323219921024,1.1570953545882954,0.3019867549668874,0.664676241816514,1.0,6/24,13.63%,CORO1C;PEX11A;MTFR1L;MTFP1;GDAP1;PRKN
prerank,neuromuscular process controlling balance (GO:0050885),-0.45539811551724496,-1.156871966194277,0.2996845425867508,0.6470064978032144,1.0,4/12,3.63%,PCDH15;NRXN1;CDH23;MYO7A
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4039471037110176,1.1567509733593675,0.2618510158013544,0.6651399050210286,1.0,20/67,23.46%,CD36;NEDD9;DOCK5;TRIOBP;RREB1;GSK3B;PTK2B;OLFM4;VIT;DOCK1;CX3CL1;UTRN;NRP1;RSU1;C1QBP;CCL25;ILK;JAK2;CDK6;FLNA
prerank,negative regulation of macroautophagy (GO:0016242),0.47186163589028096,1.1559089481645453,0.29442282749675747,0.6670229564356303,1.0,7/26,17.73%,MTM1;PIK3CA;QSOX1;USP36;RUBCN;TMEM39A;PHF23
prerank,tyrosine metabolic process (GO:0006570),0.5531509902733724,1.155889243970205,0.3108108108108108,0.6665304503953405,1.0,2/11,16.00%,DCT;FAH
prerank,regulation of oxidoreductase activity (GO:0051341),0.5219448089357007,1.1548514015763085,0.3142857142857143,0.6690197119732264,1.0,5/13,15.41%,ABL2;HP;ECSIT;MT3;ATP7A
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4110080701494586,-1.1540021704439967,0.23666666666666666,0.6520874719277722,1.0,5/16,12.67%,SALL1;FGF2;PAX2;PKD2;NPNT
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.47312088119549767,-1.1539148249947844,0.286144578313253,0.6501585035584573,1.0,8/11,23.25%,TGFBR2;FGFR2;LRP5;STAT1;SOX9;MYC;CTNNBIP1;WNT5A
prerank,glycerophospholipid metabolic process (GO:0006650),0.3961542674624523,1.1535684604147278,0.23076923076923078,0.6720447534244004,1.0,16/75,15.13%,PLA2G7;DPM2;PLA2G2D;GPCPD1;CLN3;PIGH;PIGX;ABCA3;PLAAT1;PLA2G4F;PGP;PIGC;GPLD1;GDE1;PRDX6;PIGQ
prerank,establishment of protein localization to extracellular region (GO:0035592),0.42976499145629377,1.1534900781541257,0.2911084043848965,0.6717127760854595,1.0,6/39,10.38%,ABCA1;STEAP3;RAB8B;TANGO6;RAB12;RAB10
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.35873859466126373,1.1532395598805159,0.086,0.671885288608952,1.0,105/572,14.83%,PPARG;FNIP2;SDCBP;TFEC;IRX3;FRK;TRPS1;ZNF3;MITF;VEGFA;CEBPB;FNIP1;ZEB2;ATXN1;FOXP3;DNMT3A;ATF3;WWC2;NR1H3;GATAD2A;ID2;FOXO3;LIN37;CBX8;ZNF692;TFAP2B;RUNX3;RXRA;JUN;NCOR1;RARA;MAP2K5;MZF1;CITED2;BACH1;E2F1;TAF7;SAP30;GADD45A;NR3C1;SIRT6;TCERG1;EED;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;FLCN;HNRNPU;NIPBL;ATF4;TGIF1;RPS27A;UBC;RITA1;ETV6;ZNF177;RPL23;RREB1;UXT;SNAI2;NEDD4L;RB1;LCOR;WWP2;EPC1;ZNF148;FOXP1;IRF2;CHD3;CBFB;TBL1XR1;DACH1;ARID5B;TPR;DDIT3;NR2C1;HCFC2;ESR1;VPS72;SIRT1;NFATC3;LARP7;PPARD;CUX1;NOTCH1;TBX6;SARS1;DDX20;MAZ;SIRT7;SOX2;RELA;KDM1B;PRKN;ZKSCAN3;DCAF1;HSPA1A;SUV39H2;PRDM2;ID4;EID1;PER3;RPL10
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36676134952096817,1.1532379870625868,0.20799180327868852,0.6713458995121846,1.0,49/175,22.88%,NFE2L2;ST18;FOXO3;PSMD1;TANK;RIPK1;TNFRSF1B;PID1;ZFP36L2;BRCA1;ADAM17;PTK2B;SIRT1;BIRC3;ARHGEF2;PSMF1;BAG4;PSMD14;TRAF1;PSMD12;ZFAND6;TRAF3;RELA;ERBIN;ACOD1;PSME2;CX3CL1;TRAF5;CCL7;TRAF2;LTB;LTBR;TNFRSF14;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;TNFRSF21;ASAH1;PSMA2;CCL25;PSMD11;PSMA6;TXNDC17;PSMB3;ILK;PSME3;JAK2
prerank,central nervous system neuron development (GO:0021954),0.5132870895870352,1.15245331972756,0.3,0.6730286802065284,1.0,3/15,5.70%,B4GALT5;PTEN;B4GALT6
prerank,tetrapyrrole metabolic process (GO:0033013),0.49942189177534135,1.1523452144458077,0.2958748221906117,0.6728174702099018,1.0,4/18,18.34%,MMAB;LMBRD1;MTRR;ABCC1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.41964470125825654,1.1522288234077631,0.2759433962264151,0.6725974673496677,1.0,20/46,26.10%,IPO5;PRKCD;ANP32B;GTSE1;TPR;MAVS;GSK3B;NCBP2;HCLS1;GAS6;CAMK1;RBM22;EFCAB7;TCF7L2;DMAP1;FLNA;CPSF6;UBR5;BAG3;ZIC1
prerank,cytosolic calcium ion transport (GO:0060401),0.4546862038510621,1.1518325465880144,0.29118773946360155,0.673209934617098,1.0,5/28,5.02%,ADRA1A;ATP2B1;MICU2;MICU1;SLC8A1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.463035945252551,-1.1516089010244674,0.31671554252199413,0.654020372030995,1.0,1/11,0.13%,BIN1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.38581990191440285,-1.1514021323192134,0.24324324324324326,0.6524135936476261,1.0,3/20,1.67%,ACVR1;PTCH1;BMPR1A
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.4018843754194166,1.1513694140043436,0.2727272727272727,0.6739673132965525,1.0,15/58,15.38%,NSMCE2;ERCC6;UVRAG;BABAM2;PIAS4;BRCA1;XRCC4;XRCC5;KDM2A;POLL;PSMD14;NBN;DCLRE1B;POLA1;BRCC3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.5008278300204618,1.1501200190029315,0.28368794326241137,0.6769184512243002,1.0,5/16,15.13%,DPM2;PIGH;PIGX;PIGC;PIGQ
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3719395931648586,1.1488204646127955,0.22141372141372143,0.6800361673380797,1.0,57/144,26.13%,MICALL2;IPO5;NPEPPS;KIF20B;RUFY3;FBXW7;PRKCD;SH3GLB1;E2F1;SORL1;HTRA2;UBE2L3;ANP32B;GTSE1;HUWE1;CSNK2A2;TPR;ARIH2;MAVS;MTCL1;PPP3R1;GSK3B;OAZ2;BCAS3;FZD5;HCLS1;ATG13;GAS6;TENM1;VPS11;USP36;BID;CAMK1;RAB29;OAZ1;BBC3;RBM22;TOMM7;EFCAB7;TCF7L2;VAMP2;TMEM30A;DMAP1;UBE2D3;FLNA;MYO1C;TM9SF4;HRAS;TFDP1;CASP8;UBE2J2;YWHAB;UBR5;BAG3;ABLIM3;ZIC1;CEMIP
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.5188904025203157,1.1486381829158336,0.29754601226993865,0.6799981476014333,1.0,1/13,0.14%,MDFIC
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.36671821255935844,1.14852041471942,0.18522267206477733,0.6798073232532937,1.0,37/214,16.54%,GPNMB;CD36;HTR2B;APOE;SYK;GCNT2;ADRA1A;FBXW7;CD44;TNIP1;PDGFA;NOTCH2;PTEN;FGFR4;DUSP3;FLCN;MFHAS1;CNKSR3;SIRPA;PTK2B;CCN1;MT3;FBLN1;APP;STYX;NOTCH1;ROR1;TREM2;GAS6;RRAS;SHC1;CX3CL1;ARRB1;CCL7;NRP1;ZDHHC17;PTPN1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.3739865500737802,-1.1482653626650694,0.2653846153846154,0.6583328270247282,1.0,4/21,3.74%,ANK2;CACNA1C;ATP1A2;RYR2
prerank,cellular protein modification process (GO:0006464),0.3589740092361405,1.148256640006921,0.029,0.6800576956102459,1.0,244/983,20.48%,EPAS1;CEL;MFGE8;FNIP2;FBXO32;B4GALT5;APOE;SGK1;MAP3K20;MAK;B3GNT8;SYK;MSRA;TLK1;MTM1;TIMP1;CCDC8;FRK;PRKCH;MTMR3;GCNT2;MAP3K1;ANXA1;ERN1;ATG7;TEC;NPC1;TIPARP;PDK4;GPS1;TGM2;PRKAG2;IKBKE;ITIH2;FBXW7;SPP1;PPM1H;PLK2;TAOK3;IL6;PDPK1;ABL2;PRKCD;APLP2;PPP4R1;RUNX3;PSMD1;BIRC6;SIK3;FAM20C;SRPK2;DAPK1;PPEF1;PARP4;B4GALT7;RARA;PTEN;MAPK6;GNMT;PTPRE;PIM1;PARP2;UBE2L3;MAML1;ATG10;PKN3;SPSB4;CUL3;THBS1;FBXW10;MERTK;SOCS6;SIRT6;RNASEL;MELK;FBXL3;DDOST;SIK1;MAN2A1;PPEF2;DCAF13;IRAK3;TRIOBP;STK24;STK3;MANBA;COG7;PIGH;KLHL41;PROC;PGAP1;PTPN12;PARP3;DYRK1A;NUB1;EIF2AK4;DAD1;B3GALNT2;PDP1;ST3GAL4;BTBD1;PPP4R2;RAB1B;WSB2;BRD2;ACVR2A;F13A1;KLHL20;WWP2;FBXO11;HIPK1;AGA;ZC3HAV1;MAP4K3;ACVRL1;LHPP;SPSB2;COPS5;HIPK2;QSOX1;PPP3CA;BMPR2;FSTL1;EGLN3;TNIK;DDB1;PIM3;ROCK1;GSK3B;PTK2B;SIRT1;FBXO9;ILKAP;PKN2;PAK2;PPP2R2A;ATG5;CDK7;OGA;CCN1;PSMF1;ASB4;MT3;MAN2A2;PSMD14;APP;DCUN1D3;ASB8;WDTC1;METAP1D;RHBDD1;PRKCB;ACVR1B;PSMD12;STK38;CUL4A;COPS7A;BTK;ATG4B;SIRT7;UBA3;FBXO6;RAB11B;COL3A1;FBXW2;DYRK2;GAS6;FGR;CTDP1;PPP6C;RBBP7;UBE2F;PPP1CA;SERPINC1;MCRS1;PSME2;JAK3;CUL1;NUCB1;TNKS;LATS1;CD247;CDK8;PRKCG;ATE1;SUMF1;CDC34;RNF7;CDKL4;MELTF;SIRT3;PGGT1B;RAB2A;LRRC41;PTPN1;CAMK1;DCUN1D1;UBE2M;CSNK2A1;PSMB10;KEAP1;PSMD5;ARF4;GAN;DCAF10;SRPK1;PTPRU;ICMT;CREB1;TNKS2;PSMD8;CLK3;STK4;PSMA3;PPP2R5C;CDK13;FBXO31;PPP2CA;UBE2S;FBXO7;PSMA2;PIGU;TLK2;ALG5;TBK1;PSMD11;CDC14B;MKNK2;RAB1A;PMM2;DCAF7;GMFB;DUSP10;JMJD4;SHISA5;RAB13;BRSK2;WFS1;NAGPA;PPP2R1A;DDA1;COQ8B;PSMA6;ANO8
prerank,protein secretion (GO:0009306),0.4065729127950968,1.1481605391738041,0.27387802071346373,0.6797829814598717,1.0,9/56,11.99%,ABCA1;ANXA1;STEAP3;RAB8B;TANGO6;RAB12;RAB10;WLS;CYB5R4
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.537656844251846,1.148130073262562,0.3076923076923077,0.6793397217928903,1.0,1/12,0.35%,SOAT1
prerank,nitric oxide biosynthetic process (GO:0006809),0.5243413632774852,1.1472063991890469,0.30654761904761907,0.6814538065580509,1.0,2/13,6.12%,CYB5R3;ARG2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.37283752038378637,1.14704967479834,0.21296296296296297,0.6813687486934866,1.0,37/166,14.32%,PPARG;POLR2A;NR1H3;E2F3;RXRA;NCOR1;NOTCH2;RARA;GTF2H5;GTF2B;TAF7;MAML1;NR3C1;MAML2;NR1H4;CREBBP;TAF5;POLR2L;TAF1B;TBL1XR1;NR5A1;POLR1A;NR2C1;ESR1;POLR2G;CDK7;MED26;POLR2I;PPARD;NOTCH1;RORA;GTF2F2;POLRMT;MAZ;NRBF2;GTF2A1;NAT14
prerank,regulation of chemokine production (GO:0032642),0.4290177080090548,1.1469878264628006,0.2907268170426065,0.6809910722252169,1.0,9/36,12.33%,SIGIRR;IL6;HMOX1;SNAI2;FOXP1;IL6R;ADAM17;APP;TREM2
prerank,positive regulation of cellular process (GO:0048522),0.35992811275280423,1.1469775931113113,0.091,0.6804775979102832,1.0,103/565,14.99%,CD36;HTR2B;CDCA7L;SDCBP;NAMPT;SLC6A6;TIMP1;SLC35F6;GCNT2;ADRA1D;STX3;GAB2;VEGFA;FLOT1;KIF20B;TGM2;IER5;KDM4C;LRP1;IL6;PRKCD;ANKRD17;DYNC1H1;FASN;TFAP2B;PDGFA;P2RX4;TCIRG1;SRPK2;TNFRSF1B;LMNA;CELF1;RARA;MMP14;PTEN;CITED2;MTLN;CHTOP;IGF1;FGFR4;MVD;CUL3;THBS1;RNF10;MERTK;ADAM8;IRS2;COPS9;APC;DOT1L;FLCN;CACUL1;P2RX3;CYBA;RPL23;N6AMT1;PRODH;FOLR2;SIRPA;RAD23A;CTSH;HPR;HP;TRPC3;PPP3CA;CNOT6L;EXOSC9;IL6R;FZD7;VIPR1;WDR77;CNOT7;ADAM17;RHOD;PTK2B;MTPN;POU3F3;SIRT1;MT3;CDC123;NOTCH1;TBX6;IL15;TREM2;DOCK2;MAZ;HCLS1;IL7R;DHPS;BCLAF1;POFUT2;RELA;GAS6;SLC11A1;DERL2;GDNF;SHC1;PHIP;LRP6;INO80;CX3CL1;CNOT6;NSMCE4A
prerank,oligodendrocyte development (GO:0014003),0.5019985817662377,1.1467491260638236,0.3230994152046784,0.6805881061021242,1.0,3/15,8.05%,B4GALT5;B4GALT6;PRDM8
prerank,histone H2A ubiquitination (GO:0033522),-0.3945029974680749,-1.1462449032732525,0.2730496453900709,0.6613984775728038,1.0,6/17,13.59%,RNF8;DDB2;TRIM37;RYBP;BCOR;UBE2B
prerank,melanosome localization (GO:0032400),0.47672541165240584,1.1452686915238408,0.3046979865771812,0.6842162257947015,1.0,4/21,12.95%,MYO5A;MREG;VPS33A;RAB11B
prerank,regulation of mitotic spindle organization (GO:0060236),0.4335984978566525,1.1449500634428147,0.29463171036204744,0.6845793387017248,1.0,8/35,9.43%,DYNC1H1;CHMP2A;PARP3;HSPA1B;HNRNPU;EML3;PDCD6IP;TPR
prerank,regulation of phospholipase activity (GO:0010517),0.556947936219688,1.1446818050227012,0.3253731343283582,0.6848312991598745,1.0,2/10,3.02%,LRP1;PDPK1
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3813668933103808,1.1434607729508943,0.2613390928725702,0.6877541975980054,1.0,23/95,15.73%,LILRB1;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;STAP1;SIRPA;NFKBIL1;TICAM2;FZD5;TRIM41;RELA;TNFAIP3;ACOD1;LBP;CDC73;MYD88
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.4487447009750567,1.142858036044273,0.293213828425096,0.6889616708782088,1.0,9/30,21.01%,CD300A;PIBF1;PRKCD;NF2;INPP5F;SH3BP5;PPP2CA;PPP2R1A;PTPRC
prerank,protein K63-linked ubiquitination (GO:0070534),0.4180234405218296,1.1428325832759407,0.2817073170731707,0.6884986564395095,1.0,16/41,19.10%,RNF135;BFAR;WWP2;RNF115;ARIH2;STUB1;TRAF1;TRAF3;PRKN;HECTD1;TRAF3IP2;TRAF5;TRAF2;UBE2O;UBE2V1;UBE2S
prerank,nucleoside phosphate catabolic process (GO:1901292),0.5214069310558949,1.1425533438198126,0.2994269340974212,0.6887524280049087,1.0,3/13,6.34%,ENPP1;ENTPD1;ITPA
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4611844153931666,1.142547504935701,0.3042895442359249,0.6882242299865021,1.0,6/24,17.57%,IQSEC1;VEGFA;DUSP3;ROCK1;NRP1;TEK
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.43428316824380603,1.1419764582329608,0.2969325153374233,0.6893223511305017,1.0,13/36,21.44%,OPTN;RILPL2;RAB7A;RAB31;RAB10;MACF1;GOLPH3;GOLPH3L;GOLGA4;GGA2;BBS1;VAMP2;GGA3
prerank,glycerolipid metabolic process (GO:0046486),0.5474758020626952,1.1419577483998407,0.3400286944045911,0.6888360793609097,1.0,5/11,17.18%,DGKZ;DGKA;PGP;DGKQ;DGKG
prerank,regulation of actin filament depolymerization (GO:0030834),0.5260367012619294,1.141850684276576,0.31671554252199413,0.6885841649350957,1.0,4/12,11.02%,LIMA1;PIK3CA;MTPN;WDR1
prerank,anterior/posterior axis specification (GO:0009948),0.50637514923349,1.1418277780301251,0.3192771084337349,0.6881049361857512,1.0,4/15,18.41%,DDIT3;FZD5;WLS;HOXD8
prerank,positive regulation of calcium ion transport (GO:0051928),0.43701067884652967,1.1417047921652193,0.28074534161490683,0.6879271311252939,1.0,8/36,13.05%,LGALS3;ATP2B1;P2RX4;SPHK2;P2RX3;TRPC3;MYLK;CRACR2A
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.4512204475184664,-1.1412840938658009,0.309375,0.6722520630402661,1.0,5/12,22.67%,CSF1R;CSF1;PTK2;IL34;LYN
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.436016513076229,-1.140852861895415,0.2898089171974522,0.6712416475087553,1.0,5/13,13.63%,SPRED1;ATM;ATR;SPRED2;SPRED3
prerank,cellular response to UV (GO:0034644),0.38804582902255,1.1408516685071441,0.27995642701525053,0.6898112116742566,1.0,27/76,24.08%,TIMP1;AQP1;PRKCD;CDKN1A;COPS9;CREBBP;EIF2AK4;ATF4;DDB1;SIRT1;RHBDD1;NSMCE3;MFAP4;N4BP1;INO80;RPL26;CDC25A;NOC2L;CERS1;CUL4B;EIF2S1;TAF1;XPC;RUVBL2;POLD1;ERCC4;USP47
prerank,keratan sulfate metabolic process (GO:0042339),0.43870938774977375,1.1407474837710811,0.2874015748031496,0.6895633795389178,1.0,8/31,10.87%,B4GALT5;GALNS;GNS;B4GALT6;HEXA;ST3GAL4;LUM;B4GALT3
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.41666839672159195,1.1405366136118849,0.29836829836829837,0.6896434592306235,1.0,6/45,9.37%,GDF15;SDCBP;RBPMS;ACVR2A;ACVRL1;BMPR2
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.47891209517466105,1.1402363528343267,0.31351351351351353,0.689975341764441,1.0,5/20,20.34%,NCOR1;SIK1;PGP;CRY1;GCK
prerank,ureteric bud morphogenesis (GO:0060675),-0.40318515498373586,-1.1395025382579076,0.2857142857142857,0.6726584404887016,1.0,5/16,12.67%,SALL1;FGF2;PAX2;PKD2;NPNT
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3537252389587669,1.1392198702078888,0.05,0.6922501298113678,1.0,166/834,16.62%,EPAS1;PPARG;MMP12;NAMPT;TFEC;MRTFA;LITAF;MRTFB;ZMIZ1;ATP1B4;IRX3;PLXND1;TFEB;LPIN3;LILRB1;NFE2L2;CTNNB1;MITF;NCK2;VEGFA;CEBPB;ZEB2;GRHL1;FOXP3;IER5;ST18;ATF3;VEZF1;RUNX2;NR1H3;E2F3;LMO1;IL6;HGF;FOXO3;TNIP1;TFAP2B;RXRA;JUN;MED12;RIPK1;ASXL2;RARA;MAP2K5;MZF1;CITED2;PID1;FOXO4;E2F1;TAF7;IGF1;MAPK7;MAML1;STAT5B;RNF10;AGO2;NUFIP1;GLMP;NR3C1;TCERG1;RNASEL;CRTC1;MAML2;NR1H4;CREBBP;DOT1L;FLCN;MLLT10;HNRNPU;KLF5;TET3;ATF4;REL;RPS27A;UBC;RREB1;TCF20;ACVR2A;BRCA1;ACTR3;EPC1;GABPB1;GABPB2;IRF2;NCOA3;DVL1;ACVRL1;COPS5;TBL1XR1;HIPK2;PPP3CA;TET2;NCOA1;BMPR2;NR5A1;DDIT3;PAXBP1;PAX8;MAVS;ESR1;PPP3R1;FOXO1;MED16;SIRT1;SALL2;ARHGEF2;CDK7;PRPF6;CCN1;NFATC3;LARP7;PPARD;BCAS3;APP;FZD5;SP3;NOTCH1;RORA;MEPCE;CAMTA2;MICAL2;HCLS1;SIRT7;PPRC1;RFX5;BCLAF1;SOX2;USP16;RELA;BCL11B;POU2F1;KDM1B;PRKN;SLC11A1;FOXJ3;SMARCD1;JUNB;GDNF;ATF1;PRDM2;ZNF513;MCRS1;PHIP;SQSTM1;LRP6;INO80;CX3CL1;TNKS;ZFP64;WASL;ARRB1;CDK8;ASXL1;PCBP1;CDC73;PPARGC1B;KLF6;NHLH2;WWOX;MTF1;THRAP3;NFATC2IP;TCF12;CAMK1;CREB3;CREB3L4
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.48327826522502515,1.1386435380761666,0.3254189944134078,0.6934149239293862,1.0,5/19,17.58%,VEGFA;FLOT1;NOTCH1;ADAM19;PTPRU
prerank,telomere maintenance (GO:0000723),0.41038357627003125,1.1386097354378815,0.29732868757259,0.6929615823660736,1.0,12/50,14.75%,NSMCE2;ACD;TEP1;PARP3;RTEL1;TERF1;XRCC5;NBN;DCLRE1B;WRN;TEN1;STN1
prerank,renal filtration (GO:0097205),0.5476943296992511,1.137965855422448,0.33488372093023255,0.6942249333391475,1.0,4/10,12.72%,MYO1E;SULF2;SULF1;ITGA3
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.5481432101715289,1.137692357211894,0.3355155482815057,0.6944785018661316,1.0,2/10,8.73%,PRKCH;NCOA3
prerank,phospholipid metabolic process (GO:0006644),0.3926196985257462,1.137442155713714,0.2642777155655095,0.6946099287349261,1.0,11/71,12.29%,PLPP3;LIPG;GPAT2;AGPAT4;PLA2G2D;GPX4;ABCA2;PLA2G4F;PLBD2;PLAAT3;PGP
prerank,regulation of actin filament-based process (GO:0032970),0.39363866884423354,1.1370973683633305,0.27582417582417584,0.6950488995339046,1.0,12/70,11.66%,IQGAP2;IQGAP1;BAIAP2;LRP1;PRKCD;PDGFA;DLC1;ARHGAP18;ARHGAP17;ROCK1;RHOD;BST2
prerank,extracellular matrix organization (GO:0030198),0.35943087837468235,1.137093387284796,0.19438877755511022,0.6945211875321998,1.0,49/276,15.41%,MMP12;VWF;TIMP1;ICAM2;ADAMTS8;TLL2;CTSL;FLOT1;MMP27;SPP1;CD44;LCP1;ITGA5;ITGA4;KIF9;WASHC1;PDGFA;CD151;COL4A6;MMP14;HAS3;COL1A1;THBS1;DAG1;ADAM8;CAPG;CAPN2;TIMP2;LUM;COL4A1;CTSS;QSOX1;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;SH3PXD2B;GAS6;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A
prerank,regulation of cell population proliferation (GO:0042127),0.3544999814793997,1.1370921060689292,0.084,0.6939798207946282,1.0,113/691,14.85%,GPNMB;HTR2B;CDCA7L;SDCBP;NAMPT;SGK1;TIMP1;ADAMTS8;FRK;SLC35F6;GCNT2;RPS6KA2;ADRA1D;ADRA1A;CTNNB1;NCK2;STX3;GAB2;VEGFA;KIF20B;FOXP3;IER5;ST18;KDM4C;TFRC;IFITM1;ID2;IL6;CDKN1A;NIBAN2;TFAP2B;BIRC6;PDGFA;RAB33B;TCIRG1;JUN;SRPK2;LMNA;CELF1;ABI1;RARA;PTEN;RAF1;FOXO4;OSGIN1;CHTOP;IGF1;FGFR4;STAT5B;MVD;CUL3;THBS1;IRS2;COPS9;KLHL41;APC;DOT1L;NUDT6;HSPA1B;CACUL1;RPL23;NF2;FOLR2;XIAP;TES;PPP1R9B;BNIPL;P3H3;CTSH;DLC1;STRN;ACVRL1;BRD7;BMPR2;CNOT6L;IL6R;EGLN3;XRCC5;VIPR1;WDR77;CNOT7;ADAM17;PTK2B;POU3F3;AGO3;SIRT1;ARHGEF2;FES;ING4;APP;CDC123;NOTCH1;TBX6;IL15;MAZ;HCLS1;IL7R;ARID2;DHPS;GPLD1;PODN;RELA;TENM1;DERL2;HSPA1A;JUNB;GDNF;SPEG;SHC1;PHIP;FKTN;CX3CL1;CNOT6
prerank,cellular response to growth factor stimulus (GO:0071363),0.37111892904151184,1.1366488469886091,0.2361963190184049,0.6946971541921956,1.0,29/151,13.29%,IQGAP1;ANXA1;CTNNB1;ERN1;VEGFA;RUNX2;CD44;HGF;PDPK1;KIDINS220;APPL2;MAP2K5;HTRA2;MAPK7;EEF1A1;STAT5B;DUSP3;NR3C1;PTPN12;ZFP36L2;ACVR2A;SNAI2;ACVRL1;BMPR2;NOTCH1;ACVR1B;APPL1;RAPGEF1;RELA
prerank,cellular response to sterol (GO:0036315),0.5147946865552653,1.136215298242321,0.3402061855670103,0.6954334472552135,1.0,6/13,15.56%,GRAMD1B;GRAMD1C;RORA;GPLD1;LRP6;INSIG2
prerank,cellular response to radiation (GO:0071478),0.4307246289077044,1.1361095375185684,0.28886168910648713,0.6951983834648614,1.0,11/40,20.59%,GRB2;CDKN1A;TANK;GADD45A;SIRT1;NSMCE3;INTS7;INO80;CLOCK;EEF1D;TNKS1BP1
prerank,neurotransmitter secretion (GO:0007269),-0.3132653330358006,-1.1358601798372852,0.23636363636363636,0.6802117207671182,1.0,8/44,5.23%,NRXN1;SYT1;RIMS1;RIMS2;SYN2;PTPRN2;LIN7A;SNAP25
prerank,regulation of cell motility (GO:2000145),0.3746125161525693,1.1357125560213754,0.23399790136411333,0.6957952196809779,1.0,19/121,11.46%,PLXNA1;SGK1;PLXNC1;PLXND1;ADGRG3;DIAPH1;ABL2;LMNA;RAF1;OSGIN1;DOCK10;CFAP20;ARHGAP18;ROCK1;CCDC125;PKN2;FES;FBLN1;NRG4
prerank,ESCRT complex disassembly (GO:1904896),0.5565553982800739,1.1353690671194052,0.3421875,0.695678698769889,1.0,5/10,21.40%,CHMP2A;VPS4A;CHMP5;CHMP7;CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.5565553982800739,1.1353690671194052,0.3421875,0.695678698769889,1.0,5/10,21.40%,CHMP2A;VPS4A;CHMP5;CHMP7;CHMP2B
prerank,axoneme assembly (GO:0035082),0.438816876419459,1.1349324851038305,0.30456852791878175,0.6963769715936908,1.0,6/31,12.50%,DNAJB13;SPEF1;CCDC40;DNAAF3;TOGARAM1;SPAG17
prerank,glycosaminoglycan catabolic process (GO:0006027),0.40735133885702596,1.134855750911468,0.26783625730994154,0.6960725418463765,1.0,12/55,12.89%,HPSE;GALNS;CD44;STAB2;GNS;CEMIP2;HEXA;LUM;IDUA;FUCA1;SGSH;SDC4
prerank,response to peptide (GO:1901652),0.4358258329812659,1.134394033192868,0.320659062103929,0.6968357236140565,1.0,3/33,5.39%,MMP12;ANXA1;STAT5B
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.5446362906274368,1.134039140891133,0.33384853168469864,0.6973327411146243,1.0,5/11,19.65%,IPPK;SIRT7;PWP1;SMARCB1;NCL
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5425483491213622,1.1338139490232608,0.31952662721893493,0.6974533570037467,1.0,1/10,0.14%,HTR2B
prerank,calcium ion transport into cytosol (GO:0060402),-0.3824965468440617,-1.13303888106873,0.2791666666666667,0.6853634742163404,1.0,10/21,14.96%,GRIN2A;GRIN2B;CACNA1C;RYR2;GRIN1;JPH1;TRPM2;GRIN2D;ATP2B4;CACNA2D1
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5075868534018757,1.1329337326463071,0.30600292825768666,0.699436947571296,1.0,3/13,8.66%,SYK;PRKCD;TYROBP
prerank,transcription preinitiation complex assembly (GO:0070897),0.5241128381119154,1.1328333350375497,0.32242990654205606,0.6991783103882939,1.0,3/12,8.39%,GTF2B;TAF7;TAF1B
prerank,translational termination (GO:0006415),0.3841760524403763,1.132763577002927,0.256627783669141,0.6988317529275798,1.0,30/95,20.07%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;N6AMT1;MRPS23;ETF1;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL28;MRPL30;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;APEH;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,regulation of cell size (GO:0008361),0.4660068125746702,1.1327300915896636,0.31216216216216214,0.6983863478797362,1.0,6/23,13.47%,VAV3;PTEN;MSN;VAV1;MTPN;RAP1GAP2
prerank,sensory perception of light stimulus (GO:0050953),-0.27631103079718,-1.1325930332951653,0.15584415584415584,0.6842627634374974,1.0,12/87,10.33%,WHRN;PCDH15;RP2;ABLIM1;GRM8;CDH23;MYO7A;BBS2;PAX2;CABP1;SLC4A10;ADGRV1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.45214297900855555,1.1324064861784355,0.3235685752330226,0.6987122424554425,1.0,9/27,17.19%,ID2;FBXL17;FBXL3;CRTC1;SIK1;BHLHE40;PPP1CA;PER3;CRY1
prerank,cellular response to purine-containing compound (GO:0071415),-0.463856416604995,-1.1322761390582914,0.33152173913043476,0.6828740985342908,1.0,3/10,8.16%,RYR3;RYR2;TRPM2
prerank,epidermis development (GO:0008544),0.40420068428770806,1.132216064903684,0.2895348837209302,0.6987415347512798,1.0,9/56,18.25%,FABP5;GRHL1;EMP1;DCT;SVEP1;ALDH3A2;LAMA3;PLOD1;CCN2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.53903653477377,1.1321340569971967,0.3282442748091603,0.698422557041659,1.0,2/10,3.44%,NR1H3;ABCD1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5178295767663504,1.1320029879678943,0.3373493975903614,0.6982641778623232,1.0,8/13,22.88%,MGAT5;IL6;DOT1L;IL7R;JAK3;PIGU;PTPRC;JAK2
prerank,cellular response to amino acid stimulus (GO:0071230),0.43779622659095235,1.131981051154431,0.30659767141009053,0.6977876567028651,1.0,8/33,13.38%,IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3;CASTOR1
prerank,mitochondrial translational elongation (GO:0070125),0.3859292394763657,1.1317302753656793,0.2802139037433155,0.697956063314791,1.0,27/88,20.07%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL28;MRPL30;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,protein trimerization (GO:0070206),0.5052663687022575,1.1316398771095486,0.3281907433380084,0.6971408071862268,1.0,2/14,7.20%,SLC1A5;P2RX3
prerank,protein homotrimerization (GO:0070207),0.5052663687022575,1.1316398771095486,0.3281907433380084,0.6971408071862268,1.0,2/14,7.20%,SLC1A5;P2RX3
prerank,regulation of centrosome duplication (GO:0010824),0.4391282081236057,1.131610559869014,0.30985915492957744,0.6966910843050054,1.0,9/30,17.04%,PLK2;CENPJ;CHMP2A;PDCD6IP;NAT10;SIRT1;CEP76;ALMS1;CHMP5
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3852535898574826,1.1315823984088016,0.262987012987013,0.6962223258404716,1.0,16/87,11.66%,IQGAP2;IQGAP1;BAIAP2;LRP1;ABL2;PRKCD;PDGFA;NOTCH2;PIK3CA;DLC1;ARHGAP18;ARHGAP17;ROCK1;RHOD;PTK2B;BST2
prerank,aminoglycan catabolic process (GO:0006026),0.4546769805838067,1.1314926376437748,0.30828025477707005,0.6959363976400998,1.0,8/28,14.87%,HPSE;GNS;IDUA;FUCA1;SGSH;SDC4;CTBS;GUSB
prerank,peptide biosynthetic process (GO:0043043),0.37144979334173467,1.1314720716226432,0.2381443298969072,0.6954712962043903,1.0,40/153,18.06%,RPL3L;TNIP1;RHD;IGF2BP3;EEF1A1;AGO2;RPL18A;RPS14;MRPL11;RPS11;RPS27A;MRPL23;RPL17;RPL23;DARS1;RPL36A;EIF4EBP2;COPS5;MRPS7;RPL22;RPS21;RRBP1;MRPL32;MRPL36;GGTA1;SARS1;RPL10A;MRPL28;DHPS;RPS26;MRPS21;SRBD1;MRPL35;RPL15;RPL10;RPSA;MRPL43;RPL7;RPL26;MRPS18A
prerank,regulation of cell adhesion (GO:0030155),0.3758211382776161,1.1311160708214683,0.27024185068349105,0.6959845621542139,1.0,21/129,11.32%,PLXNA1;CXCR4;PLXNC1;PLXND1;STX3;VEGFA;CYTH1;TGM2;ABL2;ADAM8;LPXN;FLCN;ACVRL1;DSCAM;PPP3CA;PLAU;ROCK1;RHOD;PTK2B;FES;FBLN1
prerank,positive regulation of B cell proliferation (GO:0030890),0.44188206288411935,1.1310652894438802,0.310828025477707,0.6955877783939183,1.0,4/29,5.81%,CD38;VAV3;TFRC;IRS2
prerank,mRNA stabilization (GO:0048255),0.42585114719816264,1.1310109411214497,0.2970059880239521,0.6952128209330081,1.0,11/40,17.11%,E2F1;TENT5A;HNRNPU;HNRNPA0;SLC11A1;TENT5D;GDNF;MYD88;THRAP3;SYNCRIP;TAF15
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3922968652053557,1.130880392254538,0.28190899001109876,0.6950442002488031,1.0,11/69,9.32%,HTR2B;PIK3R5;GAB2;PTEN;IGF1;IRS2;PIK3CA;PTAFR;PIK3C2G;PLCB4;PLEKHA1
prerank,regulation of neuron migration (GO:2001222),-0.35426523724695946,-1.1304578881639646,0.24691358024691357,0.6855080561074062,1.0,12/26,14.83%,CTNNA2;NTNG1;PHACTR1;SRGAP2;ADGRG1;ULK4;SEMA3A;DAB2IP;CAMK2A;SEMA6A;NEXMIF;RAPGEF2
prerank,cellular glucose homeostasis (GO:0001678),0.4214368108568774,1.130295933284688,0.31840193704600483,0.6961895333511476,1.0,10/41,14.55%,LRRC8D;ERN1;HK3;ZBTB20;SLC39A14;FOXK1;FOXO1;SIRT1;GAS6;ADCY8
prerank,actin filament bundle assembly (GO:0051017),0.43438223396598197,1.1299920100410383,0.2994858611825193,0.696505041807915,1.0,4/33,3.00%,LIMA1;NEDD9;BAIAP2;LCP1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3933722231943223,1.1295556609917796,0.2742663656884876,0.6971852147867804,1.0,22/62,25.34%,NFE2L2;HTRA2;MAPK7;PPIF;SNAI2;SIRT1;ARHGEF2;PRKN;HSPA1A;MCL1;CREB3;NDUFS3;NOC2L;DNAJA1;CREB3L1;PLAUR;HERPUD1;CXCL12;NDUFA13;BCL2L1;PPIA;TXNDC12
prerank,midbody abscission (GO:0061952),0.48928199339570877,1.1290611984198358,0.3299565846599132,0.6980467875268757,1.0,7/17,21.40%,CHMP2A;PDCD6IP;VPS4A;CHMP6;CHMP5;CHMP7;CHMP2B
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.45612161124401707,1.1289558541747695,0.3072916666666667,0.6978218884581877,1.0,4/25,8.02%,NIBAN2;IGF1;DOT1L;RB1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5548938982756395,1.1287720906863339,0.3269537480063796,0.6973238980555657,1.0,2/10,5.24%,MAP2K5;MAPK7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5548938982756395,1.1287720906863339,0.3269537480063796,0.6973238980555657,1.0,2/10,5.24%,MAP2K5;MAPK7
prerank,negative regulation of bone remodeling (GO:0046851),0.5350641663908497,1.128444682361544,0.3447251114413076,0.6976753625903549,1.0,2/11,2.98%,GPR137B;IL6
prerank,heart development (GO:0007507),0.3684074568486966,1.1284336436324982,0.24794238683127573,0.6971870014012926,1.0,25/150,13.59%,HTR2B;APLNR;ALPK3;SYNPO2L;STRA6;VEGFA;ID2;CDKN1A;ZDHHC16;MYL2;PTEN;CITED2;PDLIM5;NIPBL;AKAP13;MYBPC3;DLC1;ACVRL1;BMPR2;TAB2;NOTCH1;MICAL2;COL3A1;SH3PXD2B;SMYD4
prerank,positive regulation of protein phosphorylation (GO:0001934),0.35762934735754315,1.1279822109736803,0.17417417417417416,0.6979713967487166,1.0,59/348,15.44%,GPNMB;FNIP2;IQGAP1;GDF15;SDCBP;APLNR;RAP2A;VEGFA;TEC;FLOT1;TXN;FNIP1;TFRC;PRKAG2;CD44;IL6;HGF;ITGA5;CDKN1A;FAS;PDGFA;SNX9;RIPK1;RAF1;IGF1;UBE2K;FLCN;CACUL1;RBPMS;ACVR2A;ACVRL1;IL5;BMPR2;IL6R;TNIK;XRCC5;MAVS;ADAM17;PTK2B;SIRT1;PAK2;ARHGEF2;CCN1;MT3;NBN;APP;TAB2;IL15;TREM2;HCLS1;DGKQ;GAS6;TENM1;GDF10;PFN2;CX3CL1;LATS1;ARRB1;CDK2AP1
prerank,regulation of signal transduction (GO:0009966),0.3633191559331242,1.1279005200557648,0.2278738555442523,0.6976829314357834,1.0,40/190,18.17%,MTCH1;CD36;MDFIC;DTNBP1;TIMP1;NCK2;MGLL;DHRS3;FOXP3;IRAK2;CD46;CD63;FBXL17;BRAP;CDC42SE2;GSKIP;CREBBP;LFNG;CBFB;ESR1;SIRT1;APP;RORA;TREM2;SULF1;ITGA3;TSPAN15;DGKQ;CASTOR1;RGS11;GDNF;ZFAND2B;CX3CL1;BST1;ZDHHC17;PTPN1;RIC8B;GAS1;SNX3;AMFR
prerank,regulation of monocyte chemotaxis (GO:0090025),0.45166541523984044,1.1278741415205018,0.31758530183727035,0.6972345833508438,1.0,8/24,24.08%,PLA2G7;ANO6;MOSPD2;CREB3;LGMN;CXCL12;SLAMF8;CCN3
prerank,protein glycosylation (GO:0006486),0.37256214660691356,1.1278651681185747,0.26842105263157895,0.6967355865970664,1.0,21/125,10.98%,B4GALT5;B3GNT8;GCNT2;MAN1C1;NPC1;GALNT6;MGAT5;GALNT9;TMEM165;B4GALT7;DDOST;COG7;TET3;DAD1;B3GALNT2;ST3GAL4;GFPT1;TET2;ALG12;OGA;MAGT1
prerank,regulation of cell division (GO:0051302),0.3868462907051529,1.127830763935217,0.2895040369088812,0.6963010623343382,1.0,9/72,8.73%,HTR2B;PLK2;BIRC6;UVRAG;SH3GLB1;SMYD5;MYO19;FLCN;NCOA3
prerank,regulation of protein import into nucleus (GO:0042306),0.4241727982582891,1.127704287313136,0.31946144430844553,0.6961443984117759,1.0,14/36,26.10%,MDFIC;IPO5;PRKCD;TPR;MAVS;HCLS1;APOD;RBM22;EFCAB7;DMAP1;FLNA;UBR5;BAG3;ZIC1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.3442855270235202,-1.127612565223476,0.23275862068965517,0.6908383343680301,1.0,12/31,14.97%,DLG2;OPHN1;PARD3B;PARD3;LIN7A;SYNJ2BP;SH3BP1;MARK2;DLG1;RHOA;DLG3;ANK1
prerank,positive regulation of signal transduction (GO:0009967),0.3586408531762183,1.1275170309432407,0.21283095723014256,0.6961664276891182,1.0,45/238,15.64%,CCBE1;F7;SASH1;VWF;ZMIZ1;ERN1;LANCL2;MGAT5;IL6;ITGA5;FAS;CD63;SNX5;ASXL2;LY96;PTEN;CITED2;SORL1;IGF1;RWDD3;MAML1;MAML2;CREBBP;SULF2;SLC39A14;PTK2B;SIRT1;MT3;WLS;NOTCH1;PRKCB;TREM2;SULF1;IL7R;MACF1;ATP6V0C;GAS6;TNFAIP3;BAX;PHIP;ATP6AP2;DEPDC1B;ASXL1;NLGN2;CDC73
prerank,detection of visible light (GO:0009584),0.48434578402471773,1.1274842522377462,0.3193863319386332,0.6957364138240627,1.0,1/16,2.42%,GNAQ
prerank,response to tumor necrosis factor (GO:0034612),0.37554275355357775,1.1274797340253884,0.28955866523143164,0.6952295731601027,1.0,24/91,19.46%,NFE2L2;ADAM9;TANK;RIPK1;PID1;NUB1;ZFP36L2;BRCA1;MAP4K3;SIRT1;ARHGEF2;BAG4;ZFAND6;RELA;ERBIN;ACOD1;CX3CL1;YTHDC2;CCL7;CASP3;GCH1;TNFRSF21;ASAH1;CCL25
prerank,embryonic digestive tract development (GO:0048566),0.47276094773311517,1.1273793735918323,0.32167832167832167,0.6950068338293715,1.0,5/18,10.79%,STRA6;ID2;NIPBL;PKDCC;RBPMS2
prerank,protein ADP-ribosylation (GO:0006471),0.4456406780461324,1.127334174738477,0.3052362707535121,0.6946080547317023,1.0,11/28,18.04%,TIPARP;PARP4;PARP2;SIRT6;PARP3;ZC3HAV1;SIRT1;TNKS;SIRT3;ARF4;TNKS2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.37527291783352346,1.1272199622974353,0.28955866523143164,0.694381477904252,1.0,38/101,24.60%,SAMD4A;ATG7;VIM;NR1H3;IL6;CD28;YTHDF3;FGFR4;ATG10;THBS1;TBC1D10A;EIF6;LARP4B;MSN;NAT10;CYFIP2;STUB1;HNRNPD;VPS11;EIF4A3;RPL26;AURKAIP1;BCL3;EIF3C;LARP4;OGT;PCIF1;NR1H2;VPS35;PRKDC;UPF3A;FAF1;ASPSCR1;EZR;ZCCHC4;PLXNB2;CASP8;SOX4
prerank,positive regulation of embryonic development (GO:0040019),0.4769613695523609,1.1271995561115626,0.33112582781456956,0.6939227449644576,1.0,3/19,10.45%,B4GALT5;NIBAN2;CFL1
prerank,cardiac ventricle development (GO:0003231),0.4742353019618323,1.1268008148136373,0.33774834437086093,0.6944943241350167,1.0,2/20,1.11%,TMEM65;STRA6
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5338484046973618,1.126723413378846,0.3470948012232416,0.6941973857539944,1.0,4/10,15.53%,NR1H3;NINJ1;TICAM2;LBP
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.5148244017582975,1.126600237801141,0.34332833583208394,0.6940203466741577,1.0,3/13,15.42%,CBLB;CHMP6;CBL
prerank,JNK cascade (GO:0007254),0.41954975228435176,1.1261089504900297,0.3165644171779141,0.6948408545361713,1.0,8/40,11.55%,GPS1;IRAK2;RPS27A;UBC;MAP4K3;MAP2K4;PTGER4;TAB2
prerank,GPI anchor biosynthetic process (GO:0006506),0.4336998372576308,1.1258877077130804,0.3178893178893179,0.69491292609193,1.0,7/30,15.13%,PGAP3;DPM2;PIGH;PGAP1;PIGX;PIGC;PIGQ
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3640362228573813,-1.1258104141006322,0.2719665271966527,0.6934701263520204,1.0,8/22,20.32%,SPRED1;ATM;ATR;RPL37;SPRED2;SPRED3;CDK5RAP3;CHD5
prerank,negative regulation of immune system process (GO:0002683),0.4930064592838935,1.1255168688167492,0.34347826086956523,0.6954178104839019,1.0,4/16,12.97%,FOXP3;FCRLB;HMOX1;COL3A1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5209364451347669,1.1253773404230316,0.3429811866859624,0.6952957127121832,1.0,3/12,15.85%,APOBEC1;MPHOSPH8;DNMT1
prerank,photoperiodism (GO:0009648),0.4467357011067242,1.1252601770413158,0.3324607329842932,0.6951069977142391,1.0,10/28,18.84%,ID2;FBXL17;FBXL3;CRTC1;SIK1;BHLHE40;PPP1CA;PER3;CRY1;CLOCK
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3854744559652091,1.1249722789149168,0.2844638949671772,0.6953881116158239,1.0,30/78,23.37%,NFE2L2;RNF19A;SIRT6;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;PRKN;HSPA1A;HECTD1;UBQLN2;KEAP1;SGTA;BBS7;BCAP31;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP;HERPUD1;ARIH1
prerank,renal absorption (GO:0070293),0.5443496781430308,1.1247940868906463,0.33990895295902884,0.6953529415372537,1.0,1/10,0.58%,SGK1
prerank,embryonic digit morphogenesis (GO:0042733),0.4794634044368385,1.1245103749603906,0.32833787465940056,0.695670227089474,1.0,3/18,6.44%,MAP3K20;CREBBP;WDPCP
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.42083670415672886,1.1229716673159837,0.32735961768219835,0.6993920965663906,1.0,11/37,15.02%,RNASE3;ENTPD1;DFFB;ADPRM;DNASE1L1;SND1;SIDT2;RNASEH2A;HNRNPD;RNASEH1;MTREX
prerank,protein deneddylation (GO:0000338),0.5572794233328345,1.1227425663083983,0.3614457831325301,0.6995391518236377,1.0,3/10,12.63%,GPS1;COPS5;COPS7A
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.462878307012553,1.1227393526420066,0.3441295546558704,0.6990309073147464,1.0,7/22,19.06%,LILRB1;TNFRSF1B;SPHK2;BTK;TRIL;TNFRSF14;SCIMP
prerank,artery morphogenesis (GO:0048844),0.4340272533405351,1.1221570746532725,0.3181242078580482,0.7001167502861471,1.0,7/30,11.88%,STRA6;VEGFA;LRP1;TFAP2B;FOLR1;BMPR2;NOTCH1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.45398956957792436,1.1217918331255272,0.32729624838292365,0.7005621386456008,1.0,9/25,22.53%,BCL2L11;PPIF;MLLT11;BAX;BNIP3;BID;BBC3;PDCD5;PLAUR
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.45666841958677135,1.1216581926388303,0.33245033112582784,0.700428747229045,1.0,5/21,13.63%,ABCB7;ABCD1;BRCA1;MT3;PRKN
prerank,peroxisomal membrane transport (GO:0015919),0.447686935337285,1.1213449322248756,0.3390501319261214,0.7007970331891388,1.0,7/27,12.77%,RAB8B;ABCD1;PEX7;PEX14;ALDH3A2;PXMP2;GDAP1
prerank,regulation of synapse organization (GO:0050807),-0.3504348231240028,-1.1213174511938004,0.2922374429223744,0.7037159895590082,1.0,3/26,0.68%,MEF2C;IL1RAPL1;CTNNA2
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3807743598313734,-1.1210986837045698,0.29333333333333333,0.7020285532529444,1.0,5/20,15.87%,RPGRIP1L;BICD1;GRK2;STMN1;RGS2
prerank,regulation of mitochondrial fission (GO:0090140),0.45026708735053544,1.1210528342800663,0.33506493506493507,0.7010962339495532,1.0,5/24,15.63%,DDHD1;MYO19;INF2;PRKN;BNIP3
prerank,7-methylguanosine RNA capping (GO:0009452),0.4422818501856294,1.1210057897356704,0.3161209068010076,0.7001838364596938,1.0,11/31,20.22%,POLR2A;GTF2H5;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;MNAT1;RAMAC;CMTR2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.4422818501856294,1.1210057897356704,0.3161209068010076,0.7001838364596938,1.0,11/31,20.22%,POLR2A;GTF2H5;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;MNAT1;RAMAC;CMTR2
prerank,microtubule anchoring at centrosome (GO:0034454),0.5503665989036881,1.120950049169233,0.34850863422291994,0.6998072945399613,1.0,2/10,7.51%,HOOK3;KIF3A
prerank,defense response to virus (GO:0051607),0.37284189475083923,1.1208846252734506,0.2802139037433155,0.6994533278510457,1.0,22/100,16.47%,LYST;TLR8;LILRB1;ATG7;IFITM1;IL6;IFNAR2;RNASEL;RNF135;IRF2;AKAP1;IFITM2;MAVS;CNOT7;BST2;PQBP1;ATAD3A;RELA;ACOD1;BNIP3;MYD88;IFIT2
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4202010545916289,1.1198819801081303,0.3217821782178218,0.7017297462173894,1.0,14/40,21.48%,FBXW7;PTEN;GNA12;NUB1;RPL23;RAD23A;CSNK2A2;HIPK2;PTK2B;LATS1;CSNK2A1;SGTA;XPO1;TAF1
prerank,actin cytoskeleton reorganization (GO:0031532),0.3921194365588352,1.1198486605949438,0.31363636363636366,0.7013119550659087,1.0,6/63,1.74%,DTNBP1;GRB2;NEDD9;ANXA1;RAP2A;MICALL2
prerank,regulation of osteoblast proliferation (GO:0033688),0.4799880082072578,1.119551273124053,0.3245492371705964,0.7016410582780254,1.0,5/17,18.62%,HPSE;TNN;CCN1;NELL1;SOX8
prerank,glycerophospholipid catabolic process (GO:0046475),0.4427693333055108,1.1189889750197937,0.32614213197969544,0.7026790692814971,1.0,6/27,14.92%,PLA2G7;GPCPD1;PLA2G4F;INPP5F;GDE1;PRDX6
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.39449334264582325,-1.1187803373846077,0.3115264797507788,0.7061068069081076,1.0,10/15,30.50%,LIMK1;RPL5;SMAD7;BAG5;PARK7;BAG2;MAD2L2;ABL1;MAD2L1;DTX3L
prerank,steroid catabolic process (GO:0006706),0.5298000501679337,1.1184402601594545,0.35071090047393366,0.7036489812160648,1.0,2/10,17.12%,SPP1;HSD17B11
prerank,metal ion transport (GO:0030001),-0.2797970533184073,-1.1184371103956443,0.20652173913043478,0.7048269967309673,1.0,20/86,15.94%,CACNA1E;RYR3;CCR5;CDH23;TRPC1;CACNA1C;GRIN3A;RYR2;ATP2C1;NDFIP2;RAMP1;TRPM2;NIPAL2;TRPC4;CAMK2A;PKD2;ATP2B2;CACNA2D1;CACNG3;CCR1
prerank,negative chemotaxis (GO:0050919),-0.3204698586097796,-1.1181458094186862,0.28054298642533937,0.7034762776770558,1.0,9/33,14.47%,UNC5C;ROBO1;SLIT1;SEMA4G;SEMA3E;SEMA3A;EPHA7;SEMA6A;RHOA
prerank,negative regulation of B cell proliferation (GO:0030889),0.5317279314570554,1.1181159641938117,0.3601236476043277,0.7040444393541991,1.0,4/11,19.77%,CD300A;TYROBP;TNFRSF21;FCGR2B
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.41273551310510936,1.1179999378508345,0.3086269744835966,0.7038402673592382,1.0,12/43,18.20%,PRKCD;SNX5;ENPP1;PID1;SLC27A4;PTPRE;SORL1;SIRT1;PRKCB;PTPN1;PIP4K2A;ZBTB7B
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.4345680119070381,1.1177129030256385,0.32875,0.7041323436995771,1.0,9/35,12.58%,IQGAP2;BAIAP2;ABL2;NOTCH2;STAP1;PTK2B;FES;BCAS3;HCLS1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.43316726074389705,1.1177091023867727,0.31313131313131315,0.7036251709470372,1.0,10/34,20.64%,ANXA1;ERN1;VEGFA;PIK3CA;NOTCH1;RELA;NRP1;GAS1;GAB1;MT1G
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.36158646279964257,1.1176390382971872,0.28024819027921405,0.7033003975733291,1.0,38/149,18.84%,CD36;RAB7B;PRKCH;FLOT1;IRAK2;TFRC;IL6;RIPK1;TRIM25;ADAM8;NFKBIB;IRAK3;HSPA1B;RPS27A;UBC;NLRC4;RIPK4;MTPN;ARHGEF2;APP;TAB2;TRAF1;PRKCB;ROR1;BTK;RELA;HSPA1A;CX3CL1;TRAF5;MYD88;TRAF2;SLCO3A1;ERC1;ZBTB7A;TRIM14;UBE2V1;CARD11;CLOCK
prerank,regulation of heart contraction (GO:0008016),-0.2582865778470779,-1.1175680834165538,0.140625,0.7027552776566247,1.0,17/90,12.39%,ATP1B1;RYR3;ANK2;ITPR2;TRPC1;ASPH;ATP1A2;RYR2;ATP1B2;SMAD7;ATP2B3;TGFB2;CELF2;PRKACA;ATP2B2;ATP2B4;AGT
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.43446517274164415,1.1167871129331404,0.329923273657289,0.7051935609244647,1.0,15/28,26.97%,IRAK2;RPS27A;UBC;TAB2;RELA;TNFAIP3;UBE2V1;AAMP;IRAK1;TRAF6;CASP8;TAB1;MAP3K7;TAB3;CYLD
prerank,protein polymerization (GO:0051258),0.39670258767795874,1.1164663299182116,0.3033838973162194,0.7056004582217039,1.0,9/56,6.64%,DIAPH1;MICALL2;MSRB1;PSTPIP1;CENPJ;UBE2K;CHMP2A;RNF135;GPX4
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.4107219910517049,1.116309192136839,0.32068543451652387,0.7055524844218308,1.0,6/38,7.23%,SASH1;TLR8;ANKRD17;LY96;ADAM8;CYBA
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.400347813578927,1.116083572007915,0.3130841121495327,0.7056849563960316,1.0,7/52,5.48%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;STAC2
prerank,urogenital system development (GO:0001655),0.5276373550969464,1.1157575066843621,0.3488372093023256,0.706089854798179,1.0,2/11,9.86%,ANXA1;PAX8
prerank,regulation of endothelial cell proliferation (GO:0001936),0.38237725721526106,1.1157019996265718,0.3062568605927552,0.7057189268414589,1.0,12/88,10.98%,HTR2B;XDH;APOE;VEGFA;NRP2;THBS1;NRAS;ACVRL1;VASH2;BMPR2;SIRT1;ATP5F1A
prerank,purine ribonucleotide catabolic process (GO:0009154),0.45874296256526903,1.1156498527574206,0.3418918918918919,0.7053342902374037,1.0,4/21,9.10%,XDH;AMPD3;NT5C2;NT5E
prerank,regulation of chromatin organization (GO:1902275),0.5043177595311266,1.1151449410104903,0.33991537376586745,0.7061836916303686,1.0,7/14,26.81%,TLK1;HNRNPU;MLLT3;TLK2;SETD5;IGF2;METTL4
prerank,mitochondrial translational termination (GO:0070126),0.38031804096965366,1.114508036003882,0.3064516129032258,0.7074916430034865,1.0,27/88,20.07%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL28;MRPL30;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5442443066464244,1.114076642817201,0.3501577287066246,0.7081863409206299,1.0,3/10,14.51%,RENBP;NAGK;GNPDA1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.42784361389047126,1.1132504219923312,0.32955974842767294,0.70994482367729,1.0,8/36,13.23%,MAP3K20;ERCC6;BRIP1;E2F1;DOT1L;NBN;FBXO6;INTS7
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.34346933536468266,-1.1129066604043971,0.28773584905660377,0.7135086138511416,1.0,6/29,7.55%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14
prerank,negative regulation of gluconeogenesis (GO:0045721),0.5320822405034411,1.1128578141601233,0.34992458521870284,0.7105074685080804,1.0,4/11,20.34%,SIK1;PGP;CRY1;GCK
prerank,endochondral bone morphogenesis (GO:0060350),-0.4528745952426308,-1.112673767077366,0.31333333333333335,0.7118836704210152,1.0,8/11,31.00%,MEF2C;TMEM119;FGFR3;FOXC1;INPPL1;COL13A1;SCX;BMP4
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.5013199234634409,1.1125766820426202,0.3413940256045519,0.7107265790082805,1.0,5/15,16.31%,LRP1;IL6;FGFR4;CLASP1;MELTF
prerank,microvillus organization (GO:0032528),0.5082604607157915,1.1124940927004752,0.3653566229985444,0.7104283085265887,1.0,3/13,10.17%,RAP2A;TNIK;RAP2B
prerank,histone H2A monoubiquitination (GO:0035518),-0.3823023710861112,-1.1124823854255634,0.28776978417266186,0.7101741332646677,1.0,6/17,14.67%,PCGF3;DDB2;TRIM37;RYBP;BCOR;PCGF2
prerank,early endosome to Golgi transport (GO:0034498),0.5204317336101838,1.1124252731313484,0.3458528951486698,0.7101028830976915,1.0,3/11,13.84%,SNX8;STX5;TRAPPC10
prerank,histone H4-K16 acetylation (GO:0043984),0.46439994583006017,1.1123537562168526,0.34535367545076284,0.7097823985444808,1.0,7/19,22.41%,KANSL1;PHF20;ING4;MCRS1;KMT2A;OGT;KANSL3
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5375163011166058,1.1121894054070065,0.3500784929356358,0.7097058306754459,1.0,2/10,13.43%,LILRB1;FGR
prerank,DNA double-strand break processing (GO:0000729),-0.3816683888467577,-1.11194972915976,0.3146853146853147,0.7094274442603797,1.0,7/18,20.48%,EXD2;ATM;RAD50;UBE2V2;UBE2N;SMARCAD1;SETMAR
prerank,stress-activated MAPK cascade (GO:0051403),0.38951307425351994,1.1114594821048667,0.3150684931506849,0.7112117948803791,1.0,22/61,26.53%,MAP3K20;GPS1;IRAK2;RPS27A;UBC;MAP3K8;MAP4K3;MAP2K4;PTGER4;TAB2;CUL1;SH2D3C;UBE2V1;CCM2;IRAK1;TRAF6;TAB1;ZFP36;MAP3K7;TAB3;MAP3K12;MAPK14
prerank,leukotriene biosynthetic process (GO:0019370),0.5000565127484422,1.1113778255431606,0.3486646884272997,0.7109521653571113,1.0,3/14,11.96%,MGST2;LTA4H;GGTA1
prerank,lung epithelium development (GO:0060428),0.5367836862767963,1.1110177164467445,0.34810126582278483,0.7114231769425894,1.0,1/10,1.11%,STRA6
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.4789210638280848,1.1108579070702305,0.3460490463215259,0.7113359969236571,1.0,7/17,17.57%,BAIAP2;STAP1;FES;BCAS3;HCLS1;NRP1;TEK
prerank,embryonic axis specification (GO:0000578),-0.4025724891326189,-1.110726471013065,0.29354838709677417,0.7103183119197927,1.0,4/15,14.10%,PTCH1;CXXC4;SMAD2;TASOR
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.39671384354794553,-1.1105179662361881,0.31666666666666665,0.7087066289577154,1.0,8/15,22.62%,UST;B3GAT3;CSGALNACT1;DSEL;BCAN;CSPG4;NCAN;CHST12
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.4343723391779792,1.1096838058784984,0.34227330779054915,0.7140804933441491,1.0,4/33,7.09%,PPARG;CDKN1A;PTEN;HMOX1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.364491667817792,1.1096753797971795,0.3,0.7135830748075419,1.0,23/119,13.93%,PIK3R5;MTM1;PIKFYVE;MTMR3;PGAP3;DPM2;ITPKB;INPP4A;PTEN;TMEM150A;SOCS6;FIG4;PIK3CA;PIGH;PIK3C2G;SLC27A1;PLEKHA1;TTC7B;PI4K2A;PIGC;OCRL;INPP5F;EFR3A
prerank,multivesicular body organization (GO:0036257),0.43627303603493794,1.1095105102771297,0.34411384217335056,0.7135263827112619,1.0,12/31,21.82%,STAM;CHMP2A;PDCD6IP;VPS4A;CHMP6;SNF8;STAM2;CHMP5;CHMP7;VPS36;CHMP2B;VPS37B
prerank,BMP signaling pathway (GO:0030509),-0.27980138127950993,-1.1094929225027284,0.21904761904761905,0.7094126942278305,1.0,16/62,13.54%,ACVR1;SMAD3;BMPR1A;ACVR2B;HIVEP1;SMURF1;MEGF8;RGMB;ENG;SMAD1;SMAD7;PDCD4;TGFB2;RGMA;SMAD2;TMEM100
prerank,pulmonary valve development (GO:0003177),0.4663658074756648,1.1093316296087192,0.33741496598639453,0.7134801352543718,1.0,5/18,11.88%,STRA6;TNFRSF1B;NOTCH2;BMPR2;NOTCH1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.5219389157342517,1.1091244537601768,0.3374045801526718,0.7135145810749486,1.0,1/12,0.55%,XDH
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.47397457055253456,1.1089746185285505,0.343878954607978,0.7134336676578876,1.0,6/17,16.35%,TFAP2B;XIAP;FSTL1;SULF1;ITGA3;ZDHHC17
prerank,respiratory system development (GO:0060541),0.4274204300666074,1.108919505768199,0.3103448275862069,0.7130780977916641,1.0,7/32,17.37%,STRA6;VEGFA;CCDC40;ABCA3;ITGA3;CHD7;NKX2-1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5224103079133896,1.108793363020109,0.3767019667170953,0.712915683139728,1.0,5/10,22.43%,RIC1;ANXA2;NELL1;EPHA4;FURIN
prerank,actin filament organization (GO:0007015),0.3610030382596226,1.108675392590282,0.27347781217750256,0.7127203099893531,1.0,24/151,11.53%,MYO5A;GAS2L3;VILL;NEDD9;RUFY3;CORO1C;BAIAP2;MYO1E;LCP1;BIN3;ABI1;ACTN1;CAPG;TRIOBP;MYO19;SVIL;PPP1R9B;TPM3;MYO1F;ARHGAP17;RHOD;ARHGEF2;TPM4;PLS3
prerank,response to UV-A (GO:0070141),0.49624703179606405,1.1085121962509457,0.3538681948424069,0.7126623077495708,1.0,1/14,0.97%,TIMP1
prerank,mitotic recombination (GO:0006312),0.4865543068169791,1.1082441267555598,0.35664335664335667,0.7129380336804938,1.0,2/15,4.72%,NSMCE2;TEP1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5243956666598393,1.108242682188036,0.37388724035608306,0.7124354162066682,1.0,1/11,0.68%,SYK
prerank,base conversion or substitution editing (GO:0016553),0.5300883832337083,1.1079525824915029,0.362406015037594,0.71271826519734,1.0,1/11,0.51%,APOBEC1
prerank,peroxisome organization (GO:0007031),0.44514553929866335,1.1077165354576601,0.3455019556714472,0.7128302028235222,1.0,6/25,12.40%,ABCD1;PEX11A;PEX7;PEX14;PLAAT3;LONP2
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4055424494350081,1.1076950683426101,0.3234597156398104,0.7123896941234706,1.0,11/47,18.05%,NEDD9;CORO1C;DOCK5;TRIOBP;RREB1;OLFM4;FBLN1;DOCK1;NRP1;MELTF;C1QBP
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5348965124322513,1.1076039976629846,0.3640552995391705,0.7121553051486075,1.0,3/10,11.90%,ITGA5;MT3;PRKCB
prerank,mitochondrion organization (GO:0007005),0.35550214030062244,1.1075701437123546,0.28600823045267487,0.7117335049438873,1.0,49/165,20.53%,MTM1;MPV17;CHCHD4;TIMM22;PID1;LONP1;MTFR1L;IMMP2L;PITRM1;AIFM2;POLG2;TOMM20;TIMM17A;VPS13D;AFG1L;MTFP1;GABPB1;CYCS;VPS13C;ATP5F1D;TIMM17B;TMEM70;POLRMT;OMA1;GDAP1;PPRC1;ATAD3A;SSBP1;PRKN;BAX;ATP7A;NDUFS1;BNIP3;TWNK;HSPD1;BID;TOMM34;SIRT3;IFIT2;RAB29;TFB2M;GABPA;TOMM7;TOMM22;USP30;FBXO7;AFG3L2;BCAP31;FMC1
prerank,regulation of TOR signaling (GO:0032006),0.3884099936886694,1.1075485334282094,0.3239277652370203,0.7112910518913935,1.0,23/67,21.87%,FNIP1;HTR6;GNA12;PIK3CA;FLCN;EPM2A;LAMTOR1;SIRT1;FBXO9;TREM2;MIOS;SLC38A9;LAMTOR3;DGKQ;GAS6;NPRL3;GOLPH3;GPAT3;NPRL2;RHEB;AKT1S1;RICTOR;TTI1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.447871762270755,1.1071462815584499,0.348,0.7118950035280284,1.0,5/24,14.42%,LILRB1;EIF2AK4;MAVS;PQBP1;TRAF3IP2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.5067085376080954,1.1062173527463273,0.35703479576399394,0.713968315301391,1.0,2/13,11.08%,APOE;ERLIN1
prerank,positive regulation of viral life cycle (GO:1903902),0.4551093202549936,1.105934408615754,0.33378196500672946,0.7142345757694427,1.0,5/22,9.98%,TMPRSS4;KPNA2;CHMP2A;VPS4A;DDB1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4940743489992062,1.1059237108040505,0.34576757532281205,0.7137587190926663,1.0,4/15,13.63%,HGF;IGF1;PPIF;PRKN
prerank,regulation of superoxide anion generation (GO:0032928),0.49217779045099735,1.1058797073801003,0.34365781710914456,0.7133813917365982,1.0,3/14,8.66%,SYK;PRKCD;TYROBP
prerank,positive regulation of vacuole organization (GO:0044090),0.5205154197165868,1.1057886507111705,0.36850152905198774,0.7130928977061267,1.0,7/10,24.91%,SH3GLB1;ANXA2;RAB3GAP2;GRN;PIP4K2A;RAB3GAP1;PIP4K2C
prerank,cell cycle checkpoint signaling (GO:0000075),0.5227171811067837,1.1053799715678196,0.3699851411589896,0.7137302001397926,1.0,2/12,2.83%,WEE2;PLK2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.45692075725572956,-1.1050580695343668,0.3708791208791209,0.719002286458508,1.0,2/10,3.32%,BIN1;ATP1A2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.44965024549196114,1.1047838235527168,0.3477124183006536,0.7149277082709374,1.0,5/25,9.77%,CD200R1;ITGA5;ITGA4;NINJ1;ITGB1
prerank,ion homeostasis (GO:0050801),-0.32986325258612925,-1.1047409293135269,0.2850877192982456,0.7176358607415831,1.0,8/30,12.13%,SLC4A7;UNC80;WNK3;SLC4A10;SLC4A8;WNK2;SLC4A2;WNK1
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.44874139245798617,1.1045405281993375,0.34974093264248707,0.7151091474104456,1.0,10/25,22.13%,FBXL17;LONP1;CUL3;ZER1;STUB1;OMA1;UGGT1;ATXN3;TOR1A;VCP
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3569750403616901,1.1043747166313909,0.30031612223393045,0.715035641829449,1.0,34/114,22.88%,ST18;FOXO3;PSMD1;RIPK1;TNFRSF1B;ADAM17;PTK2B;BIRC3;PSMF1;BAG4;PSMD14;TRAF1;PSMD12;TRAF3;RELA;PSME2;TRAF5;TRAF2;LTB;LTBR;TNFRSF14;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;TXNDC17;PSMB3;ILK;PSME3;JAK2
prerank,positive regulation of defense response (GO:0031349),0.3704949304877367,1.1041304037244495,0.3478735005452563,0.715224020386875,1.0,12/89,12.24%,PLA2G7;OPTN;TLR8;MGST2;TNIP1;RIPK1;NINJ1;ADAM8;CYBA;PTGER4;APP;IL15
prerank,regulation of Rac protein signal transduction (GO:0035020),0.4842254145342215,1.1037410299595525,0.3601694915254237,0.7157405812803515,1.0,1/16,0.07%,ARHGAP24
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5108395641276,1.1035819807683165,0.3696682464454976,0.7156602508315243,1.0,5/12,20.44%,STX3;SNAP29;STX11;SNAP47;SNAP23
prerank,negative regulation of intracellular protein transport (GO:0090317),0.4469633736355421,1.1034960418643334,0.3492286115007013,0.7153949974965713,1.0,1/22,0.14%,MDFIC
prerank,cell junction organization (GO:0034330),-0.2710425594676414,-1.1032341156517393,0.2653061224489796,0.7196466389755097,1.0,15/71,10.46%,GRM5;OPHN1;SDK1;SMAD3;CTNND2;VASP;MAPT;PPFIA4;SEMA3E;SH3BP1;AGRN;TGFB2;SLC6A1;FERMT2;NLGN3
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.4465681346302698,1.1027965498158827,0.33288590604026846,0.7168080471009488,1.0,5/23,13.76%,MTM1;MTMR3;PTEN;OCRL;INPP5F
prerank,response to reactive oxygen species (GO:0000302),0.3949351496567358,1.1024271939624586,0.347926267281106,0.7173430547131955,1.0,10/54,13.10%,APOE;MPV17;ADAM9;JUN;STK24;HMOX1;CAT;HP;SIRT1;ERCC6L2
prerank,transcription by RNA polymerase II (GO:0006366),0.3515475571606563,1.102336003769776,0.22828282828282828,0.7170793503214831,1.0,90/305,21.95%,PPARG;TSC22D1;POLR2A;ERCC6;NR1H3;E2F3;AFF4;CPSF1;RXRA;NCOR1;NOTCH2;RARA;GTF2H5;GTF2B;TAF7;PCID2;MAML1;NR3C1;MAML2;NR1H4;INTS9;DDX5;CREBBP;CSTF3;ATF4;TAF5;POLR2L;RREB1;RPAP2;WDR33;CBFB;INTS6;TBL1XR1;SNAPC1;NR5A1;NR2C1;INTS1;ESR1;POLR2G;INTS13;INTS8;MED16;CDK7;MED26;POLR2I;PPARD;NCBP2;TRIP11;NOTCH1;RORA;GTF2F2;MAZ;NRBF2;INTS5;INTS7;ICE2;INTS2;CTDP1;POU2F1;SNRPF;GTF2A1;MLLT1;MNAT1;SSU72;CDC73;ELP4;TAF5L;TAF15;NELFE;MLLT3;ZBTB7B;CCN2;E2F2;TAF1A;CDK13;NFX1;NFIC;NR2F1;WWTR1;DTX1;NFE2L3;SNRPB;ABT1;HNF4G;TAF1;NR1H2;RARB;LSM11;SNAPC4;CCNT1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.4136287333711783,1.1023262437970418,0.33492252681764006,0.7166054506827825,1.0,15/40,25.29%,BCL2L11;HGF;IGF1;PPIF;MLLT11;PRKN;BAX;BNIP3;BID;BBC3;PDCD5;PLAUR;BCL2L1;GPX1;FXN
prerank,plasma membrane tubulation (GO:0097320),0.49786634611744907,1.1023055354520197,0.3460410557184751,0.7161575241555719,1.0,5/13,14.25%,BIN3;SNX9;MICALL1;SNX33;WHAMM
prerank,regulation of smooth muscle contraction (GO:0006940),-0.36607805900184653,-1.1018710895279171,0.3062730627306273,0.7212946879291641,1.0,5/20,11.47%,KCNB2;CHRM3;CHRM2;DAPK3;NMU
prerank,mitotic metaphase plate congression (GO:0007080),0.3914624252999152,1.1014867539272433,0.33651551312649164,0.7179372122783401,1.0,12/51,17.52%,SPDL1;PIBF1;CUL3;CHMP2A;EML3;PDCD6IP;BOD1;VPS4A;CHMP6;CHMP5;CDT1;CHMP7
prerank,positive regulation of signaling (GO:0023056),-0.3112852794633145,-1.1014232238938828,0.2677595628415301,0.7203644800351443,1.0,8/37,11.47%,SYT1;RIMS1;RIMS2;GRIK2;CD80;HOMER1;ECE1;NMU
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2675767891698876,-1.1008319757627547,0.25,0.7199395637319229,1.0,12/80,5.48%,P2RY12;TENM2;GPM6A;TWF2;NLGN1;AUTS2;ABI2;PLPPR5;RIPOR2;ANLN;NCKAP1;FMR1
prerank,fatty acid beta-oxidation (GO:0006635),0.40094400525095136,1.1003082208054584,0.33602771362586603,0.7206364920010673,1.0,22/51,25.81%,AMACR;ABCD1;HADHA;MTLN;ACADL;ACADVL;CRAT;PPARD;ECHDC1;EHHADH;ACAA2;GCDH;ACAD10;DECR2;SLC25A17;ETFA;IVD;SCP2;ABCD2;ACOT8;HSD17B4;CPT2
prerank,positive regulation of histone modification (GO:0031058),0.41557066593132386,1.1002439472449124,0.3583227445997459,0.7203151224425887,1.0,6/33,9.03%,APLNR;FOXP3;CHTOP;NIPBL;BRCA1;BRD7
prerank,mesenchyme development (GO:0060485),-0.410912692761643,-1.0998518234899863,0.3310344827586207,0.7204139367345547,1.0,10/15,37.44%,FGFR2;TGFBR1;PKD2;CRELD1;BMP2;BMP4;BMP7;HMGA2;ISL1;SFRP2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.34166554361552437,1.0996169939269722,0.085,0.7214630046843752,1.0,208/1082,16.62%,EPAS1;PPARG;MDFIC;MMP12;CD38;NAMPT;TFEC;APOE;MRTFA;LITAF;ELF2;MRTFB;ZMIZ1;ATP1B4;IRX3;TFEB;LPIN3;LILRB1;NFE2L2;CTNNB1;MITF;NCK2;VEGFA;CEBPB;ERCC6;ZEB2;GRHL1;FOXP3;IER5;ST18;ATF3;CXXC1;SPP1;ALYREF;VEZF1;RUNX2;NR1H3;E2F3;ID2;LMO1;IL6;HGF;FOXO3;TNIP1;NIBAN2;WAC;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;RIPK1;ASXL2;HNRNPAB;RARA;MAP2K5;MZF1;CITED2;PID1;FOXO4;E2F1;TAF7;IGF1;HAS3;MAPK7;PCID2;MAML1;STAT5B;COL1A1;RNF10;AGO2;NUFIP1;GLMP;NR3C1;TCERG1;RNASEL;NSD3;CRTC1;MAML2;MLLT11;NR1H4;CREBBP;DOT1L;FLCN;THOC1;MLLT10;DYRK1A;HNRNPU;KLF5;TET3;ATF4;REL;RPS27A;UBC;KDM3A;RREB1;POU3F1;TCF20;ACVR2A;BRCA1;ACTR3;EPC1;GABPB1;GABPB2;IRF2;NCOA3;DVL1;ACVRL1;COPS5;BRD7;TBL1XR1;PICALM;HIPK2;PPP3CA;TET2;NCOA1;BMPR2;NR5A1;DDIT3;PAXBP1;FZD7;PAX8;MAVS;ESR1;PPP3R1;FOXK1;POU3F3;MAFB;FOXO1;MED16;SIRT1;SALL2;KMT2E;ARHGEF2;CDK7;PRPF6;CCN1;NFATC3;PPARD;MT3;BCAS3;CAND2;APP;MYRFL;FZD5;SP3;NOTCH1;RORA;CAMTA2;MAZ;AFAP1L2;HCLS1;FZD2;SMARCC1;SIRT7;PPRC1;RFX5;BCLAF1;SOX2;USP21;USP16;RELA;BCL11B;ICE2;POU2F1;KDM1B;PRKN;SLC11A1;MSANTD1;ZKSCAN3;FOXJ3;SMARCD1;JUNB;GDNF;ATF1;NAT14;PRDM2;HNRNPD;ZNF513;SHC1;MCRS1;PHIP;SQSTM1;LRP6;MAP3K2;INO80;CX3CL1;TNKS;ZFP64;WASL;ARRB1;CDK8;QRICH1;ASXL1;PCBP1;PPARGC1B;KLF6;NHLH2;WWOX;BRPF1;MTF1;THRAP3;NFATC2IP;TCF12;CAMK1;CREB3;CREB3L4
prerank,cellular response to interferon-beta (GO:0035458),0.4963270245554844,1.0995943413424478,0.3638968481375358,0.7210089241001142,1.0,5/14,16.15%,HTRA2;UBE2K;IFITM2;ACOD1;CDC34
prerank,artery development (GO:0060840),0.45393709083387646,1.099471937803747,0.34285714285714286,0.7208233380892873,1.0,5/23,9.37%,APLNR;STRA6;VEGFA;ACVRL1;BMPR2
prerank,pharyngeal system development (GO:0060037),-0.4014900743100118,-1.099160941127711,0.32167832167832167,0.7201471376072439,1.0,4/15,8.69%,PTCH1;BMPR1A;TGFBR1;TGFB2
prerank,mRNA transport (GO:0051028),-0.25671219953355745,-1.099066405782321,0.2537313432835821,0.7182196213524362,1.0,40/101,21.36%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;FMR1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,skeletal muscle organ development (GO:0060538),0.44195440889367366,1.0988962909872078,0.3544137022397892,0.7218677235428377,1.0,3/26,7.27%,STRA6;IGSF8;SVIL
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.45550964665898686,-1.0987859473671853,0.3448275862068966,0.7168159996978029,1.0,6/10,19.47%,TGFBR2;FGFR2;LRP5;STAT1;SOX9;MYC
prerank,negative regulation of cellular protein localization (GO:1903828),0.4173676838805391,1.0986197269251825,0.3463414634146341,0.7221175407242186,1.0,13/34,20.51%,FLCN;MFHAS1;NEDD4L;PICALM;SNX33;GSK3B;LATS1;CTNNA1;CDT1;LEPROTL1;GOPC;DNAJA1;SIN3A
prerank,regulation of defense response to virus by host (GO:0050691),0.4237327193306699,1.0981037938902816,0.3389391979301423,0.7230072350518828,1.0,6/30,14.42%,LILRB1;EIF2AK4;MAVS;PQBP1;TNFAIP3;TRAF3IP2
prerank,mRNA export from nucleus (GO:0006406),-0.25596925131178716,-1.0979665222198178,0.21739130434782608,0.7170358995793461,1.0,40/102,21.36%,IWS1;NUP133;SLU7;SRSF6;SRSF5;FYTTD1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.475589369874415,1.097936680324581,0.3683453237410072,0.7229859244938222,1.0,8/17,22.65%,NPLOC4;FAF2;HM13;RHBDD1;DERL2;TMEM129;VCP;HERPUD1
prerank,negative regulation of MAPK cascade (GO:0043409),0.3723978643814219,1.097460005545423,0.3340587595212187,0.7237517920722598,1.0,16/87,12.18%,APOE;CD300A;PRKCD;TNIP1;PTEN;SORL1;DAG1;DUSP3;PPEF2;IRAK3;FLCN;CNKSR3;SIRPA;FOXO1;FBLN1;STK38
prerank,regulation of BMP signaling pathway (GO:0030510),0.37777405071308456,1.0972697393066873,0.33896396396396394,0.7237909420457426,1.0,15/73,12.74%,PPARG;TFAP2B;SORL1;XIAP;ACVR2A;ACVRL1;HIPK2;BMPR2;FSTL1;RBPMS2;CCN1;NOTCH1;SULF1;ITGA3;LEMD3
prerank,synaptic vesicle membrane organization (GO:0048499),0.47401923835509363,1.0971192261582625,0.354978354978355,0.7237247049432529,1.0,7/17,20.73%,STX3;SNAP29;STX11;AP3D1;SNAP47;SNAP23;TOR1A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4071242417732257,-1.0967453403886116,0.3450479233226837,0.7182361337358923,1.0,3/14,4.37%,MEF2C;BMPR1A;AIF1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.3676004300651307,1.0966858293857302,0.3464052287581699,0.7243459684028386,1.0,35/87,24.48%,CHCHD4;LYRM7;UQCRFS1;IMMP2L;SDHAF3;NDUFS8;NDUFA10;SDHAF4;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;COA5;OMA1;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;UQCC1;NDUFB8;COA3;NDUFAF4;SDHAF2;NDUFB9;NDUFAF2;AIFM1;NDUFA13;TMEM126B;PET100;COA8;DMAC2
prerank,positive regulation of cation channel activity (GO:2001259),-0.3023129904840817,-1.0963488808950286,0.27647058823529413,0.7171517329493254,1.0,11/40,17.41%,ANK2;ANK3;RELN;TMSB4X;NLGN3;ACTN2;PKD2;ATPSCKMT;CCR2;STAC;ANTKMT
prerank,DNA metabolic process (GO:0006259),0.3472352836288081,1.0963429165617264,0.2751004016064257,0.7248039384051749,1.0,63/270,17.53%,ACD;MUS81;RFC3;SRPK2;MUTYH;UVRAG;ZRANB3;PARP4;KPNA2;BACH1;UHRF2;LONP1;PARP2;GADD45A;HELB;DOT1L;PARP3;RPS27A;UBC;NEIL1;TOP1;ENDOV;BRCA1;DFFB;SMC1A;RTEL1;NT5E;TERF1;POLH;XRCC5;DDB1;XRCC2;POLL;DNASE1L1;DDX23;DBF4;MBD4;INIP;NBN;DCLRE1B;KMT5B;WRN;NSMCE3;SIRT7;FBXO6;POLA1;RNASEH2A;RNASEH1;NOC3L;STN1;INO80;NSMCE4A;ORC1;MNAT1;DNMT1;DNASE2;FANCA;CDC34;ORC4;ALKBH1;POLI;CDT1;SMARCB1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3571650119572979,1.0956264040854147,0.29918032786885246,0.726263067214257,1.0,13/152,6.49%,PSAP;ADGRE5;ABCA1;ADGRG3;ADRA1D;GNAQ;GNA13;LPAR2;ADCY7;CNR2;GNA12;ADGRE1;PTGER2
prerank,negative regulation of protein secretion (GO:0050709),0.41344784063124806,1.0946060161707323,0.35511713933415534,0.7285797889330249,1.0,4/38,3.76%,APOE;SERGEF;NR1H3;RHBDF2
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.42996884062810065,1.094552826389542,0.34974747474747475,0.7282284067446355,1.0,9/29,16.45%,RIPK1;HTRA2;THBS1;PAK2;DEDD2;WWOX;BID;TRAF2;LTBR
prerank,cell cycle G1/S phase transition (GO:0044843),0.38745007840631257,1.094360141426043,0.3306818181818182,0.7282706889243772,1.0,19/61,16.15%,PLK2;E2F3;CDKN1A;E2F1;CUL3;CACUL1;RB1;NASP;CDK7;USP26;CCNA2;DBF4;ACVR1B;CUL4A;PPP6C;CUL1;LATS1;MNAT1;CDC34
prerank,regulation of viral transcription (GO:0046782),0.410307952557567,1.0942037059135312,0.35499398315282793,0.7281931155951789,1.0,10/39,17.77%,MDFIC;POLR2A;POLR2L;POLR2G;POLR2I;LARP7;GTF2F2;CTDP1;NELFE;TRIM14
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.41028571709329276,1.0941044817696335,0.337888198757764,0.7279581684591722,1.0,13/37,21.81%,SDCBP;WAC;RPL23;CSNK2A2;HIPK2;N4BP1;CSNK2A1;EIF3H;SGTA;TLK2;OGT;TAF1;GIPC1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3915000864511663,1.0940896984559267,0.35624284077892326,0.7274963888049214,1.0,17/57,22.53%,DDHD1;BCL2L11;HTRA2;PPIF;MLLT11;GSK3B;TREM2;PRKN;BAX;BNIP3;BID;BBC3;HTT;FBXO7;PDCD5;VPS35;PLAUR
prerank,regulation of activated T cell proliferation (GO:0046006),0.42994236928012086,1.0938123952247687,0.3631713554987212,0.7277347497018396,1.0,3/30,5.08%,FOXP3;CD274;IGF1
prerank,cellular response to heat (GO:0034605),0.4105595023036729,1.0935397119798287,0.35398230088495575,0.7280090481488237,1.0,9/35,13.93%,IER5;HTRA2;THBS1;HSPA1B;HMOX1;TPR;STUB1;RBBP7;HSPA1A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.42379782115909803,1.0933333642904135,0.3661616161616162,0.7280811526230703,1.0,11/31,16.75%,DDX6;EXOSC3;EXOSC9;POLR2G;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1
prerank,protein monoubiquitination (GO:0006513),0.40766420827906413,1.0930061467387904,0.3397590361445783,0.7284663244556597,1.0,13/36,24.68%,WAC;TRIM25;CUL3;TOPORS;HUWE1;PRKN;CDC73;UBE2O;UBE2R2;KLHL12;OBI1;UBE2D3;UBE2E1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.25999238682891795,-1.0928518884545306,0.2702702702702703,0.7247536001363366,1.0,39/96,21.36%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,regulation of cell cycle process (GO:0010564),0.36349426746142466,1.0928170653910176,0.32438238453276047,0.7284918881097047,1.0,16/104,12.03%,CCDC8;CTNNB1;KIF20B;PLK2;DYNC1H1;BIRC6;UVRAG;SH3GLB1;APC;MYO19;FLCN;CEP85;CSNK2A2;DBF4;DCUN1D3;SND1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.37510516445252196,1.092205899360948,0.3545554335894621,0.7296775879498191,1.0,23/70,21.38%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;VAV1;ACTR3;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;MYH2;WIPF1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.525154026631302,1.092092356906793,0.3713850837138508,0.7294641724546757,1.0,5/10,19.33%,SPHK2;BRCA1;CAMK1;SMARCB1;KMT2A
prerank,regulation of neurotransmitter transport (GO:0051588),-0.39382043253588,-1.0917679133190168,0.3368055555555556,0.7254893670993109,1.0,7/16,16.84%,MEF2C;RIMS1;SNCAIP;FMR1;CAMK2A;CPLX1;CPLX2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.39839736869152736,1.0915968685738624,0.3425814234016888,0.7303274784847149,1.0,11/42,19.46%,CD36;VEGFA;ROCK1;GSK3B;PTK2B;RRAS;CX3CL1;UTRN;NRP1;TEK;CCL25
prerank,inorganic ion transmembrane transport (GO:0098660),0.5070263515736313,1.0914953874813915,0.3668639053254438,0.7301174482395503,1.0,2/12,7.20%,ATP1B4;P2RX3
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5172137454765628,1.0907328213825145,0.37575757575757573,0.7317011764697562,1.0,2/10,6.26%,RARA;SPHK2
prerank,arachidonate transport (GO:1903963),0.5219263575891778,1.0904336364190896,0.3715170278637771,0.7314926733427051,1.0,3/10,22.02%,ANXA1;ACE;DRD2
prerank,arachidonic acid secretion (GO:0050482),0.5219263575891778,1.0904336364190896,0.3715170278637771,0.7314926733427051,1.0,3/10,22.02%,ANXA1;ACE;DRD2
prerank,actin filament polymerization (GO:0030041),0.4259751340386457,1.0903968328526488,0.3436293436293436,0.7310925733804775,1.0,7/29,16.30%,DIAPH1;MICALL2;MSRB1;PSTPIP1;PSTPIP2;WASL;WASHC3
prerank,negative regulation of nuclear division (GO:0051784),0.5076587244234885,1.0900976809989384,0.37261146496815284,0.7314314368321332,1.0,3/11,18.91%,TOM1L2;AURKAIP1;FBXO5
prerank,anion transmembrane transport (GO:0098656),0.3749448496065549,1.0899741536247958,0.34841628959276016,0.7312849441563046,1.0,17/67,19.68%,LRRC8D;SLC7A2;SLC36A4;SLC25A1;MFSD12;SLC27A1;LRRC8C;SLC6A8;SLC23A2;SLC23A1;SLC25A42;SLC7A1;ABCC1;SLC35A2;SLC19A1;SLC35C2;SLC7A8
prerank,protein homotetramerization (GO:0051289),-0.2906807541025373,-1.0895149416482153,0.25806451612903225,0.7292938607584469,1.0,14/49,16.74%,HCN1;RYR3;ACACA;KCNJ2;TRPM4;TRPM2;SOD2;MCOLN1;APIP;PKD2;PKD2L1;ALDOA;GBP5;OSBPL2
prerank,organophosphate catabolic process (GO:0046434),0.5213342088216704,1.0893549258072472,0.38625954198473283,0.7324930282711133,1.0,2/11,10.92%,LIPG;PLBD2
prerank,peptidyl-lysine modification (GO:0018205),0.366638437732232,1.0893283615434095,0.33225458468176916,0.7320616661458377,1.0,34/99,24.27%,EYA1;NSMCE2;SENP3;SUMO2;ETFBKMT;PIAS4;P3H3;TOPORS;NDUFAB1;TPR;SENP5;NUP50;SIRT1;SIRT7;USPL1;ATP7A;NUP98;SIRT3;SENP7;PLOD1;SENP1;NUP88;PIAS2;BCL11A;PIAS1;NUP188;NDC1;NUP43;NUP54;P3H4;RANBP2;GCSH;EGR2;METTL21A
prerank,homotypic cell-cell adhesion (GO:0034109),0.4088614190113642,1.0891717045267477,0.34981458590852904,0.7320296880852029,1.0,16/39,25.45%,PLPP3;ACTN1;TLN1;RAP2B;STXBP3;MYH9;CLIC1;FIBP;PIK3CB;ACTG1;ILK;FLNA;PPIA;MYL12A;ACTB;ITGB3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.4325330173911885,-1.0888291658129343,0.34818941504178275,0.7290500035093216,1.0,2/11,2.63%,PTPRT;SH2B3
prerank,renal water homeostasis (GO:0003091),0.44129741639090586,1.0884956511341686,0.35834411384217335,0.7332959410382547,1.0,9/23,24.53%,AQP1;TFAP2B;ADCY7;ADCY8;ADCY3;WFS1;ADCY5;ADCY9;RAB11FIP2
prerank,cell part morphogenesis (GO:0032990),0.4956293671506811,1.0882197154293614,0.3800578034682081,0.7335511424795615,1.0,2/13,4.84%,MTM1;PID1
prerank,negative regulation of kinase activity (GO:0033673),0.38631041093893753,1.0877313371569177,0.34949267192784667,0.734331723163009,1.0,12/62,10.74%,DTNBP1;GNAQ;PRKAG2;PDPK1;TAF7;IRS2;GSKIP;HNRNPU;RB1;DVL1;CEP85;PAK2
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4965957098870451,1.0877243728104669,0.37910447761194027,0.7338542833885532,1.0,7/13,25.66%,IRAK2;UNC93B1;EPG5;MYD88;IRAK1;TRAF6;TLR9
prerank,calcium ion homeostasis (GO:0055074),0.36285380176579635,1.087343097657613,0.3344017094017094,0.7343441034322024,1.0,8/95,5.02%,HTR2B;TPCN2;ATP2B1;TFAP2B;ATP13A3;SLC8B1;TMEM165;SLC8A1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.44134279330655934,1.0873311789743367,0.3530961791831357,0.7338722076932318,1.0,10/24,24.24%,DNMT3A;SMYD5;EED;EPC1;RBBP7;MPHOSPH8;DNMT1;PHF1;MTF2;AEBP2
prerank,RNA export from nucleus (GO:0006405),-0.2564247595741449,-1.0870207287842442,0.2878787878787879,0.7318992221325664,1.0,39/100,21.36%,NUP133;SLU7;SRSF6;SRSF5;FYTTD1;SMG6;RBM8A;NUP214;ZC3H11A;AAAS;THOC5;NUP85;POM121;SEH1L;NUP35;MCM3AP;SLBP;SRSF11;NUP37;NUP155;RAE1;DDX39B;NUP153;SRRM1;HHEX;GLE1;U2AF1;CPSF3;MAGOH;SRSF1;MAGOHB;SRSF9;SEC13;THOC6;SMG7;NXT1;HNRNPA2B1;SYMPK;SRSF4
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4311698152401521,1.086981422630276,0.36421319796954316,0.7342976502475193,1.0,8/27,16.99%,PRKCD;ENPP1;PID1;SLC27A4;PTPRE;PRKCB;PTPN1;PIP4K2A
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.34144703250601693,1.086863290204723,0.232,0.7340887477252401,1.0,85/476,14.73%,PPARG;MDFIC;CD38;APOE;ELF2;ZMIZ1;TFEB;CTNNB1;MITF;CEBPB;FOXP3;CXXC1;SPP1;RUNX2;NR1H3;ID2;IL6;FOXO3;NIBAN2;WAC;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;HNRNPAB;RARA;CITED2;E2F1;IGF1;HAS3;PCID2;COL1A1;RNF10;NSD3;MLLT11;NR1H4;CREBBP;DYRK1A;ATF4;KDM3A;RREB1;POU3F1;BRCA1;EPC1;ACVRL1;BRD7;TBL1XR1;PICALM;HIPK2;NCOA1;DDIT3;FZD7;PAX8;ESR1;FOXK1;POU3F3;MAFB;FOXO1;MED16;KMT2E;PPARD;MT3;CAND2;MYRFL;SP3;NOTCH1;RORA;MAZ;AFAP1L2;FZD2;SMARCC1;SOX2;USP21;USP16;RELA;MSANTD1;ZKSCAN3;NAT14;HNRNPD;SHC1;PHIP;LRP6;MAP3K2
prerank,ameboidal-type cell migration (GO:0001667),0.39207296884054726,1.086854859393036,0.3447058823529412,0.733613791377523,1.0,6/51,5.40%,HTR2B;SGPL1;CORO1C;ITGA4;SEMA4B;PKN3
prerank,regulation of axonogenesis (GO:0050770),0.3924494795515536,1.0866144348737985,0.3605600933488915,0.7337619085042657,1.0,6/51,4.72%,PLXNA1;KIF13B;PLXNC1;PLXND1;RUFY3;PTEN
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.523257355112444,1.086519877015823,0.38413685847589424,0.7335258695193856,1.0,5/10,22.95%,MMGT1;EMC2;EMC4;EMC3;EMC10
prerank,positive regulation of developmental process (GO:0051094),0.35271901340675105,1.086100178885736,0.31384615384615383,0.7341879975178391,1.0,35/164,19.40%,DDHD1;B4GALT5;APOE;SLC6A6;VEGFA;CEBPB;CORO1C;TFRC;NIBAN2;LMNA;SORL1;DAG1;AGO2;RREB1;NCOA3;DVL1;BMPR2;CFL1;SIRT1;ACVR1B;KMT5B;PRKN;CLASP1;LLPH;GDNF;RTN4;BNIP3;SHLD1;CAMK1;C1QBP;CCN2;SOX8;FBXO5;CORO1B;PPP1R13L
prerank,ERAD pathway (GO:0036503),0.37088205512526917,1.085769018731638,0.34063526834611174,0.7345459666382924,1.0,33/83,23.39%,TRIM25;UBXN8;NPLOC4;FAM8A1;TMUB2;FAF2;UBXN4;ERLIN1;STUB1;RHBDD1;DNAJB14;FBXO6;PRKN;DERL2;UGGT1;UBQLN2;TMUB1;DNAJC18;TMEM129;SGTA;AMFR;MAN1B1;ATXN3;BRSK2;WFS1;TOR1A;FOXRED2;JKAMP;ECPAS;VCP;HERPUD1;UBE4A;UBE4B
prerank,response to cadmium ion (GO:0046686),0.4355094750447569,1.0857241270609916,0.36351875808538164,0.734164965885091,1.0,11/26,20.67%,JUN;MT3;NCF1;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,tricarboxylic acid metabolic process (GO:0072350),0.49335330414474127,1.0856908121204216,0.39143730886850153,0.7337628973641339,1.0,5/12,22.13%,IDH1;IDH3G;IDH3B;IDH2;ACO1
prerank,regulation of interferon-gamma production (GO:0032649),0.3744617966985932,1.0856512137661782,0.3548034934497817,0.7333662420193827,1.0,11/71,13.65%,TLR8;LILRB1;FOXP3;CD274;RARA;NR1H4;SIRPA;DDIT3;FZD5;GAS6;SLC11A1
prerank,regulation of neuron apoptotic process (GO:0043523),0.367110898493732,1.085604332066398,0.3426124197002141,0.7330083620655491,1.0,21/96,15.74%,APOE;CTNNB1;CPEB4;FOXO3;TFAP2B;SRPK2;PPT1;CLN3;ADAM8;ATF4;BACE1;DDIT3;EGLN3;PTK2B;MT3;TREM2;PRKN;GDNF;BAX;PRKCG;GRN
prerank,histone H3-K4 trimethylation (GO:0080182),0.5160811410033942,1.085303354135993,0.3772455089820359,0.7333207573519985,1.0,6/11,26.40%,TET3;TET2;KMT2A;OGT;KMT2D;SETD1B
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4248953586058371,1.0850034435753222,0.35868187579214195,0.7336327316205419,1.0,10/29,21.08%,FBXW7;ARRDC4;UBE2L3;TOPORS;DCUN1D5;DCUN1D3;DCUN1D4;DCUN1D1;FBXO5;ARRDC3
prerank,necroptotic process (GO:0070266),0.4655752126345539,1.0848605990728624,0.3746518105849582,0.7334891071109515,1.0,4/16,13.47%,RIPK1;LY96;TICAM2;TRPM7
prerank,DNA alkylation (GO:0006305),0.46075626635834865,1.0844650964584477,0.3881019830028329,0.7335821668612087,1.0,7/19,21.91%,DNMT3A;GATAD2A;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,DNA methylation or demethylation (GO:0044728),0.46075626635834865,1.0844650964584477,0.3881019830028329,0.7335821668612087,1.0,7/19,21.91%,DNMT3A;GATAD2A;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.4225717367834704,-1.0844195234598415,0.3434650455927052,0.7367385356090665,1.0,6/13,17.13%,HACD2;ELOVL7;ELOVL4;ELOVL6;HACD3;TECR
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.36887108116032813,-1.084162017940152,0.3274647887323944,0.7354515444893721,1.0,5/18,15.11%,IWS1;NUP133;ZC3H11A;MCM3AP;HHEX
prerank,hyaluronan metabolic process (GO:0030212),0.4417535818639888,1.083917744641557,0.3704206241519674,0.7345066560303136,1.0,5/23,6.11%,CD44;STAB2;CEMIP2;HAS3;HEXA
prerank,diol metabolic process (GO:0034311),0.46190507043187645,1.0836324076013943,0.37830319888734354,0.7347545057365554,1.0,5/19,19.90%,PLPP3;SPHK2;PTS;GCH1;SGPP2
prerank,gluconeogenesis (GO:0006094),0.40627569263780017,1.0833938472359366,0.3709483793517407,0.7349335601589163,1.0,12/39,24.01%,TPI1;SLC25A1;ATF4;ENO3;SLC39A14;PGM1;CRY1;GAPDHS;MDH1;SLC37A4;SLC25A13;GOT1
prerank,negative regulation of chemotaxis (GO:0050922),-0.325372092507043,-1.0830583157997353,0.29777777777777775,0.7363970166539475,1.0,8/31,11.89%,SEMA5A;ROBO2;ROBO1;AIF1;SEMA4G;SEMA3E;SEMA3A;SEMA6A
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.46664718752430956,1.0830466091869717,0.3711484593837535,0.7353494140180254,1.0,3/17,9.25%,PLA2G2D;SERAC1;PLA2G4F
prerank,DNA-dependent DNA replication (GO:0006261),0.35519157443685806,1.0830328317470952,0.3433922996878252,0.734902133031673,1.0,44/128,25.69%,BAZ1A;PSMD1;RFC3;SRPK2;MCMBP;HELB;POLG2;RPS27A;UBC;DDX23;PSMF1;DBF4;PSMD14;PSMD12;WRN;SIRT7;SSBP1;POLA1;PSME2;NOC3L;ORC1;CDK2AP1;TWNK;CDC34;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;RPAIN;PSMB3;PSME3;POLD1;CDK2;POLE3;PRIMPOL;PRIM2;PSMC5;ORC6;MCM3
prerank,Golgi ribbon formation (GO:0090161),0.5013509264715735,1.0830129862416584,0.3994082840236686,0.7344582118234744,1.0,5/13,14.71%,OPTN;VTI1A;TRIP11;STX6;GOLPH3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.370756671528191,1.08286620612815,0.37199124726477023,0.7343804205315164,1.0,23/71,21.38%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;VAV1;ACTR3;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;MYH2;WIPF1
prerank,regulation of epithelial cell migration (GO:0010632),0.3887345900980189,1.0827367070919478,0.35300925925925924,0.734278610308447,1.0,15/51,15.39%,SASH1;CORO1C;RHOJ;DOCK5;RREB1;MCC;CTSH;BMPR2;PFN1;DOCK1;MACF1;CAPN7;CLASP1;PFN2;RTN4
prerank,sensory organ development (GO:0007423),0.39205099792533393,1.0825559148287223,0.38388625592417064,0.7342623434086295,1.0,10/51,13.34%,STRA6;ZDHHC16;HIPK1;HIPK2;PAX8;MAFB;SALL2;RAB18;SOX2;SH3PXD2B
prerank,regulation of chondrocyte differentiation (GO:0032330),0.44112462991540125,1.0823708304879134,0.3697585768742058,0.7342288905477106,1.0,4/24,8.84%,TRPS1;SNAI2;PKDCC;ACVRL1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.4665417627031132,1.0821205954510027,0.39261285909712723,0.7344513619051746,1.0,5/18,20.75%,CXCR4;TNFRSF1B;NOTCH1;TNFRSF21;HES5
prerank,positive regulation of gene expression (GO:0010628),0.3394426045983719,1.0819977180243106,0.26626626626626626,0.7342803497024806,1.0,72/442,13.93%,CD36;HTR2B;DTNBP1;HNRNPLL;SAMD4A;LILRB1;NFE2L2;MITF;ERN1;VEGFA;FLOT1;POLR2A;ERCC6;TFRC;VIM;IL36G;NAT8;ID2;IL6;CD28;CD46;SRPK2;RIPK1;CELF1;TENT4B;CITED2;PID1;YTHDF3;E2F1;IGF1;FGFR4;THBS1;AGO2;SPHK2;EIF6;DDX5;DYRK1A;HSPA1B;NWD1;ATF4;RPL23;LARP4B;POLR2L;STAP1;POU3F1;MSN;BRCA1;TAF1B;CTSH;TYROBP;NAT10;TNRC6B;NR5A1;POLR1A;PTGER4;ROCK1;GSK3B;POU3F3;AGO3;MED26;MT3;APP;NOTCH1;IL15;TREM2;MAZ;DGKQ;GAS6;FGR;PRKN;SLC11A1;HSPA1A
prerank,neuron development (GO:0048666),0.3509530478931678,1.0819478888028582,0.3360910031023785,0.7339261549029711,1.0,32/141,14.41%,LRP12;B4GALT5;APOE;DTNBP1;STX3;MICALL2;ERCC6;IL6;RUNX3;FRY;PPT1;CLN5;UGDH;ZFYVE27;B4GALT6;TBC1D23;MICALL1;RB1;PPP1R9B;VAPA;ROCK1;GSK3B;TBC1D24;APP;THOC2;PQBP1;TDP2;TENM1;ARL3;GDNF;UHMK1;UNC5A
prerank,regulation of myoblast differentiation (GO:0045661),-0.31498808057645716,-1.0817801962622215,0.31100478468899523,0.7378446908159358,1.0,4/32,3.76%,MEF2C;PLCB1;FLOT2;RIPOR2
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4075471414905992,1.0813168905354549,0.36649874055415615,0.7351540669606833,1.0,11/35,18.10%,ACSS3;FASN;SLC25A1;PPT1;AACS;GGTA1;HMGCL;SCD;GCDH;CBR4;PAM
prerank,regulation of cellular protein metabolic process (GO:0032268),0.39043003720792235,1.0812766886599219,0.3617021276595745,0.7347606591520426,1.0,8/47,11.47%,APOE;NR1H3;FOXO3;ATXN2;WDR91;PUM3;MTPN;APP
prerank,homocysteine metabolic process (GO:0050667),0.5110138717913258,1.0811589905123227,0.39819004524886875,0.7346090919654766,1.0,3/11,17.70%,TST;BLMH;MTRR
prerank,regulation of platelet aggregation (GO:0090330),0.4675546529682405,1.081022330779844,0.3784916201117318,0.7344536157058765,1.0,2/17,3.09%,SYK;PRKCD
prerank,regulation of protein phosphorylation (GO:0001932),0.3458800498503455,1.0807624629220434,0.3063700707785642,0.7346618946633323,1.0,41/256,16.18%,GPNMB;FNIP2;PLPP3;XDH;RAP2A;VEGFA;FLOT1;CEBPB;FNIP1;CORO1C;ATF3;TFRC;HGF;FAS;PDGFA;RIPK1;SESN2;PTEN;PID1;FLCN;ATF4;ACVR2A;SIRPA;TNIK;MAVS;ADAM17;SIRT1;CCN1;MT3;FBLN1;APP;TREM2;GAS6;FGR;PRKN;PHIP;LRP6;ARRB1;CDK2AP1;BST1;CCDC88C
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4093975622857295,1.0807372327987157,0.36511919698870765,0.7342452275733065,1.0,8/34,11.93%,IL6;ENPP1;E2F1;FLCN;ZFP36L2;FOXO1;SIRT1;RORA
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3399410100817677,1.0804744179583963,0.28128128128128127,0.7344362748868667,1.0,87/366,19.07%,ATP1B4;TFEB;MITF;POLR2A;CEBPB;ATXN1;FOXP3;CXXC1;WWC2;FOXO3;ANKRD17;RUNX3;PDGFA;MYCBP;MZF1;ATXN2;FOXO4;BACH1;E2F1;UBE2L3;SAP30;APBB2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;ATF4;TAF5;RREB1;JMJD1C;SNAI2;RB1;PRDM8;RBAK;IRF2;CHD3;PUM3;DVL1;ZFAT;ACVRL1;DDIT3;FZD7;HCFC2;ESR1;ASCC1;PSPC1;ZFPL1;MTPN;MAFB;CCNA2;GPBP1L1;APP;SP3;NOTCH1;RORA;ACVR1B;PQBP1;APBB3;HCLS1;SOX2;RELA;LIMD1;PPIE;ZKSCAN5;PRDM2;HNRNPD;RPL10;SMC3;PPARGC1B;MYT1;CCAR1;ZBTB11;TAF5L;CHD7;ERC1;NFYC;HMGN5;UBE2V1;NAB1;ZNF431;CLOCK;FBXO5;NFX1;PPP2CA;NCOA2
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5208946763468661,1.0801803748629832,0.40059347181008903,0.7342249098573593,1.0,3/10,10.97%,PPP3CA;PPP3R1;NFATC3
prerank,calcineurin-mediated signaling (GO:0097720),0.5208946763468661,1.0801803748629832,0.40059347181008903,0.7342249098573593,1.0,3/10,10.97%,PPP3CA;PPP3R1;NFATC3
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4335500310003968,1.0801036423977433,0.37533875338753386,0.7339474770634375,1.0,5/25,8.85%,B3GNT8;NDST1;EXT1;HAS3;HS2ST1
prerank,positive regulation of neuron death (GO:1901216),0.38841467163104376,1.080006492848153,0.3831553973902728,0.7337420141698299,1.0,10/46,10.25%,CTNNB1;FOXO3;TFAP2B;SRPK2;ATF4;TYROBP;PICALM;BACE1;DDIT3;GSK3B
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3834104440719637,1.0799845676945,0.3755656108597285,0.7333167052383952,1.0,10/57,10.59%,CTSD;SYK;DAPK1;HTRA2;TBC1D10A;NLRC4;MEFV;CYFIP2;CYCS;SIRT1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.42566460141198054,1.0799337676778349,0.385,0.7329655096326428,1.0,14/27,29.21%,NAT8;PHF20;CREBBP;PHF20L1;SGF29;KAT2A;RUVBL2;KAT6B;KAT6A;KAT2B;MRGBP;BRD8;EP300;MORF4L1
prerank,regulation of macrophage cytokine production (GO:0010935),0.49452651869670516,1.079270395093181,0.4012158054711246,0.7342665433457403,1.0,3/13,10.59%,LILRB1;IRAK3;SIRT1
prerank,cellular response to interleukin-6 (GO:0071354),-0.3377326213738814,-1.079239024085131,0.31981981981981983,0.7426217814455437,1.0,5/26,4.96%,SELPLG;ST3GAL6;PTPRT;FER;IL6ST
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3411011729820562,1.0787577960586145,0.2928786359077232,0.735165263048716,1.0,77/327,19.07%,ZMIZ1;ATP1B4;TFEB;MITF;POLR2A;CEBPB;ATXN1;FOXP3;CXXC1;WWC2;RUNX3;MYCBP;MZF1;FOXO4;BACH1;E2F1;UBE2L3;SAP30;APBB2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;ATF4;TAF5;RREB1;JMJD1C;SNAI2;RB1;PRDM8;RBAK;IRF2;CHD3;DVL1;ZFAT;ACVRL1;DDIT3;FZD7;HCFC2;ESR1;ASCC1;PSPC1;ZFPL1;MAFB;GPBP1L1;SP3;NOTCH1;RORA;ACVR1B;PQBP1;APBB3;HCLS1;SOX2;RELA;LIMD1;PPIE;ZKSCAN5;PRDM2;HNRNPD;PPARGC1B;MYT1;CCAR1;ZBTB11;TAF5L;CHD7;ERC1;NFYC;HMGN5;UBE2V1;NAB1;ZNF431;CLOCK;NFX1;PPP2CA;NCOA2
prerank,negative regulation of protein modification process (GO:0031400),0.36857044273917705,1.0786729063343903,0.3453551912568306,0.7348944251188422,1.0,14/79,14.60%,PLPP3;XDH;CORO1C;PTEN;PID1;ENSA;MFHAS1;SIRPA;CDYL;GSK3B;SIRT1;FBLN1;PRKN;LRP6
prerank,protein mono-ADP-ribosylation (GO:0140289),0.5121948475215566,1.0784059571141318,0.4110612855007474,0.7351014451704314,1.0,3/11,6.70%,TIPARP;PARP4;PARP3
prerank,negative regulation of double-strand break repair (GO:2000780),0.4250380023069068,1.0782207669304347,0.3706111833550065,0.7351249203275277,1.0,8/30,20.00%,TRIP12;ERCC6;TFIP11;HELB;SHLD1;RNF169;RADX;SHLD2
prerank,cellular response to organic cyclic compound (GO:0071407),0.34977708137823915,1.0780597441031434,0.35294117647058826,0.7350907057742577,1.0,30/141,15.70%,HRH1;DIAPH1;CTNNB1;AQP1;TIPARP;TGM2;SPP1;P2RX4;UBE2L3;NR3C1;SLC5A5;NR1H4;P2RX3;NCOA4;MSN;FOLR1;BRCA1;LCOR;NCOA3;ESR1;EPG5;FES;RORA;FAM210B;RAPGEF1;ADCY8;ADCY3;GOLPH3;CASP6;CTNNA1
prerank,regulation of MAPK cascade (GO:0043408),0.3498438766036539,1.0775085006256593,0.34355828220858897,0.7360489709590824,1.0,27/157,15.12%,IQGAP1;GDF15;SYK;ADRA1D;ADRA1A;TAOK3;IL6;TMEM106A;FAS;PDGFA;IGF1;DAG1;DUSP3;PPEF2;STK3;LAMTOR1;TNIK;ROCK1;PAK2;CCN1;STYX;ROR1;SOX2;RRAS;SHC1;CX3CL1;ATP6AP2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.49727909139034165,1.0775075114731458,0.3880597014925373,0.735566401480086,1.0,3/13,7.97%,CTNNB1;VEGFA;COL4A1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.44182981392489,1.0774276722955907,0.38341968911917096,0.7353112617214395,1.0,5/23,12.89%,WEE2;PLK2;ZFYVE19;VPS4A;CHFR
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.48424171587380965,1.0771845625061425,0.3933933933933934,0.7354901302135924,1.0,4/14,16.09%,TIMP1;CD63;PHACTR4;BST1
prerank,ncRNA 3'-end processing (GO:0043628),0.4848326497620524,1.077080295395263,0.38848920863309355,0.7352921688498366,1.0,7/14,13.45%,TOE1;INTS6;INTS8;ERI1;INTS5;INTS7;INTS2
prerank,ribosomal small subunit assembly (GO:0000028),0.47439099519894845,1.076753894195227,0.39574468085106385,0.7356687865811945,1.0,8/16,22.19%,RPS14;MRPS7;XRCC5;RPSA;PWP2;RPS27;ABT1;PRKDC
prerank,negative regulation of protein kinase activity (GO:0006469),0.36675003128201944,1.0766174325888391,0.3519913885898816,0.7355492939486814,1.0,15/88,8.94%,DTNBP1;CORO1C;GNAQ;PRKAG2;PDPK1;CDKN1A;SLC8A1;SORL1;TAF7;GADD45A;DUSP3;GSKIP;RB1;DVL1;CEP85
prerank,acyl-CoA biosynthetic process (GO:0071616),0.46922029776131574,1.0762054137496075,0.3899280575539568,0.7361722213281321,1.0,6/16,17.80%,FASN;SLC25A1;PPT1;SCD;GCDH;CBR4
prerank,positive regulation of T cell migration (GO:2000406),-0.35405478469726265,-1.0760468892486774,0.34572490706319703,0.7493674553355868,1.0,6/20,15.79%,DOCK8;AIF1;PYCARD;WNK1;RHOA;CCR2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.46273786879265744,1.0759131596955585,0.4037089871611983,0.73645716166169,1.0,7/17,22.72%,MVD;ALG13;ALG12;MPDU1;ALG6;DPAGT1;SRD5A3
prerank,organic substance transport (GO:0071702),0.3565132408347297,1.0758801296573717,0.34764397905759165,0.7360637835102157,1.0,31/121,21.63%,ABCA1;FLVCR1;SLC18A1;ABCG1;RAB7A;ABCD1;ARRDC4;PPT1;PLTP;MFSD12;CHMP2A;KIF3A;ABCA3;ABCA2;ABCA6;GM2A;MYH9;SLC23A1;TOM1;ABCG4;SLC6A4;LRP2;SLC19A1;SLC50A1;SLC19A2;CALCRL;VAMP2;ARRDC3;CHMP2B;NDC1;SLC22A5
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.3908849556088675,-1.0754187199683227,0.3470031545741325,0.7489033490964926,1.0,4/15,7.54%,ACVR1;ACVR2B;MAGI2;SMAD7
prerank,rRNA processing (GO:0006364),0.3455303923998182,1.07540505790573,0.34791454730417093,0.7368232128846731,1.0,68/172,27.29%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;EIF6;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;SART1;NAT10;WDR18;EXOSC9;POP4;WDR74;RPL22;NOB1;DKC1;MRPL1;ERI1;EXOSC8;NOL8;RPL10A;KRR1;MRM2;TSR3;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;UTP15;RCL1;DHX37;EXOSC7;RPS27;WDR43;FBL;PRKDC;BOP1;NOLC1;RPL7A;LYAR;NOL6;XRN2;RPL32;SNU13;LSM6;RRP36;RPS9;WDR36;EXOSC4;DDX49;MPHOSPH6;RIOK3;RPL6
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.44443408265430334,1.0753730658147815,0.38511749347258484,0.7364341476563186,1.0,10/22,21.35%,NOP14;EXOSC3;EXOSC9;RPS21;ERI1;EXOSC8;EXOSC10;WDR12;EXOSC7;ABT1
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.41998132579631625,1.075185838939115,0.375,0.7364518302993128,1.0,7/27,19.57%,MAP3K20;RPS27A;UBC;MAP3K8;CUL1;CCDC88C;CCM2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.36745752475755566,1.0744860712204929,0.3796498905908096,0.7378500735829608,1.0,23/73,21.38%,SYK;GRB2;VAV3;ARPC2;BAIAP2;PRKCD;PLD2;ABI1;PIK3CA;VAV1;ACTR3;CYFIP2;DOCK1;FGR;WASL;CD247;ARPC1A;PIK3CB;FCGR2B;ARPC4;ACTG1;MYH2;WIPF1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3338187660866753,1.0741856112175696,0.21,0.7381657192256307,1.0,137/807,14.83%,PPARG;MDFIC;FNIP2;CD38;SDCBP;TFEC;IRX3;FRK;RCOR1;TRPS1;ZNF3;CTNNB1;MITF;VEGFA;WWP1;CEBPB;FNIP1;ZEB2;ATXN1;FOXP3;DNMT3A;ATF3;WWC2;LANCL2;RUNX2;ARID4A;NR1H3;GATAD2A;ID2;FOXO3;NIBAN2;LIN37;CBX8;ZNF692;TFAP2B;RUNX3;RXRA;JUN;NCOR1;RARA;MAP2K5;MZF1;CITED2;BACH1;E2F1;TAF7;SAP30;GADD45A;NR3C1;SIRT6;TCERG1;EED;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;FLCN;HNRNPU;PEX14;NIPBL;ATF4;TGIF1;RPS27A;UBC;RITA1;ETV6;ZNF177;RPL23;RREB1;UXT;PIAS4;BRCA1;SNAI2;NEDD4L;RB1;RBAK;LCOR;WWP2;EPC1;ZNF148;FOXP1;IRF2;CHD3;CBFB;BRD7;TBL1XR1;DACH1;ARID5B;TPR;DDIT3;XRCC5;NR2C1;HCFC2;RLIM;ESR1;PSPC1;CNOT7;FOXK1;KDM2A;VPS72;POU3F3;FOXO1;SIRT1;LARP7;PPARD;ING4;CUX1;MT3;CBX3;CIPC;SP3;NOTCH1;TBX6;SARS1;DEDD2;DDX20;MAZ;SIRT7;BCLAF1;SOX2;RELA;GAS6;ATP8B1;POU2F1;KDM1B;LIMD1;PRKN;ZKSCAN3;DCAF1;SUV39H2;PRDM2;SHC1;ID4;EID1;PER3;RPL10
prerank,cellular response to interleukin-12 (GO:0071349),0.3904123626437092,1.0741489476385286,0.37132784958871917,0.7377767932510694,1.0,17/48,24.50%,LCP1;TALDO1;ANXA2;MSN;SIRPA;PITPNA;CFL1;PAK2;PSME2;CAPZA1;HNRNPDL;GSTO1;CD47;JAK2;HSPA9;AIP;PPIA
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.42816201700032175,1.0740241105357027,0.37548387096774194,0.7376379228919802,1.0,5/29,13.04%,APOE;SHISA9;CLN3;APP;MCTP1
prerank,ribosomal large subunit biogenesis (GO:0042273),0.3834483126447231,1.0738593757557482,0.3792697290930506,0.7375863845511557,1.0,19/54,24.95%,RPL3L;MRPL20;EBNA1BP2;EIF6;WDR74;MRPL1;RPL10A;PAK1IP1;RPL10;WDR12;RPL7;RPL26;MALSU1;NOC2L;PPAN;GTF3A;BOP1;RPL7A;SNU13
prerank,response to interferon-gamma (GO:0034341),0.37363218312982427,1.0738545156861878,0.3731513083048919,0.7371148490348238,1.0,18/67,20.76%,KYNU;IFITM1;DAPK1;GBP6;NUB1;SIRPA;MEFV;IFITM2;BST2;EPRS1;SLC11A1;ACOD1;CX3CL1;CCL7;SYNCRIP;GCH1;CCL25;CD47
prerank,regulation of protein transport (GO:0051223),0.42364627093835416,1.0736825646116628,0.3952254641909814,0.7370670651670679,1.0,12/27,25.11%,LCP1;RHBDF2;STXBP5;WWP2;GAPVD1;PTPN1;SNX3;DNAJA1;NDFIP1;DNAJC1;ATP13A2;DISP1
prerank,positive regulation of axonogenesis (GO:0050772),0.39562617775449554,1.073493028427185,0.375609756097561,0.737111677606268,1.0,5/43,5.22%,PLXNA1;PLXNC1;PLXND1;RUFY3;ZFYVE27
prerank,glucan catabolic process (GO:0009251),0.47275483873374885,1.0733673235453145,0.402002861230329,0.7369603163538533,1.0,5/15,21.74%,PYGL;AGL;PHKG2;MGAM;PYGB
prerank,regulation of calcium ion transport (GO:0051924),0.38724383397180684,1.0731740025524283,0.37727272727272726,0.7369802159823751,1.0,8/54,5.19%,LILRB1;CTNNB1;CD84;ATP2B1;P2RX4;SLC8B1;HOMER3;GRIN3B
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.46487205017444316,1.0729558903002352,0.4033850493653032,0.7371196238484415,1.0,7/16,19.89%,SNRNP200;SART1;DDX23;NCBP2;WBP11;RBM22;PRPF39
prerank,aminoglycan metabolic process (GO:0006022),0.5146410275953378,1.072596810236847,0.4090909090909091,0.7375871899800595,1.0,2/10,4.53%,XYLT1;B4GALT7
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.44861693494605565,1.0724143638808754,0.3713490959666203,0.7375906390627058,1.0,7/21,20.59%,SAMD4A;CNOT4;CNOT6L;CNOT7;CNOT6;PAN3;TNKS1BP1
prerank,muscle organ development (GO:0007517),-0.2857933329186643,-1.0719141313323595,0.29850746268656714,0.7562348322850496,1.0,7/54,6.62%,MEF2C;SGCE;MEF2A;CAPN3;SGCD;VAMP5;POU6F1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.35136801511572585,-1.0717296891648156,0.32558139534883723,0.7546183727374679,1.0,2/19,3.76%,CAMK1D;RIPOR2
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4382454275567227,1.0713110662902345,0.3896457765667575,0.7400874304265614,1.0,6/23,12.69%,MGAT5;IL6;IL10RB;CENPJ;NOTCH1;IL7R
prerank,cytoplasmic microtubule organization (GO:0031122),-0.28195420321900766,-1.071281961947812,0.30612244897959184,0.7536063374109352,1.0,19/54,23.03%,TUBGCP5;DST;MAPT;STMN3;TPPP;SPAST;RAB11A;DLG1;NUMA1;LIMK2;WDR73;RHOA;FIGNL2;TUBGCP6;KATNAL2;FSD1;CAMSAP1;CIB1;PLK3
prerank,regulation of insulin secretion (GO:0050796),-0.24701337482033303,-1.0711745290928485,0.25,0.7518144113352253,1.0,24/101,14.77%,EPHA5;CACNA1E;KCNC2;ITPR2;CACNA1C;IRS1;SNAP25;SYT7;LRP5;RAPGEF4;ACSL4;REST;CACNA2D2;PICK1;RFX3;GLUD1;LRRC8A;MYRIP;TM7SF3;PRKCA;DPP4;BAD;STX1A;RAPGEF3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.34673097287813975,1.071129171649027,0.3364293085655315,0.7401012479655992,1.0,43/153,19.96%,SGK1;TLK1;PIKFYVE;PRKCH;RPS6KA2;ERN1;MAPKAPK3;IKBKE;PLK2;PDPK1;PRKCD;SRPK2;RIPK1;PKN3;DYRK1A;TOP1;HIPK1;CSNK2A2;HIPK2;ROCK1;GSK3B;PKN2;PAK2;DCLK3;PRKCB;STK38;DGKQ;DYRK2;GAS6;MAST4;UHMK1;TNKS;LATS1;PRKCG;CAMK1;CSNK2A1;CSNK1G1;STK4;STK32C;TLK2;TBK1;MKNK2;CAB39
prerank,regulation of lamellipodium assembly (GO:0010591),-0.31221443425397366,-1.0706594578923119,0.34782608695652173,0.7510955385577642,1.0,6/34,4.56%,TWF2;AUTS2;FER;ABI2;WAS;NCKAP1
prerank,regulation of mononuclear cell migration (GO:0071675),0.43726865174569796,1.070573427383157,0.4019073569482289,0.7410775499988684,1.0,3/23,7.73%,LGALS3;THBS1;MSN
prerank,cellular response to organonitrogen compound (GO:0071417),0.3548258651574314,1.0703071459705429,0.3782051282051282,0.7412749712383618,1.0,22/99,15.70%,HRH1;DIAPH1;CTNNB1;AQP1;IPO5;CPEB4;P2RX4;SESN2;SLC5A5;NR1H4;CAPN2;P2RX3;FOLR1;BRCA1;LAMTOR1;RAPGEF1;SLC38A9;LAMTOR3;RELA;HTR1B;GOLPH3;CTNNA1
prerank,endoderm development (GO:0007492),0.4990604273664508,1.0703047270245163,0.3881278538812785,0.7408033770420968,1.0,1/13,3.73%,KIF16B
prerank,megakaryocyte differentiation (GO:0030219),-0.4385851764452847,-1.0699111418373703,0.3801916932907348,0.7510036366067432,1.0,2/11,5.25%,SH2B3;TAL1
prerank,protein sumoylation (GO:0016925),0.3882766918781031,1.0695905629624654,0.3832752613240418,0.7422463644634713,1.0,18/49,23.68%,EYA1;NSMCE2;SUMO2;PIAS4;TOPORS;TPR;NUP50;NUP98;NUP88;PIAS2;BCL11A;PIAS1;NUP188;NDC1;NUP43;NUP54;RANBP2;EGR2
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3608548059837467,1.0692897076518781,0.3642311886586696,0.7425701227446793,1.0,32/84,26.51%,PSMD1;ANAPC1;CUL3;RPS27A;UBC;RB1;PSMF1;PSMD14;PSMD12;PSME2;ANAPC10;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;FBXO31;UBE2S;PSMA2;ANAPC15;PSMD11;PSMA6;PSMB3;PSME3;CDK2;PTTG1;UBE2E1;ANAPC7;PSMC5;FZR1;PSMC1;ANAPC2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4311999562653719,1.069196428374438,0.3916554508748318,0.7423580293480602,1.0,2/23,2.87%,SASH1;TAOK3
prerank,negative regulation of translation (GO:0017148),0.36091271879622566,1.0685961286042052,0.36681222707423583,0.743421938166915,1.0,15/87,11.87%,SAMD4A;CPEB4;DAPK1;DDX6;CELF1;IGF2BP3;YTHDF3;AGO2;EIF2AK4;EIF4EBP2;TPR;ROCK1;CNOT7;FTO;EPRS1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4726983852128216,1.068020932817433,0.3942307692307692,0.7443903845102551,1.0,3/15,10.35%,TEC;DYRK1A;PTK2B
prerank,pre-replicative complex assembly (GO:0036388),0.3702776010054199,1.0680074576930607,0.3581920903954802,0.7439417839107131,1.0,23/64,26.25%,PSMD1;RPS27A;UBC;PSMF1;PSMD14;PSMD12;PSME2;ORC1;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;PSMC5;ORC6;MCM3;PSMC1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.47579951932605863,1.067873429925884,0.3938953488372093,0.743817371614854,1.0,4/16,8.74%,TBC1D25;CLN3;IRAK3;ETF1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.5090973466133923,1.067744634002615,0.41654357459379615,0.7432061728627614,1.0,4/11,18.37%,AGO2;EIF6;AGO3;AGO4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.5090973466133923,1.067744634002615,0.41654357459379615,0.7432061728627614,1.0,4/11,18.37%,AGO2;EIF6;AGO3;AGO4
prerank,positive regulation of type 2 immune response (GO:0002830),0.47793250045446534,1.0677353134860257,0.38865248226950355,0.7427522160134217,1.0,3/14,8.00%,IL6;RARA;DENND1B
prerank,positive regulation of cell division (GO:0051781),0.3998202082747644,1.0676098671033687,0.3982947624847747,0.7425813582688016,1.0,5/38,10.73%,HTR2B;KIF20B;CUL3;SVIL;PKN2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.3674329345088241,-1.0675861084147988,0.35251798561151076,0.7554385168497585,1.0,6/17,13.63%,SPRED1;PARD3;SMAD7;SPRED2;SIRT2;SPRED3
prerank,lung development (GO:0030324),0.41226570350368946,1.0670039974010275,0.40102827763496146,0.7436522087892443,1.0,4/33,7.78%,STRA6;VEGFA;CCDC40;ABCA3
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3468145555753471,-1.0667110558021309,0.35833333333333334,0.7557122086348477,1.0,7/23,16.41%,ANK2;UBASH3B;ATP1A2;NOS1AP;PRNP;CACNA2D1;CACNB1
prerank,cAMP metabolic process (GO:0046058),0.4970442293773502,1.066558246602897,0.4069591527987897,0.7443380096730715,1.0,7/13,23.07%,ADCY7;ADCY8;ADCY3;EPHA2;PDE4D;ADCY5;ADCY9
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.46847912574919603,1.0665104723429206,0.4153846153846154,0.7439721134068841,1.0,1/15,0.68%,SYK
prerank,neural crest cell differentiation (GO:0014033),0.45199511414852445,1.0661755072455326,0.40756302521008403,0.744374379663327,1.0,8/18,23.00%,HTR2B;FBXL17;SNAI2;LRP6;SOX8;PEF1;KLHL12;NOLC1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4370572701033513,1.065651396399569,0.40324763193504737,0.7452538256602994,1.0,6/24,11.88%,PIBF1;IL6;IL10RB;CENPJ;PTK2B;NOTCH1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5134993983628946,1.0656482608866626,0.4103703703703704,0.7447913841213041,1.0,5/10,22.10%,ACADL;ACADVL;GCDH;ETFA;IVD
prerank,regulation of JUN kinase activity (GO:0043506),0.4052120650265585,1.0655983590140194,0.38276299112801015,0.7444557034560346,1.0,4/33,6.33%,SASH1;TAOK3;AIDA;PPEF2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.3106107642870559,-1.0652721203684046,0.30412371134020616,0.757543706360703,1.0,15/33,20.66%,CCND3;RPTOR;PLCB1;AIF1;EGFR;PHB2;EZH2;PAF1;HYAL1;UBE2E2;FGF10;RGCC;PLCG2;STXBP4;EIF4G1
prerank,regulation of DNA repair (GO:0006282),0.3922586544469842,1.0652326998092498,0.376357056694813,0.7449295320954781,1.0,11/44,17.84%,EYA1;TRIP12;ERCC6;BABAM2;BRCA1;POLH;SIRT1;SIRT7;BRCC3;UBE2V1;RADX
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.4481531956414834,1.0650063606018014,0.4120805369127517,0.745043102741052,1.0,5/21,15.85%,ERN1;JUN;IGF1;HTR1B;DNMT1
prerank,phospholipid catabolic process (GO:0009395),0.4319677987105231,1.0649643182926547,0.3887434554973822,0.7446724850302249,1.0,6/24,14.92%,LIPG;GPCPD1;PLA2G4F;PLBD2;GDE1;PRDX6
prerank,glycerolipid catabolic process (GO:0046503),0.44917889630068086,1.0645399600087628,0.39748953974895396,0.7453301136713717,1.0,6/19,17.89%,MGLL;GPCPD1;PLA2G4F;GDE1;PRDX6;LYPLA2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.44076430865137295,1.0644558156468928,0.3714670255720054,0.7450750738652945,1.0,9/21,25.34%,BCL2L11;DDIT3;PRKN;HSPA1A;CREB3;CREB3L1;HERPUD1;BCL2L1;TXNDC12
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.49479124965253907,1.0637121087971921,0.39598278335724535,0.7460484286450283,1.0,5/12,25.42%,CORO1C;FBLN1;MELTF;RCC2;EFNA5
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.49479124965253907,1.0637121087971921,0.39598278335724535,0.7460484286450283,1.0,5/12,25.42%,CORO1C;FBLN1;MELTF;RCC2;EFNA5
prerank,regulation of response to cytokine stimulus (GO:0060759),0.44686904414097506,1.0635682037968728,0.4098360655737705,0.7459333328102893,1.0,5/19,9.94%,IRAK2;MAP2K5;MAPK7;CBFB;MAVS
prerank,defense response to symbiont (GO:0140546),0.35728171088636623,1.0631734347652644,0.37393162393162394,0.746439757239321,1.0,19/92,16.47%,LYST;TLR8;LILRB1;ATG7;IFITM1;IL6;IFNAR2;RNASEL;IRF2;IFITM2;MAVS;CNOT7;BST2;PQBP1;RELA;ACOD1;BNIP3;MYD88;IFIT2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.43793876365937134,1.0629520330544404,0.40027322404371585,0.746581831977428,1.0,6/22,22.14%,NFE2L2;PSMB10;PSMA3;PSMA2;PSMA6;PSMB3
prerank,iron-sulfur cluster assembly (GO:0016226),0.43112040487609204,1.0627437702626277,0.3835616438356164,0.7466780473623573,1.0,11/24,25.40%,ABCB7;NUBP2;NUBP1;GLRX3;CIAO2B;CIAO2A;GLRX5;NFS1;HSPA9;FXN;CIAO1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.37426248188022077,1.0618676140422008,0.3970080552359033,0.7484677740170471,1.0,14/51,18.81%,CTNNB1;ACD;TENT4B;HNRNPU;TERF1;NAT10;XRCC5;TEN1;STN1;TNKS;EXOSC10;TNKS2;GNL3L;CCT2
prerank,regulation of sodium ion transport (GO:0002028),-0.31179437286940714,-1.0618328051855452,0.3247422680412371,0.7651255384388441,1.0,13/34,13.68%,SNTA1;ANK3;SCN1B;FGF12;WNK3;SPTBN4;WNK2;DLG1;NKAIN3;WNK1;ATP2B4;YWHAH;NKAIN2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.4203286798319858,1.0615396468936313,0.40803108808290156,0.7488383596944785,1.0,6/29,10.19%,YTHDF3;IFNAR2;UBE2K;RNASEL;MAVS;CNOT7
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.3586794405038524,-1.06122917728073,0.37681159420289856,0.7646790705792815,1.0,6/21,10.04%,CYRIB;RASAL3;SH3BP1;TGFB2;DAB2IP;CD2AP
prerank,regulation of chemotaxis (GO:0050920),0.41527034387866674,1.0608003025148076,0.37467700258397935,0.7503059600828745,1.0,5/30,5.64%,CXCR4;STX3;P2RX4;THBS1;DUSP3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.4723141073492834,1.0603670798161948,0.40665701881331406,0.7509801949682404,1.0,5/13,23.60%,SORL1;EDEM2;BCAP31;TMEM30A;TM9SF4
prerank,osteoclast differentiation (GO:0030316),0.43223393879662236,1.0600338406573893,0.4074074074074074,0.7513712602584318,1.0,6/22,12.33%,GAB2;SNX10;ANXA2;FOXP1;TYROBP;TREM2
prerank,long-term synaptic potentiation (GO:0060291),-0.361470139458985,-1.0599317513611648,0.3576923076923077,0.7662755721664462,1.0,4/21,4.64%,GRIN2A;GRIN2B;SLC24A2;TSHZ3
prerank,copper ion transport (GO:0006825),0.499627281702284,1.0598814779454822,0.4071207430340557,0.7512892148019574,1.0,4/11,16.59%,STEAP3;SLC11A2;ATP7A;SLC31A2
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.2777004727097534,-1.0598255785742088,0.3356164383561644,0.7645128548763783,1.0,12/50,15.28%,PTCH1;SMO;FGFR2;MEGF8;INTU;RACK1;GLI3;ARMC9;TTC23;BTRC;ULK3;PDCL
prerank,gas transport (GO:0015669),0.5011647115665465,1.0596828216629586,0.42063492063492064,0.7513216169561977,1.0,3/10,16.72%,AQP1;MB;CA2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.33370955251252005,1.059634646476873,0.35685483870967744,0.7509728548578789,1.0,54/291,13.60%,LILRB1;AQP1;IPO5;PDK4;TGM2;MPV17;CPEB4;VIM;IL36G;NR1H3;ADAM9;IL6;ABL2;PRKCD;P2RX4;JUN;CD274;DAPK1;TNFRSF1B;LY96;SESN2;SHPK;PID1;HTRA2;NFKBIB;SLC5A5;NR1H4;CAPN2;P2RX3;STAP1;FOLR1;LCOR;SIRPA;NFKBIL1;TICAM2;NCOA3;LAMTOR1;FZD7;ESR1;PTK2B;FOXO1;FES;MT3;TRIM41;RORA;KCNK4;FAM210B;RAPGEF1;GPLD1;ERCC6L2;SLC38A9;LAMTOR3;RELA;TNFAIP3
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.34821762926622635,1.0593544697487043,0.3821391484942887,0.7512162963597407,1.0,25/124,14.41%,LRP12;APOE;DTNBP1;LIMA1;STX3;MICALL2;ERCC6;IL6;FRY;ZFYVE27;TBC1D23;WDPCP;MICALL1;RB1;PPP1R9B;VAPA;PLEKHA1;ROCK1;GSK3B;TBC1D24;APP;PQBP1;GDNF;UHMK1;UNC5A
prerank,cellular response to metal ion (GO:0071248),-0.23404040897073475,-1.0591810662958796,0.2978723404255319,0.7641503532615629,1.0,27/123,12.28%,DLG2;SLC12A2;MEF2C;SYT1;NLGN1;MEF2A;RYR3;CAPN3;ADD1;ANK3;PRKAA2;KCNH1;SYT7;EGFR;SYT2;TRPM2;SYT4;GLRA1;SYT6;CPNE8;MCOLN1;ADGRV1;ADCY1;PKD2;CPNE4;PRNP;HVCN1
prerank,regulation of intracellular signal transduction (GO:1902531),0.33063157695540585,1.058955225183605,0.306,0.7518167307503383,1.0,107/420,20.39%,ARHGAP24;ARHGAP21;ARHGAP10;ABR;SGK1;ARHGAP19;VWF;OPTN;ARHGAP15;VAV3;VEGFA;PRKAG2;WWC2;TAOK3;SOS1;PDPK1;RHOJ;ARAP2;ARHGAP9;RFC3;ARHGAP31;MYO9B;PHF20;GNA13;PTEN;BRIP1;TAF7;GNA12;SPHK2;STK3;FLCN;ARAP1;TAF5;NF2;XIAP;BRCA1;AKAP13;VAV1;HIPK1;CHD3;TRIP10;DLC1;BRD7;ARHGAP18;CSNK2A2;STYXL1;HIPK2;TNIK;ARHGAP17;RHOD;FBXO9;FAM13B;BIRC3;PAK2;ARHGEF2;NBN;TRAF1;TREM2;ZFAND6;WRN;RNF34;TRAF3;DYRK2;RELA;CASTOR1;RBBP7;OCRL;MCF2;SOS2;RRAS;PAK1IP1;SQSTM1;FGD3;ATP6AP2;TRAF5;SMYD2;DEPDC1B;MAPKAP1;BST1;TMBIM4;GPAT3;TRAF2;BRPF1;ARHGAP25;MYO9A;PIP4K2A;TAF15;CSNK2A1;SGMS1;TEK;AKAP7;BIRC2;TTC5;ITSN1;STK4;PPP2R5C;NOC2L;CCNG1;RMI1;PPP1R13L;MOB3B;BCL3;FGD4;TOP3A;ITGAV;SYDE2;MRE11
prerank,regulation of cell cycle phase transition (GO:1901987),0.3567381178473821,1.0583829009239696,0.3987138263665595,0.7528065349184594,1.0,33/91,26.51%,FBXW7;CDKN1A;PSMD1;ANAPC1;GTSE1;DDB1;PSMF1;DBF4;PSMD14;PSMD12;PSME2;CUL1;ANAPC10;PSMB10;PSMD5;PSMD8;PSMA3;FBXO5;UBE2S;PSMA2;ANAPC15;PSMD11;PSMA6;TAF1;XPC;PSMB3;PSME3;UBE2E1;ANAPC7;PSMC5;FZR1;PSMC1;ANAPC2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4571779848951708,1.0579360774355742,0.40915593705293274,0.7534414828904603,1.0,7/16,22.71%,PIBF1;NF2;INPP5F;PPP2CA;BCL3;PPP2R1A;ADIPOR1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),-0.25086187523794773,-1.0578017621143934,0.3125,0.76578911559241,1.0,29/95,18.66%,CEP83;CNTRL;CSNK1E;RPGRIP1L;RAB3IP;HSP90AA1;NINL;DYNC1I2;TUBB4A;AKAP9;CSNK1D;DCTN2;CEP57;SCLT1;TCTN3;TMEM67;RAB11A;PRKACA;MARK4;NPHP1;CEP164;YWHAG;MKS1;MAPRE1;CEP97;PRKAR2B;TCTN2;TMEM216;CEP290
prerank,endoplasmic reticulum organization (GO:0007029),0.3675805508912739,1.0576720956868526,0.39370932754880694,0.7536342195262763,1.0,22/72,20.28%,REEP4;GAK;STX5;HMOX1;RTN3;VAPA;CYB5A;VCPIP1;RAB10;RAB18;APP;ALDH3A2;LPCAT3;ATL2;ATL1;MOSPD3;RTN4;SGTA;TMEM170A;SEC31A;SHTN1;VAMP2
prerank,cellular protein localization (GO:0034613),0.33528858444244936,1.0572301782633267,0.34808853118712274,0.7542613824715484,1.0,99/285,25.11%,TLK1;CTNNB1;STX3;SNX8;RAP2A;ACD;TBC1D22A;SNX27;RIC1;TBC1D25;RAB20;TBC1D1;TBC1D2;CTSA;CD63;SNX9;TBC1D12;GRIN3B;RAB21;STX8;TBC1D10A;COG7;STX5;RAB3GAP2;NIPBL;TBC1D2B;RAB31;RAB1B;HPS6;TICAM2;RAB28;VPS33A;UNC93B1;STX11;LAMTOR1;EPB41L3;SIL1;TBC1D22B;ARHGEF2;RAB18;TBC1D15;WLS;STXBP3;RAB24;AP3D1;CPLANE2;PACS2;RAB43;ATG13;LAMTOR3;SH3PXD2B;ARL4C;STX6;CELSR1;AP3B1;SNX17;TBC1D9;RABGAP1;RAB29;GGA2;RAB22A;ARF4;PTPRU;VPS29;ITSN1;AP4M1;ARF5;STXBP2;CORO1B;PIGU;ARL5B;SEC31A;TM9SF1;RAB1A;SGSM2;CROCC;GGA3;RPGR;TBC1D4;DNAJC27;TM9SF3;VPS35;SNX13;TRAPPC8;VPS45;MFN2;TMED3;TMED10;FLNA;TM9SF4;ARMCX3;RRAGC;ARL11;STX17;CEP250;PRPF19;ARFGAP3;STX16;CLTC
prerank,T cell differentiation (GO:0030217),0.38922446573812375,1.0566226137656052,0.3889570552147239,0.7553667572303918,1.0,8/40,17.11%,ANXA1;CD28;ZFP36L2;LFNG;ADAM17;GPR89A;GPR89B;CHD7
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3772218663032725,1.056357970435088,0.3938679245283019,0.7555391897981037,1.0,17/50,22.88%,PSMD1;OAZ2;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3407085138622084,1.0563190770167679,0.3818737270875764,0.7551542431555448,1.0,59/173,24.45%,F7;DYNC1H1;RANGRF;MCFD2;F10;CUL3;VTI1B;YIF1A;COG7;STX5;PROC;PGAP1;YIF1B;TRAPPC5;RAB1B;FOLR1;CTSZ;TICAM2;VAPA;CAPZB;VTI1A;BET1;TRIP11;KDELR2;ATL2;GAS6;WHAMM;COG5;TRAPPC6A;RAB2A;RAB29;CAPZA1;COG2;ARF4;BCAP29;ARFGAP2;GOPC;SEC31A;RAB1A;BCAP31;ERGIC2;SEC24C;SEC24B;PREB;COG6;PEF1;TRAPPC2L;TRAPPC8;DYNC1LI2;KLHL12;TRAPPC1;TMED3;TMED10;GOLT1A;TFG;SPTBN5;COPB1;DCTN4;STX17
prerank,negative regulation of response to stimulus (GO:0048585),0.36739997419461384,1.0561256483853727,0.3900462962962963,0.755156903222393,1.0,14/60,13.77%,FOXP3;NR1H3;FCRLB;APPL2;MAP2K5;BRAP;MAPK7;PIM3;SIRT1;VPS13C;LPCAT3;COL3A1;MCTP1;ZKSCAN3
prerank,regulation of stem cell proliferation (GO:0072091),0.45803346966002184,1.0557637077068223,0.4157458563535912,0.7556586382127582,1.0,5/17,21.01%,HNRNPU;AGO3;FBLN1;ACE;PTPRC
prerank,negative regulation of cell junction assembly (GO:1901889),0.42891316041060606,1.055622200712121,0.38726790450928383,0.7555340325725216,1.0,9/25,17.47%,CORO1C;PTEN;THBS1;DLC1;ACVRL1;ROCK1;BCAS3;ACE;APOD
prerank,mitochondrial translation (GO:0032543),0.353832143538983,1.0554747601786447,0.3939075630252101,0.7554057187017,1.0,38/104,26.08%,MRPS26;MRPL20;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;MRPS35;MRPS28;MRPL28;MRPL30;IARS2;MRPL19;MRPS21;MRPL44;QRSL1;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31;MTIF2;MTIF3;MRPS2;MRPL16;MRPS18B;MRPL42;GATB;MRPL54;MRPS18C
prerank,motile cilium assembly (GO:0044458),0.492267826980184,1.0553842707525678,0.41478129713423834,0.7551424100277359,1.0,2/12,5.72%,CCDC40;DNAAF3
prerank,mitochondrial transport (GO:0006839),0.3787178036079726,1.0548760688825898,0.4068801897983393,0.7559786485337429,1.0,20/53,24.20%,FLVCR1;TIMM22;PPIF;PITRM1;TOMM20;TIMM17A;TIMM17B;GDAP1;BNIP3;TOMM34;TOMM7;TOMM22;FBXO7;BCAP31;SLC25A13;MFN2;SLC25A24;AIP;MTX2;BCL2L1
prerank,canonical Wnt signaling pathway (GO:0060070),0.36208793293431624,1.0546545856015477,0.3937007874015748,0.7560675613698299,1.0,11/68,14.60%,PLPP3;CTNNB1;PTEN;APC;DVL1;FZD7;GSK3B;FZD5;FZD2;PPP1CA;LRP6
prerank,gene silencing by miRNA (GO:0035195),0.406874776006182,1.0546259024280316,0.416141235813367,0.7556771389403872,1.0,9/32,14.85%,AGO2;EIF6;TNRC6B;CNOT7;AGO3;PUM2;SPOUT1;LIMD1;CNOT6
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.32066340262504406,-1.054020901188615,0.3442622950819672,0.7739673283902204,1.0,10/29,14.58%,SMAD3;DGCR8;METTL3;TUT4;PUM1;SMAD1;SNIP1;SMAD2;ADAR;DICER1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.33375554385813133,-1.0536348799403448,0.3434343434343434,0.7729241582216411,1.0,12/27,25.56%,CACNB2;ANK2;CACNB4;JPH1;PRKACA;SELENON;CACNB1;FKBP1B;JPH4;ADRA2A;NOS1;JPH3
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.4882781694995304,1.0532349102378493,0.4065281899109792,0.7587931197747892,1.0,5/12,9.93%,HNRNPU;BRCA1;CDYL;LRIF1;RLIM
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.318803721087186,-1.0532340306173351,0.36444444444444446,0.7719984304761307,1.0,7/29,13.63%,LDLRAD4;SPRED1;SMAD7;DAB2IP;SPRED2;HPN;SPRED3
prerank,DNA repair (GO:0006281),0.33401640729697185,1.052479972016209,0.357429718875502,0.7602223244492093,1.0,81/284,22.19%,EYA1;ERCC6;MUS81;RFC3;MUTYH;UVRAG;ZRANB3;PARP4;KPNA2;GTF2H5;BRIP1;BACH1;PARP2;FAM111A;GADD45A;BABAM2;ASCC2;DOT1L;PARP3;PMS1;RPS27A;UBC;NEIL1;PIAS4;EME1;ENDOV;BRCA1;WDR33;RAD23A;SMC1A;HUWE1;VCPIP1;POLH;XRCC4;XRCC5;DDB1;ASCC1;XRCC2;FTO;SIRT1;POLL;MBD4;INIP;NBN;DCLRE1B;KMT5B;TDP2;WRN;NSMCE3;FBXO6;ERCC6L2;POLA1;RNASEH2A;INO80;NSMCE4A;MNAT1;BRCC3;CENPX;FANCA;TEX264;BAZ1B;ALKBH1;POLI;UBE2V1;ALKBH5;RAD21;ATXN3;PDS5A;MRE11;TNKS1BP1;CUL4B;USP3;RAD51B;XPC;APEX2;MGMT;FANCM;RPAIN;XRCC1;VCP;PRKDC
prerank,negative regulation of cell migration (GO:0030336),0.3433143848529682,1.0523626818611618,0.40498442367601245,0.7600781870404051,1.0,32/137,15.30%,TIMP1;MITF;RAP2A;CORO1C;LRP1;IFITM1;FOXO3;PTEN;CITED2;ZMYND8;DAG1;DUSP3;TNN;STK24;FLCN;HMOX1;NF2;MCC;DLC1;ACVRL1;DACH1;RAP2B;BST2;SULF1;ARID2;COL3A1;MCTP1;PODN;CLASP1;PFN2;CX3CL1;ADARB1
prerank,activation of protein kinase activity (GO:0032147),0.3501380956687487,1.0523484795816789,0.38373305526590196,0.7596381820931407,1.0,21/106,16.19%,OSBPL8;VEGFA;TXN;PIBF1;TAOK3;PDPK1;PRKCD;IGF1;ADCY7;STK3;TNIK;PTK2B;PRRC1;PAK2;MT3;GAS6;SLC11A1;ADCY8;ADCY3;MAPKAP1;TRAF2
prerank,cellular response to amyloid-beta (GO:1904646),0.4002618231817853,1.0521973326547691,0.4114713216957606,0.7595432569693465,1.0,7/35,12.33%,CD36;LRP1;ITGA4;IGF1;GSK3B;APP;TREM2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.3818130217381826,1.052139519324527,0.41509433962264153,0.7592199704960944,1.0,17/46,23.94%,CHCHD4;TIMM22;PITRM1;TOMM20;TIMM17A;TIMM17B;GDAP1;HSPD1;TOMM34;TOMM7;TOMM22;FBXO7;BCAP31;MFN2;AIFM1;AIP;HK1
prerank,regulation of mitotic nuclear division (GO:0007088),0.3774272904102506,1.0521330939662643,0.39770114942528734,0.7587589316238086,1.0,5/55,5.08%,CCDC8;KIF20B;CD28;TOM1L2;IGF1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3629714234860335,1.0520694437557738,0.41228070175438597,0.7584518736984212,1.0,14/72,15.80%,GALNT3;GRB2;POLR2A;KIF16B;FGFR4;POLR2L;POLR2G;POLR2I;NCBP2;HNRNPM;GTF2F2;CBL;FRS2;FLRT1
prerank,microvillus assembly (GO:0030033),0.4758916232169024,1.051901051728885,0.4153400868306802,0.7584288270885098,1.0,3/14,10.17%,RAP2A;TNIK;RAP2B
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.4488404791797847,1.0518213548065511,0.40771349862258954,0.7581581052447448,1.0,7/18,19.11%,RPS27A;UBC;EDEM2;DERL2;UGGT1;AMFR;MAN1B1
prerank,glycine transport (GO:0015816),0.5091444213266884,1.0513860664783643,0.42814814814814817,0.7588370872631164,1.0,4/10,23.01%,SLC36A2;SLC36A1;SLC7A8;SLC25A38
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4844953651790927,1.0509145357419287,0.4229607250755287,0.7590754722571901,1.0,3/12,13.27%,HOMER3;GSK3B;DYRK2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4844953651790927,1.0509145357419287,0.4229607250755287,0.7590754722571901,1.0,3/12,13.27%,HOMER3;GSK3B;DYRK2
prerank,synaptic vesicle localization (GO:0097479),-0.40449230405193237,-1.0509081890397014,0.4006734006734007,0.7765090260985964,1.0,4/13,8.43%,NLGN1;RAB27A;KIF5A;SYNDIG1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.49664161265628093,1.0508738509088686,0.4205748865355522,0.7587177738336554,1.0,6/11,25.23%,NR1H3;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1
prerank,protein modification by small protein removal (GO:0070646),0.3338689168582397,1.050365444075777,0.3708206686930091,0.7595703901283032,1.0,78/252,22.14%,GPS1;TNIP1;PSMD1;RIPK1;ASXL2;PTEN;FOXO4;STAM;BABAM2;SENP3;APC;RNF128;TOMM20;RPS27A;UBC;USP42;BRCA1;RAD23A;USP12;VCPIP1;COPS5;SENP5;ESR1;FOXK1;USP40;BIRC3;USP26;CCNA2;PSMF1;USP48;PSMD14;PSMD12;COPS7A;TRAF3;USP21;USP16;KDM1B;TNFAIP3;PRKN;RNF123;USPL1;MCRS1;PSME2;INO80;STAM2;USP36;CCP110;BRCC3;ASXL1;USP8;TRAF2;NFRKB;OTUD5;SENP7;PSMB10;KEAP1;PSMD5;SNX3;USP32;BIRC2;SENP1;CDC25A;PSMD8;PSMA3;USP30;STAMBP;PSMA2;ATXN3;PSMD11;PSMA6;OGT;TOR1A;USP3;USP9X;KAT2A;USP2;VCP;PSMB3
prerank,regulation of mitochondrial depolarization (GO:0051900),0.5047452086099209,1.0503486385435377,0.42857142857142855,0.7591377742159127,1.0,2/10,6.20%,ABCD1;MLLT11
prerank,glycerol metabolic process (GO:0006071),0.5042445323399481,1.0499734854370812,0.4385432473444613,0.7596547249346149,1.0,6/10,24.01%,TPI1;TKFC;PGP;GK5;GK;GOT1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.46839053512605355,1.0496211037864736,0.4246987951807229,0.7600706666641256,1.0,3/14,11.88%,MAP2K5;THBS1;NOTCH1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.4784831912673879,1.0495465940226885,0.4111600587371512,0.7597972600843808,1.0,5/14,20.44%,TFRC;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,epithelial to mesenchymal transition (GO:0001837),0.38668660764271046,1.0494143887284737,0.4044032444959444,0.7596682173375666,1.0,8/47,11.88%,CTNNB1;HGF;HNRNPAB;DDX5;SNAI2;ROCK1;GSK3B;NOTCH1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.39453348936968063,1.0491168924806802,0.42168674698795183,0.7599597352673086,1.0,8/36,12.67%,CTNNB1;AGO2;PPP3CA;TNRC6B;PPP3R1;AGO3;FZD5;FZD2
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3488997980397003,1.0488356566374581,0.4044823906083244,0.7601792864914739,1.0,22/101,15.73%,LILRB1;VIM;IL36G;NR1H3;ADAM9;IL6;CD274;TNFRSF1B;LY96;SHPK;NFKBIB;STAP1;SIRPA;NFKBIL1;TICAM2;TRIM41;RELA;TNFAIP3;ACOD1;LBP;CDC73;MYD88
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5135535250599594,1.048812106149146,0.43167701863354035,0.7597772899173435,1.0,3/11,8.73%,RUNX3;CD274;CBFB
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.3497462268539425,1.0486307147493608,0.40943193997856375,0.7597833888405758,1.0,34/94,26.33%,ST18;IRAK2;PSMD1;IRAK3;RPS27A;UBC;MAP3K8;PSMF1;PSMD14;TAB2;PSMD12;RELA;PSME2;SQSTM1;CUL1;MYD88;PSMB10;PSMD5;UBE2V1;PSMD8;PSMA3;PSMA2;PSMD11;PELI2;PSMA6;PSMB3;PSME3;IRAK1;TRAF6;PSMC5;TAB1;MAP3K7;PSMC1;TAB3
prerank,protein localization to organelle (GO:0033365),0.3452679387182189,1.0485077739249986,0.3958115183246073,0.759642100023119,1.0,20/133,8.95%,OPTN;PIKFYVE;LAMP1;SNX10;RAB33B;LMNA;SORL1;TSPAN17;COL1A1;GAK;COG7;STX5;LMBRD1;HMOX1;MICALL1;LAMP2;DVL1;VAPA;CYB5A;TOPORS
prerank,DNA duplex unwinding (GO:0032508),0.3803646521617621,1.0484851297499584,0.3986013986013986,0.7592247371066082,1.0,12/50,15.71%,ANXA1;MCM9;GTF2H5;RPS27A;UBC;RTEL1;DDB1;NBN;CUL4A;WRN;SSBP1;TWNK
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5105630201952532,1.0482044467894776,0.44144144144144143,0.7595047146492908,1.0,1/10,0.78%,GALNT3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.36125846795069183,1.0481696940531864,0.40934371523915464,0.7591270923619319,1.0,7/76,4.92%,HTR2B;HRH1;ADRA1D;ADRA1A;TGM2;GPR157;C3AR1
prerank,substantia nigra development (GO:0021762),-0.3039243927821838,-1.0480518092421856,0.3604060913705584,0.7826316700527501,1.0,15/37,22.14%,MBP;PADI2;BASP1;GLUD1;INA;SIRT2;YWHAH;ATP5PF;RHOA;SUDS3;RAD1;TTBK1;CKB;COX6B1;GNB4
prerank,regulation of defense response to virus (GO:0050688),0.47001158371552787,1.0476069813524125,0.43206106870229005,0.7601103338441149,1.0,4/14,18.05%,RNF26;TRAF3;TNFAIP3;C1QBP
prerank,inorganic anion transport (GO:0015698),0.37038857658081753,1.0474962659289229,0.4189675870348139,0.7599226130456799,1.0,9/53,17.01%,SLC26A11;ANO6;ENPP1;SLC26A1;SLC5A5;XPR1;SLC11A1;CLIC1;CLCN4
prerank,Golgi to plasma membrane transport (GO:0006893),0.37802443133373764,1.0472339422032668,0.41113744075829384,0.7601100980452398,1.0,18/47,21.44%,OPTN;RABEP1;RAB31;RAB10;VPS35L;ARFGEF2;MACF1;ARL3;GOLPH3;EXOC4;GOLPH3L;GOLGA4;GGA2;EXOC1;GOPC;BBS1;VAMP2;GGA3
prerank,ERBB2 signaling pathway (GO:0038128),0.4015511370647341,1.046648936086051,0.4148527528809219,0.7611810008956138,1.0,8/31,14.49%,GRB2;SOS1;PIK3CA;PTPN12;NRG4;STUB1;ERBIN;SHC1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4444579261310712,1.0464902708630257,0.41506849315068495,0.7611314473359965,1.0,8/20,20.20%,FAS;GSK3B;APPL1;BAX;MCL1;CASP2;CASP3;ITGAV
prerank,negative regulation of cell adhesion (GO:0007162),0.3615527493046115,1.0462012389655286,0.42681564245810055,0.7614707120116703,1.0,12/72,11.88%,PLXNA1;PLXNC1;PLXND1;GCNT2;LPXN;NF2;SNAI2;ACVRL1;DSCAM;FZD7;FBLN1;NOTCH1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.35886245258510824,1.0460250032311293,0.40728476821192056,0.7614411597275201,1.0,29/80,22.44%,SAMD4A;ABCG1;VIM;IL6;CD28;PRKCD;YTHDF3;THBS1;SPHK2;EIF6;LARP4B;ABCA2;NAT10;PICALM;RELA;HNRNPD;EIF4A3;SIRT3;RPL26;CASP3;NSMAF;BCL3;EIF3C;LARP4;PCIF1;GSAP;EPHA4;PRKDC;UPF3A
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.5026182720234061,1.0459859090420316,0.4589905362776025,0.761085560623767,1.0,4/11,17.90%,RIPK1;BIRC3;ARHGEF2;BIRC2
prerank,positive regulation of behavior (GO:0048520),-0.4213188384826978,-1.045607941775544,0.4048913043478261,0.7873738800982925,1.0,3/10,1.91%,MEF2C;NLGN1;SGIP1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.36200349579869184,1.0455079717142284,0.4074074074074074,0.7618681638500292,1.0,18/64,20.26%,CD36;CORO1C;THBS1;DUSP3;NF2;PLAU;ROCK1;GSK3B;PTK2B;MACF1;CLASP1;CX3CL1;UTRN;BST1;ACER2;PIK3CB;CCL25;ACTG1
prerank,cellular response to interleukin-4 (GO:0071353),0.5109519065934671,1.0449754555026676,0.4324734446130501,0.7627728088225051,1.0,3/10,19.37%,SHPK;JAK3;STAT6
prerank,engulfment of apoptotic cell (GO:0043652),-0.37542542186942807,-1.044638082548788,0.38,0.7882007944326468,1.0,10/15,31.54%,RHOBTB1;ADGRB1;RHOBTB2;RHOG;RHOH;RAC1;XKR8;RAC2;XKR4;XKR6
prerank,production of siRNA involved in RNA interference (GO:0030422),0.5021868342872647,1.0443512355399593,0.4349157733537519,0.7638989885116726,1.0,4/10,22.39%,AGO2;DROSHA;MRPL44;TSNAX
prerank,hyaluronan catabolic process (GO:0030214),0.4465809776902472,1.0443293797339854,0.41818181818181815,0.7634913651001378,1.0,4/18,6.11%,CD44;STAB2;CEMIP2;HEXA
prerank,DNA methylation (GO:0006306),0.4274092635712278,1.0442573462731843,0.42587601078167114,0.7632283049034668,1.0,8/23,21.91%,DNMT3A;GATAD2A;N6AMT1;KMT2E;DNMT1;MTRR;EHMT2;DMAP1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3232866202933725,1.0439996961457683,0.251,0.7634162846499061,1.0,389/1667,21.95%,EPAS1;PPARG;FNIP2;MMP12;ANXA4;SDCBP;NAMPT;TFEC;APOE;MRTFA;LITAF;ELF2;MRTFB;ZMIZ1;ATP1B4;IRX3;FRK;RCOR1;TFEB;HOPX;LPIN3;LILRB1;TRPS1;NFE2L2;ZNF3;CTNNB1;MITF;NCK2;VEGFA;CEBPB;FNIP1;ZEB2;ATXN1;GRHL1;FOXP3;EN2;IER5;DNMT3A;ST18;ATF3;KDM4C;VEZF1;WWC2;RUNX2;ARID4A;NR1H3;GATAD2A;E2F3;ID2;LMO1;IL6;HGF;TOX4;CDKN1A;FOXO3;TNIP1;LIN37;CBX8;BAZ1A;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;MED12;RIPK1;ASXL2;NCOR1;PHF20;RARA;MAP2K5;ZFP28;MZF1;PTEN;CITED2;GTF2H5;PID1;FOXO4;BRIP1;BACH1;E2F1;TAF7;IGF1;ZBTB42;MAPK7;MAML1;STAT5B;SAP30;GADD45A;RNF10;AGO2;NUFIP1;GLMP;NR3C1;SIRT6;TCERG1;RNASEL;EED;CRTC1;MAML2;NR1H4;DDX5;CREBBP;BHLHE40;RPS14;DOT1L;FLCN;MLLT10;HNRNPU;KLF5;TET3;NIPBL;ATF4;REL;IFRD1;TGIF1;RPS27A;UBC;MED15;RITA1;KDM3A;ZBTB20;ETV6;ZNF177;RPL23;BAZ2B;RREB1;UXT;POU3F1;PIAS4;TCF20;JMJD1C;BRD2;ACVR2A;BRCA1;SNAI2;RPAP2;NEDD4L;HOXA3;RB1;RBAK;ACTR3;LCOR;WWP2;ABCA2;EPC1;ZNF148;FOXP1;GABPB1;GABPB2;IRF2;CHD3;NCOA3;CBFB;DVL1;ACVRL1;COPS5;CARF;BRD7;TBL1XR1;DACH1;ARID5B;CHD2;HIPK2;PPP3CA;TET2;NCOA1;BMPR2;TNRC6B;TPR;NR5A1;DDIT3;PAXBP1;BRD3;PAX8;NR2C1;WDR77;HCFC2;MAVS;ESR1;PPP3R1;FOXK1;KDM2A;VPS72;POU3F3;AGO3;MAFB;FOXO1;MED16;SIRT1;MAFG;SALL2;ARHGEF2;CDK7;PRPF6;MED26;CCN1;NFATC3;LARP7;PPARD;ZNF691;CUX1;BCAS3;LCORL;APP;FZD5;ZKSCAN7;SP3;NOTCH1;PRKCB;RORA;TBX6;SARS1;CAMTA2;RELB;DDX20;MAZ;RFX1;HCLS1;SMARCC1;SIRT7;PPRC1;RFX5;BCLAF1;BUD31;DGKQ;SOX2;USP16;RELA;BBX;BCL11B;CTDP1;POU2F1;KDM1B;PRKN;HBP1;SLC11A1;ZKSCAN3;FOXJ3;SMARCD1;DCAF1;PGBD1;JUNB;SUV39H2;GDNF;ATF1;ZKSCAN5;KDM7A;PRDM2;BAX;ZNF513;CREG1;MCRS1;PHIP;ID4;SQSTM1;LRP6;EID1;PER3;INO80;CX3CL1;RPL10;SNF8;TNKS;ZFP64;ETV3;WASL;MNAT1;SSU72;ARRB1;CDK8;SMYD2;ASXL1;PCBP1;CDC73;PPARGC1B;PHF20L1;HSPD1;KLF6;NHLH2;ZNF32;WWOX;MTF1;MYT1;THRAP3;NFATC2IP;TCF12;CAMK1;CREB3;CREB3L4;ELP4;BRWD1;BAZ1B;PLAGL2;ZNF18;CRY1;NKX2-1;ARF4;SMARCB1;ZBTB41;ZBTB7A;GABPA;NFYC;CIR1;ZNF23;SENP1;CREB1;C1QBP;ZBTB7B;ZNF319;E2F2;AGO4;BBS7;HOXD8;NOC2L;NCOA6;RAD21;FLI1;KLF8;SOX8;CRTC3;ZNF431;CLOCK;CDK13;NFX1;ATAD2B;MCPH1;NCOA2;ZBTB40;METTL23;KMT2A;HDAC8;STAT6;PPP1R13L;NFIC;AKIRIN1;CREB3L1;NR2F1;OSM;TBK1;PURB;PIAS2;ZNF367;WWTR1;PRDM16;EFCAB7;TCF7L2;TCF4;PHF2;PFKM;HSF2;WFS1;NFE2L3;SREBF1;SPEN;SSBP4;BCL11A;SIN3A;OGT;HES5;ZFP62;JMJD6;SP8;ZBTB16;MGA;SAFB;MLXIP;FUBP3;NPAS2;PIAS1;MYPOP;EHMT2;HNF4G;CEBPA;TAF1;MBD2;USP9X;NR1H2;ZBTB24;HSBP1;KAT2A;RARB;TARBP1;USP2;MED31;DMAP1;CBX5;CCNT1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.43410294270272726,1.04378575567619,0.4340369393139842,0.7634695277536131,1.0,5/21,13.10%,MITF;JUN;MED12;MED16;BCLAF1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.37588233376303887,1.0435732454201951,0.4179456906729634,0.7635414634634334,1.0,14/52,16.80%,SAMD4A;DDX6;CNOT4;EXOSC3;CNOT6L;EXOSC9;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1;PAN3
prerank,negative regulation of coagulation (GO:0050819),0.4695548580386805,1.043394590534033,0.44379562043795623,0.7635633230012475,1.0,2/14,6.55%,APOE;PROC
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.39243695764064646,1.0433316237519907,0.42823250296559906,0.7632548046149282,1.0,9/39,15.42%,GRB2;DUSP3;STAM;PTPN12;SH3KBP1;RNF115;EPS15;STAM2;CBL
prerank,regulation of phagocytosis (GO:0050764),0.37198494278115213,1.0433307464517292,0.40540540540540543,0.7627962507539963,1.0,17/53,21.01%,SYK;TGM2;MERTK;CYBA;SIRPA;OLFM4;IL15;TREM2;DOCK2;GAS6;FGR;SLC11A1;SNX3;FCGR2B;ITGAV;CD47;PTPRC
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3418424856131899,1.0427281868964184,0.4069400630914827,0.7639087961698183,1.0,42/122,24.60%,NAMPT;SAMD4A;VIM;IL6;HGF;CD28;TMEM106A;YTHDF3;IGF1;FGFR4;THBS1;IRS2;EIF6;LARP4B;NAT10;MTPN;SIRT1;NPM2;DYRK2;HNRNPD;STN1;EIF4A3;ATAD5;CDT1;RPL26;EPM2AIP1;BCAR3;BCL3;EIF3C;LARP4;GCK;PCIF1;PRKDC;UPF3A;FAF1;JAK2;NMD3;ZCCHC4;PDGFRB;PLXNB2;IGF2;SOX4
prerank,glucose catabolic process to pyruvate (GO:0061718),0.4262437148152831,1.0424401328714057,0.43297587131367293,0.7637363903845424,1.0,10/24,23.94%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,canonical glycolysis (GO:0061621),0.4262437148152831,1.0424401328714057,0.43297587131367293,0.7637363903845424,1.0,10/24,23.94%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4683152205213933,1.0422314673801887,0.4515235457063712,0.7638302740512801,1.0,8/14,25.44%,AMACR;ABCD1;CRAT;EHHADH;DECR2;SCP2;ACOT8;HSD17B4
prerank,translational elongation (GO:0006414),0.3501467923332823,1.0420502091151334,0.4197271773347324,0.7638083113689592,1.0,30/101,20.32%,MRPS26;MRPL20;EEF1A1;MRPL39;MRPL40;MRPL11;MRPL23;MRPS23;MRPS7;MRPL14;MRPL32;MRPL1;MRPL36;GTPBP2;MRPS35;MRPS28;MRPL28;MRPL30;MRPL19;MRPS21;MRPL44;MRPL35;MRPL48;MRPL43;MRPS18A;AURKAIP1;MRPS10;MRPL17;MRPS31;EEF1D
prerank,ncRNA processing (GO:0034470),0.33349899163505414,1.0420222625999636,0.41260162601626016,0.7634225960338122,1.0,54/200,18.99%,C1D;FARS2;EBNA1BP2;MPHOSPH10;BYSL;AGO2;SENP3;RPL18A;INTS9;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;INTS6;EXOSC3;TEX10;WDR18;EXOSC9;POP4;WDR74;RPL22;INTS1;NOB1;INTS8;DKC1;AGO3;DROSHA;EXOSC8;NOL8;SARS1;RPL10A;KRR1;INTS5;INTS7;INTS2;MRPL44;MRM2;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;AGO4;UTP15;RCL1;DHX37
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3805514649383213,1.0419594899397548,0.43227326266195526,0.7631324308350874,1.0,17/48,25.85%,ZMIZ1;ERCC6;SPHK2;POLR2L;TAF1B;POLR1A;SMARCD1;BAZ1B;TAF1A;ATAD2B;PHF2;KAT2A;MYO1C;ELOF1;ACTB;POLR2F;KAT2B
prerank,positive regulation of vascular permeability (GO:0043117),0.4860330246180644,1.0417522681809104,0.44017094017094016,0.7632078193383536,1.0,1/12,1.73%,VEGFA
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.38488771648928166,1.04154816702273,0.4227053140096618,0.7632663575476559,1.0,12/42,16.45%,FARS2;DARS1;TARS3;NARS2;EPRS1;SARS1;SARS2;TARS2;IARS2;PARS2;CARS2;AIMP1
prerank,positive regulation of protein import (GO:1904591),0.4093512029234833,1.0413053503148393,0.41624365482233505,0.7634507557534878,1.0,13/30,26.10%,IPO5;PRKCD;TPR;MAVS;HCLS1;RBM22;EFCAB7;PDCD5;DMAP1;FLNA;UBR5;BAG3;ZIC1
prerank,positive regulation of cellular protein localization (GO:1903829),0.367037293200601,1.0410587570117193,0.4011049723756906,0.7636188127374888,1.0,14/69,15.39%,GPR137B;STX3;TFRC;RANGRF;SESN2;GPD1L;APC;GTSE1;TYROBP;SNX33;GSK3B;PRKN;PARD6A;RTN4
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3285996764593453,1.04076861034972,0.3877139979859013,0.7638994350166967,1.0,63/264,16.87%,DHX8;POLR2A;ALYREF;TFIP11;HNRNPH2;PLRG1;CPSF1;SRPK2;SCAF11;CLNS1A;RNPC3;RBM41;HNRNPUL1;DDX5;CSTF3;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;WDR77;PSPC1;POLR2G;PRPF6;DDX23;POLR2I;NCBP2;SRSF3;SYF2;ZMAT5;HNRNPM;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;DDX20;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;ZRSR2;PCBP1;DDX39A;EIF4A3;SMN1;PUF60;SYNCRIP;CCAR1;DHX38
prerank,aorta morphogenesis (GO:0035909),0.44981577422731467,1.0406797564890993,0.4125,0.7636688562596599,1.0,4/17,12.19%,LRP1;TFAP2B;ACVRL1;MYLK
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.4208603657623443,1.04037314638097,0.43023255813953487,0.7639961445216469,1.0,8/25,16.21%,FOXO3;STAT5B;HSPA1B;ACVR2A;ACVR1B;FAM210B;HSPA1A;BRD1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3513727243959991,-1.0403257628245985,0.36666666666666664,0.7979283193019098,1.0,2/17,3.76%,CAMK1D;RIPOR2
prerank,positive regulation of macrophage migration (GO:1905523),-0.35752485617573515,-1.0402825419958195,0.3724137931034483,0.7959344232139982,1.0,3/19,2.94%,P2RY12;CSF1R;CSF1
prerank,peptidyl-glutamic acid modification (GO:0018200),-0.3310296054570858,-1.0399542733001663,0.40977443609022557,0.7947500876923912,1.0,8/24,15.65%,AGBL4;TTLL7;TTLL3;AGBL5;PARP1;TTLL11;AGTPBP1;TTLL1
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3881865817916979,1.0398358796347345,0.41325301204819276,0.7649254446755519,1.0,7/38,10.59%,XDH;PTEN;DAG1;FLCN;PLEKHA1;DDIT3;SIRT1
prerank,RNA biosynthetic process (GO:0032774),0.4057001654134102,1.0397077634888017,0.43494897959183676,0.7647638942072482,1.0,10/31,18.52%,POLR2A;GTF2B;TAF7;HELB;TAF5;POLA1;NAT14;SMN1;TTF1;NCOA6
prerank,regulation of phosphorylation (GO:0042325),0.34541539194331483,1.0394429176218722,0.4308176100628931,0.7649929515429388,1.0,37/120,23.54%,FNIP2;SDCBP;FNIP1;CORO1C;PRKAG2;CDKN1A;SESN2;THBS1;EIF6;FLCN;STAP1;DSCAM;TPR;FZD7;ROCK1;NUP50;SIRT1;APP;PHIP;NUP98;NRP1;CCDC88C;ZBTB7A;PPP2CA;KCTD20;NUP88;GCK;OGT;NUP188;NDC1;NUP43;ILK;NUP54;RANBP2;CDH5;BCL10;SLAMF8
prerank,regulation of neurogenesis (GO:0050767),0.37122347223643715,1.0390421460567296,0.4085648148148148,0.7655520293227812,1.0,9/55,11.88%,CTNNB1;HOOK3;TGM2;IL6;APPL2;SORL1;BHLHE40;NUMBL;NOTCH1
prerank,response to growth factor (GO:0070848),0.38050579538589124,1.0389908505971273,0.4223826714801444,0.7652219517687963,1.0,11/41,14.49%,CTNNB1;MAP2K5;HTRA2;MAPK7;STAT5B;ACVR2A;ACVRL1;BMPR2;ACVR1B;SOX2;SHC1
prerank,smoothened signaling pathway (GO:0007224),-0.30893159455864727,-1.0380834649858768,0.38524590163934425,0.798022420810013,1.0,16/32,26.41%,PTCH1;SMO;GLI3;TCTN3;MAP3K10;PKD2L1;ULK3;IFT27;TCTN2;TTBK2;GPC2;DISP2;CC2D2A;EVC2;STIL;GLI2
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.4371146215674021,1.03797376728265,0.4435146443514644,0.7672780292106058,1.0,9/20,25.27%,AGO2;AGO3;DROSHA;PUM2;SPOUT1;MRPL44;AGO4;TSNAX;ZC3H7A
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35366762971150945,1.037548586833881,0.43042071197411,0.7679401186681752,1.0,16/87,15.80%,GALNT3;GRB2;POLR2A;CD44;KIF16B;FGFR4;ZFP36L2;POLR2L;POLR2G;POLR2I;NCBP2;HNRNPM;GTF2F2;CBL;FRS2;FLRT1
prerank,regulation of lamellipodium organization (GO:1902743),-0.3916751605545168,-1.0370920103532584,0.4152823920265781,0.7989169808166842,1.0,4/14,7.80%,TWF2;FER;WAS;CARMIL1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.41345385869779905,1.0370208332299153,0.42012578616352203,0.7688102059161277,1.0,12/26,26.40%,SMYD5;TET3;ETFBKMT;TET2;KMT5B;SUV39H2;KMT2A;OGT;SETD3;SETD5;KMT2D;SETD1B
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4943494039581626,1.0366396996909406,0.41304347826086957,0.7693271706500671,1.0,5/10,20.29%,PIBF1;NF2;INPP5F;PPP2CA;PPP2R1A
prerank,neuron cell-cell adhesion (GO:0007158),-0.3879821305600598,-1.0366016171673773,0.38943894389438943,0.7982617821210575,1.0,8/14,11.71%,NRXN1;NRXN3;NLGN1;CNTN4;CDK5R1;ASTN2;NLGN3;NCAM2
prerank,polyamine metabolic process (GO:0006595),0.4776251075184843,1.0359859577418398,0.44573082489146165,0.770504202326851,1.0,4/13,13.01%,PAOX;SAT1;OAZ2;DHPS
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.40343964972043783,1.0355285110344918,0.4410994764397906,0.7711812305494178,1.0,6/30,10.59%,CD44;THOC1;DYRK1A;SNAI2;RTEL1;SIRT1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.41644543512644194,1.0354188623266198,0.43691899070385126,0.7710003234966393,1.0,10/25,23.94%,HK3;TPI1;ENO3;FOXK1;PFKP;GAPDHS;PFKM;GCK;PKM;HK1
prerank,cell-cell junction assembly (GO:0007043),-0.2588178299670575,-1.03514710354137,0.3508771929824561,0.8003427206354854,1.0,13/63,8.99%,CTNND1;TLN2;CTNND2;CDH11;CDH9;JUP;CDH8;PATJ;CDH2;CDH6;SMAD7;CDH12;CLDN11
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.36640935123617685,1.0351355142112242,0.42470588235294116,0.771243335120255,1.0,17/53,22.88%,PSMD1;OAZ2;PSMF1;PSMD14;PSMD12;PSME2;AZIN1;OAZ1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.36980200153958126,1.034942860543225,0.42560553633217996,0.7712835373721325,1.0,10/59,17.80%,BAAT;LIPG;AMACR;OSBPL1A;ACSM3;NDUFAB1;CYP46A1;ALDH1A2;CYP27A1;CBR4
prerank,indolalkylamine catabolic process (GO:0046218),0.49279160833411234,1.03461301649887,0.4552352048558422,0.7716781972964353,1.0,1/10,2.53%,KYNU
prerank,regulation of nervous system process (GO:0031644),-0.3635313560223199,-1.0343648008916588,0.41454545454545455,0.8005298227147005,1.0,4/18,6.42%,HTR2C;DLGAP1;DLGAP2;AKAP9
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.40524846642250495,1.0343008784670737,0.43918053777208704,0.7719933149872457,1.0,10/29,16.75%,DDX6;EXOSC3;EXOSC9;PATL1;CNOT7;EXOSC8;NT5C3B;CNOT6;EDC3;EXOSC1
prerank,manganese ion transport (GO:0006828),0.4654441858808675,1.0341634876523287,0.4449275362318841,0.7718614710658847,1.0,5/14,13.65%,SLC11A2;TMEM165;TRPC3;SLC39A14;SLC11A1
prerank,inner dynein arm assembly (GO:0036159),0.4782295288549683,1.034102202035631,0.4355083459787557,0.7715540714904294,1.0,1/11,3.81%,CCDC40
prerank,regulation of transferase activity (GO:0051338),-0.36282794855173417,-1.0338978022822283,0.3776223776223776,0.7997534785135181,1.0,10/17,29.15%,ATM;SMG6;FEM1B;LDB1;LDB2;BAG5;PPP1R3F;SPTSSB;FEM1A;EMP2
prerank,vitamin D metabolic process (GO:0042359),0.46949772803799006,1.033804382257321,0.4538799414348463,0.771866254018486,1.0,3/13,20.88%,PIAS4;LRP2;LGMN
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.39511538447428707,1.033722780858281,0.42085427135678394,0.7716234251670573,1.0,8/34,18.05%,NEDD9;DOCK5;TRIOBP;RREB1;OLFM4;DOCK1;NRP1;C1QBP
prerank,regulation of cellular protein catabolic process (GO:1903362),0.4402908168671411,1.0334678623316722,0.4536652835408022,0.7717934097391435,1.0,8/18,23.13%,RIC1;WDR91;MSN;VPS11;NELL1;VPS35;FAF1;EZR
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.3641033640785831,1.033336730294787,0.4408839779005525,0.7716632966525544,1.0,13/65,15.42%,GRB2;RHBDF2;DUSP3;STAM;MVB12B;PTPN12;ARAP1;SH3KBP1;RNF115;AFAP1L2;EPS15;STAM2;CBL
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.3689613023837048,1.0332457088983458,0.43896713615023475,0.7714307863977868,1.0,10/49,12.33%,TFIP11;RAF1;AIDA;SORL1;MEFV;NLRP2B;PTGER4;NLRC3;GSK3B;TREM2
prerank,maturation of 5.8S rRNA (GO:0000460),0.44846427005662715,1.0328891532272992,0.4426229508196721,0.7719068348122791,1.0,5/17,16.12%,C1D;EIF6;MTREX;EXOSC10;WDR12
prerank,lymphocyte mediated immunity (GO:0002449),0.47155456288395575,1.0321300381756473,0.43377001455604075,0.7734054001323054,1.0,2/12,15.17%,CD46;KLRD1
prerank,response to amino acid (GO:0043200),0.39932982396957395,1.0320919011403724,0.41161290322580646,0.7730363889683572,1.0,7/31,13.12%,IPO5;CPEB4;SESN2;CAPN2;LAMTOR1;SLC38A9;LAMTOR3
prerank,signal release from synapse (GO:0099643),-0.2852107372564038,-1.0318319550598924,0.43023255813953487,0.8035421391767199,1.0,7/43,5.23%,NRXN1;SYT1;RIMS1;SYN2;PTPRN2;LIN7A;SNAP25
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.3450518932958797,-1.0315053788477833,0.36162361623616235,0.8023253014991606,1.0,5/20,11.89%,SEMA5A;SEMA4G;SEMA3E;SEMA3A;SEMA6A
prerank,tRNA transport (GO:0051031),-0.2949889293547172,-1.0313225752235087,0.39473684210526316,0.8007444442155072,1.0,12/35,14.85%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.4090117331117893,1.0313110357785857,0.4454664914586071,0.7745331243308816,1.0,6/27,11.54%,LPIN3;PLA2G2D;SLC27A1;ABHD4;PLAAT1;PLAAT3
prerank,regulation of hormone secretion (GO:0046883),0.4526868782985041,1.0312463906705045,0.4489208633093525,0.7742308313804181,1.0,4/15,20.28%,ANXA1;VAMP3;OSM;VAMP2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3883216469283009,1.0305651826286182,0.43,0.7754690160198098,1.0,5/36,8.84%,PPARG;APOE;THBS1;GADD45A;ACVRL1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.4878279856267799,1.0299357572566208,0.4465592972181552,0.7766376544645205,1.0,2/10,7.78%,MTMR3;ABCA3
prerank,positive regulation of protein modification process (GO:0031401),0.33212968765367323,1.0298569154954498,0.4336372847011145,0.7763747533366384,1.0,25/203,11.47%,GPNMB;RAP2A;ATG7;VEGFA;FLOT1;TXN;FNIP1;TFRC;HGF;PRKCD;FAS;RIPK1;ATG10;RAB3GAP2;FLCN;DYRK1A;ACVR2A;DLC1;TNIK;MAVS;ADAM17;SIRT1;CCN1;MT3;APP
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4944007634714889,1.0295235284120956,0.44516129032258067,0.7767387792561774,1.0,3/10,2.56%,CTNNB1;VEGFA;DCT
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.46157132250873145,1.029508066894054,0.450070323488045,0.7763098569156427,1.0,2/15,3.64%,ERN1;CPSF1
prerank,ncRNA export from nucleus (GO:0097064),-0.2946043903469728,-1.029470235382743,0.40217391304347827,0.8035811232697421,1.0,12/36,14.85%,NUP133;SSB;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;NUP37;NUP155;RAE1;NUP153
prerank,sulfur amino acid catabolic process (GO:0000098),0.49868334510075774,1.029293828923981,0.44684129429892144,0.7763732886484428,1.0,4/10,20.73%,TST;BLMH;MTRR;TXN2
prerank,mRNA processing (GO:0006397),0.32386778992630855,1.0280209301660825,0.43343343343343343,0.7791471951995635,1.0,67/287,16.87%,DHX8;ERN1;POLR2A;ALYREF;TFIP11;HNRNPH2;PLRG1;CPSF1;SCAF11;CELF1;GTF2H5;CHTOP;RNPC3;TCERG1;RBM41;HNRNPUL1;DDX5;CSTF3;THOC1;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;PSPC1;POLR2G;CDK7;PRPF6;DDX23;POLR2I;NCBP2;SRSF3;SYF2;ZMAT5;THOC2;HNRNPM;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;MNAT1;ZRSR2;PCBP1;DDX39A;EIF4A3;PUF60;SYNCRIP;CCAR1;DHX38
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.40254319459069654,-1.0279767902607857,0.42485549132947975,0.8056060427008066,1.0,3/12,8.87%,NFIB;SPTBN4;SZT2
prerank,positive regulation of neurogenesis (GO:0050769),0.3583941728532575,1.0277550126313504,0.44130925507900676,0.7793597183945802,1.0,7/68,2.56%,PLXNA1;PLXNC1;PLXND1;CTNNB1;VEGFA;TGM2;DCT
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3965042622564432,-1.0276751145242593,0.4,0.804431098080015,1.0,3/13,9.70%,MAPT;NEFL;SPAST
prerank,positive regulation of protein import into nucleus (GO:0042307),0.41108067389948755,1.0275973786229202,0.435630689206762,0.7792910846469076,1.0,12/28,26.10%,IPO5;PRKCD;TPR;MAVS;HCLS1;RBM22;EFCAB7;DMAP1;FLNA;UBR5;BAG3;ZIC1
prerank,macrophage activation (GO:0042116),0.3908190387541077,1.0275896230198185,0.4457070707070707,0.7788534522373615,1.0,11/34,18.64%,SYK;TMEM106A;CD93;FOXP1;APP;TREM2;SLC11A1;CX3CL1;LBP;TLR1;CRTC3
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3251074538061759,1.0274631954991775,0.43605236656596175,0.7787180752383095,1.0,57/241,16.87%,DHX8;POLR2A;ALYREF;TFIP11;HNRNPH2;PLRG1;CPSF1;RNPC3;RBM41;HNRNPUL1;DDX5;CSTF3;CTNNBL1;HNRNPU;PRPF8;SNRNP200;POLR2L;WDR33;ISY1;SNRNP25;SART1;HNRNPA0;SF1;PPIH;PSPC1;POLR2G;PRPF6;DDX23;POLR2I;NCBP2;SRSF3;SYF2;ZMAT5;HNRNPM;CWC27;GTF2F2;SF3A3;PQBP1;SNRNP35;CWF19L2;RSRC1;BUD31;SUGP1;RBM10;PPIE;WBP11;SNRPF;HNRNPD;MTREX;ZRSR2;PCBP1;DDX39A;EIF4A3;PUF60;SYNCRIP;CCAR1;DHX38
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.48788027230390224,1.0272176394033015,0.4410480349344978,0.7788638743218191,1.0,5/10,25.36%,PKDCC;ACVRL1;ZBTB16;BMPR1B;SOX5
prerank,regulation of ERBB signaling pathway (GO:1901184),0.45470739866298915,1.0266282410500656,0.4566145092460882,0.7798508521912236,1.0,3/15,6.66%,RHBDF2;MVB12B;PTPN12
prerank,Golgi to endosome transport (GO:0006895),0.44999018458329915,1.026435451504072,0.4564032697547684,0.7798744871784425,1.0,6/16,19.25%,KIF16B;KLHL20;VPS13C;EPS15;AP4M1;VPS13A
prerank,cognition (GO:0050890),0.3794450979938084,1.0257546681947511,0.4430844553243574,0.7810980119617715,1.0,7/42,11.47%,CBR3;STRA6;NIPBL;ST3GAL4;JAKMIP1;MAGT1;APP
prerank,regulation of collagen biosynthetic process (GO:0032965),0.42542204450857496,1.0254687551560684,0.435723951285521,0.7813409567013317,1.0,2/19,2.98%,VIM;IL6
prerank,regulation of Notch signaling pathway (GO:0008593),0.3522421939769343,1.0254592494195318,0.4410143329658214,0.7809063272985831,1.0,11/76,8.16%,ZMIZ1;FBXW7;CD46;NIBAN2;MMP14;MAML1;MAML2;CREBBP;RITA1;LFNG;WWP2
prerank,positive regulation of neuron migration (GO:2001224),0.4866325670319969,1.0251747507860374,0.44462025316455694,0.7811533156220726,1.0,5/11,20.35%,KIF20B;NIPBL;ARHGEF2;SHTN1;PLAA
prerank,endothelial cell migration (GO:0043542),0.38510540983736385,1.0250613034486622,0.4440344403444034,0.7809931531583584,1.0,12/37,24.08%,PLXND1;VEGFA;LPXN;PIK3CA;FSTL1;MYH9;NRP1;CORO1B;RAB13;GIPC1;CDH5;CCN3
prerank,regulation of cell morphogenesis (GO:0022604),0.4037749079906164,1.0249990380734022,0.44065656565656564,0.7807014457133422,1.0,10/30,21.12%,ZMYM6;CD44;CAPZB;CFL1;MACF1;PHIP;SH3D19;MYO9A;LARP4;FMNL2
prerank,regulation of DNA replication (GO:0006275),0.3732993409827965,1.0247217935947113,0.4447086801426873,0.7809661562175183,1.0,20/49,22.80%,ANKRD17;ACVRL1;TERF1;CCNA2;NPM2;STN1;SMC3;ATAD5;CDT1;FBXO5;PPP2CA;BCAR3;PDS5A;PPP2R1A;EHMT2;GTPBP4;CDAN1;WAPL;FAF1;OBI1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.36109010450363016,1.024661629543489,0.42374854481955765,0.7806675949249207,1.0,12/61,12.78%,EYA1;ERCC6;HGF;FGFR4;BABAM2;SIRT6;PARP3;BRCA1;RTEL1;SIRT1;NBN;WRN
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.304797613673391,-1.0244947274984324,0.37606837606837606,0.8113674081668878,1.0,12/26,20.92%,CCND3;RPTOR;PLCB1;AIF1;EGFR;HYAL1;CDK10;UBE2E2;FGF10;RGCC;EIF4G1;MTBP
prerank,selective autophagy (GO:0061912),0.3601443416399344,1.0244388321429436,0.45671981776765375,0.7807506764230103,1.0,22/56,23.39%,RAB7A;VIM;DYNC1H1;AMBRA1;RPS27A;UBC;ATG5;ATG13;UBA5;WDFY3;PRKN;SQSTM1;TEX264;UBE2V1;USP30;ARL13B;ACBD5;IFT88;RETREG1;ATG2B;DYNC1LI2;KLHL3
prerank,regulation of gene expression (GO:0010468),0.31907398006203297,1.0240189822975336,0.41,0.7812819467236295,1.0,151/903,15.11%,CD36;APLNR;XDH;APOE;DTNBP1;HNRNPLL;AFF1;ATP1B4;TFEB;LILRB1;NFE2L2;GCNT2;MITF;AHNAK;VEGFA;POLR2A;CEBPB;TIPARP;ATXN1;FOXP3;TMPRSS4;TFRC;FBXW7;C1D;CXXC1;WWC2;IL36G;NAT8;ID2;IL6;CD28;CD46;AFF4;COQ7;HNRNPH2;RUNX3;MBNL1;SRPK2;HNRNPAB;NOTCH2;CELF1;TRIM17;MYCBP;MZF1;IGF2BP3;CITED2;PID1;FOXO4;AHNAK2;BACH1;E2F1;SLC8A1;IGF1;UBE2L3;FGFR4;SAP30;APBB2;AGO2;NR3C1;ASCC2;NSD3;CREBBP;BHLHE40;TESMIN;FLCN;HSPA1B;NWD1;ATF4;REL;RPL23;TAF5;RREB1;STAP1;POU3F1;MSN;JMJD1C;BRCA1;SNAI2;RB1;PRDM8;RBAK;WWP2;SIRPA;ZNF148;FOXP1;IRF2;CTSH;CHD3;MEFV;TYROBP;DVL1;ZFAT;ACVRL1;PICALM;TNRC6B;NR5A1;DDIT3;FZD7;HCFC2;RLIM;CNPY2;ESR1;ASCC1;ROCK1;PSPC1;CNOT7;GRSF1;GSK3B;ZFPL1;POU3F3;AGO3;MAFB;SIRT1;MED26;PTBP3;MT3;GPBP1L1;APP;SP3;NOTCH1;RORA;PUM2;ACVR1B;PTBP2;PQBP1;TREM2;APBB3;SPOUT1;MAZ;HCLS1;TRAF3;DGKQ;SOX2;RELA;GAS6;LIMD1;PPIE;PRKN;SLC11A1;HSPA1A;GDNF;ZKSCAN5;PRDM2;HNRNPD;ZNF513;ADAM19;SNF8;ZFP64;PRX;USP36;TOB2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.4514269161120549,1.023248931697217,0.4514200298953662,0.7826906548776809,1.0,2/15,8.73%,PRKCH;NCOA3
prerank,positive regulation of cell aging (GO:0090343),0.4839785904397719,1.0232133639850716,0.4681818181818182,0.7823192557406853,1.0,3/11,10.59%,LMNA;ARG2;SIRT1
prerank,histone lysine methylation (GO:0034968),0.3929557350244749,1.0231857134773499,0.44218551461245237,0.7819333117668907,1.0,14/33,26.40%,SMYD3;CXXC1;DOT1L;N6AMT1;SUV39H2;SMYD2;KMT2A;PAXIP1;EHMT2;SETD3;MEN1;SETD6;KMT2D;SETD1B
prerank,T cell proliferation (GO:0042098),-0.3887958724814388,-1.0231263718278474,0.4491803278688525,0.8131682417051804,1.0,2/13,0.25%,CADM1;DOCK8
prerank,protein stabilization (GO:0050821),0.3317717329612868,1.0225251221218243,0.45257731958762887,0.7830793414441899,1.0,46/168,22.53%,PLPP3;LAMP1;FLOT1;GNAQ;FBXW7;PRKCD;CDKN1A;PTEN;IGF1;RAB21;GLMP;STK3;COG7;HSPA1B;RPL23;GTSE1;LAMP2;TYROBP;DVL1;CDK7;BAG4;IFT46;MT3;SUGT1;PFN1;PRKN;HSPA1A;PER3;PFN2;USP36;RTN4;GRN;HSPD1;TBRG1;CREB1;STK4;CCT2;BAG1;WFS1;TAF1;GTPBP4;USP9X;EPHA4;USP2;NAA15;AAK1
prerank,positive regulation of synaptic transmission (GO:0050806),-0.25710154711782607,-1.0224772443105226,0.40625,0.8129026430549967,1.0,23/72,17.31%,GRIN2A;NRXN1;SYT1;NLGN1;RIMS1;GRIN2B;SLC24A2;RIMS2;GRIK2;RELN;TSHZ3;FMR1;CACNG4;NLGN3;NMU;ADCY1;GRIN2D;CACNG3;AKAP5;CCR2;CACNG2;SHISA7;TNF
prerank,cellular response to retinoic acid (GO:0071300),-0.28939421255124786,-1.0224741956960508,0.40932642487046633,0.8108426373929581,1.0,6/42,2.96%,BRINP3;TWF2;SETX;RORB;EPHA3;ATM
prerank,B cell activation (GO:0042113),0.35181828681310046,1.0223334174627123,0.425,0.7831092729121153,1.0,15/68,15.90%,ADGRG3;TPD52;ITGA4;MS4A1;BLNK;CD22;ITGB1;ADAM17;CTPS1;PRKCB;BTK;DCAF1;JAK3;HSPD1;KLF6
prerank,axonal transport (GO:0098930),0.38722294696475923,1.0209577222367647,0.44987775061124696,0.7859989241534137,1.0,5/36,7.51%,DTNBP1;AP3S1;DYNC1H1;RAB21;KIF3A
prerank,substrate-dependent cell migration (GO:0006929),-0.3794484472905074,-1.0209247601933784,0.4096774193548387,0.8130760053716475,1.0,5/14,10.04%,P2RY12;OPHN1;ITGB1BP1;ANKS1A;CD2AP
prerank,neural crest cell migration (GO:0001755),0.38489277638976965,1.0203512783721307,0.45073891625615764,0.7871214756428325,1.0,8/36,16.18%,HTR2B;CORO1C;SEMA4B;FOLR1;PHACTR4;GDNF;SEMA3B;NRP1
prerank,negative regulation of binding (GO:0051100),0.3487725284764541,1.0202730007881733,0.44383860414394766,0.7868652793644394,1.0,18/81,16.59%,PRKCD;CDKN1A;TFIP11;JUN;E2F1;SORL1;PSME3IP1;PEX14;CTSZ;DVL1;ROCK1;GSK3B;STYX;PPP1CA;SLPI;BAX;IFIT2;CAMK1
prerank,negative regulation of cell differentiation (GO:0045596),0.32842825597164865,1.0200125387681038,0.4517766497461929,0.7870809983744089,1.0,24/181,11.93%,PPARG;ABCA1;XDH;HOPX;ABCG1;NR1H3;ID2;IL6;ENPP1;PTEN;E2F1;TNN;HNRNPU;EIF2AK4;ZFP36L2;ANP32B;SNAI2;RB1;COL5A2;PTK2B;FOXO1;SIRT1;NOTCH1;RORA
prerank,cellular response to misfolded protein (GO:0071218),0.42972170205761767,1.0197006606080272,0.4567243675099867,0.7873961063892053,1.0,12/20,28.86%,CUL3;STUB1;DNAJB14;UGGT1;DNAJC18;ATXN3;TOR1A;VCP;DNAJB12;KLHL15;RNF185;RNF5
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.4191428785521019,1.0193794333388007,0.45006839945280436,0.7877394718262827,1.0,9/23,22.65%,RANGRF;NPLOC4;TECPR2;FAF2;DERL2;TMEM129;PREB;VCP;HERPUD1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.35116176692622125,1.0185722571252394,0.45372460496614,0.7893440651921088,1.0,28/72,26.25%,PSMD1;REL;BIRC3;PSMF1;PSMD14;PSMD12;RELB;RELA;PSME2;CUL1;TRAF2;PSMB10;PSMD5;BIRC2;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;TIRAP;MALT1;PSME3;IRAK1;TRAF6;PSMC5;MAP3K7;PSMC1
prerank,telomere organization (GO:0032200),0.37312975838630474,1.018257207515799,0.4502994011976048,0.7896567230406829,1.0,10/43,14.75%,ACD;DOT1L;PARP3;RTEL1;TERF1;XRCC5;NBN;DCLRE1B;WRN;STN1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.35716008471147026,1.0182357706799816,0.4460674157303371,0.7892439918080189,1.0,23/66,26.10%,IPO5;TFRC;PRKCD;SESN2;GTSE1;TPR;MAVS;DKC1;LARP7;MEPCE;HCLS1;MCRS1;RBM22;CCT2;WWTR1;EFCAB7;DMAP1;NMD3;FLNA;UBR5;BAG3;CCT7;ZIC1
prerank,ribosome biogenesis (GO:0042254),0.3258620718401851,1.0180378754582375,0.45989847715736043,0.7892939878851049,1.0,66/187,26.36%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;EIF6;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;WDR18;EXOSC9;POP4;WDR74;RPL22;NOB1;DKC1;MRPL36;EXOSC8;NOL8;RPL10A;CUL4A;KRR1;MRM2;PAK1IP1;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;MALSU1;NOC2L;UTP15;RCL1;DHX37;XPO1;CUL4B;EXOSC7;RPS27;WDR43;FBL;GTF3A;BOP1;NOLC1;RPL7A;LYAR;NOL6;XRN2;RPL32;SNU13;RRP36;RPS9;LSG1;WDR36;EXOSC4
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.3417904610179471,1.0179051460524464,0.46702702702702703,0.789176850975681,1.0,19/95,14.94%,SDCBP;ZEB2;PDPK1;CITED2;THBS1;CREBBP;FLCN;RPS27A;UBC;FOLR1;HIPK2;SNX25;ADAM17;SIRT1;STUB1;ITGA3;LEMD3;HSPA1A;LATS1
prerank,regulation of telomerase activity (GO:0051972),0.37022527856091003,1.0177456778016933,0.4498186215235792,0.7891222434362719,1.0,13/45,23.93%,CTNNB1;ACD;PARP4;TERF1;XRCC5;DKC1;TNKS;CCT2;CERS1;PKIB;ERCC4;NEK7;MEN1
prerank,ceramide catabolic process (GO:0046514),0.4587819124858139,1.0176797831211444,0.44942196531791906,0.7888384578494997,1.0,6/14,19.17%,GLA;HEXA;GM2A;NEU1;ACER2;ASAH1
prerank,embryonic organ morphogenesis (GO:0048562),-0.28401918215489597,-1.0175076913410168,0.40789473684210525,0.8208468827263053,1.0,14/42,21.98%,ACVR1;FGFR2;RYR2;MEGF8;RARG;FBN2;HOXD4;HOXD3;HOXC9;HOXA9;FOXE1;SOX11;HOXB9;DSCAML1
prerank,response to UV (GO:0009411),0.33881180920006126,1.017460892852251,0.4676724137931034,0.78893130767788,1.0,34/95,25.22%,AQP1;ERCC6;PRKCD;ZRANB3;COPS9;CREBBP;EIF2AK4;ATF4;CAT;MAP4K3;POLH;DCUN1D3;RHBDD1;WRN;NSMCE3;MFAP4;RELA;N4BP1;INO80;RPL26;CDC25A;NOC2L;BCL3;EIF2S1;TAF1;RUVBL2;POLD1;SPRTN;UBE4B;ERCC4;MEN1;USP47;PRIMPOL;GPX1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.41196070476063407,1.0173947660799874,0.45257452574525747,0.788626010190665,1.0,4/23,6.20%,PDK4;TFAP2B;SLC12A3;SLC12A8
prerank,sprouting angiogenesis (GO:0002040),0.3675406350569577,1.0173396899416915,0.45528455284552843,0.7883050567103548,1.0,5/51,10.35%,CCBE1;VEGFA;THBS1;ACVRL1;PTK2B
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3488224461575793,1.0173018129489888,0.47117516629711753,0.7874895627920198,1.0,32/78,28.42%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;DYNC1LI1;KIF22;AP2A1;DCTN5;AP1B1;SEC24A;KIF3B;CANX
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3488224461575793,1.0173018129489888,0.47117516629711753,0.7874895627920198,1.0,32/78,28.42%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;DYNC1LI1;KIF22;AP2A1;DCTN5;AP1B1;SEC24A;KIF3B;CANX
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.30037338760026583,-1.0171938935906801,0.42391304347826086,0.8196995799218171,1.0,9/34,12.33%,P2RY12;IRS1;FGF2;FLT3;PRKD1;ATG14;DAB2IP;PIK3R2;PIK3R3
prerank,protein localization to cell periphery (GO:1990778),0.33068767881501926,1.0170816595016914,0.47016460905349794,0.7875882473224334,1.0,26/133,14.60%,MYO5A;DENND4C;RAP2A;FLOT1;RAB8B;PRAM1;PDZD11;TMEM150A;ZFYVE27;TSPAN17;GAK;RABEP1;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;PACS2;TSPAN15;GAS6;EFR3A;ARL3;CACNB3;LRP6
prerank,negative regulation of potassium ion transport (GO:0043267),-0.37630659125453086,-1.0163813946875144,0.4382716049382716,0.8198035399870262,1.0,1/13,0.13%,BIN1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.351366769840296,1.0163779086413416,0.45372460496614,0.7888343326761745,1.0,27/73,25.85%,ERCC6;DNMT3A;SMYD5;EED;SPHK2;POLR2L;EPC1;TAF1B;POLR1A;KDM1B;RBBP7;MPHOSPH8;DNMT1;BAZ1B;TAF1A;PHF1;PHF2;KAT2A;MTF2;MYO1C;AEBP2;IGF2;TDG;GPX1;ACTB;POLR2F;KAT2B
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.48045508891577665,1.0163770644887093,0.45896656534954405,0.7879320694430659,1.0,5/11,19.53%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.48045508891577665,1.0163770644887093,0.45896656534954405,0.7879320694430659,1.0,5/11,19.53%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3361170250161179,1.0162070278864275,0.4502118644067797,0.7879163105302704,1.0,19/109,13.76%,PIK3R5;MTM1;PIKFYVE;MTMR3;PGAP3;PLA2G2D;INPP4A;PTEN;FIG4;PIK3CA;PGAP1;PIK3C2G;SLC27A1;PLA2G4F;PLEKHA1;PLAAT3;PI4K2A;OCRL;INPP5F
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.30165610427199585,-1.016122839140458,0.4291845493562232,0.8185155653675589,1.0,14/28,32.84%,MAPT;STMN3;MAP2;STMN4;STMN2;MAPRE1;STMN1;CAMSAP1;GBA2;ABL1;MAP1S;CLASP2;CAMSAP3;SKA3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.43584080072818493,1.0158996622511018,0.4696969696969697,0.7882511170007784,1.0,4/19,10.11%,PRKCH;SNAI2;CBFB;ROCK1
prerank,lymphocyte chemotaxis (GO:0048247),-0.3047331869996605,-1.0158533520424589,0.4207920792079208,0.8172453285257771,1.0,5/34,7.37%,SLC12A2;GPR183;CYP7B1;CCL4;CXCL16
prerank,protein destabilization (GO:0031648),0.3960563357590626,1.0156850361598169,0.4799498746867168,0.7883289731686939,1.0,11/32,18.68%,CUL3;FBXL3;CREBBP;RAD23A;CTSH;SIRT1;PRKN;CDC73;CCDC88C;HTT;SERF2
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3977839008838916,1.0154055371564368,0.46153846153846156,0.7885812239085046,1.0,11/30,21.44%,OPTN;RAB31;RAB10;MACF1;GOLPH3;GOLPH3L;GOLGA4;GGA2;BBS1;VAMP2;GGA3
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.3766520891248683,1.0152678140672637,0.4643734643734644,0.7884691009125993,1.0,4/38,8.21%,CD36;GLA;P2RX4;SIRPA
prerank,positive regulation of acute inflammatory response (GO:0002675),0.46030794061836866,1.01454512737664,0.46244477172312226,0.7898020166335468,1.0,2/14,5.73%,IL6;ADAM8
prerank,nuclear body organization (GO:0030575),0.47526717027633375,1.0142355796597078,0.4430769230769231,0.7900788862535606,1.0,4/12,13.96%,SRPK2;HIPK2;SERBP1;USPL1
prerank,protein hydroxylation (GO:0018126),-0.36718425270534905,-1.0139240388857798,0.42946708463949845,0.8204089585210179,1.0,3/15,8.02%,P3H2;ASPH;PLOD2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4124542958119946,1.0138474913228728,0.46586345381526106,0.7906177439958219,1.0,11/24,25.34%,NR1H3;LPCAT3;PRKN;HSPA1A;CREB3;CREB3L1;WFS1;NR1H2;HERPUD1;BCL2L1;TXNDC12
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.4843268911829388,1.0138098131569837,0.4575757575757576,0.79026372101348,1.0,2/10,14.60%,CTNNB1;LRP6
prerank,magnesium ion transport (GO:0015693),0.4813738248423975,1.0137810078829252,0.4821705426356589,0.7898772042059454,1.0,4/12,15.22%,NIPAL3;MMGT1;MAGT1;NIPA1
prerank,camera-type eye development (GO:0043010),0.40429437406232127,1.0134219223876315,0.4476067270375162,0.790297244496111,1.0,2/25,1.73%,STRA6;VEGFA
prerank,regulation of supramolecular fiber organization (GO:1902903),0.4195151283949904,1.0130918588295157,0.45657894736842103,0.7906534334625437,1.0,3/22,7.98%,APOE;PIK3CA;AKAP13
prerank,cell-matrix adhesion (GO:0007160),0.3430101374464884,1.0130046883907713,0.4588235294117647,0.790398720126486,1.0,17/95,14.97%,HPSE;CD44;ADAM9;ITGA4;CD63;ACTN1;TNN;DLC1;OTOA;ITGB1;RHOD;ITGA10;SIGLEC1;ITGA3;COL3A1;WHAMM;ITGA8
prerank,peptidyl-lysine methylation (GO:0018022),0.4099011373055817,1.0129287205151505,0.4582798459563543,0.7901495716351364,1.0,10/26,25.51%,SMYD3;ETFBKMT;N6AMT1;SETD7;SUV39H2;SMYD2;EHMT2;SETD3;METTL21A;SETD6
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.405450432954528,1.0128446476293451,0.45382585751978893,0.7899077358540855,1.0,3/25,6.71%,ERCC6;ALYREF;THOC1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3254446959798646,1.0127325509965603,0.4764344262295082,0.7897206219849188,1.0,51/166,24.60%,CD36;SAMD4A;ZEB2;VIM;NR1H3;IL6;HGF;CD28;PAOX;P2RX4;YTHDF3;IGF1;FGFR4;THBS1;IRS2;EIF6;LARP4B;SLC27A1;NAT10;DDB1;SIRT1;APPL1;GPLD1;NPM2;DYRK2;HNRNPD;STN1;ATP7A;EIF4A3;ATAD5;CDT1;RPL26;EPM2AIP1;BCAR3;BCL3;EIF3C;LARP4;SREBF1;GCK;PCIF1;NR1H2;GIPC1;PRKDC;UPF3A;FAF1;NMD3;ZCCHC4;PDGFRB;PLXNB2;IGF2;SOX4
prerank,positive regulation of inflammatory response (GO:0050729),0.34529795538283153,1.0126330071711784,0.47707423580786024,0.7895027092528863,1.0,13/86,15.74%,PLA2G7;MGST2;IL6;TNIP1;RIPK1;NINJ1;ADAM8;PTGER4;APP;IL15;CX3CL1;LBP;GRN
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.37806467479565226,1.012372986647041,0.4665856622114216,0.7896791910742617,1.0,13/39,22.73%,ITPKB;TMEM150A;SOCS6;PIK3CA;PIK3C2G;TTC7B;PI4K2A;EFR3A;PIP4K2A;PIK3CB;PI4K2B;SOCS4;SOCS7
prerank,protein-containing complex assembly (GO:0065003),0.3217284475488597,1.012196551242091,0.47129909365558914,0.7896485751098121,1.0,85/259,24.82%,REPS2;CTNNB1;MITF;ANO6;SKAP2;FAS;PDZD11;MCFD2;SNX9;RIPK1;CUL3;CAPG;WDCP;LPXN;CREBBP;STX5;APC;DET1;PEX14;DARS1;TRAPPC5;RAB1B;FOLR1;CTSZ;MEFV;PICALM;PPIH;GSK3B;PTK2B;BET1;CAND2;TUBGCP4;TRAF1;CDC123;EPRS1;SLC2A1;DNAJB14;SH3PXD2B;VAMP3;PPP6C;TRAPPC10;ADCY8;CUL1;CX3CL1;WASL;MNAT1;CD247;CDC73;FANCA;TRAF2;TRAPPC6A;KPNA3;CAPZA1;RANBP9;TAPBP;KMT2A;SEC31A;RAB1A;TCF7L2;AFG3L2;VAMP2;PPP2R1A;HES5;SEC24C;PPP6R1;ADAM10;SEC24B;WIPF1;PREB;PEF1;HGSNAT;TRAPPC2L;TLE3;KLHL12;TRAPPC1;CXCL12;TMED10;GSDMD;MEN1;TFG;ST13;CASP8;AFDN;TRAPPC9;TSPAN33
prerank,cAMP biosynthetic process (GO:0006171),0.48616377018061274,1.012187826592636,0.481981981981982,0.789214363402926,1.0,5/10,23.07%,ADCY7;ADCY8;ADCY3;ADCY5;ADCY9
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.4106642934306303,1.012165120093119,0.45794392523364486,0.7888250120772418,1.0,5/25,11.47%,SDCBP;THBS1;DSCAM;FZD7;APP
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3957538310368909,1.0121409350168826,0.4674479166666667,0.78843376783867,1.0,3/27,5.28%,SLC7A2;SLC36A4;SLC38A1
prerank,peptidyl-lysine acetylation (GO:0018394),0.48419607730972625,1.011954166819209,0.46788990825688076,0.7884231694057899,1.0,5/10,29.18%,CREBBP;SIRT1;KAT2A;KAT2B;EP300
prerank,establishment of spindle localization (GO:0051293),0.45789415338062245,1.0118851697661686,0.4880952380952381,0.7881404136972825,1.0,3/14,13.74%,DYNC1H1;CFL1;CLASP1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.37270207436849007,1.0114707387430253,0.46424242424242423,0.788717709455506,1.0,4/44,2.43%,BAAT;AMACR;OSBPL1A;PRKAG2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.2876153568167602,-1.0104880819056252,0.40236686390532544,0.8281166793129613,1.0,8/39,12.89%,PTPRG;TENM3;FLOT2;FUT9;SMAD7;EPHA7;DPP4;CELSR2
prerank,supramolecular fiber organization (GO:0097435),0.3197503011984524,1.0101835222727902,0.4678714859437751,0.7913825071239998,1.0,67/334,19.15%,CD36;MFGE8;MYO5A;MTM1;TLL2;HOOK3;RUFY3;CORO1C;MYO1E;VIM;DNAJB6;NAT8;DYNC1H1;BIN3;CD151;COL4A6;RIPK1;B4GALT7;CENPJ;SORL1;ACTN1;COL1A1;TRIOBP;KLHL41;MYO19;RPS27A;UBC;NCKAP5L;LUM;COL4A1;PPP1R9B;CALB1;TPM3;BACE1;MYO1F;COL5A2;ARHGAP17;RHOD;ARHGEF2;TPM4;COL11A1;KLHL24;APP;TUBGCP4;COL5A3;MFAP4;COL3A1;TSPAN15;PRKN;WHAMM;LAMA3;NCSTN;COL6A2;ATP7A;RND2;CCDC88C;ARHGAP25;GGA2;COL11A2;COL4A5;PLOD1;COL12A1;PLEC;FLII;KATNA1;CALCA;CORO1B
prerank,positive regulation of macrophage differentiation (GO:0045651),0.4813566277546062,1.0099100066680144,0.48036253776435045,0.7915936850820259,1.0,2/11,4.15%,ID2;RIPK1
prerank,rRNA metabolic process (GO:0016072),0.32690935645586705,1.009867525279606,0.47579814624098865,0.7912574444998797,1.0,69/160,29.25%,C1D;EBNA1BP2;MPHOSPH10;BYSL;SENP3;RPL18A;DCAF13;RPS14;WDR55;RPL17;RPL23;RPL36A;NOP14;EXOSC3;TEX10;WDR18;EXOSC9;POP4;WDR74;RPL22;NOB1;DKC1;EXOSC8;NOL8;DEDD2;RPL10A;KRR1;MRM2;RPL15;RPL10;MTREX;EXOSC10;WDR12;UTP11;EXOSC1;RPL7;RPL26;PWP2;UTP15;RCL1;DHX37;EXOSC7;RPS27;WDR43;FBL;BOP1;NOLC1;RPL7A;LYAR;NOL6;XRN2;RPL32;SNU13;RRP36;RPS9;WDR36;EXOSC4;DDX49;MPHOSPH6;RPL6;DIS3L;PELP1;NOL11;RPL4;RPL14;MRTO4;EMG1;RPS7;ESF1
prerank,positive regulation of biomineral tissue development (GO:0070169),0.37296352117642884,1.00975536837081,0.4589963280293758,0.7910750094511148,1.0,8/40,10.92%,CEBPB;ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,regulation of cytokinesis (GO:0032465),0.344721936736545,1.0097237581040035,0.4889867841409692,0.7907121411980366,1.0,12/78,10.73%,KIF20B;PLK2;BIRC6;UVRAG;SH3GLB1;CUL3;MYO19;FLCN;SVIL;ZFYVE19;VPS4A;PKN2
prerank,DNA replication (GO:0006260),0.3373091637171864,1.009576963579331,0.4729011689691817,0.7906329683406984,1.0,25/105,20.39%,RBMS1;BAZ1A;MCM9;RFC3;BRIP1;FAM111A;MCMBP;HELB;POLG2;TOP1;BRCA1;POLL;DBF4;ING4;NBN;WRN;POLA1;RNASEH2A;ORC1;CDK2AP1;ORC4;TBRG1;RMI1;TOP3A;MRE11
prerank,phosphate ion transport (GO:0006817),0.442098188017803,1.0093748875436985,0.4684813753581662,0.79068674547809,1.0,6/16,28.56%,XPR1;SLC37A3;SLC20A2;SLC37A4;SLC25A30;SLC25A10
prerank,protein localization to membrane (GO:0072657),0.3241975772287577,1.00934383870072,0.48484848484848486,0.7903183299571461,1.0,38/187,14.60%,MYO5A;DENND4C;RFTN1;RAP2A;FLOT1;NPC1;RAB8B;PRAM1;ITGA4;PDZD11;SH3GLB1;SYNE3;TMEM150A;ZFYVE27;TSPAN17;GAK;RABEP1;HPS6;DVL1;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;CYP46A1;AP3D1;PACS2;RAB11B;TSPAN15;SH3PXD2B;GAS6;NRXN2;EFR3A;ARL3;CACNB3;LRP6
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.3574215882087072,1.0092112917341292,0.4753521126760563,0.7902227059330104,1.0,9/51,12.74%,PPARG;SORL1;ACVR2A;HIPK2;BMPR2;FSTL1;RBPMS2;NOTCH1;LEMD3
prerank,positive regulation of histone methylation (GO:0031062),0.4067379223600982,1.0079128191772397,0.4493927125506073,0.7929316755472499,1.0,10/24,22.24%,CTNNB1;CHTOP;BRCA1;SIRT1;DNMT1;KMT2A;PHF1;PAXIP1;OGT;MTF2
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.3067604143954262,-1.007840473276608,0.42201834862385323,0.8315208121632303,1.0,13/29,24.86%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH
prerank,CENP-A containing chromatin organization (GO:0061641),-0.3067604143954262,-1.007840473276608,0.42201834862385323,0.8315208121632303,1.0,13/29,24.86%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3546042773790273,1.0077573722682944,0.46145251396648046,0.7928520570307209,1.0,17/62,17.20%,POLR2A;AFF4;GTF2H5;PCID2;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;CTDP1;MLLT1;MNAT1;CDC73;ELP4;NELFE;MLLT3
prerank,positive regulation of translation (GO:0045727),0.33949407405763676,1.0075387940575486,0.46254071661237783,0.7929651849145525,1.0,29/94,22.44%,SAMD4A;VIM;IL6;CD28;YTHDF3;THBS1;AGO2;EIF6;LARP4B;NAT10;POLR2G;CDC123;RMND1;USP16;UHMK1;HNRNPD;EIF4A3;RPL26;C1QBP;TRMT10C;BCL3;JMJD4;EIF3C;LARP4;PCIF1;COA3;PKM;PRKDC;UPF3A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.44091231339907627,1.0074605764476008,0.46785225718194257,0.7927173735176483,1.0,5/17,11.88%,PLXND1;MAML1;MAML2;CREBBP;NOTCH1
prerank,eye development (GO:0001654),0.3579831864767738,1.007416902635979,0.46875,0.7923739085986692,1.0,10/54,13.34%,STRA6;ZDHHC16;NIPBL;HIPK1;HIPK2;COL5A2;SALL2;RAB18;SOX2;SH3PXD2B
prerank,regulation of regulated secretory pathway (GO:1903305),-0.29131714311048423,-1.0073599450397446,0.42487046632124353,0.8308215047829695,1.0,8/34,8.86%,SYT1;RIMS1;RAB27A;RIMS2;SYT7;SYT2;SYT4;SYT6
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3541108842607374,1.0073286005941031,0.46747519294377066,0.792140568289195,1.0,18/72,19.58%,PIK3R5;HGF;PDGFA;IGF1;IRS2;PIK3CA;SIRT1;ROR1;TREM2;MAZ;HCLS1;FGR;CBL;NCF1;TEK;PIK3CB;GAB1;OSM
prerank,triglyceride biosynthetic process (GO:0019432),0.4329139115261043,1.0072939866915906,0.4602510460251046,0.7917793392472908,1.0,2/18,1.54%,LPIN3;GPAT2
prerank,protein deacylation (GO:0035601),0.410366221604281,1.0071546115392611,0.4553805774278215,0.7916856332353129,1.0,9/23,21.03%,PPT1;SIRT6;ABHD10;SIRT1;SIRT7;SIRT3;LYPLA2;SIN3A;ABHD17C
prerank,negative regulation of cell cycle (GO:0045786),0.3497325199566415,1.0069508131925016,0.4730473047304731,0.7917004342138987,1.0,10/73,9.53%,LILRB1;RPS6KA2;IPO5;RUNX3;PTEN;HTRA2;APC;NUDT6;RB1;NLRP2B
prerank,regulation of T cell cytokine production (GO:0002724),0.4394622922439992,1.0069468189308655,0.45911047345767575,0.7912680218573188,1.0,7/15,26.01%,FOXP3;TNFRSF1B;FZD5;TRAF2;MALT1;TRAF6;MAP3K7
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.41672857062491925,-1.0068482350541448,0.46153846153846156,0.8302965721142714,1.0,2/10,2.63%,SERPINE2;SH2B3
prerank,regulation of secretion (GO:0051046),0.4630874877207688,1.0067840936247563,0.48905109489051096,0.7912191078976251,1.0,3/13,13.26%,SGK1;GPLD1;POFUT2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3384019562246805,1.0067155778918488,0.47956989247311826,0.7909405679845959,1.0,33/100,22.65%,SDCBP;WAC;RNF19A;GNA12;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;N4BP1;PRKN;HSPA1A;HECTD1;KEAP1;EIF3H;BBS7;TLK2;XPO1;DDA1;RNF19B;OGT;PIAS1;CEBPA;TAF1;GIPC1;HSPBP1;VCP;HERPUD1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.45177890071321486,1.006715112305776,0.48255813953488375,0.790499523779525,1.0,7/15,24.79%,ADRA1A;CLN3;ZDHHC12;NLGN2;BAIAP3;DRD2;USP46
prerank,protein modification process (GO:0036211),0.34450299014064817,1.006446256209511,0.48325892857142855,0.7907386196364172,1.0,23/76,22.45%,MSRA;ABL2;PARP4;B4GALT7;GNMT;UBE2L3;MANBA;PIGH;PPP4R2;WWP2;FBXO11;STK38;UBA3;FBXW2;MCRS1;CDC34;UBE2M;ICMT;UBE2S;NAGPA;NTAQ1;PRKDC;DUSP12
prerank,T-helper cell differentiation (GO:0042093),0.45186956613776896,1.0064083664273855,0.49624060150375937,0.7903861056780145,1.0,4/14,15.41%,IL6;FOXP1;PTGER4;ATP7A
prerank,external encapsulating structure organization (GO:0045229),0.32368552804809886,1.0062488288939144,0.47878787878787876,0.7903315017084253,1.0,36/205,17.14%,MMP12;VWF;ICAM2;ADAMTS8;MMP27;SPP1;CD44;ITGA5;ITGA4;PDGFA;COL4A6;MMP14;COL1A1;THBS1;DAG1;LUM;COL4A1;HRNR;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A;ADAMTSL4;COL11A2;COL4A5
prerank,protein phosphorylation (GO:0006468),0.3158144376584832,1.0061441071870718,0.5085085085085085,0.7901506704036487,1.0,79/479,13.89%,FNIP2;SGK1;MAP3K20;MAK;SYK;TLK1;FRK;PRKCH;MAP3K1;RPS6KA2;ERN1;TEC;PDK4;MAPKAPK3;PRKAG2;IKBKE;PLK2;TAOK3;PDPK1;ABL2;PRKCD;PPP4R1;RUNX3;BIRC6;SIK3;FAM20C;SRPK2;DAPK1;RIPK1;ABI1;RARA;MAPK6;GTF2H5;PIM1;FGFR4;MAML1;PKN3;MERTK;RNASEL;MELK;SIK1;IRAK3;STK24;STK3;INCENP;DYRK1A;EIF2AK4;TOP1;BRD2;ACVR2A;PKDCC;HIPK1;MAP4K3;ACVRL1;CSNK2A2;HIPK2;BMPR2;TNIK;PIM3;ROCK1;GSK3B;PTK2B;PKN2;PAK2;FES;CDK7;CCNA2;APP;DCLK3;PRKCB;ACVR1B;STK38;BTK;DGKQ;DYRK2;GAS6;FGR;STK16;MAST4
prerank,meiosis I (GO:0007127),0.4027498976095154,1.006141165358323,0.4699599465954606,0.7897164573171362,1.0,6/23,26.62%,BCL2L11;FOXJ3;SGO1;PTTG1;MYBL1;FOXJ2
prerank,covalent chromatin modification (GO:0016569),0.45480334326665234,1.0060178837892235,0.46875,0.7895654128453256,1.0,7/14,25.53%,PARP2;SIRT1;MT3;SIRT7;MBD2;SETD5;HDAC1
prerank,regulation of secretion by cell (GO:1903530),0.3527955535298505,1.0060139786167215,0.4796380090497738,0.7891360198147922,1.0,12/54,13.52%,ANXA1;RAB8B;RIC1;RHBDF2;RAB21;STXBP5;RAB12;RAB10;CPLANE2;SYN1;MCTP1;VAMP3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.39935134513334863,1.00589294948405,0.4694408322496749,0.7889688558444083,1.0,3/26,8.02%,NSMCE2;CUL3;RB1
prerank,"phototransduction, visible light (GO:0007603)",0.4533881336337004,1.0058919565368813,0.45875542691751087,0.7885316846986089,1.0,1/14,2.42%,GNAQ
prerank,mammary gland epithelium development (GO:0061180),-0.36762888028410345,-1.0058074643595123,0.44155844155844154,0.8311071596762889,1.0,2/14,1.05%,ERBB4;CSF1R
prerank,protein deubiquitination (GO:0016579),0.3194310113986949,1.0054613449899266,0.48328267477203646,0.7890973616180376,1.0,85/242,26.01%,MINDY1;TNIP1;PSMD1;RIPK1;ASXL2;PTEN;FOXO4;STAM;BABAM2;APC;RNF128;TOMM20;RPS27A;UBC;USP42;BRCA1;RAD23A;USP12;VCPIP1;COPS5;ESR1;FOXK1;USP40;BIRC3;USP26;CCNA2;PSMF1;USP48;PSMD14;PSMD12;TRAF3;USP21;USP16;KDM1B;TNFAIP3;PRKN;RNF123;MCRS1;PSME2;INO80;STAM2;USP36;CCP110;BRCC3;ASXL1;USP8;TRAF2;NFRKB;OTUD5;PSMB10;KEAP1;PSMD5;SNX3;USP32;BIRC2;CDC25A;PSMD8;PSMA3;USP30;STAMBP;PSMA2;ATXN3;PSMD11;PSMA6;OGT;USP3;USP9X;KAT2A;USP2;VCP;PSMB3;SIAH2;PSME3;TRAF6;USP47;SHMT2;ATXN7;USP46;PSMC5;TAB1;RCE1;ACTB;WDR20;KAT2B;MAP3K7
prerank,regulation of stress fiber assembly (GO:0051492),-0.24569498439931722,-1.0053955553614569,0.4392523364485981,0.8301799149203963,1.0,23/74,18.10%,TMEFF2;F11R;EVL;ASAP3;PPM1E;LIMCH1;WAS;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;ARHGAP6;ARHGEF18;RHOA;RAPGEF3;STMN1;RGCC;SLC9A1;TPM1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.39557747382055347,1.0051023217425987,0.48227848101265824,0.789505735512834,1.0,6/30,10.59%,KLK3;KDM4C;NCOR1;DDX5;FOXP1;SIRT1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.4345779975982085,1.0051003767100082,0.46831955922865015,0.7890718514537137,1.0,3/17,4.33%,CXCR4;ID2;TNFRSF1B
prerank,response to interleukin-4 (GO:0070670),0.49304332669090545,1.005066935058612,0.4785276073619632,0.7887127009530598,1.0,2/10,14.64%,SHPK;JAK3
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4859243742177529,1.00468398443346,0.464339908952959,0.7892108046085277,1.0,2/10,9.52%,FOXP3;DDIT3
prerank,negative regulation of viral process (GO:0048525),0.3585165701392318,1.004225395011039,0.47706422018348627,0.7898932118766057,1.0,14/57,17.77%,IFITM1;TNIP1;SRPK2;FAM111A;RNASEL;ZC3HAV1;IFITM2;MAVS;LARP7;BST2;N4BP1;SLPI;SRPK1;TRIM14
prerank,regulation of microglial cell activation (GO:1903978),0.44083997155237337,1.003798712206493,0.4859675036927622,0.7904682317634183,1.0,5/15,15.74%,IL6;STAP1;TREM2;CX3CL1;GRN
prerank,metallo-sulfur cluster assembly (GO:0031163),0.40748957559473387,1.0034412006701718,0.4713896457765668,0.790863663926541,1.0,10/22,25.40%,ABCB7;NUBP2;NUBP1;CIAO2B;CIAO2A;GLRX5;NFS1;HSPA9;FXN;CIAO1
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.427605252065308,1.0033247810697687,0.478494623655914,0.790704443322343,1.0,4/22,10.59%,CDKN1A;STAP1;ROCK1;SIRT1
prerank,Wnt signaling pathway (GO:0016055),0.3357530129342473,1.0032793061831962,0.5054229934924078,0.7903837231477765,1.0,20/92,17.97%,PLPP3;CTNNB1;PTEN;APC;RPS27A;UBC;DVL1;STRN;FZD7;GSK3B;FZD5;WLS;FZD2;LRP6;CUL1;CCDC88C;DIXDC1;CSNK1G1;SNX3;VPS29
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.467791869775645,1.0031934536054887,0.5007473841554559,0.7901418744173436,1.0,4/12,14.58%,UMPS;CTPS1;CRMP1;CTPS2
prerank,import into nucleus (GO:0051170),0.34509815630607116,1.0031001527558554,0.4820224719101124,0.7899355490274351,1.0,19/73,22.66%,MMP12;SYK;IPO5;E2F3;APPL2;TPR;NUP50;TNPO1;APPL1;DDX20;SNRPF;SMN1;NUP88;CSE1L;NUP188;SNRPB;PPP1R10;RPAIN;STAT3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.4538672966724893,1.003066262912268,0.4808823529411765,0.7895737266459281,1.0,7/14,25.34%,PRKN;HSPA1A;CREB3;CREB3L1;HERPUD1;BCL2L1;TXNDC12
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.37225295159185234,1.0030654440922713,0.4867469879518072,0.7891395960322343,1.0,7/40,9.01%,ALYREF;MCM9;ZRANB3;FAM111A;THOC1;EME1;RTEL1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.47381050447822554,1.0027940612196393,0.471841704718417,0.7893616507920287,1.0,2/12,7.51%,HOOK3;KIF3A
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4758242794135187,1.0023493759597875,0.4849445324881141,0.7899721293579085,1.0,2/10,13.36%,LILRB1;GAS6
prerank,neuron projection development (GO:0031175),0.32547543665120393,1.0019940206960676,0.5040983606557377,0.7903420582471857,1.0,27/168,12.10%,LRP12;APOE;SGK1;DTNBP1;STX3;MICALL2;ERCC6;KIF20B;TAOK3;IL6;FRY;PTEN;ZFYVE27;TBC1D23;DOCK10;MICALL1;RB1;PPP1R9B;VAPA;VASH2;EPB41L3;TNIK;ROCK1;GSK3B;TBC1D24;APP;PQBP1
prerank,striated muscle cell differentiation (GO:0051146),0.441497331363243,1.0018059152824859,0.475,0.790349977810764,1.0,4/16,7.98%,PLD3;MTLN;SIK1;AKAP13
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3423136713876026,-1.0017417876682928,0.4581818181818182,0.8385198394855565,1.0,3/19,6.10%,CX3CR1;CD33;NLRP3
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3630832892151352,1.001701975728397,0.4817432273262662,0.7901641582256558,1.0,8/49,10.76%,RAB7B;THBS1;EIF6;CNOT4;CBFB;TNRC6B;AGO3;KMT2E
prerank,peptidyl-lysine dimethylation (GO:0018027),0.4229656473785164,1.001420397359085,0.46398891966759004,0.7904246706410539,1.0,11/18,30.62%,SETD7;SUV39H2;SMYD2;KMT2A;ASH1L;EHMT2;SETD3;KMT2D;SETD1B;EHMT1;SETD4
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.31575933960057156,-1.0014034214175827,0.47520661157024796,0.8374405049320549,1.0,6/26,10.60%,VSIR;GRIN2B;MBP;GRIN1;PRELID1;PYCARD
prerank,UV-damage excision repair (GO:0070914),0.4583471602710099,1.0002342166376335,0.4946236559139785,0.7928599902505572,1.0,6/12,21.49%,DDB1;SIRT1;POLA1;INO80;CUL4B;XPC
prerank,nervous system development (GO:0007399),-0.2462149449005882,-1.0,1.0,0.8394732372754636,1.0,88/429,12.35%,NAV3;NAV2;RAPGEF5;RBFOX1;ADGRL3;MEF2C;OPHN1;ERBB4;SEMA5A;LSAMP;SDK1;GPM6A;SPOCK1;NRXN1;ADAM23;DCLK1;ROBO2;KIRREL3;ROBO1;NLGN1;CNTN6;MARCKS;RBFOX2;EVL;GRIK1;DNM3;SIAH1;RYK;MBP;SCN2A;SMO;BTBD3;GLRB;CHRM3;CNTN4;CHRM2;ANKLE2;FUT10;RBFOX3;FGF12;RELN;LIMK1;SRRM4;MYT1L;TGFBR1;NCKAP1;STMN3;TRIM3;ARNT2;FGF2;FGF13;TMOD2;IL1RAPL2;MOBP;INTU;ARHGAP26;FARP1;CDH2;VLDLR;EDNRB;ADORA1;GSS;MBD5;ATN1;MAL;DNER;SZT2;PPP2R5D;SERPINI1;IRF2BPL;EFNB3;ADGRV1;SOX6;ADAM22;NLGN3;SH3GL3;KCNQ2;MARK4;SREBF2;HAPLN2;SNTG2;PKD2;SEMA6A;RPS6KA6;LDB1;LDB2;ERBB3;GFRA2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.34330714711473825,0.9999330375665688,0.49498327759197325,0.7931136473272177,1.0,21/72,20.59%,PLK2;CDKN1A;SESN2;E2F1;GADD45A;CNOT4;GTSE1;HIPK2;CNOT6L;CNOT7;ING4;NBN;BAX;CNOT6;RPL26;ACER2;CASP2;CRADD;BCL3;PAXIP1;TNKS1BP1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.42482419153996537,0.999710904499308,0.496551724137931,0.7932296775728759,1.0,4/18,15.53%,SYK;TYROBP;DOCK2;LBP
prerank,COPII-coated vesicle budding (GO:0090114),0.34852053905811664,0.9996265249042816,0.4843400447427293,0.7929953360991349,1.0,27/68,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;VAPA;SEC23B;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,regulation of intracellular pH (GO:0051453),0.37848303819781354,0.9995234856118655,0.4744897959183674,0.7928019027051443,1.0,8/34,16.72%,SLC9B1;SLC9A3;TMEM165;CLN3;VPS33A;GPR89A;GPR89B;CA2
prerank,piRNA metabolic process (GO:0034587),0.4222022193081005,0.9993123247623712,0.4695290858725762,0.792888005584231,1.0,1/19,1.54%,GPAT2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.33849464933414336,0.9988620816119075,0.4799566630552546,0.7935284093680939,1.0,18/87,15.42%,GDF15;ZMIZ1;GCNT2;ADAM9;JUN;APPL2;LPXN;RPS27A;UBC;ACVRL1;ITGB1;SIRT1;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.31529981858367945,0.99879146140115,0.5115346038114343,0.7932634151675747,1.0,61/348,15.85%,CD36;DTNBP1;LILRB1;NFE2L2;MITF;VEGFA;TFRC;IL36G;NAT8;ID2;IL6;CD28;CD46;CD63;SRPK2;CELF1;MAP2K5;CITED2;PID1;E2F1;IGF1;MAPK7;FGFR4;AGO2;ANXA2;HSPA1B;NWD1;ATF4;RPL23;STAP1;POU3F1;MSN;BRCA1;CTSH;TYROBP;TNRC6B;NR5A1;ROCK1;GSK3B;MTPN;POU3F3;AGO3;MED26;MT3;APP;NOTCH1;TREM2;MAZ;DGKQ;GAS6;VAMP3;PRKN;SLC11A1;INPP5F;HSPA1A;ADAM19;SNF8;ARRB1;MPHOSPH8;MYD88;DNMT1
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.2472574335140184,-0.998227498252329,0.4864864864864865,0.8426421278077719,1.0,12/70,6.39%,MEF2C;OPHN1;TMEFF2;NTNG1;FER;ABI2;SRGAP2;RELN;METTL3;SIPA1L3;RILPL1;SRCIN1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.4121914817040063,-0.9981307618605063,0.49722222222222223,0.8408842705437671,1.0,2/10,4.65%,THRA;PSMC2
prerank,metal ion export (GO:0070839),-0.2934538162197308,-0.9981291643769132,0.4527363184079602,0.8388432893045833,1.0,3/31,5.31%,ATP1B1;ATP1A2;ATP1B2
prerank,tRNA methylation (GO:0030488),0.3797526406916589,0.9980397572067927,0.48930817610062893,0.7946133181449817,1.0,19/34,28.33%,TRMT12;LCMT2;TRDMT1;TRMT44;GTPBP3;ALKBH8;PRORP;TRMT1L;TRMT10C;TARBP1;TRMT13;DALRD3;TRMT10A;FTSJ1;TRMO;THUMPD3;MTO1;METTL1;METTL6
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3414469006369875,0.9980190170059372,0.5005537098560354,0.794232030697939,1.0,32/79,28.42%,CTSD;PIKFYVE;CTSL;OSBPL1A;RAB7A;DYNC1H1;KIF3A;CTSS;CAPZB;AP1G1;AP2B1;CAPZA1;ACTR1B;AP1M1;SEC31A;FCGR2B;LGMN;SEC24C;SEC24B;DYNC1LI2;AP2S1;DCTN4;CLTC;AP2A2;DYNC1LI1;KIF22;AP2A1;DCTN5;AP1B1;SEC24A;KIF3B;CANX
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.3019562283931182,-0.9980064928161753,0.4577114427860697,0.8372051928252335,1.0,8/28,10.71%,SMURF1;PSMC2;OSBPL7;FMR1;CLU;ECSCR;DAB2IP;RNF139
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.315426862488655,0.9975741505811186,0.5005025125628141,0.7948399128749222,1.0,50/260,15.49%,MTSS1;SDCBP;MAK;RILPL2;FGD6;RAP2A;RAB8B;PIBF1;SPEF1;SNX10;ANO6;EMP1;CFAP70;SNAP29;ATP6V0D1;KIF27;CENPJ;ASAP1;ABCC4;PARVB;WDPCP;CFAP20;FBF1;KIF3A;DYNC2I2;PPP1R9B;ACTR3;TNIK;ITGB1;RAP2B;RHOD;IFT46;CCDC66;NOTCH1;CFAP410;PMP22;MYLK;CPLANE2;FGD5;IFT52;OCRL;IFT140;SSX2IP;ARL3;WHAMM;GOLPH3;FGD3;EXOC4;OFD1;VSTM5
prerank,RNA splicing (GO:0008380),0.33464351594284414,0.9975732242211457,0.4940152339499456,0.7944066107372736,1.0,33/95,25.39%,DHX8;MBNL1;SRPK2;MPHOSPH10;SCAF11;RNPC3;TCERG1;PRPF8;PPP1R9B;SNRNP25;PRPF6;DDX23;NCBP2;ZMAT5;SF3A3;SNRNP35;RSRC1;SNRPF;ZRSR2;SYNCRIP;SRPK1;PPP2CA;PPP2R1A;SNRNP40;YJU2;SNRPB;SNRNP48;WDR83;RRAGC;PPIG;SF3B2;PRPF3;LSM6
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.34470279443183754,0.9975311385275396,0.4820224719101124,0.794072155313893,1.0,18/70,18.54%,PDPK1;FAS;RIPK1;TNFRSF1B;MLLT11;HIPK1;IL6R;GSK3B;ACVR1B;DEDD2;APPL1;BAX;MCL1;BID;TRAF2;CASP2;CASP3;CRADD
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.3869274491657132,0.9974828305870256,0.47468354430379744,0.7937470539025573,1.0,4/29,8.02%,APOE;NR1H3;ZBTB20;SLC27A1
prerank,negative regulation of translational initiation (GO:0045947),0.4534867478535821,0.9974272773811085,0.487369985141159,0.793453752174151,1.0,4/13,9.43%,AGO2;EIF2AK4;EIF4EBP2;TPR
prerank,RNA methylation (GO:0001510),0.34771008034434947,0.9967055153165626,0.48299319727891155,0.7947091710918727,1.0,30/60,27.01%,TRMT12;WTAP;LCMT2;TRDMT1;NSUN3;TRMT44;MEPCE;MRM2;GTPBP3;ALKBH8;TFB2M;CBLL1;TRMT10C;RBM15;PCIF1;TARBP1;FBL;TRMT13;DIMT1;MTERF4;TRMT6;METTL8;ZCCHC4;TGS1;NSUN4;TRMT10A;FTSJ1;TRMO;THUMPD3;MTO1
prerank,response to nutrient levels (GO:0031667),-0.35443220465964675,-0.996605564903993,0.4377358490566038,0.8393828941453488,1.0,2/17,3.14%,RPTOR;PRKAA2
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.3635056201046966,0.9964455632178861,0.47928994082840237,0.7948823443460137,1.0,15/46,24.50%,LCP1;TALDO1;ANXA2;MSN;PITPNA;CFL1;PAK2;PSME2;CAPZA1;HNRNPDL;GSTO1;JAK2;HSPA9;AIP;PPIA
prerank,negative regulation of signaling (GO:0023057),0.3987863887074709,0.9962792196106818,0.4584450402144772,0.7948613589463717,1.0,3/25,5.80%,OPTN;BRAP;TRAT1
prerank,regulation of cell growth (GO:0001558),0.3176078590621507,0.9962465299031047,0.5096251266464032,0.7944997323153754,1.0,36/204,13.93%,SDCBP;SGK1;TFRC;CDKN1A;RAB33B;PPT1;ENPP1;MYL2;SESN2;MMP14;OSGIN1;APBB2;NUBP1;SPHK2;FLCN;HSPA1B;N6AMT1;RB1;PPP1R9B;ACVRL1;BMPR2;EXOSC9;LAMTOR1;ADAM17;NAIF1;DCUN1D5;MTPN;SIRT1;MT3;DCUN1D3;BST2;ACVR1B;ATAD3A;RBBP7;DERL2;HSPA1A
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.40634480305712883,0.9962162787708706,0.48157894736842105,0.7941351387675558,1.0,2/23,1.57%,LILRB1;LAMP1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3547022600975798,0.995979530354122,0.5005793742757821,0.7942422036720965,1.0,7/56,10.13%,GDF15;SDCBP;RBPMS;ACVR2A;ACVRL1;BMPR2;SNX25
prerank,regulation of neuron death (GO:1901214),0.33961556542003607,0.9958301845540022,0.5021645021645021,0.794172944422908,1.0,12/82,10.83%,GPNMB;CD200R1;TNFRSF1B;SORL1;HTRA2;CTSZ;TYROBP;PICALM;EGLN3;GSK3B;SNCG;NENF
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3438903017452925,0.9957868135741702,0.4977924944812362,0.793833162392589,1.0,25/76,22.13%,FBXW7;RNF19A;PTEN;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;PRKN;HSPA1A;HECTD1;KEAP1;BBS7;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP
prerank,histone methylation (GO:0016571),0.3990318125918676,0.9954854964334797,0.4867924528301887,0.7941067343465196,1.0,7/26,15.36%,SMYD3;NSD3;CREBBP;N6AMT1;SIRT7;SUV39H2;SMYD2
prerank,regulation of neutrophil migration (GO:1902622),0.47655060334166416,0.995385954529676,0.4893292682926829,0.7939103275628326,1.0,3/10,16.09%,MPP1;OLFM4;BST1
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.33612290736054246,-0.9951050963291301,0.4574468085106383,0.8416689452159192,1.0,3/19,2.94%,CAMK1D;CSF1R;CSF1
prerank,protein localization to synapse (GO:0035418),-0.3782572520199649,-0.994923334880952,0.44753086419753085,0.8401436504104297,1.0,2/12,1.04%,NRXN1;NLGN1
prerank,positive regulation of telomere capping (GO:1904355),0.4256684289055985,0.9948006128350847,0.4844632768361582,0.7948433277906252,1.0,6/17,23.86%,RTEL1;HNRNPD;TNKS;TNKS2;PKIB;NEK7
prerank,vascular transport (GO:0010232),0.3382998781760204,0.9947523385083106,0.4994547437295529,0.7945228864385121,1.0,13/81,8.18%,SLC6A6;SLC7A2;TFRC;LRP1;SLC1A5;SLC16A1;SLC27A4;SLC38A1;SLC5A5;ABCC4;ABCC3;SLC27A1;ABCA2
prerank,cellular response to light stimulus (GO:0071482),0.3435288801343529,0.994549348357519,0.5016949152542373,0.7945401241382695,1.0,19/66,24.08%,AQP1;PRKCD;COPS9;CREBBP;EIF2AK4;ATF4;RHBDD1;NSMCE3;N4BP1;INO80;RPL26;CDC25A;NOC2L;EIF2S1;TAF1;RUVBL2;POLD1;ERCC4;USP47
prerank,regulation of sequestering of calcium ion (GO:0051282),0.4630219893437744,0.9942878374800751,0.4948604992657856,0.794727868552811,1.0,3/12,10.35%,DIAPH1;MTLN;PTK2B
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3485870619417175,0.9942060861676677,0.48977272727272725,0.7944987955498002,1.0,11/64,12.82%,MGLL;ABCD1;SLC27A4;SLC27A3;ACADL;GPX4;CPT1A;AIG1;LTA4H;ELOVL1;ACSL5
prerank,mucosal immune response (GO:0002385),0.44631535326596516,0.9941848216354223,0.4804804804804805,0.7941269057955223,1.0,2/15,17.91%,RNASE3;DEFA6
prerank,DNA catabolic process (GO:0006308),0.4666799465702163,0.9937489162915691,0.4954545454545455,0.7947340719697602,1.0,3/11,10.71%,MUS81;DFFB;DNASE1L1
prerank,regulation of myelination (GO:0031641),-0.31596629801868503,-0.9933998832331804,0.4330357142857143,0.8423997092592878,1.0,15/25,26.69%,PARD3;JAM2;TPPP;MYRF;CST7;TENM4;SIRT2;DICER1;TMEM98;EIF2AK3;NSUN5;LGI4;KLK8;NKX6-2;KIF14
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.4235115284227503,0.9930296034052062,0.4881450488145049,0.7959277921568071,1.0,6/19,10.11%,APOE;SORL1;IGF1;RTN3;PICALM;ROCK1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3170740907252051,0.9929383988503262,0.5070993914807302,0.7957219084903244,1.0,33/199,15.87%,GPNMB;GDF15;TIMP1;FOXP3;CORO1C;WWC2;NR1H3;ATP2B1;PTEN;NR1H4;PROC;FLCN;PARP3;ATF4;MCC;RB1;BMPR2;DDIT3;PTGER4;WDR77;ROCK1;ADAM17;GSK3B;NOTCH1;IL15;PLCL2;GAS6;N4BP1;SLC11A1;PFN2;LAMA4;GRN;LNPEP
prerank,presynapse organization (GO:0099172),-0.41343383297724556,-0.9928727584396522,0.4827586206896552,0.841815317011637,1.0,3/10,10.46%,NLGN1;LRRTM3;NLGN3
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.27125440863043476,-0.9927817353207191,0.46153846153846156,0.8400309306032044,1.0,15/44,18.10%,EVL;PPM1E;LIMCH1;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;RHOA;RAPGEF3;RGCC;TPM1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.33340656982803485,0.991872267559014,0.5183189655172413,0.7977692327988325,1.0,19/95,14.69%,B4GALT5;GCNT2;XYLT1;DSE;NDST1;EXT1;UGDH;B4GALT7;HAS3;B4GALT6;HEXA;ST3GAL4;LUM;HS2ST1;B4GALT3;SDC4;B4GALT2;SLC10A7;HS3ST2
prerank,inositol lipid-mediated signaling (GO:0048017),-0.25735974585752663,-0.9915365545556396,0.45517241379310347,0.8413445146286425,1.0,7/50,4.92%,PLCL1;CSF1R;PLCB1;ADAP2;KCNH1;IRS1;PLCH1
prerank,histone H3-K9 demethylation (GO:0033169),0.47055274318321283,0.9915081754302694,0.5023041474654378,0.7981732665352023,1.0,4/11,14.30%,KDM4C;KDM3A;JMJD1C;KDM7A
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3487217256848387,0.9914478438477929,0.49887640449438203,0.7978877145029862,1.0,17/64,17.20%,POLR2A;AFF4;GTF2H5;PCID2;POLR2L;POLR2G;CDK7;POLR2I;NCBP2;GTF2F2;CTDP1;MLLT1;MNAT1;CDC73;ELP4;NELFE;MLLT3
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3285612813601325,0.9912949036611985,0.491005291005291,0.7977904701060178,1.0,28/107,23.27%,BCL2L11;ERN1;FLOT1;CEBPB;ATF3;JUN;ATG10;THBS1;ATF4;DDIT3;GSK3B;RHBDD1;UBA5;PRKN;BAX;QRICH1;TRAF2;BBC3;CREB3L1;BCAP31;BRSK2;WFS1;EIF2S1;VCP;PPP1R15B;HERPUD1;TMCO1;AIFM1
prerank,mismatch repair (GO:0006298),0.39181108635759154,0.9905392642057714,0.5044472681067345,0.7991405416206272,1.0,4/27,6.86%,MCM9;MSH4;MUTYH;PMS1
prerank,endodermal cell differentiation (GO:0035987),0.3818951923072707,0.9904378793178074,0.48331273176761436,0.7989297169732928,1.0,8/31,20.20%,ITGA5;ITGA4;MMP14;COL11A1;LAMA3;CDC73;COL12A1;ITGAV
prerank,transition metal ion transport (GO:0000041),0.3703396201597334,0.9904068839282926,0.49755501222493886,0.7985790380989319,1.0,11/35,19.25%,TFRC;SLC11A2;HEPH;TRPC3;MT3;SLC11A1;ATP7A;MELTF;SLC31A2;FTH1;SLC30A1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.48410113745789773,0.9903802537326755,0.5205047318611987,0.7981977465190908,1.0,2/10,3.15%,XYLT1;DSE
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.329489808323924,0.9903469911967362,0.5046632124352332,0.7978517086029275,1.0,12/113,10.59%,HTR2B;MMP12;VEGFA;NOTCH2;IGF1;NRP2;NRAS;RREB1;VASH2;BMPR2;FZD7;SIRT1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.4535293999625448,0.990332405514027,0.5,0.7974651356652138,1.0,1/14,0.68%,SYK
prerank,I-kappaB phosphorylation (GO:0007252),-0.41654830392563735,-0.9897534087715262,0.4759036144578313,0.8444602429825354,1.0,4/10,18.57%,TLR3;DAB2IP;TLR2;CHUK
prerank,chordate embryonic development (GO:0043009),0.3554417513334109,0.9896209198462794,0.4958968347010551,0.7986662854475112,1.0,15/55,21.30%,VEGFA;XYLT1;MBNL1;COL1A1;FLCN;SULF2;BRCA1;DVL1;SULF1;ALDH1A2;CHD7;FUT8;SOX8;HES5;ADAM10
prerank,regulation of peptide hormone secretion (GO:0090276),-0.25921860727406026,-0.9896191213856479,0.4444444444444444,0.8428203972255086,1.0,18/67,17.31%,CACNA1E;KCNC2;HTR2C;ITPR2;CACNA1C;SNAP25;SYT7;RAPGEF4;CACNA2D2;PICK1;RFX3;PRKCA;DPP4;STX1A;RAPGEF3;HFE;KCNG2;TNF
prerank,tRNA metabolic process (GO:0006399),-0.35051463213534395,-0.9894176202109126,0.4797297297297297,0.8413473008436897,1.0,13/17,33.17%,ADAT1;AARS1;SSB;DTD2;KARS1;RPP30;YARS2;POP5;DTD1;POP7;THG1L;POP1;TRPT1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3842221688399234,0.9892188780301255,0.4880803011292346,0.799185843034027,1.0,6/33,8.84%,APOE;CORO1C;PTEN;THBS1;MCC;ACVRL1
prerank,regulation of centriole replication (GO:0046599),0.41947658863282383,0.9890946968535493,0.47994467496542187,0.7990552581276197,1.0,5/18,15.12%,PLK2;CENPJ;BRCA1;CEP76;ALMS1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3681183411298878,0.9890380591126671,0.5037406483790524,0.7987670542237991,1.0,12/40,19.60%,TIMP1;RIC1;CTSA;IRAK3;TIMP2;ROCK1;AZIN1;PRKCG;NELL1;SNX3;HMGCR;AZIN2
prerank,linoleic acid metabolic process (GO:0043651),0.4250532632914603,0.9884439090410749,0.48700410396716826,0.7997218094295356,1.0,2/17,11.40%,ABCD1;ELOVL1
prerank,establishment of epithelial cell polarity (GO:0090162),0.41572123063515964,0.9882173312424203,0.5049928673323824,0.7998319406447417,1.0,7/19,16.64%,RAP2A;CYTH1;FBF1;MSN;CLASP1;GOLPH3;MYO9A
prerank,ubiquinone biosynthetic process (GO:0006744),-0.3658873201910052,-0.9881525168541816,0.46864686468646866,0.8430028138547858,1.0,9/15,23.63%,COQ3;COQ10B;NDUFA9;COQ2;COQ9;COQ10A;COQ5;COQ8A;UBIAD1
prerank,mesenchymal to epithelial transition (GO:0060231),-0.4096169787462808,-0.9878518821484737,0.45664739884393063,0.8419687643285224,1.0,3/10,8.48%,SALL1;PAX2;BASP1
prerank,regulation of amyloid-beta formation (GO:1902003),0.3777447396462248,0.9877929839981986,0.4975429975429975,0.8003792256384288,1.0,16/34,23.24%,APOE;ABCG1;SORL1;IGF1;RTN3;ABCA2;PICALM;ROCK1;RELA;RTN4;CASP3;GSAP;GGA3;EPHA4;ABCA7;TMED10
prerank,C4-dicarboxylate transport (GO:0015740),0.4406549445754391,0.9877447668335463,0.5014925373134328,0.800051299664901,1.0,1/14,0.63%,LRRC8D
prerank,metal ion homeostasis (GO:0055065),0.36531553976949416,0.9876331761679829,0.49872773536895676,0.7998695087571341,1.0,9/40,14.15%,TFAP2B;SLC8A1;LETM2;SLC12A3;SLC12A8;TESMIN;LETM1;MT3;SLC12A7
prerank,positive regulation of peptidase activity (GO:0010952),0.41333072727023495,0.9872390556556748,0.4835164835164835,0.8003422192677585,1.0,9/20,23.52%,TANK;CTSH;PSME2;NCSTN;GRN;VCP;APH1B;PSME3;NDUFA13
prerank,actin filament capping (GO:0051693),0.4245509784357094,0.98711175028078,0.4909090909090909,0.7997888675412954,1.0,5/18,9.42%,VILL;CAPG;TRIOBP;SVIL;CAPZB
prerank,barbed-end actin filament capping (GO:0051016),0.4245509784357094,0.98711175028078,0.4909090909090909,0.7997888675412954,1.0,5/18,9.42%,VILL;CAPG;TRIOBP;SVIL;CAPZB
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.39558256073262127,-0.9870166328670279,0.4880952380952381,0.8423520359238967,1.0,4/11,22.32%,REST;PARK7;UBQLN1;STK26
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.34689726992629855,0.9869788000866321,0.5095613048368954,0.7996619508313578,1.0,14/67,14.64%,SYK;TEC;PIBF1;ABL2;ABI1;FGFR4;DYRK1A;PKDCC;PTK2B;FES;IL15;BTK;FGR;JAK3
prerank,vasculogenesis (GO:0001570),0.3847789452109507,0.9862956952428403,0.5012886597938144,0.800800395479203,1.0,2/32,1.73%,APLNR;VEGFA
prerank,positive regulation of telomerase activity (GO:0051973),0.38098843213151784,0.9857815425338101,0.49111675126903553,0.801559249592626,1.0,7/33,20.80%,CTNNB1;ACD;XRCC5;DKC1;TNKS;CCT2;PKIB
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.3613752002471625,-0.9856036644132536,0.4658753709198813,0.8443505795190768,1.0,2/13,3.74%,TGFBR2;RYR2
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.31644884515654753,0.985563480689733,0.5172764227642277,0.8016552117245992,1.0,41/190,19.22%,APLNR;XDH;ADGRG3;FNIP1;WWC2;TNIP1;TANK;RIPK1;PTEN;PPIF;THBS1;DAG1;DUSP3;GPD1L;NR1H4;PPEF2;FLCN;EPM2A;CD22;PLEKHA1;DDIT3;ESR1;NLRC3;SIRT1;RORA;TREM2;RNF34;RELA;NPRL3;LIMD1;TNFAIP3;MCL1;CDC34;ARHGAP25;NPRL2;NDUFS3;DGKG;PPP2R5C;NOC2L;STAMBP;PIK3CB
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.3320490646127314,0.9854198938448748,0.5087527352297593,0.8015724916400097,1.0,30/88,26.25%,FBXW7;PSMD1;FBXL17;FBXL3;FBXO9;PSMF1;PSMD14;PSMD12;CUL4A;FBXO6;PSME2;CUL1;AMN1;PSMB10;PSMD5;PSMD8;PSMA3;FBXO31;PSMA2;PSMD11;PSMA6;CUL4B;FBXL4;PSMB3;PSME3;FBXO4;DMAC2;PSMC5;FBXL12;PSMC1
prerank,negative regulation of developmental growth (GO:0048640),0.3867490608193756,0.9852434167075872,0.4917825537294564,0.801564319585038,1.0,4/30,4.72%,GDF15;WWC2;CDKN1A;PTEN
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.34625272041991384,0.985196260485521,0.5067873303167421,0.800393026646824,1.0,25/61,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,COPII vesicle coating (GO:0048208),0.34625272041991384,0.985196260485521,0.5067873303167421,0.800393026646824,1.0,25/61,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,vesicle coating (GO:0006901),0.34625272041991384,0.985196260485521,0.5067873303167421,0.800393026646824,1.0,25/61,25.12%,MCFD2;CUL3;STX5;TRAPPC5;RAB1B;FOLR1;CTSZ;BET1;PPP6C;TRAPPC10;TRAPPC6A;SEC31A;RAB1A;SEC24C;PPP6R1;SEC24B;PREB;PEF1;TRAPPC2L;KLHL12;TRAPPC1;TMED10;TFG;TRAPPC9;PPP6R3
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.46716950782338895,0.9851386207833976,0.49921507064364207,0.8000932055554008,1.0,1/10,2.06%,FOXP3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.4109542905983626,-0.9851166952358793,0.46408839779005523,0.8437627121047926,1.0,2/10,3.32%,PRKCE;ATP1A2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.4284025645250298,0.9850952791128262,0.4930747922437673,0.7993422488844646,1.0,5/17,16.83%,STAT5B;IRS2;IL7R;JAK3;BRWD1
prerank,cellular response to interleukin-7 (GO:0098761),0.4284025645250298,0.9850952791128262,0.4930747922437673,0.7993422488844646,1.0,5/17,16.83%,STAT5B;IRS2;IL7R;JAK3;BRWD1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.24224206634969803,-0.9844070866345249,0.4649122807017544,0.8438255772876729,1.0,14/65,13.63%,LDLRAD4;SMAD3;TGFBR2;SPRED1;SNX6;SMURF1;TGFBR1;SMAD7;HTRA3;LTBP1;SPRED2;FBN2;SMAD2;SPRED3
prerank,keratinocyte differentiation (GO:0030216),0.3863062248781428,0.9841968753073197,0.5056179775280899,0.8009067927361669,1.0,2/29,2.89%,ANXA1;ADAM9
prerank,heterocycle biosynthetic process (GO:0018130),0.4414310478474175,0.9839519383477175,0.49851190476190477,0.8010211285842403,1.0,4/14,19.00%,MOCOS;LIAS;GCH1;NFS1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3749654867369739,0.9837961032041659,0.5036496350364964,0.8009304629347344,1.0,18/35,28.44%,FOXO3;STAT5B;HSPA1B;ACVR2A;MAFB;ACVR1B;FAM210B;HSPA1A;BRD1;PRKDC;STAT3;CDK6;HSPA9;ZFP36;MAPK14;NCKAP1L;INHBA;ZFP36L1
prerank,myofibril assembly (GO:0030239),0.36201809452932276,0.9834485518637759,0.49336550060313633,0.8012783018713789,1.0,4/42,11.02%,SYNPO2L;MYL2;KLHL41;WDR1
prerank,"DNA-templated transcription, termination (GO:0006353)",0.34550676508070355,0.9831370855074939,0.5189732142857143,0.801558822016524,1.0,17/68,18.54%,POLR2A;CPSF1;GTF2H5;CSTF3;POLR2L;WDR33;TAF1B;POLR1A;CDK7;NCBP2;MAZ;SNRPF;MNAT1;SSU72;SMN1;TTF1;TAF1A
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.43235887801310713,0.9830414943215827,0.5065312046444121,0.80135268128916,1.0,3/15,6.26%,SAMD8;PRKCD;SPHK2
prerank,cranial nerve development (GO:0021545),-0.3913620173991957,-0.9827969635936272,0.46546546546546547,0.8462280086818283,1.0,3/11,12.20%,SALL1;PAX2;ERBB3
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3839247195438667,0.9826702749103483,0.50186799501868,0.8018095832330804,1.0,2/32,3.02%,APLNR;PDPK1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.45240131561701524,0.982630455523411,0.4992503748125937,0.8014616851116373,1.0,2/12,5.01%,ADSL;PPAT
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.47311358031012085,0.9825961201990805,0.49770290964777947,0.8011217581815915,1.0,3/10,12.89%,RPS27A;UBC;CHFR
prerank,regulation of macrophage differentiation (GO:0045649),0.4386539874501033,0.9821985171700857,0.5,0.8016470060678313,1.0,2/15,4.15%,ID2;RIPK1
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2715445166895494,-0.9821608417280426,0.4791666666666667,0.8459519667002069,1.0,24/38,37.76%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;ATRX;ASF1B;CENPQ;CENPN;CENPH;ASF1A;CENPI;HIRA;HAT1;CENPW;SMARCA5;CENPL;CENPS;H3-3A
prerank,positive regulation of immune response (GO:0050778),0.3423138162061903,0.9819081833543294,0.5056689342403629,0.8019036565517955,1.0,9/64,12.24%,TLR8;LILRB1;CD46;ADAM8;SPHK2;EIF2AK4;CYBA;SIRT1;IL15
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.33639101695999024,-0.9818239306496026,0.4921259842519685,0.8409556529890658,1.0,12/20,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.33639101695999024,-0.9818239306496026,0.4921259842519685,0.8409556529890658,1.0,12/20,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.33639101695999024,-0.9818239306496026,0.4921259842519685,0.8409556529890658,1.0,12/20,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3235070979405257,0.9813154594348117,0.5217391304347826,0.8028552834946717,1.0,24/128,15.42%,GDF15;ZMIZ1;GCNT2;RUNX2;ADAM9;JUN;APPL2;LPXN;DDX5;RPS27A;UBC;ACVR2A;ACVRL1;BMPR2;ITGB1;SIRT1;STUB1;ACVR1B;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.446803766028824,0.9812797405272061,0.5029325513196481,0.8025120865641636,1.0,1/13,0.92%,ZMIZ1
prerank,translation (GO:0006412),0.3155425638586422,0.9812563442323868,0.5490394337714863,0.8021470390180137,1.0,47/208,17.35%,RPL3L;FARS2;TNIP1;IGF2BP3;EEF1A1;AGO2;RPL18A;RPS14;MRPL11;RPS11;RPS27A;MRPL23;RPL17;RPL23;N6AMT1;DARS1;RPL36A;ETF1;EIF4EBP2;COPS5;MRPS7;RPL22;RPS21;RRBP1;MRPL32;MRPL36;GTPBP2;EPRS1;MRPS28;SARS1;SARS2;RPL10A;MRPL28;DHPS;RPS26;IARS2;MRPS21;SRBD1;QRSL1;MRPL35;RPL15;RPL10;RPSA;AIMP1;MRPL43;RPL7;RPL26
prerank,sarcomere organization (GO:0045214),0.3818184450544899,0.9804456074304049,0.5083655083655083,0.8035567366583797,1.0,2/27,11.02%,SYNPO2L;WDR1
prerank,actin filament network formation (GO:0051639),0.4587163971347896,0.9803574056970609,0.5081967213114754,0.803342511656904,1.0,3/11,11.53%,LCP1;ACTN1;PLS3
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3831573113545485,0.9801443946813908,0.5142118863049095,0.8033848937352692,1.0,9/30,21.81%,SDCBP;WAC;STYX;N4BP1;EIF3H;SGTA;TLK2;OGT;GIPC1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.38538276012240874,0.9798608513868889,0.5025974025974026,0.8036132001061752,1.0,15/29,27.61%,ACD;RTEL1;TERF1;DKC1;PPP6C;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPIA;PPP6R3;TINF2;WRAP53;RFC1
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4141691085934645,0.979659767783514,0.5033647375504711,0.8036456699699337,1.0,6/19,18.75%,MTHFS;FOLR2;SLC25A32;MTHFD1L;MTRR;SLC19A1
prerank,defense response to fungus (GO:0050832),-0.34374159572199003,-0.979361995648753,0.47985347985347987,0.8457778422646303,1.0,1/17,0.09%,CX3CR1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.42379679549757787,0.9791720251245531,0.5,0.8042964518278741,1.0,2/17,2.89%,SYK;ADAM9
prerank,protein auto-ADP-ribosylation (GO:0070213),0.4605662731140156,0.9791652829638805,0.5045045045045045,0.8038891673137009,1.0,5/12,18.04%,TIPARP;PARP2;PARP3;TNKS;TNKS2
prerank,regulation of neuroblast proliferation (GO:1902692),0.4304647138653192,0.9791358653283881,0.5088757396449705,0.8035400330697998,1.0,3/15,2.56%,CTNNB1;VEGFA;DCT
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.3877393740260992,-0.9788817765182646,0.4749262536873156,0.845197487869999,1.0,5/12,15.78%,MAP2;TUBB4A;STMN2;MAPRE1;STMN1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.40501938074577504,0.9779437415576565,0.5186721991701245,0.8057907108470146,1.0,6/20,17.80%,FASN;SLC25A1;PPT1;SCD;GCDH;CBR4
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3063503029989073,0.9777919618968627,0.5871743486973948,0.8057254919713126,1.0,65/417,14.65%,PPARG;MDFIC;CD38;RCOR1;CTNNB1;WWP1;ATXN1;FOXP3;LANCL2;RUNX2;ARID4A;GATAD2A;ID2;NIBAN2;TFAP2B;JUN;NCOR1;RARA;CITED2;E2F1;TAF7;NR3C1;EED;BHLHE40;PEX14;NIPBL;PIAS4;BRCA1;RB1;RBAK;WWP2;EPC1;ZNF148;FOXP1;BRD7;DACH1;ARID5B;DDIT3;XRCC5;RLIM;PSPC1;CNOT7;FOXK1;POU3F3;FOXO1;SIRT1;PPARD;ING4;MT3;CBX3;CIPC;SP3;NOTCH1;DEDD2;BCLAF1;RELA;GAS6;ATP8B1;POU2F1;LIMD1;ZKSCAN3;SUV39H2;SHC1;ID4;EID1
prerank,chromatin remodeling (GO:0006338),0.32831819807272067,0.9776524393895227,0.5329018338727076,0.8056220986428442,1.0,33/100,25.93%,ERCC6;FOXP3;KDM4C;BAZ1A;BAZ2B;TOP1;RB1;CHD3;HCFC2;ESR1;SIRT1;CBX3;SMARCC1;NPM2;SMARCD1;SUV39H2;INO80;BAZ1B;PBRM1;SMARCB1;ZBTB7A;MBD2;KAT2A;KDM5C;RUVBL2;POLE3;SMARCE1;SMARCD2;ACTB;HDAC1;SMARCA1;KAT2B;CECR2
prerank,regulation of B cell activation (GO:0050864),0.3870605939613778,0.9774792782290176,0.5045992115637319,0.8055968737096488,1.0,5/25,13.60%,IL6;SH3KBP1;ZFP36L2;CD22;TNFAIP3
prerank,response to sterol (GO:0036314),-0.38217944800622233,-0.9774587291639926,0.48695652173913045,0.8471909835681302,1.0,3/11,4.28%,CCR5;TGFBR2;TGFBR1
prerank,negative regulation of defense response to virus (GO:0050687),0.4597012315049581,0.9772620908398288,0.4854838709677419,0.805676598022876,1.0,1/10,2.86%,RNF26
prerank,cilium movement (GO:0003341),0.3511781691421184,0.9770796384535915,0.5011627906976744,0.8056723446042383,1.0,6/48,12.50%,SPEF1;CFAP70;CCDC40;CFAP53;ODAD1;SPAG17
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.4057411088734185,-0.9770141896017859,0.5012594458438288,0.8464626439795605,1.0,3/10,6.42%,DLGAP1;DLGAP2;AKAP9
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4269892872756527,0.9767037915897357,0.5036179450072359,0.8060685366996183,1.0,2/17,10.64%,CEBPB;MAFG
prerank,negative regulation of protein binding (GO:0032091),0.33970159454132076,0.9766309917252317,0.5189309576837416,0.805804066682461,1.0,17/71,16.59%,PRKCD;CDKN1A;ITGA4;TFIP11;SORL1;PSME3IP1;PEX14;CTSZ;DVL1;ROCK1;GSK3B;STYX;PPP1CA;SLPI;BAX;IFIT2;CAMK1
prerank,peptide hormone secretion (GO:0030072),0.39049391902922886,0.976590764298601,0.5058670143415906,0.8054695325548175,1.0,2/26,2.98%,ANXA1;IL6
prerank,extracellular structure organization (GO:0043062),0.3142352148366159,0.9765254601881618,0.562058526740666,0.8051900867250558,1.0,35/204,17.14%,MMP12;VWF;ICAM2;ADAMTS8;MMP27;SPP1;CD44;ITGA5;ITGA4;PDGFA;COL4A6;MMP14;COL1A1;THBS1;DAG1;LUM;COL4A1;COL5A2;ITGB1;ITGA10;COL11A1;APP;VIT;COL5A3;ITGA3;COL3A1;ADAM19;ITGA8;LAMA4;LAMA3;COL6A2;ATP7A;ADAMTSL4;COL11A2;COL4A5
prerank,nucleotide biosynthetic process (GO:0009165),0.41075000721459554,0.9764752905005818,0.497907949790795,0.8048803578550048,1.0,3/18,6.98%,ADSL;PPAT;NMNAT1
prerank,skin development (GO:0043588),0.33923789716249636,0.9763598299449363,0.5214994487320838,0.8047194527853682,1.0,12/65,19.17%,ANXA1;ADAM9;PDGFA;COL1A1;HRNR;COL5A2;COL5A3;ITGA3;COL3A1;ATP7A;CASP3;ASAH1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.4267082058739794,0.976088319920917,0.521865889212828,0.8049118255302081,1.0,5/15,14.18%,ZFAND2A;RAB3GAP2;RAB10;SPCS2;ZFAND2B
prerank,regulation of mitochondrial translation (GO:0070129),0.40808437392694874,0.9756029691559621,0.5054054054054054,0.8056111634164185,1.0,9/21,24.33%,NSUN3;RMND1;ALKBH1;MTG1;C1QBP;MALSU1;TRMT10C;COA3;SHMT2
prerank,positive regulation of tissue remodeling (GO:0034105),0.46672394948979806,0.9753628065438728,0.49244712990936557,0.8057472048816717,1.0,2/10,12.24%,ROCK1;IL15
prerank,peptidyl-serine modification (GO:0018209),0.3151149899964803,0.9749851767546723,0.558974358974359,0.8061677214055553,1.0,43/166,19.96%,SGK1;GALNT3;TLK1;PRKCH;RPS6KA2;MAPKAPK3;IKBKE;PLK2;PDPK1;PRKCD;SRPK2;PARP2;PKN3;DYRK1A;TOP1;HIPK1;CSNK2A2;HIPK2;ROCK1;GSK3B;PKN2;PAK2;DCLK3;PRKCB;STK38;NAA10;DGKQ;DYRK2;GAS6;MAST4;UHMK1;TNKS;LATS1;PRKCG;CAMK1;CSNK2A1;CSNK1G1;STK4;STK32C;TLK2;TBK1;MKNK2;CAB39
prerank,regulation of cilium assembly (GO:1902017),0.34193263544382807,0.9747199838865582,0.5242937853107345,0.8063450406611008,1.0,17/62,21.60%,TBC1D22A;TBC1D1;TBC1D2;ODF2L;TBC1D10A;TBC1D2B;TBC1D22B;ATG5;TBC1D24;TBC1D15;IFT140;CCP110;RABGAP1;HTT;IFT88;CROCC;CDKL5
prerank,actin filament depolymerization (GO:0030042),0.4574715566094767,0.9746064249887082,0.5317220543806647,0.8061747911950251,1.0,6/11,19.63%,CFL1;WDR1;MICAL2;DSTN;CFL2;MICAL1
prerank,cellular response to gamma radiation (GO:0071480),0.42072685063610227,0.9741374069814892,0.5240875912408759,0.8068080964929921,1.0,5/17,19.38%,MAP3K20;XRCC5;WRN;RPL26;TLK2
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.42511671743603724,0.9739329283047081,0.5182481751824818,0.8068267785688163,1.0,5/17,10.11%,APOE;SORL1;IGF1;RTN3;ROCK1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3075966963169947,-0.9738735129914539,0.46887966804979253,0.8532996301332002,1.0,8/26,24.68%,THADA;ATP1A2;FMR1;PKD2;UBQLN1;FKBP1B;ADRA2A;CALM3
prerank,regulation of inclusion body assembly (GO:0090083),0.45763038519257326,0.9736786602483792,0.49698795180722893,0.806961767800023,1.0,3/11,13.93%,DNAJB6;HSPA1B;HSPA1A
prerank,cellular response to osmotic stress (GO:0071470),0.39629533056619065,0.9731612085947359,0.5246575342465754,0.8076907487229374,1.0,4/21,12.19%,LRRC8D;AQP1;ARHGEF2;MYLK
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3743900550576062,0.9731423797915016,0.49255583126550867,0.8073134178386563,1.0,4/33,4.71%,CEL;ABR;FABP5;BTBD9
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3210048475992022,-0.9729992792191484,0.4642857142857143,0.8537529708340912,1.0,7/23,20.41%,SMAD3;TRIM33;ENG;SMAD7;SMAD2;SMAD4;SOX11
prerank,modulation by symbiont of host process (GO:0044003),0.4661209469151924,0.9726128595134305,0.5195007800312013,0.8080579792610021,1.0,2/10,7.16%,RPS27A;UBC
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.31562370463657846,0.9725525366252171,0.5581874356333677,0.8077665818652842,1.0,39/168,17.35%,DHX34;SAMD4A;TENT4B;RPL18A;DDX5;RPS14;RPS11;CNOT4;RPS27A;RPL17;RPL23;RPL36A;ETF1;TENT2;CNOT6L;EXOSC9;RPL22;RPS21;POLR2G;PATL1;CNOT7;PPP2R2A;NBDY;ERI1;NCBP2;EXOSC8;RPL10A;RPS26;UPF2;RPL15;RPL10;CNOT6;RPSA;EXOSC10;EIF4A3;THRAP3;PAN3;RPL7;RPL26
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4213121050321361,0.9724224350315375,0.5190735694822888,0.8076346221807793,1.0,8/18,19.80%,KIF20B;RUFY3;ROCK1;PTK2B;BCAS3;TEK;ARFGEF1;SHTN1
prerank,metanephros development (GO:0001656),-0.3085583767880661,-0.9721674540673438,0.5098814229249012,0.85416155379399,1.0,7/26,16.28%,ROBO2;PTCH1;PAX2;BASP1;PKD2;PKD1;FGF10
prerank,regulation of focal adhesion assembly (GO:0051893),0.3494235356030626,0.9720558990430749,0.5219454329774614,0.8080166672119206,1.0,14/54,17.57%,VEGFA;CORO1C;PTEN;THBS1;DUSP3;DLC1;ACVRL1;ROCK1;BCAS3;MACF1;CLASP1;NRP1;APOD;TEK
prerank,calcium ion transmembrane transport (GO:0070588),0.3337280698767315,0.9719262896827199,0.5387096774193548,0.8078932215528366,1.0,14/86,9.35%,MCOLN3;MCOLN2;ANO6;ATP2B1;P2RX4;SLC8B1;TMEM165;MICU2;MICU1;SLC8A1;PMPCA;LETM1;TRPC3;TRPV2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.44099523551215813,0.9718278994169425,0.5289634146341463,0.807693380724142,1.0,1/13,0.65%,B3GNT8
prerank,regulation of gene silencing by miRNA (GO:0060964),0.34142865290672064,0.9715962694333862,0.5147392290249433,0.8077662167975908,1.0,18/62,22.97%,PPARG;POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;LIMD1;NUP98;NUP88;NUP188;NDC1;NUP43;STAT3;NUP54;RANBP2
prerank,folic acid metabolic process (GO:0046655),0.41331103594185253,0.9713045648935327,0.5144429160935351,0.8079987662844219,1.0,6/18,18.75%,MTHFS;FOLR2;SLC25A32;MTHFD1L;MTRR;SLC19A1
prerank,tryptophan catabolic process (GO:0006569),0.45522576052681724,0.9712188762819224,0.5173978819969742,0.8077890987000129,1.0,1/11,2.53%,KYNU
prerank,positive regulation of GTPase activity (GO:0043547),0.31288543220721543,0.9709249813246741,0.5598377281947262,0.8080304123469421,1.0,25/188,11.45%,ARHGAP24;ABR;TBC1D22A;TGM2;RIC1;CORO1C;TBC1D25;TBC1D1;TBC1D2;SNX9;TBC1D12;RALGAPA2;SLC27A4;TBC1D10A;FLCN;DOCK10;ARAP1;TBC1D2B;PICALM;ITGB1;GSK3B;TBC1D22B;CCDC125;BCAS3;TBC1D15
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.38780705791253606,0.9707811327574002,0.5198412698412699,0.8079264220428569,1.0,11/25,21.62%,PSME3IP1;RPL23;CSNK2A2;HIPK2;PSMF1;PRKCG;CSNK2A1;SGTA;ALAD;TAF1;EPHA4
prerank,regulation of protein localization to membrane (GO:1905475),0.38440454167039545,0.9705583127934972,0.5019305019305019,0.808042391950721,1.0,7/28,13.63%,MMP14;CLN3;STX8;VTI1B;VPS4A;APPL1;PRKN
prerank,regulation of translation (GO:0006417),0.31300856998393256,0.9705188658294478,0.5634674922600619,0.8077214095360937,1.0,44/173,20.71%,SAMD4A;EIF1;VIM;IL6;CD28;FOXO3;DAPK1;DDX6;ATXN2;IGF2BP3;YTHDF3;NSUN3;THBS1;EIF6;EIF2AK4;LARP4B;PUM3;ETF1;NAT10;EIF3B;EIF5;CNOT7;MTPN;NCBP2;APP;EPRS1;HNRNPD;RPL10;EIF4A3;SYNCRIP;ALKBH1;MTG1;CAPRIN1;RPL26;EIF3H;EIF2B2;MALSU1;EIF4G3;EIF4G2;NCL;BCL3;EIF3C;LARP4;PCIF1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.24565445009016923,-0.970514961177075,0.4866666666666667,0.8569075143335944,1.0,21/59,19.20%,ACVR1;TGFBR2;CIT;CDC42BPA;TGFBR1;WNK3;CDK5R1;PRKD1;MAP2K1;MARK2;MAP3K10;PRKCA;CAMK2A;PRKD2;WNK1;CDK10;DYRK4;CSNK2B;TTBK1;SBK1;LMTK2
prerank,detection of mechanical stimulus (GO:0050982),0.41221236274601053,0.9700421262427105,0.523224043715847,0.8083803481597733,1.0,4/19,11.91%,CTNNB1;PKD1L2;PIEZO1;PIEZO2
prerank,negative regulation of cell motility (GO:2000146),0.3188163598665732,0.970013960512993,0.5295358649789029,0.8080140320142352,1.0,23/108,13.09%,MITF;RAP2A;IFITM1;FOXO3;PTEN;CITED2;ZMYND8;DAG1;DUSP3;STK24;FLCN;NF2;DLC1;ACVRL1;DACH1;RAP2B;CCDC125;FBLN1;BST2;SULF1;ARID2;MCTP1;PODN
prerank,aromatic amino acid family metabolic process (GO:0009072),0.47250998037920067,0.9698879727880825,0.5163297045101088,0.8078912844246472,1.0,2/10,15.41%,KYNU;ATP7A
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.4153196278763954,0.9698248678116075,0.5117891816920943,0.8076212367402476,1.0,3/18,7.99%,SLC43A2;PPIF;NEDD4L
prerank,regulation of sister chromatid cohesion (GO:0007063),0.44981999162644837,0.9696957056064661,0.5138461538461538,0.8074877254190838,1.0,5/12,22.54%,CTNNB1;RB1;RAD21;HDAC8;WAPL
prerank,chromatin remodeling at centromere (GO:0031055),-0.2941072467972014,-0.9694091847430254,0.4827586206896552,0.8580560997207953,1.0,18/31,35.07%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;CENPQ;CENPN;CENPH;CENPI;CENPW;HELLS;SMARCA5;CENPL
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.29716987650909416,-0.9688257942259397,0.514018691588785,0.8578119921673761,1.0,14/30,22.62%,ARSB;HEXB;CHST11;CSGALNACT1;CHST7;HYAL1;CHST9;DSEL;CHSY1;IDS;BCAN;CSPG4;NCAN;CHST12
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4504309287922804,0.9682071266890816,0.5175953079178885,0.8103869477453737,1.0,3/13,17.73%,MTM1;TMEM39A;PHF23
prerank,clathrin-dependent endocytosis (GO:0072583),0.387708297157629,0.968040249500602,0.5270618556701031,0.8103830010396295,1.0,16/26,28.42%,GAK;LMBRD1;PICALM;FCHO1;SIGLEC1;AP2B1;INPP5F;ITSN1;FCHO2;AP2S1;GPR107;CLTC;AP2A2;AP2A1;DNAJC6;CANX
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3799306210971289,0.9678941589048204,0.5096525096525096,0.8102888854788418,1.0,6/31,11.77%,CHCHD4;PEX7;TOMM20;PEX14;TIMM17A;TIMM17B
prerank,regulation of cellular localization (GO:0060341),-0.26325016180040617,-0.9678724304752245,0.5121951219512195,0.8584254161845185,1.0,8/46,6.42%,EPHA5;CSNK1E;REEP5;FER;MAP2;HSP90AA1;LRP5;PPM1F
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3632624092930213,0.9674373777892566,0.529192546583851,0.8109090286205203,1.0,16/36,24.52%,APAF1;FOXO4;E2F1;EED;UXT;BRCA1;EPC1;CBX3;RBBP7;MGA;EHMT2;CBX5;TFDP1;PHC3;RNF2;PCGF6
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.39134571215249325,0.9674215656912497,0.511318242343542,0.8105355428915797,1.0,6/24,17.57%,NFE2L2;PDPK1;MAPK7;GAS6;TNFAIP3;TEK
prerank,regulation of histone acetylation (GO:0035065),0.3700128628846925,0.9673767552058437,0.5118012422360249,0.8102272006301373,1.0,13/33,23.59%,FOXP3;TAF7;FLCN;BRCA1;BRD7;ARRB1;CAMK1;NOC2L;KMT2A;PAXIP1;RUVBL2;CTBP1;SETD5
prerank,regulation of viral entry into host cell (GO:0046596),0.38123753223926005,0.966590225404209,0.5380710659898477,0.8115463370660218,1.0,4/30,8.88%,TMPRSS4;IFITM1;TRIM25;IFITM2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3016882271573653,0.966258731571952,0.615,0.8118610810644487,1.0,76/497,14.65%,PPARG;MDFIC;CD38;RCOR1;SAMD4A;CTNNB1;WWP1;ATXN1;FOXP3;LANCL2;RUNX2;ARID4A;GATAD2A;ID2;CDKN1A;NIBAN2;TFAP2B;JUN;DAPK1;ENPP1;DDX6;NCOR1;RARA;IGF2BP3;CITED2;E2F1;TAF7;NR3C1;EED;BHLHE40;PEX14;NIPBL;PIAS4;BRCA1;RB1;RBAK;WWP2;EPC1;ZNF148;FOXP1;ACVRL1;BRD7;DACH1;ARID5B;TERF1;BMPR2;DDIT3;XRCC5;RLIM;PSPC1;CNOT7;GSK3B;FOXK1;POU3F3;FOXO1;SIRT1;PPARD;ING4;MT3;CBX3;CIPC;SP3;EPRS1;NOTCH1;DEDD2;BCLAF1;RELA;GAS6;ATP8B1;POU2F1;LIMD1;ZKSCAN3;SUV39H2;SHC1;ID4;EID1
prerank,modulation by host of viral genome replication (GO:0044827),0.43302536953509263,0.96568738723097,0.5232383808095952,0.812739593519015,1.0,4/13,14.90%,EIF2AK4;VAPA;PRKN;YTHDC2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3422691067123181,0.9655677509225381,0.5480880648899189,0.8125894405093029,1.0,8/60,10.48%,CTNNB1;ACD;HGF;RFC3;FGFR4;POLG2;XRCC5;DKC1
prerank,positive regulation of T cell differentiation (GO:0045582),0.36597210566540184,0.9654088623244887,0.5148883374689827,0.8125213681273407,1.0,4/36,9.06%,ZMIZ1;CD46;ADAM8;SART1
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3875510248757432,0.9651773687051411,0.5138339920948617,0.8126187114897105,1.0,8/25,18.60%,P2RX4;TRAT1;P2RX3;CD22;TREM2;BST1;TMBIM4;HTT
prerank,ATP transport (GO:0015867),0.46500618456201215,0.9649188498840133,0.5275229357798165,0.812787307023591,1.0,5/10,23.40%,SLC25A42;SLC17A9;SLC25A17;CD47;SLC25A24
prerank,kidney development (GO:0001822),0.33439437841979797,0.9647481351203278,0.5437219730941704,0.8127433591194696,1.0,17/65,21.03%,STRA6;VEGFA;TFAP2B;NIPBL;SULF2;CTSH;PAX8;SULF1;ARL3;GDNF;ITGA8;VANGL2;ACE;IFT88;WFS1;ZBTB16;C1GALT1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.3422124457305205,0.9646358271540149,0.5244040862656073,0.8125773387148764,1.0,25/57,29.24%,EBNA1BP2;BYSL;NOP14;WDR74;MRPL36;CUL4A;PAK1IP1;WDR12;RPL7;RPL26;SHQ1;MALSU1;NOC2L;DHX37;XPO1;CUL4B;GTF3A;BOP1;TGS1;RRP36;RBIS;RPL14;MRTO4;EMG1;RPS7
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3970784370488366,-0.9637995802795056,0.5074183976261127,0.8676837731387753,1.0,1/10,1.82%,TGFBR2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.4624411361102476,0.9633905215831355,0.5007874015748032,0.8149552626057932,1.0,5/10,23.94%,HK3;GFPT1;PFKP;PFKM;HK1
prerank,response to glucagon (GO:0033762),0.40236805052049834,0.9633005977718193,0.5392022008253095,0.8147354058548313,1.0,7/19,23.07%,ADCY7;ADCY8;ADCY3;CRY1;CREB1;ADCY5;ADCY9
prerank,ncRNA catabolic process (GO:0034661),0.3853912092980317,0.963280915907048,0.5278858625162127,0.8143676757908321,1.0,9/28,17.19%,TENT4B;EXOSC3;EXOSC9;EXOSC8;SND1;DEDD2;MTREX;EXOSC10;RBM7
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.30917608519921586,-0.9632030888342303,0.5158730158730159,0.8673836552467308,1.0,3/23,6.10%,CX3CR1;CD33;NLRP3
prerank,positive regulation of histone acetylation (GO:0035066),0.38749850781640893,0.9630963996782916,0.5158730158730159,0.8143465741924854,1.0,8/23,22.16%,FOXP3;SPHK2;BRCA1;BRD7;ARRB1;SMARCB1;PAXIP1;RUVBL2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.3612312797270729,-0.9630032638041182,0.48514851485148514,0.8659679588880459,1.0,3/15,4.28%,TGFBR2;FGFR2;TGFBR1
prerank,regulation of vasculogenesis (GO:2001212),0.43369144293566286,0.9628848991648793,0.5369030390738061,0.8144096613675209,1.0,3/14,14.16%,XDH;ASB4;RRAS
prerank,protein acetylation (GO:0006473),0.37661060783658074,0.9628315077176356,0.5261845386533666,0.8141236455142736,1.0,13/30,25.85%,GTF2B;CREBBP;NAT10;FOXO1;SIRT1;ING4;NAA10;NAT9;CLOCK;NAA80;NAA15;KAT6A;KAT2B
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.4585783354943977,0.96279148388213,0.5347432024169184,0.8138018844300164,1.0,1/11,0.92%,ZMIZ1
prerank,regulation of establishment of planar polarity (GO:0090175),0.31930687505337213,0.9623867658717201,0.5498357064622125,0.8143093601674943,1.0,31/88,26.25%,SPEF1;PSMD1;DVL1;FZD7;PSMF1;PSMD14;FZD5;PFN1;PSMD12;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;NPHP3;AP2S1;PSMC5;CLTC;AP2A2;PSMC1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.3949533464356749,0.9622363578092764,0.5227272727272727,0.8142111269800899,1.0,5/23,12.13%,PLA2G2D;ABHD4;PLA2G4F;PLAAT3;LPCAT3
prerank,cellular response to pH (GO:0071467),-0.3391085546509902,-0.9622046042490002,0.5172413793103449,0.8661882736509651,1.0,7/17,17.94%,MCOLN1;HVCN1;RAB11FIP5;HYAL1;PKD2L1;GPR68;SLC9A1
prerank,response to ATP (GO:0033198),-0.3321599373899342,-0.9621163645996456,0.5324232081911263,0.8645025407555585,1.0,3/18,6.68%,P2RY12;RYR3;HSP90B1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.2890520095905159,-0.960888508023466,0.5023696682464455,0.8660851461430892,1.0,5/34,6.52%,PTPRT;UBASH3B;PTPRO;DUSP6;DUSP7
prerank,replication fork processing (GO:0031297),0.3559275279382828,0.9604453177405928,0.5265060240963856,0.8177480617487125,1.0,8/38,15.88%,ALYREF;ZRANB3;FAM111A;THOC1;EME1;RTEL1;WRN;CENPX
prerank,positive regulation of phospholipase activity (GO:0010518),0.3969402037620779,0.9596449623164321,0.5240572171651495,0.8190710429079181,1.0,4/22,10.01%,PDPK1;ABL2;GNA13;ESR1
prerank,macrophage activation involved in immune response (GO:0002281),0.42957771252512134,0.9592003097879134,0.5309734513274337,0.8196336934512508,1.0,5/13,15.74%,SYK;TYROBP;TREM2;LBP;GRN
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.4654772756588313,0.9591341337460474,0.508500772797527,0.8193668761563653,1.0,5/10,26.28%,NOTCH1;PHACTR4;LRP6;ARHGAP12;LIN7C
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.32015503094419023,0.9587829227049043,0.5746031746031746,0.8197414641000421,1.0,22/112,16.05%,GDF15;ZMIZ1;GCNT2;ADAM9;JUN;APPL2;MAPK7;NR3C1;LPXN;RPS27A;UBC;ZFP36L2;ACVRL1;ITGB1;SIRT1;APPL1;COL3A1;GDF10;PARD6A;NRROS;CBL;WWOX
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3570344692363706,0.9586882122628265,0.5278450363196125,0.819541959797884,1.0,7/39,8.16%,RANGRF;RIPK1;PPIF;GPD1L;SPHK2;NEDD4L;WWP2
prerank,error-prone translesion synthesis (GO:0042276),0.39731459321976315,0.9585107988352404,0.5264550264550265,0.81951213679426,1.0,4/21,9.32%,RFC3;RPS27A;UBC;POLH
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.4409956414761043,0.9584365653850799,0.5378670788253478,0.8192594290001852,1.0,1/12,0.65%,B3GNT8
prerank,apoptotic nuclear changes (GO:0030262),0.39039726140833897,0.9582434800501507,0.5183727034120735,0.8192723654252049,1.0,7/24,21.13%,DFFB;BLCAP;DEDD2;DNASE2;ACIN1;CASP3;DFFA
prerank,pre-miRNA processing (GO:0031054),0.42756202748011346,0.9581421270927718,0.5354558610709117,0.8190625985462842,1.0,5/14,18.37%,AGO2;AGO3;DROSHA;MRPL44;AGO4
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),0.42371666227361027,0.9580762863790796,0.5245664739884393,0.8188084235189864,1.0,6/14,20.44%,CTNNB1;BRCA1;KMT2E;DNMT1;KMT2A;PAXIP1
prerank,prostanoid metabolic process (GO:0006692),-0.3643078844203669,-0.9579970853642025,0.5117845117845118,0.872257519254823,1.0,3/13,3.77%,HPGD;PTGS1;ACOX1
prerank,positive regulation of cell differentiation (GO:0045597),0.3049594103110897,0.957882801248227,0.6138415245737212,0.8188433472906193,1.0,29/237,11.50%,CD36;PPARG;SDCBP;SLC6A6;PRKCH;GCNT2;CTNNB1;CEBPB;IFITM1;RUNX2;ID2;IL6;HGF;ASXL2;ZC4H2;IGF1;COL1A1;ACVR2A;PKDCC;ACVRL1;BMPR2;IL6R;PAX8;ARHGEF2;FES;CCN1;ASB4;PPARD;KCTD11
prerank,apical junction assembly (GO:0043297),0.3451481172565356,0.9578789232710271,0.5367816091954023,0.8184387105735909,1.0,10/53,15.70%,MICALL2;APC;FBF1;PDCD6IP;STRN;PKN2;PAK2;WDR1;PARD6A;CTNNA1
prerank,regulation of mitotic cell cycle (GO:0007346),0.30802833831512916,0.9578510527119221,0.5912778904665315,0.8180935381589985,1.0,43/171,22.88%,IQGAP1;SDCBP;CCDC8;KIF20B;PSMD1;ANAPC1;DUSP3;SIK1;HNRNPU;RB1;DDB1;PIM3;INTS13;SIRT1;PKN2;PSMF1;PSMD14;APP;PSMD12;AFAP1L2;PSME2;CUL1;ANAPC10;GAS1;PSMB10;PSMD5;PSMD8;PSMA3;CDK13;FBXO5;UBE2S;PSMA2;ANAPC15;PSMD11;PSMA6;LGMN;TTL;XPC;CCDC57;USP2;PSMB3;BTG1;PSME3
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.24844928753929102,-0.957746865752625,0.5454545454545454,0.8710466243986538,1.0,14/57,15.83%,P2RY12;GRM8;OPRM1;CHRM3;CHRM2;AKAP12;GPR37;GABBR1;GNAL;HTR1F;ADCY1;HTR4;AKAP5;GRM7
prerank,regulation of microtubule nucleation (GO:0010968),0.4604896840348372,0.9577125294352362,0.5276923076923077,0.817975503483414,1.0,6/10,27.02%,RANGRF;HSPA1B;HSPA1A;EML2;CKAP5;MECP2
prerank,rRNA modification (GO:0000154),0.3941093584319282,0.9573901741409856,0.5344603381014305,0.8182286543955787,1.0,11/21,25.71%,NSUN3;NAT10;DKC1;MRM2;TSR3;TFB2M;FBL;DIMT1;MTERF4;ZCCHC4;NSUN4
prerank,aerobic respiration (GO:0009060),0.403288678838294,0.9570445691200494,0.5385674931129476,0.8185524167768446,1.0,5/20,16.35%,MTFR1L;NDUFS8;SDHB;ATP5F1D;SIRT3
prerank,ceramide biosynthetic process (GO:0046513),0.35637681917150216,0.9569062190729246,0.5351609058402861,0.818414683230565,1.0,6/40,7.34%,SPTLC2;SAMD8;SGMS2;B4GALT6;CERS6;SPTSSA
prerank,phosphate ion transmembrane transport (GO:0035435),0.442169871892075,0.9568215822381575,0.5505952380952381,0.8182006090398967,1.0,6/12,28.56%,XPR1;SLC37A3;SLC20A2;SLC37A4;SLC25A30;SLC25A10
prerank,positive regulation of chromosome organization (GO:2001252),0.42151670750945214,0.9561009170557374,0.5178571428571429,0.819313094689325,1.0,7/15,21.65%,SIRT6;RTEL1;SHCBP1L;NBN;RAD21;MRE11;PPP1R10
prerank,regulation of protein polymerization (GO:0032271),-0.2830914482587593,-0.9559920701250691,0.5147058823529411,0.8739889674880326,1.0,18/35,30.93%,FCHSD2;MAPT;MAP2;HSP90AA1;TPPP;DBNL;TPPP3;TTBK1;ABITRAM;DBN1;CAMSAP1;PAK3;GBA2;ABL1;FCHSD1;ARHGAP28;ESAM;CAMSAP3
prerank,cellular metal ion homeostasis (GO:0006875),0.31882483043840343,0.9556936024716798,0.5740149094781682,0.8197951802626376,1.0,11/102,8.77%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;SLC8A1;LETM2;TESMIN;NEDD4L;LETM1
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.45241853504955054,0.9553934878872024,0.5460030165912518,0.8200600746560335,1.0,1/11,1.59%,CTNNB1
prerank,cation transmembrane transport (GO:0098655),0.3519362215596892,0.9552878833198344,0.5353658536585366,0.8198652026575777,1.0,6/44,9.92%,SLC7A2;ATP1B4;SLC36A4;MFSD12;P2RX3;SLC25A20
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4002754184452899,0.9551363168351544,0.5224489795918368,0.8197643386350568,1.0,5/21,10.25%,ENSA;MFHAS1;STYXL1;BOD1;GSK3B
prerank,establishment of vesicle localization (GO:0051650),-0.3380062793306785,-0.9550267114295399,0.4944649446494465,0.8747937997024016,1.0,6/18,12.85%,RAB27A;KIF5A;CCDC186;TESK1;RAB11A;LIMK2
prerank,regulation of establishment of cell polarity (GO:2000114),0.4228462856892304,0.9548377489736903,0.5287671232876713,0.8200149407521895,1.0,5/16,11.32%,KIF20B;RUFY3;ROCK1;PTK2B;BCAS3
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.3855150108679795,0.9545836451310158,0.5521390374331551,0.8201885662011859,1.0,5/24,16.54%,ITGA5;NIBAN2;MT3;PRKCB;PTPN1
prerank,epithelial cell morphogenesis (GO:0003382),0.4080113260383417,0.9544414459286747,0.5463215258855586,0.8200815155992899,1.0,1/17,0.95%,RILPL2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.37011124928801076,0.9544303583570162,0.5440993788819876,0.8196916371964464,1.0,5/32,8.12%,ARPC2;CORO1C;PIK3CA;RREB1;ACTR3
prerank,endothelial tube morphogenesis (GO:0061154),0.45599157005712443,0.9543982266781067,0.5271565495207667,0.8193458523447694,1.0,2/10,8.84%,CTNNB1;ACVRL1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.46140176001430067,0.9539906398461717,0.5475460122699386,0.8197558653597845,1.0,3/10,13.93%,JUN;CITED2;HSPA1A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.38623509770932485,0.9535949680032535,0.5329032258064517,0.8202158080113087,1.0,11/24,26.94%,FLVCR1;PGRMC1;FECH;COX15;RSAD1;ALAD;SLC25A38;NFE2L1;FXN;UROS;TSPO
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.4361265913304123,0.9533598585784793,0.5337331334332833,0.8203323401582354,1.0,5/13,24.87%,EDEM2;DERL2;BCAP31;BRSK2;SVIP
prerank,telomere maintenance via telomerase (GO:0007004),0.37768641598835984,0.9529896229007977,0.541994750656168,0.8206899347483841,1.0,14/28,27.61%,ACD;RTEL1;TERF1;DKC1;PPP6C;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPP6R3;TINF2;WRAP53;RFC1
prerank,regulation of leukocyte activation (GO:0002694),0.4353027036286212,0.9527859578942152,0.5461200585651538,0.8207137946217806,1.0,3/14,7.28%,GPR137B;SHPK;MFHAS1
prerank,circulatory system development (GO:0072359),0.3191617683182658,0.9524448283771473,0.5979166666666667,0.821012403208071,1.0,20/118,13.59%,APLNR;ALPK3;STRA6;FBXW7;ID2;CDKN1A;ZDHHC16;MYL2;PTEN;CITED2;PIK3CA;PDLIM5;AKAP13;ACVRL1;TAB2;NOTCH1;MICAL2;COL3A1;SH3PXD2B;SMYD4
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.31443563408246616,-0.9524447696615622,0.5203252032520326,0.8797405452307737,1.0,9/24,25.56%,JPH1;PRKACA;PKD2;SELENON;FKBP1B;JPH4;CALM3;NOS1;JPH3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3034624474059123,0.95231215284758,0.6080808080808081,0.8209033725124898,1.0,46/198,20.35%,HTR2B;PLPP3;CERK;HK3;ITPKB;NUDT14;PLA2G2D;ENPP1;SHPK;INPP4A;PTEN;DUSP3;SPHK2;PIK3CA;GPX4;IPPK;TOP1;GFPT1;LHPP;PLCB4;PLA2G4F;PPP3CA;HDHD2;ACYP1;PAK2;PLAAT3;PGP;LIMD1;OCRL;PPP1CA;GDE1;PANK2;PRKCG;INPP5A;IMPA2;PIP4K2A;GK5;PFKP;CERKL;PIK3CB;XYLB;PFKM;DUSP10;GCK;GK;PLAA
prerank,ganglion development (GO:0061548),-0.3789933529355058,-0.9522791265814372,0.522911051212938,0.8782628987299719,1.0,4/11,9.05%,UNC5C;FZD3;TUBB3;SEMA3A
prerank,T cell mediated immunity (GO:0002456),-0.3613429082435927,-0.9522120530141933,0.49258160237388726,0.8765215088922178,1.0,1/13,0.11%,CADM1
prerank,axon extension (GO:0048675),-0.31083034311935914,-0.952144792466992,0.5333333333333333,0.87478379945787,1.0,8/23,14.28%,SEMA5A;AUTS2;HSP90AA1;SLIT1;SEMA3A;NLGN3;ULK2;CYFIP1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.40679382292028293,0.9520868220943682,0.5085470085470085,0.8209798396637178,1.0,8/16,30.93%,ABCD1;PPIF;ATP7A;VCP;SHMT2;NUPR1;UQCC2;SLC25A33
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.35626238431752066,0.9519971483982007,0.5448877805486284,0.820768559233606,1.0,13/36,22.88%,IL6;IL10RB;CENPJ;DOT1L;NF2;NOTCH1;JAK3;PIGU;BCL3;HES5;PTPRC;ADIPOR1;JAK2
prerank,protein insertion into ER membrane (GO:0045048),0.3602246715683246,0.9512461945373555,0.552439024390244,0.8220161087738741,1.0,13/37,20.28%,STX5;HMOX1;GET3;MMGT1;VAPA;CYB5A;APP;ALDH3A2;EMC2;EMC4;SGTA;EMC3;VAMP2
prerank,protein localization to plasma membrane (GO:0072659),0.31177759062765537,0.9512389219421697,0.5927461139896373,0.821626058042272,1.0,23/129,14.60%,MYO5A;DENND4C;RAP2A;FLOT1;RAB8B;PRAM1;TMEM150A;ZFYVE27;TSPAN17;GAK;TTC7B;EPB41L3;TNIK;RAB12;ROCK1;RAB10;RAB40C;PACS2;TSPAN15;GAS6;EFR3A;CACNB3;LRP6
prerank,negative regulation of transmembrane transport (GO:0034763),0.45608207495207975,0.9512088606831591,0.5493827160493827,0.8212864829943655,1.0,3/10,11.90%,THBS1;IRS2;PRKCB
prerank,mesoderm formation (GO:0001707),0.4160553115030341,0.9507325115175588,0.5339943342776204,0.8219045889434908,1.0,4/17,14.97%,BMPR2;ITGB1;ITGA3;ITGA8
prerank,apical protein localization (GO:0045176),0.4492185518206126,0.9505408672286253,0.5285285285285285,0.8218909770846512,1.0,5/10,25.32%,ATP8B1;CELSR1;VANGL2;GOPC;ACTB
prerank,positive regulation of protein depolymerization (GO:1901881),-0.37924487772017434,-0.9504947602837044,0.5247252747252747,0.8773501863953861,1.0,4/11,24.66%,SEMA5A;STMN2;NES;KATNB1
prerank,lipid phosphorylation (GO:0046834),0.4757105264826364,0.9501261497054949,0.5426829268292683,0.8223785424352219,1.0,4/10,17.18%,DGKZ;DGKA;DGKQ;DGKG
prerank,proteoglycan biosynthetic process (GO:0030166),0.3681437298234852,0.949579668678892,0.5298416565164433,0.8231038405231559,1.0,6/31,9.37%,XYLT1;EXT1;UGDH;B4GALT7;IGF1;BMPR2
prerank,regulation of amyloid fibril formation (GO:1905906),0.4204901415597341,0.9490626051611076,0.5542347696879644,0.8238151648800424,1.0,3/15,12.33%,APOE;APP;TREM2
prerank,peptidyl-lysine monomethylation (GO:0018026),0.46100352576072046,0.9489595903864437,0.5355521936459909,0.8235998554794732,1.0,6/10,30.62%,SETD7;SMYD2;SETD3;SETD6;EHMT1;SETD4
prerank,response to UV-B (GO:0010224),0.4437860069137893,0.9486724300501503,0.533724340175953,0.8238299229137968,1.0,3/12,13.29%,CDKN1A;MFAP4;RELA
prerank,cellular response to estradiol stimulus (GO:0071392),0.399508878743504,0.9486629896077506,0.5419532324621733,0.8234381649978719,1.0,4/18,12.68%,LCOR;NCOA3;ESR1;FAM210B
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.32395415586006115,0.9485830129633656,0.5759562841530055,0.8231938481500564,1.0,24/83,18.91%,PLK2;E2F3;CDKN1A;BACH1;E2F1;CUL3;CACUL1;RB1;NASP;CDK7;USP26;DBF4;ACVR1B;CUL4A;POLA1;PPP6C;CUL1;LATS1;ORC1;MNAT1;CDC34;CDT1;CDC25A;FBXO5
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.35894339220665655,-0.9485056674893257,0.4934210526315789,0.8809733541998441,1.0,4/13,6.56%,TGFBR2;NKAP;PNP;GLI3
prerank,regulation of osteoblast differentiation (GO:0045667),0.3286270090864454,0.9484466130083219,0.5758241758241758,0.8230835307921289,1.0,17/82,14.31%,PPARG;IFITM1;RUNX2;IL6;HGF;IGF1;TNN;DDX5;ATF4;ACVR2A;SNAI2;BMPR2;IL6R;CCN1;NOTCH1;LIMD1;GDF10
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3289980096502581,0.9479998356694127,0.5699888017917133,0.8236143337483895,1.0,17/76,14.81%,SYNPO2L;NCK2;BAIAP2;SORBS3;DYNC1H1;SNX9;STAP1;PTK2B;FES;WDR1;BCAS3;PFN1;HCLS1;SYNPO;TENM1;PFN2;CX3CL1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.2661003987294534,-0.9478624521056825,0.5287356321839081,0.8809803013431351,1.0,10/41,12.39%,GRM5;CSF1R;TGFA;RELN;NTRK2;SRCIN1;LRP8;ERBB3;PRNP;AGT
prerank,hemidesmosome assembly (GO:0031581),-0.3796961884760788,-0.9478241071393265,0.5360230547550432,0.8791646920022629,1.0,2/11,2.10%,DST;ITGA6
prerank,positive regulation of reproductive process (GO:2000243),0.37014038665171656,0.9477425099562393,0.5444162436548223,0.8237574523390717,1.0,4/31,11.98%,VEGFA;LHFPL2;AGO2;ACVR1B
prerank,regulation of endothelial cell migration (GO:0010594),0.3228710066941521,0.9477289872178508,0.5566448801742919,0.8233844697532355,1.0,19/85,19.22%,SASH1;APOE;VEGFA;RHOJ;NRP2;THBS1;FOXP1;ACVRL1;BMPR2;PTK2B;BCAS3;GPLD1;RRAS;GRN;NRP1;TEK;AAMP;PRCP;PIK3CB
prerank,nucleoside salvage (GO:0043174),-0.3949517525200696,-0.9476828816008834,0.5361111111111111,0.8776719261773541,1.0,4/10,18.29%,UPP2;DCK;UCK1;UCKL1
prerank,histone H4 deacetylation (GO:0070933),0.4610271149546784,0.9476461068519668,0.5349922239502333,0.8231555010748103,1.0,1/10,1.19%,RCOR1
prerank,ncRNA transcription (GO:0098781),0.4357435836585327,0.9475895223635918,0.5464071856287425,0.8228709510571713,1.0,4/13,22.19%,RPAP2;SIRT7;USPL1;GTF3A
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.30253009358786437,-0.9466893743571216,0.5474137931034483,0.8784727429701807,1.0,5/22,8.09%,CACNB2;CACNB4;FMR1;NOS1AP;PDE4B
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.39272912720595177,0.946255408090803,0.5576158940397351,0.8253061779178685,1.0,6/22,11.88%,P2RX4;IGF1;GLRX3;ROCK1;MTPN;NOTCH1
prerank,centromere complex assembly (GO:0034508),-0.27901850262710515,-0.9461309103841858,0.5494505494505495,0.8781713309931521,1.0,14/36,24.86%,RSF1;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPF;CENPT;CENPQ;CENPN;CENPH
prerank,mitotic spindle organization (GO:0007052),-0.196142214463236,-0.9457551114412813,0.6521739130434783,0.8772778655083183,1.0,49/153,20.31%,EML1;BUB3;NUP133;DYNC1I2;DYNLL2;ZW10;NUDC;DCTN2;AHCTF1;GPSM2;AAAS;LSM14A;NUP85;SPAST;RAB11A;CHEK2;SEH1L;ITGB3BP;CENPP;ZWILCH;EML4;KNL1;CENPA;NUP37;KIF18A;MAP9;NDEL1;RHOA;MAPRE1;KIF23;KIF11;PMF1;STMN1;RMDN1;CENPK;TPX2;CENPO;BUB1;DCTN6;PRC1;CENPF;CCDC61;CENPT;DYNC1I1;KIFC2;EFHC2;EFHC1;SEC13;NDC80
prerank,protein autophosphorylation (GO:0046777),0.3067568009048681,0.9452223049242026,0.6041025641025641,0.8270613699309158,1.0,26/157,14.30%,MAK;PIKFYVE;ERN1;TEC;MAPKAPK3;TAOK3;PDPK1;DAPK1;RIPK1;PIM1;FGFR4;MELK;SIK1;STK24;DYRK1A;EIF2AK4;TNIK;PIM3;GSK3B;PTK2B;PAK2;FES;ACVR1B;FGR;STK16;UHMK1
prerank,positive regulation of cell adhesion (GO:0045785),0.3293966298270878,0.9452015893548527,0.5863991081382386,0.8266993313566332,1.0,10/74,10.27%,SYK;STX3;VEGFA;TGM2;ADAM9;CITED2;ADAM8;FLCN;PPP3CA;RHOD
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3263119060800422,0.9447989763644681,0.5671806167400881,0.8271300666972999,1.0,13/67,13.79%,TBC1D22A;TBC1D1;TBC1D2;P2RX4;TBC1D10A;TBC1D2B;CAPZB;TBC1D22B;ATG5;TBC1D24;TBC1D15;ATP8B1;IFT140
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3202193473531033,-0.9446653222542549,0.5268456375838926,0.8783330650785985,1.0,6/18,22.12%,COX16;COX19;COX17;SCO1;COX14;COX18
prerank,positive regulation of protein transport (GO:0051222),0.3292299196961277,0.9445752889340205,0.5679012345679012,0.8272116837674055,1.0,18/67,17.94%,ABCG1;KIF20B;RUFY3;ADAM9;IGF1;CLN3;ADAM8;TPR;OAZ2;BCAS3;TREM2;APBB3;TENM1;GOLPH3;GOLPH3L;RAB29;OAZ1;EXOC1
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2927420311189104,0.9443083321250015,0.819,0.8273696025890931,1.0,348/1645,21.55%,EPAS1;PPARG;MDFIC;ANXA4;CD38;TFEC;APOE;LITAF;ELF2;ZMIZ1;ATP1B4;IRX3;RCOR1;TFEB;HOPX;TRPS1;NFE2L2;ZNF3;CTNNB1;MITF;VEGFA;POLR2A;WWP1;CEBPB;ERCC6;ZEB2;ATXN1;GRHL1;FOXP3;EN2;ST18;ATF3;KDM4C;CXXC1;SPP1;VEZF1;WWC2;LANCL2;RUNX2;ARID4A;NR1H3;GATAD2A;E2F3;ID2;IL6;TOX4;CDKN1A;FOXO3;NIBAN2;WAC;BAZ1A;ZNF160;ZNF692;TFAP2B;RUNX3;RXRA;JUN;MED12;SNX5;NCOR1;PHF20;HNRNPAB;RARA;ZFP28;MYCBP;MZF1;CITED2;FOXO4;BRIP1;BACH1;E2F1;TAF7;IGF1;HAS3;ZBTB42;UBE2L3;PCID2;STAT5B;COL1A1;SAP30;APBB2;RNF10;NR3C1;ASCC2;EED;NSD3;MLLT11;NR1H4;DDX5;CREBBP;BHLHE40;TESMIN;THOC1;DYRK1A;KLF5;PEX14;NIPBL;ATF4;REL;IFRD1;TGIF1;KDM3A;ZBTB20;ETV6;ZNF177;TAF5;BAZ2B;POLR2L;RREB1;UXT;POU3F1;PIAS4;TCF20;JMJD1C;BRD2;BRCA1;SNAI2;HOXA3;RB1;PRDM8;RBAK;LCOR;WWP2;ABCA2;EPC1;ZNF148;FOXP1;IRF2;CHD3;CBFB;DVL1;ZFAT;ACVRL1;CARF;BRD7;TBL1XR1;DACH1;ARID5B;CHD2;PICALM;HIPK2;NCOA1;NR5A1;DDIT3;BRD3;FZD7;XRCC5;PAX8;NR2C1;WDR77;HCFC2;RLIM;ESR1;ASCC1;PSPC1;CNOT7;FOXK1;ZFPL1;KDM2A;POU3F3;MAFB;FOXO1;MED16;SIRT1;MAFG;SALL2;KMT2E;MED26;NFATC3;PPARD;ZNF691;ING4;CUX1;MT3;GPBP1L1;CAND2;LCORL;CBX3;CIPC;MYRFL;ZKSCAN7;SP3;NOTCH1;PRKCB;RORA;ACVR1B;TBX6;PQBP1;DEDD2;CAMTA2;RELB;APBB3;MAZ;RFX1;AFAP1L2;HCLS1;FZD2;SMARCC1;RFX5;BCLAF1;DGKQ;SOX2;USP21;USP16;RELA;BBX;BCL11B;GAS6;ATP8B1;POU2F1;LIMD1;PPIE;POLA1;HBP1;MSANTD1;TENM1;ZKSCAN3;FOXJ3;SMARCD1;PGBD1;JUNB;SUV39H2;ATF1;ZKSCAN5;KDM7A;NAT14;PRDM2;HNRNPD;CREG1;SHC1;PHIP;ID4;LRP6;EID1;MAP3K2;SNF8;ETV3;ORC1;MNAT1;ARRB1;QRICH1;MPHOSPH8;PPARGC1B;PHF20L1;HSPD1;KLF6;NHLH2;ZNF32;BRPF1;MTF1;MYT1;THRAP3;RRP8;CCAR1;TCF12;CREB3;CREB3L4;NCF1;ELP4;ZBTB11;BRWD1;BAZ1B;PLAGL2;TAF5L;ZNF18;CHD7;TAF15;CRY1;MLLT3;ERC1;CDT1;NKX2-1;SMARCB1;ZBTB41;ZBTB7A;GABPA;NFYC;HMGN5;UBE2V1;CIR1;ZNF23;CREB1;NAB1;ZBTB7B;ZNF319;E2F2;BBS7;HOXD8;NCOA6;RAD21;FLI1;KLF8;SOX8;ZNF431;CLOCK;FBXO5;NFX1;PPP2CA;NCOA2;ZBTB40;CALCA;KMT2A;STAT6;PPP1R13L;NFIC;CREB3L1;NR2F1;PURB;PIAS2;ZNF367;WWTR1;PRDM16;BCL3;SAP30L;TCF7L2;TCF4;PHF1;PHF2;HSF2;SCMH1;SFMBT2;POLR3C;NFE2L3;PPP2R1A;SREBF1;RBM15;SPEN;BCL11A;SIN3A;OGT;HES5;ZFP62;JMJD6;SP8;ZBTB16;MGA;SAFB;MLXIP;FUBP3;NPAS2;PIAS1;MYPOP;HNF4G;CEBPA;XPC;MBD2;NR1H2;ZBTB24
prerank,glucose transmembrane transport (GO:1904659),-0.32323661527829306,-0.9442614510310949,0.5133079847908745,0.8776782432597995,1.0,5/18,16.87%,SLC2A3;SLC2A5;SLC2A9;SLC2A8;SLC2A6
prerank,negative regulation of signal transduction (GO:0009968),0.3011512308874549,0.9440295016324066,0.6341708542713568,0.8275708473571942,1.0,47/249,17.62%,GDF15;XDH;SIGIRR;FBXW7;LRP1;PRKCD;NIBAN2;ENPP1;MMP14;BRAP;PTEN;PID1;SLC27A4;PTPRE;PALM;THBS1;IRAK3;PTPN12;RITA1;SULF2;KCTD21;GPR108;SNAI2;RB1;WWP2;NFKBIL1;CSNK2A2;NLRP2B;PRKCB;APPL1;APCDD1;MAZ;SULF1;TSPAN15;TNFAIP3;PHACTR4;CX3CL1;ARRB1;ASXL1;WWOX;PTPN1;EGFL7;PIP4K2A;CRY1;CSNK2A1;APOD;ZBTB7A
prerank,positive regulation of response to wounding (GO:1903036),0.386653407626939,0.9438495294499689,0.55078125,0.8275520700285697,1.0,9/24,26.84%,ANXA1;ITGB1;MYLK;GRN;ARFGEF1;ACTG1;HRAS;HBEGF;VTN
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.36873223147075684,-0.9438406455841276,0.5434083601286174,0.8768773876913639,1.0,3/13,9.18%,IL6ST;OAS2;STAT1
prerank,cellular component maintenance (GO:0043954),-0.377134645660219,-0.9436653909192425,0.5174603174603175,0.8754916274499726,1.0,4/12,12.26%,PICK1;IGF1R;MTMR2;PRNP
prerank,myelination (GO:0042552),0.3486008375054643,0.9433005144153213,0.573943661971831,0.8282859047792224,1.0,11/46,19.13%,B4GALT5;CXCR4;ABCD1;B4GALT6;EPB41L3;PLLP;PMP22;DEGS1;ARHGEF10;EIF2B2;TNFRSF21
prerank,respiratory chain complex IV assembly (GO:0008535),-0.31479587449570484,-0.9430633684737633,0.5270758122743683,0.875253559181736,1.0,8/21,24.59%,COX16;COX10;COX19;COX17;SCO1;COX14;COX18;COA6
prerank,regulation of stem cell differentiation (GO:2000736),0.3160110628918331,0.942870600428721,0.5754614549402823,0.8287474117025501,1.0,26/89,22.88%,LMO1;PSMD1;SMYD5;HNRNPU;ZFP36L2;CBFB;PSMF1;PSMD14;NOTCH1;PSMD12;GDNF;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;HES5;PSMB3;PRKDC;PSME3
prerank,sodium ion homeostasis (GO:0055078),0.3894707864495198,0.942301454841439,0.5363276089828269,0.8295571463965634,1.0,4/21,7.99%,TFAP2B;SLC8A1;SLC12A3;NEDD4L
prerank,glutamate metabolic process (GO:0006536),0.39546951526465735,0.9416031495494416,0.5490463215258855,0.8306565967202317,1.0,4/19,17.96%,MTHFS;PRODH;ALDH18A1;OAT
prerank,"transcription, DNA-templated (GO:0006351)",0.3007554766975794,0.9410787895871442,0.6321138211382114,0.8313773943868584,1.0,59/207,22.66%,TSC22D1;POLR2A;ERCC6;AFF4;FOXO3;GTF2H5;GTF2B;E2F1;TAF7;NFKBIB;DDX5;ATF4;TAF5;POLR2L;RREB1;EPC1;TAF1B;CBFB;TOPORS;PAX8;POLR2G;MED16;GTF3C4;CDK7;POLR2I;NCBP2;TRIP11;GTF2F2;POLRMT;CTDP1;GTF2A1;NAT14;MLLT1;PWP1;MNAT1;CDC73;TWNK;SMN1;TAF5L;TAF15;NELFE;MLLT3;TFB2M;TTF1;ZBTB7B;NCOA6;TAF1A;NFX1;NFIC;BCL3;DTX1;NFE2L3;FUBP3;ABT1;TAF1;CCNT1;GTF3A;POLR3K;SUPT4H1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.36293727193057174,0.9410722361092647,0.5684340320591862,0.830981937826014,1.0,6/35,10.01%,ZMIZ1;NR3C1;DDX5;KDM3A;NCOA4;ESR1
prerank,mitotic cytokinesis (GO:0000281),-0.25693012863412845,-0.940551494184211,0.5443037974683544,0.8803836501275105,1.0,21/47,22.72%,ANK3;CIT;ANLN;TRIM36;KLHDC8B;SPAST;SNX18;CENPA;RACGAP1;MYH10;KIF23;STMN1;ECT2;CUL7;CNTROB;EFHC2;EFHC1;NUSAP1;RTKN;KIF4A;CEP55
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.33330279344364955,-0.9404245563796412,0.5247524752475248,0.8788876441481127,1.0,3/16,4.62%,ANK2;RYR2;GABARAPL2
prerank,regulation of telomere capping (GO:1904353),-0.3024583009376431,-0.9401200729788838,0.544,0.8778793434576302,1.0,5/23,8.53%,ATM;USP7;SMG6;MAP2K7;RAD50
prerank,base-excision repair (GO:0006284),0.34398676720156923,0.9398627197206025,0.5671296296296297,0.8331764571979957,1.0,8/48,12.78%,ERCC6;RFC3;MUTYH;NEIL1;HUWE1;POLL;MBD4;WRN
prerank,regulation of GTPase activity (GO:0043087),0.3047555512438428,0.939641402985951,0.6264189886480909,0.8332154191039173,1.0,26/177,12.79%,PLXNA1;GPR137B;PLXNC1;PLXND1;ARHGAP15;FGD6;VAV3;TGM2;RIC1;TBC1D2;ARHGAP9;SNX9;ADAP1;RASA4;RAB3GAP2;FLCN;DOCK10;ARAP1;VAV1;PICALM;ITGB1;GSK3B;BCAS3;TBC1D15;FGD5;RAPGEF1
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.37200610772399967,0.9390978279709875,0.5566750629722922,0.8339114221084492,1.0,3/26,8.77%,HTR2B;SLC8B1;LETM1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.39043726708275056,0.9388187987266586,0.551490514905149,0.8340928045975103,1.0,3/21,2.56%,CTNNB1;VEGFA;DCT
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3208156678455733,0.9382764866944836,0.6002265005662514,0.8348334401427476,1.0,7/74,5.60%,SDCBP;GCNT2;CTNNB1;IL6;PTEN;COL1A1;DAG1
prerank,heart looping (GO:0001947),0.3490042527872629,0.9382680319650565,0.5691554467564259,0.8344480055343003,1.0,6/40,12.40%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.3687601540358676,-0.9381778945529098,0.5389221556886228,0.8812383958895001,1.0,6/12,28.93%,CHEK2;STK33;SETMAR;NAE1;TOPBP1;TICRR
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.3492053732562528,0.9381405227904935,0.5624242424242424,0.8342974472072333,1.0,11/39,19.75%,MYO5A;MYO1E;CLN3;MYO19;MYO1F;NDE1;WASL;KIF5B;PAFAH1B1;HTT;RAB1A
prerank,protein K11-linked ubiquitination (GO:0070979),0.3719270705385474,0.9380029883776009,0.5805194805194805,0.8341656057796571,1.0,11/27,26.51%,RNF26;UBE2L3;ANAPC1;PRKN;ANAPC10;UBE2S;UBE2H;UBE2D3;ANAPC7;FZR1;ANAPC2
prerank,carnitine shuttle (GO:0006853),0.4403189366590993,0.9379446274196358,0.5496987951807228,0.8338929280372749,1.0,3/11,9.92%,PRKAG2;CPT1A;SLC25A20
prerank,carbohydrate catabolic process (GO:0016052),0.3536299754281394,0.9367661740749584,0.5635018495684341,0.8359400364274067,1.0,14/38,26.55%,HK3;TPI1;MANBA;ENO3;DERA;PGM1;NEU1;GAPDHS;PFKM;GCK;PKM;HK1;PGK1;MAN2C1
prerank,regulation of interleukin-13 production (GO:0032656),0.42447706458320755,0.9365962656646429,0.5552325581395349,0.8358998029416422,1.0,2/13,6.26%,RARA;SPHK2
prerank,sulfur compound catabolic process (GO:0044273),0.34539052856008934,0.9362558921039893,0.5566502463054187,0.8362332964404227,1.0,6/38,9.45%,GALNS;GNS;TST;HEXA;LUM;IDUA
prerank,mitochondrial genome maintenance (GO:0000002),-0.37883155194624674,-0.9362267302757136,0.5169230769230769,0.8846942814308867,1.0,5/11,9.62%,MEF2A;AKT3;SLC25A36;SLC25A4;PARP1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.38711252258370593,0.9360058084669474,0.5447263017356475,0.8363671957338171,1.0,5/21,13.36%,ENPP1;ROCK1;PTK2B;NOTCH1;GAS6
prerank,endothelial cell proliferation (GO:0001935),0.3977613825329862,0.9359251589110918,0.5623229461756374,0.8361336453048264,1.0,4/17,9.37%,ERN1;HMOX1;ACVRL1;BMPR2
prerank,postreplication repair (GO:0006301),0.3417069126127193,0.935850016220691,0.5796407185628742,0.8358813143060079,1.0,7/45,9.32%,RFC3;TRIM25;RPS27A;UBC;BRCA1;WDR33;POLH
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3386960771983222,0.9358037775028917,0.5903187721369539,0.8355627348358329,1.0,10/53,15.38%,EYA1;ERCC6;PRKCD;BABAM2;DDX5;BRCA1;SIRT1;BCLAF1;NSMCE4A;BRCC3
prerank,T cell receptor signaling pathway (GO:0050852),0.3034865120924664,0.9357771335448404,0.6068821689259646,0.8352179798727846,1.0,37/138,23.92%,RFTN1;TEC;PRAM1;CD28;PDPK1;PSMD1;CD3D;TRAT1;PIK3CA;DENND1B;PAK2;PSMF1;PSMD14;TAB2;PSMD12;RELA;PSME2;CUL1;CD247;PSMB10;PSMD5;EIF2B2;PSMD8;CARD11;PSMA3;TNFRSF21;PIK3CB;PSMA2;PSMD11;PSMA6;PTPRC;PSMB3;PDE4D;MALT1;PSME3;BCL10;TRAF6
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.34837981489582054,0.9355382320139791,0.5548780487804879,0.8353180831624538,1.0,14/42,24.63%,RFC3;TRIM25;RPS27A;UBC;POLH;SIRT1;WRN;POLA1;POLI;VCP;POLD1;SPRTN;ISG15;PRIMPOL
prerank,positive regulation of protein sumoylation (GO:0033235),0.44809804479750415,0.9351132992684875,0.5683563748079877,0.8357915084129095,1.0,2/10,7.73%,RWDD3;PIAS4
prerank,regulation of RNA export from nucleus (GO:0046831),-0.3756580565280759,-0.9350957865160743,0.5402298850574713,0.8858788559052616,1.0,4/11,14.85%,IWS1;KHDRBS1;NSUN2;NUP153
prerank,positive regulation of T cell cytokine production (GO:0002726),0.391832279546121,0.9349048381161518,0.5547945205479452,0.8358318582194096,1.0,7/20,26.01%,IL6;DENND1B;FZD5;TRAF2;MALT1;TRAF6;MAP3K7
prerank,mitochondrial gene expression (GO:0140053),0.34377811637012085,0.9348957214626553,0.5676959619952494,0.8354427538823164,1.0,15/42,25.14%,FOXO3;MRPL23;MRPS7;MRPS28;POLRMT;IARS2;MRPS21;QRSL1;TWNK;TFB2M;MRPS18A;MRPS2;MRPL16;MRPS18B;GATB
prerank,ether lipid biosynthetic process (GO:0008611),-0.3883422315718629,-0.934841902456994,0.5325779036827195,0.8846565764164293,1.0,4/10,7.08%,AGPS;LPCAT2;CHPT1;PLA2G4A
prerank,striated muscle tissue development (GO:0014706),-0.27839775470508726,-0.9347120247447813,0.5700934579439252,0.883162895771539,1.0,5/29,13.07%,MEF2C;SGCD;SGCZ;ZBTB18;MYH14
prerank,response to glucose (GO:0009749),0.3391416506283789,0.9345760436253087,0.5752105896510229,0.8356891133129797,1.0,12/46,20.34%,ERN1;THBS1;IRS2;ZBTB20;SLC39A14;GPLD1;GAS6;ADCY8;EIF2B2;TCF7L2;VAMP2;GCK
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4011265637062315,0.933986382114832,0.5519203413940256,0.8365391226879602,1.0,7/18,22.88%,ST18;IL6;IL6R;CBL;CEBPA;STAT3;JAK2
prerank,steroid biosynthetic process (GO:0006694),0.3309392072662449,0.9336935184829969,0.5876288659793815,0.8367393945460689,1.0,4/56,2.43%,BAAT;AMACR;OSBPL1A;PRKAG2
prerank,arachidonic acid metabolic process (GO:0019369),0.35391620401950885,0.9328727412984119,0.5830212234706617,0.8380709181730618,1.0,4/35,8.66%,MGLL;GPX4;PTGES2;HPGDS
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.2332344949714757,-0.9327002309123782,0.6190476190476191,0.8866997645365584,1.0,18/75,17.09%,GIT2;PLCB1;RGS6;RPGRIP1L;KCTD8;RGS20;FRMPD1;METAP2;ADCYAP1;NMT1;CAMK2A;USP20;RGS12;GIT1;RASGRP4;RGS2;SYP;SAG
prerank,response to axon injury (GO:0048678),-0.33059786394370944,-0.9326417764656237,0.5298245614035088,0.8850573462473421,1.0,2/18,0.30%,P2RY12;RTN4RL1
prerank,regulation of endocytic recycling (GO:2001135),0.4442753577742244,0.9326275102773054,0.5692541856925418,0.838181695607082,1.0,4/11,13.76%,SORL1;EIPR1;RAB11B;INPP5F
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4229110604547137,0.9325477010567677,0.5741279069767442,0.837937794274734,1.0,1/14,0.55%,XDH
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.20255256594472726,-0.9323734447364481,0.6341463414634146,0.8839322935522748,1.0,38/125,20.59%,EML1;BUB3;NUP133;DYNC1I2;DYNLL2;ZW10;NUDC;DCTN2;AHCTF1;GPSM2;NUP85;SEH1L;ITGB3BP;CENPP;ZWILCH;EML4;KNL1;CENPA;NUP37;KIF18A;NDEL1;MAPRE1;KIF11;PMF1;STMN1;RMDN1;CENPK;CENPO;BUB1;DCTN6;CENPF;CENPT;DYNC1I1;EFHC2;EFHC1;SEC13;NDC80;NUSAP1
prerank,ribonucleoprotein complex assembly (GO:0022618),0.30478523870110946,0.9319573664938393,0.6150627615062761,0.8387379454645273,1.0,37/132,21.35%,RPL3L;MRPL20;SRPK2;SCAF11;CELF1;CLNS1A;EIF6;EIF3A;RPS14;SNRNP200;ISY1;SART1;MRPS7;SF1;EIF5;XRCC5;WDR77;PRPF6;DDX23;DDX20;SNRPF;RPL10;ZRSR2;RPSA;CDC73;SMN1;PUF60;LUC7L;SRPK1;SHQ1;PWP2;EIF2S2;RAMAC;PPAN;RPS27;SNRPB;ABT1
prerank,regulation of TORC1 signaling (GO:1903432),0.3600567350651192,0.9319259780813592,0.5590452261306532,0.8384021001412449,1.0,6/33,13.38%,GPR137B;SIK3;SESN2;FLCN;DGKQ;CASTOR1
prerank,sister chromatid segregation (GO:0000819),0.35694526108379365,0.9312063434827736,0.5662042875157629,0.8394694077701843,1.0,5/31,14.94%,NCAPG2;RB1;SMC1A;INO80;LATS1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.4192157348118496,0.9311921585421888,0.5726744186046512,0.839099286365906,1.0,4/14,13.02%,IRS2;DDB1;SIRT1;GPLD1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.43002387317886365,0.9308140988100704,0.5691176470588235,0.8394935131392942,1.0,2/13,5.15%,SHISA9;CLN3
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.28384623039586027,-0.9308115781897537,0.5425531914893617,0.8862635871656546,1.0,9/32,15.28%,PTPRD;IL1RAPL1;ADGRB3;KNDC1;CUX2;CDKL3;YWHAH;RAPGEF2;SS18L2
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.34002536274038253,0.9306210251510718,0.5906362545018007,0.8394921602083405,1.0,5/45,7.16%,WEE2;CTNNB1;PLK2;TOM1L2;ZFP36L2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.42342992476669244,0.9306003168980133,0.5876577840112202,0.8391265269163259,1.0,2/13,11.39%,CPSF1;NCBP2
prerank,peptidyl-tyrosine modification (GO:0018212),0.33286316295069485,0.9299879854546408,0.6006944444444444,0.8399917766416993,1.0,12/56,14.64%,SYK;TEC;ABL2;ABI1;FGFR4;DYRK1A;PKDCC;PTK2B;FES;BTK;FGR;JAK3
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.20098554545362185,-0.9299219510538589,0.84,0.8868269225982766,1.0,34/152,16.39%,GPC5;SEMA5A;SALL1;DISC1;CSNK1E;LGR4;CSNK1G3;FGFR2;JUP;PSMC2;TRPM4;LGR5;CSNK1D;EGFR;PSMD6;CSNK1G2;AMER1;PRDM15;DAPK3;WNK2;WNK1;PSMD7;RSPO3;RSPO2;UBE2B;SCEL;RNF220;PSMB5;DAAM2;HHEX;WNT5B;TLR2;FGF10;PSMB4
prerank,pulmonary valve morphogenesis (GO:0003184),0.39831888927622805,0.9297376029777636,0.5588235294117647,0.840108525876648,1.0,3/17,11.88%,STRA6;NOTCH2;NOTCH1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.34423756822759843,-0.9295780676709087,0.5525525525525525,0.8859819443273492,1.0,9/13,36.80%,BMPR1A;TGFBR1;DAB2;SMAD4;TGFB1;BMP4;TGFB3;SH2B1;NUP93
prerank,fatty acid biosynthetic process (GO:0006633),0.3255755525268059,0.9292398301468102,0.5907514450867052,0.840738876590446,1.0,13/63,17.80%,LIPG;ABCD1;HACD4;ACSM3;GPX4;NDUFAB1;LTA4H;LIAS;ELOVL1;DEGS1;SCD;DECR2;CBR4
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.2737086050278866,-0.9291034970029234,0.5612244897959183,0.8853816529908687,1.0,14/32,24.66%,NAV3;HDGFL3;MAP2;FGF13;TUBB4A;STMN2;MAPRE1;STMN1;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1;KATNB1
prerank,activation of protein kinase A activity (GO:0034199),0.4016689689824219,0.9290145464749243,0.5619834710743802,0.8407527584629924,1.0,6/16,23.07%,ADCY7;PRRC1;ADCY8;ADCY3;ADCY5;ADCY9
prerank,positive regulation of chemokine production (GO:0032722),0.33985306692465644,0.9283673827459552,0.5860805860805861,0.841661054861208,1.0,7/44,11.47%,SYK;IL6;HMOX1;IL6R;MAVS;ADAM17;APP
prerank,epithelial tube morphogenesis (GO:0060562),0.3557333143112142,0.9279246223919887,0.605296343001261,0.8422151305230932,1.0,4/32,8.84%,MTSS1;CTNNB1;COL4A1;ACVRL1
prerank,cellular response to inorganic substance (GO:0071241),0.3863706481560731,0.9278997808415205,0.582312925170068,0.8418578161221025,1.0,8/21,23.83%,AQP1;FOXO1;MT3;NSMCE3;DDI2;RTF2;SPIDR;CDK2
prerank,negative regulation of developmental process (GO:0051093),0.3264026575130219,0.9276705581792677,0.5908071748878924,0.8419328504243659,1.0,12/69,13.63%,VAT1;HOPX;TFRC;PARP3;ANP32B;HUWE1;WDR77;ROCK1;NOTCH1;OMA1;GAS6;PRKN
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3542381096884313,0.927477824096569,0.5847880299251871,0.8419278682829286,1.0,7/32,17.29%,LPIN3;SLC27A1;CSNK2A2;PCYT1A;LPCAT3;SLC44A2;CSNK2A1
prerank,fibrinolysis (GO:0042730),0.41966379585634683,0.9274611127886551,0.5574963609898108,0.8415603530576122,1.0,2/13,22.53%,PLAU;PLAUR
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.44879021113543816,0.9267931534647142,0.5879556259904913,0.8425282681200684,1.0,1/10,0.48%,APLNR
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.3732473234070607,0.9267211421141149,0.5701058201058201,0.8422682426660616,1.0,9/26,21.89%,CUL3;DUSP3;PKN2;APP;LGMN;TTL;PPP1R10;CCDC57;USP2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.37272409504098014,0.9266020728353307,0.5589005235602095,0.842101556135441,1.0,6/25,12.01%,MPHOSPH10;SCAF11;PRPF8;PRPF6;DDX23;SF3A3
prerank,relaxation of cardiac muscle (GO:0055119),0.42544069625478254,0.926456578854591,0.57856093979442,0.8419758902925357,1.0,3/13,6.41%,P2RX4;SLC8A1;PIK3CA
prerank,RNA transport (GO:0050658),0.31973913945780885,0.9264537743796414,0.6028761061946902,0.8415797054167669,1.0,16/71,18.02%,RFTN1;FLOT1;ALYREF;TST;ATXN2;CHTOP;THOC1;TPR;NCBP2;SRSF3;THOC2;SIDT2;DDX39A;EIF4A3;DHX38;KIF5C
prerank,regulation of histone H3-K9 methylation (GO:0051570),0.4467985466799762,0.9263654921724744,0.5694656488549619,0.841347188357255,1.0,3/10,15.85%,BRCA1;SIRT1;DNMT1
prerank,negative regulation of cellular component movement (GO:0051271),-0.34458532756644994,-0.9263070323283294,0.5494880546075085,0.8908735498695604,1.0,3/15,5.16%,FRMD5;WAS;SPOCK3
prerank,regulation of sensory perception of pain (GO:0051930),0.43225897773356675,0.925987988295265,0.5813953488372093,0.8417018653326569,1.0,1/11,1.78%,MGLL
prerank,peptidyl-amino acid modification (GO:0018193),0.44486776731790495,0.9258681007465231,0.5722627737226277,0.8415510787103679,1.0,4/10,22.16%,METAP1D;FKBP7;ATP7A;TTLL4
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3202416136333295,0.9255565562493593,0.6054421768707483,0.841779590385387,1.0,21/63,24.90%,PLK2;CDKN1A;WAC;E2F1;GADD45A;CNOT4;GTSE1;CNOT6L;CNOT7;BAX;CNOT6;RPL26;CASP2;CRADD;FBXO31;TNKS1BP1;PRKDC;CDK2;TFDP1;SOX4;CARM1
prerank,embryonic organ development (GO:0048568),-0.2335601582069295,-0.9254196751097554,0.6639344262295082,0.8913348266258599,1.0,10/61,8.69%,SALL1;BMPR1A;TGFBR2;KITLG;SH2B3;FGFR2;PBX3;TAL1;GLI3;TGFB2
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2701338714603664,-0.9252293524073212,0.5497382198952879,0.8900080664120514,1.0,7/33,12.13%,CHRM3;WNK3;KCNJ2;KCNJ3;AKAP9;KCNJ9;WNK1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.42754878942083807,0.924906056874144,0.5630630630630631,0.8427211603670843,1.0,6/12,25.64%,GFPT1;UGP2;FUT8;EXTL2;GALT;SLC35A3
prerank,response to metal ion (GO:0010038),0.3234451880742661,0.9248623671836937,0.594170403587444,0.842404258973038,1.0,20/67,21.58%,SLC11A2;ADAM9;D2HGDH;THBS1;TESMIN;NEDD4L;TRPC3;PPP3CA;MT3;ATP5F1D;PPP1CA;MTF1;ANXA11;PAM;PPP2CA;CALM2;SEC31A;MT1X;MT1A;PEF1
prerank,nerve growth factor signaling pathway (GO:0038180),0.4497990395754887,0.9248145681369545,0.5513595166163142,0.8420955061511152,1.0,2/10,12.79%,KIDINS220;RAPGEF1
prerank,cellular response to alkaloid (GO:0071312),0.399980263622135,0.9246422459424697,0.5762237762237762,0.8420404795903512,1.0,5/17,18.31%,TGM2;SLC8A1;HTR1B;CASP6;CASP3
prerank,cellular response to interleukin-1 (GO:0071347),0.299832209730567,0.9244451083079456,0.6407867494824017,0.8420496907952454,1.0,44/143,26.38%,ST18;IRAK2;PSMD1;TANK;IRAK3;RPS27A;UBC;SIRPA;MAP3K8;PSMF1;PSMD14;TAB2;PSMD12;RELA;ACOD1;PSME2;SQSTM1;CUL1;CX3CL1;MYD88;CCL7;PSMB10;PSMD5;UBE2V1;PSMD8;PSMA3;PSMA2;CCL25;PSMD11;PELI2;PSMA6;CD47;PSMB3;PSME3;IRAK1;TRAF6;PSMC5;TAB1;MAP3K7;GBP3;PSMC1;RC3H1;TAB3;CCL2
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.2641438918807173,-0.9240588169194721,0.61,0.8912435988231007,1.0,7/35,9.05%,PLXNA4;SEMA5A;ARHGDIA;SEMA4G;SEMA3E;SH3BP1;SEMA3A
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2938706455659493,0.9239002079443843,0.6717325227963525,0.8427371724425691,1.0,49/185,21.49%,ID2;DYNC1H1;PSMD1;APPL2;HAUS6;CENPJ;E2F1;ANAPC1;CUL3;RPS27A;UBC;ZFP36L2;PPP1R9B;DDB1;PSMF1;PSMD14;CEP76;PSMD12;APPL1;NPM2;CLASP1;CEP192;TUBA1A;PSME2;CUL1;INO80;NDE1;ALMS1;OFD1;ANAPC10;CCP110;SSNA1;HAUS7;PSMB10;PSMD5;PSMD8;PSMA3;PAFAH1B1;FBXO5;UBE2S;PSMA2;ANAPC15;PSMD11;CDC14B;PPP2R1A;PSMA6;HAUS5;CEP41;XPC
prerank,kinetochore organization (GO:0051383),-0.3490567305112687,-0.9238609141950933,0.5379939209726444,0.8899060136355658,1.0,7/13,33.22%,CENPA;CENPF;CENPT;NDC80;CENPH;CENPW;NUF2
prerank,defense response to tumor cell (GO:0002357),0.4375625758924871,0.9238535865171156,0.5522620904836193,0.8424327641676488,1.0,2/10,8.29%,DAPK1;DLEC1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.42870630484283795,0.9237813627320584,0.5676077265973254,0.8421726790265344,1.0,3/12,12.10%,FLOT1;MAVS;PQBP1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.36679609776689653,0.9237422476070284,0.5800273597811217,0.8418561127049577,1.0,6/26,14.17%,B4GALT5;B4GALT6;ST3GAL4;LUM;B4GALT3;B4GALT2
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.4258801075416093,0.9234948792439557,0.5741279069767442,0.8419553292723582,1.0,6/13,22.75%,TCERG1;HNRNPU;LARP7;NELFE;SUPT4H1;RNF168
prerank,positive regulation of ruffle assembly (GO:1900029),-0.3615308590849262,-0.9234931881333401,0.5246913580246914,0.8891013472606278,1.0,2/13,1.04%,P2RY12;NLGN1
prerank,pyroptosis (GO:0070269),-0.3391844918886055,-0.9233209191930826,0.535031847133758,0.8877390240449023,1.0,4/15,11.18%,CASP4;GSDME;APIP;ZBP1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.4263531041389561,0.9228931203021025,0.5681818181818182,0.8427589714500966,1.0,1/12,0.58%,APOE
prerank,tryptophan metabolic process (GO:0006568),0.43130107145978985,0.9226815274051668,0.573134328358209,0.8427951586005161,1.0,2/11,15.41%,KYNU;ATP7A
prerank,mesoderm development (GO:0007498),0.39515813900434077,0.9226245073800515,0.5690376569037657,0.8425223388882502,1.0,3/18,12.78%,VEGFA;TBX6;BTK
prerank,regulation of G0 to G1 transition (GO:0070316),0.34469492300507426,0.9218227344896879,0.5779702970297029,0.8437621969306668,1.0,16/38,24.52%,APAF1;FOXO4;E2F1;EED;UXT;BRCA1;EPC1;CBX3;RBBP7;MGA;EHMT2;CBX5;TFDP1;PHC3;RNF2;PCGF6
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.40431446708603913,0.921675608185348,0.5691868758915835,0.8436700945765682,1.0,6/16,25.23%,NR1H3;SLC27A1;GPLD1;SREBF1;NR1H2;CTDNEP1
prerank,spermatid development (GO:0007286),-0.2747010393495467,-0.921064678361075,0.5841584158415841,0.8916104551063507,1.0,11/32,26.87%,JAM2;RNF8;CEP57;IQCG;TDRD5;ZMYND15;NME5;CIB1;RFX2;MKKS;SYCP3
prerank,N-glycan processing (GO:0006491),-0.3190528129449805,-0.9210387788873355,0.5664335664335665,0.8898634756467968,1.0,6/18,10.93%,MGAT4A;ST8SIA6;MAN1A2;ST8SIA1;ST8SIA5;ST8SIA3
prerank,translesion synthesis (GO:0019985),0.3404487386740789,0.9197257095845847,0.5929951690821256,0.8470996574930165,1.0,6/42,9.32%,RFC3;TRIM25;NPLOC4;RPS27A;UBC;POLH
prerank,negative regulation of innate immune response (GO:0045824),0.35366167798768555,0.9196824121293916,0.5975308641975309,0.8467756256371469,1.0,12/34,24.46%,YTHDF3;IRAK3;NLRC3;CNOT7;TRAFD1;TNFAIP3;ACOD1;GRN;SLAMF8;ISG15;LYAR;DHX58
prerank,filopodium assembly (GO:0046847),0.4046108995326333,0.9196092737378098,0.5759312320916905,0.8465220215643136,1.0,6/16,15.49%,FGD6;SPEF1;PPP1R9B;FGD5;FGD3;VSTM5
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.37558947705690404,0.9193109180202953,0.5950196592398427,0.8467315324997196,1.0,2/25,3.02%,APLNR;PDPK1
prerank,maturation of SSU-rRNA (GO:0030490),0.3572403733308619,0.9191642759800724,0.5865504358655044,0.8466392186109688,1.0,10/34,18.99%,DCAF13;RPS14;HELB;NOP14;NAT10;NOB1;TSR3;PWP2;NGDN;DHX37
prerank,mRNA 3'-end processing (GO:0031124),0.31327038956400105,0.9190563249594037,0.6251354279523293,0.8464473074139207,1.0,18/78,16.87%,ALYREF;CPSF1;TENT4B;CHTOP;CSTF3;THOC1;WDR33;TENT2;GRSF1;NCBP2;APP;SRSF3;THOC2;SSU72;DDX39A;CDC73;EIF4A3;DHX38
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3998222571056355,0.918968893442398,0.5714285714285714,0.8462366218541308,1.0,8/17,22.50%,AFG1L;COX6A1;CYCS;COX8A;COX7B;COX15;COX4I1;COX5A
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.4486699666911994,0.9186935754361386,0.6073529411764705,0.8464002063708247,1.0,3/10,16.76%,FBXW7;ADAM17;NCF1
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.42619879433661445,0.9186320160723491,0.5718562874251497,0.8461275875849336,1.0,3/12,12.33%,IL6;STAP1;TREM2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.38563087719607336,-0.9186069766957311,0.5459940652818991,0.8944006870775595,1.0,3/10,13.94%,PDE3B;WNK1;NEXMIF
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.334046633376579,-0.918471660053248,0.578397212543554,0.8929342256935585,1.0,9/14,36.30%,TGFBR1;ADAMTS12;SOX9;CHADL;GREM1;PTHLH;RFLNB;RFLNA;WNT9A
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3429202534597605,0.9180581016411399,0.5854545454545454,0.8468812541815881,1.0,11/35,25.64%,CTNNB1;ACD;RTEL1;XRCC5;TNKS;TNKS2;CCT2;PKIB;NEK7;FBXO4;CCT7
prerank,nuclear pore complex assembly (GO:0051292),0.4464849369900098,0.9180071162510719,0.5823170731707317,0.8465781030028011,1.0,5/10,21.59%,TPR;RTN4;NUP98;TMEM170A;NDC1
prerank,heart contraction (GO:0060047),-0.2524088565402186,-0.9177144097004972,0.6153846153846154,0.8931233509303217,1.0,5/41,3.96%,ATP1B1;ATP1A2;SGCD;RYR2;SCN1B
prerank,heme biosynthetic process (GO:0006783),0.37678843468396606,0.9176281623691155,0.575197889182058,0.8469439039912721,1.0,10/22,26.94%,FLVCR1;PGRMC1;FECH;COX15;ALAD;SLC25A38;NFE2L1;FXN;UROS;TSPO
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.36078270309987015,0.9168076164632821,0.5786163522012578,0.848164309016262,1.0,6/28,16.20%,ERCC6;TFIP11;PARP3;KMT5B;SIRT7;SHLD1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.39202332145963553,0.9163402448591423,0.5783633841886269,0.848694697623136,1.0,4/19,15.14%,CCDC40;CFAP53;SPAG17;OFD1
prerank,negative regulation of organelle assembly (GO:1902116),0.3485761482416196,0.9157567133749299,0.607487922705314,0.8495175341754696,1.0,8/35,17.73%,MTM1;ODF2L;BRCA1;STYXL1;NBDY;CCP110;TMEM39A;PHF23
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.2982698047985045,0.9157511444060906,0.6375131717597471,0.8491272239859315,1.0,31/124,20.47%,CTNNB1;PSMD1;AGO2;DVL1;PPP3CA;TNRC6B;FZD7;PPP3R1;AGO3;PSMF1;PSMD14;FZD5;PFN1;PSMD12;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;CCDC88C;PSMB10;PSMD5;PSMD8;AGO4;PSMA3;PSMA2;PSMD11;TCF7L2;PSMA6
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3379086484397019,0.9149065919693183,0.6074429771908764,0.8504226803375636,1.0,18/42,25.93%,ERCC6;ZNHIT1;NASP;CHD3;VPS72;SMARCC1;INO80;PBRM1;SMARCB1;MBD2;DMAP1;SMARCE1;ANP32E;SMARCD2;ACTB;HDAC1;SMARCA1;CECR2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.3289971967275413,-0.9148401759087869,0.5433333333333333,0.898797958198248,1.0,5/15,11.82%,SEMA5A;FGF2;PRKD1;TMSB4X;PRKD2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.3879554421441066,0.9147038501080678,0.592087312414734,0.8504220347264481,1.0,2/18,3.06%,LILRB1;CD46
prerank,regulation of protein binding (GO:0043393),0.30181530406532797,0.9146624461018537,0.6431578947368422,0.8500985449754628,1.0,27/114,18.94%,FLOT1;LRP1;PRKCD;CDKN1A;TFIP11;SORL1;PSME3IP1;STK3;PEX14;BTBD1;CTSZ;DVL1;HIPK2;ROCK1;GSK3B;APP;STYX;PRKN;PPP1CA;SLPI;BAX;IFIT2;CAMK1;AMFR;STK4;GNL3L;PPP2CA
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.32518792973784705,0.9143228656306878,0.6011695906432749,0.8503705056310721,1.0,11/53,15.44%,APOE;FBXW7;PSME3IP1;GNA12;RAD23A;PSMF1;PSMD14;TREM2;PRKN;PSME2;PRKCG
prerank,nuclear export (GO:0051168),-0.21719461740360008,-0.9139121922402632,0.6341463414634146,0.8994185182783362,1.0,35/80,26.24%,SLU7;SRSF6;SMURF1;SRSF5;WASHC4;RBM8A;NUP214;ZC3H11A;THOC5;STRADB;POM121;SRSF11;NUP155;RAE1;PKD1;DDX39B;NUP153;SRRM1;U2AF1;RANBP17;MAGOH;SRSF1;MAGOHB;STRADA;SRSF9;CCHCR1;THOC6;SRSF4;XPO6;EIF4E;PHAX;UPF3B;TGFB1;POLDIP3;XPO4
prerank,protein complex oligomerization (GO:0051259),0.3064926402541117,0.9136792494810198,0.6345945945945946,0.8512254912611833,1.0,17/85,15.71%,LRRC8D;UGDH;MICU1;NINJ1;MS4A1;WDCP;CHMP2A;RNF135;NLRC4;PDCD6IP;LETM1;LRRC8C;ATL2;ATL1;ADCY8;VSTM5;TWNK
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.24384915369140733,-0.9136097859815792,0.6645161290322581,0.8984592773281571,1.0,14/51,14.77%,EVL;PPM1E;LIMCH1;LIMK1;TGFBR1;PAK1;PPM1F;ITGB1BP1;CARMIL1;TESK1;FERMT2;SYNPO2;RHOA;RAPGEF3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.44249667849404817,0.9133684322201837,0.6040372670807453,0.8514657815390073,1.0,2/10,11.88%,VEGFA;NOTCH1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3047953366480798,0.9132139441392644,0.652452025586354,0.851365275631118,1.0,22/107,20.67%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;SLC8A1;SLC39A14;MT3;SLC11A1;SLC39A12;SLC10A7;CCL7;SLC30A1;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B
prerank,homologous chromosome segregation (GO:0045143),-0.3046249982716678,-0.9129543846635348,0.6224066390041494,0.8982686621527646,1.0,5/20,19.63%,FMN2;FANCD2;ZCWPW1;IHO1;TERB1
prerank,endoderm formation (GO:0001706),0.35082486378987504,0.9128274101835726,0.6019900497512438,0.8517041204054951,1.0,7/35,20.20%,ITGA5;ITGA4;MMP14;COL11A1;LAMA3;COL12A1;ITGAV
prerank,ribosomal subunit export from nucleus (GO:0000054),0.40641031870747335,0.9128123070368809,0.5964912280701754,0.8513327443975192,1.0,6/13,26.16%,EIF6;NUP88;XPO1;NMD3;NOP9;LSG1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.33346960288022537,0.9122510491328877,0.6124121779859485,0.8520258326571205,1.0,3/48,3.02%,APLNR;DIAPH1;PDPK1
prerank,calcium ion import into cytosol (GO:1902656),0.40618547187099757,0.9121735678288306,0.6065808297567954,0.851771174892988,1.0,3/15,9.35%,SLC8A1;MS4A1;TRPV2
prerank,prostaglandin metabolic process (GO:0006693),-0.2848923046078249,-0.9113754496633574,0.6103896103896104,0.9006658192006886,1.0,4/26,7.08%,HPGD;PTGS1;ACOX1;PLA2G4A
prerank,Ras protein signal transduction (GO:0007265),0.296461446689068,0.9112745536261899,0.6645962732919255,0.8531665447853192,1.0,29/137,15.95%,GRB2;RAP2A;PLK2;SOS1;CDKN1A;JUN;RGL2;MYO9B;GNA13;BRAP;IGF1;NRAS;GNA12;RREB1;RB1;KSR2;ROCK1;RAP2B;RHOD;CFL1;CCNA2;RAPGEF1;RIT1;PHACTR4;RRAS;CELSR1;SHC1;DNMT1;USP8
prerank,negative regulation of dephosphorylation (GO:0035305),0.390576817790832,0.9111282199999569,0.5878284923928078,0.8530607159573428,1.0,3/18,12.26%,ENSA;MFHAS1;GPATCH2
prerank,mitotic nuclear division (GO:0140014),0.3125869888371792,0.9109901983614324,0.6301218161683277,0.8529295024501373,1.0,21/71,23.74%,NCAPG2;PIBF1;CHMP2A;SMC1A;TOGARAM1;STAG2;CTDP1;CLASP1;CEP192;INO80;SMC3;NDE1;OFD1;CHMP7;ARHGEF10;UBE2S;SGO1;MZT1;FLNA;EPS8;BCCIP
prerank,RNA destabilization (GO:0050779),0.3973886220153796,0.9105347108999503,0.5986111111111111,0.853447215237568,1.0,4/18,10.56%,CELF1;YTHDF3;ROCK1;FTO
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2927955309936581,0.9104899713270195,0.6873065015479877,0.8531343634898504,1.0,45/161,23.83%,APOE;PSMD1;ZNRF3;CUL3;TNN;STK3;APC;MCC;SNAI2;DVL1;DDIT3;GSK3B;PSMF1;PSMD14;PSMD12;SOX2;LIMD1;PRKN;PSME2;LRP6;KREMEN1;LATS1;CCDC88C;MLLT3;PSMB10;PSMD5;PTPRU;PSMD8;AMFR;STK4;PSMA3;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;PSMB3;RUVBL2;SDHAF2;KLHL12;SIAH2;PSME3;NPHP3;BICC1
prerank,ribosome assembly (GO:0042255),0.3295647607858619,0.9102157005103995,0.6103286384976526,0.853269780999888,1.0,15/47,23.29%,RPL3L;MRPL20;EIF6;RPS14;MRPS7;RPL10;RPSA;C1QBP;PWP2;DHX37;PPAN;RPS27;BOP1;MTERF3;MRPS2
prerank,autophagy of peroxisome (GO:0030242),-0.3575370037109378,-0.9100631813721007,0.5504587155963303,0.9022242225602157,1.0,3/12,8.33%,ATM;NBR1;RB1CC1
prerank,mitochondrial fission (GO:0000266),0.3946185613871924,0.909804289870372,0.5776223776223777,0.8537271013289812,1.0,4/16,13.63%,MTFR1L;MTFP1;GDAP1;PRKN
prerank,cardiac muscle contraction (GO:0060048),-0.2646824077774266,-0.9097545410017577,0.6195121951219512,0.9012138534318535,1.0,4/34,3.96%,ATP1B1;ATP1A2;RYR2;SCN1B
prerank,negative regulation of protein depolymerization (GO:1901880),0.37035499723427967,0.9094631703394599,0.598937583001328,0.8539537396012921,1.0,6/24,13.74%,LIMA1;SPEF1;PIK3CA;APC;ARHGEF2;CLASP1
prerank,lipid translocation (GO:0034204),0.3782460882312402,0.909138386556581,0.607094133697135,0.8541921538815245,1.0,9/21,23.20%,ABCA1;ATP8B4;ATP8B1;RFT1;ABCC1;ATP11C;TMEM30A;ATP9B;ABCA7
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.30865695704705093,0.9090685517057644,0.6453038674033149,0.8539228160981513,1.0,12/79,12.74%,PPARG;NIBAN2;SORL1;THBS1;SULF2;ACVR2A;HIPK2;BMPR2;RBPMS2;NOTCH1;SULF1;LEMD3
prerank,spinal cord development (GO:0021510),-0.35266622294073013,-0.9089045119042409,0.5581395348837209,0.9014508748936562,1.0,5/12,26.41%,RELN;PKD2;PKD1;SOX11;GLI2
prerank,relaxation of muscle (GO:0090075),0.41941233443529014,0.9087328904945433,0.5858585858585859,0.854204614941327,1.0,3/13,6.41%,P2RX4;SLC8A1;PIK3CA
prerank,miRNA metabolic process (GO:0010586),0.38342917016088063,0.9086368622308972,0.5918653576437588,0.8540092582484405,1.0,4/20,12.03%,TENT4B;AGO2;DROSHA;SND1
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.3484840919040852,0.9079280866132455,0.6044776119402985,0.8550339999803779,1.0,8/33,20.21%,NFE2L2;PDPK1;MAPK7;GAS6;TNFAIP3;TEK;TCF7L2;WFS1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.32683630466973135,0.9076347684133369,0.6098707403055229,0.8552096503300475,1.0,6/45,8.42%,CD44;PRKCD;IFNGR2;TRIM25;PTAFR;IRF2
prerank,regulation of bone mineralization (GO:0030500),0.3227318577147959,0.90739884156029,0.6155606407322655,0.8552603425172519,1.0,10/55,10.92%,ANO6;ATP2B1;ENPP1;SLC8A1;SGMS2;ACVR2A;PKDCC;BMPR2;PTK2B;CCN1
prerank,histone H4 acetylation (GO:0043967),0.3284553590773784,0.9073685602545473,0.6128654970760234,0.8549147915453944,1.0,12/47,22.41%,KANSL1;ZZZ3;PHF20;ING3;EPC1;ING4;MCRS1;KMT2A;OGT;DMAP1;RUVBL2;KANSL3
prerank,positive regulation of phosphorylation (GO:0042327),0.29082763398200157,0.9072932617925169,0.7112462006079028,0.8546689223612566,1.0,29/240,12.33%,GPNMB;SDCBP;RAP2A;VEGFA;FLOT1;FNIP1;TFRC;HGF;FAS;RIPK1;IGF1;FGFR4;THBS1;MERTK;FLCN;ZBTB20;ACVR2A;DSCAM;TNIK;FZD7;MAVS;ADAM17;SIRT1;CCN1;MT3;NBN;APP;ROR1;TREM2
prerank,cellular response to estrogen stimulus (GO:0071391),0.4074397159430828,0.907028843989577,0.581294964028777,0.8548066955731617,1.0,3/14,11.32%,RARA;NCOA4;BCAS3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.41478235574475397,0.906551155775519,0.592375366568915,0.8553266235847258,1.0,5/14,23.46%,TRAT1;RELA;RAB29;CARD11;BCL10
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.32578123257561,0.9065310859408892,0.6470588235294118,0.8549668937355697,1.0,15/55,18.54%,BCL2L11;FAS;RIPK1;STYXL1;DDIT3;PAK2;DEDD2;BCLAF1;BAX;WWOX;BID;TRAF2;LTBR;BBC3;CRADD
prerank,cellular response to organic substance (GO:0071310),0.30052455641658976,0.9063357892824354,0.6733615221987315,0.8549608165548179,1.0,16/116,9.37%,CXCR4;CTNNB1;SIGIRR;TIPARP;MAP2K5;PID1;HTRA2;MAPK7;STAT5B;NR1H4;PTPN12;ACVR2A;NCOA3;ACVRL1;NCOA1;BMPR2
prerank,mitotic cytokinetic process (GO:1902410),0.3781663363296742,0.9062372452643542,0.6076487252124646,0.8547593413658524,1.0,7/20,21.40%,CHMP2A;PDCD6IP;VPS4A;CHMP6;CHMP5;CHMP7;CHMP2B
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.339479235214887,-0.9061540343839197,0.5907692307692308,0.9066560879552055,1.0,2/14,2.94%,CSF1R;CSF1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.3908531546001722,0.9055265585110444,0.5764192139737991,0.8557165937457349,1.0,3/15,15.73%,IL6;APPL1;MYD88
prerank,endothelial cell differentiation (GO:0045446),0.42478532367395416,0.9051893846808551,0.5932721712538226,0.8559677777238136,1.0,3/12,9.48%,ACVRL1;BMPR2;FSTL1
prerank,striated muscle contraction (GO:0006941),-0.2387667596536154,-0.9050842705140593,0.6148648648648649,0.9075139589208417,1.0,6/53,4.90%,ATP1B1;DTNA;ATP1A2;RYR2;SCN1B;RCSD1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.3527547353715625,-0.9047358069190999,0.5654596100278552,0.906666423208588,1.0,3/12,8.69%,PTCH1;MEGF8;TGFB2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.3048163262333011,-0.904267654199334,0.5804195804195804,0.9060222595484024,1.0,5/19,11.94%,GMPR2;PNP;AMPD2;DCK;GMPR
prerank,cardiac atrium morphogenesis (GO:0003209),0.3967270890304567,0.9035594264313456,0.5934379457917262,0.8587240452470275,1.0,3/16,11.88%,NOTCH2;BMPR2;NOTCH1
prerank,tRNA wobble uridine modification (GO:0002098),0.4051825189680234,0.9034719146507503,0.5960170697012802,0.8584931375865027,1.0,5/14,16.81%,CTU2;ELP1;GTPBP3;ALKBH8;ELP4
prerank,anion transport (GO:0006820),0.34388282541559834,0.9031940673137554,0.6162642947903431,0.8586542505528219,1.0,4/33,8.80%,LRRC8D;VDAC2;SLC17A5;LRRC8C
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3034157779560902,0.903089597084677,0.6652221018418202,0.8584611348431878,1.0,19/98,17.75%,LGALS3;PRKCH;STX3;LRP1;PDPK1;RANGRF;E2F1;STAC2;ITGB1;MTCL1;PPP3R1;TREM2;ITGA3;PRKN;SQSTM1;STAC3;BID;BBC3;KIF5B
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.36634109571547446,-0.9027260419859658,0.6017699115044248,0.9080988469597159,1.0,6/11,22.10%,FBH1;MSH3;DONSON;LIG3;TIMELESS;TIPIN
prerank,polarized epithelial cell differentiation (GO:0030859),0.4074907775002844,0.902530715969866,0.5959752321981424,0.8591076213489266,1.0,4/13,16.64%,RAP2A;MSN;RAB10;MYO9A
prerank,cellular response to leucine starvation (GO:1990253),0.4361077475615434,0.9023633641044446,0.5951612903225807,0.8590417310664606,1.0,2/10,6.97%,SESN2;EIF2AK4
prerank,determination of heart left/right asymmetry (GO:0061371),0.3306374698143288,0.9019406353451103,0.6292270531400966,0.8594965579481864,1.0,6/43,12.40%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.33783876463780543,0.9019100007197952,0.6219211822660099,0.8591549228957753,1.0,5/39,11.88%,VEGFA;MAP2K5;MAPK7;NF2;NOTCH1
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.3322678666345542,-0.9018592544776224,0.5740181268882175,0.9084874856813153,1.0,4/14,6.54%,PPP5C;NCK1;PPM1F;PPP2CB
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.4024753408839537,0.9016991874214164,0.5988200589970502,0.8591592806949038,1.0,6/15,22.65%,NPLOC4;FAF2;DERL2;TMEM129;VCP;HERPUD1
prerank,androgen metabolic process (GO:0008209),0.3786355634988364,0.9016589799266668,0.5986111111111111,0.8588394434341122,1.0,5/18,25.44%,SPP1;HSD17B11;SRD5A1;SRD5A3;HSD17B4
prerank,positive regulation of chromatin organization (GO:1905269),0.4166243383639393,0.9014629611110624,0.6009174311926605,0.8588174125199121,1.0,2/12,9.14%,ACD;TERF1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3491833035409101,0.9012602711561527,0.6155717761557178,0.8588299693911567,1.0,11/33,26.55%,FBXW7;ARAP1;ADAM17;AFAP1L2;CBL;NCF1;BCAR3;PLAUR;HIP1;DOK1;HBEGF
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.4001065225711681,0.9005849809882914,0.6020710059171598,0.8596911602423065,1.0,3/15,13.63%,CD44;SIRT1;PRKN
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.34077425115292836,0.9004927010258612,0.620049504950495,0.8594691233443517,1.0,9/37,13.85%,KIF3A;DYNC2I2;DYNLRB1;IFT46;TRIP11;TNPO1;IFT52;IFT140;SSX2IP
prerank,regulation of T cell migration (GO:2000404),-0.3049387316720212,-0.9004003251867455,0.5952380952380952,0.91041511607527,1.0,6/18,14.47%,DOCK8;RIPOR2;AIF1;CD200;PYCARD;RHOA
prerank,negative regulation of locomotion (GO:0040013),-0.35544690646925153,-0.9003673341357497,0.5818181818181818,0.9087361228402796,1.0,3/12,5.16%,FRMD5;WAS;SPOCK3
prerank,erythrocyte development (GO:0048821),-0.3780181260635737,-0.9001863170579768,0.5747126436781609,0.9073920934189538,1.0,5/10,26.57%,SH2B3;ABCB10;ALAS2;MED1;ALAS1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24410263643394736,-0.8999805714229188,0.6582278481012658,0.9061746784401069,1.0,15/50,20.81%,CD86;NR3C2;PTP4A3;TLR3;EGFR;IFI35;PDCD4;PHB2;LIMS1;RHOA;TLR2;TNF;CD14;TCIM;NOD1
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3246376424156479,-0.8998307301316705,0.5709342560553633,0.904762881309753,1.0,10/17,29.14%,VPS9D1;ATP5PO;DMAC2L;ATP5F1E;ATP5PF;ATP5MC3;ATP5ME;ATP5F1B;ATP5MG;STOML2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2899632620317397,0.8994648426921246,0.691358024691358,0.8610574593935507,1.0,39/148,21.89%,SGK1;PRKAG2;PDPK1;RFC3;PHF20;BRIP1;TAF7;RPL23;TAF5;BRCA1;HIPK1;CHD3;BRD7;CSNK2A2;HIPK2;NBN;WRN;RNF34;DYRK2;RBBP7;PAK1IP1;SMYD2;MAPKAP1;BRPF1;PIP4K2A;TAF15;CSNK2A1;TTC5;PPP2R5C;NOC2L;CCNG1;RMI1;PPP1R13L;TOP3A;MRE11;RICTOR;EHMT2;TAF1;USP2
prerank,histone mRNA catabolic process (GO:0071044),-0.3248725203134938,-0.8993695102590828,0.593167701863354,0.9041236755780845,1.0,6/15,13.11%,ATM;TUT4;SSB;MTPAP;LSM1;XRN1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.3904554461407748,0.8991779408704309,0.5879043600562588,0.8612145446639158,1.0,7/17,22.95%,GET3;MMGT1;EMC2;EMC4;SGTA;EMC3;EMC10
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3528282197063254,0.8987911163083215,0.6253263707571801,0.8615840849300113,1.0,7/29,14.94%,BRCA1;CBFB;ESR1;STRN3;UBA5;VPS11;LATS1
prerank,glycolytic process (GO:0006096),0.3564126622964787,0.8987317505950724,0.6194805194805195,0.8613044482253991,1.0,9/28,23.94%,HK3;TPI1;ENO3;PGM1;GAPDHS;PFKM;GCK;PKM;HK1
prerank,photoreceptor cell development (GO:0042461),0.4092156656840387,0.8984247890722709,0.6119186046511628,0.8615041573415293,1.0,3/14,13.99%,VEGFA;TOPORS;ARL3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.325895853490728,0.8980879062047619,0.6398601398601399,0.861756524430404,1.0,17/49,24.20%,BCL2L11;PPIF;STYXL1;DDIT3;BCLAF1;BAX;MCL1;BID;NDUFS3;SGMS1;BBC3;NOC2L;BCAP31;PLAUR;HERPUD1;NDUFA13;BCL2L1
prerank,cation transport (GO:0006812),0.2891479156181431,0.897927495198801,0.7101449275362319,0.861678084735392,1.0,15/167,7.99%,SGK1;SLC6A6;SLC36A2;SLC36A4;AQP1;ANO6;SLC11A2;SLC8B1;SLC8A1;TAF7;CLN3;SLC5A5;SLC12A3;SLC38A7;NEDD4L
prerank,cellular calcium ion homeostasis (GO:0006874),0.2953376797835264,0.8975497246147227,0.6936656282450675,0.8620267705170791,1.0,13/133,9.30%,HTR2B;TPCN2;ATP2B1;ATP13A3;SLC8B1;TMEM165;MICU2;MICU1;SLC8A1;CLN3;CALB1;LETM1;TRPC3
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.3713718770693568,-0.8974874677694662,0.5647382920110193,0.9068997033869076,1.0,4/10,13.83%,GABRA2;GABRA3;GABRG3;GABRA4
prerank,hexose transmembrane transport (GO:0008645),-0.29355026548948926,-0.8973457263930436,0.5679012345679012,0.9054980863735524,1.0,6/21,19.92%,SLC2A3;SLC2A5;SLC2A9;SLC2A8;SLC2A6;SLC45A3
prerank,inositol phosphate catabolic process (GO:0071545),0.41658511665021897,0.8971025246648964,0.6048632218844985,0.8624802030263133,1.0,5/12,19.53%,PTEN;OCRL;INPP5A;IMPA2;SYNJ2
prerank,inositol phosphate biosynthetic process (GO:0032958),-0.35931861603476667,-0.8962629844753701,0.5669515669515669,0.9064570632528807,1.0,6/11,16.98%,IP6K2;PPIP5K1;FGF2;ITPKC;PPIP5K2;IP6K1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.303646402630839,0.8960555226570942,0.6538461538461539,0.8640700481385516,1.0,23/100,19.58%,PIK3R5;HGF;PDGFA;PTEN;IGF1;IRS2;PIK3CA;NLRC3;SIRT1;ROR1;TREM2;MAZ;HCLS1;FGR;CBL;NCF1;PIP4K2A;TEK;PPP2R5C;STAMBP;PIK3CB;GAB1;OSM
prerank,positive regulation of receptor internalization (GO:0002092),0.37124966378960605,0.8954238583503655,0.6169934640522876,0.8648737575752867,1.0,2/22,3.68%,VEGFA;CD63
prerank,acylglycerol biosynthetic process (GO:0046463),0.3614067542924764,0.8953912790359059,0.6160830090791181,0.8645437671585753,1.0,2/23,1.54%,LPIN3;GPAT2
prerank,membrane lipid metabolic process (GO:0006643),0.3693329351488798,0.8946565254718851,0.6175675675675676,0.865552041735064,1.0,3/22,6.26%,MGST2;CERK;SPHK2
prerank,gonad development (GO:0008406),-0.2528277119715364,-0.8944779689311035,0.6613756613756614,0.909063535397513,1.0,12/41,24.84%,SALL1;KITLG;BASP1;TGFB2;AR;SOX9;WNT4;BIK;COL9A3;WNT5A;MKKS;WNT2B
prerank,negative regulation of vascular permeability (GO:0043116),0.4177702903599348,0.8940745538359289,0.5930930930930931,0.8662331667399978,1.0,1/12,1.73%,VEGFA
prerank,neuron projection morphogenesis (GO:0048812),0.29296797823814186,0.8936304395309935,0.7079002079002079,0.8666763927094147,1.0,18/137,10.38%,IQGAP1;SGK1;DTNBP1;CTNNB1;KIF20B;BAIAP2;ALCAM;TAOK3;SLITRK6;PTEN;TNN;DOCK10;EIF2AK4;DVL1;EPB41L3;TNIK;ROCK1;RAB10
prerank,mitochondrial transcription (GO:0006390),0.4285660873002772,0.8936040556814302,0.609642301710731,0.8663297447913071,1.0,4/10,17.36%,FOXO3;POLRMT;TWNK;TFB2M
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3726192156480568,0.8934855948854449,0.6134800550206327,0.8661533460313883,1.0,6/23,22.73%,CBLB;CHMP6;CBL;SH3BP5;PTPRC;SOCS4
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.322617436506735,-0.893040612600781,0.6212624584717608,0.9108950943785684,1.0,7/15,15.96%,CSNK1E;TIAM1;CSNK1D;RNF213;RSPO3;DAAM2;WNT5B
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.29676213520455974,-0.8930362546728371,0.6448979591836734,0.9091703045293443,1.0,7/22,23.87%,PDE3B;APOC1;TNF;PPP2R5A;CCDC3;IL1B;ADRA2A
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3813415168633997,0.8926609989961827,0.6143250688705234,0.8673021718097352,1.0,5/18,17.81%,RAB21;MSN;VPS11;DNAJC13;SNX3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.1980313640969505,-0.8925745143451004,0.8863636363636364,0.9085005393799844,1.0,28/129,16.39%,GPC5;SEMA5A;CSNK1E;LGR4;CSNK1G3;FGFR2;JUP;PSMC2;TRPM4;LGR5;CSNK1D;EGFR;PSMD6;CSNK1G2;AMER1;PRDM15;DAPK3;WNK2;WNK1;PSMD7;UBE2B;SCEL;RNF220;PSMB5;DAAM2;HHEX;FGF10;PSMB4
prerank,positive regulation of response to stimulus (GO:0048584),0.3286986623791277,0.892374097988884,0.6324062877871826,0.8674434741581244,1.0,8/40,14.99%,IER5;PRKCD;ARG2;MAVS;SIRT1;IL15;BCLAF1;NSMCE4A
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.3330339006578113,0.8922705438197808,0.6436498150431565,0.8672386821610578,1.0,10/39,17.41%,GCNT2;CORO1C;THBS1;NF2;FZD7;FBLN1;NOTCH1;CX3CL1;MELTF;ACER2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.42449532177605565,0.8920742726622339,0.6127527216174183,0.8672060434945489,1.0,2/11,10.59%,CD44;SIRT1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.3383313001029247,0.8919900919816228,0.6166868198307134,0.8669856212823756,1.0,5/40,5.78%,VEGFA;CD63;PPT1;RAB21;ANXA2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.43170441517720365,0.8918822489242674,0.6224648985959438,0.8668033194597274,1.0,2/10,8.02%,SORL1;RB1
prerank,limb morphogenesis (GO:0035108),0.37235222228158565,0.8917003022663197,0.603905160390516,0.8667456543884745,1.0,3/20,6.98%,TFAP2B;MBNL1;NIPBL
prerank,histone H2A acetylation (GO:0043968),0.3921379770898708,0.8916075013411466,0.6139860139860139,0.8665248058768626,1.0,3/16,8.20%,SPHK2;ING3;EPC1
prerank,sterol biosynthetic process (GO:0016126),0.344467425037431,0.8915416500384092,0.6303258145363408,0.8662503938789573,1.0,10/33,20.50%,PRKAG2;MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;SC5D;HMGCR;ARV1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.39105184944174287,0.8914789817284657,0.6031976744186046,0.8659654828787088,1.0,2/15,9.43%,ANAPC1;TPR
prerank,response to iron ion (GO:0010039),0.41558572111333053,0.8914305003639567,0.6182873730043541,0.8656663504479142,1.0,1/12,2.49%,SLC11A2
prerank,positive regulation of isotype switching (GO:0045830),0.39950764184016563,0.8913987448018681,0.599713055954089,0.8653357414829448,1.0,5/15,20.44%,TFRC;KMT5B;SHLD1;SHLD2;PAXIP1
prerank,positive regulation of protein acetylation (GO:1901985),-0.35705065571079275,-0.891246196695793,0.56656346749226,0.9099654067013014,1.0,5/12,25.92%,PRKAA2;DIP2B;RAPGEF3;DIP2A;DDX3X
prerank,microtubule bundle formation (GO:0001578),0.3262134553934158,0.8911836324416743,0.6557971014492754,0.8653372309208611,1.0,8/42,13.74%,SPEF1;CCDC40;NCKAP5L;MTCL1;CCDC66;TOGARAM1;GAS2L1;CLASP1
prerank,negative regulation of cell growth (GO:0030308),0.29180747975723537,0.8907748002838592,0.6821541710665259,0.8657053517890491,1.0,22/121,13.93%,CDKN1A;PPT1;ENPP1;MYL2;SESN2;OSGIN1;APBB2;SPHK2;FLCN;HSPA1B;RB1;PPP1R9B;ACVRL1;BMPR2;NAIF1;SIRT1;MT3;DCUN1D3;BST2;ACVR1B;RBBP7;HSPA1A
prerank,muscle cell migration (GO:0014812),0.43613458895636015,0.890658615216593,0.620845921450151,0.8655122493653269,1.0,5/10,28.64%,ROCK1;AAMP;CCN3;ITGB3;DDR1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.3813017177829942,0.8905895693292097,0.6129476584022039,0.8652470866593454,1.0,5/19,8.85%,XYLT1;NDST1;EXT1;UGDH;HS2ST1
prerank,positive regulation of cell development (GO:0010720),-0.26778305665489555,-0.8896016101017116,0.6394230769230769,0.9122110687477661,1.0,6/31,12.90%,CX3CR1;NUMB;OPRM1;RFX3;NAP1L1;BAD
prerank,hepaticobiliary system development (GO:0061008),0.3696421291642342,0.8890890576689858,0.6087551299589603,0.867709081558787,1.0,3/20,9.11%,CITED2;NIPBL;ARID5B
prerank,cellular copper ion homeostasis (GO:0006878),-0.33195741946725527,-0.888800932204283,0.5867507886435331,0.9124733844287971,1.0,4/14,12.26%,SLC31A1;COX19;ATOX1;PRNP
prerank,positive regulation of innate immune response (GO:0045089),0.3498140794897718,0.8887452066353929,0.6290956749672346,0.8679572001239456,1.0,4/30,9.94%,TLR8;ADAM8;UBE2K;MAVS
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3542259119460693,0.8886832091342414,0.635752688172043,0.867677795788777,1.0,5/25,13.63%,TFAP2B;SLC8A1;MT3;TRPM7;PRKN
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3229879233631773,0.8886440971536803,0.6498800959232613,0.8673707323143338,1.0,9/45,14.83%,GCNT2;FOXO3;ATXN2;PUM3;MTPN;APP;PUM2;SPOUT1;RPL10
prerank,regulation of axon guidance (GO:1902667),0.42900234684225874,0.8883490718131948,0.6136724960254372,0.8675493855748182,1.0,3/10,18.10%,VEGFA;NRP1;MYCBP2
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.300512430690769,0.8881647164445962,0.6702819956616052,0.8674820139538115,1.0,7/88,5.15%,APOE;SAMD4A;RIC1;DAPK1;DDX6;IGF2BP3;CLN3
prerank,ribosomal large subunit assembly (GO:0000027),0.3584471569193105,0.8880752527697888,0.6258234519104084,0.8672660435042965,1.0,2/24,3.30%,RPL3L;MRPL20
prerank,presynapse assembly (GO:0099054),0.39163455147534304,0.8880211305922355,0.6260623229461756,0.8669703991962999,1.0,3/16,8.74%,CEL;PTEN;DVL1
prerank,double-strand break repair (GO:0006302),0.28756865960942907,0.8877478947574788,0.731404958677686,0.8671015683380445,1.0,42/158,23.56%,EYA1;NSMCE2;SEM1;MCM9;KPNA2;BRIP1;PARP2;BABAM2;PARP3;PIAS4;EME1;BRCA1;XRCC4;XRCC5;XRCC2;KDM2A;POLL;AP5S1;PSMD14;NBN;DCLRE1B;TDP2;WRN;POLA1;INO80;AP5Z1;BRCC3;BAZ1B;RAD21;RMI1;MRE11;PAXIP1;TNKS1BP1;RAD51B;XRCC1;VCP;PRKDC;RNF168;SPIDR;RNF138;PALB2;ERCC4
prerank,neuron apoptotic process (GO:0051402),-0.29842181679481367,-0.8873847700959208,0.6284722222222222,0.9142980785875021,1.0,6/19,12.20%,SIAH1;SCN2A;CIT;BCL2;ATN1;ERBB3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.30233838957863446,0.8873130203428364,0.6730975348338692,0.8675773220866531,1.0,8/85,10.06%,MTSS1;VEGFA;RUNX3;RAB33B;IGF1;MCC;ACVRL1;NLRC3
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.3474640777146471,0.8872690485989275,0.6368352788586251,0.8668788180705532,1.0,8/29,23.87%,BAAT;ACSM3;GLYAT;ACOT9;ACOT2;ACOT6;ACOT13;ACOT8
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.3474640777146471,0.8872690485989275,0.6368352788586251,0.8668788180705532,1.0,8/29,23.87%,BAAT;ACSM3;GLYAT;ACOT9;ACOT2;ACOT6;ACOT13;ACOT8
prerank,rRNA catabolic process (GO:0016075),0.39299430541770974,0.8867659521762747,0.614950634696756,0.8674202832478993,1.0,6/16,21.01%,EXOSC3;EXOSC9;EXOSC8;DEDD2;EXOSC10;EXOSC7
prerank,N-terminal protein amino acid modification (GO:0031365),-0.33386179601806176,-0.8866287320083613,0.5966101694915255,0.9142717624414013,1.0,5/14,15.57%,NAA35;METAP2;NTMT1;NAA60;NAA16
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3432941906250543,-0.8863208558748285,0.6160990712074303,0.9133100392562423,1.0,3/12,13.30%,TMEFF2;SELENOS;AR
prerank,serine family amino acid biosynthetic process (GO:0009070),0.4123908753308171,0.8861847403534345,0.6153846153846154,0.8681233465895607,1.0,2/12,6.92%,PHGDH;SEPHS2
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.3051663071586322,0.8859200654397894,0.6728665207877462,0.8682480895306418,1.0,6/75,5.58%,PPARG;CTNNB1;KLK3;NIBAN2;FOXO4;THBS1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.3983163570713131,0.8858535076930659,0.6427525622254758,0.8679669467985408,1.0,2/14,4.62%,ANXA1;RARA
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.39825230668452605,0.8849792344211611,0.6084425036390102,0.8691738419830234,1.0,5/13,19.87%,GLRX3;CIAO2B;CIAO2A;GLRX5;YAE1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.35205244665364394,0.8848272752936078,0.6466916354556804,0.8690677359863853,1.0,11/29,22.88%,STAT5B;SOCS6;IFNAR2;IL15;JAK3;IFNAR1;STAMBP;STAT6;PIAS1;STAT3;JAK2
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.34436298125439846,0.8846511814679607,0.6266149870801033,0.8689968418110029,1.0,5/29,12.13%,NR1H3;PLA2G2D;PLA2G4F;PLAAT3;LPCAT3
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.3325377172302677,0.8844209857194757,0.6305418719211823,0.8690590251966865,1.0,11/36,21.81%,SDCBP;WAC;PSME3IP1;PSMF1;N4BP1;PRKCG;EIF3H;ALAD;TLK2;OGT;GIPC1
prerank,regulation of feeding behavior (GO:0060259),0.42242953692116825,0.8841966500819805,0.6191176470588236,0.8690869909646398,1.0,2/11,6.97%,CFAP20;EIF2AK4
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2984525061631843,-0.8836665755973958,0.6129032258064516,0.9179443349927738,1.0,12/21,32.24%,ATM;BUB3;ZW10;BUB1;CENPF;TRIP13;IK;MAD2L2;MAD2L1;KNTC1;TTK;PLK1
prerank,renal system development (GO:0072001),0.3129480821588792,0.883591816631642,0.6534422403733956,0.869814014087318,1.0,12/52,21.03%,STRA6;VEGFA;TFAP2B;SULF2;PAX8;SULF1;ARL3;ITGA8;ACE;IFT88;WFS1;C1GALT1
prerank,calcium-mediated signaling (GO:0019722),0.297174603458963,0.8835546179728282,0.6849462365591398,0.8694924627449786,1.0,10/93,9.31%,HTR2B;TPCN2;CXCR4;PDPK1;P2RX4;XCR1;SLC8A1;PPP1R9B;KSR2;PPP3CA
prerank,negative regulation of cell projection organization (GO:0031345),-0.24344862073545814,-0.8831681971030454,0.6778523489932886,0.9173941192533959,1.0,12/48,15.73%,RTN4RL1;SPOCK1;DCC;GRIN2B;PTPRO;MAG;SEMA3A;PRNP;STMN2;YWHAH;RAPGEF2;BAG5
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.4013472424792709,0.8831440851802203,0.6276276276276276,0.8698373840371496,1.0,6/13,20.34%,IGF1;IRS2;DYRK2;EPM2AIP1;PHKG2;GCK
prerank,response to interleukin-1 (GO:0070555),0.30326046849703225,0.8829518180386485,0.6718403547671841,0.8697958284601467,1.0,12/73,15.84%,ANXA1;IRAK2;TANK;IRAK3;SIRPA;APP;RELA;ACOD1;CX3CL1;YTHDC2;MYD88;CCL7
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.3165079278451089,0.8829223559600494,0.6508670520231213,0.8694678072425788,1.0,7/57,7.94%,TAOK3;CDKN1A;WAC;MUS81;BABAM2;EME1;BRCA1
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.38903777446548854,0.8822846594356395,0.6154929577464788,0.870263478606377,1.0,4/15,18.62%,VEGFA;PAX8;GDNF;SOX8
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3130601378376892,0.8819520235588014,0.6612339930151339,0.8704937689532131,1.0,13/54,18.54%,PLK2;CDKN1A;E2F1;GADD45A;CNOT4;GTSE1;CNOT6L;CNOT7;BAX;CNOT6;RPL26;CASP2;CRADD
prerank,positive regulation of osteoblast differentiation (GO:0045669),0.3311475702241103,0.8818076845246371,0.66429418742586,0.8703687348200485,1.0,9/43,10.92%,IFITM1;RUNX2;IL6;HGF;IGF1;ACVR2A;BMPR2;IL6R;CCN1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.28905221143482235,-0.8815471411292517,0.650375939849624,0.9195127061415866,1.0,6/23,14.15%,PTCH1;MEGF8;RACK1;GLI3;BTRC;ULK3
prerank,positive regulation of heart contraction (GO:0045823),-0.30494852853003396,-0.8815091853386162,0.6360294117647058,0.9179159815875442,1.0,4/19,8.69%,ATP1A2;RYR2;TRPM4;TGFB2
prerank,positive regulation of axon extension (GO:0045773),0.3603531434054725,0.8814891631176025,0.6214765100671141,0.8705426778957377,1.0,10/22,21.76%,VEGFA;RUFY3;ZFYVE27;DSCAM;MACF1;GOLGA4;NRP1;SHTN1;CDKL5;NTN1
prerank,negative regulation of cell division (GO:0051782),0.4156903594378192,0.8812314438012694,0.6061538461538462,0.8706364974600859,1.0,2/11,9.77%,ZFYVE19;VPS4A
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.40819044888612044,0.881034724259439,0.6149341142020498,0.8706066592660021,1.0,4/12,18.62%,VEGFA;PAX8;GDNF;SOX8
prerank,positive regulation of cell cycle process (GO:0090068),0.30016650427787617,0.8809919586847069,0.6994594594594594,0.8702843509189541,1.0,15/91,16.07%,MAP3K20;KIF20B;CD28;DYNC1H1;IGF1;PCID2;CUL3;SVIL;TPR;PKN2;DBF4;NPM2;PHIP;INO80;RANBP1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.3635904938810516,0.8808368252227545,0.6472184531886025,0.8701863090341007,1.0,5/22,12.33%,GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.3362663545124603,0.8806682435620499,0.6378244746600742,0.8700897307618375,1.0,10/32,25.64%,CTNNB1;ACD;XRCC5;TNKS;TNKS2;CCT2;PKIB;NEK7;FBXO4;CCT7
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.3412030546178752,0.8806576845672159,0.6530089628681178,0.8697226848001811,1.0,8/32,18.91%,ID2;BACH1;E2F1;RB1;POLA1;ORC1;CDT1;FBXO5
prerank,myeloid dendritic cell activation (GO:0001773),-0.35078155409723444,-0.8803262391492035,0.6125,0.9190438039643212,1.0,6/12,30.76%,TGFBR2;PYCARD;BATF3;BATF;CAMK4;BATF2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.30993190601421833,0.8800544883438555,0.6831228473019518,0.8704798678452057,1.0,22/65,26.25%,PSMD1;ZFYVE19;VPS4A;PSMF1;PSMD14;PSMD12;CHFR;PSME2;CUL1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;USP47;PSMC5;AVEN;PSMC1
prerank,regulation of microtubule-based movement (GO:0060632),0.40928030450719916,0.8799981265478223,0.6312399355877617,0.8701931524205961,1.0,1/11,1.57%,LAMP1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.3352335969309427,-0.8796367065442556,0.5943396226415094,0.9190156763622163,1.0,5/13,15.79%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,camera-type eye morphogenesis (GO:0048593),0.42808161969400393,0.8795457787642216,0.6373626373626373,0.8706627740569008,1.0,1/10,1.73%,VEGFA
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.31975408381247694,0.8792988208778417,0.6733490566037735,0.8707213761083001,1.0,4/51,2.87%,SGK1;DTNBP1;KIF20B;TAOK3
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.338143965122678,0.8790342102195231,0.6612090680100756,0.870814699716229,1.0,16/33,27.61%,ACD;RTEL1;TERF1;DKC1;DCLRE1B;PPP6C;STN1;SHQ1;MRE11;TNKS1BP1;CDK2;TERF2IP;PPP6R3;TINF2;WRAP53;RFC1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3244777083047974,-0.8788134857180445,0.6158730158730159,0.9192937749387853,1.0,5/15,18.38%,SNAP91;DGKD;TNK2;HIP1R;DAB2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.23759980730429647,-0.8785556981737638,0.6956521739130435,0.91822573763665,1.0,14/40,21.38%,SYT1;RIMS1;UNC13C;RIMS2;SNAP25;SYT7;SYT2;STX1A;CPLX1;CPLX2;BLOC1S6;UNC13A;STX4;OTOF
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.3643155812723571,0.8785312384820366,0.6201117318435754,0.8713565952363476,1.0,9/19,24.53%,LY96;NR1H4;TICAM2;LBP;TRIL;SCIMP;TIRAP;IRAK1;RAB11FIP2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3430784632398577,0.8783068948042919,0.6457800511508951,0.8713718401815399,1.0,8/30,18.54%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TTF1;TAF1A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.4150070401398745,0.8781826861966802,0.6482558139534884,0.8712084085854207,1.0,5/12,25.46%,PTEN;UBE2S;CDC14B;RAB1A;FZR1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.4239085842394571,0.8779802079742228,0.6257763975155279,0.8711830561858513,1.0,2/10,11.13%,HIPK2;ING4
prerank,morphogenesis of an epithelium (GO:0002009),0.3498666771459244,0.8776293722856766,0.6214765100671141,0.8714398641172909,1.0,10/25,26.43%,DAG1;RIPK4;LRP6;LAMA3;SOX8;ACTG1;ARHGAP12;ACTB;LIN7C;KDM2B
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3482927944164912,0.8773756636590873,0.6448717948717949,0.8715143682842251,1.0,5/27,10.59%,CD44;DDX5;DYRK1A;SNAI2;SIRT1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.324049857899948,0.8771577476829597,0.6658446362515413,0.8715472986980465,1.0,10/42,19.37%,GCNT2;CORO1C;FZD7;NOTCH1;VIT;CX3CL1;BST1;RSU1;PIK3CB;ATXN3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.4132167610487173,0.8768364118907347,0.6450662739322534,0.8717671303451829,1.0,4/12,15.41%,MAOA;TRH;OAZ2;ATP7A
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.2893917629859196,0.8765547155459261,0.7172557172557172,0.8718787604523629,1.0,19/121,13.36%,NEDD9;VEGFA;TEC;PIBF1;CD44;IL6;HGF;ITGA5;IGF1;IL5;IL6R;PTK2B;PAK2;ARHGEF2;IL15;TREM2;HCLS1;DGKQ;GAS6
prerank,histone H3-K4 methylation (GO:0051568),0.3478998906959886,0.876440249160804,0.6559691912708601,0.871707866591414,1.0,10/26,26.70%,CXXC1;TET3;TET2;KMT2A;PAXIP1;OGT;MEN1;KMT2D;SETD1B;KMT2C
prerank,protein localization to cell junction (GO:1902414),-0.28083572736920637,-0.8763438285076329,0.6614785992217899,0.9217066645313958,1.0,12/22,33.21%,NLGN1;HEG1;FERMT2;ARHGEF18;NECTIN1;BSN;MPP4;JAM3;SHANK1;PCLO;TJP3;JAK1
prerank,proteasome assembly (GO:0043248),-0.351304362660671,-0.8762527112005399,0.6442577030812325,0.9201864388789435,1.0,5/11,22.96%,PSMG1;PSMG2;POMP;PSMD10;ADRM1
prerank,stem cell differentiation (GO:0048863),0.3242052680614908,0.8757699539429784,0.6629766297662977,0.8725392904195646,1.0,3/39,4.86%,HTR2B;FBXL17;FOXO4
prerank,leukotriene metabolic process (GO:0006691),0.3718936204209219,0.8752731407604606,0.6504297994269341,0.8730454776325635,1.0,4/19,21.50%,MGST2;LTA4H;ABCC1;DPEP2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.3791487007292952,0.8752439013941549,0.6385714285714286,0.872719166857165,1.0,4/16,12.33%,PID1;SPHK2;FLCN;TREM2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29874199852023925,0.8745175722236885,0.6991341991341992,0.8736427160820551,1.0,26/85,22.13%,FBXW7;RNF19A;SUMO2;HSPA1B;DET1;NUB1;RAD23A;DVL1;ARIH2;GSK3B;ZER1;STUB1;TREM2;PRKN;HSPA1A;HECTD1;KEAP1;BBS7;ATXN3;DDA1;RNF19B;PIAS1;CEBPA;TAF1;HSPBP1;VCP
prerank,in utero embryonic development (GO:0001701),0.3483029237066459,0.8745010923914107,0.6282722513089005,0.8732859769008421,1.0,7/25,21.30%,VEGFA;MBNL1;FLCN;CHD7;FUT8;SOX8;ADAM10
prerank,protein localization to kinetochore (GO:0034501),-0.3204042180561691,-0.8742597640077177,0.6111111111111112,0.9230927437708266,1.0,11/14,31.47%,BUB3;ZW10;ZWILCH;KNL1;CENPT;MTBP;IK;CDK1;CHAMP1;AURKB;TTK
prerank,regulation of T cell differentiation (GO:0045580),0.3314803055619635,0.8730569603026015,0.6405648267008985,0.8755418896239779,1.0,3/33,8.73%,ZMIZ1;FOXP3;CBFB
prerank,embryonic skeletal system development (GO:0048706),0.32905801607628754,0.8728903517116192,0.674074074074074,0.8754480170767023,1.0,5/35,12.64%,XYLT1;COL1A1;SULF2;HOXA3;SULF1
prerank,cardiolipin metabolic process (GO:0032048),0.39428430348613785,0.8727753755459206,0.6411347517730497,0.8752729756903544,1.0,3/13,9.49%,HADHA;SLC27A1;TAMM41
prerank,gland development (GO:0048732),0.30750127719555964,0.8726003449760372,0.665903890160183,0.8752087959853094,1.0,6/59,9.86%,STRA6;ANXA1;CITED2;MSN;ARID5B;PAX8
prerank,eye morphogenesis (GO:0048592),0.37291043869867424,0.8725691855589969,0.655359565807327,0.8748870736008011,1.0,3/19,9.57%,VEGFA;NIPBL;COL5A2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2849337877697668,0.8724794925605022,0.7111801242236024,0.8746658180513445,1.0,35/129,22.33%,OPTN;CDKN1A;DYNC1H1;HAUS6;FBXL17;CENPJ;BACH1;MELK;FBXL3;ENSA;PPP2R2A;CDK7;CCNA2;CEP76;CLASP1;CEP192;TUBA1A;CUL1;NDE1;LATS1;MNAT1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;CDC25A;PAFAH1B1;BRSK2;PPP2R1A;PHLDA1;HAUS5;CEP41;CCDC57;PPP1R12A
prerank,negative regulation of cyclase activity (GO:0031280),-0.326155554723622,-0.8723909505772952,0.6238244514106583,0.9258218738968305,1.0,5/14,15.79%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.35156308240927864,-0.8719944321594262,0.6052631578947368,0.9250396000944201,1.0,4/11,23.02%,HSP90AA1;QDPR;DHFR;SPR
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.32325125440489944,0.871938063835698,0.6607142857142857,0.8752218592724602,1.0,12/41,25.44%,MGLL;ABCD1;GPX4;ELOVL1;DEGS1;SCD;DECR2;SCP2;ACOT8;EPHX1;GPX1;HSD17B4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.3568219534225526,0.8716748876777553,0.6538952745849298,0.87532539588181,1.0,1/24,0.14%,HTR2B
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.29130770104997294,-0.8708457259747855,0.6796875,0.926032315388734,1.0,9/21,22.62%,CHST11;CSGALNACT1;CHST7;CHST9;CHSY1;BCAN;CSPG4;NCAN;CHST12
prerank,nuclear envelope organization (GO:0006998),0.36396920530133015,0.8708054396738673,0.6448979591836734,0.8764913815193189,1.0,6/20,20.73%,REEP4;VPS4A;LEMD3;NEMP1;TMEM170A;TOR1A
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.2828754878670522,-0.8704248733874093,0.6898954703832753,0.9236704649187423,1.0,7/23,13.58%,TFDP2;BCL2;PPP1R13B;NMT1;BAD;YWHAG;YWHAH
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.2828754878670522,-0.8704248733874093,0.6898954703832753,0.9236704649187423,1.0,7/23,13.58%,TFDP2;BCL2;PPP1R13B;NMT1;BAD;YWHAG;YWHAH
prerank,platelet aggregation (GO:0070527),0.3346955360778314,0.870233150913787,0.6511335012594458,0.8771490638300664,1.0,15/33,25.45%,ACTN1;TLN1;RAP2B;STXBP3;MYH9;CLIC1;FIBP;PIK3CB;ACTG1;ILK;FLNA;PPIA;MYL12A;ACTB;ITGB3
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.3316238308411981,-0.8694470302539706,0.6067073170731707,0.9242257646924751,1.0,8/13,31.30%,TOX;CLPTM1;TESPA1;GLI2;FOXJ1;CAMK4;BMP4;ZC3H8
prerank,regulation of pH (GO:0006885),0.4079600894471824,0.8694274031167367,0.6385542168674698,0.878218236936058,1.0,1/11,1.98%,PDK4
prerank,cellular response to virus (GO:0098586),-0.25919560098266897,-0.8693386646011655,0.6816143497757847,0.9227899189173936,1.0,12/30,25.92%,POU2F2;HSP90AA1;IRGM;FMR1;GSDME;IFIH1;RRP1B;CHUK;CCL5;GBF1;LGALS9;DDX3X
prerank,negative regulation of ossification (GO:0030279),-0.2765100183578532,-0.8690885083096764,0.6798418972332015,0.921658739833149,1.0,6/23,17.49%,MEF2C;TRPM4;BCOR;CCR1;CHSY1;SOX9
prerank,neural tube closure (GO:0001843),0.338140634727217,0.869004734915247,0.6490566037735849,0.878582962645972,1.0,13/34,26.43%,FOLR1;DLC1;DVL1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI;KDM2B
prerank,regulation of cellular response to heat (GO:1900034),-0.21454302550778429,-0.868964007854022,0.7582417582417582,0.9202424939492728,1.0,27/77,22.35%,RPTOR;MAPT;ATM;NUP133;CD34;HSP90AA1;HIKESHI;ATR;NUP214;AAAS;NUP85;POM121;SEH1L;NUP35;CAMK2A;NUP37;NUP155;RAE1;NUP153;BAG5;CRYAB;RPA3;MLST8;SEC13;DNAJB1;HSF1;RPA1
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.3245250813394641,0.8688949819888051,0.6557575757575758,0.8784041505102271,1.0,15/41,22.97%,PRKAG2;EIF6;SCARB2;TPR;NUP50;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.3409562450399629,-0.8687989452726098,0.6160990712074303,0.9189740697114986,1.0,3/12,32.28%,SOX9;STRAP;INAVA
prerank,apoptotic DNA fragmentation (GO:0006309),0.3804160661343611,0.8684909819840717,0.6312849162011173,0.878715622480898,1.0,5/16,25.93%,DFFB;DNASE2;CASP3;DFFA;CECR2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.40218783571650096,0.868271653157788,0.6357039187227866,0.8787107488618,1.0,5/12,25.44%,ABCD1;ELOVL1;SCP2;ACOT8;HSD17B4
prerank,positive regulation of bone mineralization (GO:0030501),0.32900707870490054,0.868016725008204,0.6683107274969173,0.8787830577146271,1.0,7/35,10.92%,ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,positive regulation of locomotion (GO:0040017),-0.27367609438195195,-0.8678044610785822,0.7106382978723405,0.9195457842765427,1.0,4/27,6.42%,P2RY12;CSF1R;AIF1;PPM1F
prerank,apoptotic process (GO:0006915),0.2757373579034921,0.8674840042783449,0.7834008097165992,0.8793411777019267,1.0,52/203,20.91%,CXCR4;ADRA1A;BCL2L11;PRKCD;FAS;APAF1;DAPK1;RIPK1;NOTCH2;RAF1;GADD45A;AIFM2;MELK;STK3;PIK3CA;THOC1;BNIPL;AKAP1;DLC1;CYFIP2;EGLN3;PTK2B;FOXO1;PPARD;ING4;APP;BCLAF1;VDAC1;CASP12;BAX;KREMEN1;CASP6;RTN4;NDUFS1;BNIP3;MYD88;HSPD1;BID;IFIT2;BBC3;CASP2;CASP3;STK4;TNFAIP1;PPP2CA;TNFRSF21;NUDT2;PPP2R1A;OGT;PAWR;RELT;ZBTB16
prerank,ion transport (GO:0006811),0.28715046148451884,0.8674499468522208,0.723404255319149,0.8790095565348458,1.0,11/111,6.03%,SLC26A11;SLC36A2;ANO6;SLC9A3;VDAC2;SLC8B1;SLC8A1;SLC26A1;SLC17A5;SLC5A5;SLC12A3
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.2916230209641979,0.8669845706541883,0.7125813449023861,0.8794665736334736,1.0,16/84,18.12%,APOE;SAMD4A;DAPK1;DDX6;IGF2BP3;SORL1;IGF1;RTN3;ROCK1;CNOT7;EPRS1;RTN4;EIF4A3;SYNCRIP;CAPRIN1;MALSU1
prerank,calcium ion import (GO:0070509),0.3459115409199299,0.8669358414587205,0.668806161745828,0.8791739345227274,1.0,4/28,5.19%,MICU2;MICU1;SLC8A1;MS4A1
prerank,inner ear morphogenesis (GO:0042472),-0.27875962256713466,-0.8669346532018448,0.6934865900383141,0.9198439938179195,1.0,5/22,19.45%,FGFR2;PAX2;HPN;SOX9;MYO3B
prerank,lymphocyte migration (GO:0072676),0.33629301247408766,0.8661780380627264,0.6571798188874515,0.8801263136657264,1.0,6/32,19.46%,ADAM8;CKLF;MSN;CX3CL1;CCL7;CCL25
prerank,activation of adenylate cyclase activity (GO:0007190),0.33430498754934057,0.8657792967755311,0.6826196473551638,0.8804692558928766,1.0,6/35,14.56%,EDNRA;RAF1;ADCY7;CAP1;ADCY8;ADCY3
prerank,quinone biosynthetic process (GO:1901663),-0.33151472924896097,-0.865741772311342,0.6611842105263158,0.9208072322579268,1.0,8/14,23.63%,COQ3;COQ10B;COQ2;COQ9;COQ10A;COQ5;COQ8A;UBIAD1
prerank,positive regulation of type I interferon production (GO:0032481),0.293782474696013,0.8652688559028382,0.6846240179573513,0.8809914306090815,1.0,25/73,25.94%,TLR8;CTNNB1;FLOT1;CREBBP;RNF135;POLR2L;XRCC5;MAVS;PQBP1;RELA;MYD88;HSPD1;STAT6;TBK1;POLR3C;MRE11;PRKDC;POLR3K;IRAK1;ISG15;LRRFIP1;DHX58;TLR9;POLR2F;IRF7
prerank,regulation of centrosome cycle (GO:0046605),0.3612271358413825,0.8647227214455846,0.6643929058663028,0.8815414842614887,1.0,6/21,21.40%,CHMP2A;PDCD6IP;NAT10;SIRT1;CHMP5;CHMP2B
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.282753206399766,-0.8646429019129909,0.6666666666666666,0.9215094214379029,1.0,10/21,24.66%,NAV3;HDGFL3;FGF13;STMN2;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1;KATNB1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.40882977562781486,0.8646039184441063,0.6531531531531531,0.8813668131340514,1.0,4/12,17.18%,TCERG1;HNRNPU;LARP7;NELFE
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.2965982755193253,0.8645075943562656,0.7138009049773756,0.8811621868226507,1.0,20/70,22.88%,LMO1;PSMD1;CBFB;PSMF1;PSMD14;PSMD12;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;PSMB3;PRKDC;PSME3
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.38372644958347124,0.864016417929292,0.6371814092953523,0.8816714705431862,1.0,3/13,12.37%,PRPF8;PRPF6;DDX20
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.40159129443598574,0.8633862595504117,0.6533127889060092,0.8824191649296962,1.0,3/12,17.35%,CD44;SIRT1;RPL26
prerank,response to gamma radiation (GO:0010332),0.3462247600675814,0.8633440915076058,0.6562073669849932,0.8821106796848495,1.0,8/24,23.98%,MAP3K20;XRCC5;DCUN1D3;WRN;RPL26;TLK2;MEN1;HRAS
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.3714381027299721,0.8622236383698929,0.6428571428571429,0.8837354100963176,1.0,3/17,11.54%,PLA2G2D;PLA2G4F;PLAAT3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3386526788966176,0.8620337629847704,0.6503856041131105,0.8836961020245188,1.0,4/28,8.66%,IL6;SH3KBP1;SIRPA;TYROBP
prerank,regulation of actomyosin structure organization (GO:0110020),0.3944545282163573,0.8614812822204025,0.6184798807749627,0.8842829543745808,1.0,5/13,20.26%,AKAP13;PTGER4;ROCK1;ALMS1;ACTG1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3055165439632797,0.860751303211283,0.6790697674418604,0.8851497435208207,1.0,19/55,26.25%,PSMD1;PSMF1;PSMD14;PSMD12;PSME2;CUL1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;USP47;PSMC5;AVEN;PSMC1
prerank,lipid biosynthetic process (GO:0008610),0.29426304887272325,0.8607124030561435,0.7108433734939759,0.884832681442851,1.0,15/77,21.35%,LIPG;GPAT2;AGPAT4;MVD;ACSM3;NDUFAB1;ACSL5;DHRS11;SCD;CBR4;PAM;HMGCR;PDSS1;SREBF1;SRD5A1
prerank,anterograde axonal transport (GO:0008089),0.3243242799419021,0.8604786068667233,0.6711165048543689,0.8848292213701233,1.0,8/37,18.02%,DTNBP1;AP3S1;RAB21;KIF3A;AP3D1;AP3B1;KIF5B;KIF5C
prerank,regulation of lipase activity (GO:0060191),-0.3247169208624628,-0.8604661373794202,0.6646525679758308,0.9292351427053379,1.0,4/13,28.15%,RHOA;ANGPTL3;PCSK5;LPL
prerank,histone modification (GO:0016570),0.28805418764955376,0.8602037315118578,0.7407407407407407,0.8849192740333991,1.0,33/109,25.76%,EYA1;RCOR1;PRKCD;PHF20;PARP2;NSD3;CREBBP;INCENP;HUWE1;TBL1XR1;SIRT1;CCNA2;MT3;SIRT7;USP21;USP16;USP36;PHF20L1;BAZ1B;SGF29;SIN3A;USP3;EHMT2;KAT2A;RUVBL2;KAT6B;CDK2;ATXN7;MIDEAS;CARM1;KAT6A;HDAC1;RCOR3
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.3910321400716411,0.8600184000597005,0.6533127889060092,0.884861665664892,1.0,3/13,10.85%,RENBP;NAGK;OGA
prerank,DNA strand elongation (GO:0022616),0.3648640409041786,0.8600014817576789,0.6601671309192201,0.8845054934002085,1.0,4/18,13.59%,RFC3;NBN;DCLRE1B;POLA1
prerank,fatty acid oxidation (GO:0019395),0.3087680159220386,0.859946954055109,0.6995412844036697,0.8842148676503245,1.0,18/57,25.81%,ABCD1;HADHA;MTLN;ACADL;ACADVL;PPARD;ALDH3A2;ECHDC1;EHHADH;ACAA2;ACAD10;SLC25A17;ADIPOR1;SCP2;ADIPOR2;ABCD2;HSD17B4;CPT2
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.31748197543948026,-0.8598390241724511,0.6554878048780488,0.9289299630557085,1.0,8/15,27.28%,ZC3H12B;DICER1;RPP30;NUDT16;ZC3H12C;NYNRIN;KHNYN;POP7
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.33016513284871785,0.8593183376949274,0.6791044776119403,0.8849477443267326,1.0,9/33,20.03%,KLK3;KDM4C;DDX5;CBFB;ESR1;UBA5;LATS1;NCOA2;UFSP2
prerank,pancreas development (GO:0031016),0.4029474088794768,0.859242992653515,0.6476043276661515,0.8846902157850705,1.0,3/12,23.77%,CCDC40;TCF7L2;NPHP3
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.3762051242362733,0.859233652970981,0.6458333333333334,0.8843240247321983,1.0,4/15,14.51%,RENBP;NAGK;OGA;GNPDA1
prerank,protein-DNA complex disassembly (GO:0032986),0.3770372930374637,0.8590017495759693,0.655076495132128,0.884343545858229,1.0,7/16,25.08%,RPL23;SMARCC1;ARID2;SMARCD1;SMARCB1;SMARCE1;SMARCD2
prerank,striated muscle cell development (GO:0055002),-0.31357523724312947,-0.8588655277295487,0.6490066225165563,0.929501793474512,1.0,2/14,5.42%,CAPN3;TMOD2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.2873246756632248,-0.8587407905565958,0.6856060606060606,0.9280862953144033,1.0,2/18,3.76%,CAMK1D;RIPOR2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.3854947560402961,0.8587083465924077,0.6517985611510791,0.884465153441496,1.0,1/14,1.73%,CD84
prerank,monoacylglycerol metabolic process (GO:0046462),0.389659072347612,0.8581365158234121,0.6753623188405797,0.8851005171593139,1.0,1/13,1.78%,MGLL
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.26001502634002244,-0.8580960210143701,0.7393162393162394,0.9278789304057755,1.0,12/27,25.59%,SNTA1;SCN1B;FGF12;PTPN3;DLG1;ATP2B4;YWHAH;FXYD7;SCN4B;FXYD1;NOS1;SCN2B
prerank,acyl-CoA metabolic process (GO:0006637),0.3259539792374949,0.8580090363078535,0.6908396946564885,0.8849383666408064,1.0,10/35,23.87%,BAAT;ACSM3;GLYAT;MCEE;ACOT9;OGDH;ACOT2;ACOT6;ACOT13;ACOT8
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3493467220007848,-0.8578330084211867,0.6448598130841121,0.9267835288026149,1.0,6/11,31.82%,MEF2C;SOX6;TGFB1;GREM1;BMP2;EFNB2
prerank,protein kinase A signaling (GO:0010737),0.39273269999154353,0.8572989189236789,0.6783536585365854,0.8858080888367605,1.0,1/12,3.00%,LCP1
prerank,chondrocyte differentiation (GO:0002062),0.33251143723571613,0.8571270476431082,0.6728624535315985,0.8857303409544857,1.0,7/32,13.02%,RUNX2;RUNX3;SULF2;BMPR2;SLC39A14;SULF1;GPLD1
prerank,positive regulation of protein binding (GO:0032092),0.3066138134586279,0.8570682684375404,0.6981351981351981,0.8854475596593463,1.0,16/56,23.93%,APOE;FLOT1;LRP1;STK3;HIPK2;GSK3B;APP;PRKN;AMFR;STK4;PPP2CA;TCF7L2;TAF1;FKBP1A;NMD3;MEN1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.30525649370441976,0.856624918162332,0.7016129032258065,0.8858356475011546,1.0,10/57,13.76%,VEGFA;PIBF1;IL6;IGF1;NF2;IL6R;CNOT7;IL15;HCLS1;INPP5F
prerank,tetrahydrofolate metabolic process (GO:0046653),0.40439268377004556,0.8563337528763112,0.6597938144329897,0.8859375743181401,1.0,2/10,12.55%,MTHFS;MTHFD1L
prerank,protein localization to condensed chromosome (GO:1903083),-0.3343794972982917,-0.8562998188595793,0.676829268292683,0.9285587088940387,1.0,10/12,31.47%,BUB3;ZW10;ZWILCH;KNL1;MTBP;IK;CDK1;CHAMP1;AURKB;TTK
prerank,histone H3-K36 demethylation (GO:0070544),0.42013023953290773,0.856157810388284,0.6589147286821705,0.8858705685776992,1.0,4/10,16.92%,KDM4C;KDM2A;KDM7A;RIOX2
prerank,homeostasis of number of cells (GO:0048872),-0.3314419127213045,-0.8559952636908653,0.6525679758308157,0.9275786690075029,1.0,1/12,0.09%,CX3CR1
prerank,aortic valve development (GO:0003176),0.3268644695528661,0.8558252104053861,0.6691449814126395,0.8860718790527458,1.0,6/34,11.88%,TNFRSF1B;SNAI2;RB1;BMPR2;ROCK1;NOTCH1
prerank,negative regulation of proteolysis (GO:0045861),0.3271391886849888,0.8553200188297255,0.6596273291925466,0.8865948762957927,1.0,4/34,10.11%,TIMP1;CLN3;TIMP2;ROCK1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.35410492665494997,-0.8547931050323313,0.6617647058823529,0.9285334043768285,1.0,2/10,5.92%,CX3CR1;ARRB2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.3773856967407362,0.854714988329262,0.6666666666666666,0.8872412304232392,1.0,3/16,14.52%,IGF1;ZFAND2B;PHIP
prerank,sensory perception of mechanical stimulus (GO:0050954),0.29144839527909333,0.85470388429239,0.7268770402611534,0.8868859065195546,1.0,11/85,11.94%,EYA1;LOXHD1;P2RX4;COL1A1;NIPBL;SNAI2;WDR1;COL11A1;LHFPL3;PIEZO2;ROR1
prerank,cellular response to leucine (GO:0071233),-0.36148533830126406,-0.8546326362477167,0.6345029239766082,0.9255954607412704,1.0,2/10,2.76%,RPTOR;SESN3
prerank,response to leucine (GO:0043201),-0.36148533830126406,-0.8546326362477167,0.6345029239766082,0.9255954607412704,1.0,2/10,2.76%,RPTOR;SESN3
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.3511937630791822,0.8545022557436329,0.6806495263870095,0.8868465693198938,1.0,5/23,20.34%,NCOR1;SIK1;PGP;CRY1;GCK
prerank,global genome nucleotide-excision repair (GO:0070911),0.3424244069366875,0.8544427022186138,0.6901595744680851,0.8865586412058964,1.0,5/26,12.33%,GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,skeletal system morphogenesis (GO:0048705),-0.23662295335836414,-0.854164169192619,0.775,0.925065642937094,1.0,13/42,21.98%,FGFR2;TGFBR1;MEGF8;LRP5;FBN2;HOXD4;HOXD3;HOXC9;FGFR3;HOXA9;SOX11;HOXB9;DSCAML1
prerank,autonomic nervous system development (GO:0048483),0.368241377924634,0.853982183090575,0.6637806637806638,0.8869637983452521,1.0,5/17,18.62%,TFAP2B;PHACTR4;GDNF;NRP1;SOX8
prerank,B cell activation involved in immune response (GO:0002312),-0.3289211292794746,-0.853844995634765,0.667621776504298,0.9240735832822036,1.0,2/13,5.04%,GPR183;RNF8
prerank,regulation of transcription by RNA polymerase III (GO:0006359),-0.29114467467090777,-0.8530555327333883,0.6906474820143885,0.9241906079487185,1.0,7/19,21.01%,RPTOR;MAF1;AR;POLR3F;CHD8;POLR3G;BRF2
prerank,cell chemotaxis (GO:0060326),0.3026397602657606,0.8528920864992557,0.6949152542372882,0.8884176015845172,1.0,5/60,3.93%,CXCR4;VEGFA;HGF;PRKCD;XCR1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.39745914161293416,0.852890364442574,0.6732522796352584,0.8880386345650293,1.0,2/11,5.58%,CD46;THBS1
prerank,positive regulation of macrophage activation (GO:0043032),0.37042596617105444,0.8528860890427854,0.6477438136826783,0.8876630899203621,1.0,5/17,15.88%,THBS1;STAP1;TREM2;LBP;HSPD1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4034402416085795,0.8525183106027951,0.6641566265060241,0.8879016833498063,1.0,3/12,11.88%,HNRNPU;ZFP36L2;NOTCH1
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.3453658454326627,0.8524929800868345,0.6631578947368421,0.8875640931282354,1.0,7/24,20.34%,ENPP1;IGF1;IRS2;GSK3B;DYRK2;EPM2AIP1;GCK
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.3027684123015142,0.85241443593319,0.7053364269141531,0.887316046351945,1.0,18/54,21.50%,CTNNB1;COPS9;HSPA1B;DCUN1D3;SIRT7;N4BP1;TNFAIP3;HSPA1A;SQSTM1;ARRB1;PRKCG;CRY1;PRR7;GNL3L;DNAJA1;HDAC8;OGT;GTPBP4
prerank,negative regulation of viral life cycle (GO:1903901),0.3851433877371218,0.8523592737453856,0.6427525622254758,0.8870258126961392,1.0,4/15,17.81%,IFITM1;IFITM2;BST2;SNX3
prerank,positive regulation of cartilage development (GO:0061036),0.36884809785335376,0.8522409492698522,0.6685082872928176,0.8868554667754456,1.0,3/17,9.37%,PKDCC;ACVRL1;BMPR2
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3274450825303766,0.8522390372716026,0.6943765281173594,0.8864787461373913,1.0,5/35,11.05%,RFC3;MUTYH;NEIL1;POLL;MBD4
prerank,aerobic electron transport chain (GO:0019646),0.29364400967183735,0.8521022968583447,0.7232142857142857,0.8863136322895273,1.0,23/68,23.52%,UQCRFS1;NDUFS8;NDUFA10;AFG1L;NDUFC1;COX6A1;NDUFAB1;CYCS;SDHA;COX8A;NDUFB6;NDUFS6;COX7B;NDUFS1;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;SDHAF2;COX5A;NDUFB9;NDUFA13
prerank,cellular response to drug (GO:0035690),0.3407760943562124,0.8517644588609011,0.6823687752355316,0.8865031479567216,1.0,8/25,20.41%,RAP2A;TFRC;GPLD1;GAS6;HTR1B;ACER2;RBM22;CERS1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3020131791911322,-0.8516948014525504,0.6524822695035462,0.9255864849780833,1.0,6/17,20.37%,BCL2;CLU;SOD2;BAD;FIS1;TIMM50
prerank,histone lysine demethylation (GO:0070076),0.34504820136661674,0.8513319810411282,0.652,0.8868626183270465,1.0,9/25,22.12%,KDM4C;KDM3A;JMJD1C;KDM2A;KDM1B;KDM7A;RIOX2;PHF2;KDM5C
prerank,regulation of interferon-alpha production (GO:0032647),0.34762087572111544,0.851129108082674,0.6598360655737705,0.8868191380658894,1.0,5/23,19.59%,TLR8;MAVS;NLRC3;HSPD1;TBK1
prerank,regulation of cellular component organization (GO:0051128),0.27879579801848414,0.8510265142228843,0.7615621788283659,0.8866083655882728,1.0,23/135,17.20%,CD36;APOE;SGK1;TFRC;ABL2;RAB33B;NUBP1;IRAK3;HNRNPU;CD22;PICALM;LAMTOR1;ROCK1;DCUN1D5;RAPGEF1;ATAD3A;STON1;LATS1;SNX17;TRAF2;MELTF;PTPN1;MLLT3
prerank,histone ubiquitination (GO:0016574),-0.28602129891171146,-0.8510254279598637,0.69140625,0.9253858985809305,1.0,7/21,15.58%,RNF8;PHC1;RNF20;PAF1;UBE2B;ATXN7L3;UBE2N
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.34820616878478083,0.8509618641669691,0.6751336898395722,0.8863414336775105,1.0,3/22,8.73%,FOXP3;CD46;CBFB
prerank,regulation of cartilage development (GO:0061035),0.36419614907427345,0.8509563810997072,0.665742024965326,0.8859735378991962,1.0,6/18,25.36%,TRPS1;BMPR2;ZBTB16;KAT2A;BMPR1B;SOX5
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.3342419573048553,0.8507846588141446,0.6871794871794872,0.8858887325482881,1.0,7/29,15.08%,GTF2H5;RPS27A;UBC;DDB1;CDK7;CUL4A;MNAT1
prerank,neuron projection regeneration (GO:0031102),-0.3460127218784112,-0.8505350714919363,0.676056338028169,0.9248782458655991,1.0,1/10,0.30%,RTN4RL1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.3339281529975074,0.8504344653743248,0.6824146981627297,0.88612709749909,1.0,3/25,5.51%,ADSL;PPAT;AMPD3
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.40445527114232077,0.8499014001803559,0.6726998491704375,0.88665174898306,1.0,6/10,22.88%,STAT5B;JAK3;PTPN1;STAT6;STAT3;JAK2
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4018176913709039,0.8494919225102335,0.654320987654321,0.8865696548390559,1.0,4/11,18.81%,DKC1;LARP7;MEPCE;CCT2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4018176913709039,0.8494919225102335,0.654320987654321,0.8865696548390559,1.0,4/11,18.81%,DKC1;LARP7;MEPCE;CCT2
prerank,spliceosomal complex assembly (GO:0000245),0.30896458254104114,0.8493999483241403,0.697560975609756,0.8863500522658634,1.0,13/46,17.55%,SRPK2;SCAF11;CELF1;SNRNP200;SF1;PRPF6;DDX23;SF3A3;ZRSR2;SMN1;PUF60;LUC7L;SRPK1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2886612267985194,-0.8493049768756152,0.6629213483146067,0.9259552950985361,1.0,9/18,28.28%,RAB11A;CDK4;CDC7;CDC25B;BRD4;DTL;CDK1;CCND1;STOX1
prerank,mitotic cell cycle phase transition (GO:0044772),0.2720910413891127,0.8488268268541719,0.8152284263959391,0.8869487251527556,1.0,41/204,16.25%,OPTN;PLK2;E2F3;CDKN1A;DYNC1H1;HAUS6;FBXL17;CENPJ;E2F1;ANAPC1;CUL3;MELK;FBXL3;CHMP2A;ENSA;CACUL1;RB1;NASP;PPP2R2A;CDK7;USP26;CCNA2;DBF4;CEP76;ACVR1B;CUL4A;CTDP1;PPP6C;CLASP1;CEP192;TUBA1A;CUL1;NDE1;LATS1;MNAT1;ALMS1;OFD1;CCP110;SSNA1;CDC34;HAUS7
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.32599730319101317,0.8486527033522381,0.6754057428214731,0.8868567419733194,1.0,5/31,14.31%,PPARG;TNN;NOTCH1;LIMD1;GDF10
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.39306835839256316,0.8482441994784371,0.6732223903177005,0.887161480606869,1.0,2/12,4.23%,FYCO1;UVRAG
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.34661991056796504,0.8480712010684829,0.6890080428954424,0.887073428031697,1.0,6/23,21.13%,MUS81;DFFB;DNASE1L1;DNASE2;CASP3;DFFA
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.3136524896612819,-0.8480684353228171,0.6466666666666666,0.9269912405248595,1.0,5/15,12.39%,MEF2A;IL6ST;PARP1;PRKCA;AGT
prerank,organic anion transport (GO:0015711),0.2929620290208907,0.8478877242822582,0.7193763919821826,0.8870003391594756,1.0,18/76,19.80%,LRRC8D;AQP1;ABCC4;LRRC8C;CYB5R4;SLC23A1;MGST1;SLC52A1;SLC25A42;SLC17A9;CA2;SLCO3A1;CYB5R2;CYB5R1;SLC35A2;SLC19A1;SLC35C2;SLC25A17
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.28698389371946287,-0.8473580017066338,0.6985815602836879,0.926959011061752,1.0,3/18,7.03%,NAV3;CD34;HDAC7
prerank,tRNA wobble base modification (GO:0002097),0.37739718243734977,0.8469837580445226,0.6709770114942529,0.8881516197669832,1.0,5/14,17.02%,CTU2;GTPBP3;ALKBH8;ELP4;ALKBH1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.3356379273385242,0.8467606178620982,0.6628498727735369,0.8881428904268271,1.0,9/26,27.35%,HOMER3;IGF1;GSK3B;DYRK2;STIMATE;HOMER2;EFHB;SPPL3;CHP1
prerank,positive regulation of protein kinase activity (GO:0045860),0.27577857949584417,0.8466416958402981,0.7902892561983471,0.887975847781192,1.0,19/148,11.55%,IQGAP1;NEDD9;VEGFA;PRKAG2;TAOK3;PRKCD;CDKN1A;SNX9;STK3;INCENP;CACUL1;SLC27A1;IL6R;TNIK;XRCC5;PTK2B;PAK2;CCN1;TAB2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.24628493500902443,-0.8464213305723791,0.7365853658536585,0.927263557452407,1.0,8/32,14.65%,ERBB4;HK2;BCL2;CLU;SOD2;CAMK2A;BAD;FIS1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.2618918001268063,-0.8461687429459784,0.7198275862068966,0.9262118789868143,1.0,12/27,22.62%,B3GAT3;CHST11;CSGALNACT1;B3GAT1;B3GAT2;CHST7;CHST9;CHSY1;BCAN;CSPG4;NCAN;CHST12
prerank,positive regulation of myelination (GO:0031643),-0.34186437197265507,-0.8461439737704564,0.6574923547400612,0.924655160520726,1.0,6/11,14.58%,PARD3;TPPP;MYRF;CST7;TENM4;DICER1
prerank,positive regulation of growth (GO:0045927),0.2970181030444292,0.8461264994644747,0.7200447928331467,0.8884708139150331,1.0,7/64,10.42%,RFTN1;SDCBP;MMP14;N6AMT1;EXOSC9;ADAM17;MTPN
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.30062165843567573,0.845978764806654,0.7027348394768134,0.8879639051030408,1.0,21/56,24.48%,NDUFS8;NDUFA10;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;NDUFB8;NDUFAF4;NDUFB9;NDUFAF2;NDUFA13;TMEM126B;DMAC2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.30062165843567573,0.845978764806654,0.7027348394768134,0.8879639051030408,1.0,21/56,24.48%,NDUFS8;NDUFA10;NDUFC1;ECSIT;NDUFAB1;TMEM126A;NDUFAF8;NDUFB6;DMAC1;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFAF7;NDUFB8;NDUFAF4;NDUFB9;NDUFAF2;NDUFA13;TMEM126B;DMAC2
prerank,negative regulation of protein processing (GO:0010955),0.3919765673902959,0.8457712347633964,0.6656580937972768,0.8879225281394354,1.0,3/12,17.32%,THBS1;CTSZ;GAS1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.336589424824883,0.845483385729079,0.6956521739130435,0.888012113380297,1.0,12/29,26.15%,DCAF13;RPS14;HELB;NOP14;RPS21;PWP2;NGDN;DHX37;ABT1;RRP36;NOP9;RPP40
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.3687158858044975,0.8452847391468253,0.637660485021398,0.8879794758238485,1.0,2/14,8.02%,LPIN3;SLC27A1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.32274524915231506,-0.8452557594474074,0.6407185628742516,0.9249235137615865,1.0,1/12,1.90%,TMEM119
prerank,muscle tissue development (GO:0060537),0.38401811628001237,0.8450724771335157,0.6455331412103746,0.8879677965055903,1.0,1/13,1.11%,STRA6
prerank,TOR signaling (GO:0031929),0.3359852895729341,0.8449949890220045,0.6797900262467191,0.8877120398629276,1.0,8/26,22.58%,FNIP1;FLCN;EIF4EBP2;NPRL3;MAPKAP1;CARD11;RICTOR;SYAP1
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3301369272440659,0.8442838752686377,0.6842767295597484,0.8884969169789988,1.0,8/31,21.01%,TFRC;IL6;KMT5B;VAMP3;SHLD1;SHLD2;PAXIP1;PTPRC
prerank,regulation of cell development (GO:0060284),0.32355108785923714,0.8439334501049067,0.7139240506329114,0.8886770899611227,1.0,9/36,20.75%,CTNNB1;NOTCH2;BHLHE40;FOXO1;CX3CL1;GRN;RHEB;CLOCK;HES5
prerank,glycolipid biosynthetic process (GO:0009247),0.31720669269205415,0.8438841470156327,0.7083854818523154,0.8883882736763244,1.0,8/38,15.13%,PGAP3;DPM2;B4GALT6;PIGH;ST3GAL4;A4GALT;PIGC;PIGQ
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3209449930508526,-0.843449479827042,0.7234726688102894,0.9270953559060803,1.0,5/14,17.19%,PKIA;PKIG;ATP2B4;RAPGEF2;PRKAR2B
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.3791321789692448,0.8434303402520958,0.6524822695035462,0.8887715478229389,1.0,4/14,19.53%,THBS1;SULF2;SULF1;CREB3L1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.38735802238640066,0.8429930469496769,0.6911544227886057,0.8891192674397035,1.0,3/13,14.64%,CD46;FSTL1;NRROS
prerank,positive regulation of leukocyte activation (GO:0002696),0.3635073783298425,0.8425690090520013,0.6562054208273894,0.8894362599643058,1.0,4/18,15.88%,CLEC4D;THBS1;LBP;HSPD1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.39685144544411843,0.8421303647803131,0.656671664167916,0.8898455513132993,1.0,1/12,1.99%,DHRS3
prerank,glycogen catabolic process (GO:0005980),0.3720284469258857,0.8420758122337058,0.6738505747126436,0.8895555480259562,1.0,4/15,21.74%,PYGL;AGL;PHKG2;PYGB
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.2684947776166064,0.8416024443949645,0.808316430020284,0.8899735627040685,1.0,49/186,23.89%,APOE;LRP1;PSMD1;ZNRF3;CUL3;STK3;APC;MCC;SNAI2;DVL1;DDIT3;GSK3B;PSMF1;PSMD14;PSMD12;APCDD1;SOX2;LIMD1;PRKN;PSME2;LRP6;KREMEN1;LATS1;WWOX;CCDC88C;MLLT3;PSMB10;PSMD5;PTPRU;PSMD8;AMFR;STK4;PSMA3;RNF43;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;PSMB3;RUVBL2;SDHAF2;KLHL12;SIAH2;PSME3;NPHP3;BICC1;HMGXB4
prerank,protein targeting to ER (GO:0045047),0.2843564810236544,0.841497597889024,0.7543290043290043,0.8897683864395628,1.0,22/99,17.78%,ZFAND2A;RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;GET3;RPL36A;RPL22;RPS21;RPL10A;RPS26;SPCS2;ZFAND2B;RPL15;RPL10;RPSA;RPL7;RPL26;SGTA;SEC63
prerank,maturation of LSU-rRNA (GO:0000470),0.3344692808270715,0.8400713095164223,0.6935064935064935,0.8917738550394533,1.0,9/26,24.95%,EIF6;MRPL1;RPL10A;RPL7L1;WDR12;RPL7;BOP1;RPL7A;SNU13
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3972457685539233,0.8400367553884589,0.7003058103975535,0.8914510032490455,1.0,2/11,9.87%,UQCRFS1;CYCS
prerank,zinc ion transmembrane transport (GO:0071577),0.3418603394703233,0.8394738936339357,0.678763440860215,0.8919832578958969,1.0,9/22,29.02%,SLC39A14;SLC39A12;SLC39A3;SLC39A11;SLC30A1;SLC39A10;SLC39A1;SLC39A13;SLC30A5
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.326602691133363,0.8394116593895813,0.7099143206854345,0.8917147525683006,1.0,3/32,8.69%,CD300A;PRKCD;DLC1
prerank,zinc ion transport (GO:0006829),0.3497163383850564,0.8393977483945693,0.6758620689655173,0.8913637467112522,1.0,9/21,29.02%,SLC39A14;MT3;SLC39A3;SLC39A11;SLC30A1;SLC30A9;SLC39A1;SLC39A13;SLC30A5
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2886255752920693,0.8393704452140432,0.7413213885778276,0.8910351157464531,1.0,23/69,23.52%,UQCRFS1;NDUFS8;NDUFA10;AFG1L;NDUFC1;COX6A1;NDUFAB1;CYCS;SDHA;COX8A;NDUFB6;NDUFS6;COX7B;NDUFS1;COX15;NDUFS3;NDUFB4;NDUFB8;COX4I1;SDHAF2;COX5A;NDUFB9;NDUFA13
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.3446600126198778,0.8392688862241191,0.6589358799454298,0.8908223072014604,1.0,5/21,13.74%,CORO1C;DUSP3;ROCK1;MACF1;CLASP1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2830580056318464,0.8392421937494802,0.7620578778135049,0.8904946120461248,1.0,22/91,17.32%,SYK;RAB8B;ABL2;RAB33B;RAB21;STXBP5;CD22;PICALM;RAB12;RAB10;FES;OLFM4;CPLANE2;RAB11B;FGR;INPP5F;STON1;DNAJC13;SNX17;NRP1;PTPN1;GAS1
prerank,determination of bilateral symmetry (GO:0009855),0.3332724660120835,0.839073024335899,0.6933158584534731,0.8904223048240336,1.0,7/25,25.49%,CITED2;CFAP53;NOTCH1;BBS7;NPHP3;DNAH5;ARL6
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.31630313428569334,-0.8390185154737614,0.671280276816609,0.9346955441541048,1.0,4/15,11.45%,WHRN;ADGRV1;TMEM120A;HPN
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.40205802017061154,0.8386741715890424,0.6712749615975423,0.8907118208631128,1.0,4/10,17.33%,DBF4;SSBP1;INO80;CDT1
prerank,cell junction maintenance (GO:0034331),-0.3174361812348171,-0.8380277423168867,0.6718266253869969,0.935155691163311,1.0,10/14,41.63%,CSF1R;CHCHD10;CBLN2;F2R;DCTN1;MYADM;CLDN1;CBLN1;PRTN3;CD177
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.37313560794901246,0.8380030974528719,0.6715758468335787,0.8914383106678462,1.0,4/13,23.60%,SORL1;BRSK2;TMEM30A;TM9SF4
prerank,cell projection organization (GO:0030030),0.3216653882211634,0.8379589641712134,0.6952141057934509,0.8911247259365015,1.0,5/30,9.77%,RHOJ;PDGFA;CAPG;PARVB;ITGB1
prerank,ncRNA metabolic process (GO:0034660),-0.23843288090380618,-0.8378777328310225,0.7969543147208121,0.9338759743395185,1.0,11/37,25.17%,MAPT;DGCR8;TDRKH;TUT4;DTD2;DICER1;BCDIN3D;PARN;DTD1;EXD1;DDX4
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.34741916960368535,0.8376772274234344,0.675,0.8912383257499676,1.0,6/20,18.81%,HOPX;LONP1;HSPA1A;HSPD1;HSPA4;CCT2
prerank,organelle assembly (GO:0070925),0.26305118250582105,0.8376577464989758,0.888,0.890893157182098,1.0,91/385,21.86%,MAK;RILPL2;ATG7;RAB8B;PIBF1;SNX10;RAB7A;CFAP70;DYNC1H1;SNAP29;UBAP2L;ATP6V0D1;KIF27;DDX6;NCOR1;HAUS6;ATXN2;YTHDF3;CENPJ;ASAP1;STAM;ABCC4;WDPCP;KLHL41;CHMP2A;CFAP20;FBF1;AMBRA1;VMP1;KIF3A;RAB1B;ABCA3;DYNC2I2;ACTR3;PDCD6IP;VPS4A;PATL1;ATG5;IFT46;CCDC66;CHMP6;TUBGCP4;NOTCH1;CFAP410;CPLANE2;PACS2;RAB43;ATG13;SYNPO;SH3PXD2B;CDS2;IFT52;LIMD1;OCRL;IFT140;SSX2IP;ARL3;INO80;SNF8;TNKS;STAM2;UBQLN2;EXOC4;OFD1;PRRC2C;EDC3;HAUS7;TRAPPC6A;CHMP5;ARF4;CHMP7;EXOC7;EXOC1;BBS7;FLII;DHX37;ARL13B;TMEM231;CDC14B;RAB1A;BBS1;IFT88;TCTN1;VPS36;EIF2S1;HAUS5;CHMP2B;CEP41;RPGR;VPS37B;CCDC57
prerank,negative regulation of lymphocyte migration (GO:2000402),0.4085477056471164,0.8370834465955981,0.6796267496111975,0.8914617895993766,1.0,4/10,21.42%,CD200R1;WASL;APOD;LRCH1
prerank,regulation of axon extension (GO:0030516),0.31600907891325586,0.8370441733526413,0.7319201995012469,0.8911612225937111,1.0,12/37,21.76%,APOE;RUFY3;ZFYVE27;GSK3B;MT3;MACF1;GOLGA4;RTN4;SHTN1;SIN3A;CDKL5;NTN1
prerank,regulation of actin nucleation (GO:0051125),-0.3329833836598074,-0.8369489086815792,0.6632996632996633,0.9342915716821252,1.0,3/12,8.24%,CORO1A;PICK1;ARFIP2
prerank,myotube cell development (GO:0014904),0.40240318191404656,0.8359716946665443,0.6701649175412294,0.8925368638318476,1.0,1/10,5.08%,IGF1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.33825126281364476,0.835514663753699,0.6947368421052632,0.8929279118614513,1.0,9/25,22.75%,TCERG1;HNRNPU;LARP7;CDC73;NELFE;CDK13;WDR43;SUPT4H1;RNF168
prerank,organelle fusion (GO:0048284),0.34520843842560217,0.8348113334172509,0.6879150066401063,0.8937139127021906,1.0,7/22,22.77%,EEA1;GDAP1;BAX;VPS11;USP30;AFG3L2;MFN2
prerank,regulation of viral release from host cell (GO:1902186),0.3460873287526094,0.8347006597872325,0.7059620596205962,0.8935321301708676,1.0,4/21,9.98%,TRIM25;CHMP2A;VPS4A;DDB1
prerank,cardiocyte differentiation (GO:0035051),0.40673942640939464,0.8344858765648178,0.6612903225806451,0.8935169977810976,1.0,2/10,7.98%,SIK1;AKAP13
prerank,dendritic spine morphogenesis (GO:0060997),0.36531983111677296,0.8344649567539557,0.6874115983026874,0.8931771912486809,1.0,3/15,15.07%,PTEN;DOCK10;WASL
prerank,positive regulation of interferon-beta production (GO:0032728),0.3202974549487737,0.8344636992779507,0.7194337194337195,0.8928067176534639,1.0,4/33,9.94%,TLR8;FLOT1;RNF135;MAVS
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.3486251035741231,0.8343502272837692,0.7087765957446809,0.8926131556479103,1.0,6/21,19.75%,PTEN;RPL23;FBXO5;UBE2S;CDC14B;RAB1A
prerank,Golgi inheritance (GO:0048313),0.3906163007731308,0.8341432630003571,0.704647676161919,0.8925765264979247,1.0,2/11,9.00%,STX5;VCPIP1
prerank,negative regulation of TOR signaling (GO:0032007),0.31888046293023703,0.8329276558585472,0.7204433497536946,0.894257255710115,1.0,7/36,13.44%,FNIP1;SESN2;FLCN;EPM2A;SIRT1;CASTOR1;NPRL3
prerank,plasma membrane invagination (GO:0099024),0.3203704114776153,0.8329191660264298,0.6875816993464052,0.8938981074560852,1.0,7/29,17.61%,CD36;SNX9;SNX33;MYH9;DOCK1;ARHGAP25;MSR1
prerank,neural crest cell development (GO:0014032),0.30494078762335464,0.8327831513761281,0.7057387057387058,0.8937503136875891,1.0,12/44,23.00%,HTR2B;CORO1C;SEMA4B;SNAI2;PHACTR4;GDNF;SEMA3B;SOX8;SEMA4F;PEF1;KLHL12;NOLC1
prerank,macrophage differentiation (GO:0030225),0.3801449663370667,0.832385795463062,0.6773722627737226,0.8940155734406353,1.0,3/13,12.24%,VEGFA;SIRT1;IL15
prerank,axon guidance (GO:0007411),0.2674483690010164,0.8323649335008108,0.840242669362993,0.8936719755242207,1.0,20/201,7.15%,PLXNA1;CXCR4;PLXNC1;GRB2;PLXND1;PALLD;GAB2;VEGFA;ALCAM;SOS1;NIBAN2;SEMA4B;NTN3;NOTCH2;MAPK7;NRP2;DAG1;IRS2;PIK3CA;SH3KBP1
prerank,spindle assembly (GO:0051225),0.2875789089220957,0.8323371515341762,0.7251655629139073,0.8933543697067653,1.0,20/67,23.86%,PIBF1;NCOR1;HAUS6;SMC1A;TOGARAM1;TUBGCP4;STAG2;CLASP1;CEP192;INO80;SMC3;TNKS;OFD1;HAUS7;ARHGEF10;MZT1;HAUS5;FLNA;BCCIP;NEK7
prerank,mRNA metabolic process (GO:0016071),0.2789816678859739,0.8318361607847687,0.7633262260127932,0.8937732090861632,1.0,31/90,25.90%,ERN1;SCAF11;CELF1;TCERG1;DDX5;CSTF3;HSPA1B;PRPF8;ZFP36L2;HNRNPA0;AGO3;NCBP2;SF3A3;HSPA1A;SNRPF;RNH1;ALKBH5;AGO4;AURKAIP1;SNRPB;LSM11;HNRNPR;SUPT4H1;LSM5;ZC3H12D;SF3B2;CPSF6;PRPF3;LSM6;ZFP36;RIDA
prerank,epithelial cell development (GO:0002064),0.3524926662414447,0.8314426010129102,0.6924101198402131,0.894024747928451,1.0,1/20,0.95%,RILPL2
prerank,regulation of phosphatase activity (GO:0010921),-0.2673991211558257,-0.8313114511847197,0.7241379310344828,0.944221556031272,1.0,15/24,42.16%,PPP6R2;TIPRL;HSP90B1;MTMR9;CDK5RAP3;PPP1R35;BMP2;PTPA;PPP1R2;CHP2;SH2D4A;ZCCHC9;PPP1R26;PPP1R17;RIPK3
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.30525509881087837,-0.8311765429010468,0.6707317073170732,0.9428841482098808,1.0,2/14,4.74%,ZFP91;TLR3
prerank,protein K48-linked deubiquitination (GO:0071108),0.34134589261399506,0.8310863280953728,0.6903137789904502,0.8942290082346156,1.0,6/23,19.37%,MINDY1;VCPIP1;TNFAIP3;USP8;OTUD5;ATXN3
prerank,cell cycle G2/M phase transition (GO:0044839),0.2715038917289936,0.8306604030646451,0.7966804979253111,0.8945417418665921,1.0,34/130,22.33%,OPTN;CDKN1A;DYNC1H1;HAUS6;FBXL17;CENPJ;MELK;FBXL3;ENSA;PPP2R2A;CDK7;CCNA2;CEP76;CLASP1;CEP192;TUBA1A;CUL1;NDE1;LATS1;MNAT1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;CDC25A;PAFAH1B1;BRSK2;PPP2R1A;PHLDA1;HAUS5;CEP41;CCDC57;PPP1R12A
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.37086423584940165,0.8304540219603863,0.6863033873343152,0.8944783990799113,1.0,2/15,7.77%,MUS81;EME1
prerank,regulation of lipid kinase activity (GO:0043550),0.397235110421065,0.830372458303529,0.6829268292682927,0.8942351847352563,1.0,2/11,8.02%,WDR91;RB1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.2886755326424522,-0.8301190344684406,0.6906474820143885,0.9433417112351447,1.0,2/18,1.72%,FCHSD2;DTNA
prerank,regulation of cytoplasmic translation (GO:2000765),0.3745059783697891,0.8298784359343964,0.7014492753623188,0.8946662873166368,1.0,4/14,23.41%,CPEB4;CPEB2;PKM;CPEB1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.40019277193086267,0.8293864676647826,0.7076205287713841,0.8950825139373645,1.0,5/10,27.02%,DNMT3A;KDM1B;IGF2;PCGF5;MECP2
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.3110310207830799,0.8290614201365136,0.7199046483909416,0.8952277778560321,1.0,8/43,15.38%,TAOK3;CDKN1A;BABAM2;BRCA1;NBN;CHFR;ORC1;BRCC3
prerank,heme catabolic process (GO:0042167),0.36362024226296713,0.8287468223875588,0.6616314199395771,0.8949963492567156,1.0,5/14,18.34%,BLVRB;HMOX1;HMOX2;BLVRA;ABCC1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.36362024226296713,0.8287468223875588,0.6616314199395771,0.8949963492567156,1.0,5/14,18.34%,BLVRB;HMOX1;HMOX2;BLVRA;ABCC1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.320894584249351,-0.8287424267359698,0.6892655367231638,0.9444938344929341,1.0,4/12,14.76%,CCT3;CCT5;CCT4;GNL3
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.27835140023139215,-0.8283844844588919,0.6902985074626866,0.9436422285630716,1.0,3/21,4.22%,CSF1R;CSF1;MTUS1
prerank,positive regulation of cell cycle (GO:0045787),0.29274324525292855,0.8281178424238685,0.7301401869158879,0.8956291697334503,1.0,9/62,11.47%,ANKRD17;SRPK2;RARA;CITED2;DUSP3;RAD23A;ADAM17;PKN2;APP
prerank,regulation of protein acetylation (GO:1901983),0.3893073871161181,0.8274336558633659,0.7039764359351989,0.8963637394110546,1.0,5/12,26.20%,GSK3B;SIRT1;CAMK1;TERF2IP;CEP295
prerank,negative regulation of wound healing (GO:0061045),0.3238575883866169,0.8274196005816912,0.7067183462532299,0.8960136341205708,1.0,3/28,6.55%,APOE;PTEN;PROC
prerank,tRNA aminoacylation (GO:0043039),0.309728428950155,0.8269552184276212,0.7450980392156863,0.8963812638113609,1.0,13/37,25.14%,FARS2;DARS1;EPRS1;SARS1;SARS2;IARS2;QRSL1;AIMP1;IARS1;FARSA;WARS2;LARS1;GATB
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.38753327337040233,0.8267320514454042,0.684375,0.8963680963474119,1.0,3/12,10.59%,SNX5;SORL1;SIRT1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.32778554750203126,0.8262966394573116,0.6974900924702774,0.8966986889456983,1.0,8/25,26.01%,SPHK2;FZD5;TRAF2;TNFRSF14;SCIMP;MALT1;TRAF6;MAP3K7
prerank,regulation of protein secretion (GO:0050708),0.27476615154784473,0.8258026313509436,0.8122362869198312,0.8971438279428872,1.0,13/119,8.56%,APOE;ABCG1;SERGEF;ADAM9;IL6;TFAP2B;RHBDF2;SLC8B1;IGF1;ADAM8;ENSA;STXBP5;EIPR1
prerank,regulation of protein localization to centrosome (GO:1904779),0.406764193937445,0.8252056525090222,0.6925418569254186,0.8977063471416693,1.0,3/10,14.33%,APC;GSK3B;PARD6A
prerank,methylguanosine-cap decapping (GO:0110156),-0.3390138959256126,-0.8249790566409255,0.6607669616519174,0.9489540240385244,1.0,7/10,30.07%,DCPS;PNRC2;LSM1;DCP1B;DCP1A;PATL2;DCP2
prerank,maintenance of protein location in nucleus (GO:0051457),0.3458568826282981,0.8249299419375312,0.7006896551724138,0.8977806104834897,1.0,5/20,23.44%,HNRNPU;TOPORS;SUPT7L;BCL3;TAF8
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3172366711676204,0.8246390742200971,0.6983311938382541,0.8978858179442779,1.0,8/29,17.80%,FASN;SLC25A1;PPT1;ELOVL1;ACSL5;SCD;GCDH;CBR4
prerank,negative regulation of secretion (GO:0051048),0.3986282731646412,0.8246275359509182,0.6773211567732116,0.8975336922102731,1.0,2/10,13.52%,NR1H3;VAMP3
prerank,receptor signaling pathway via STAT (GO:0097696),0.3394670173899084,0.8239262928587056,0.7097186700767263,0.8982627545542431,1.0,9/25,22.88%,STAT5B;SOCS6;IFNAR2;IFNAR1;STAMBP;STAT6;PIAS1;STAT3;JAK2
prerank,regulation of ossification (GO:0030278),-0.2397170453507555,-0.8237930848893533,0.8072916666666666,0.949694656834856,1.0,5/36,8.69%,MEF2C;ACVR1;NBR1;S1PR1;TGFB2
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.2478636816516571,-0.823583524755326,0.7488584474885844,0.9485064714422512,1.0,10/30,18.68%,HACD2;ELOVL7;ACOX1;ACSL6;ELOVL4;ELOVL6;HACD3;ABCD4;TECR;ACSBG1
prerank,RNA 3'-end processing (GO:0031123),0.2834443266278136,0.8227733324789062,0.7588105726872246,0.8997450309023565,1.0,14/69,16.87%,ALYREF;CPSF1;TENT4B;CHTOP;CSTF3;THOC1;WDR33;TENT2;NCBP2;SRSF3;THOC2;DDX39A;EIF4A3;DHX38
prerank,neuron remodeling (GO:0016322),-0.33804631598197066,-0.8226498641276141,0.6782608695652174,0.9487736378955252,1.0,2/10,9.35%,ADGRB3;ANKS1A
prerank,intracellular protein transmembrane transport (GO:0065002),0.3070230074171551,0.822280133310468,0.7423687423687424,0.9001651602945323,1.0,9/42,17.78%,CHCHD4;PEX7;TOMM20;PEX14;TIMM17A;TIMM17B;ZFAND2B;HSPD1;SEC63
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.3320859002648401,-0.8222712645594425,0.691131498470948,0.9479189862470968,1.0,3/11,12.74%,DCK;DCTD;ERH
prerank,positive regulation of DNA repair (GO:0045739),0.2997524491616135,0.8222395184320435,0.7569193742478941,0.8998567574801777,1.0,14/46,23.96%,EYA1;ERCC6;BABAM2;BRCA1;SIRT1;BRCC3;PRKCG;NPAS2;MGMT;XRCC1;RNF168;SPIDR;SLF1;FOXM1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.3849107414653561,0.8218879915666871,0.6866359447004609,0.90002948832669,1.0,3/11,9.94%,STAP1;TYROBP;MAVS
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.29564331803040117,0.82185505053247,0.7253765932792584,0.899721394792071,1.0,7/49,12.58%,VEGFA;PIBF1;IL6;IGF1;IL6R;IL15;HCLS1
prerank,protein-DNA complex assembly (GO:0065004),0.2710104038700219,0.8217511931793118,0.7878787878787878,0.8995083813924071,1.0,30/116,23.25%,PSMD1;GTF2H5;RPS27A;UBC;ANP32B;BRD2;DDB1;CDK7;PSMF1;PSMD14;PSMD12;CUL4A;PSME2;ORC1;MNAT1;ORC4;CDT1;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;TCF4;PSMA6;CUL4B;XPC;PSMB3;PSME3;KAT6B
prerank,regulation of ATP metabolic process (GO:1903578),0.2963310009811218,0.8216252237052258,0.7532314923619271,0.8993145851912739,1.0,17/54,22.97%,PRKAG2;ABCD1;SPHK2;EIF6;TPR;NUP50;ATP7A;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,anterior/posterior pattern specification (GO:0009952),-0.21772823052352483,-0.8214359166529134,0.7777777777777778,0.9479729474439869,1.0,30/53,37.63%,ACVR2B;TGFBR1;LRP5;BASP1;SMAD2;CELSR2;HHEX;HOXD4;HOXA7;HOXD3;HOXC9;HOXC5;HOXA9;HOXB9;HOXC6;PCSK5;HOXA5;HOXB5;HOXB7;BHLHE41;BMP2;LHX1;HEY1;HEY2;HES1;HOXB6;CYP26C1;HEYL;HOXD9;HES7
prerank,dopamine metabolic process (GO:0042417),0.352262049500687,0.8213778312530687,0.6983695652173914,0.8993370945350905,1.0,6/18,22.28%,MAOA;PRKN;ATP7A;GCH1;DRD2;COMT
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.3308290733913427,-0.8208406200400725,0.6593059936908517,0.9476263454807742,1.0,2/11,17.99%,NFKBID;CARD9
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.33035462279731564,0.8208141596163957,0.7055702917771883,0.8998665388924016,1.0,2/23,3.04%,BCL2L11;TIMM22
prerank,transcription by RNA polymerase III (GO:0006383),-0.2477496700946884,-0.8204604195087263,0.7818930041152263,0.9467359719695618,1.0,7/27,16.29%,IVNS1ABP;CRCP;TBP;RO60;POLR2K;GTF3C6;POLR3H
prerank,regulation of microtubule depolymerization (GO:0031114),-0.25672260188321144,-0.8203937282859418,0.7615062761506276,0.9452851164608771,1.0,10/25,24.66%,NAV3;HDGFL3;FGF13;STMN2;MID1IP1;TPX2;TTBK2;CAMSAP1;CIB1;KATNB1
prerank,catecholamine metabolic process (GO:0006584),0.378870647274726,0.8203525416579842,0.7182890855457227,0.9002446663868789,1.0,5/14,24.37%,PRKN;ATP7A;DRD2;COMT;RNF180
prerank,negative regulation of viral transcription (GO:0032897),-0.3127911737457175,-0.8200598487126818,0.7029702970297029,0.9443836965752396,1.0,6/13,27.51%,TRIM11;TRIM13;TRIM62;IFITM3;TRIM32;TRIM27
prerank,synaptic vesicle recycling (GO:0036465),0.3157171354557485,0.8197641725675014,0.7141041931385006,0.900797807565917,1.0,9/31,20.28%,CEL;PLD2;SNCG;TBC1D24;STON1;NLGN2;FCHO2;SYNJ2;VAMP2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3778575563687633,0.8195672317865718,0.6941896024464832,0.9007445038470959,1.0,5/12,20.34%,IGF1;IRS2;DYRK2;EPM2AIP1;GCK
prerank,mitochondrial RNA metabolic process (GO:0000959),0.36529793477725647,0.8190838505678611,0.6915204678362573,0.9011251839127257,1.0,4/14,17.36%,FOXO3;POLRMT;TWNK;TFB2M
prerank,microtubule nucleation (GO:0007020),-0.27482233419853586,-0.8188903908024754,0.7463235294117647,0.9450433896622442,1.0,4/20,6.59%,TUBGCP5;AKAP9;TPPP;CSNK1D
prerank,histone deubiquitination (GO:0016578),0.35006139229719424,0.8185782180672775,0.7055555555555556,0.901526227646784,1.0,7/18,24.55%,USP21;USP16;USP36;BRCC3;USP3;KAT2A;ATXN7
prerank,secretion (GO:0046903),0.3676987270057382,0.8184957615870496,0.6984352773826458,0.9012854230499702,1.0,1/14,2.59%,TPD52
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3487500534579572,0.8178575938817062,0.6896551724137931,0.901905306374378,1.0,4/18,12.85%,DTNBP1;RIMS4;GSK3B;SYN1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.3614466928811141,0.8176339674834882,0.707977207977208,0.9018765230748809,1.0,6/16,23.95%,KLK3;BMPR2;ACE;PRCP;DRD2;KLK1
prerank,cartilage development (GO:0051216),0.29715024789708555,0.817620510129557,0.75,0.9015318199223791,1.0,10/49,16.92%,RUNX2;CD44;RUNX3;SULF2;SLC39A14;TRIP11;SULF1;GPLD1;ATP7A;COL11A2
prerank,endocrine system development (GO:0035270),0.33980222955075073,0.8172423405619015,0.7006896551724138,0.901800078195614,1.0,4/21,17.37%,STRA6;PAX8;SOX2;NKX2-1
prerank,regulation of exocytosis (GO:0017157),0.2966853181701703,0.816313309876557,0.7382953181272509,0.902889319904503,1.0,9/46,13.74%,ANXA1;RAB8B;RAB21;STXBP5;RAB12;RAB10;CHMP6;CPLANE2;CLASP1
prerank,dephosphorylation (GO:0016311),0.26603621182336834,0.8161065640122808,0.8281573498964804,0.9028606025569743,1.0,24/147,14.04%,PLPP3;MTM1;MTMR3;PPM1H;PPP4R1;PPEF1;PTEN;PTPRE;DUSP3;PPEF2;PTPN12;PLPP6;PDP1;PPP4R2;PLPP5;LHPP;PPP3CA;HDHD2;ILKAP;PPP2R2A;PGP;CTDP1;PPP6C;PPP1CA
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.3415144662826619,0.8157559969066813,0.7065217391304348,0.9030253708902417,1.0,6/21,17.90%,PCID2;MEFV;BIRC3;MT3;SOX2;BIRC2
prerank,regulation of cellular pH (GO:0030641),0.3171557015570943,0.8149631520840861,0.7107001321003963,0.9039265429307787,1.0,3/29,5.15%,SLC9B1;SLC9A3;CLN3
prerank,eye photoreceptor cell development (GO:0042462),0.3581810891315731,0.8148788958166399,0.7060518731988472,0.9036906860038342,1.0,2/15,8.95%,VEGFA;TOPORS
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3172337917422983,0.8147955017612324,0.7391304347826086,0.9034436798730087,1.0,7/33,15.09%,CPSF1;CSTF3;WDR33;NCBP2;MAZ;SNRPF;SSU72
prerank,double-strand break repair via homologous recombination (GO:0000724),0.2736211145936797,0.8143111618285069,0.778969957081545,0.9038544142673414,1.0,24/95,23.56%,NSMCE2;SEM1;MUS81;MCM9;NIPBL;BRCA1;XRCC2;POLL;AP5S1;PSMD14;NBN;WRN;INO80;AP5Z1;RAD21;RMI1;MRE11;RAD51B;FANCM;XRCC1;SPIDR;RNF138;PALB2;ERCC4
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.3574535867134127,0.8142907733229721,0.7134670487106017,0.9035189831180728,1.0,1/17,0.63%,CD300A
prerank,transcription by RNA polymerase I (GO:0006360),0.30986096713890704,0.8137793545392339,0.7525,0.9039478122529943,1.0,10/34,21.48%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TTF1;TAF1A;RRN3;TAF1
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.27175531363746563,-0.813748428641561,0.7519685039370079,0.9534280038038407,1.0,3/22,7.99%,CYRIB;STX7;FBXO38
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.31719027494479785,0.8136743855713411,0.7343173431734318,0.903737169579519,1.0,8/32,20.39%,TAOK3;CDKN1A;BABAM2;BRCA1;NBN;BRCC3;CDC14B;MRE11
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3393015181586917,-0.8136419704386681,0.6778711484593838,0.9520573336250889,1.0,4/10,14.80%,WDR76;THOC5;FEM1B;DDX39B
prerank,lipoxygenase pathway (GO:0019372),0.36780082032493616,0.8133520474483692,0.7151162790697675,0.9038830193725479,1.0,2/14,6.64%,PON3;GPX4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.2722392969590687,-0.813166585124837,0.7280334728033473,0.9513878334474445,1.0,3/22,3.74%,ATP1B1;ANK2;RYR2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.36069003051766946,0.8130802182917304,0.6891117478510028,0.9039214786590763,1.0,2/15,3.86%,VEGFA;P2RX4
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.3128399802314304,0.8129536804336561,0.7336683417085427,0.9037320465940363,1.0,13/35,27.46%,FLOT1;PPT1;RAB21;PICALM;CBL;PIK3CB;MKLN1;AAK1;LDLRAP1;HIP1;C3;VTN;SMAP1
prerank,ganglioside biosynthetic process (GO:0001574),0.3651442576558035,0.8129113295052844,0.7078488372093024,0.9034297221090014,1.0,2/15,5.70%,B4GALT5;B4GALT6
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.3728973674927487,0.8126624810510136,0.6979969183359014,0.903432325913389,1.0,3/13,10.59%,SNX5;SORL1;SIRT1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.3152735939678618,0.8126589406253846,0.7592829705505761,0.9030713812231432,1.0,9/32,21.48%,GTF2H5;POLR2L;TAF1B;POLR1A;CDK7;MNAT1;TAF1A;RRN3;TAF1
prerank,response to retinoic acid (GO:0032526),0.2885598439989153,0.812554641499199,0.7685185185185185,0.9028696380898854,1.0,8/59,10.35%,AQP1;ABL2;RXRA;RARA;HTRA2;CTSH;FZD7;PTK2B
prerank,lymphocyte proliferation (GO:0046651),-0.25950834746120705,-0.8123737309394403,0.7816091954022989,0.9513006105052804,1.0,6/22,17.39%,MEF2C;FLT3;BCL2;CD40;PIK3CG;LMBR1L
prerank,cardiac muscle tissue development (GO:0048738),0.2938962079354307,0.8121368412390297,0.7572115384615384,0.9031379028187515,1.0,6/50,11.88%,NOTCH2;MAML1;SIK1;AKAP13;BMPR2;NOTCH1
prerank,atrioventricular valve development (GO:0003171),0.3631670078262084,0.8120544093883638,0.725925925925926,0.9028928408321226,1.0,3/14,11.88%,APLNR;BMPR2;NOTCH1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.3395463781685706,-0.8118077207524347,0.7038043478260869,0.950771954295151,1.0,4/10,15.37%,CD34;TMEM100;RAPGEF2;RIN2
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.35869079981537116,0.8117504754686654,0.71900826446281,0.9030017456599185,1.0,1/16,1.46%,LILRB1
prerank,response to cholesterol (GO:0070723),0.3540975195883689,0.811334544519632,0.7281690140845071,0.9032654557417896,1.0,6/17,15.72%,GRAMD1B;ABCA2;GRAMD1C;GPLD1;LRP6;PMVK
prerank,regulation of lymphocyte migration (GO:2000401),0.3919396996053406,0.8112781701663823,0.7129629629629629,0.9029822451672246,1.0,3/10,15.07%,SLC8B1;MSN;WASL
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.29306999838115844,0.8112516822219543,0.7441037735849056,0.902660050435207,1.0,16/46,22.84%,NR1H3;FLCN;ATF4;RB1;DDIT3;ADAM17;NOTCH1;IL15;PLCL2;LAMA4;LNPEP;RHEB;ARRDC3;NR1H2;TLE3;ACOT13
prerank,Notch signaling pathway (GO:0007219),0.28728402611433085,0.8101309405916234,0.750281214848144,0.9039990108858846,1.0,17/59,24.57%,PLXND1;NOTCH2;MAML1;MAML2;CREBBP;SNAI2;ADAM17;NOTCH1;NCSTN;DTX1;HES5;DTX2;ADAM10;APH1B;PSEN2;MIB1;DLGAP5
prerank,pyruvate metabolic process (GO:0006090),0.2939155501264793,0.8097753541374361,0.7505773672055427,0.904188529250428,1.0,11/52,20.34%,HK3;TPI1;SLC16A1;ENO3;PGM1;HAGH;VDAC1;ME2;GAPDHS;PFKM;GCK
prerank,cellular response to dsRNA (GO:0071359),0.3600909297459852,0.8096838427005344,0.7058823529411765,0.9039633190440268,1.0,3/15,12.10%,FLOT1;MAVS;PQBP1
prerank,protein kinase B signaling (GO:0043491),-0.26121954896133415,-0.8093626788373788,0.7420634920634921,0.9537405425078873,1.0,13/23,24.88%,SETX;PAX2;PIK3R3;SIRT2;TSC2;TNF;TYRO3;PLK3;CCL3;IL1B;THEM4;CCL5;TGFB1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.37239468241608353,0.8089445244598535,0.6991017964071856,0.9047441146814038,1.0,4/12,23.83%,WAC;FBXO31;PRKDC;CDK2
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.34514836620911793,0.808938142611319,0.7021276595744681,0.9043881369074568,1.0,3/17,14.37%,UBE2L3;NR3C1;ACOD1
prerank,chromatin organization (GO:0006325),0.26475797037264553,0.8088845553782165,0.826722338204593,0.9040973666622554,1.0,39/132,25.85%,FOXP3;KDM4C;BAZ1A;BAZ2B;TOP1;RB1;SETD7;HCFC2;ESR1;SIRT1;CBX3;SMARCC1;NPM2;SOX2;SMARCD1;SUV39H2;INO80;BRWD1;BAZ1B;PBRM1;SMARCB1;ZBTB7A;HDAC8;PRDM16;PHF1;SAFB;CDAN1;KAT2A;HMG20A;KDM5C;RUVBL2;MTF2;SUPT4H1;SETD5;SMARCE1;SMARCD2;HDAC1;SMARCA1;KAT2B
prerank,axonemal dynein complex assembly (GO:0070286),0.3165708089360115,0.808813802692749,0.7395171537484116,0.90383886209594,1.0,3/28,10.00%,CCDC40;DNAAF3;ODAD1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3001189825222487,-0.8084889998535197,0.7258566978193146,0.953804495873842,1.0,3/14,17.31%,CSF1;CCR1;TNF
prerank,neuron fate commitment (GO:0048663),0.3606724290702472,0.8076193389690823,0.7166900420757363,0.9052488274975372,1.0,1/14,2.96%,ID2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.32171615271417164,-0.805777942539298,0.7247706422018348,0.9572964219844241,1.0,3/12,4.33%,ANK3;SCN1B;WNK3
prerank,brain morphogenesis (GO:0048854),-0.32246104548194987,-0.8057187621286882,0.7017543859649122,0.9558617410205194,1.0,3/12,7.93%,CTNNA2;BBS2;PAX2
prerank,histone exchange (GO:0043486),-0.228002395815542,-0.8052228592688955,0.7978723404255319,0.9552273830826392,1.0,15/37,24.86%,RSF1;RNF8;ITGB3BP;CENPP;KNL1;CENPA;CENPK;RBBP4;CENPO;NPM1;CENPT;ACTR6;CENPQ;CENPN;CENPH
prerank,regulation of intracellular transport (GO:0032386),0.3017385456303751,0.8051372476011417,0.7458033573141487,0.9086120423406175,1.0,8/38,17.32%,LAMP1;LCP1;DYNC1H1;MYBPC3;RAB11B;INPP5F;PTPN1;GAS1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.37983700268246495,0.805029327577621,0.6938461538461539,0.9084089511558724,1.0,2/11,11.13%,HIPK2;ING4
prerank,oxoacid metabolic process (GO:0043436),0.3141132261621604,0.8040062191989054,0.7245817245817245,0.9095881922601468,1.0,4/27,11.07%,ENPP1;GNMT;GRHPR;LIAS
prerank,negative regulation of cilium assembly (GO:1902018),-0.315016618814426,-0.8039670391147558,0.73125,0.9560184640777902,1.0,5/12,17.95%,TESK1;LIMK2;CDK10;CEP97;YAP1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.34862940443438795,0.8036138925097803,0.7071005917159763,0.9097863193042456,1.0,6/16,25.02%,IL6;ST3GAL4;RELA;IRAK1;TRAF6;NFAT5
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.29315892426489937,-0.8035939784569343,0.7127659574468085,0.9551945937820674,1.0,5/15,21.86%,GGT5;GGT7;SARDH;ABHD12;ALDH4A1
prerank,histone H3 acetylation (GO:0043966),-0.21765621558563586,-0.8034241169229088,0.8813559322033898,0.9539534672438537,1.0,17/40,26.67%,YEATS2;PHF14;BRPF3;TADA1;TAF12;LDB1;NAA60;TAF10;WDR5;MEAF6;DR1;ING5;KAT14;TAF6L;TAF9;JADE1;LEF1
prerank,response to hexose (GO:0009746),0.31993253409922345,0.80279350127081,0.7203166226912929,0.9106814540835435,1.0,6/25,20.28%,THBS1;IRS2;GPLD1;EIF2B2;TCF7L2;VAMP2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.32436734015215096,0.8024782823926867,0.7389610389610389,0.9107997521074599,1.0,8/25,26.47%,ARAP1;AFAP1L2;RTN4;CBL;BCAR3;PLAUR;HIP1;DOK1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.23946600164912196,-0.8023485139382576,0.8412698412698413,0.9542900277621255,1.0,13/32,22.92%,FHIT;STK11;PML;PPP1R13B;PYCARD;AEN;JMY;MYBBP1A;CDIP1;HINT1;SNW1;RPS27L;PHLDA3
prerank,oligodendrocyte differentiation (GO:0048709),-0.27464081511969524,-0.8020791263372222,0.7463235294117647,0.9532128091331475,1.0,8/19,24.75%,TPPP;MYRF;SOX6;EIF2B5;SOX10;SOX9;NSUN5;EIF2B1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.3159718022766983,0.8017824060817056,0.7483870967741936,0.9114789717179947,1.0,10/27,26.38%,CD44;IL6;SIRPA;RELA;HSPD1;CD47;IRAK1;TRAF6;NFAT5;CCL2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.29336546714196693,0.801556171203048,0.7724550898203593,0.9114335487384687,1.0,7/47,14.37%,TIMP1;SORL1;PCID2;TIMP2;MT3;SERPINB8;SERPINC1
prerank,response to cAMP (GO:0051591),-0.22799608664446663,-0.8015548629986805,0.8434343434343434,0.9526628988968369,1.0,11/37,19.70%,HCN1;AKAP9;STAT1;HCN2;NDUFS4;RAP1B;PKD2;RAPGEF3;RAPGEF2;AHR;SLC26A6
prerank,dendritic cell chemotaxis (GO:0002407),0.3595891278599945,0.8014113964698042,0.7338129496402878,0.9112783693133196,1.0,1/14,0.59%,CXCR4
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.28237458257616765,0.8011914019147514,0.8070175438596491,0.9112541849512383,1.0,12/69,15.74%,APOE;CPEB4;PPT1;CLN3;ADAM8;PTK2B;MT3;PRKN;GDNF;CX3CL1;PRKCG;GRN
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.2763265907807744,-0.8009348186619395,0.7677902621722846,0.9522292117036526,1.0,5/18,12.28%,PHF8;HEATR1;MAF1;POLR2K;UBTF
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.35146876728460413,0.8009271897429662,0.7549575070821529,0.9112710040613526,1.0,3/16,15.17%,LAMP1;AP1G1;KLRD1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.3262569194459534,-0.8008901058210581,0.7068965517241379,0.9507656756570325,1.0,3/10,16.60%,HNMT;SARDH;CHDH
prerank,cellular response to cAMP (GO:0071320),-0.2400281520522551,-0.8008657088711141,0.7914691943127962,0.9492794166864663,1.0,18/30,34.77%,HCN1;AKAP9;HCN2;RAP1B;PKD2;RAPGEF3;RAPGEF2;AHR;SLC26A6;HCN3;PDE2A;IGFBP5;HCN4;AANAT;CRHBP;DMTN;AKAP6;KCNQ1
prerank,myeloid cell development (GO:0061515),0.33887297366011326,0.8007411514462359,0.7243319268635724,0.9111806318525002,1.0,4/18,14.64%,ANXA2;FOXP1;APP;NRROS
prerank,protein insertion into membrane (GO:0051205),0.3106259656536659,0.8001690564934305,0.7460122699386503,0.9116921897708619,1.0,7/32,11.80%,GRIN3B;STX5;HMOX1;VAPA;CYB5A;APP;ALDH3A2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.2660088014327011,0.8000525928919082,0.7834602829162133,0.9115091011484044,1.0,29/85,26.25%,PSMD1;DVL1;FZD7;PSMF1;PSMD14;FZD5;PFN1;PSMD12;FZD2;AP2B1;PARD6A;CELSR1;PSME2;DAAM1;VANGL2;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;PSMD11;PSMA6;PSMB3;PSME3;AP2S1;PSMC5;CLTC;AP2A2;PSMC1
prerank,collagen fibril organization (GO:0030199),0.26736171266696207,0.7998565972861642,0.8034557235421166,0.9114369280869484,1.0,18/88,18.24%,TLL2;CD151;COL4A6;COL1A1;LUM;COL4A1;COL5A2;COL11A1;COL5A3;COL3A1;LAMA3;COL6A2;ATP7A;COL11A2;COL4A5;PLOD1;COL12A1;PLEC
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2487431553146856,-0.7997908410805127,0.7982062780269058,0.9496461957868209,1.0,3/27,3.57%,GRM1;HTR2C;GNA15
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.32772224808535333,-0.7996346575486074,0.7309782608695652,0.9484126399761018,1.0,3/10,6.42%,MAPT;NDFIP2;PPM1F
prerank,positive regulation of DNA recombination (GO:0045911),0.3192936983277664,0.7983822198012517,0.7229551451187335,0.91329505083194,1.0,7/27,20.44%,ERCC6;TFRC;KMT5B;ARID2;SHLD1;SHLD2;PAXIP1
prerank,cellular response to hexose stimulus (GO:0071331),0.32781048669473417,0.7983155508708697,0.718421052631579,0.9130285300121108,1.0,5/23,14.55%,ERN1;ZBTB20;SLC39A14;GAS6;ADCY8
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.27712762638851074,-0.7980991074147391,0.7862068965517242,0.9496849922972568,1.0,9/17,26.63%,TGFB2;ARL6IP5;RNF13;CARD9;STK25;KLHDC10;TAOK2;LYN;MID1
prerank,alpha-amino acid metabolic process (GO:1901605),-0.2203714041347018,-0.7980588987175887,0.8741721854304636,0.9482271918327929,1.0,19/45,33.04%,NAALAD2;ASPA;NAT8L;FOLH1;GLUD1;ASNS;KMO;PYCR2;PYCR3;NOX4;DDAH1;MTHFD1;GLS;RIMKLB;DDAH2;KYAT1;CBS;SLC25A12;GPT
prerank,cellular response to glucose stimulus (GO:0071333),0.3099166047699324,0.7975310763082885,0.735969387755102,0.9138008758371974,1.0,6/30,14.55%,ERN1;ZBTB20;SLC39A14;RAB11B;GAS6;ADCY8
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.3462560160808318,0.7973803038249438,0.7576601671309192,0.9136573367690894,1.0,3/17,10.11%,VEGFA;PROC;ROCK1
prerank,regulation of chromosome segregation (GO:0051983),-0.28528734517602927,-0.7973570491390279,0.7737003058103975,0.9479630136101752,1.0,11/16,35.49%,SMC6;PUM1;NUMA1;MKI67;BUB1;IHO1;RMI2;AURKB;KIF2C;RAD18;HORMAD1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.31169366112815,0.7969495410911853,0.72544080604534,0.9139272262735485,1.0,7/29,14.80%,LIMA1;PRKCD;PIK3CA;PFN1;PRKN;CLASP1;PFN2
prerank,B cell homeostasis (GO:0001782),-0.33150041233730615,-0.796899536777436,0.7441176470588236,0.9472348620992805,1.0,1/10,0.41%,MEF2C
prerank,positive regulation of ossification (GO:0045778),0.2970633749756733,0.7964339847352564,0.7667887667887668,0.9143148243326182,1.0,7/39,10.92%,ANO6;ATP2B1;SLC8A1;ACVR2A;PKDCC;BMPR2;CCN1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.3884439817943175,0.7963021294048156,0.7261345852895149,0.9137826579826595,1.0,7/10,30.55%,AP2B1;MYLIP;AP2S1;CLTC;AP2A2;AP2A1;AP2M1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.3884439817943175,0.7963021294048156,0.7261345852895149,0.9137826579826595,1.0,7/10,30.55%,AP2B1;MYLIP;AP2S1;CLTC;AP2A2;AP2A1;AP2M1
prerank,visual system development (GO:0150063),0.3018433754797958,0.7961834950121269,0.7515605493133583,0.9135969946351008,1.0,7/37,13.34%,ZDHHC16;HIPK1;HIPK2;SALL2;RAB18;SOX2;SH3PXD2B
prerank,response to organonitrogen compound (GO:0010243),0.2983867946248615,0.7956666730535531,0.7633209417596035,0.9140088050959149,1.0,6/38,13.63%,KYNU;IL6;NR1H4;IRAK3;RHBDD1;PRKN
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.2647310606683602,0.7952078505346616,0.8250790305584826,0.9143145310625103,1.0,22/110,17.35%,DHX34;RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;ETF1;RPL22;RPS21;PPP2R2A;NCBP2;RPL10A;RPS26;UPF2;RPL15;RPL10;RPSA;EIF4A3;RPL7;RPL26
prerank,cellular protein-containing complex assembly (GO:0034622),0.25832094989761134,0.7951039823624134,0.8660531697341514,0.9141041975811386,1.0,36/160,20.28%,HOPX;NCK2;CHCHD4;CCDC40;SNX9;UVRAG;GTF2B;LONP1;IMMP2L;DNAAF3;CHMP2A;GPX4;CYBA;PICALM;TPR;FCHO1;DNAJB14;OMA1;EPS15;VAMP3;HSPA1A;TBCA;RTN4;NUP98;HSPD1;TRAF2;TBCEL;HSPA4;SHQ1;TMEM170A;FCHO2;CCT2;VBP1;PSMD11;TCF4;VAMP2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.266959456476486,0.795050131842033,0.832438238453276,0.9138233104022782,1.0,9/101,10.59%,HTR2B;PIK3R5;VEGFA;PDGFA;ADAM8;INCENP;SLC27A1;ADAM17;SIRT1
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.3692270995479723,0.7948832093188977,0.7240853658536586,0.913715681614406,1.0,2/12,8.32%,MAP2K5;FOXP1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27444539544049873,0.7937609673157854,0.8149779735682819,0.9150354106426669,1.0,19/78,23.99%,IPO5;CDKN1A;PTEN;GADD45A;APC;ADAM17;CDK7;CCNA2;CNPPD1;LATS1;MNAT1;CDC25A;CCNG1;CEBPA;GTPBP4;CCNT1;BCCIP;MEN1;NR2F2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.34446171227317574,0.7937597107031981,0.7580872011251758,0.914672352123802,1.0,3/17,15.17%,LAMP1;AP1G1;KLRD1
prerank,positive regulation of secretion by cell (GO:1903532),0.2753770332509873,0.7935978616022789,0.794413407821229,0.9145390616821739,1.0,12/70,15.16%,DTNBP1;ABCG1;ADAM9;P2RX4;IGF1;ADAM8;STXBP5;TREM2;APBB3;CLASP1;GOLPH3;GOLPH3L
prerank,dendrite self-avoidance (GO:0070593),0.34517354667096106,0.7934554278923641,0.7422535211267606,0.9143800251587502,1.0,3/16,9.16%,PALLD;TNN;DSCAM
prerank,histone mRNA metabolic process (GO:0008334),-0.24599671079200042,-0.7929813434959068,0.8061674008810573,0.9526005600104391,1.0,8/27,13.11%,ATM;TUT4;SSB;SNRPE;MTPAP;LSM1;SLBP;XRN1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.31699920939426846,-0.792946950605778,0.75,0.9511416922727174,1.0,2/11,5.96%,JUP;PLEKHA7
prerank,positive regulation of interferon-gamma production (GO:0032729),0.2888132834689421,0.7928894784313432,0.7872340425531915,0.9148470648460804,1.0,2/48,1.46%,TLR8;LILRB1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3072515426800254,-0.7928340735000287,0.7155688622754491,0.9498241015382494,1.0,4/12,9.55%,KHDRBS1;NUP214;AAAS;IFI27
prerank,inorganic cation transmembrane transport (GO:0098662),0.25192362169905735,0.7927708218144192,0.9005025125628141,0.914670811214964,1.0,31/268,13.91%,MCOLN3;SLC6A6;ATP1B4;SLC36A2;MCOLN2;ATP6V1A;ABCB7;ANO6;SLC9A3;SLC11A2;KCNK13;RHD;P2RX4;ATP6V0D1;TMEM165;SLC8A1;SLC12A3;P2RX3;KCNAB2;TRPC3;TRPV2;SLC39A14;SLC6A8;KCNK4;NNT;ATP6V0E1;ATP6V0C;GAS6;TRPM7;SLC11A1;ATP6V1H
prerank,nuclear membrane disassembly (GO:0051081),-0.29163091724080453,-0.7924285801405103,0.7357357357357357,0.9490052425732762,1.0,8/14,32.62%,PRKCA;VRK1;CNEP1R1;DCTN1;CDK1;CCNB2;PLK1;LPIN1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.29166439878726924,-0.792334523485655,0.7763975155279503,0.9476540541342905,1.0,5/14,18.45%,TMSB4X;PKD2;NFKBIE;PKD1;PSMD10
prerank,regulation of actin filament-based movement (GO:1903115),-0.32779259650169884,-0.7923262430575362,0.7031700288184438,0.9461654701996959,1.0,2/10,8.09%,ANK2;PDE4B
prerank,dicarboxylic acid catabolic process (GO:0043649),0.36026875536894626,0.7921298993402995,0.7399425287356322,0.915211958831676,1.0,1/13,2.62%,MTHFS
prerank,positive regulation of rRNA processing (GO:2000234),-0.32132460976032107,-0.7919929050538491,0.7209944751381215,0.9452501757679006,1.0,4/10,17.08%,HEATR1;BUD23;RIOK2;TRMT112
prerank,positive regulation of translational initiation (GO:0045948),0.34150732178381493,0.7918549427400526,0.726890756302521,0.9152643131422695,1.0,4/18,14.30%,YTHDF3;POLR2G;CDC123;UHMK1
prerank,autophagosome organization (GO:1905037),0.28365420591327634,0.7918490778430418,0.7820965842167256,0.9149120026472513,1.0,10/50,15.04%,ATG7;RAB7A;AMBRA1;VMP1;RAB1B;ATG5;PACS2;RAB43;ATG13;UBQLN2
prerank,positive regulation of telomere maintenance (GO:0032206),0.30512484184031446,0.7916504170970489,0.7516005121638925,0.914832615801422,1.0,10/31,23.86%,SIRT6;RTEL1;NBN;HNRNPD;TNKS;TNKS2;MRE11;PKIB;PPP1R10;NEK7
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.2602618036287988,-0.7910642193185861,0.8078291814946619,0.9452980497186766,1.0,12/20,33.40%,TGFBR1;ENG;PDCD4;TGFB2;RBPJ;OLFM1;SPRY1;BMP2;HAS2;BMP4;HEY1;HEY2
prerank,cortical cytoskeleton organization (GO:0030865),-0.22130424146831623,-0.7908053487780197,0.8324022346368715,0.9442488209445198,1.0,16/41,27.34%,NLGN1;RHOBTB1;NCKAP1;RND3;DLG1;RHOA;TNF;LLGL2;RHOBTB3;RHOBTB2;STRIP1;RHOG;RHOH;RAC1;RAC3;FMNL1
prerank,myelin assembly (GO:0032288),0.38791151727433265,0.7907608160140596,0.7413010590015129,0.9157620004591362,1.0,3/10,11.92%,ABCA2;EPB41L3;PMP22
prerank,response to calcium ion (GO:0051592),0.2623784697791466,0.7905526994513201,0.821353065539112,0.9157211989498052,1.0,12/102,9.97%,IQGAP1;CPNE2;ADAM9;ITPKB;D2HGDH;PPIF;THBS1;RASA4;CARF;TRPC3;PPP3CA;SYT17
prerank,regulation of monooxygenase activity (GO:0032768),0.3214572747070902,0.7903289597126295,0.741851368970013,0.9156685720827915,1.0,4/23,15.07%,POR;NOSIP;GDNF;WASL
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.3777278546133991,0.789190545791721,0.7313915857605178,0.9169423008500875,1.0,2/10,7.73%,RAP2A;MSN
prerank,regulation of muscle contraction (GO:0006937),-0.2510213842813576,-0.7891782580233286,0.8189300411522634,0.9455566457803373,1.0,3/26,3.60%,KCNB2;ATP1A2;CHRM2
prerank,sodium ion transport (GO:0006814),0.2685771740937322,0.7889344246652887,0.8167770419426048,0.916984835355109,1.0,8/85,7.99%,SGK1;SLC6A6;ANO6;SLC8A1;SLC5A5;SLC12A3;SLC38A7;NEDD4L
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.24902191696288897,-0.7889029535363303,0.8117647058823529,0.944513111890191,1.0,9/24,21.46%,SAR1B;ERAP1;MFSD6;IDE;TAP2;PDIA3;HFE;SEC13;FCER1G
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.3429030252869537,0.7888049820581976,0.7295850066934404,0.9168108834069171,1.0,2/17,5.08%,DOCK5;IGF1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.27453555379307504,-0.7883430640616903,0.7516778523489933,0.9439177044130764,1.0,8/18,27.75%,PTGS1;PLA2G4A;CD74;CBR1;PNPLA8;PTGDS;PTGIS;PRXL2B
prerank,histone acetylation (GO:0016573),0.2756761583851813,0.7880210753718818,0.8013245033112583,0.9176213349271006,1.0,28/69,29.21%,ZZZ3;PHF20;CREBBP;TAF5;ING3;EPC1;ING4;SUPT7L;PHF20L1;BRD1;BRPF1;TAF5L;SGF29;KAT2A;DMAP1;RUVBL2;KAT6B;POLE3;MBIP;KAT6A;BRCA2;KAT2B;MAP3K7;MRGBP;PER1;BRD8;EP300;MORF4L1
prerank,mitochondrion disassembly (GO:0061726),0.3021661393573762,0.7875960788181481,0.7884378843788438,0.9178647323774108,1.0,10/34,19.16%,ATG7;AMBRA1;ATG5;FUNDC1;PRKN;FUNDC2;SQSTM1;BNIP3;USP30;FBXO7
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.3088213207182495,0.7869057999830094,0.7764857881136951,0.9185011684763876,1.0,5/27,14.47%,ERN1;TOE1;CSTF3;LACTB2;RNASEH1
prerank,nucleocytoplasmic transport (GO:0006913),0.28993546241875545,0.7864864898506486,0.7793939393939394,0.9187440251160726,1.0,11/40,22.62%,ATXN1;RITA1;NCBP2;DDX20;RSRC1;SNRPF;NUP98;SMN1;XPO1;SNRPB;MALT1
prerank,regulation of coagulation (GO:0050818),0.36459654276745607,0.7864246979594101,0.7348242811501597,0.9184792355499906,1.0,1/11,6.55%,PROC
prerank,tube closure (GO:0060606),0.31092216900325315,0.7864208764564177,0.7512755102040817,0.9181193161897975,1.0,11/31,26.15%,FOLR1;DLC1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI
prerank,mRNA methylation (GO:0080009),-0.28474101042829014,-0.7864092145330767,0.7587412587412588,0.9456738894253983,1.0,4/15,8.59%,METTL3;VIRMA;CMTR1;NSUN2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.22779719590891073,-0.7864021994461001,0.9245283018867925,0.9442097708741074,1.0,9/37,13.63%,RPTOR;SPRED1;PARD3;WNK3;IRGM;SMAD7;SPRED2;SIRT2;SPRED3
prerank,cilium organization (GO:0044782),0.249037766649083,0.7858618093716421,0.900709219858156,0.918559155156158,1.0,43/210,20.23%,MAK;RILPL2;RAB8B;PIBF1;SNX10;CFAP70;SNAP29;ATP6V0D1;KIF27;CENPJ;ASAP1;ABCC4;WDPCP;CFAP20;FBF1;KIF3A;DYNC2I2;ACTR3;IFT46;CCDC66;NOTCH1;CFAP410;CPLANE2;IFT52;OCRL;IFT140;SSX2IP;ARL3;EXOC4;OFD1;CCP110;RTTN;ARF4;EXOC7;EXOC1;BBS7;ARL13B;TMEM231;CDC14B;RAB1A;BBS1;IFT88;TCTN1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.30619711811342604,0.7858304578169689,0.7561881188118812,0.9182410139005848,1.0,5/30,15.15%,SYNPO2L;AKAP13;COL3A1;LPAR6;ARRB1
prerank,negative regulation of cation channel activity (GO:2001258),-0.2485717909961278,-0.7856775169867486,0.8245614035087719,0.9439556406234655,1.0,7/26,24.80%,KCNAB1;FMR1;PKD2;UBQLN1;FKBP1B;CALM3;SLC6A9
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.26976697738757044,0.7856017140726627,0.8280542986425339,0.9182242667376387,1.0,20/73,22.88%,LMO1;PSMD1;CBFB;PSMF1;PSMD14;PSMD12;PSME2;TCF12;PSMB10;PSMD5;PSMD8;PSMA3;PSMA2;KMT2A;OSM;PSMD11;PSMA6;PSMB3;PRKDC;PSME3
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.25850550571237524,0.7852241463756585,0.8412017167381974,0.9184198766900306,1.0,16/104,13.93%,PPARG;PDPK1;SORL1;RPS27A;UBC;ACVR2A;HIPK2;BMPR2;SNX25;ADAM17;SIRT1;RBPMS2;STUB1;NOTCH1;LEMD3;HSPA1A
prerank,dendritic cell migration (GO:0036336),0.3424629425340965,0.7850769621417512,0.7447405329593267,0.9182668516013235,1.0,1/16,0.59%,CXCR4
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.2597959457213035,-0.7845711825768299,0.7590361445783133,0.9442057567334948,1.0,11/21,30.49%,RAB11A;CDK4;CDC7;CDC25B;NPM1;BRD4;DTL;CDK1;CCND1;STOX1;DYRK3
prerank,cellular response to glucagon stimulus (GO:0071377),0.3349049919049364,0.78455808621978,0.7279102384291725,0.9186521110430277,1.0,5/17,23.07%,ADCY7;ADCY8;ADCY3;ADCY5;ADCY9
prerank,regulation of mRNA processing (GO:0050684),0.3017418851135589,0.784447697039586,0.7868852459016393,0.9184552338139141,1.0,8/32,21.06%,SRPK2;RBM39;SF1;LARP7;SRSF3;SRPK1;JMJD6;SAFB
prerank,histone monoubiquitination (GO:0010390),-0.24979714534592778,-0.7841749350861336,0.7768924302788844,0.9434149365664432,1.0,7/24,13.80%,DDB2;TRIM37;RYBP;RNF20;BCOR;PAF1;ATXN7L3
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3369371216445218,0.7841285408587969,0.7461645746164575,0.918548907391624,1.0,3/17,9.36%,SPDL1;RB1;BOD1
prerank,smooth muscle tissue development (GO:0048745),0.3720379703287895,0.7837482833527447,0.7484939759036144,0.9187354783285814,1.0,1/10,1.11%,STRA6
prerank,positive regulation of nuclear division (GO:0051785),0.3156969147526888,0.7836431863826316,0.7639429312581063,0.9185290610220894,1.0,4/25,14.52%,CD28;IGF1;NPM2;PHIP
prerank,negative regulation of angiogenesis (GO:0016525),0.26783787211506394,0.783213095036016,0.8302300109529025,0.9187682297054445,1.0,6/84,5.58%,PPARG;CTNNB1;KLK3;NIBAN2;FOXO4;THBS1
prerank,skeletal muscle tissue development (GO:0007519),0.30478637924237895,0.7826829015525408,0.76,0.9191592757702074,1.0,3/32,7.27%,IGSF8;KLHL41;SVIL
prerank,synaptic vesicle endocytosis (GO:0048488),0.29771944724161825,0.7820836868611186,0.7632552404438965,0.9196545941627338,1.0,10/33,20.28%,CEL;GAK;PICALM;SNCG;STON1;NLGN2;ITSN1;FCHO2;SYNJ2;VAMP2
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.31949938926514654,-0.7816661417687932,0.7444444444444445,0.946067537095352,1.0,2/10,3.61%,PRKCE;IRS1
prerank,aspartate family amino acid metabolic process (GO:0009066),0.3380752609718682,0.7815135776840306,0.768688293370945,0.9201276427720385,1.0,1/18,0.75%,MSRA
prerank,protein localization to mitochondrion (GO:0070585),-0.3230655122521099,-0.7814400321761884,0.7142857142857143,0.9449681166018975,1.0,1/11,1.24%,HK2
prerank,mRNA modification (GO:0016556),-0.2556837624811902,-0.7811983242206832,0.8116591928251121,0.94389427050888,1.0,5/22,8.59%,METTL3;VIRMA;PUS7;CMTR1;NSUN2
prerank,regulation of histone modification (GO:0031056),-0.28907813996920045,-0.781179708339865,0.7828947368421053,0.9424694721853903,1.0,4/13,16.22%,HPF1;UBE2N;CDK9;PARK7
prerank,recombinational repair (GO:0000725),0.26573087169337034,0.7811232692789554,0.8271334792122538,0.9203014072367548,1.0,20/77,23.56%,NSMCE2;SEM1;MCM9;BRCA1;XRCC2;POLL;AP5S1;PSMD14;NBN;WRN;INO80;AP5Z1;RMI1;MRE11;RAD51B;XRCC1;SPIDR;RNF138;PALB2;ERCC4
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.3666867631952291,0.7810931294181823,0.7373134328358208,0.9199895948152219,1.0,3/12,17.33%,WDR18;NBN;CDT1
prerank,regulation of glycolytic process (GO:0006110),0.2711633147957262,0.7808890104385511,0.7990970654627539,0.9199135697094127,1.0,19/68,22.97%,PRKAG2;NCOR1;IGF1;EIF6;ZBTB20;TPR;NUP50;APP;NUP98;ZBTB7A;NUP88;GAPDHS;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3135507987732149,-0.7807327060915904,0.7669616519174042,0.9417717049582439,1.0,5/12,18.29%,UPP2;DCK;DHODH;UCK1;UCKL1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.31942034950468234,0.780526818035387,0.7642384105960265,0.9200827634697466,1.0,3/23,10.31%,GSTM1;GPX4;LTA4H
prerank,reticulophagy (GO:0061709),-0.308512931974892,-0.7804180549521096,0.7739130434782608,0.9408139615092779,1.0,5/12,17.23%,RB1CC1;UFM1;ULK2;UFL1;ATG2A
prerank,insulin secretion (GO:0030073),0.3241896745811651,0.7803437934206883,0.7750342935528121,0.9199881593345933,1.0,3/19,12.95%,ANXA1;CYB5R4;RAB11B
prerank,regulation of histone H3-K4 methylation (GO:0051569),0.33865500521768677,0.7800826165077651,0.7550143266475645,0.9200096450628981,1.0,5/16,20.44%,CTNNB1;BRCA1;DNMT1;KMT2A;PAXIP1
prerank,positive regulation of transferase activity (GO:0051347),0.2547321370319179,0.7794654720616669,0.865979381443299,0.9205042882686305,1.0,21/142,14.89%,CTNNB1;ACD;FBXW7;ARRDC4;RFC3;SORL1;UBE2L3;FGFR4;MERTK;POLG2;TOPORS;XRCC5;DCUN1D5;DKC1;NBN;DCUN1D3;ROR1;TREM2;DCUN1D4;HNRNPD;TNKS
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2768386176037958,0.7792241706693989,0.7711386696730552,0.9204904138975513,1.0,7/56,10.76%,NSMCE2;ANXA1;ANKRD17;CUL3;RB1;ADAM17;KMT2E
prerank,eye photoreceptor cell differentiation (GO:0001754),0.35984301653634276,0.7790466560586917,0.735207100591716,0.9204111412047243,1.0,2/12,9.16%,VEGFA;DSCAM
prerank,neuron projection organization (GO:0106027),0.35034959947575944,0.7787457520731266,0.7485549132947977,0.9204574509325535,1.0,3/15,11.47%,ABCD1;GSK3B;APP
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.266310651098082,0.7784757269345656,0.832967032967033,0.9204900072902381,1.0,13/72,14.80%,APOE;LIMA1;SPEF1;PRKCD;PIK3CA;APC;DYRK1A;ARHGEF2;PFN1;TREM2;PRKN;CLASP1;PFN2
prerank,aromatic amino acid family catabolic process (GO:0009074),0.34059364386862967,0.7784724519495905,0.7704225352112676,0.9201341733788644,1.0,1/15,2.53%,KYNU
prerank,regulation of telomere maintenance (GO:0032204),0.3045964406925022,0.778327659373489,0.7617765814266487,0.9200043699140288,1.0,10/26,24.25%,SIRT6;RTEL1;XRCC5;NBN;HNRNPD;HDAC8;MRE11;PPP1R10;ERCC4;TERF2IP
prerank,protein dephosphorylation (GO:0006470),0.25576338242816626,0.7781196460918562,0.8697478991596639,0.9199306809382856,1.0,22/135,14.04%,EYA1;MTM1;MTMR3;PPM1H;PPP4R1;PPEF1;PTEN;PTPRE;DUSP3;PPEF2;PTPN12;PDP1;PPP4R2;RPAP2;LHPP;PPP3CA;ILKAP;PPP2R2A;PGP;CTDP1;PPP6C;PPP1CA
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.24615346812793207,0.7774827910302321,0.9202020202020202,0.9204777850418462,1.0,61/248,22.88%,APOE;CTNNB1;ZEB2;GNAQ;PSMD1;ZNRF3;COL1A1;CUL3;GSKIP;STK3;APC;FOLR1;XIAP;MCC;SNAI2;RNF146;DVL1;TBL1XR1;DDIT3;FZD7;GSK3B;PSMF1;PSMD14;WLS;PSMD12;SOX2;LIMD1;PRKN;PPP1CA;PSME2;LRP6;KREMEN1;TNKS;LATS1;ATP6AP2;USP8;CCDC88C;MLLT3;PSMB10;PSMD5;CSNK1G1;PTPRU;TNKS2;PSMD8;AMFR;STK4;PSMA3;PSMA2;PSMD11;WWTR1;TCF7L2;PSMA6;TLE3;VCP;PSMB3;RUVBL2;SDHAF2;KLHL12;ILK;SIAH2;PSME3
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),-0.3188746806066901,-0.7773927922591708,0.771117166212534,0.9440783712123499,1.0,3/10,14.63%,CCT3;CCT5;CCT4
prerank,digestive tract development (GO:0048565),0.2973059057305499,0.777120243033516,0.7703412073490814,0.9206069072818123,1.0,4/33,8.26%,STRA6;CCDC40;NIPBL;PKDCC
prerank,regulation of double-strand break repair (GO:2000779),0.29328889736424285,0.7770631837693258,0.7975155279503106,0.9203378574188562,1.0,13/39,25.27%,TRIP12;SIRT6;PPP4R2;RTEL1;SIRT7;RNF169;SHLD2;MGMT;SPIDR;SLF1;FOXM1;TERF2IP;UBR5
prerank,MAPK cascade (GO:0000165),0.24496779449637077,0.7767625732322598,0.9408224674022067,0.9203872698329739,1.0,44/295,14.67%,HTR2B;MAP3K20;GRB2;TAOK3;SOS1;HGF;RASA3;PSMD1;PDGFA;RGL1;RGL2;BRAP;RAF1;IGF1;FGFR4;CUL3;IRS2;NRAS;RASA4;PIK3CA;CSF2RB;RPS27A;UBC;ZFP36L2;MAP3K8;CTSH;IL5;TNIK;PTGER4;IL3RA;PSMF1;MT3;PSMD14;ARTN;NRG4;PSMD12;CSF2RA;RASGEF1A;LAMTOR3;GDNF;SHC1;PSME2;JAK3;CUL1
prerank,mitochondrion distribution (GO:0048311),0.356507125055652,0.7767202869500872,0.7437037037037038,0.9200899606301588,1.0,1/12,0.94%,MTM1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.2465334026990288,-0.776211136836532,0.8333333333333334,0.9445421540568368,1.0,10/26,25.68%,EPHA5;TRPM4;LRP5;PLA2G6;KLF7;C2CD2L;STXBP4;STX4;ADRA2A;CDK16
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3187759272240086,-0.7755299158800986,0.7741046831955923,0.9441311245575338,1.0,7/10,28.07%,CST3;TNFRSF1A;DPP4;FAP;TGFB1;EMILIN1;CHADL
prerank,microtubule-based transport (GO:0099111),0.35527523674185046,0.7754473537177234,0.7438136826783115,0.9215059229719166,1.0,3/13,18.60%,CCDC40;SPAG17;HTT
prerank,regulation of viral life cycle (GO:1903900),0.32425691450979616,0.7753686272688408,0.7855191256830601,0.9212602507191479,1.0,3/21,9.77%,KPNA2;TRIM25;VPS4A
prerank,nucleus organization (GO:0006997),0.28348834038791526,0.7750073672574823,0.8087367178276269,0.9214092532837618,1.0,18/47,25.23%,REEP4;CHMP2A;PDCD6IP;TPR;VPS4A;CHMP6;LEMD3;USP36;NUP98;CHMP5;CHMP7;TMEM170A;TOR1A;CHMP2B;NDC1;NUP54;ATXN7;CTDNEP1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3028860511666864,0.7742653209532495,0.7718631178707225,0.9220857863480869,1.0,6/29,16.89%,RAB33B;VTI1B;VTI1A;TRAPPC10;COG5;COG2
prerank,rRNA transcription (GO:0009303),0.3371373217572651,0.7736287217433626,0.7549575070821529,0.9225590847411977,1.0,3/17,12.83%,TAF1B;GTF3C4;SIRT7
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.32643390175102643,0.7735092130181628,0.7566489361702128,0.9223779854620976,1.0,3/20,9.22%,PID1;PKDCC;PICALM
prerank,dermatan sulfate metabolic process (GO:0030205),0.3602035380966469,0.7735082028464565,0.7737226277372263,0.9220201470832132,1.0,2/13,9.45%,DSE;IDUA
prerank,negative regulation of complement activation (GO:0045916),0.38106471728503727,0.7734508143860052,0.7718223583460949,0.92174116996133,1.0,1/10,3.06%,CD46
prerank,negative regulation of viral entry into host cell (GO:0046597),0.36433633679964994,0.7730960976420512,0.7396449704142012,0.9218599802697667,1.0,2/12,8.88%,IFITM1;IFITM2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.31940034980696524,0.772893722336772,0.7758620689655172,0.9218044281418486,1.0,4/23,14.14%,VEGFA;SIRT6;PAX8;GDNF
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.3624835388378202,0.7724415779332305,0.7243401759530792,0.9220760991815896,1.0,4/12,20.33%,ABCA2;LPCAT3;DGKQ;SREBF1
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.3294343763989742,0.7723974718790405,0.7580645161290323,0.9217751165200934,1.0,7/18,21.62%,ABCG1;ABCA2;PICALM;RELA;CASP3;GSAP;EPHA4
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3434126895781494,0.7719731549890304,0.7464589235127479,0.9219997699114159,1.0,4/16,10.42%,IGF1;TRPC3;ROCK1;MTPN
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2801376880474858,-0.7717353351309569,0.7980769230769231,0.9487713265150926,1.0,3/15,10.01%,ACSS1;ACACA;HMGCS1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3510149396223015,0.7715665962916162,0.7642857142857142,0.9221938489796833,1.0,5/13,21.54%,NR1H3;LPCAT3;FCGR2B;WFS1;NR1H2
prerank,nuclear pore organization (GO:0006999),-0.2868105928078984,-0.7695899656280164,0.7987012987012987,0.9507400056974147,1.0,5/14,14.85%,NUP133;AHCTF1;SEH1L;NUP35;NUP153
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.36664975616697154,0.7692964693063004,0.7660550458715596,0.9249407781794206,1.0,1/10,4.24%,ENPP1
prerank,polyol biosynthetic process (GO:0046173),-0.27838273442992234,-0.7691300829417649,0.7687296416938111,0.9500152049961557,1.0,6/16,16.98%,IP6K2;PPIP5K1;FGF2;ITPKC;PPIP5K2;IP6K1
prerank,cellular response to interferon-gamma (GO:0071346),0.25918693222418904,0.7686537563148291,0.8533333333333334,0.9254629091160531,1.0,14/88,16.50%,CD44;PRKCD;DAPK1;IFNGR2;TRIM25;PTAFR;GBP6;SIRPA;IRF2;EPRS1;ACOD1;CX3CL1;CCL7;SYNCRIP
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.35192150113820275,0.7681746590802772,0.7653061224489796,0.925754503890357,1.0,5/13,20.88%,EIF2AK4;APP;ADCY8;SQSTM1;LGMN
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2933972313530406,0.7677626527298359,0.8089480048367593,0.9259651981516761,1.0,12/36,26.55%,FBXW7;NCOA3;ITGB1;ADAM17;BUD31;NRP1;NCF1;TAF1;JAK2;HDAC1;CCL2;HBEGF
prerank,negative regulation of protein metabolic process (GO:0051248),0.27752980021260465,0.7677016186687395,0.8220640569395018,0.925673904794299,1.0,12/48,20.20%,APOE;CD84;IRAK3;ROCK1;TREM2;AZIN1;PRKCG;SNX3;HMGCR;VBP1;AZIN2;ITGAV
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.2476124511361536,-0.7669592380045256,0.8333333333333334,0.9518845498816793,1.0,6/24,15.78%,TMEFF2;F11R;WAS;ARHGAP6;ARHGEF18;STMN1
prerank,positive regulation of kinase activity (GO:0033674),0.25613890926977684,0.7668771916951856,0.8640674394099052,0.9264315909572514,1.0,15/107,13.36%,IQGAP1;PRKAG2;CDKN1A;SNX9;FGFR4;MERTK;CACUL1;XRCC5;PTK2B;CCN1;NBN;TAB2;ROR1;TREM2;GAS6
prerank,autophagy of mitochondrion (GO:0000422),0.29018160169626994,0.7664032924229968,0.8081180811808119,0.9267119873671689,1.0,11/38,19.16%,ATG7;AMBRA1;ATG5;FUNDC1;ATG13;PRKN;FUNDC2;SQSTM1;BNIP3;USP30;FBXO7
prerank,regulation of cardiac muscle contraction (GO:0055117),0.2946070979771813,0.7663438873524157,0.8002528445006322,0.9264394849292519,1.0,3/34,5.02%,ADRA1A;P2RX4;SLC8A1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.3130080273199094,0.7661477167571716,0.7747035573122529,0.9263342092701823,1.0,2/22,4.47%,ID2;APPL2
prerank,establishment of spindle orientation (GO:0051294),0.30089557245693627,0.7657580804030519,0.7916137229987293,0.9265123143562631,1.0,6/28,18.60%,SPDL1;ITGB1;CLASP1;NDE1;PAFAH1B1;HTT
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.31861792788748056,0.7654401543263671,0.7707182320441989,0.9265879191861499,1.0,7/20,24.50%,PPIF;PPIH;CWC27;PPIE;FKBP1A;PPIG;PPIA
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.28857032093773494,0.7652916919986542,0.804583835946924,0.9264377179340785,1.0,6/39,12.33%,RFC3;GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,embryonic heart tube morphogenesis (GO:0003143),0.2806313322494736,0.7649714021315737,0.8197115384615384,0.9265351826347311,1.0,6/44,12.40%,APLNR;CCDC40;FOLR1;NOTCH1;TBX6;MICAL2
prerank,nucleosome disassembly (GO:0006337),0.3451354186547962,0.7646431929407909,0.7710674157303371,0.9262745392792513,1.0,6/14,25.08%,SMARCC1;ARID2;SMARCD1;SMARCB1;SMARCE1;SMARCD2
prerank,chromatin disassembly (GO:0031498),0.3451354186547962,0.7646431929407909,0.7710674157303371,0.9262745392792513,1.0,6/14,25.08%,SMARCC1;ARID2;SMARCD1;SMARCB1;SMARCE1;SMARCD2
prerank,cell proliferation in forebrain (GO:0021846),0.3717280277804197,0.7640390516256332,0.7413249211356467,0.926776639253026,1.0,2/10,11.35%,HOOK3;NUMBL
prerank,synaptic vesicle transport (GO:0048489),0.36241865058123035,0.7638071960025634,0.7614814814814815,0.9267256015432506,1.0,5/11,21.78%,SPG11;KIF5B;KIF5C;TOR1A;TMEM230
prerank,cell differentiation in spinal cord (GO:0021515),-0.32300685139578533,-0.7637171207974461,0.7264437689969605,0.9555348732669352,1.0,2/10,10.37%,MDGA2;SOX6
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.2914042000794705,0.7631014604360057,0.7953144266337855,0.9273439240954336,1.0,6/37,12.33%,RFC3;GTF2H5;RPS27A;UBC;DDB1;CUL4A
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.31671042800223326,0.7629970212683955,0.7716216216216216,0.9271231582155276,1.0,2/23,7.56%,PPEF1;CAMKMT
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3219196681511033,0.7623222493076184,0.7874125874125875,0.9276749630271752,1.0,4/19,19.59%,TLR8;MAVS;HSPD1;TBK1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.3059318378811531,0.7622941083088394,0.7840314136125655,0.9273610000997863,1.0,10/25,23.72%,ACVR2A;ACVRL1;BMPR2;CCN1;NOTCH1;SULF1;UBE2O;HES5;CDH5;BMPR1B
prerank,cyclooxygenase pathway (GO:0019371),0.36992569980899737,0.7622183189323778,0.7636932707355243,0.9271158926594745,1.0,2/10,8.66%,PTGES2;HPGDS
prerank,negative regulation of telomere maintenance (GO:0032205),0.33572043811708774,0.7618695804645852,0.7672672672672672,0.9272202541341248,1.0,7/15,24.25%,RTEL1;TERF1;NBN;TNKS;TNKS2;ERCC4;TERF2IP
prerank,negative regulation of blood pressure (GO:0045776),0.3497427485401506,0.7614637781393121,0.7867435158501441,0.9274109301311775,1.0,3/13,22.02%,BMPR2;PRCP;DRD2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.33854484630151915,0.7611837739914926,0.782608695652174,0.9274513171231055,1.0,2/15,7.94%,CELF1;BRCA1
prerank,negative regulation of cartilage development (GO:0061037),-0.2850205361657835,-0.7611097111371046,0.81,0.9577983954191559,1.0,7/13,36.30%,TGFBR1;ADAMTS12;SOX9;CHADL;GREM1;PTHLH;WNT9A
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.28288345806996057,-0.7610919153309764,0.8068965517241379,0.9563730008925567,1.0,9/16,29.14%,ATP5PO;DMAC2L;ATP5F1E;ATP5PF;ATP5MC3;ATP5ME;ATP5F1B;ATP5MG;STOML2
prerank,gastrulation (GO:0007369),0.3397222142938457,0.7601790215817921,0.7815602836879433,0.9284381173915678,1.0,2/15,6.78%,UGDH;LMBRD1
prerank,muscle tissue morphogenesis (GO:0060415),0.32947538666393694,0.7598715249537487,0.7694483734087695,0.9284998504677856,1.0,2/16,12.19%,NOTCH1;MYLK
prerank,potassium ion export across plasma membrane (GO:0097623),0.34787795077850303,0.7597788184075395,0.7767857142857143,0.9282592231188731,1.0,13/13,65.24%,KCNK5;KCND3;KCNH2;KCNK18;KCNE5;KCNE1;KCNE2;KCNA5;KCNE4;KCNE3;KCNT2;KCNIP2;KCNQ1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.2737077291896055,-0.7594647834563949,0.8187919463087249,0.9572948318275878,1.0,12/17,35.35%,FGF2;RFX3;BAD;TMEM100;SOX9;AHI1;ATOH8;FOXJ1;BMP4;SFRP4;SFN;SULT2B1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.2890915434960085,0.7570757644126517,0.7886792452830189,0.9314252205909256,1.0,5/32,12.33%,PID1;IGF1;ZBTB20;APP;TREM2
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.3367787249968423,0.7569622284488475,0.7793296089385475,0.9312046112427114,1.0,7/16,25.85%,CREBBP;NAA10;NAA30;NAA25;NAA80;NAA15;KAT2B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.25772365548766557,0.7563554976920879,0.8481561822125814,0.9316367161925043,1.0,18/87,17.78%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;RPL22;RPS21;RPL10A;RPS26;ZFAND2B;RPL15;RPL10;RPSA;RPL7;RPL26;SEC63
prerank,bicellular tight junction assembly (GO:0070830),0.27717248113997445,0.7557527139133873,0.8311990686845169,0.9320779719517168,1.0,6/46,14.33%,MICALL2;APC;PDCD6IP;STRN;PAK2;PARD6A
prerank,cell-cell junction maintenance (GO:0045217),-0.3070932668989593,-0.7547100479590623,0.7592592592592593,0.9626623447668203,1.0,2/11,10.44%,CSF1R;FERMT2
prerank,T cell differentiation in thymus (GO:0033077),0.3436006035200765,0.7545563109740762,0.7807807807807807,0.9332866515049459,1.0,2/14,10.24%,ZFP36L2;ADAM17
prerank,cholesterol biosynthetic process (GO:0006695),0.2937449814863933,0.7545294560948835,0.7944862155388471,0.9329590743010773,1.0,9/31,20.50%,MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;SC5D;HMGCR;ARV1
prerank,nucleotide metabolic process (GO:0009117),0.30964124377268726,0.7540588655156755,0.7837837837837838,0.9332229139547719,1.0,2/23,6.98%,AK8;NMNAT1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.3055004425199617,0.7537399566561127,0.8083989501312336,0.9332609057549944,1.0,3/24,8.12%,ARPC2;PIK3CA;ACTR3
prerank,retina homeostasis (GO:0001895),0.3109848426458265,0.7536577282203651,0.807741935483871,0.9330141587863795,1.0,6/23,25.32%,PRDX1;CCDC66;ACTG1;SLC28A2;ACTB;POTEF
prerank,protein O-linked mannosylation (GO:0035269),0.3188804412525849,0.7536162603121954,0.7821782178217822,0.9327096555739377,1.0,5/18,23.15%,DPM2;TMTC4;FKTN;CRPPA;FKRP
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.2716807746071995,-0.7531512564956698,0.8053691275167785,0.96343800678166,1.0,4/14,13.37%,FAM98B;DDX1;TSEN34;RTRAF
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3113563993536121,0.752886922989068,0.7989487516425755,0.9332836851556875,1.0,8/22,21.62%,ABCG1;ABCA2;PICALM;RELA;RANBP9;CASP3;GSAP;EPHA4
prerank,fatty acid elongation (GO:0030497),0.3384246763620875,0.7524987526024927,0.7934131736526946,0.9334271561523664,1.0,3/13,11.40%,ABCD1;HACD4;ELOVL1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.3020998002444151,0.7523705386486439,0.7957559681697612,0.9332374202126664,1.0,5/24,16.18%,VEGFA;SEMA4B;DSCAM;SEMA3B;NRP1
prerank,retinoic acid metabolic process (GO:0042573),-0.28466142142732054,-0.7520756260542935,0.8104575163398693,0.9635455320627201,1.0,9/14,43.92%,BCO2;CYP26B1;CYP26C1;ALDH1A3;ALDH8A1;CYP2S1;UGT1A7;UGT1A8;UGT1A1
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.293862435961515,0.751918536922467,0.8007662835249042,0.9334831305010411,1.0,6/30,14.94%,TFAP2B;FOLR1;XIAP;FSTL1;ITGA3;LATS1
prerank,protein import into mitochondrial matrix (GO:0030150),0.31972730842530217,0.7518421503202739,0.7943548387096774,0.933225454457469,1.0,3/18,11.77%,TOMM20;TIMM17A;TIMM17B
prerank,positive regulation of double-strand break repair (GO:2000781),-0.2094595511577063,-0.7513048529169242,0.9313725490196079,0.9632171758637125,1.0,12/39,20.48%,FMN2;SPIRE1;WAS;FUS;KMT5C;PARP1;SMCHD1;KDM4D;ZCWPW1;TIMELESS;RAD51AP1;SETMAR
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2568305967416882,0.7507711136780923,0.8826695371367062,0.934254397866843,1.0,22/84,20.81%,WTAP;MBNL1;SRPK2;CELF1;RBM39;DDX5;HNRNPU;SF1;LARP7;SRSF3;PRDX6;MBNL2;NUP98;PUF60;THRAP3;RBM7;SRPK1;ZBTB7A;C1QBP;NCL;RBM15;JMJD6
prerank,histone H3 deacetylation (GO:0070932),0.3363261476220884,0.7505211984090949,0.7909356725146199,0.9342155982246984,1.0,4/15,19.35%,SIRT6;SIRT1;SIRT7;HDAC8
prerank,peptidyl-threonine modification (GO:0018210),0.2617012011943783,0.7501519766204836,0.8369690011481056,0.9343230171838889,1.0,12/66,14.89%,GALNT3;PDPK1;PRKCD;DYRK1A;HIPK1;CSNK2A2;HIPK2;ROCK1;GSK3B;ACVR1B;DYRK2;TNKS
prerank,ruffle organization (GO:0031529),0.3279019458651766,0.7498332696955654,0.7888111888111888,0.934378107664474,1.0,2/16,9.32%,LIMA1;PLEKHA1
prerank,negative regulation of lipid catabolic process (GO:0050995),-0.26531013569365397,-0.7491067608170403,0.8284671532846716,0.9649269881041971,1.0,5/17,23.87%,PDE3B;APOC1;TNF;IL1B;ADRA2A
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3016391964917841,-0.7489121174091883,0.7935103244837758,0.9637451743880422,1.0,2/11,3.83%,NOVA1;PCBP3
prerank,type I interferon signaling pathway (GO:0060337),0.2766473327099626,0.7479849218523621,0.8412322274881516,0.9360830205343342,1.0,9/41,16.95%,IFITM1;IFNAR2;RNASEL;IRF2;IFITM2;BST2;MYD88;IFIT2;IFNAR1
prerank,cellular response to type I interferon (GO:0071357),0.2766473327099626,0.7479849218523621,0.8412322274881516,0.9360830205343342,1.0,9/41,16.95%,IFITM1;IFNAR2;RNASEL;IRF2;IFITM2;BST2;MYD88;IFIT2;IFNAR1
prerank,regulation of cellular response to stress (GO:0080135),0.24875072483316554,0.7479625676047945,0.8890041493775933,0.9357610829445803,1.0,30/115,22.97%,CEBPB;ATF3;DNAJB6;ABCD1;CLN3;AIFM2;CREBBP;HSPA1B;ATF4;TPR;GSK3B;NUP50;SIRT1;BAG4;PRKN;HSPA1A;ADCY8;MCL1;NUP98;AMFR;BAG1;NUP88;AKT1S1;NPAS2;NUP188;HSBP1;NDC1;NUP43;NUP54;RANBP2
prerank,spliceosomal snRNP assembly (GO:0000387),0.27791848301065386,0.7479382536528216,0.8165024630541872,0.9354374292877026,1.0,8/38,16.02%,CLNS1A;PRPF8;SART1;WDR77;PRPF6;DDX20;SNRPF;SMN1
prerank,regulation of astrocyte differentiation (GO:0048710),0.3478588967883613,0.7479208438956672,0.7396449704142012,0.9351046119270379,1.0,2/12,2.98%,ID2;IL6
prerank,dicarboxylic acid transport (GO:0006835),0.28785158512604136,0.7477943411539578,0.8204456094364351,0.9349076572114345,1.0,4/28,8.91%,SLC26A1;FOLR2;FOLR1;SLC25A32
prerank,alpha-amino acid catabolic process (GO:1901606),0.2915775592801035,0.7473755857567655,0.8190104166666666,0.9350842241563382,1.0,5/29,17.70%,KYNU;PRODH;FAH;BLMH;MTRR
prerank,positive regulation of cytokinesis (GO:0032467),0.2898527484703757,0.7473329263571992,0.8140703517587939,0.9347844264017321,1.0,4/32,10.73%,KIF20B;CUL3;SVIL;PKN2
prerank,lipid droplet organization (GO:0034389),0.30531431671860776,0.747021538569745,0.7800269905533064,0.9348184043257871,1.0,6/22,27.64%,FAF2;RAB18;CDS2;RAB3GAP1;PPIA;BSCL2
prerank,positive regulation of phosphatase activity (GO:0010922),0.3087093488003401,0.7470139352339856,0.7983978638184246,0.9344711918418254,1.0,1/21,0.63%,CD300A
prerank,regulation of dephosphorylation (GO:0035303),0.32592652149987544,0.7468092492083449,0.7907303370786517,0.9343695196606654,1.0,1/15,1.34%,MTMR3
prerank,cytoplasmic translation (GO:0002181),0.25398637722315964,0.7467474831183625,0.8669574700109052,0.9340923466160658,1.0,18/91,17.35%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;ETF1;EIF4A1;RPL22;RPS21;RPL10A;RPS26;RPL15;RPL10;RPSA;RPL7;RPL26
prerank,autophagosome assembly (GO:0000045),0.26667527027667276,0.7465754575636624,0.8509389671361502,0.9339623600306148,1.0,10/52,15.04%,ATG7;RAB7A;AMBRA1;VMP1;RAB1B;ATG5;PACS2;RAB43;ATG13;UBQLN2
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.3341248750962105,0.7464550492743458,0.7816091954022989,0.9337699527021733,1.0,9/14,32.56%,SEC23B;SEC31A;RAB1A;SEC24C;SEC24B;SEC24A;SAR1A;SEC23A;SEC24D
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.3454744538603156,0.7462599036329167,0.7880184331797235,0.9336519048082185,1.0,1/11,3.04%,TIMM22
prerank,C-terminal protein amino acid modification (GO:0018410),0.34844173833863445,0.7458026154093496,0.7586206896551724,0.933898235928828,1.0,5/11,21.28%,ATG7;ATG5;GPLD1;ICMT;TTL
prerank,cellular response to nitrogen compound (GO:1901699),0.31039716101930565,0.7456740878826894,0.7975376196990424,0.9336994364042277,1.0,6/20,22.98%,NR1H4;EPG5;NSMCE3;DDI2;RTF2;SPIDR
prerank,establishment of mitotic spindle orientation (GO:0000132),0.3021953448879599,0.7455248093209004,0.8169014084507042,0.9335374619039007,1.0,5/23,18.60%,SPDL1;ITGB1;NDE1;PAFAH1B1;HTT
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.29409166412160515,0.7454853646672264,0.81877444589309,0.9332406678312255,1.0,7/28,14.94%,ARHGAP18;COTL1;WDR1;PFN1;HCLS1;PFN2;LATS1
prerank,V(D)J recombination (GO:0033151),0.3583496039888706,0.7454494436191819,0.7909090909090909,0.9329359113133698,1.0,3/11,22.19%,XRCC4;DCAF1;PRKDC
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.28779177549431856,0.7450041523216479,0.8322903629536921,0.9331473630963656,1.0,4/33,9.74%,SYK;ADAM9;SNAI2;PLAU
prerank,signal transduction by p53 class mediator (GO:0072331),-0.22411156717189534,-0.7449902350009978,0.8536585365853658,0.9677097140477959,1.0,9/30,16.95%,FHIT;STK11;MDM4;PPP1R13B;PYCARD;USP10;JMY;MYBBP1A;HINT1
prerank,positive regulation of cilium assembly (GO:0045724),-0.25382919942823773,-0.7447447389425682,0.844,0.9665795500393722,1.0,5/18,21.31%,ENTR1;MARK4;TAPT1;CEP135;KCTD17
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3062218035394779,0.7446674889702748,0.8124174372523117,0.9332324362648996,1.0,3/23,13.29%,ADGRG3;NLRC3;RELA
prerank,positive regulation of protein secretion (GO:0050714),0.26206469505534963,0.7446613428060365,0.8608017817371938,0.9328890867125945,1.0,13/69,15.41%,ABCG1;ADAM9;IGF1;ADAM8;IRS2;TRH;AACS;WLS;TREM2;APBB3;GOLPH3;GOLPH3L;NLGN2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.30304056544480656,0.7445319408807458,0.8,0.9327114361772009,1.0,3/24,10.59%,CD44;SNAI2;SIRT1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.2216311136397596,-0.744413706156252,0.8947368421052632,0.965614707726457,1.0,8/31,13.58%,TFDP2;BCL2;PPP1R13B;NMT1;HIP1R;BAD;YWHAG;YWHAH
prerank,regulation of gene silencing by RNA (GO:0060966),0.2673393838700725,0.7443660018396022,0.826945412311266,0.9322273975442795,1.0,15/50,22.97%,POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;NUP98;NUP88;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2673393838700725,0.7443660018396022,0.826945412311266,0.9322273975442795,1.0,15/50,22.97%,POLR2A;AGO2;POLR2L;TPR;POLR2G;NUP50;POLR2I;PUM2;NUP98;NUP88;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,contractile actin filament bundle assembly (GO:0030038),-0.2721386584201129,-0.7437370219189606,0.8306709265175719,0.9635735390244944,1.0,4/15,14.47%,SORBS1;PHACTR1;FHDC1;RHOA
prerank,stress fiber assembly (GO:0043149),-0.2721386584201129,-0.7437370219189606,0.8306709265175719,0.9635735390244944,1.0,4/15,14.47%,SORBS1;PHACTR1;FHDC1;RHOA
prerank,regulation of transposition (GO:0010528),0.3432383169313521,0.7435705390775155,0.8053097345132744,0.9328795699551875,1.0,2/13,12.83%,SMYD5;SIRT7
prerank,protein export from nucleus (GO:0006611),-0.23239217680019067,-0.7435336067974473,0.8820960698689956,0.9624056050537074,1.0,11/27,28.91%,SMURF1;NUP214;STRADB;PKD1;RANBP17;STRADA;CCHCR1;XPO6;TGFB1;XPO4;DUSP16
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24785676632906967,0.7433783882266015,0.880675818373812,0.9327733199160213,1.0,26/104,22.58%,CDKN1A;UVRAG;SLC8A1;GADD45A;PPEF2;INCENP;SLC27A1;RB1;SIRT1;CDK7;CCNA2;CNPPD1;LRP6;SNF8;MNAT1;CAMK1;CDC25A;HTT;CCNG1;PPP2CA;CALM2;CAB39;KSR1;GTPBP4;CCNT1;SYAP1
prerank,establishment of mitotic spindle localization (GO:0040001),0.29223907793479864,0.7432324552185721,0.82875,0.9325956594344629,1.0,6/28,18.60%,SPDL1;ITGB1;CLASP1;NDE1;PAFAH1B1;HTT
prerank,cilium assembly (GO:0060271),0.23294094222041686,0.7425266139182066,0.9678714859437751,0.9331242245565711,1.0,61/297,20.29%,MAK;RILPL2;RAB8B;PIBF1;SNX10;CFAP70;DYNC1H1;SNAP29;CCDC40;ATP6V0D1;KIF27;HAUS6;CENPJ;ASAP1;DNAAF3;ABCC4;WDPCP;CFAP20;FBF1;KIF3A;DYNC2I2;ACTR3;DYNLRB1;IFT46;CCDC66;TRIP11;TOGARAM1;CEP76;TNPO1;NOTCH1;CFAP410;CPLANE2;IFT52;CLASP1;OCRL;IFT140;CEP192;TUBA1A;SSX2IP;ARL3;NDE1;ALMS1;EXOC4;OFD1;CCP110;SSNA1;VANGL2;HAUS7;ARF4;EXOC7;EXOC1;BBS7;PAFAH1B1;ARL13B;TMEM231;CDC14B;RAB1A;BBS1;IFT88;TCTN1;PPP2R1A
prerank,catecholamine biosynthetic process (GO:0042423),-0.2967049122028229,-0.7423708233987343,0.8011695906432749,0.9625875731170411,1.0,4/11,36.20%,TGFB2;MOXD1;GATA3;DAO
prerank,positive regulation of hydrolase activity (GO:0051345),0.24310144268660158,0.7419181127971671,0.9001040582726326,0.9335106826979932,1.0,16/137,12.79%,PSAP;TGM2;RIC1;TBC1D2;SNX9;FLCN;DOCK10;ARAP1;CTSH;PICALM;ITGB1;MTCL1;GSK3B;BCAS3;WRN;RAPGEF1
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2543825954467461,0.7415660897765668,0.8651059085841695,0.9335991795636046,1.0,17/68,23.87%,BAAT;ENPP1;AMPD3;ACSM3;GLYAT;NT5C2;ACOT9;BPNT2;ADSS1;ACOT2;ACOT6;PDE9A;EPHA2;HPRT1;ACOT13;GNAI3;ACOT8
prerank,DNA packaging (GO:0006323),0.32544527448784294,0.7410989520078919,0.8197424892703863,0.933841238214062,1.0,8/16,30.44%,NAA10;NOC2L;PRM1;CDAN1;AIFM1;KAT6A;TP53;CHAF1B
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.27234803917772343,0.7397518637325202,0.8446601941747572,0.9351856430100072,1.0,9/42,20.00%,ERCC6;SIRT6;HELB;PPP4R2;RTEL1;ARID2;SHLD1;RADX;SHLD2
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.27769974636335454,0.7394520185396916,0.812958435207824,0.935216036353078,1.0,9/38,17.15%,NEDD9;NCK2;RAP2B;APP;GAS6;SHC1;PTPN1;ACE;SH3BP5
prerank,basement membrane organization (GO:0071711),-0.27853711158329664,-0.7382324693521567,0.8233438485804416,0.9666070374713542,1.0,7/14,25.12%,NTNG1;HPN;NTN4;NID2;FLRT2;LAMB2;LAMB1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3020961259118756,-0.7380929994161953,0.825136612021858,0.9653907174428662,1.0,2/10,12.45%,UPP2;NT5C
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.3269242002162796,0.7376815627517156,0.8045977011494253,0.9370588044956917,1.0,6/16,18.85%,DDX5;HNRNPM;PQBP1;RSRC1;PUF60;CDK13
prerank,DNA recombination (GO:0006310),-0.21405371875915835,-0.7375120477420153,0.9243243243243243,0.9647409350419265,1.0,18/37,33.44%,RHNO1;FBH1;RAD50;MSH3;RECQL;GEN1;RAD54B;RAD54L;RPA1;TSN;SUPV3L1;RAD51;HMGB3;LIG4;EXO1;ENDOG;XRCC3;DMC1
prerank,cardiac conduction system development (GO:0003161),0.2998818801021617,0.7373608056594457,0.8060109289617486,0.9370973802357516,1.0,2/24,5.35%,NOTCH2;MAML1
prerank,atrial septum morphogenesis (GO:0060413),0.3509695881515802,0.7370251336162257,0.7765625,0.9371576113925243,1.0,2/10,9.37%,NOTCH2;BMPR2
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.30363381971517445,0.7370115656740478,0.8300395256916996,0.9368233667031679,1.0,3/24,7.16%,RFC3;RPS27A;UBC
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.33723805593030887,0.7366473541277148,0.7960339943342776,0.9369045497837735,1.0,3/13,9.33%,TBC1D10A;NLRC4;CYFIP2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3411443801084959,0.7365534426347236,0.7981927710843374,0.936667347409233,1.0,2/11,15.64%,NCBP2;CDC73
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.28392414964502405,-0.7364443685318445,0.8074534161490683,0.9646961847258398,1.0,5/13,17.31%,FUT9;ETS1;ITGB2;RHOA;TNF
prerank,interstrand cross-link repair (GO:0036297),0.26144746922608264,0.736313907200242,0.8576349024110218,0.9366132039634508,1.0,9/53,15.99%,MUS81;MCM9;RPS27A;UBC;EME1;DCLRE1B;ERCC6L2;CENPX;FANCA
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.24189018495531436,-0.7362889156520879,0.8366533864541833,0.9634774875468115,1.0,11/21,38.35%,BMPR1A;TGFBR1;DAB2;SMAD4;TGFB1;FAM89B;BMP4;TGFB3;SH2B1;NUP93;VEPH1
prerank,response to purine-containing compound (GO:0014074),0.32567702805043397,0.7362406539167866,0.8,0.9363612154970736,1.0,3/17,13.22%,P2RX4;TRPC3;DGKQ
prerank,mitochondrial membrane organization (GO:0007006),-0.21881866409550732,-0.73610764609169,0.9226804123711341,0.9622927055902033,1.0,9/32,20.37%,SLC25A4;BCL2;MFN1;BAD;SAMM50;CHCHD6;RCC1L;CHCHD3;TIMM50
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.22182243167646346,-0.7360898168831913,0.9166666666666666,0.9609059831812892,1.0,13/29,36.40%,FANCD2;ZCWPW1;IHO1;TERB1;STAG3;TRIP13;PRDM9;SYCE2;TEX11;MAJIN;REC8;HORMAD1;BAG6
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.31893911912762557,0.7360707860659863,0.803921568627451,0.9362202985832335,1.0,1/17,3.06%,CD46
prerank,regulation of interleukin-2 production (GO:0032663),0.2699700731432576,0.7348911930393229,0.8532863849765259,0.9373029868373387,1.0,4/43,4.59%,ANXA1;FOXP3;CD28;HOMER3
prerank,bicarbonate transport (GO:0015701),0.2962817140920611,0.7344517776879649,0.8130081300813008,0.9374795508335153,1.0,5/25,18.30%,AQP1;CYB5R4;CA2;CYB5R2;CYB5R1
prerank,regulation of axon regeneration (GO:0048679),-0.28777654033413586,-0.7344470472345054,0.8228228228228228,0.961623165233701,1.0,1/12,0.30%,RTN4RL1
prerank,negative regulation of macrophage activation (GO:0043031),0.320215411904876,0.7341551580975321,0.7977044476327116,0.9374784610427075,1.0,5/16,21.01%,NR1H3;CX3CL1;GRN;FCGR2B;PTPRC
prerank,establishment of apical/basal cell polarity (GO:0035089),0.32196821036927614,0.734042096266187,0.7928464977645305,0.9372790853194317,1.0,2/14,7.73%,RAP2A;MSN
prerank,negative regulation of calcium ion transport (GO:0051926),0.33578187880862476,0.7339098299138667,0.7857142857142857,0.9370787019469561,1.0,1/15,1.46%,LILRB1
prerank,sensory perception of smell (GO:0007608),0.35490052253680293,0.7332715805397053,0.794251134644478,0.9375125884370834,1.0,3/11,22.21%,ADCY3;DRD2;UBR3
prerank,regulation of dopamine secretion (GO:0014059),0.2942056458488132,0.7319376805446846,0.8267195767195767,0.9388278062222243,1.0,4/25,14.14%,DTNBP1;SYT17;PRKN;GDNF
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.3175285332100567,0.7319070441209395,0.7888111888111888,0.9385088137437587,1.0,1/16,2.51%,VIM
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.330153246179391,0.7314134808055325,0.7943786982248521,0.9387649409447152,1.0,1/13,3.19%,NIBAN2
prerank,lysine metabolic process (GO:0006553),0.34466072803251335,0.7310253522833164,0.8133333333333334,0.9385128659149157,1.0,3/12,16.77%,GCDH;OGDH;ALDH7A1
prerank,lysine catabolic process (GO:0006554),0.34466072803251335,0.7310253522833164,0.8133333333333334,0.9385128659149157,1.0,3/12,16.77%,GCDH;OGDH;ALDH7A1
prerank,regulation of transmembrane transport (GO:0034762),0.2818712369347395,0.7300190564703664,0.8260325406758448,0.9393771734629964,1.0,5/31,12.32%,PIM1;NEDD4L;WWP2;PRKCB;SLC2A1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.29011949340162013,-0.7296863204308622,0.8440366972477065,0.9661260758650424,1.0,2/11,9.18%,IL6ST;STAT1
prerank,negative regulation of lyase activity (GO:0051350),-0.26656077713506987,-0.7294099358398763,0.8435374149659864,0.9650820072876543,1.0,5/16,15.79%,GRM3;EDNRB;ADGRV1;AKAP5;CCR2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.22033193468306678,-0.7288077574913506,0.9047619047619048,0.9644311005196645,1.0,4/30,12.72%,CSF1R;FLT3;PLD4;UFL1
prerank,regulation of spindle organization (GO:0090224),0.3113000303064781,0.7287322963283205,0.8192934782608695,0.9405949387529124,1.0,2/18,6.70%,DYNC1H1;PARP3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.2813373246590271,0.7282703084337891,0.8405612244897959,0.9408009998806646,1.0,8/33,24.45%,ID2;RIPK1;FES;HCLS1;ACIN1;TRAF6;HAX1;CASP8
prerank,hemopoiesis (GO:0030097),0.246529972902731,0.7280662300967663,0.8948497854077253,0.9406826512621975,1.0,25/87,22.18%,RUNX2;ZNF160;RUNX3;NOTCH2;MELK;FLCN;ATF4;ZFP36L2;ETV6;HIPK1;TET2;ARIH2;RRAS;PRRC2C;TEK;NCOA6;GLRX5;CDK13;KMT2A;MKNK2;ZBTB16;PTPRC;CEBPA;SNRK;TIRAP
prerank,growth hormone receptor signaling pathway (GO:0060396),0.32548979140950407,0.7274853782779322,0.8022922636103151,0.9410006676648034,1.0,6/14,22.88%,STAT5B;JAK3;PTPN1;STAT6;STAT3;JAK2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.30216115345451666,-0.726888880717573,0.8147058823529412,0.9653873295590863,1.0,1/10,5.48%,FMR1
prerank,negative regulation of neuron differentiation (GO:0045665),0.30489491346576153,0.726884115550977,0.8161073825503355,0.9413852462855427,1.0,6/22,22.26%,EIF2AK4;GSK3B;SOX2;DTX1;HES5;DISP3
prerank,tRNA processing (GO:0008033),0.254839190857692,0.7263511774144422,0.8704954954954955,0.9416482701519788,1.0,5/61,4.19%,DTWD1;FARS2;CPSF1;LCMT2;TRDMT1
prerank,tight junction assembly (GO:0120192),0.26327929822413804,0.7261256616754624,0.8668981481481481,0.9415639242999844,1.0,12/49,25.41%,MICALL2;APC;PDCD6IP;STRN;PAK2;PARD6A;RAB13;ACTG1;FRMPD2;CDH5;AFDN;TBCD
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.2949238238621506,0.7258928379147126,0.8340306834030683,0.9414880776735813,1.0,1/24,0.48%,APLNR
prerank,peripheral nervous system development (GO:0007422),0.2999885416566157,0.7258290762161159,0.8350649350649351,0.9412190880989181,1.0,7/23,26.24%,ARTN;ALDH3A2;PMP22;GDNF;SOX8;EGR2;ADGRG6
prerank,ephrin receptor signaling pathway (GO:0048013),0.24515898828892915,0.7257857654720887,0.8925438596491229,0.9409142787730806,1.0,21/82,24.06%,SDCBP;VAV3;NCK2;ARPC2;ANKS1B;ACTR3;ROCK1;AP2B1;NCSTN;WASL;ARPC1A;ITSN1;ARPC4;ACTG1;EPHA2;EPHA4;ARPC5;APH1B;PSEN2;HRAS;AP2S1
prerank,negative regulation of DNA replication (GO:0008156),0.33139606144446027,0.7256099736533632,0.7978560490045942,0.9407839825024084,1.0,5/13,22.54%,TERF1;PDS5A;GTPBP4;CDAN1;WAPL
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.31534371095483704,0.7254253362231173,0.8212290502793296,0.940638466879983,1.0,1/17,2.82%,NR1H3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.33524524925512444,0.7253115408158826,0.8028985507246377,0.9404302863140199,1.0,1/12,3.31%,MUS81
prerank,coenzyme A biosynthetic process (GO:0015937),-0.2906241981717489,-0.7250168067912216,0.833810888252149,0.9634224907951026,1.0,2/11,5.58%,PANK3;ACOT7
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.2906241981717489,-0.7250168067912216,0.833810888252149,0.9634224907951026,1.0,2/11,5.58%,PANK3;ACOT7
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.2906241981717489,-0.7250168067912216,0.833810888252149,0.9634224907951026,1.0,2/11,5.58%,PANK3;ACOT7
prerank,amino acid import (GO:0043090),0.30197635989377486,0.724777688013194,0.8340136054421768,0.9407185189989197,1.0,1/21,0.69%,SLC6A6
prerank,positive regulation of cellular senescence (GO:2000774),0.352560378799535,0.7247453970447747,0.8151658767772512,0.9404010744582098,1.0,2/10,10.59%,ARG2;SIRT1
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.25237946639164055,-0.7238281780617372,0.8937728937728938,0.9634311146833977,1.0,6/17,22.27%,VIRMA;RNF20;CDK9;CPEB3;NUDT21;HSF1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.34378760853460844,0.7235719095816374,0.8144654088050315,0.9414587473320085,1.0,2/11,10.59%,ANXA1;SIRT1
prerank,chemokine-mediated signaling pathway (GO:0070098),-0.2018023501551286,-0.7233014329038671,0.9473684210526315,0.9626467954296049,1.0,11/42,26.38%,SH2B3;CCL4;WNK1;CCR2;CCR1;CIB1;CCL3;CCL14;FOXC1;CCL5;GPR75
prerank,L-serine metabolic process (GO:0006563),0.3499789461022657,0.7229740725948332,0.8047244094488188,0.9417856438527052,1.0,1/10,2.26%,PHGDH
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.26689243939382823,0.7225419840850363,0.8811524609843937,0.9419602408996429,1.0,7/46,11.32%,TNIP1;PTEN;DUSP3;FLCN;CNKSR3;SIRPA;FBLN1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),0.2703024640012582,0.7220298205626019,0.8555691554467564,0.9422152918050618,1.0,14/41,22.97%,PRKAG2;EIF6;TPR;NUP50;NUP98;ZBTB7A;NUP88;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,body fluid secretion (GO:0007589),0.320236309968301,0.7216872938259788,0.8171428571428572,0.9422743058041037,1.0,1/15,1.73%,VEGFA
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.2566870066147461,0.7211659157449649,0.8660508083140878,0.9424840193103975,1.0,8/56,10.11%,BIN3;SNX9;APC;INCENP;PDCD6IP;VPS4A;SNX33;ROCK1
prerank,presynaptic endocytosis (GO:0140238),0.2893195509085074,0.7209950998260172,0.833116036505867,0.9423227720532457,1.0,7/24,20.28%,CEL;SNCG;STON1;NLGN2;FCHO2;SYNJ2;VAMP2
prerank,regulation of lipid catabolic process (GO:0050994),-0.2373066761040648,-0.7207622301077923,0.8881118881118881,0.9642607938417397,1.0,6/19,23.87%,PDE3B;APOC1;TNF;ANGPTL3;IL1B;ADRA2A
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.26004624964370127,0.7202513167141693,0.8571428571428571,0.9428724729635268,1.0,5/47,10.58%,RAP2A;TAOK3;FAS;COPS5;FOXO1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.3470236889144738,0.7201303615531792,0.8114874815905744,0.9426707935903456,1.0,3/10,22.16%,NUFIP1;SHQ1;RUVBL2
prerank,dendritic cell differentiation (GO:0097028),0.2963396147022252,0.7198787273819723,0.8113975576662144,0.942608351700612,1.0,3/22,13.36%,LILRB1;TREM2;GAS6
prerank,toxin transport (GO:1901998),0.34595853368037344,0.7196730132956938,0.8170731707317073,0.9424808181464097,1.0,3/10,21.30%,ANTXR2;RAB29;ADAM10
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.303501356465717,0.7193876393959413,0.8147632311977716,0.942453905359624,1.0,4/19,17.57%,VEGFA;ROCK1;NRP1;TEK
prerank,regulation of microtubule-based process (GO:0032886),0.2738466289343903,0.7186243503272737,0.841978287092883,0.9429690460380257,1.0,7/36,13.74%,DIAPH1;APC;ROCK1;GSK3B;CDK2AP2;MACF1;CLASP1
prerank,endodermal cell fate commitment (GO:0001711),0.3413908823250448,0.7184835473898186,0.7901049475262368,0.9427916749425633,1.0,2/10,15.64%,SOX2;CDC73
prerank,regulation of immunoglobulin production (GO:0002637),0.2899512424781183,0.7183384111399722,0.8352490421455939,0.9426296492181975,1.0,5/23,21.01%,IL6;CD22;VAMP3;FCGR2B;PTPRC
prerank,chromatin assembly or disassembly (GO:0006333),0.33671283679585207,0.7183167109444458,0.8269525267993875,0.9423046286104284,1.0,4/11,21.66%,SUV39H2;NOC2L;HDAC8;CDAN1
prerank,RNA modification (GO:0009451),0.25393338077769934,0.7179764750345929,0.8661233993015134,0.9423249603624138,1.0,11/54,17.02%,DTWD1;LCMT2;TRDMT1;NSUN3;NAT10;CTU2;MEPCE;MRM2;TSR3;ADARB1;ALKBH1
prerank,antibacterial humoral response (GO:0019731),0.3127206298315864,0.7174310446558507,0.8163841807909604,0.9426081954531845,1.0,3/16,17.91%,RNASE3;SLPI;DEFA6
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.31370617773594234,0.7173677732414615,0.8227146814404432,0.9423306373248577,1.0,4/16,15.66%,DDX5;NCOA4;ESR1;PPARGC1B
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.30643731865584756,0.7170308540203217,0.8181818181818182,0.9423509370193744,1.0,4/19,13.27%,HIPK1;HIPK2;SIRT1;DYRK2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.27357034603576336,-0.716854386459868,0.8369565217391305,0.9674190440555895,1.0,8/14,27.35%,ENTPD5;NUDT5;ENTPD6;ENTPD7;NUDT16;NUDT1;ENTPD3;NUDT18
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.30518674501867615,0.7167353126929478,0.8411602209944752,0.9423401011230945,1.0,4/18,16.31%,IL6;RB1;CLASP1;MELTF
prerank,regulation of proteolysis (GO:0030162),0.2610526259608197,0.7165154430001802,0.8834498834498834,0.9422613641450781,1.0,14/48,24.54%,CLN3;FGFR4;TBC1D10A;CYFIP2;STUB1;TRAF3;PARL;AURKAIP1;SPOP;OGT;GSAP;PLAUR;CASP8;DNAJC1
prerank,negative regulation of glycolytic process (GO:0045820),0.344272772124441,0.7164676373028046,0.8119122257053292,0.9416188146343627,1.0,1/10,4.34%,NCOR1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.344272772124441,0.7164676373028046,0.8119122257053292,0.9416188146343627,1.0,1/10,4.34%,NCOR1
prerank,GTP metabolic process (GO:0046039),-0.26371693884358977,-0.7163836215581347,0.8689024390243902,0.9665432120607682,1.0,7/15,31.26%,GTPBP1;RAB23;MFN1;ENTPD7;EFL1;IMPDH1;AK4
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.3461459635212922,0.7163295139331562,0.7817896389324961,0.9410840379428433,1.0,4/10,19.06%,PRKCD;SPHK2;SIRT3;NSMAF
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.3461459635212922,0.7163295139331562,0.7817896389324961,0.9410840379428433,1.0,4/10,19.06%,PRKCD;SPHK2;SIRT3;NSMAF
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2842190625246091,-0.7161830070674231,0.8525073746312685,0.9653770092844811,1.0,7/12,32.62%,PRKCA;VRK1;CNEP1R1;CDK1;CCNB2;PLK1;LPIN1
prerank,chromosome organization (GO:0051276),0.24145810643284712,0.7160755212107905,0.9154929577464789,0.9410320364005339,1.0,25/99,22.66%,GPS1;DOT1L;RPS27A;UBC;COPS5;SETD7;DDB1;SIRT1;CUL4A;COPS7A;SOX2;LATS1;BRWD1;CDT1;ZBTB7A;HDAC8;TCF7L2;PHF1;CUL4B;SAFB;XPC;CDAN1;HMG20A;MTF2;SUPT4H1
prerank,mRNA destabilization (GO:0061157),0.26877261335118047,0.7156127637541777,0.85375,0.9412117419798834,1.0,5/38,10.56%,CELF1;YTHDF3;ZFP36L2;ROCK1;FTO
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.33540050495881485,0.7152987734848015,0.8241590214067278,0.9412134652377339,1.0,1/11,2.99%,HGF
prerank,protein K63-linked deubiquitination (GO:0070536),0.2763995151239132,0.7152467690743093,0.8642765685019206,0.9409250571749125,1.0,9/31,19.37%,BABAM2;PSMD14;USP16;TNFAIP3;BRCC3;USP8;OTUD5;STAMBP;ATXN3
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.23293530894320835,-0.7148800381845082,0.8917910447761194,0.9640658845064565,1.0,9/21,24.65%,GTF2H2;DDB2;PARP1;ERCC5;XPA;RPA3;GTF2H4;RPA1;ERCC2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.23293530894320835,-0.7148800381845082,0.8917910447761194,0.9640658845064565,1.0,9/21,24.65%,GTF2H2;DDB2;PARP1;ERCC5;XPA;RPA3;GTF2H4;RPA1;ERCC2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.2590722480860754,0.7144233109965266,0.8909730363423212,0.9414986127457237,1.0,14/48,23.46%,NEDD9;DOCK5;TRIOBP;RREB1;CUX1;OLFM4;DOCK1;NRP1;CAPRIN1;C1QBP;CDKL5;PRKDC;ILK;FLNA
prerank,regulation of catabolic process (GO:0009894),-0.24841106486611242,-0.7129665579595434,0.8540925266903915,0.9649214055353414,1.0,4/18,13.19%,HPGD;CENATAC;CHEK2;ODC1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.27595043537562275,0.7127831100878466,0.8475452196382429,0.9430530057080047,1.0,11/29,30.22%,CTNNB1;CREBBP;CDC73;TCF7L2;TLE3;MEN1;HDAC1;KMT2D;SMARCA4;EP300;TLE4
prerank,Rho protein signal transduction (GO:0007266),0.25437604619037885,0.7126256816057656,0.8882421420256111,0.9428802402823144,1.0,9/53,14.39%,RHOJ;MYO9B;GNA13;GNA12;ROCK1;RHOD;CFL1;PHACTR4;CELSR1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2724633389156464,0.7115632368029687,0.8729763387297634,0.9437330879720071,1.0,7/31,22.94%,MOCOS;LIAS;DHRS11;GCH1;NFS1;SRD5A1;SCP2
prerank,negative regulation of metabolic process (GO:0009892),0.2523964023578767,0.7111245658487458,0.8803222094361335,0.943866411653866,1.0,16/54,22.84%,NR1H3;FLCN;ATF4;RB1;DDIT3;ADAM17;NOTCH1;IL15;PLCL2;LAMA4;LNPEP;RHEB;ARRDC3;NR1H2;TLE3;ACOT13
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.3074098541069846,0.7110387027031404,0.8045977011494253,0.9436184286261566,1.0,6/16,28.44%,ZFP36L2;PLEKHN1;ZC3H12D;ZFP36;RC3H1;ZFP36L1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.27809094830947545,-0.7108669067652167,0.8469387755102041,0.9658193797286064,1.0,4/13,13.30%,NR3C2;PLPP1;PGR;AR
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.21162724588105952,-0.7102650702751231,0.9137931034482759,0.9650852885818741,1.0,8/28,25.92%,TNFRSF1A;BCL2;DAB2IP;DEDD;TNF;DIABLO;DELE1;DDX3X
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.29699977170161496,0.7093391882317414,0.837465564738292,0.9447892929260928,1.0,3/20,11.47%,IGF1;ZBTB20;APP
prerank,positive regulation of glycolytic process (GO:0045821),0.29699977170161496,0.7093391882317414,0.837465564738292,0.9447892929260928,1.0,3/20,11.47%,IGF1;ZBTB20;APP
prerank,B cell proliferation (GO:0042100),-0.2444010109112979,-0.7090966208596428,0.8664495114006515,0.9650095346599822,1.0,2/17,7.48%,MEF2C;BCL2
prerank,lipid droplet formation (GO:0140042),-0.2883243737617478,-0.7084279704530254,0.828080229226361,0.9644255899688058,1.0,2/10,12.01%,CDS1;SQLE
prerank,regulation of endopeptidase activity (GO:0052548),0.2514224271626229,0.7081059390818767,0.8998875140607424,0.9458027546240136,1.0,13/59,22.88%,TIMP1;TIMP2;PICALM;BIRC3;SERPINB8;SERPINC1;PSME2;NCSTN;BIRC2;PSMA3;APH1B;FURIN;PSME3
prerank,cristae formation (GO:0042407),-0.2228677553913255,-0.7078162516159384,0.9330357142857143,0.9637310549659022,1.0,12/27,26.56%,ATP5PO;DMAC2L;ATP5F1E;SAMM50;ATP5PF;ATP5MC3;CHCHD6;CHCHD3;ATP5ME;UQCC3;ATP5F1B;ATP5MG
prerank,maintenance of protein localization in organelle (GO:0072595),0.2980550326086275,0.7074074966564098,0.8270571827057183,0.9462279151577234,1.0,6/19,23.94%,HNRNPU;TOPORS;SUPT7L;BCL3;TAF8;HK1
prerank,positive regulation of cellular respiration (GO:1901857),0.33784165604694677,0.7072288503414431,0.8151515151515152,0.9460759686812147,1.0,3/11,22.13%,IL10RB;IFNAR1;VCP
prerank,mitotic nuclear membrane organization (GO:0101024),0.2538602621405727,0.7071161350465536,0.8971098265895954,0.9455077508457854,1.0,14/51,21.70%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2538602621405727,0.7071161350465536,0.8971098265895954,0.9455077508457854,1.0,14/51,21.70%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,cytoplasmic translational initiation (GO:0002183),0.3025889754324085,0.707032196900569,0.8542234332425068,0.9452621509098388,1.0,3/17,9.69%,EIF3A;EIF4A1;EIF5
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.33269052696683293,0.7068976083077555,0.8430769230769231,0.9450588640920292,1.0,5/11,27.56%,TERF1;DKC1;CCT2;CCT7;WRAP53
prerank,regulation of plasminogen activation (GO:0010755),0.330978683231453,0.7064335553903107,0.8243451463790447,0.9452366715930158,1.0,3/12,16.31%,THBS1;CTSZ;MELTF
prerank,limb development (GO:0060173),0.2829258860494082,0.7062918206712061,0.8644295302013423,0.9450335424012378,1.0,2/28,5.26%,MAP3K20;ZNRF3
prerank,SNARE complex assembly (GO:0035493),0.3351221221656963,0.7053503750947189,0.8254211332312404,0.9457174090069899,1.0,3/10,20.28%,UVRAG;VAMP3;VAMP2
prerank,tRNA modification (GO:0006400),0.24611858148928695,0.7044881588545517,0.9024390243902439,0.9462952204881782,1.0,11/62,17.02%,TRMT12;DTWD1;LCMT2;TRDMT1;OSGEP;TRMT44;CTU2;DUS2;GTPBP3;ALKBH8;ALKBH1
prerank,mitochondrion localization (GO:0051646),0.2995953442254786,0.702843194743042,0.8491847826086957,0.9477411631466454,1.0,1/19,0.94%,MTM1
prerank,non-motile cilium assembly (GO:1905515),-0.20573134839610666,-0.7023559068766653,0.9227467811158798,0.9681284960211204,1.0,12/30,26.78%,DISC1;RPGRIP1L;CSNK1D;GORAB;IFT57;TMEM216;CEP290;TMEM80;BBS10;TTC8;DCTN1;C2CD3
prerank,establishment of endothelial barrier (GO:0061028),0.2770010238705954,0.7021294049007539,0.8669154228855721,0.9481845592520334,1.0,9/29,24.83%,RAB1B;MSN;RAP2B;RAPGEF1;RAB1A;PDE4D;EZR;AFDN;RAP2C
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.28840685147148143,0.7020221335695986,0.8620236530880421,0.9479537094468916,1.0,6/23,18.02%,HOOK3;TUBA1A;TUBA1C;CCDC88C;KIF5B;KIF5C
prerank,negative regulation of peptidase activity (GO:0010466),0.25532296003873556,0.7018800323876487,0.8838028169014085,0.9477466589471311,1.0,5/47,14.37%,TIMP1;LRP1;TIMP2;SERPINB8;SERPINC1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.2636455992647327,0.7015268062761983,0.8854679802955665,0.9477767353822778,1.0,4/39,6.44%,ZMIZ1;MAML1;MAML2;CREBBP
prerank,protein import into peroxisome matrix (GO:0016558),0.3252942334531723,0.7008669455827488,0.841715976331361,0.948184989380242,1.0,2/12,6.94%,PEX7;PEX14
prerank,protein localization to cilium (GO:0061512),0.2712682055449349,0.700141564883334,0.8632911392405064,0.9486446536461993,1.0,7/32,20.23%,SNX10;RABEP1;IFT140;ARL3;RAB29;BBS1;TCTN1
prerank,sensory perception of sound (GO:0007605),0.23712930144654132,0.6997641958960511,0.9128094725511302,0.9487043351384941,1.0,9/88,11.94%,EYA1;LOXHD1;COL1A1;NIPBL;SNAI2;WDR1;COL11A1;LHFPL3;ROR1
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.2892579417322708,0.6996372638181403,0.8498694516971279,0.9484902741334483,1.0,6/23,20.59%,PRKAG2;UBE2K;APP;CALM2;CAB39;TNKS1BP1
prerank,positive regulation of ion transport (GO:0043270),0.2553633845755493,0.6994886128211473,0.8994152046783626,0.948294334146834,1.0,9/48,14.14%,ANO6;ATP2B1;P2RX4;GPD1L;CNKSR3;MYLK;CRACR2A;PRSS8;GDNF
prerank,regulation of chromosome organization (GO:0033044),0.2844957536818732,0.6992533428982421,0.871191135734072,0.9482107801045886,1.0,8/22,24.25%,RB1;XRCC5;SHCBP1L;HNRNPD;CDT1;HDAC8;WAPL;TERF2IP
prerank,regulation of cilium movement (GO:0003352),0.33196853446264685,0.6988606101513568,0.7996820349761526,0.9482978351383976,1.0,1/10,3.81%,CCDC40
prerank,autophagy of nucleus (GO:0044804),0.3058265200273208,0.6987157908859651,0.8466947960618847,0.9481100296182972,1.0,3/16,12.98%,ATG7;ATG5;ATG13
prerank,regulation of cell killing (GO:0031341),0.30740948526973516,0.6984942167207493,0.8284883720930233,0.947984400907661,1.0,2/16,9.79%,CYBA;FZD7
prerank,nucleoside catabolic process (GO:0009164),0.32654024587357144,0.6984583267903456,0.808446455505279,0.9476780395114918,1.0,2/11,9.82%,NT5E;DERA
prerank,negative regulation of bone mineralization (GO:0030502),0.31815187139871465,0.6981320230950301,0.8158682634730539,0.9476927087388957,1.0,2/13,10.35%,ENPP1;PTK2B
prerank,secondary alcohol biosynthetic process (GO:1902653),0.2712454327379133,0.6980988967850873,0.8573216520650814,0.9473814483793651,1.0,8/30,20.50%,MVD;PLPP6;IDI1;INSIG2;PMVK;ACAA2;HMGCR;ARV1
prerank,atrial septum development (GO:0003283),0.3159673566677563,0.6974947295113435,0.8550074738415545,0.9477141781802582,1.0,2/13,9.37%,NOTCH2;BMPR2
prerank,sensory perception of pain (GO:0019233),0.28738872041602587,0.697262800598352,0.8492957746478873,0.9476072002420426,1.0,7/21,29.73%,P2RX4;KCNK4;RETREG1;OPRK1;CCL2;PTGES;KCNA2
prerank,heterochromatin organization (GO:0070828),0.31732583789832436,0.6968425222472046,0.8652694610778443,0.947735989467056,1.0,5/14,27.84%,SETD7;SIRT1;PRDM16;POLE3;HP1BP3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.2879244350506529,0.6967111650358714,0.8365122615803815,0.9475366286642644,1.0,4/20,21.12%,LCP1;ROCK1;RAB13;FMNL2
prerank,extracellular matrix assembly (GO:0085029),0.2823866127399852,0.6963123565565672,0.8594164456233422,0.9476191407833064,1.0,5/23,15.41%,HAS3;QSOX1;MFAP4;GAS6;ATP7A
prerank,positive regulation of hormone secretion (GO:0046887),0.29796586058368213,0.6961439827564274,0.8395061728395061,0.9474385924915149,1.0,1/17,2.67%,SPP1
prerank,regulation of neuron projection arborization (GO:0150011),-0.253025485307287,-0.6959307394884929,0.9183006535947712,0.9734585340963182,1.0,2/15,5.80%,NTNG1;MAP3K13
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.3160662218165236,0.6957395191821285,0.8281938325991189,0.9475221975639515,1.0,2/13,9.43%,PCID2;TPR
prerank,positive regulation of interleukin-2 production (GO:0032743),0.27779157886748657,0.695534363917631,0.8690012970168612,0.9474036087708797,1.0,2/25,3.00%,ANXA1;CD28
prerank,UV protection (GO:0009650),0.336715849858457,0.694671317945761,0.8368580060422961,0.9479642222746909,1.0,2/10,12.80%,CAT;MFAP4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.2867274342333003,0.6943100877113951,0.8658854166666666,0.9479958412147521,1.0,8/22,24.19%,ATF4;IPPK;PWP1;SMARCB1;UTP15;NCL;WDR43;LYAR
prerank,regulation of neurotransmitter secretion (GO:0046928),0.26500305757704495,0.6941865845021006,0.8930348258706468,0.9477890814018972,1.0,5/32,13.04%,DTNBP1;RIMS4;GSK3B;SYN1;MCTP1
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2676474522298132,0.6940416995090517,0.8595360824742269,0.9475921353819344,1.0,1/31,0.68%,SYK
prerank,ubiquinone metabolic process (GO:0006743),0.30589107274301575,0.6934457641144974,0.8465909090909091,0.9478531203500005,1.0,2/15,5.94%,COQ7;AIFM2
prerank,negative regulation of transferase activity (GO:0051348),0.27342157421077556,0.692281412456334,0.8681462140992167,0.9487420356909508,1.0,13/28,29.72%,IRS2;HNRNPU;TERF1;GSK3B;NPRL2;FBXO5;CERS1;ERCC4;MEN1;ZFP36;SRC;TP53;GSK3A
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.3105964935673737,0.6916660673684074,0.8391812865497076,0.9490005616126173,1.0,1/14,1.91%,ERCC6
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2817410679732348,0.6916176825413776,0.8454301075268817,0.9487114102329973,1.0,4/23,17.64%,TGM2;ATF4;PRKN;GABPA
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2648580601461661,0.6910782444262881,0.8816793893129771,0.9489248643406862,1.0,12/35,25.12%,CD300A;STYXL1;BOD1;GSK3B;HTT;CALM2;PPP6R1;FKBP1A;PPP1R12A;PPP1R15B;PDGFRB;PPP6R3
prerank,positive regulation by host of viral transcription (GO:0043923),0.3051980649846777,0.6910731062860036,0.85997171145686,0.9485899551528921,1.0,4/15,21.95%,JUN;CTDP1;SMARCB1;CCNT1
prerank,regulation of nervous system development (GO:0051960),0.26200401524727046,0.6908186072296599,0.8858560794044665,0.9485044509318528,1.0,3/37,6.45%,CTNNB1;TNFRSF1B;BHLHE40
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.22374620279144203,-0.6905507101815238,0.9055793991416309,0.9772289509541976,1.0,6/24,20.26%,NUMB;ITGB1BP1;GDI1;PPP2R5A;DAB2;ABI3
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2503155928040192,0.6899995744187144,0.9223416965352449,0.9490027761407567,1.0,17/50,21.50%,HSPA1B;SIRT7;N4BP1;TNFAIP3;HSPA1A;SQSTM1;ARRB1;PRKCG;CRY1;PRR7;GNL3L;FBXO5;DNAJA1;HDAC8;OGT;TAF1;GTPBP4
prerank,dendritic spine organization (GO:0097061),0.2703569034096006,0.6898727256853757,0.8711734693877551,0.9488019554195032,1.0,5/26,15.07%,PTEN;DOCK10;TREM2;ITGA3;WASL
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.31520359389327435,0.6887532963083162,0.8368263473053892,0.9496283423539342,1.0,2/12,15.56%,KDELR2;INSIG2
prerank,regulation of peptidase activity (GO:0052547),-0.2326391168665197,-0.6879412495344275,0.9372549019607843,0.9783974229072806,1.0,3/19,12.18%,CST3;CST7;SVBP
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.3268917155180931,0.6876041879288317,0.8350668647845468,0.9504837551461983,1.0,5/11,24.83%,RAB1B;RAP2B;RAB1A;AFDN;RAP2C
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.32966847270911476,0.6872365370044864,0.8451127819548873,0.9501552532195273,1.0,4/11,22.24%,SRI;CALM2;GSTO1;FKBP1A
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.32966847270911476,0.6872365370044864,0.8451127819548873,0.9501552532195273,1.0,4/11,22.24%,SRI;CALM2;GSTO1;FKBP1A
prerank,chromatin assembly (GO:0031497),-0.20016181225935573,-0.6868774148934297,0.956989247311828,0.9780097694087496,1.0,19/38,34.35%,RSF1;CTCF;NAP1L1;PAF1;NAA60;RBBP4;SOX9;NPM1;ATRX;H1-0;ASF1A;PRDM9;NAP1L4;LIN54;SPTY2D1;CHAF1A;SART3;EZH1;SMARCA5
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.250967915979597,0.6864965801015015,0.8912529550827423,0.9505450265976234,1.0,15/48,22.97%,PRKAG2;EIF6;TPR;NUP50;NUP98;ZBTB7A;NUP88;PRDM16;GCK;OGT;NUP188;NDC1;NUP43;NUP54;RANBP2
prerank,primary neural tube formation (GO:0014020),0.27247662965462766,0.6858578115346555,0.8676092544987146,0.9508472674430319,1.0,13/30,30.36%,DLC1;MTHFD1L;PHACTR4;CELSR1;LRP6;VANGL2;LRP2;BCL10;PLXNB2;SKI;DEAF1;MTHFR;LMO4
prerank,negative regulation of histone methylation (GO:0031061),0.331590432427037,0.6851207101144239,0.8591549295774648,0.9512320780085698,1.0,4/10,22.24%,BRCA1;DNMT1;PHF1;MTF2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.28192317082031926,0.6846846968214834,0.8646517739816032,0.9513136634334228,1.0,6/21,23.07%,ADCY7;ADCY8;ADCY3;NPR2;ADCY5;ADCY9
prerank,positive regulation of dendritic spine development (GO:0060999),0.2877494380412519,0.6845764224082111,0.8643835616438356,0.9510738838753996,1.0,1/20,0.58%,APOE
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.2554807310309328,0.6845307118740337,0.9019370460048426,0.9507740989059004,1.0,8/39,17.37%,CTNNB1;VEGFA;COL4A1;PAX8;GDNF;LRP6;NRP1;NKX2-1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.252229919165375,0.6843424300458647,0.8854041013268998,0.9506214118796769,1.0,12/40,21.12%,PRKCD;POLH;SIRT7;BCLAF1;MCL1;NSMCE4A;SMYD2;CRY1;UBE2V1;RADX;FBXO5;NPAS2
prerank,outer dynein arm assembly (GO:0036158),-0.24386476418088593,-0.6842935929537519,0.8951048951048951,0.9792029341608832,1.0,9/15,39.45%,DNAH8;LRRC49;DNAAF5;ODAD2;ODAD4;DNAL1;ODAD3;DNAH17;DNAAF1
prerank,"phagocytosis, engulfment (GO:0006911)",0.2559531997238014,0.6834032072133304,0.897908979089791,0.9512015115436342,1.0,2/36,5.58%,CD36;THBS1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.2562956376176375,-0.6825108465095523,0.8859649122807017,0.979508630731759,1.0,11/14,49.07%,ECE1;ENPEP;RASL10B;AVPR2;ACE2;OXTR;EDN3;EDN2;AVPR1A;AGTR1;EDN1
prerank,response to light stimulus (GO:0009416),0.24570824753665993,0.6819298922785508,0.9213615023474179,0.952300082203087,1.0,14/55,24.63%,ERCC6;DCT;ZRANB3;MAP4K3;FECH;CRY1;CLOCK;DRD2;POLD1;SPRTN;UBE4B;ERCC4;MEN1;PRIMPOL
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.2693668842689963,-0.6816578892965373,0.8721590909090909,0.9789406935835312,1.0,4/12,21.07%,TRPM4;PLA2G6;C2CD2L;STX4
prerank,regulation of cellular protein localization (GO:1903827),0.25243841136747763,0.6804698571311986,0.8951707891637221,0.9534063458796574,1.0,8/45,12.95%,CTNNB1;LCP1;KCNAB2;ABCA2;DVL1;VCPIP1;CCDC66;RAB11B
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.26555653652416805,-0.6793255647787487,0.8524096385542169,0.9797484252844254,1.0,7/12,38.29%,PLCB1;NBL1;BMP5;GREM1;DUSP1;SLIT2;ADTRP
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.2649470064001269,-0.6791442948237313,0.8495297805642633,0.9785541546004439,1.0,3/12,23.37%,IL18;CCR2;IL1B
prerank,negative regulation of synaptic transmission (GO:0050805),0.2790191794896061,0.6787859536355694,0.8734693877551021,0.9547163497717722,1.0,2/23,4.72%,PLK2;PTEN
prerank,cotranslational protein targeting to membrane (GO:0006613),0.2297823266491836,0.6779105024740586,0.933982683982684,0.9552403703312797,1.0,18/91,17.78%,RPL18A;RPS14;RPS11;RPS27A;RPL17;RPL23;RPL36A;RPL22;RPS21;SIL1;RPL10A;RPS26;RPL15;RPL10;RPSA;RPL7;RPL26;SEC63
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2652557785121083,-0.6771124562994167,0.8779661016949153,0.9790311102712451,1.0,4/13,13.74%,GET4;PKD2;NFKBIE;PKD1
prerank,regulation of T cell mediated immunity (GO:0002709),-0.28801429392824124,-0.6770069364402872,0.8614130434782609,0.9777458659158321,1.0,2/10,4.84%,WAS;TRPM4
prerank,negative regulation of DNA binding (GO:0043392),0.26591973571523086,0.6765229622946574,0.8951406649616368,0.9562236071323486,1.0,2/28,4.96%,JUN;E2F1
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.25798311175419086,0.6764429159070889,0.8913308913308914,0.9559515533165871,1.0,10/36,18.54%,FAS;RB1;CSNK2A2;STYXL1;TRAF1;MAZ;CX3CL1;CSNK2A1;SGMS1;CRADD
prerank,icosanoid metabolic process (GO:0006690),0.25183008221550796,0.6763568624373352,0.8948655256723717,0.9556914697872967,1.0,4/40,10.31%,MGLL;PON3;GPX4;LTA4H
prerank,protein homooligomerization (GO:0051260),0.2217326821013685,0.6762103450623141,0.9523809523809523,0.9554981559724842,1.0,23/114,19.15%,SLC1A5;MICU1;APPL2;GNMT;NINJ1;CHMP2A;RNF135;P2RX3;NLRC4;PDCD6IP;LETM1;ATL2;USP16;SSBP1;ATL1;ADCY8;VSTM5;ALDH1A2;TK1;ALDH9A1;CBR4;CARD11;ALAD
prerank,regulation of striated muscle contraction (GO:0006942),0.2662988131801906,0.6758405341274961,0.8881664499349805,0.9554998803018819,1.0,3/27,8.14%,P2RX4;MYL2;MYBPC3
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.2688750271934296,-0.6752073807130439,0.8892307692307693,0.9780084532997195,1.0,6/11,35.93%,NOS1AP;ALG10B;LRRC55;RNF207;AKAP6;KCNIP2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.31912480378051583,0.6748333209835445,0.8518518518518519,0.9561180769187647,1.0,1/12,3.15%,DSE
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.19986275448380153,-0.6743691929968357,0.9365853658536586,0.9773873284416369,1.0,10/32,31.90%,RPL30;RNASE7;ANG;ROMO1;HMGN2;RNASE6;CAMP;GAPDH;CXCL14;PGLYRP1
prerank,regulation of cellular senescence (GO:2000772),-0.2124278004713009,-0.6728936674000555,0.963302752293578,0.9772987322513946,1.0,8/28,21.05%,NUAK1;AKT3;YPEL3;CGAS;RBL1;VASH1;ABI3;NEK4
prerank,ear morphogenesis (GO:0042471),0.28119235826913686,0.6718955769619892,0.8809523809523809,0.9585008095449131,1.0,3/20,17.11%,NIPBL;PAX8;CHD7
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.29353214896200897,0.671408478556039,0.8595744680851064,0.958620113306903,1.0,3/16,11.91%,NT5E;TET2;CRMP1
prerank,positive regulation of cell growth (GO:0030307),0.22479485567510551,0.6703369124384824,0.9579741379310345,0.959318792474946,1.0,15/96,15.28%,SDCBP;RUFY3;MMP14;IGF1;ZFYVE27;N6AMT1;NEDD4L;EXOSC9;SYT17;ADAM17;MTPN;MACF1;DERL2;INO80;GOLGA4
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.28018586181323185,0.6702671026436839,0.8824324324324324,0.9590464113507355,1.0,3/20,12.64%,THBS1;SULF2;SULF1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.2541779439653802,-0.6692461575055596,0.9006211180124224,0.9789577105924654,1.0,6/13,23.81%,TPST1;TPST2;SULT1A1;ABHD14B;SULT4A1;BPNT1
prerank,mitotic spindle assembly (GO:0090307),0.24508522845463573,0.6688671617658863,0.9220623501199041,0.9600020402441835,1.0,9/42,17.72%,PIBF1;SMC1A;TOGARAM1;STAG2;CLASP1;CEP192;SMC3;OFD1;ARHGEF10
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.32727129748096195,0.6685926256778458,0.8678678678678678,0.9598928446120322,1.0,3/10,14.82%,ATP5F1A;ATP5F1D;ATP5F1C
prerank,regulation of membrane repolarization (GO:0060306),-0.2570194668563276,-0.6684879104761258,0.889937106918239,0.9782332359951867,1.0,3/13,14.96%,KCNJ2;AKAP9;CACNA2D1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.2306710705833301,0.6683148318393306,0.9201312910284464,0.9598082948768016,1.0,9/72,12.33%,MUS81;RFC3;ENPP1;GTF2H5;RPS27A;UBC;DDB1;DNASE1L1;CUL4A
prerank,negative regulation of cell aging (GO:0090344),0.29288586447684506,0.6678969273834457,0.8757062146892656,0.9598359722815589,1.0,7/16,30.02%,SIRT1;ZKSCAN3;FBXO5;CDK6;FOXM1;YBX1;TERF2
prerank,stabilization of membrane potential (GO:0030322),0.2948340168376521,0.6672703569599311,0.8753501400560224,0.9600754256249253,1.0,3/16,19.13%,KCNK13;KCNK4;KCNK5
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.316936918267385,0.6670880475091768,0.8661654135338346,0.9598960299324198,1.0,2/11,10.23%,STAP1;RIN3
prerank,regulation of wound healing (GO:0061041),0.24715736420056753,0.666848650621048,0.9038929440389294,0.9597709546035921,1.0,5/42,13.60%,ANXA1;PLAU;ITGB1;MYLK;TNFAIP3
prerank,regulation of adaptive immune response (GO:0002819),0.2883066211097379,0.6662599886903958,0.8738127544097694,0.9599475833719961,1.0,3/18,10.59%,ADCY7;EIF2AK4;SIRT1
prerank,negative regulation of ATPase activity (GO:0032780),0.28984970281122957,0.665391258775954,0.8542857142857143,0.9604171789377547,1.0,2/16,10.59%,PPIF;SIRT1
prerank,positive regulation of cellular component movement (GO:0051272),0.26878626896021307,0.664664374070652,0.8900662251655629,0.9607441534497349,1.0,3/24,10.24%,VEGFA;CFAP20;ADAM17
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3004733835747855,0.6645688672971289,0.883551673944687,0.9604964625362311,1.0,6/14,28.74%,HNRNPA0;MYD88;TIRAP;ZFP36;MAPK14;HNRNPC
prerank,intraciliary retrograde transport (GO:0035721),-0.2578785981758378,-0.6626387376403249,0.8765432098765432,0.9817220780386243,1.0,6/12,29.73%,DYNC2H1;IFT43;TTC21B;DYNLT2B;DYNC2LI1;DYNC2I1
prerank,protein methylation (GO:0006479),0.2525476258902781,0.6624147913533046,0.9288299155609168,0.9620933537950599,1.0,12/40,24.90%,NSD3;ETFBKMT;N6AMT1;CAMKMT;ETF1;ICMT;METTL22;SNRPB;EHMT2;SETD3;METTL21A;CARM1
prerank,nuclear membrane reassembly (GO:0031468),0.2356077278402254,0.6621362062050876,0.9299655568312285,0.96200174655895,1.0,14/54,21.70%,REEP4;LMNA;CHMP2A;VPS4A;PPP2R2A;CHMP6;NUP98;CHMP7;PPP2CA;PPP2R1A;NUP188;CHMP2B;NDC1;NUP43
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.32182943807710934,0.6612663942652509,0.8586626139817629,0.9624562670382086,1.0,1/10,3.47%,FAS
prerank,blood vessel endothelial cell migration (GO:0043534),0.2767178770681872,0.6603003861457997,0.9095816464237517,0.9629699815718917,1.0,4/22,16.18%,VEGFA;MYH9;GPLD1;NRP1
prerank,copper ion homeostasis (GO:0055070),0.285435978104061,0.6600934573744367,0.8954154727793696,0.9628077160397508,1.0,4/17,16.59%,XIAP;APP;ATP7A;SLC31A2
prerank,DNA replication initiation (GO:0006270),0.24766725577011156,0.6599499303429633,0.901985111662531,0.96259849702192,1.0,15/37,29.43%,DBF4;POLA1;NOC3L;ORC1;CDC34;ORC4;CDT1;CDK2;POLE3;PRIM2;ORC6;MCM3;ORC2;POLE;POLA2
prerank,modulation by host of symbiont process (GO:0051851),0.25436229165511737,0.6590899633023724,0.9040590405904059,0.9630200653800385,1.0,3/31,5.56%,AQP1;JUN;SAP30
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.3020297424099817,0.6585638859885119,0.8918518518518519,0.9631587602132695,1.0,2/13,10.19%,ZC3HAV1;CNOT7
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.23301938023163501,-0.6584810146764586,0.9205776173285198,0.9835406771522316,1.0,7/16,26.91%,RBMX;CIRBP;CELF4;TRA2B;SNW1;SF3B4;TRA2A
prerank,tRNA 5'-leader removal (GO:0001682),0.29577176544333544,0.6583964807185356,0.8751835535976505,0.962953648367922,1.0,3/13,16.04%,RPP25L;POP4;PRORP
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.2636844274055077,0.6582680552095452,0.9094488188976378,0.9627282776853531,1.0,6/27,13.74%,ARAP1;DLC1;PAK2;PFN1;PRKN;CLASP1
prerank,pseudouridine synthesis (GO:0001522),-0.25348445913313666,-0.6571085205333964,0.9066666666666666,0.9832556571298053,1.0,3/13,15.85%,PUS7;GAR1;TRUB2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.27871135474207326,-0.6564885999215861,0.8888888888888888,0.9824004356778712,1.0,4/10,26.76%,DPP4;WNK1;CCL5;PODXL
prerank,regulation of cellular respiration (GO:0043457),0.28355684104735235,0.6553817217451173,0.8888888888888888,0.9649444764053178,1.0,5/17,24.33%,IL10RB;IFNAR1;PRDM16;VCP;SHMT2
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2748964048266175,0.6553275192309601,0.898236092265943,0.9646497470430709,1.0,3/20,9.03%,FOXP3;BRCA1;BRD7
prerank,peptidyl-methionine modification (GO:0018206),0.3079688313821861,0.6552766153248831,0.8794326241134752,0.9643515862049135,1.0,4/12,22.29%,METAP1D;NAA30;NAA25;NAA15
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.28620839654377334,0.6547898068183241,0.8874824191279888,0.9644367601300512,1.0,3/17,11.88%,NOTCH2;SNAI2;NOTCH1
prerank,negative regulation of neuron projection development (GO:0010977),0.2346530680831763,0.6544391548470756,0.9493670886075949,0.9643887552549596,1.0,11/56,18.04%,APOE;RUFY3;PTEN;GAK;MT3;CRMP1;ITM2C;MCF2;RTN4;RAB29;MYLIP
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.2736364165875387,0.6540173494189595,0.8981481481481481,0.9644091380262558,1.0,7/22,24.99%,MED12;ESR1;MED16;PAXIP1;MED30;PSMC5;MED13
prerank,positive regulation of mRNA processing (GO:0050685),0.2716107026715585,0.6537399624173047,0.8945945945945946,0.9643211966413066,1.0,6/21,19.65%,NCBP2;PRDX6;CDC73;NUP98;THRAP3;NCL
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.24668860628785869,0.6535418127353907,0.9243902439024391,0.9641522952486212,1.0,8/37,20.16%,BCL2L11;STYXL1;DDIT3;BCLAF1;BAX;BID;BBC3;BCAP31
prerank,negative regulation by host of viral transcription (GO:0043922),0.3038612904270689,0.652926945190488,0.8723098995695839,0.9643514339203181,1.0,1/12,4.00%,JUN
prerank,neural tube development (GO:0021915),-0.2409244765989685,-0.6521095612212479,0.89198606271777,0.9844406333771791,1.0,7/15,26.40%,PTCH1;PKD2;PKD1;SOX11;TGFB1;DACT1;STIL
prerank,positive regulation of insulin secretion (GO:0032024),0.24829369739582116,0.6519069029432881,0.9120879120879121,0.9648888148223183,1.0,9/36,20.34%,IRS2;TRH;AACS;GPLD1;ADCY8;NLGN2;BAIAP3;TCF7L2;GCK
prerank,diacylglycerol metabolic process (GO:0046339),0.2688174200704426,0.6516567662327273,0.9041450777202072,0.9647583639884519,1.0,4/23,17.18%,DGKZ;DGKA;DGKQ;DGKG
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2107065658532491,0.6513041136183841,0.9740932642487047,0.9647295934286813,1.0,46/146,27.02%,DYNC1H1;PSMD1;HAUS6;CENPJ;PSMF1;PSMD14;CEP76;PSMD12;CLASP1;CEP192;TUBA1A;PSME2;CUL1;NDE1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;PSMB10;PSMD5;CDC25A;PSMD8;PSMA3;PAFAH1B1;FBXO5;PSMA2;PSMD11;PPP2R1A;PSMA6;HAUS5;CEP41;RAD51B;PSMB3;RCC2;PSME3;CDK2;USP47;CEP250;PSMC5;CEP152;CKAP5;AVEN;PSMC1;TUBA4A;MECP2
prerank,regulation of rRNA processing (GO:2000232),-0.23561968461495428,-0.6510390620806811,0.8865979381443299,0.9839035757564356,1.0,6/16,19.80%,HEATR1;BUD23;RIOK2;YTHDF2;TRMT112;NUDT16
prerank,bone morphogenesis (GO:0060349),-0.24400479922741694,-0.6505437496818134,0.9245901639344263,0.9829806840460943,1.0,2/14,5.89%,FGFR2;LRP5
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3133462533373813,0.6501861527618318,0.8726708074534162,0.9653174127794217,1.0,3/10,20.07%,AIDA;DNAJA1;DUSP10
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.29473461619821834,0.6501484133399026,0.8967551622418879,0.9650092942362682,1.0,2/13,12.33%,PID1;TREM2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.24980296369903643,-0.649047102357342,0.9133333333333333,0.9826749869431114,1.0,4/13,23.02%,HSP90AA1;QDPR;FPGS;SPR
prerank,regulation of monocyte differentiation (GO:0045655),-0.24570452136444534,-0.6488614216607028,0.8858858858858859,0.9814783116283554,1.0,6/14,20.73%,CSF1;CD74;HOXA7;MYC;CTNNBIP1;IL34
prerank,regulation of ion transport (GO:0043269),0.22302061265154946,0.6480015665828932,0.9572368421052632,0.9664128005497381,1.0,10/76,14.14%,DTNBP1;P2RX4;SIK1;NEDD4L;WWP2;SYT17;RAB11B;VAMP3;PRKN;GDNF
prerank,regulation of histone methylation (GO:0031060),0.29444096473757436,0.6475528871246775,0.8834269662921348,0.9664468921800716,1.0,1/13,4.99%,CHTOP
prerank,regulation of exit from mitosis (GO:0007096),0.2431092475076067,0.6473367732990396,0.9291819291819292,0.966275967038171,1.0,9/38,19.70%,ANAPC1;RPS27A;UBC;PPP1R9B;NPM2;ANAPC10;UBE2S;ANAPC15;CDC14B
prerank,calcium ion import across plasma membrane (GO:0098703),0.2932878902964785,0.6472146891258478,0.9033189033189033,0.9660396308095132,1.0,2/14,9.35%,SLC8A1;TRPV2
prerank,cellular amino acid catabolic process (GO:0009063),0.2198992557970712,0.6471101308546526,0.9622030237580994,0.9657850024981782,1.0,19/87,24.33%,ARG1;KYNU;PRODH;MCCC1;HMGCL;HIBADH;FAH;GCDH;SLC25A44;BLMH;OGDH;ALDH7A1;MTRR;BCAT2;CARNMT1;IVD;GCSH;GOT1;SHMT2
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.30841502868973353,0.6469721866381495,0.8817365269461078,0.965544663066067,1.0,3/11,19.18%,NASP;UBN1;CABIN1
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.2389375961417236,-0.6464142951668546,0.9121621621621622,0.9818155102472784,1.0,10/15,34.35%,PHB2;EZH2;PAF1;NPM1;PLCG2;STXBP4;DDRGK1;DYRK3;CRNN;FAM83D
prerank,determination of left/right symmetry (GO:0007368),0.24240380780721626,0.6452409252909627,0.9326805385556916,0.9666065029279867,1.0,6/37,18.39%,CCDC40;CITED2;CFAP53;NOTCH1;OFD1;BBS7
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3019033074933553,0.6452363714599747,0.89067055393586,0.9662702350931426,1.0,6/13,26.15%,NOP14;RPS21;RCL1;ABT1;NOP9;RPP40
prerank,cGMP biosynthetic process (GO:0006182),-0.26685020142042176,-0.6440957635521047,0.8923512747875354,0.9821579199319223,1.0,6/10,40.67%,GUCY1A1;GUCY1B1;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,modulation by symbiont of entry into host (GO:0052372),0.28422464274865455,0.6437742124721496,0.9005763688760807,0.9671095276276246,1.0,3/16,17.93%,TRIM25;TRIM14;EXOC7
prerank,histone H2B ubiquitination (GO:0033523),0.3096600643200422,0.6435649108004406,0.8830128205128205,0.9669395122451738,1.0,1/10,3.25%,WAC
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.2723407024389035,0.6433170089886014,0.9131016042780749,0.9667891188230147,1.0,7/20,22.72%,TGM2;PACS2;BAX;BCAP31;WFS1;HERPUD1;TMCO1
prerank,regulation of chromatin binding (GO:0035561),-0.27383318594397127,-0.6430892937676311,0.9,0.9815071028450959,1.0,2/10,12.07%,MED25;KDM4D
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.2616436595896018,0.641880356620511,0.8900804289544236,0.9676165162410232,1.0,3/23,11.47%,IGF1;ZBTB20;APP
prerank,negative regulation of phosphatase activity (GO:0010923),0.2581238630300385,0.6411377420405321,0.9078947368421053,0.9678586606106048,1.0,4/25,12.26%,STYXL1;BOD1;GSK3B;GPATCH2
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.30161728570578017,0.6408275438075547,0.8937784522003035,0.9677557267110863,1.0,4/11,19.53%,THBS1;E2F2;PIK3CB;CREB3L1
prerank,negative regulation of hormone secretion (GO:0046888),-0.2673828110043792,-0.6390459690274768,0.9005847953216374,0.982975731630414,1.0,2/10,23.37%,RAB11FIP5;IL1B
prerank,protein localization to phagophore assembly site (GO:0034497),0.2983506668451249,0.6368626108060005,0.8927492447129909,0.970538841213055,1.0,5/11,24.45%,PACS2;ATG13;TRAPPC8;MFN2;STX17
prerank,ribosomal small subunit biogenesis (GO:0042274),0.24071732785599728,0.6368486779584286,0.9337423312883436,0.9702136757221159,1.0,15/39,29.24%,RPS14;NOP14;MRPS7;NOB1;TSR3;RPSA;PWP2;RPS27;SNU13;LSM6;RRP36;RIOK3;NOL11;EMG1;RPS7
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.27355914640451706,0.6367369680662079,0.8962655601659751,0.9699644226615914,1.0,5/18,25.53%,FZD7;NOTCH1;FRS2;CCN3;HDAC1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.2660309245862442,0.634625238825099,0.907563025210084,0.9712526525509523,1.0,8/19,27.56%,CENPJ;DKC1;TREM2;CCT2;CCT7;CEP295;CHP1;WRAP53
prerank,DNA replication checkpoint signaling (GO:0000076),-0.22957991350395918,-0.633735876820547,0.9290780141843972,0.9850512151438267,1.0,6/16,28.93%,RAD9B;TIMELESS;NAE1;TIPIN;TOPBP1;TICRR
prerank,mammary gland development (GO:0030879),0.26094529423785046,0.6336244590323645,0.9168900804289544,0.9716864201385831,1.0,1/21,1.73%,VEGFA
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.21016864156517773,-0.6332443906991665,0.9607142857142857,0.9826924461132888,1.0,5/20,20.35%,BCAT1;DBT;ACADSB;AUH;ACAT1
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.21016864156517773,-0.6332443906991665,0.9607142857142857,0.9826924461132888,1.0,5/20,20.35%,BCAT1;DBT;ACADSB;AUH;ACAT1
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.26388687429826974,-0.6329514546843464,0.9207650273224044,0.9815464557351453,1.0,1/10,2.17%,PRKCE
prerank,regulation of phospholipase C activity (GO:1900274),0.2834545439079398,0.6321938276062713,0.8916666666666667,0.9724187068485378,1.0,2/15,10.01%,ABL2;ESR1
prerank,regulation of execution phase of apoptosis (GO:1900117),-0.2552215301841385,-0.6315024788071982,0.9214501510574018,0.9812018858962129,1.0,3/11,17.73%,FZD3;SIRT2;FAP
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.27471097985679216,0.6303384266441127,0.8982808022922636,0.9734794315650855,1.0,3/16,16.54%,PDGFA;NRP1;PTPN1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.30730766747675603,0.6301773940586621,0.8846737481031867,0.9732658106890707,1.0,4/10,30.98%,APP;DRD2;RAB5A;DLG4
prerank,cAMP-mediated signaling (GO:0019933),0.25260522640545424,0.6294000797215875,0.9271356783919598,0.9735141292923081,1.0,4/24,13.22%,PDE7B;MAPK7;CAP1;DGKQ
prerank,myelination in peripheral nervous system (GO:0022011),-0.24356395775659118,-0.627943250136979,0.9436201780415431,0.9820983913147818,1.0,6/13,29.70%,PARD3;SIRT2;DICER1;LGI4;CNTNAP1;MYOC
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.272025294186569,0.627861690990867,0.9192200557103064,0.9743364349496468,1.0,3/17,16.18%,VEGFA;GPLD1;NRP1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.30511457315052654,0.6276890951238018,0.9023622047244094,0.9741216604877007,1.0,2/10,14.74%,DKC1;TSR3
prerank,negative regulation of GTPase activity (GO:0034260),0.25724041514135076,0.6271008877411575,0.9330708661417323,0.9742095441752049,1.0,10/22,29.51%,RASA4;BCAS3;ARFGEF1;CPEB2;LRCH1;RCC2;HRAS;SH3BP4;GPSM1;LRRK2
prerank,rRNA methylation (GO:0031167),0.2605869516753495,0.6267209199469228,0.9363395225464191,0.9741256936726496,1.0,9/22,26.23%,NSUN3;MRM2;TFB2M;FBL;DIMT1;MTERF4;ZCCHC4;NSUN4;FDXACB1
prerank,regulation of water loss via skin (GO:0033561),-0.22753118775962644,-0.6257380951568701,0.9375,0.9807994152450175,1.0,6/15,33.49%,STMN1;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,establishment of skin barrier (GO:0061436),-0.22753118775962644,-0.6257380951568701,0.9375,0.9807994152450175,1.0,6/15,33.49%,STMN1;FA2H;LSR;ALOXE3;SFN;CLDN1
prerank,tRNA 5'-end processing (GO:0099116),0.27512689386164424,0.6253714135431445,0.9035971223021583,0.9747513315274464,1.0,4/15,19.62%,RPP25L;POP4;PRORP;TRMT10C
prerank,focal adhesion assembly (GO:0048041),0.2616833115989434,0.6251762460321746,0.9193548387096774,0.974529174923568,1.0,4/21,14.25%,ACTN1;DLC1;RHOD;WHAMM
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27106530371899173,0.6247526516114276,0.9154929577464789,0.9744994754735448,1.0,8/16,30.09%,PARP3;KMT5B;SHLD1;SHLD2;PRKDC;WRAP53;PARP9;RIF1
prerank,nucleosome organization (GO:0034728),0.2229740722126029,0.6235129038739976,0.9502890173410404,0.9750138662417401,1.0,16/55,25.08%,ANP32B;BRD2;ZNHIT1;NASP;VPS72;SMARCC1;ARID2;SMARCD1;INO80;SMARCB1;DMAP1;KAT6B;POLE3;SMARCE1;ANP32E;SMARCD2
prerank,vascular process in circulatory system (GO:0003018),0.28122368696041905,0.6229602178690602,0.9097320169252469,0.9747226664874673,1.0,2/13,16.73%,ROCK1;ACE
prerank,regulation of tube diameter (GO:0035296),0.28122368696041905,0.6229602178690602,0.9097320169252469,0.9747226664874673,1.0,2/13,16.73%,ROCK1;ACE
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.23411978028201777,0.6210309682822689,0.9570707070707071,0.9757179636552283,1.0,12/38,23.52%,NDUFS8;NDUFA10;NDUFC1;NDUFAB1;NDUFB6;NDUFS6;NDUFS1;NDUFS3;NDUFB4;NDUFB8;NDUFB9;NDUFA13
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.2994550643421613,0.6206337415057256,0.8887240356083086,0.9756434920527476,1.0,3/11,19.16%,ATF4;PRKN;FBXO7
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.20847451150789842,0.6192861377185179,0.973568281938326,0.9761941843092564,1.0,19/83,21.45%,DYNC1H1;HAUS6;CENPJ;GTSE1;CEP76;CLASP1;CEP192;TUBA1A;NDE1;ALMS1;OFD1;CCP110;SSNA1;HAUS7;ATAD5;PAFAH1B1;PPP2R1A;HAUS5;CEP41
prerank,regulation of cell aging (GO:0090342),0.29459660652663927,0.618698117333697,0.9131736526946108,0.9762552434719322,1.0,1/11,4.39%,LMNA
prerank,cell-substrate junction assembly (GO:0007044),0.23974677769794664,0.6185810069034708,0.9372647427854455,0.9760003434655676,1.0,6/33,15.01%,CD151;ACTN1;DLC1;RHOD;WHAMM;LAMA3
prerank,nuclear membrane organization (GO:0071763),0.2643431861861295,0.6184613971200598,0.926490984743412,0.9757406132773822,1.0,5/19,20.73%,CHMP2A;VPS4A;NEMP1;CHMP7;TOR1A
prerank,positive regulation of ATPase activity (GO:0032781),0.22657012533984175,0.6179419648965642,0.9531812725090036,0.9757427740839141,1.0,7/41,14.80%,CHTOP;HNRNPU;VMP1;MYBPC3;PFN1;SSBP1;PFN2
prerank,regulation of protein dephosphorylation (GO:0035304),0.23495887429153328,0.615190373621829,0.9395807644882861,0.9772253021540939,1.0,12/37,25.50%,PRKCD;ENSA;MFHAS1;DLC1;HTT;CALM2;PPP6R1;CDH5;PPIA;PPP6R3;YWHAB;SPPL3
prerank,negative regulation of cellular senescence (GO:2000773),0.2832266212742881,0.6145264062085897,0.9228486646884273,0.9773244842121359,1.0,6/13,30.02%,SIRT1;ZKSCAN3;FBXO5;CDK6;YBX1;TERF2
prerank,hippo signaling (GO:0035329),0.24326772928610468,0.6140105632206517,0.932,0.9773196649514223,1.0,11/26,30.64%,STK3;LATS1;CASP3;STK4;WWTR1;MOB1A;YWHAB;MOB1B;TJP1;YWHAE;TEAD2
prerank,aortic valve morphogenesis (GO:0003180),0.2408275832925793,0.6138357436605213,0.940279542566709,0.9770974160464114,1.0,4/30,11.88%,SNAI2;RB1;ROCK1;NOTCH1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.28896752605112974,0.6134457433412853,0.9169139465875371,0.9770063067630536,1.0,3/12,17.78%,GET3;SGTA;SEC63
prerank,regulation of catecholamine secretion (GO:0050433),0.23929975386141936,0.6126861674236262,0.9462227912932138,0.9771785683194402,1.0,1/29,0.64%,DTNBP1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.2738575671704753,0.6098393461876551,0.911976911976912,0.9786543104661234,1.0,4/14,21.30%,ADAM17;PTK2B;CCL7;ADAM10
prerank,regulation of stem cell population maintenance (GO:2000036),-0.21831096227330352,-0.6089716461106709,0.9597069597069597,0.9889344147232247,1.0,6/18,22.97%,REST;CNOT2;CNOT1;MYC;ELAVL1;TAF6L
prerank,hematopoietic stem cell proliferation (GO:0071425),0.28923160001004755,0.6089381850183524,0.9276218611521418,0.9788761545167207,1.0,2/11,9.67%,ETV6;ARIH2
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.23972735657161862,0.6087406110391699,0.9502487562189055,0.978668364629272,1.0,3/29,11.88%,MYL2;MYBPC3;NOTCH1
prerank,regulation of gastrulation (GO:0010470),0.27325060812932467,0.6071578435763031,0.9121037463976945,0.9793119002268156,1.0,2/14,13.74%,DAG1;CLASP1
prerank,clathrin coat assembly (GO:0048268),0.2723584676705119,0.6068906649315708,0.9320652173913043,0.9791468436398826,1.0,7/15,25.11%,PICALM;FCHO1;EPS15;FCHO2;HIP1;AP2S1;CLTC
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.2762977977930669,0.6067919529484501,0.9239766081871345,0.9788708148144983,1.0,2/14,9.10%,UMPS;NT5E
prerank,regulation of complement activation (GO:0030449),0.22592462100430194,0.606448280068852,0.9564691656590084,0.9787426846728045,1.0,2/40,4.92%,CD46;C3AR1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.23653223435608448,-0.6058749268812478,0.9305135951661632,0.989168780545954,1.0,3/12,23.37%,CCR2;CARD9;IL1B
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.2447439960600159,-0.6046627556427326,0.9337349397590361,0.9884949314689506,1.0,2/11,6.48%,FMR1;PUM1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.26003427395431694,0.60415410109144,0.9342465753424658,0.9798325463038077,1.0,6/18,25.64%,DKC1;EXOSC10;SHQ1;CCT2;RUVBL2;CCT7
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.22482392763030537,0.6039654603423289,0.9635036496350365,0.9796074284595427,1.0,3/40,4.98%,ABCD1;PID1;MTLN
prerank,regulation of humoral immune response (GO:0002920),0.22035842817400486,0.6034442056402729,0.9560570071258907,0.979584065330991,1.0,2/44,4.92%,CD46;C3AR1
prerank,protein alkylation (GO:0008213),0.2514948410552679,0.6031848891556973,0.931758530183727,0.9794125032721938,1.0,3/22,8.74%,ETFBKMT;CAMKMT;ETF1
prerank,mitotic DNA replication (GO:1902969),-0.25131939602324965,-0.6029398823875988,0.9113149847094801,0.9880323306881822,1.0,6/10,37.40%,LIG1;MCM6;MCMDC2;MCM4;GINS3;CDC45
prerank,organelle disassembly (GO:1903008),0.23232816669112466,0.6027541573205164,0.9507772020725389,0.9793185169393666,1.0,10/33,22.33%,KIF9;STX5;UBA5;TEX264;KIF5B;MTIF2;RETREG1;ATG2B;VCP;MTIF3
prerank,regulation of cell projection organization (GO:0031344),-0.23503585247886208,-0.6023501996895506,0.9504643962848297,0.9870084057328308,1.0,1/13,0.90%,NTNG1
prerank,histone deacetylation (GO:0016575),0.2200690808662244,0.6010304983207717,0.9726516052318668,0.9800436560009419,1.0,5/43,12.83%,RCOR1;SIRT6;TBL1XR1;SIRT1;SIRT7
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.29125773657921833,0.6008020812979298,0.8998482549317147,0.9798433527162954,1.0,2/10,10.59%,FLCN;SIRT1
prerank,female gamete generation (GO:0007292),-0.18396683823238785,-0.599847623264519,0.9732142857142857,0.986936779330885,1.0,14/29,38.85%,FMN2;METTL3;IHO1;PARN;TRIP13;PRDM9;MCM8;GDF9;PIWIL2;PTN;DMC1;HORMAD1;NANOS1;M1AP
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.26540259696155316,0.599673826345178,0.9214285714285714,0.9801770202368422,1.0,5/15,25.64%,DKC1;SHQ1;CCT2;RUVBL2;CCT7
prerank,protein deacetylation (GO:0006476),0.22099593576635435,0.599261804596349,0.961768219832736,0.9800832549181573,1.0,5/41,12.83%,RCOR1;SIRT6;TBL1XR1;SIRT1;SIRT7
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.20268373507375897,0.5989299130970692,0.9802197802197802,0.9799384776908473,1.0,20/80,24.86%,PLPP3;UVRAG;COG7;KIF3A;RAB1B;KDELR2;GOLPH3;GOLPH3L;ARF4;ARF5;HTT;TAPBP;ARFGAP2;RAB1A;ERGIC2;ATP9B;TMED3;TMED10;COPB1;ARFGAP3
prerank,glial cell development (GO:0021782),0.24188028103587927,0.5984795915221977,0.9400278940027894,0.9798636514975677,1.0,8/25,24.60%,PRDM8;MT3;APP;NRROS;EIF2B2;HES5;CDK6;SOX4
prerank,positive regulation of collagen metabolic process (GO:0010714),0.25522005535855774,0.5968882434381338,0.9381868131868132,0.9804616297742467,1.0,1/17,2.51%,VIM
prerank,development of primary male sexual characteristics (GO:0046546),0.22488173404318537,0.5953004499250423,0.956575682382134,0.9810428975265518,1.0,3/34,9.47%,LHFPL2;NCOA4;NR5A1
prerank,cellular response to hydroxyurea (GO:0072711),0.2862556422520922,0.5948273997263169,0.9162790697674419,0.9809727277831116,1.0,4/10,22.98%,NSMCE3;DDI2;RTF2;SPIDR
prerank,negative regulation of hydrolase activity (GO:0051346),0.2165037723055176,0.5938251288352894,0.9798816568047337,0.9811685265150106,1.0,6/49,12.26%,MAPK7;RASA4;NEIL1;SLC39A14;BCAS3;GPATCH2
prerank,regulation of mRNA metabolic process (GO:1903311),0.2801187117217472,0.5923003493632188,0.9353846153846154,0.9817064764025527,1.0,3/11,21.06%,SRPK2;SRPK1;SAFB
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.26524197795986476,0.5914552864302505,0.9343794579172611,0.9818442119446756,1.0,2/15,10.19%,YTHDF3;CNOT7
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.24036344772592305,-0.5910264780113264,0.9395770392749244,0.9897989220709135,1.0,4/10,24.81%,WNK1;CCR2;WNT5A;CCL5
prerank,isotype switching (GO:0045190),0.28919777071090735,0.5900694471860254,0.9183673469387755,0.9822878237919058,1.0,3/10,22.75%,EXOSC3;HSPD1;RNF168
prerank,male gonad development (GO:0008584),-0.17233467035097264,-0.5894702792934504,0.9856459330143541,0.9892029592605736,1.0,9/34,24.84%,KITLG;TGFB2;AR;SOX9;WNT4;BIK;COL9A3;WNT5A;WNT2B
prerank,protein prenylation (GO:0018342),-0.23851238475649256,-0.587174936792167,0.9261363636363636,0.9888967372559839,1.0,2/10,18.14%,CHML;PTAR1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.24518234887954302,-0.586282638674664,0.9619883040935673,0.9866530529427219,1.0,10/10,75.50%,CACNA2D4;REEP6;CNGB1;TULP1;GRM6;GNAT1;RPE65;GNAT2;CACNA1F;CEP250
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.24518234887954302,-0.586282638674664,0.9619883040935673,0.9866530529427219,1.0,10/10,75.50%,CACNA2D4;REEP6;CNGB1;TULP1;GRM6;GNAT1;RPE65;GNAT2;CACNA1F;CEP250
prerank,regulation of aerobic respiration (GO:1903715),0.2566770348746644,0.584062613410002,0.9304733727810651,0.9851260786191977,1.0,4/15,24.33%,ABCD1;ATP7A;VCP;SHMT2
prerank,coenzyme A metabolic process (GO:0015936),0.2638763738726026,0.5820676596891139,0.9458646616541353,0.9857803487618891,1.0,3/14,18.41%,COASY;PANK2;NUDT7
prerank,epithelial structure maintenance (GO:0010669),0.27489014438167003,0.5820405870129963,0.9341317365269461,0.9854557173235976,1.0,11/11,72.53%,TLR9;VSIG1;MUC13;MUC4;MUC2;RBP4;NOD2;MUC6;PIWIL4;CXADR;STRAP
prerank,negative regulation of ion transport (GO:0043271),0.242702985907029,0.5813852824713803,0.9661898569570871,0.9854481633982392,1.0,3/24,14.29%,LILRB1;PTK2B;HTR1B
prerank,male meiosis I (GO:0007141),0.2518681318681318,0.5809982053407211,0.956268221574344,0.9853141986052567,1.0,16/16,74.84%,FOXJ3;MYBL1;FOXJ2;BRDT;CCNA1;BTBD18;MEIOC;DNMT3L;ZSCAN21;MOV10L1;TDRD9;SLC25A31;ING2;HSF2BP;SYCP3;DDX4
prerank,regulation of hippo signaling (GO:0035330),0.25145277043296843,0.580737557772343,0.936231884057971,0.9851107852953671,1.0,3/17,13.58%,WWC2;NF2;LIMD1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.26313440961863693,0.5806815405572415,0.9283625730994152,0.9848012957591412,1.0,7/13,28.96%,BFAR;PTPN1;WFS1;PPP1R15B;ABCA7;ATF6B;DNAJB9
prerank,protein depolymerization (GO:0051261),0.2281446588294812,0.580655004566579,0.958656330749354,0.9844712055976539,1.0,7/27,19.63%,NCKAP5L;CFL1;WDR1;MICAL2;DSTN;CFL2;MICAL1
prerank,protein localization to cell-cell junction (GO:0150105),-0.21024422341018817,-0.5798205266391446,0.9587628865979382,0.9879579426654286,1.0,1/15,1.34%,F11R
prerank,monosaccharide transmembrane transport (GO:0015749),0.25385274198593033,0.579029422566568,0.9408450704225352,0.9849407627686146,1.0,3/16,19.45%,SLC23A2;SLC23A1;SLC50A1
prerank,mesenchymal cell development (GO:0014031),0.24670381414750814,0.5787811607084777,0.9382022471910112,0.984728942743538,1.0,6/18,23.00%,SNAI2;NOTCH1;SOX8;PEF1;KLHL12;NOLC1
prerank,regulation of immune effector process (GO:0002697),0.21422171330700518,0.5786893963733055,0.9675090252707581,0.9844379792102312,1.0,2/41,4.92%,CD46;C3AR1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.2098974347776314,0.5785390428169948,0.9810874704491725,0.9841778623231483,1.0,4/46,6.27%,MICALL2;ITGA4;LPXN;PARVB
prerank,protein localization to cell surface (GO:0034394),0.22821973171612192,0.5781811420007029,0.9602053915275995,0.9840151171803331,1.0,6/26,23.46%,CTNNB1;GGA2;PTPRU;PIGU;GGA3;FLNA
prerank,peptidyl-proline modification (GO:0018208),0.23061857974404673,0.5780491861916007,0.963855421686747,0.9837514501504673,1.0,5/25,15.17%,PPIF;PPIH;CWC27;PPIE;FKBP7
prerank,heart process (GO:0003015),0.26733240351473825,0.5770640348724257,0.9344978165938864,0.9838986438740663,1.0,7/14,32.28%,MYL2;ACE;GPX1;FYN;SGCG;SOD1;PPCS
prerank,positive regulation of DNA replication (GO:0045740),0.2523657392880578,0.5761148119446553,0.9600550964187328,0.9840190009514196,1.0,6/16,22.70%,NPM2;STN1;ATAD5;CDT1;BCAR3;FAF1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.19919961441994458,-0.5759398982223377,0.9743589743589743,0.9881640196663757,1.0,2/18,7.27%,IRS1;REST
prerank,C21-steroid hormone metabolic process (GO:0008207),0.24216867565812816,0.5742364264690537,0.9504685408299867,0.9845577646369962,1.0,2/20,12.19%,TSPOAP1;CYP46A1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.25310479469234887,0.5740122627936908,0.9360730593607306,0.9843255603595034,1.0,4/16,18.04%,RTEL1;TERF1;TNKS;TNKS2
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.19337498862327784,0.5727399877538947,0.9877777777777778,0.9845851669263744,1.0,2/76,1.43%,SASH1;ADGRG3
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.22218591347059882,-0.5725919115055041,0.9560117302052786,0.9881830769279966,1.0,6/13,33.98%,SRA1;SOX9;TGFB1;EID2B;BMP4;PRICKLE1
prerank,response to acidic pH (GO:0010447),0.26307371032158455,0.572309874459492,0.9466666666666667,0.984447614445438,1.0,3/13,20.88%,CTSS;RAB11B;LGMN
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.2577016756365188,0.5722814255286836,0.9425981873111783,0.9841247264654971,1.0,2/14,11.96%,ANKRD17;PUM2
prerank,xenobiotic transport (GO:0042908),0.24565020731210935,0.5703812361701449,0.9471428571428572,0.9846477912735756,1.0,2/17,7.78%,ABCC3;ABCA3
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.21864045468196863,0.5687387096676053,0.9752168525402726,0.9850652140038492,1.0,6/34,21.01%,IL6;SPHK2;VAMP3;TNFRSF14;SCIMP;PTPRC
prerank,serine family amino acid catabolic process (GO:0009071),-0.2332559161383466,-0.5682127815221498,0.9581151832460733,0.9885128577961578,1.0,10/10,76.70%,SHMT1;CBS;THNSL2;DAO;GLDC;SDS;DLD;AMT;SHMT2;GCSH
prerank,negative regulation of insulin secretion (GO:0046676),0.24730858344642498,0.5669289807089217,0.9457142857142857,0.9855304166125068,1.0,3/17,13.63%,PIM3;MIDN;PRKN
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.25089340712265107,0.5649199241646584,0.9464788732394366,0.9860531702935719,1.0,3/16,15.71%,WRN;SSBP1;TWNK
prerank,negative regulation of hippo signaling (GO:0035331),0.26385427181600657,0.5643588350179123,0.9506172839506173,0.9859508091629228,1.0,1/12,2.73%,WWC2
prerank,negative regulation of cholesterol transport (GO:0032375),0.2743148162971582,0.562685403549595,0.9541864139020537,0.9863265656597519,1.0,1/10,8.18%,ABCA2
prerank,DNA conformation change (GO:0071103),0.24465229768157923,0.5623619258758211,0.9521800281293952,0.9861267822385675,1.0,6/17,27.33%,TOP1;NAA10;PRM1;TOP3A;KAT6A;ERCC3
prerank,neurotransmitter biosynthetic process (GO:0042136),0.24882275381427765,0.5619840080263595,0.946980854197349,0.985943245525462,1.0,14/14,75.14%,ALDH9A1;SLC6A4;DAGLB;PAH;DBH;SLC6A3;SLC44A4;SLC22A2;DAGLA;SLC5A7;ACHE;MOXD1;NOS1;CHAT
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.2534060624370875,0.5580787783224789,0.9565217391304348,0.9871806115962868,1.0,2/14,13.36%,NLRP2B;GAS6
prerank,response to hydroxyurea (GO:0072710),0.2650447451584198,0.5578033938352097,0.9439252336448598,0.9869544917456265,1.0,4/11,22.98%,NSMCE3;DDI2;RTF2;SPIDR
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2343129636683023,0.5572995314553141,0.961436170212766,0.9868180947457641,1.0,7/20,25.70%,PTK2B;MAFB;CDC73;ZBTB16;CDK6;HSPA9;ZFP36
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.26263283935225795,0.5572381901312272,0.9479940564635958,0.98617285944875,1.0,2/12,16.60%,IGF1;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.26263283935225795,0.5572381901312272,0.9479940564635958,0.98617285944875,1.0,2/12,16.60%,IGF1;STIMATE
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.21154082225332813,0.5556368675427459,0.9769696969696969,0.9864807618504359,1.0,8/39,22.02%,IRS2;TRH;AACS;NLGN2;AIMP1;TCF7L2;GCK;DRD2
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.1996068748136715,0.5553208646699197,0.9838895281933256,0.9862776246508347,1.0,10/50,21.95%,CDKN1A;GADD45A;CDK7;CCNA2;CNPPD1;MNAT1;CDC25A;CCNG1;GTPBP4;CCNT1
prerank,regulation of transport (GO:0051049),0.20991190545275684,0.55456799121062,0.9777777777777777,0.9862394886438058,1.0,10/36,22.26%,TRAT1;FES;POFUT2;PRKN;GAPVD1;NRP1;DNAJA1;ACTG1;VAMP2;DISP3
prerank,negative regulation of RNA splicing (GO:0033119),0.23634345402681894,0.5532977497629806,0.9656538969616909,0.9863948179181483,1.0,4/19,18.05%,PTBP3;PTBP2;RPS26;C1QBP
prerank,stem cell development (GO:0048864),0.2380514984497184,0.5522367414772276,0.939521800281294,0.9864941938960863,1.0,6/16,23.00%,SNAI2;SOX8;PTPRC;PEF1;KLHL12;NOLC1
prerank,embryonic eye morphogenesis (GO:0048048),-0.22907411751238027,-0.5516472144989559,0.9665653495440729,0.9927414490803865,1.0,2/11,11.98%,RARG;FBN2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.23462616361914282,0.5514784067560276,0.967479674796748,0.9864396234812509,1.0,2/20,9.22%,PID1;PICALM
prerank,cardiac myofibril assembly (GO:0055003),0.24490185780608636,0.5488172271590742,0.963924963924964,0.9870760906456094,1.0,1/15,4.40%,MYL2
prerank,protein mannosylation (GO:0035268),0.2246459961975653,0.5479860865973605,0.9608108108108108,0.9870304263418912,1.0,3/22,14.54%,DPM2;TMTC4;FKTN
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.19500219893162957,-0.5477605394844451,0.982078853046595,0.9925674732448511,1.0,11/16,44.19%,FBH1;CLU;TRIM32;CDKN2D;TMEM161A;ACKR3;SFRP2;DDIAS;CCAR2;NACC2;RPS3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.2218946661866859,-0.5464378453602687,0.9669669669669669,0.9916354508129118,1.0,4/11,22.53%,UGGT2;DERL1;UFD1;POMT2
prerank,regulation of T cell chemotaxis (GO:0010819),-0.2160233452418144,-0.5462605605973359,0.9634146341463414,0.9903802238575676,1.0,4/11,24.81%,WNK1;CCR2;WNT5A;CCL5
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.22816047074845314,0.5411350448357882,0.9763888888888889,0.9891689829677796,1.0,3/18,15.63%,PPIF;NAIF1;BNIP3
prerank,motor neuron axon guidance (GO:0008045),0.23740417480018552,0.5411046682382677,0.9601139601139601,0.9888431767231399,1.0,1/15,3.91%,NTN3
prerank,visual perception (GO:0007601),0.18435585153093023,0.5372429332035071,0.9967284623773174,0.9897629147059346,1.0,16/84,24.55%,DHRS3;RDH12;COL1A1;PITPNA;COL11A1;MYO9A;DRAM2;OAT;WFS1;RPGR;POU6F2;EML2;KIFC3;RGS16;CEP250;ATXN7
prerank,inner mitochondrial membrane organization (GO:0007007),0.19291137309970607,0.5366385350354971,0.992831541218638,0.989622383461837,1.0,11/47,23.64%,TIMM22;LETM1;ATP5F1A;ATP5F1D;ATP5F1C;AFG3L2;IMMT;MICOS13;HSPA9;NDUFA13;MTX2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2598467404143695,0.5351132178984954,0.956060606060606,0.9897691354414693,1.0,1/10,6.54%,APC
prerank,cGMP metabolic process (GO:0046068),-0.2110012997255935,-0.5341349924981297,0.9748427672955975,0.9923959073683921,1.0,7/12,40.67%,GUCY1A1;GUCY1B1;PDE2A;NPR1;GUCY2F;GUCY2D;GUCY2C
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.2543123258982846,0.5340708472821936,0.951734539969834,0.9897689367583149,1.0,3/10,23.41%,NCBP2;CDC73;CPEB1
prerank,glutamine family amino acid metabolic process (GO:0009064),0.20091272791296313,0.5319646880217934,0.9847522236340533,0.9900786921128037,1.0,4/33,17.96%,MTHFS;PRODH;ALDH18A1;OAT
prerank,negative regulation of transposition (GO:0010529),0.2332636274301062,0.5305788254337882,0.9745403111739745,0.9901611546702652,1.0,2/16,12.83%,SMYD5;SIRT7
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.21614634314715922,0.5304699242037493,0.97911227154047,0.9898611606494141,1.0,4/23,18.05%,MPP1;MOSPD2;BST1;C1QBP
prerank,amino sugar metabolic process (GO:0006040),0.24694527264709357,0.5272699994082443,0.9552469135802469,0.9904756940190945,1.0,5/10,31.25%,GFPT1;EXTL2;SLC35A3;GFPT2;ST3GAL1
prerank,endothelial cell development (GO:0001885),-0.1646797670241582,-0.5260405935580882,1.0,0.9930835540777103,1.0,13/25,38.51%,RAP1B;RAPGEF3;RAPGEF2;MARVELD2;PDE2A;PPP1R16B;COL22A1;MYADM;COL18A1;PECAM1;RAP1A;STC1;COL15A1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.2361733868865328,0.5252031433479496,0.9709923664122138,0.9907382413706013,1.0,2/12,17.33%,BOD1;CDT1
prerank,regulation of response to interferon-gamma (GO:0060330),0.2381102939667614,0.5250582894477501,0.9647577092511013,0.9904428708928906,1.0,1/14,4.49%,IFNGR2
prerank,skeletal muscle contraction (GO:0003009),0.22085747662406746,0.5209655005757643,0.9732016925246827,0.9912371148336854,1.0,2/19,16.08%,STAC2;STAC3
prerank,estrogen metabolic process (GO:0008210),-0.18536126108622125,-0.5173287656158962,0.9837662337662337,0.9937329646817152,1.0,9/15,43.92%,HSD17B7;SULT1A1;HSD17B10;HSD17B1;CYP1A1;CYP1B1;HSD17B14;UGT1A7;UGT1A1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.23440571946108796,0.5144627542208027,0.9804804804804805,0.9925784714417173,1.0,4/14,22.83%,RPL7L1;WDR12;RPL7;BOP1
prerank,nucleosome assembly (GO:0006334),0.20281953522912805,0.513903521039906,0.9911504424778761,0.9923757582696274,1.0,3/31,8.38%,ANP32B;BRD2;NASP
prerank,protein polyglutamylation (GO:0018095),0.24042697730081558,0.5123015461250757,0.9761904761904762,0.9924152606225628,1.0,3/11,22.16%,CFAP20;CEP41;TTLL4
prerank,mitochondrial fusion (GO:0008053),0.2190916064626628,0.5059892911725007,0.9763888888888889,0.9935475393558149,1.0,5/18,22.77%,GDAP1;BAX;USP30;AFG3L2;MFN2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.2284237951239849,0.5043493781128169,0.977810650887574,0.9935793427122653,1.0,3/13,21.48%,DDIT3;SIN3A;TAF1
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.21608639547947606,0.49934163384521385,0.9740082079343365,0.9943206917447347,1.0,1/18,5.08%,IGF1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.21267770892949958,0.49434772658775566,0.9722222222222222,0.9949832668770754,1.0,8/16,30.09%,HELB;SHLD1;RADX;SHLD2;UBQLN4;KLHL15;FANCB;RIF1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.22133436544134294,0.4905680578395958,0.9728183118741058,0.9953708320176387,1.0,4/14,20.98%,RMND1;C1QBP;TRMT10C;COA3
prerank,positive regulation of dephosphorylation (GO:0035306),0.1965578968885402,0.4904101040657966,0.9910600255427842,0.9950620911792054,1.0,2/27,8.69%,PRKCD;DLC1
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.21801228259468292,0.48333056702623367,0.9824046920821115,0.9960237344164609,1.0,2/13,13.36%,MAVS;GAS6
prerank,odontogenesis (GO:0042476),0.18506317378595646,0.4821880414604427,0.991128010139417,0.9958737437176152,1.0,1/35,1.89%,AQP1
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.22044636332564624,0.4798365867481412,0.9856527977044476,0.9959126444889336,1.0,2/13,11.05%,NEIL1;MBD4
prerank,regulation of lymphocyte differentiation (GO:0045619),-0.16547763039094682,-0.4779923248798497,0.9965277777777778,0.998927743490529,1.0,6/18,28.39%,METTL3;PRELID1;CCR2;IL4I1;ABL1;CD2
prerank,regulation of ERAD pathway (GO:1904292),-0.19520283947961503,-0.4765440571285099,0.9848484848484849,0.9977977864250481,1.0,2/11,12.58%,TMEM259;USP19
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.20284009526896435,0.4764121155624476,0.9836956521739131,0.9961340248501545,1.0,2/18,13.59%,RFC3;POLA1
prerank,synaptonemal complex organization (GO:0070193),0.20130604043702094,0.4567170161753948,0.9929278642149929,0.9981573411965416,1.0,15/15,79.89%,RAD21;P3H4;SYCP2;SYCE3;SYCE1;SYCP1;RAD21L1;TEX12;BAG6;HORMAD1;REC8;TEX11;SYCE2;TRIP13;STAG3
prerank,synaptonemal complex assembly (GO:0007130),0.20130604043702094,0.4567170161753948,0.9929278642149929,0.9981573411965416,1.0,15/15,79.89%,RAD21;P3H4;SYCP2;SYCE3;SYCE1;SYCP1;RAD21L1;TEX12;BAG6;HORMAD1;REC8;TEX11;SYCE2;TRIP13;STAG3
prerank,positive regulation of stem cell proliferation (GO:2000648),0.19201305263184398,0.4467461611523899,0.993006993006993,0.9988294085716298,1.0,1/17,6.84%,HNRNPU
prerank,hematopoietic stem cell differentiation (GO:0060218),0.2129651046582699,0.44470817072672353,0.9828660436137072,0.9986929322898194,1.0,2/10,17.20%,ACE;MLLT3
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.15792257114583572,-0.43889761679556605,0.9968944099378882,0.99962205199203,1.0,9/15,45.81%,EDA;FOXC1;GLI2;BMP2;ROGDI;WNT6;MSX1;TBX1;AMELX
prerank,mesonephros development (GO:0001823),0.20022755756993413,0.4221753885274471,0.9954198473282443,1.0,1.0,2/11,20.91%,PAX8;ZBTB16
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.2055978622613001,0.4186819459467155,0.9967373572593801,0.999982579500004,1.0,3/10,30.32%,DERL2;SVIP;UBE2G2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.18181034570427712,0.4169908051347209,1.0,0.9997389523748437,1.0,1/16,9.94%,SLC39A14
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.14183197828723354,-0.4168870861054349,1.0,0.9992225159384233,1.0,1/20,2.17%,PRKCE
prerank,aspartate family amino acid catabolic process (GO:0009068),0.17802252136478042,0.4163569977515005,0.9959731543624161,0.9994379184262956,1.0,3/19,16.77%,GCDH;OGDH;ALDH7A1
prerank,organic cation transport (GO:0015695),0.17400108445069085,0.4142758501692413,1.0,0.9992335778371663,1.0,3/20,21.63%,SLC25A42;SLC44A2;SLC22A5
prerank,nuclear transport (GO:0051169),0.17906126648460985,0.4088663958378301,0.9956647398843931,0.9991768194847293,1.0,3/16,19.72%,RSRC1;NUP98;XPO1
prerank,steroid hormone biosynthetic process (GO:0120178),0.1478712486670292,0.37583322821952514,0.9987179487179487,1.0,1.0,7/29,28.99%,TSPOAP1;HSD17B11;SRD5A1;SRD5A3;HSD17B2;TSPO;FDXR
prerank,heterochromatin assembly (GO:0031507),0.1487825154932684,0.3560132444066613,0.9973333333333333,1.0,1.0,6/20,27.21%,SIRT1;RRP8;MBD2;POLE3;HDAC1;BAZ2A
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.16474246287730404,0.35411259714413795,1.0,0.9997098782830989,1.0,1/12,11.25%,TSPOAP1
